Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'Hyde (prurigo nodulaire de)'
(id=16868252 ; fe=Hyde (prurigo nodulaire de) ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=10793 creation date=2021-07-25 touchdate=2025-12-18 16:24:48.000)
≈ 7696 relations sortantes

  1. Hyde (prurigo nodulaire de) -- r_associated #0: 77 / 1 -> chimie
    n1=Hyde (prurigo nodulaire de) | n2=chimie | rel=r_associated | relid=0 | w=77
  2. Hyde (prurigo nodulaire de) -- r_associated #0: 59 / 0.766 -> Hyde
    n1=Hyde (prurigo nodulaire de) | n2=Hyde | rel=r_associated | relid=0 | w=59
  3. Hyde (prurigo nodulaire de) -- r_associated #0: 55 / 0.714 -> prurigo
    n1=Hyde (prurigo nodulaire de) | n2=prurigo | rel=r_associated | relid=0 | w=55
  4. Hyde (prurigo nodulaire de) -- r_associated #0: 54 / 0.701 -> processus pathologique
    n1=Hyde (prurigo nodulaire de) | n2=processus pathologique | rel=r_associated | relid=0 | w=54
  5. Hyde (prurigo nodulaire de) -- r_associated #0: 52 / 0.675 -> nodulaire
    n1=Hyde (prurigo nodulaire de) | n2=nodulaire | rel=r_associated | relid=0 | w=52
  6. Hyde (prurigo nodulaire de) -- r_associated #0: 51 / 0.662 -> médecine
    n1=Hyde (prurigo nodulaire de) | n2=médecine | rel=r_associated | relid=0 | w=51
  7. Hyde (prurigo nodulaire de) -- r_associated #0: 50 / 0.649 -> hydrargyrisme
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyrisme | rel=r_associated | relid=0 | w=50
  8. Hyde (prurigo nodulaire de) -- r_associated #0: 50 / 0.649 -> hydroa
    n1=Hyde (prurigo nodulaire de) | n2=hydroa | rel=r_associated | relid=0 | w=50
  9. Hyde (prurigo nodulaire de) -- r_associated #0: 45 / 0.584 -> Chimie
    n1=Hyde (prurigo nodulaire de) | n2=Chimie | rel=r_associated | relid=0 | w=45
  10. Hyde (prurigo nodulaire de) -- r_associated #0: 45 / 0.584 -> en:hydrargyria
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrargyria | rel=r_associated | relid=0 | w=45
  11. Hyde (prurigo nodulaire de) -- r_associated #0: 45 / 0.584 -> hydramnios
    n1=Hyde (prurigo nodulaire de) | n2=hydramnios | rel=r_associated | relid=0 | w=45
  12. Hyde (prurigo nodulaire de) -- r_associated #0: 45 / 0.584 -> hydrargyrie
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyrie | rel=r_associated | relid=0 | w=45
  13. Hyde (prurigo nodulaire de) -- r_associated #0: 41 / 0.532 -> intoxication mercurielle
    n1=Hyde (prurigo nodulaire de) | n2=intoxication mercurielle | rel=r_associated | relid=0 | w=41
  14. Hyde (prurigo nodulaire de) -- r_associated #0: 41 / 0.532 -> pathologie
    n1=Hyde (prurigo nodulaire de) | n2=pathologie | rel=r_associated | relid=0 | w=41
  15. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> carbone
    n1=Hyde (prurigo nodulaire de) | n2=carbone | rel=r_associated | relid=0 | w=40
  16. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:exposure as collected domain
    n1=Hyde (prurigo nodulaire de) | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=40
  17. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:historical aspects qualifier
    n1=Hyde (prurigo nodulaire de) | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=40
  18. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:hydrargyrism
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrargyrism | rel=r_associated | relid=0 | w=40
  19. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:hydrocarbon
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocarbon | rel=r_associated | relid=0 | w=40
  20. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:in blood
    n1=Hyde (prurigo nodulaire de) | n2=en:in blood | rel=r_associated | relid=0 | w=40
  21. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:in cerebrospinal fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=40
  22. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:in urine
    n1=Hyde (prurigo nodulaire de) | n2=en:in urine | rel=r_associated | relid=0 | w=40
  23. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> en:taxonomic
    n1=Hyde (prurigo nodulaire de) | n2=en:taxonomic | rel=r_associated | relid=0 | w=40
  24. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> hydramnios aigu
    n1=Hyde (prurigo nodulaire de) | n2=hydramnios aigu | rel=r_associated | relid=0 | w=40
  25. Hyde (prurigo nodulaire de) -- r_associated #0: 40 / 0.519 -> maladies
    n1=Hyde (prurigo nodulaire de) | n2=maladies | rel=r_associated | relid=0 | w=40
  26. Hyde (prurigo nodulaire de) -- r_associated #0: 39 / 0.506 -> en:carbohydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate | rel=r_associated | relid=0 | w=39
  27. Hyde (prurigo nodulaire de) -- r_associated #0: 39 / 0.506 -> hydroa aestivalis
    n1=Hyde (prurigo nodulaire de) | n2=hydroa aestivalis | rel=r_associated | relid=0 | w=39
  28. Hyde (prurigo nodulaire de) -- r_associated #0: 39 / 0.506 -> hydrocarboné
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarboné | rel=r_associated | relid=0 | w=39
  29. Hyde (prurigo nodulaire de) -- r_associated #0: 38 / 0.494 -> hydrargirose
    n1=Hyde (prurigo nodulaire de) | n2=hydrargirose | rel=r_associated | relid=0 | w=38
  30. Hyde (prurigo nodulaire de) -- r_associated #0: 37 / 0.481 -> hydramnios chronique
    n1=Hyde (prurigo nodulaire de) | n2=hydramnios chronique | rel=r_associated | relid=0 | w=37
  31. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> chimie organique
    n1=Hyde (prurigo nodulaire de) | n2=chimie organique | rel=r_associated | relid=0 | w=35
  32. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> composé organique
    n1=Hyde (prurigo nodulaire de) | n2=composé organique | rel=r_associated | relid=0 | w=35
  33. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> effet toxique du mercure et ses composés
    n1=Hyde (prurigo nodulaire de) | n2=effet toxique du mercure et ses composés | rel=r_associated | relid=0 | w=35
  34. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:1 carbon compound
    n1=Hyde (prurigo nodulaire de) | n2=en:1 carbon compound | rel=r_associated | relid=0 | w=35
  35. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:2-ethyl-3-hydroxypropionate
    n1=Hyde (prurigo nodulaire de) | n2=en:2-ethyl-3-hydroxypropionate | rel=r_associated | relid=0 | w=35
  36. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:2-hydroxybutyrate
    n1=Hyde (prurigo nodulaire de) | n2=en:2-hydroxybutyrate | rel=r_associated | relid=0 | w=35
  37. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:agonists
    n1=Hyde (prurigo nodulaire de) | n2=en:agonists | rel=r_associated | relid=0 | w=35
  38. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:alcohol [chemical class]
    n1=Hyde (prurigo nodulaire de) | n2=en:alcohol [chemical class] | rel=r_associated | relid=0 | w=35
  39. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:alcohols, phenols, and ethers
    n1=Hyde (prurigo nodulaire de) | n2=en:alcohols, phenols, and ethers | rel=r_associated | relid=0 | w=35
  40. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aldehyde
    n1=Hyde (prurigo nodulaire de) | n2=en:aldehyde | rel=r_associated | relid=0 | w=35
  41. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aldehydes and ketones
    n1=Hyde (prurigo nodulaire de) | n2=en:aldehydes and ketones | rel=r_associated | relid=0 | w=35
  42. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:alicyclic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:alicyclic compound | rel=r_associated | relid=0 | w=35
  43. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:alkaloid
    n1=Hyde (prurigo nodulaire de) | n2=en:alkaloid | rel=r_associated | relid=0 | w=35
  44. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:alpha-hydroxyglutarate
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-hydroxyglutarate | rel=r_associated | relid=0 | w=35
  45. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:amides
    n1=Hyde (prurigo nodulaire de) | n2=en:amides | rel=r_associated | relid=0 | w=35
  46. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:amidines
    n1=Hyde (prurigo nodulaire de) | n2=en:amidines | rel=r_associated | relid=0 | w=35
  47. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:amine
    n1=Hyde (prurigo nodulaire de) | n2=en:amine | rel=r_associated | relid=0 | w=35
  48. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:amino acid
    n1=Hyde (prurigo nodulaire de) | n2=en:amino acid | rel=r_associated | relid=0 | w=35
  49. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:amino acid, peptide, or protein
    n1=Hyde (prurigo nodulaire de) | n2=en:amino acid, peptide, or protein | rel=r_associated | relid=0 | w=35
  50. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:analysis aspect
    n1=Hyde (prurigo nodulaire de) | n2=en:analysis aspect | rel=r_associated | relid=0 | w=35
  51. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:anhydrides
    n1=Hyde (prurigo nodulaire de) | n2=en:anhydrides | rel=r_associated | relid=0 | w=35
  52. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:animal alkaloids
    n1=Hyde (prurigo nodulaire de) | n2=en:animal alkaloids | rel=r_associated | relid=0 | w=35
  53. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aspects of adverse effects
    n1=Hyde (prurigo nodulaire de) | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=35
  54. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aspects of radiation effects
    n1=Hyde (prurigo nodulaire de) | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=35
  55. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aza compound
    n1=Hyde (prurigo nodulaire de) | n2=en:aza compound | rel=r_associated | relid=0 | w=35
  56. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:aza compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:aza compounds | rel=r_associated | relid=0 | w=35
  57. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:azides
    n1=Hyde (prurigo nodulaire de) | n2=en:azides | rel=r_associated | relid=0 | w=35
  58. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:azo compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:azo compounds | rel=r_associated | relid=0 | w=35
  59. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:biphosphonate
    n1=Hyde (prurigo nodulaire de) | n2=en:biphosphonate | rel=r_associated | relid=0 | w=35
  60. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:boron compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:boron compounds | rel=r_associated | relid=0 | w=35
  61. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carbamylhydrazine
    n1=Hyde (prurigo nodulaire de) | n2=en:carbamylhydrazine | rel=r_associated | relid=0 | w=35
  62. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carbohydrate derivative
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate derivative | rel=r_associated | relid=0 | w=35
  63. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carbon disulfide
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon disulfide | rel=r_associated | relid=0 | w=35
  64. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carbonyl compound
    n1=Hyde (prurigo nodulaire de) | n2=en:carbonyl compound | rel=r_associated | relid=0 | w=35
  65. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carboxylic acids
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxylic acids | rel=r_associated | relid=0 | w=35
  66. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:carboxylic acids and derivatives
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxylic acids and derivatives | rel=r_associated | relid=0 | w=35
  67. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:catenanes
    n1=Hyde (prurigo nodulaire de) | n2=en:catenanes | rel=r_associated | relid=0 | w=35
  68. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:chemical aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:chemical aspects | rel=r_associated | relid=0 | w=35
  69. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:chemical synthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=35
  70. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:contraindications aspect
    n1=Hyde (prurigo nodulaire de) | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=35
  71. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:cyanates
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanates | rel=r_associated | relid=0 | w=35
  72. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:cyclic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclic compound | rel=r_associated | relid=0 | w=35
  73. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:dioxamate
    n1=Hyde (prurigo nodulaire de) | n2=en:dioxamate | rel=r_associated | relid=0 | w=35
  74. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:ethers
    n1=Hyde (prurigo nodulaire de) | n2=en:ethers | rel=r_associated | relid=0 | w=35
  75. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:free radical
    n1=Hyde (prurigo nodulaire de) | n2=en:free radical | rel=r_associated | relid=0 | w=35
  76. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:glycols and derivatives
    n1=Hyde (prurigo nodulaire de) | n2=en:glycols and derivatives | rel=r_associated | relid=0 | w=35
  77. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:glycoside
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoside | rel=r_associated | relid=0 | w=35
  78. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:glycoside compound
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoside compound | rel=r_associated | relid=0 | w=35
  79. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:halocarbon compound
    n1=Hyde (prurigo nodulaire de) | n2=en:halocarbon compound | rel=r_associated | relid=0 | w=35
  80. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:heterocyclic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:heterocyclic compound | rel=r_associated | relid=0 | w=35
  81. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:hydrazines
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrazines | rel=r_associated | relid=0 | w=35
  82. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:imides
    n1=Hyde (prurigo nodulaire de) | n2=en:imides | rel=r_associated | relid=0 | w=35
  83. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:imines
    n1=Hyde (prurigo nodulaire de) | n2=en:imines | rel=r_associated | relid=0 | w=35
  84. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:imino acids
    n1=Hyde (prurigo nodulaire de) | n2=en:imino acids | rel=r_associated | relid=0 | w=35
  85. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:immunology aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:immunology aspects | rel=r_associated | relid=0 | w=35
  86. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:isocyanates
    n1=Hyde (prurigo nodulaire de) | n2=en:isocyanates | rel=r_associated | relid=0 | w=35
  87. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:isopentane
    n1=Hyde (prurigo nodulaire de) | n2=en:isopentane | rel=r_associated | relid=0 | w=35
  88. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:isoprenoid
    n1=Hyde (prurigo nodulaire de) | n2=en:isoprenoid | rel=r_associated | relid=0 | w=35
  89. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:ketone
    n1=Hyde (prurigo nodulaire de) | n2=en:ketone | rel=r_associated | relid=0 | w=35
  90. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:lactone compound
    n1=Hyde (prurigo nodulaire de) | n2=en:lactone compound | rel=r_associated | relid=0 | w=35
  91. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:lewis acids
    n1=Hyde (prurigo nodulaire de) | n2=en:lewis acids | rel=r_associated | relid=0 | w=35
  92. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:lewis bases
    n1=Hyde (prurigo nodulaire de) | n2=en:lewis bases | rel=r_associated | relid=0 | w=35
  93. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:lipid
    n1=Hyde (prurigo nodulaire de) | n2=en:lipid | rel=r_associated | relid=0 | w=35
  94. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:lipid or lipoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:lipid or lipoprotein | rel=r_associated | relid=0 | w=35
  95. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:mechanism of action qualifier
    n1=Hyde (prurigo nodulaire de) | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=35
  96. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:mesylates
    n1=Hyde (prurigo nodulaire de) | n2=en:mesylates | rel=r_associated | relid=0 | w=35
  97. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitrate
    n1=Hyde (prurigo nodulaire de) | n2=en:nitrate | rel=r_associated | relid=0 | w=35
  98. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitriles
    n1=Hyde (prurigo nodulaire de) | n2=en:nitriles | rel=r_associated | relid=0 | w=35
  99. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitrites
    n1=Hyde (prurigo nodulaire de) | n2=en:nitrites | rel=r_associated | relid=0 | w=35
  100. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitro compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:nitro compounds | rel=r_associated | relid=0 | w=35
  101. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitroarene compound
    n1=Hyde (prurigo nodulaire de) | n2=en:nitroarene compound | rel=r_associated | relid=0 | w=35
  102. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitrogen compound
    n1=Hyde (prurigo nodulaire de) | n2=en:nitrogen compound | rel=r_associated | relid=0 | w=35
  103. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nitroso compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:nitroso compounds | rel=r_associated | relid=0 | w=35
  104. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nucleic acids
    n1=Hyde (prurigo nodulaire de) | n2=en:nucleic acids | rel=r_associated | relid=0 | w=35
  105. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nucleic acids, nucleosides, and nucleotides
    n1=Hyde (prurigo nodulaire de) | n2=en:nucleic acids, nucleosides, and nucleotides | rel=r_associated | relid=0 | w=35
  106. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nucleoside
    n1=Hyde (prurigo nodulaire de) | n2=en:nucleoside | rel=r_associated | relid=0 | w=35
  107. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:nucleotide
    n1=Hyde (prurigo nodulaire de) | n2=en:nucleotide | rel=r_associated | relid=0 | w=35
  108. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:onium compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:onium compounds | rel=r_associated | relid=0 | w=35
  109. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic acid (substance)
    n1=Hyde (prurigo nodulaire de) | n2=en:organic acid (substance) | rel=r_associated | relid=0 | w=35
  110. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic acid or derivative
    n1=Hyde (prurigo nodulaire de) | n2=en:organic acid or derivative | rel=r_associated | relid=0 | w=35
  111. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic base
    n1=Hyde (prurigo nodulaire de) | n2=en:organic base | rel=r_associated | relid=0 | w=35
  112. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic boron compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organic boron compound | rel=r_associated | relid=0 | w=35
  113. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic chemical
    n1=Hyde (prurigo nodulaire de) | n2=en:organic chemical | rel=r_associated | relid=0 | w=35
  114. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic chloride compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organic chloride compound | rel=r_associated | relid=0 | w=35
  115. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic ester
    n1=Hyde (prurigo nodulaire de) | n2=en:organic ester | rel=r_associated | relid=0 | w=35
  116. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic halogen compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:organic halogen compounds | rel=r_associated | relid=0 | w=35
  117. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic nitrogen compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organic nitrogen compound | rel=r_associated | relid=0 | w=35
  118. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:organic oxide | rel=r_associated | relid=0 | w=35
  119. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic oxoacids
    n1=Hyde (prurigo nodulaire de) | n2=en:organic oxoacids | rel=r_associated | relid=0 | w=35
  120. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic phosphate
    n1=Hyde (prurigo nodulaire de) | n2=en:organic phosphate | rel=r_associated | relid=0 | w=35
  121. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic phosphorus and sulfur compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:organic phosphorus and sulfur compounds | rel=r_associated | relid=0 | w=35
  122. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic silicon compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organic silicon compound | rel=r_associated | relid=0 | w=35
  123. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic solvents
    n1=Hyde (prurigo nodulaire de) | n2=en:organic solvents | rel=r_associated | relid=0 | w=35
  124. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organic sulfur compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organic sulfur compound | rel=r_associated | relid=0 | w=35
  125. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organo-metallic, phosphorus, boron derivatives
    n1=Hyde (prurigo nodulaire de) | n2=en:organo-metallic, phosphorus, boron derivatives | rel=r_associated | relid=0 | w=35
  126. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organochlorine compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organochlorine compound | rel=r_associated | relid=0 | w=35
  127. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organometallic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organometallic compound | rel=r_associated | relid=0 | w=35
  128. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organophosphorus compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:organophosphorus compounds | rel=r_associated | relid=0 | w=35
  129. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organoselenium compound
    n1=Hyde (prurigo nodulaire de) | n2=en:organoselenium compound | rel=r_associated | relid=0 | w=35
  130. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:organosilicon compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:organosilicon compounds | rel=r_associated | relid=0 | w=35
  131. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:oxalate
    n1=Hyde (prurigo nodulaire de) | n2=en:oxalate | rel=r_associated | relid=0 | w=35
  132. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:paraphenylene
    n1=Hyde (prurigo nodulaire de) | n2=en:paraphenylene | rel=r_associated | relid=0 | w=35
  133. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:pharmacokinetic aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=35
  134. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:phenol compound
    n1=Hyde (prurigo nodulaire de) | n2=en:phenol compound | rel=r_associated | relid=0 | w=35
  135. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:poisoning aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=35
  136. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:polycyclic compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:polycyclic compounds | rel=r_associated | relid=0 | w=35
  137. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:polymethane
    n1=Hyde (prurigo nodulaire de) | n2=en:polymethane | rel=r_associated | relid=0 | w=35
  138. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:polyphenol
    n1=Hyde (prurigo nodulaire de) | n2=en:polyphenol | rel=r_associated | relid=0 | w=35
  139. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:protein
    n1=Hyde (prurigo nodulaire de) | n2=en:protein | rel=r_associated | relid=0 | w=35
  140. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:quinone compound
    n1=Hyde (prurigo nodulaire de) | n2=en:quinone compound | rel=r_associated | relid=0 | w=35
  141. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:ring compound
    n1=Hyde (prurigo nodulaire de) | n2=en:ring compound | rel=r_associated | relid=0 | w=35
  142. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:rotaxanes
    n1=Hyde (prurigo nodulaire de) | n2=en:rotaxanes | rel=r_associated | relid=0 | w=35
  143. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:semicarbazides
    n1=Hyde (prurigo nodulaire de) | n2=en:semicarbazides | rel=r_associated | relid=0 | w=35
  144. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:simple organic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:simple organic compound | rel=r_associated | relid=0 | w=35
  145. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:standards characteristics
    n1=Hyde (prurigo nodulaire de) | n2=en:standards characteristics | rel=r_associated | relid=0 | w=35
  146. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:steroid compound
    n1=Hyde (prurigo nodulaire de) | n2=en:steroid compound | rel=r_associated | relid=0 | w=35
  147. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:sulfur compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:sulfur compounds | rel=r_associated | relid=0 | w=35
  148. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:synthetic monomer
    n1=Hyde (prurigo nodulaire de) | n2=en:synthetic monomer | rel=r_associated | relid=0 | w=35
  149. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:synthetic polymer
    n1=Hyde (prurigo nodulaire de) | n2=en:synthetic polymer | rel=r_associated | relid=0 | w=35
  150. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:therapeutic use - qualifier
    n1=Hyde (prurigo nodulaire de) | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=35
  151. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:toxicity aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=35
  152. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:triazene compound
    n1=Hyde (prurigo nodulaire de) | n2=en:triazene compound | rel=r_associated | relid=0 | w=35
  153. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:urea
    n1=Hyde (prurigo nodulaire de) | n2=en:urea | rel=r_associated | relid=0 | w=35
  154. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:vivonex
    n1=Hyde (prurigo nodulaire de) | n2=en:vivonex | rel=r_associated | relid=0 | w=35
  155. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> en:volatile organic compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:volatile organic compounds | rel=r_associated | relid=0 | w=35
  156. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> énergie
    n1=Hyde (prurigo nodulaire de) | n2=énergie | rel=r_associated | relid=0 | w=35
  157. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> intoxication au mercure
    n1=Hyde (prurigo nodulaire de) | n2=intoxication au mercure | rel=r_associated | relid=0 | w=35
  158. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> intoxication par le mercure
    n1=Hyde (prurigo nodulaire de) | n2=intoxication par le mercure | rel=r_associated | relid=0 | w=35
  159. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> mercure
    n1=Hyde (prurigo nodulaire de) | n2=mercure | rel=r_associated | relid=0 | w=35
  160. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> mercure et ses composés
    n1=Hyde (prurigo nodulaire de) | n2=mercure et ses composés | rel=r_associated | relid=0 | w=35
  161. Hyde (prurigo nodulaire de) -- r_associated #0: 35 / 0.455 -> mercurialisme
    n1=Hyde (prurigo nodulaire de) | n2=mercurialisme | rel=r_associated | relid=0 | w=35
  162. Hyde (prurigo nodulaire de) -- r_associated #0: 32 / 0.416 -> hydroa vacciniforme de Bazin
    n1=Hyde (prurigo nodulaire de) | n2=hydroa vacciniforme de Bazin | rel=r_associated | relid=0 | w=32
  163. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> Arabie Saoudite
    n1=Hyde (prurigo nodulaire de) | n2=Arabie Saoudite | rel=r_associated | relid=0 | w=30
  164. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> biochimie
    n1=Hyde (prurigo nodulaire de) | n2=biochimie | rel=r_associated | relid=0 | w=30
  165. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> butane
    n1=Hyde (prurigo nodulaire de) | n2=butane | rel=r_associated | relid=0 | w=30
  166. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> combustibilité
    n1=Hyde (prurigo nodulaire de) | n2=combustibilité | rel=r_associated | relid=0 | w=30
  167. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:21-methyl-7-hentriacontanone
    n1=Hyde (prurigo nodulaire de) | n2=en:21-methyl-7-hentriacontanone | rel=r_associated | relid=0 | w=30
  168. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:5-acetoxy-19-methylnonacosane
    n1=Hyde (prurigo nodulaire de) | n2=en:5-acetoxy-19-methylnonacosane | rel=r_associated | relid=0 | w=30
  169. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:alkenes
    n1=Hyde (prurigo nodulaire de) | n2=en:alkenes | rel=r_associated | relid=0 | w=30
  170. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:asphalt
    n1=Hyde (prurigo nodulaire de) | n2=en:asphalt | rel=r_associated | relid=0 | w=30
  171. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:emulkop
    n1=Hyde (prurigo nodulaire de) | n2=en:emulkop | rel=r_associated | relid=0 | w=30
  172. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:genetic aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic aspects | rel=r_associated | relid=0 | w=30
  173. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:maleic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:maleic acid | rel=r_associated | relid=0 | w=30
  174. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:mercury poisoning
    n1=Hyde (prurigo nodulaire de) | n2=en:mercury poisoning | rel=r_associated | relid=0 | w=30
  175. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> en:metabolic aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=30
  176. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> Erika
    n1=Hyde (prurigo nodulaire de) | n2=Erika | rel=r_associated | relid=0 | w=30
  177. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> fuel
    n1=Hyde (prurigo nodulaire de) | n2=fuel | rel=r_associated | relid=0 | w=30
  178. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> huile
    n1=Hyde (prurigo nodulaire de) | n2=huile | rel=r_associated | relid=0 | w=30
  179. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> hydrargyrismes
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyrismes | rel=r_associated | relid=0 | w=30
  180. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> hydrargyrose
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyrose | rel=r_associated | relid=0 | w=30
  181. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> hydrocéphalie
    n1=Hyde (prurigo nodulaire de) | n2=hydrocéphalie | rel=r_associated | relid=0 | w=30
  182. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> incendie
    n1=Hyde (prurigo nodulaire de) | n2=incendie | rel=r_associated | relid=0 | w=30
  183. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> intoxication
    n1=Hyde (prurigo nodulaire de) | n2=intoxication | rel=r_associated | relid=0 | w=30
  184. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> maladie
    n1=Hyde (prurigo nodulaire de) | n2=maladie | rel=r_associated | relid=0 | w=30
  185. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> maladie de Minamata
    n1=Hyde (prurigo nodulaire de) | n2=maladie de Minamata | rel=r_associated | relid=0 | w=30
  186. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> maladie
    (médecine)
    n1=Hyde (prurigo nodulaire de) | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=30
  187. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> Médecine
    n1=Hyde (prurigo nodulaire de) | n2=Médecine | rel=r_associated | relid=0 | w=30
  188. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> médecine
    (science)
    n1=Hyde (prurigo nodulaire de) | n2=médecine
    (science)
    | rel=r_associated | relid=0 | w=30
  189. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> pétrole brut
    n1=Hyde (prurigo nodulaire de) | n2=pétrole brut | rel=r_associated | relid=0 | w=30
  190. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> pétrolier
    n1=Hyde (prurigo nodulaire de) | n2=pétrolier | rel=r_associated | relid=0 | w=30
  191. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> protéine
    n1=Hyde (prurigo nodulaire de) | n2=protéine | rel=r_associated | relid=0 | w=30
  192. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> prurigo nodulaire de Hyde
    n1=Hyde (prurigo nodulaire de) | n2=prurigo nodulaire de Hyde | rel=r_associated | relid=0 | w=30
  193. Hyde (prurigo nodulaire de) -- r_associated #0: 30 / 0.39 -> raffinage
    n1=Hyde (prurigo nodulaire de) | n2=raffinage | rel=r_associated | relid=0 | w=30
  194. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> bitume
    n1=Hyde (prurigo nodulaire de) | n2=bitume | rel=r_associated | relid=0 | w=29
  195. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> chymie
    n1=Hyde (prurigo nodulaire de) | n2=chymie | rel=r_associated | relid=0 | w=29
  196. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:alkanes
    n1=Hyde (prurigo nodulaire de) | n2=en:alkanes | rel=r_associated | relid=0 | w=29
  197. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:aromex
    n1=Hyde (prurigo nodulaire de) | n2=en:aromex | rel=r_associated | relid=0 | w=29
  198. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:carpenter's kumylotox
    n1=Hyde (prurigo nodulaire de) | n2=en:carpenter's kumylotox | rel=r_associated | relid=0 | w=29
  199. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:glucid
    n1=Hyde (prurigo nodulaire de) | n2=en:glucid | rel=r_associated | relid=0 | w=29
  200. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:m-2000 compound
    n1=Hyde (prurigo nodulaire de) | n2=en:m-2000 compound | rel=r_associated | relid=0 | w=29
  201. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:mercurialism
    n1=Hyde (prurigo nodulaire de) | n2=en:mercurialism | rel=r_associated | relid=0 | w=29
  202. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:resorcin(4)arene receptor
    n1=Hyde (prurigo nodulaire de) | n2=en:resorcin(4)arene receptor | rel=r_associated | relid=0 | w=29
  203. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> en:s-8 fuel
    n1=Hyde (prurigo nodulaire de) | n2=en:s-8 fuel | rel=r_associated | relid=0 | w=29
  204. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> hydrargie
    n1=Hyde (prurigo nodulaire de) | n2=hydrargie | rel=r_associated | relid=0 | w=29
  205. Hyde (prurigo nodulaire de) -- r_associated #0: 29 / 0.377 -> sans plomb 98
    n1=Hyde (prurigo nodulaire de) | n2=sans plomb 98 | rel=r_associated | relid=0 | w=29
  206. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> carburant
    (Nom)
    n1=Hyde (prurigo nodulaire de) | n2=carburant
    (Nom)
    | rel=r_associated | relid=0 | w=28
  207. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> cuisine
    (art culinaire)
    n1=Hyde (prurigo nodulaire de) | n2=cuisine
    (art culinaire)
    | rel=r_associated | relid=0 | w=28
  208. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> en:gilsonite
    n1=Hyde (prurigo nodulaire de) | n2=en:gilsonite | rel=r_associated | relid=0 | w=28
  209. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> en:jp8 aviation fuel
    n1=Hyde (prurigo nodulaire de) | n2=en:jp8 aviation fuel | rel=r_associated | relid=0 | w=28
  210. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> en:petrolatum
    n1=Hyde (prurigo nodulaire de) | n2=en:petrolatum | rel=r_associated | relid=0 | w=28
  211. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> essence
    n1=Hyde (prurigo nodulaire de) | n2=essence | rel=r_associated | relid=0 | w=28
  212. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> golfe Persique
    n1=Hyde (prurigo nodulaire de) | n2=golfe Persique | rel=r_associated | relid=0 | w=28
  213. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> hydrocarbone
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbone | rel=r_associated | relid=0 | w=28
  214. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> hydrocarbure insaturé
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure insaturé | rel=r_associated | relid=0 | w=28
  215. Hyde (prurigo nodulaire de) -- r_associated #0: 28 / 0.364 -> supertanker
    n1=Hyde (prurigo nodulaire de) | n2=supertanker | rel=r_associated | relid=0 | w=28
  216. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> 205-207 hydrocarbures
    n1=Hyde (prurigo nodulaire de) | n2=205-207 hydrocarbures | rel=r_associated | relid=0 | w=27
  217. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> en:histosol
    n1=Hyde (prurigo nodulaire de) | n2=en:histosol | rel=r_associated | relid=0 | w=27
  218. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> en:hydranencephaly
    n1=Hyde (prurigo nodulaire de) | n2=en:hydranencephaly | rel=r_associated | relid=0 | w=27
  219. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> en:jp4 aviation fuel
    n1=Hyde (prurigo nodulaire de) | n2=en:jp4 aviation fuel | rel=r_associated | relid=0 | w=27
  220. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> en:solvent of abuse
    n1=Hyde (prurigo nodulaire de) | n2=en:solvent of abuse | rel=r_associated | relid=0 | w=27
  221. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> en:volatile inhalant
    n1=Hyde (prurigo nodulaire de) | n2=en:volatile inhalant | rel=r_associated | relid=0 | w=27
  222. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> goudron
    n1=Hyde (prurigo nodulaire de) | n2=goudron | rel=r_associated | relid=0 | w=27
  223. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> or noir
    n1=Hyde (prurigo nodulaire de) | n2=or noir | rel=r_associated | relid=0 | w=27
  224. Hyde (prurigo nodulaire de) -- r_associated #0: 27 / 0.351 -> raffinerie
    n1=Hyde (prurigo nodulaire de) | n2=raffinerie | rel=r_associated | relid=0 | w=27
  225. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> brut
    n1=Hyde (prurigo nodulaire de) | n2=brut | rel=r_associated | relid=0 | w=26
  226. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> cuisine
    n1=Hyde (prurigo nodulaire de) | n2=cuisine | rel=r_associated | relid=0 | w=26
  227. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:alkynes
    n1=Hyde (prurigo nodulaire de) | n2=en:alkynes | rel=r_associated | relid=0 | w=26
  228. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:aromatic naphtha, type i
    n1=Hyde (prurigo nodulaire de) | n2=en:aromatic naphtha, type i | rel=r_associated | relid=0 | w=26
  229. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:hydrargyrirism
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrargyrirism | rel=r_associated | relid=0 | w=26
  230. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:hydrocarbons, cyclic
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocarbons, cyclic | rel=r_associated | relid=0 | w=26
  231. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:paraffin
    n1=Hyde (prurigo nodulaire de) | n2=en:paraffin | rel=r_associated | relid=0 | w=26
  232. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> en:technique
    n1=Hyde (prurigo nodulaire de) | n2=en:technique | rel=r_associated | relid=0 | w=26
  233. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> explosion
    n1=Hyde (prurigo nodulaire de) | n2=explosion | rel=r_associated | relid=0 | w=26
  234. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> hydrocarbure aromatique polycyclique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure aromatique polycyclique | rel=r_associated | relid=0 | w=26
  235. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> hydrocarbure polycyclique aromatique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure polycyclique aromatique | rel=r_associated | relid=0 | w=26
  236. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> hydrocarbure ramifié
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure ramifié | rel=r_associated | relid=0 | w=26
  237. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> maladie de minamata
    n1=Hyde (prurigo nodulaire de) | n2=maladie de minamata | rel=r_associated | relid=0 | w=26
  238. Hyde (prurigo nodulaire de) -- r_associated #0: 26 / 0.338 -> marée noire
    n1=Hyde (prurigo nodulaire de) | n2=marée noire | rel=r_associated | relid=0 | w=26
  239. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> butanier
    n1=Hyde (prurigo nodulaire de) | n2=butanier | rel=r_associated | relid=0 | w=25
  240. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> craquer
    (hydrocarbure)
    n1=Hyde (prurigo nodulaire de) | n2=craquer
    (hydrocarbure)
    | rel=r_associated | relid=0 | w=25
  241. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:benzene
    n1=Hyde (prurigo nodulaire de) | n2=en:benzene | rel=r_associated | relid=0 | w=25
  242. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:campomelic dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:campomelic dysplasia | rel=r_associated | relid=0 | w=25
  243. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:d-bifunctional protein deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:d-bifunctional protein deficiency | rel=r_associated | relid=0 | w=25
  244. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:halogenated hydrocarbon
    n1=Hyde (prurigo nodulaire de) | n2=en:halogenated hydrocarbon | rel=r_associated | relid=0 | w=25
  245. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:hydratase
    n1=Hyde (prurigo nodulaire de) | n2=en:hydratase | rel=r_associated | relid=0 | w=25
  246. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:lissencephaly
    n1=Hyde (prurigo nodulaire de) | n2=en:lissencephaly | rel=r_associated | relid=0 | w=25
  247. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:palmitone
    n1=Hyde (prurigo nodulaire de) | n2=en:palmitone | rel=r_associated | relid=0 | w=25
  248. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:pemphigoid gestationis
    n1=Hyde (prurigo nodulaire de) | n2=en:pemphigoid gestationis | rel=r_associated | relid=0 | w=25
  249. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:persistent fetal circulation
    n1=Hyde (prurigo nodulaire de) | n2=en:persistent fetal circulation | rel=r_associated | relid=0 | w=25
  250. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:peters-plus syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:peters-plus syndrome | rel=r_associated | relid=0 | w=25
  251. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:roberts syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:roberts syndrome | rel=r_associated | relid=0 | w=25
  252. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:stoddard solvent
    n1=Hyde (prurigo nodulaire de) | n2=en:stoddard solvent | rel=r_associated | relid=0 | w=25
  253. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> en:uniparental disomy
    n1=Hyde (prurigo nodulaire de) | n2=en:uniparental disomy | rel=r_associated | relid=0 | w=25
  254. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> hydrocarbon
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbon | rel=r_associated | relid=0 | w=25
  255. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> hydrocarbure
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure | rel=r_associated | relid=0 | w=25
  256. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> hydrocarbure aromatique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure aromatique | rel=r_associated | relid=0 | w=25
  257. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> naphte
    n1=Hyde (prurigo nodulaire de) | n2=naphte | rel=r_associated | relid=0 | w=25
  258. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> obstétrique
    n1=Hyde (prurigo nodulaire de) | n2=obstétrique | rel=r_associated | relid=0 | w=25
  259. Hyde (prurigo nodulaire de) -- r_associated #0: 25 / 0.325 -> opep
    n1=Hyde (prurigo nodulaire de) | n2=opep | rel=r_associated | relid=0 | w=25
  260. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> benzène
    n1=Hyde (prurigo nodulaire de) | n2=benzène | rel=r_associated | relid=0 | w=24
  261. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> carburant
    n1=Hyde (prurigo nodulaire de) | n2=carburant | rel=r_associated | relid=0 | w=24
  262. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> en:aromatic hydrocarbon
    n1=Hyde (prurigo nodulaire de) | n2=en:aromatic hydrocarbon | rel=r_associated | relid=0 | w=24
  263. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> en:ligroin
    n1=Hyde (prurigo nodulaire de) | n2=en:ligroin | rel=r_associated | relid=0 | w=24
  264. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> en:methacrol 2138f
    n1=Hyde (prurigo nodulaire de) | n2=en:methacrol 2138f | rel=r_associated | relid=0 | w=24
  265. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> glucide
    n1=Hyde (prurigo nodulaire de) | n2=glucide | rel=r_associated | relid=0 | w=24
  266. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> hydrocarbure aliphatique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure aliphatique | rel=r_associated | relid=0 | w=24
  267. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> produit
    n1=Hyde (prurigo nodulaire de) | n2=produit | rel=r_associated | relid=0 | w=24
  268. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> raffiner
    (hydrocarbure)
    n1=Hyde (prurigo nodulaire de) | n2=raffiner
    (hydrocarbure)
    | rel=r_associated | relid=0 | w=24
  269. Hyde (prurigo nodulaire de) -- r_associated #0: 24 / 0.312 -> Total
    n1=Hyde (prurigo nodulaire de) | n2=Total | rel=r_associated | relid=0 | w=24
  270. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> composé chimique
    n1=Hyde (prurigo nodulaire de) | n2=composé chimique | rel=r_associated | relid=0 | w=23
  271. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:flit-mlo
    n1=Hyde (prurigo nodulaire de) | n2=en:flit-mlo | rel=r_associated | relid=0 | w=23
  272. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:granugenol oil
    n1=Hyde (prurigo nodulaire de) | n2=en:granugenol oil | rel=r_associated | relid=0 | w=23
  273. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:hexadecylamine
    n1=Hyde (prurigo nodulaire de) | n2=en:hexadecylamine | rel=r_associated | relid=0 | w=23
  274. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:jp5 jet fuel
    n1=Hyde (prurigo nodulaire de) | n2=en:jp5 jet fuel | rel=r_associated | relid=0 | w=23
  275. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:product containing solvent
    n1=Hyde (prurigo nodulaire de) | n2=en:product containing solvent | rel=r_associated | relid=0 | w=23
  276. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:rubber solvent
    n1=Hyde (prurigo nodulaire de) | n2=en:rubber solvent | rel=r_associated | relid=0 | w=23
  277. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> en:terpene compound
    n1=Hyde (prurigo nodulaire de) | n2=en:terpene compound | rel=r_associated | relid=0 | w=23
  278. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> gaz
    n1=Hyde (prurigo nodulaire de) | n2=gaz | rel=r_associated | relid=0 | w=23
  279. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> hydrocarbure cyclique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure cyclique | rel=r_associated | relid=0 | w=23
  280. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> mazout
    n1=Hyde (prurigo nodulaire de) | n2=mazout | rel=r_associated | relid=0 | w=23
  281. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> oléoduc
    n1=Hyde (prurigo nodulaire de) | n2=oléoduc | rel=r_associated | relid=0 | w=23
  282. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> Or noir
    n1=Hyde (prurigo nodulaire de) | n2=Or noir | rel=r_associated | relid=0 | w=23
  283. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> plate-forme pétrolière
    n1=Hyde (prurigo nodulaire de) | n2=plate-forme pétrolière | rel=r_associated | relid=0 | w=23
  284. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> pollueur
    n1=Hyde (prurigo nodulaire de) | n2=pollueur | rel=r_associated | relid=0 | w=23
  285. Hyde (prurigo nodulaire de) -- r_associated #0: 23 / 0.299 -> spécialités médicales
    n1=Hyde (prurigo nodulaire de) | n2=spécialités médicales | rel=r_associated | relid=0 | w=23
  286. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> Amoco Cadiz
    n1=Hyde (prurigo nodulaire de) | n2=Amoco Cadiz | rel=r_associated | relid=0 | w=22
  287. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> anatomie
    n1=Hyde (prurigo nodulaire de) | n2=anatomie | rel=r_associated | relid=0 | w=22
  288. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> asphalte
    n1=Hyde (prurigo nodulaire de) | n2=asphalte | rel=r_associated | relid=0 | w=22
  289. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> détachant
    n1=Hyde (prurigo nodulaire de) | n2=détachant | rel=r_associated | relid=0 | w=22
  290. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:aliphatic hydrocarbon
    n1=Hyde (prurigo nodulaire de) | n2=en:aliphatic hydrocarbon | rel=r_associated | relid=0 | w=22
  291. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:hydrocarbons, acyclic
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocarbons, acyclic | rel=r_associated | relid=0 | w=22
  292. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:kogasin
    n1=Hyde (prurigo nodulaire de) | n2=en:kogasin | rel=r_associated | relid=0 | w=22
  293. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:mastic asphalt
    n1=Hyde (prurigo nodulaire de) | n2=en:mastic asphalt | rel=r_associated | relid=0 | w=22
  294. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:melamine bitumens
    n1=Hyde (prurigo nodulaire de) | n2=en:melamine bitumens | rel=r_associated | relid=0 | w=22
  295. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> en:pyrazole
    n1=Hyde (prurigo nodulaire de) | n2=en:pyrazole | rel=r_associated | relid=0 | w=22
  296. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> énergie fossile
    n1=Hyde (prurigo nodulaire de) | n2=énergie fossile | rel=r_associated | relid=0 | w=22
  297. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> énergies fossiles
    n1=Hyde (prurigo nodulaire de) | n2=énergies fossiles | rel=r_associated | relid=0 | w=22
  298. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> essence
    (carburant)
    n1=Hyde (prurigo nodulaire de) | n2=essence
    (carburant)
    | rel=r_associated | relid=0 | w=22
  299. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> gisement
    n1=Hyde (prurigo nodulaire de) | n2=gisement | rel=r_associated | relid=0 | w=22
  300. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> hydrocarbure articulaire
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure articulaire | rel=r_associated | relid=0 | w=22
  301. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> hydrocarbure éthylénique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbure éthylénique | rel=r_associated | relid=0 | w=22
  302. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> hydrocarbures
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarbures | rel=r_associated | relid=0 | w=22
  303. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> hydrogène
    n1=Hyde (prurigo nodulaire de) | n2=hydrogène | rel=r_associated | relid=0 | w=22
  304. Hyde (prurigo nodulaire de) -- r_associated #0: 22 / 0.286 -> kérosène
    n1=Hyde (prurigo nodulaire de) | n2=kérosène | rel=r_associated | relid=0 | w=22
  305. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> brut
    (pétrole)
    n1=Hyde (prurigo nodulaire de) | n2=brut
    (pétrole)
    | rel=r_associated | relid=0 | w=21
  306. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> en:hentriacontane
    n1=Hyde (prurigo nodulaire de) | n2=en:hentriacontane | rel=r_associated | relid=0 | w=21
  307. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> gaz naturel
    n1=Hyde (prurigo nodulaire de) | n2=gaz naturel | rel=r_associated | relid=0 | w=21
  308. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> gazole
    n1=Hyde (prurigo nodulaire de) | n2=gazole | rel=r_associated | relid=0 | w=21
  309. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> gynécologie-obstétrique
    n1=Hyde (prurigo nodulaire de) | n2=gynécologie-obstétrique | rel=r_associated | relid=0 | w=21
  310. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> médecine spécialisée
    n1=Hyde (prurigo nodulaire de) | n2=médecine spécialisée | rel=r_associated | relid=0 | w=21
  311. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> méthane
    n1=Hyde (prurigo nodulaire de) | n2=méthane | rel=r_associated | relid=0 | w=21
  312. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> pétrole
    n1=Hyde (prurigo nodulaire de) | n2=pétrole | rel=r_associated | relid=0 | w=21
  313. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> pétrole
    (Nom)
    n1=Hyde (prurigo nodulaire de) | n2=pétrole
    (Nom)
    | rel=r_associated | relid=0 | w=21
  314. Hyde (prurigo nodulaire de) -- r_associated #0: 21 / 0.273 -> synthétique
    n1=Hyde (prurigo nodulaire de) | n2=synthétique | rel=r_associated | relid=0 | w=21
  315. Hyde (prurigo nodulaire de) -- r_associated #0: 20 / 0.26 -> en:nodular prurigo
    n1=Hyde (prurigo nodulaire de) | n2=en:nodular prurigo | rel=r_associated | relid=0 | w=20
  316. Hyde (prurigo nodulaire de) -- r_associated #0: 20 / 0.26 -> prurigo nodulaire de hyde
    n1=Hyde (prurigo nodulaire de) | n2=prurigo nodulaire de hyde | rel=r_associated | relid=0 | w=20
  317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> raffinerie
    [peut]
    raffiner
    [objet]
    hydrocarbure
    n1=Hyde (prurigo nodulaire de) | n2=raffinerie
    [peut]
    raffiner
    [objet]
    hydrocarbure | rel=r_associated | relid=0 | w=15
  318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> raffinerie
    [peut]
    raffiner
    n1=Hyde (prurigo nodulaire de) | n2=raffinerie
    [peut]
    raffiner | rel=r_associated | relid=0 | w=15
  319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> citerne
    (réservoir)
    [peut]
    stocker
    [objet]
    hydrocarbure
    n1=Hyde (prurigo nodulaire de) | n2=citerne
    (réservoir)
    [peut]
    stocker
    [objet]
    hydrocarbure | rel=r_associated | relid=0 | w=15
  320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> citerne
    (réservoir)
    [peut]
    contenir
    [objet]
    hydrocarbure
    n1=Hyde (prurigo nodulaire de) | n2=citerne
    (réservoir)
    [peut]
    contenir
    [objet]
    hydrocarbure | rel=r_associated | relid=0 | w=15
  321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> citerne
    (réservoir)
    [peut]
    contenir
    n1=Hyde (prurigo nodulaire de) | n2=citerne
    (réservoir)
    [peut]
    contenir | rel=r_associated | relid=0 | w=15
  322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> citerne
    (réservoir)
    [peut]
    stocker
    n1=Hyde (prurigo nodulaire de) | n2=citerne
    (réservoir)
    [peut]
    stocker | rel=r_associated | relid=0 | w=15
  323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> entreprise pétroličre
    [peut]
    raffiner
    [objet]
    hydrocarbure
    n1=Hyde (prurigo nodulaire de) | n2=entreprise pétroličre
    [peut]
    raffiner
    [objet]
    hydrocarbure | rel=r_associated | relid=0 | w=15
  324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> entreprise pétroličre
    [peut]
    raffiner
    n1=Hyde (prurigo nodulaire de) | n2=entreprise pétroličre
    [peut]
    raffiner | rel=r_associated | relid=0 | w=15
  325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> 2-céto-4-penténoate hydratase
    n1=Hyde (prurigo nodulaire de) | n2=2-céto-4-penténoate hydratase | rel=r_associated | relid=0 | w=15
  326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> 2-oxopent-4-énoate hydratase
    n1=Hyde (prurigo nodulaire de) | n2=2-oxopent-4-énoate hydratase | rel=r_associated | relid=0 | w=15
  327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> 3-cyanoalanine hydratase
    n1=Hyde (prurigo nodulaire de) | n2=3-cyanoalanine hydratase | rel=r_associated | relid=0 | w=15
  328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> 619-61c hydrates de carbone
    n1=Hyde (prurigo nodulaire de) | n2=619-61c hydrates de carbone | rel=r_associated | relid=0 | w=15
  329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> absence congénitale d'hémisphères cérébraux
    n1=Hyde (prurigo nodulaire de) | n2=absence congénitale d'hémisphères cérébraux | rel=r_associated | relid=0 | w=15
  330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> absence congénitale des hémisphères cérébraux
    n1=Hyde (prurigo nodulaire de) | n2=absence congénitale des hémisphères cérébraux | rel=r_associated | relid=0 | w=15
  331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> absence d'une partie de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=absence d'une partie de l'encéphale | rel=r_associated | relid=0 | w=15
  332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> aestivalis
    n1=Hyde (prurigo nodulaire de) | n2=aestivalis | rel=r_associated | relid=0 | w=15
  333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> agénésie d'une partie de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=agénésie d'une partie de l'encéphale | rel=r_associated | relid=0 | w=15
  334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> agyrie
    n1=Hyde (prurigo nodulaire de) | n2=agyrie | rel=r_associated | relid=0 | w=15
  335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> aigu
    n1=Hyde (prurigo nodulaire de) | n2=aigu | rel=r_associated | relid=0 | w=15
  336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> amidon
    n1=Hyde (prurigo nodulaire de) | n2=amidon | rel=r_associated | relid=0 | w=15
  337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> amniocentèse
    n1=Hyde (prurigo nodulaire de) | n2=amniocentèse | rel=r_associated | relid=0 | w=15
  338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> amniotique
    n1=Hyde (prurigo nodulaire de) | n2=amniotique | rel=r_associated | relid=0 | w=15
  339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> aplasie d'une partie de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=aplasie d'une partie de l'encéphale | rel=r_associated | relid=0 | w=15
  340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> artère carotide interne
    n1=Hyde (prurigo nodulaire de) | n2=artère carotide interne | rel=r_associated | relid=0 | w=15
  341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> atome
    n1=Hyde (prurigo nodulaire de) | n2=atome | rel=r_associated | relid=0 | w=15
  342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> autres anomalies localisées du développement de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=autres anomalies localisées du développement de l'encéphale | rel=r_associated | relid=0 | w=15
  343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> Bazin
    n1=Hyde (prurigo nodulaire de) | n2=Bazin | rel=r_associated | relid=0 | w=15
  344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> calambres
    n1=Hyde (prurigo nodulaire de) | n2=calambres | rel=r_associated | relid=0 | w=15
  345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> carbohydrate
    n1=Hyde (prurigo nodulaire de) | n2=carbohydrate | rel=r_associated | relid=0 | w=15
  346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> carbone 14
    n1=Hyde (prurigo nodulaire de) | n2=carbone 14 | rel=r_associated | relid=0 | w=15
  347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> caryotype
    n1=Hyde (prurigo nodulaire de) | n2=caryotype | rel=r_associated | relid=0 | w=15
  348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cellule
    n1=Hyde (prurigo nodulaire de) | n2=cellule | rel=r_associated | relid=0 | w=15
  349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cellulose
    n1=Hyde (prurigo nodulaire de) | n2=cellulose | rel=r_associated | relid=0 | w=15
  350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> céramide
    n1=Hyde (prurigo nodulaire de) | n2=céramide | rel=r_associated | relid=0 | w=15
  351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cerveau
    n1=Hyde (prurigo nodulaire de) | n2=cerveau | rel=r_associated | relid=0 | w=15
  352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> chronique
    n1=Hyde (prurigo nodulaire de) | n2=chronique | rel=r_associated | relid=0 | w=15
  353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> combustible
    n1=Hyde (prurigo nodulaire de) | n2=combustible | rel=r_associated | relid=0 | w=15
  354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> complexe
    n1=Hyde (prurigo nodulaire de) | n2=complexe | rel=r_associated | relid=0 | w=15
  355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> complication de la grossesse
    n1=Hyde (prurigo nodulaire de) | n2=complication de la grossesse | rel=r_associated | relid=0 | w=15
  356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> complication
    (médecine)
    n1=Hyde (prurigo nodulaire de) | n2=complication
    (médecine)
    | rel=r_associated | relid=0 | w=15
  357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cortex
    n1=Hyde (prurigo nodulaire de) | n2=cortex | rel=r_associated | relid=0 | w=15
  358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> crâne
    n1=Hyde (prurigo nodulaire de) | n2=crâne | rel=r_associated | relid=0 | w=15
  359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> Cuisine
    n1=Hyde (prurigo nodulaire de) | n2=Cuisine | rel=r_associated | relid=0 | w=15
  360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cutanée
    n1=Hyde (prurigo nodulaire de) | n2=cutanée | rel=r_associated | relid=0 | w=15
  361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> cytomégalovirus
    n1=Hyde (prurigo nodulaire de) | n2=cytomégalovirus | rel=r_associated | relid=0 | w=15
  362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> désoxyribose
    n1=Hyde (prurigo nodulaire de) | n2=désoxyribose | rel=r_associated | relid=0 | w=15
  363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> diététique
    n1=Hyde (prurigo nodulaire de) | n2=diététique | rel=r_associated | relid=0 | w=15
  364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> échographie
    n1=Hyde (prurigo nodulaire de) | n2=échographie | rel=r_associated | relid=0 | w=15
  365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> empoisonnement
    n1=Hyde (prurigo nodulaire de) | n2=empoisonnement | rel=r_associated | relid=0 | w=15
  366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:'second wind' phenomenon
    n1=Hyde (prurigo nodulaire de) | n2=en:'second wind' phenomenon | rel=r_associated | relid=0 | w=15
  367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:'variant 2' has isolated methylmalonicaciduria and decreased adocbl
    n1=Hyde (prurigo nodulaire de) | n2=en:'variant 2' has isolated methylmalonicaciduria and decreased adocbl | rel=r_associated | relid=0 | w=15
  368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:'variant' form of x-linked cgd retains residual cytochrome b(-245)
    n1=Hyde (prurigo nodulaire de) | n2=en:'variant' form of x-linked cgd retains residual cytochrome b(-245) | rel=r_associated | relid=0 | w=15
  369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(1) classic severe (onset of symptoms 4 to 7 days of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:(1) classic severe (onset of symptoms 4 to 7 days of age) | rel=r_associated | relid=0 | w=15
  370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(1) infantile nephropathic (219800)
    n1=Hyde (prurigo nodulaire de) | n2=en:(1) infantile nephropathic (219800) | rel=r_associated | relid=0 | w=15
  371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(2) intermittent
    n1=Hyde (prurigo nodulaire de) | n2=en:(2) intermittent | rel=r_associated | relid=0 | w=15
  372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(2) juvenile or adolescent nephropathic (219900)
    n1=Hyde (prurigo nodulaire de) | n2=en:(2) juvenile or adolescent nephropathic (219900) | rel=r_associated | relid=0 | w=15
  373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(3) adult nonnephropathic (219750)
    n1=Hyde (prurigo nodulaire de) | n2=en:(3) adult nonnephropathic (219750) | rel=r_associated | relid=0 | w=15
  374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(3) intermediate
    n1=Hyde (prurigo nodulaire de) | n2=en:(3) intermediate | rel=r_associated | relid=0 | w=15
  375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(4) thiamine-responsive form
    n1=Hyde (prurigo nodulaire de) | n2=en:(4) thiamine-responsive form | rel=r_associated | relid=0 | w=15
  376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(5) dihydrolipoyl dehydrogenase (e3)-deficient
    n1=Hyde (prurigo nodulaire de) | n2=en:(5) dihydrolipoyl dehydrogenase (e3)-deficient | rel=r_associated | relid=0 | w=15
  377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:(acyl-carrier-protein) phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:(acyl-carrier-protein) phosphodiesterase | rel=r_associated | relid=0 | w=15
  378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1 in 17,000 in china
    n1=Hyde (prurigo nodulaire de) | n2=en:1 in 17,000 in china | rel=r_associated | relid=0 | w=15
  379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1 in 19,000 in japan
    n1=Hyde (prurigo nodulaire de) | n2=en:1 in 19,000 in japan | rel=r_associated | relid=0 | w=15
  380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1 in 50,000 in korea
    n1=Hyde (prurigo nodulaire de) | n2=en:1 in 50,000 in korea | rel=r_associated | relid=0 | w=15
  381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1 patient reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:1 patient reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
    n1=Hyde (prurigo nodulaire de) | n2=en:1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | rel=r_associated | relid=0 | w=15
  383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1,3-alpha-l-fucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:1,3-alpha-l-fucosidase | rel=r_associated | relid=0 | w=15
  384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1,6-alpha-l-fucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:1,6-alpha-l-fucosidase | rel=r_associated | relid=0 | w=15
  385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:1.02 kb genomic deletion in 85% of batten disease alleles worldwide
    n1=Hyde (prurigo nodulaire de) | n2=en:1.02 kb genomic deletion in 85% of batten disease alleles worldwide | rel=r_associated | relid=0 | w=15
  386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:10-15% with primarily defects of cellular immunity, not manifesting until >2yrs of age
    n1=Hyde (prurigo nodulaire de) | n2=en:10-15% with primarily defects of cellular immunity, not manifesting until >2yrs of age | rel=r_associated | relid=0 | w=15
  387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:10% due to paternal deletion
    n1=Hyde (prurigo nodulaire de) | n2=en:10% due to paternal deletion | rel=r_associated | relid=0 | w=15
  388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:11-cis-retinyl-palmitate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:11-cis-retinyl-palmitate hydrolase | rel=r_associated | relid=0 | w=15
  389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:12% due to epimutation
    n1=Hyde (prurigo nodulaire de) | n2=en:12% due to epimutation | rel=r_associated | relid=0 | w=15
  390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:13% of cases secondary to familial translocation (often maternally derived)
    n1=Hyde (prurigo nodulaire de) | n2=en:13% of cases secondary to familial translocation (often maternally derived) | rel=r_associated | relid=0 | w=15
  391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:14 patients in 8 recessive kindreds reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:14 patients in 8 recessive kindreds reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:14% of patients survive with polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:14% of patients survive with polyhydramnios | rel=r_associated | relid=0 | w=15
  393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:15 patients from 5 kindreds reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:15 patients from 5 kindreds reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:15% cases are familial
    n1=Hyde (prurigo nodulaire de) | n2=en:15% cases are familial | rel=r_associated | relid=0 | w=15
  395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2 patients described
    n1=Hyde (prurigo nodulaire de) | n2=en:2 patients described | rel=r_associated | relid=0 | w=15
  396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-(acetamidomethylene) succinate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:2-(acetamidomethylene) succinate hydrolase | rel=r_associated | relid=0 | w=15
  397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-3% due to imprinting defects
    n1=Hyde (prurigo nodulaire de) | n2=en:2-3% due to imprinting defects | rel=r_associated | relid=0 | w=15
  398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-carboxy-d-arabinitol-1-phosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:2-carboxy-d-arabinitol-1-phosphatase | rel=r_associated | relid=0 | w=15
  399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-deoxy-d-glucose
    n1=Hyde (prurigo nodulaire de) | n2=en:2-deoxy-d-glucose | rel=r_associated | relid=0 | w=15
  400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-deoxyglucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:2-deoxyglucosidase | rel=r_associated | relid=0 | w=15
  401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-hydroxymuconate-semialdehyde hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:2-hydroxymuconate-semialdehyde hydrolase | rel=r_associated | relid=0 | w=15
  402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-locus model fits simultaneous autosomal recessive gene and mitochondrial gene mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:2-locus model fits simultaneous autosomal recessive gene and mitochondrial gene mutation | rel=r_associated | relid=0 | w=15
  403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2-oxopent-4-enoate hydratase
    n1=Hyde (prurigo nodulaire de) | n2=en:2-oxopent-4-enoate hydratase | rel=r_associated | relid=0 | w=15
  404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2,6-beta-fructan 6-levanbiohydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:2,6-beta-fructan 6-levanbiohydrolase | rel=r_associated | relid=0 | w=15
  405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2:1 female preponderance
    n1=Hyde (prurigo nodulaire de) | n2=en:2:1 female preponderance | rel=r_associated | relid=0 | w=15
  406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2',3'-cyclic nucleotide 3'-phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:2',3'-cyclic nucleotide 3'-phosphodiesterase | rel=r_associated | relid=0 | w=15
  407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:2% due to paternal uniparental disomy of 15q11.2-q13
    n1=Hyde (prurigo nodulaire de) | n2=en:2% due to paternal uniparental disomy of 15q11.2-q13 | rel=r_associated | relid=0 | w=15
  408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:20-40% patients are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:20-40% patients are asymptomatic | rel=r_associated | relid=0 | w=15
  409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:20% die before age one (usually secondary to renal or laryngeal defects)
    n1=Hyde (prurigo nodulaire de) | n2=en:20% die before age one (usually secondary to renal or laryngeal defects) | rel=r_associated | relid=0 | w=15
  410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:21 patients from 17 kindreds reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:21 patients from 17 kindreds reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:21% of hereditary wilms tumor are bilateral
    n1=Hyde (prurigo nodulaire de) | n2=en:21% of hereditary wilms tumor are bilateral | rel=r_associated | relid=0 | w=15
  412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:22q11.2 deletion can present with a variety of phenotypes including velocardiofacial syndrome (192430)
    n1=Hyde (prurigo nodulaire de) | n2=en:22q11.2 deletion can present with a variety of phenotypes including velocardiofacial syndrome (192430) | rel=r_associated | relid=0 | w=15
  413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:23 patients from 2 kindreds reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:23 patients from 2 kindreds reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:25% due to mutations in ube3a (601623)
    n1=Hyde (prurigo nodulaire de) | n2=en:25% due to mutations in ube3a (601623) | rel=r_associated | relid=0 | w=15
  415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:3 reported cases, 1 pedigree of affected sibs, neither parent affected
    n1=Hyde (prurigo nodulaire de) | n2=en:3 reported cases, 1 pedigree of affected sibs, neither parent affected | rel=r_associated | relid=0 | w=15
  416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:3-cyanoalanine hydratase
    n1=Hyde (prurigo nodulaire de) | n2=en:3-cyanoalanine hydratase | rel=r_associated | relid=0 | w=15
  417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:3-deoxy-2-octulosonidase
    n1=Hyde (prurigo nodulaire de) | n2=en:3-deoxy-2-octulosonidase | rel=r_associated | relid=0 | w=15
  418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:3-oxoadipate enol-lactonase
    n1=Hyde (prurigo nodulaire de) | n2=en:3-oxoadipate enol-lactonase | rel=r_associated | relid=0 | w=15
  419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:3',5'-cyclic-gmp phosphodiesterases
    n1=Hyde (prurigo nodulaire de) | n2=en:3',5'-cyclic-gmp phosphodiesterases | rel=r_associated | relid=0 | w=15
  420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:35% of cases involve ileum only (ileitis), 45% of cases involve ileum and colon (ileocolitis), 20% of cases involve colon alone - rectum spared (granulomatous colitis)
    n1=Hyde (prurigo nodulaire de) | n2=en:35% of cases involve ileum only (ileitis), 45% of cases involve ileum and colon (ileocolitis), 20% of cases involve colon alone - rectum spared (granulomatous colitis) | rel=r_associated | relid=0 | w=15
  421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:35% of patients have facial dysmorphism
    n1=Hyde (prurigo nodulaire de) | n2=en:35% of patients have facial dysmorphism | rel=r_associated | relid=0 | w=15
  422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:4-acetamidobutyryl-coa deacetylase
    n1=Hyde (prurigo nodulaire de) | n2=en:4-acetamidobutyryl-coa deacetylase | rel=r_associated | relid=0 | w=15
  423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:4-chlorobenzoate dehalogenase
    n1=Hyde (prurigo nodulaire de) | n2=en:4-chlorobenzoate dehalogenase | rel=r_associated | relid=0 | w=15
  424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:4-hydroxybenzoyl-coa thioesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:4-hydroxybenzoyl-coa thioesterase | rel=r_associated | relid=0 | w=15
  425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:4-pyridoxolactonase
    n1=Hyde (prurigo nodulaire de) | n2=en:4-pyridoxolactonase | rel=r_associated | relid=0 | w=15
  426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:40 patients in 16 dominant kindreds reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:40 patients in 16 dominant kindreds reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:40% patients have associated abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:40% patients have associated abnormalities | rel=r_associated | relid=0 | w=15
  428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene deacetylase
    n1=Hyde (prurigo nodulaire de) | n2=en:5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene deacetylase | rel=r_associated | relid=0 | w=15
  429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5-10% of all wilms tumor are bilateral
    n1=Hyde (prurigo nodulaire de) | n2=en:5-10% of all wilms tumor are bilateral | rel=r_associated | relid=0 | w=15
  430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5-10% of patients have a first degree relative with ibd (crohn or ulcerative colitis)
    n1=Hyde (prurigo nodulaire de) | n2=en:5-10% of patients have a first degree relative with ibd (crohn or ulcerative colitis) | rel=r_associated | relid=0 | w=15
  431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5-10% of patients have a first degree relative with ibd (ulcerative colitis or crohn disease)
    n1=Hyde (prurigo nodulaire de) | n2=en:5-10% of patients have a first degree relative with ibd (ulcerative colitis or crohn disease) | rel=r_associated | relid=0 | w=15
  432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5-oxoprolinase (atp-hydrolysing)
    n1=Hyde (prurigo nodulaire de) | n2=en:5-oxoprolinase (atp-hydrolysing) | rel=r_associated | relid=0 | w=15
  433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:5'-nucleotidase
    n1=Hyde (prurigo nodulaire de) | n2=en:5'-nucleotidase | rel=r_associated | relid=0 | w=15
  434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:50% of cases are de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:50% of cases are de novo | rel=r_associated | relid=0 | w=15
  435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:50% of cases represent new mutations associated with advanced paternal age
    n1=Hyde (prurigo nodulaire de) | n2=en:50% of cases represent new mutations associated with advanced paternal age | rel=r_associated | relid=0 | w=15
  436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:50% of females have learning disability or mild mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:50% of females have learning disability or mild mental retardation | rel=r_associated | relid=0 | w=15
  437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:6-aminohexanoate-cyclic-dimer hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:6-aminohexanoate-cyclic-dimer hydrolase | rel=r_associated | relid=0 | w=15
  438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:6-phospho-beta-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:6-phospho-beta-glucosidase | rel=r_associated | relid=0 | w=15
  439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:7 unrelated patients have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:7 unrelated patients have been reported | rel=r_associated | relid=0 | w=15
  440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:7,8-dihydro-8-oxoguanine triphosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:7,8-dihydro-8-oxoguanine triphosphatase | rel=r_associated | relid=0 | w=15
  441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:70% due to de novo maternal deletion of 15q11.2-q13
    n1=Hyde (prurigo nodulaire de) | n2=en:70% due to de novo maternal deletion of 15q11.2-q13 | rel=r_associated | relid=0 | w=15
  442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:72kda type iv collagenase
    n1=Hyde (prurigo nodulaire de) | n2=en:72kda type iv collagenase | rel=r_associated | relid=0 | w=15
  443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:75% of affected individuals are female
    n1=Hyde (prurigo nodulaire de) | n2=en:75% of affected individuals are female | rel=r_associated | relid=0 | w=15
  444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:78% due to chromosome 14 maternal uniparental disomy
    n1=Hyde (prurigo nodulaire de) | n2=en:78% due to chromosome 14 maternal uniparental disomy | rel=r_associated | relid=0 | w=15
  445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:80% cases new mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:80% cases new mutations | rel=r_associated | relid=0 | w=15
  446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:85-90% with manifestations in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:85-90% with manifestations in first months of life | rel=r_associated | relid=0 | w=15
  447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:87% patients are female
    n1=Hyde (prurigo nodulaire de) | n2=en:87% patients are female | rel=r_associated | relid=0 | w=15
  448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:94% develop hypertension at 18 years of age or less
    n1=Hyde (prurigo nodulaire de) | n2=en:94% develop hypertension at 18 years of age or less | rel=r_associated | relid=0 | w=15
  449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:95% of cases are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:95% of cases are sporadic | rel=r_associated | relid=0 | w=15
  450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:98% of finnish cases due to one mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:98% of finnish cases due to one mutation | rel=r_associated | relid=0 | w=15
  451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:99+% of the mutations are fgfr3, g380r (134934.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:99+% of the mutations are fgfr3, g380r (134934.0001) | rel=r_associated | relid=0 | w=15
  452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a heterozygous mutation resulting in haploinsufficiency has been reported in 1 patient
    n1=Hyde (prurigo nodulaire de) | n2=en:a heterozygous mutation resulting in haploinsufficiency has been reported in 1 patient | rel=r_associated | relid=0 | w=15
  453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a milder form has also been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:a milder form has also been reported | rel=r_associated | relid=0 | w=15
  454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a minority of patients have onset after age 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:a minority of patients have onset after age 30 years | rel=r_associated | relid=0 | w=15
  455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a mutation in the cxorf5 gene has been reported in 1 affected family
    n1=Hyde (prurigo nodulaire de) | n2=en:a mutation in the cxorf5 gene has been reported in 1 affected family | rel=r_associated | relid=0 | w=15
  456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a mutation in the lbr gene has been identified in 1 patient (as of july 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:a mutation in the lbr gene has been identified in 1 patient (as of july 2010) | rel=r_associated | relid=0 | w=15
  457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a nonspecific marker of somatic mosaicism
    n1=Hyde (prurigo nodulaire de) | n2=en:a nonspecific marker of somatic mosaicism | rel=r_associated | relid=0 | w=15
  458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a second family had mild intellectual disability
    n1=Hyde (prurigo nodulaire de) | n2=en:a second family had mild intellectual disability | rel=r_associated | relid=0 | w=15
  459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a second patient died at age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:a second patient died at age 3 years | rel=r_associated | relid=0 | w=15
  460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a severe infantile variant has been rarely reported
    n1=Hyde (prurigo nodulaire de) | n2=en:a severe infantile variant has been rarely reported | rel=r_associated | relid=0 | w=15
  461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subgroup of patients with sponastrime dysplasia have severe mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:a subgroup of patients with sponastrime dysplasia have severe mental retardation | rel=r_associated | relid=0 | w=15
  462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients are responsive to vitamin b12 therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients are responsive to vitamin b12 therapy | rel=r_associated | relid=0 | w=15
  463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients have a 'visual variant'
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients have a 'visual variant' | rel=r_associated | relid=0 | w=15
  464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients have additional features, including mental retardation and hypogonadism associated with larger deletions at xp22.3
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients have additional features, including mental retardation and hypogonadism associated with larger deletions at xp22.3 | rel=r_associated | relid=0 | w=15
  465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients have heterozygous mutations consistent with a dominant-negative effect
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients have heterozygous mutations consistent with a dominant-negative effect | rel=r_associated | relid=0 | w=15
  466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients have heterozygous mutations, which may predispose to disease development
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients have heterozygous mutations, which may predispose to disease development | rel=r_associated | relid=0 | w=15
  467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients improve with thiamine
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients improve with thiamine | rel=r_associated | relid=0 | w=15
  468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a subset of patients may have congenital abnormalities of the ocular anterior segment
    n1=Hyde (prurigo nodulaire de) | n2=en:a subset of patients may have congenital abnormalities of the ocular anterior segment | rel=r_associated | relid=0 | w=15
  469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:a wnt3 mutation has been identified in 1 affected family
    n1=Hyde (prurigo nodulaire de) | n2=en:a wnt3 mutation has been identified in 1 affected family | rel=r_associated | relid=0 | w=15
  470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal amnion
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal amnion | rel=r_associated | relid=0 | w=15
  471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal amniotic fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal amniotic fluid | rel=r_associated | relid=0 | w=15
  472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal chorion
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal chorion | rel=r_associated | relid=0 | w=15
  473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal fetal duplication
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal fetal duplication | rel=r_associated | relid=0 | w=15
  474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal immature chorion
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal immature chorion | rel=r_associated | relid=0 | w=15
  475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal morphogenesis of first and second branchial arches
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal morphogenesis of first and second branchial arches | rel=r_associated | relid=0 | w=15
  476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal pregnancy | rel=r_associated | relid=0 | w=15
  477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal products of conception
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal products of conception | rel=r_associated | relid=0 | w=15
  478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal sensitivity to therapeutic radiation
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal sensitivity to therapeutic radiation | rel=r_associated | relid=0 | w=15
  479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal transferrin pattern tends to improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal transferrin pattern tends to improve with age | rel=r_associated | relid=0 | w=15
  480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormal yolk sac
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormal yolk sac | rel=r_associated | relid=0 | w=15
  481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:abnormality of organs and soft tissues of pelvis complicating pregnancy, childbirth, or the puerperium
    n1=Hyde (prurigo nodulaire de) | n2=en:abnormality of organs and soft tissues of pelvis complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=15
  482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 1 to 5% of patients who undergo renal transplantation develop anti-glomerular basement membrane nephritis
    n1=Hyde (prurigo nodulaire de) | n2=en:about 1 to 5% of patients who undergo renal transplantation develop anti-glomerular basement membrane nephritis | rel=r_associated | relid=0 | w=15
  483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 10% of patients develop exercise-induced renal failure and nephrolithiasis
    n1=Hyde (prurigo nodulaire de) | n2=en:about 10% of patients develop exercise-induced renal failure and nephrolithiasis | rel=r_associated | relid=0 | w=15
  484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 10% of patients have a severe early onset in the first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:about 10% of patients have a severe early onset in the first months of life | rel=r_associated | relid=0 | w=15
  485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 15% of female carriers develop renal insufficiency in the second or third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:about 15% of female carriers develop renal insufficiency in the second or third decade | rel=r_associated | relid=0 | w=15
  486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 20% of female mutation carriers may show mild muscle weakness
    n1=Hyde (prurigo nodulaire de) | n2=en:about 20% of female mutation carriers may show mild muscle weakness | rel=r_associated | relid=0 | w=15
  487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 25% of cases due to new mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:about 25% of cases due to new mutations | rel=r_associated | relid=0 | w=15
  488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 5% of patients have a history of febrile seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:about 5% of patients have a history of febrile seizures | rel=r_associated | relid=0 | w=15
  489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 50% of mutation carriers are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:about 50% of mutation carriers are asymptomatic | rel=r_associated | relid=0 | w=15
  490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 50% of patients become wheelchair-bound at an average age of 37 years
    n1=Hyde (prurigo nodulaire de) | n2=en:about 50% of patients become wheelchair-bound at an average age of 37 years | rel=r_associated | relid=0 | w=15
  491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 50% of patients have intellectual disability and/or hydrocephalus
    n1=Hyde (prurigo nodulaire de) | n2=en:about 50% of patients have intellectual disability and/or hydrocephalus | rel=r_associated | relid=0 | w=15
  492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about 8% of female mutation carriers develop dilated cardiomyopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:about 8% of female mutation carriers develop dilated cardiomyopathy | rel=r_associated | relid=0 | w=15
  493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about a dozen patients have been reported (as of march 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:about a dozen patients have been reported (as of march 2012) | rel=r_associated | relid=0 | w=15
  494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about half of individuals are asymptomatic and identified by newborn screening programs
    n1=Hyde (prurigo nodulaire de) | n2=en:about half of individuals are asymptomatic and identified by newborn screening programs | rel=r_associated | relid=0 | w=15
  495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about half of patients become wheelchair bound after long duration
    n1=Hyde (prurigo nodulaire de) | n2=en:about half of patients become wheelchair bound after long duration | rel=r_associated | relid=0 | w=15
  496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about half of patients report vestibular symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:about half of patients report vestibular symptoms | rel=r_associated | relid=0 | w=15
  497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:about half of patients with gjb2/gjb6 deafness report vestibular symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:about half of patients with gjb2/gjb6 deafness report vestibular symptoms | rel=r_associated | relid=0 | w=15
  498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:absence of both inner and outer dynein arms of cilia
    n1=Hyde (prurigo nodulaire de) | n2=en:absence of both inner and outer dynein arms of cilia | rel=r_associated | relid=0 | w=15
  499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:absence of premature birth, low birthweight, and exposure to oxygen
    n1=Hyde (prurigo nodulaire de) | n2=en:absence of premature birth, low birthweight, and exposure to oxygen | rel=r_associated | relid=0 | w=15
  500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:absence seizures show onset between 3.5 and 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:absence seizures show onset between 3.5 and 4 years | rel=r_associated | relid=0 | w=15
  501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:absence seizures usually remit by puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:absence seizures usually remit by puberty | rel=r_associated | relid=0 | w=15
  502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acanthosis nigricans fades during adolescence and reappears in pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:acanthosis nigricans fades during adolescence and reappears in pregnancy | rel=r_associated | relid=0 | w=15
  503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accidental injury to the self (mouth, digits) has been referred by some as 'self-mutilation'
    n1=Hyde (prurigo nodulaire de) | n2=en:accidental injury to the self (mouth, digits) has been referred by some as 'self-mutilation' | rel=r_associated | relid=0 | w=15
  504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for <2% of patients with alzheimer's disease
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for <2% of patients with alzheimer's disease | rel=r_associated | relid=0 | w=15
  505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for 1-2% of lymphomas in adults
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for 1-2% of lymphomas in adults | rel=r_associated | relid=0 | w=15
  506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for 30-50% of lymphomas in children
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for 30-50% of lymphomas in children | rel=r_associated | relid=0 | w=15
  507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for 5 to 7% of all cases of congenital adrenal hyperplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for 5 to 7% of all cases of congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=15
  508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for 5-15% of childhood epilepsies
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for 5-15% of childhood epilepsies | rel=r_associated | relid=0 | w=15
  509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for 70% of all usher syndrome patients
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for 70% of all usher syndrome patients | rel=r_associated | relid=0 | w=15
  510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:accounts for approximately 5% of the epilepsies
    n1=Hyde (prurigo nodulaire de) | n2=en:accounts for approximately 5% of the epilepsies | rel=r_associated | relid=0 | w=15
  511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetazolamide is often effective
    n1=Hyde (prurigo nodulaire de) | n2=en:acetazolamide is often effective | rel=r_associated | relid=0 | w=15
  512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetazolamide may benefit attacks of vertigo
    n1=Hyde (prurigo nodulaire de) | n2=en:acetazolamide may benefit attacks of vertigo | rel=r_associated | relid=0 | w=15
  513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetoacetyl-coa hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:acetoacetyl-coa hydrolase | rel=r_associated | relid=0 | w=15
  514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetylalkylglycerol acetylhydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:acetylalkylglycerol acetylhydrolase | rel=r_associated | relid=0 | w=15
  515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetylornithine deacetylase
    n1=Hyde (prurigo nodulaire de) | n2=en:acetylornithine deacetylase | rel=r_associated | relid=0 | w=15
  516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetylpyruvate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:acetylpyruvate hydrolase | rel=r_associated | relid=0 | w=15
  517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acetylxylan esterase
    n1=Hyde (prurigo nodulaire de) | n2=en:acetylxylan esterase | rel=r_associated | relid=0 | w=15
  518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:achondrogenesis type 1a
    n1=Hyde (prurigo nodulaire de) | n2=en:achondrogenesis type 1a | rel=r_associated | relid=0 | w=15
  519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:achondrogenesis, type ib (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:achondrogenesis, type ib (disorder) | rel=r_associated | relid=0 | w=15
  520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acid anhydride hydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:acid anhydride hydrolases | rel=r_associated | relid=0 | w=15
  521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acid ceramidase
    n1=Hyde (prurigo nodulaire de) | n2=en:acid ceramidase | rel=r_associated | relid=0 | w=15
  522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acid sphingomyelinase
    n1=Hyde (prurigo nodulaire de) | n2=en:acid sphingomyelinase | rel=r_associated | relid=0 | w=15
  523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired autoimmune disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired autoimmune disorder | rel=r_associated | relid=0 | w=15
  524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired disorder | rel=r_associated | relid=0 | w=15
  525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired form - presence of inhibiting autoantibody (igg) to vwf-cleaving protease
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired form - presence of inhibiting autoantibody (igg) to vwf-cleaving protease | rel=r_associated | relid=0 | w=15
  526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired protein c deficiency seen in liver disease, dic, and following surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired protein c deficiency seen in liver disease, dic, and following surgery | rel=r_associated | relid=0 | w=15
  527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired protein s deficiency seen in pregnancy, oral contraceptive use, warfarin use, liver disease, dic, and diabetes
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired protein s deficiency seen in pregnancy, oral contraceptive use, warfarin use, liver disease, dic, and diabetes | rel=r_associated | relid=0 | w=15
  528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acquired sporadic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:acquired sporadic disorder | rel=r_associated | relid=0 | w=15
  529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acral form of skin peeling limited to hands and feet (609796)
    n1=Hyde (prurigo nodulaire de) | n2=en:acral form of skin peeling limited to hands and feet (609796) | rel=r_associated | relid=0 | w=15
  530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acral hemorrhagic variant
    n1=Hyde (prurigo nodulaire de) | n2=en:acral hemorrhagic variant | rel=r_associated | relid=0 | w=15
  531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:actinomycin lactonase
    n1=Hyde (prurigo nodulaire de) | n2=en:actinomycin lactonase | rel=r_associated | relid=0 | w=15
  532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute attacks lasting 24-48 hours
    n1=Hyde (prurigo nodulaire de) | n2=en:acute attacks lasting 24-48 hours | rel=r_associated | relid=0 | w=15
  533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute attacks rarely occur before puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:acute attacks rarely occur before puberty | rel=r_associated | relid=0 | w=15
  534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute encephalopathic episodes may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:acute encephalopathic episodes may occur | rel=r_associated | relid=0 | w=15
  535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute episodes decrease with age and disappear
    n1=Hyde (prurigo nodulaire de) | n2=en:acute episodes decrease with age and disappear | rel=r_associated | relid=0 | w=15
  536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute neurologic deterioration after viral illness has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:acute neurologic deterioration after viral illness has been reported | rel=r_associated | relid=0 | w=15
  537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acute polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:acute polyhydramnios | rel=r_associated | relid=0 | w=15
  538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acyl-lysine deacylase
    n1=Hyde (prurigo nodulaire de) | n2=en:acyl-lysine deacylase | rel=r_associated | relid=0 | w=15
  539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acylcarnitine hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:acylcarnitine hydrolase | rel=r_associated | relid=0 | w=15
  540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:acylpyruvate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:acylpyruvate hydrolase | rel=r_associated | relid=0 | w=15
  541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adcon-t-n
    n1=Hyde (prurigo nodulaire de) | n2=en:adcon-t-n | rel=r_associated | relid=0 | w=15
  542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:additional developmental abnormalities may be seen in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:additional developmental abnormalities may be seen in some patients | rel=r_associated | relid=0 | w=15
  543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:additional features are variably present
    n1=Hyde (prurigo nodulaire de) | n2=en:additional features are variably present | rel=r_associated | relid=0 | w=15
  544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adenosine deaminase
    n1=Hyde (prurigo nodulaire de) | n2=en:adenosine deaminase | rel=r_associated | relid=0 | w=15
  545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adenosine nucleosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:adenosine nucleosidase | rel=r_associated | relid=0 | w=15
  546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adenosylhomocysteinase
    n1=Hyde (prurigo nodulaire de) | n2=en:adenosylhomocysteinase | rel=r_associated | relid=0 | w=15
  547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adenosylmethionine hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:adenosylmethionine hydrolase | rel=r_associated | relid=0 | w=15
  548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adenylylsulphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:adenylylsulphatase | rel=r_associated | relid=0 | w=15
  549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adjuvax
    n1=Hyde (prurigo nodulaire de) | n2=en:adjuvax | rel=r_associated | relid=0 | w=15
  550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adolescent or adult onset associated with neuropsychiatric symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:adolescent or adult onset associated with neuropsychiatric symptoms | rel=r_associated | relid=0 | w=15
  551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adp-dependent short-chain-acyl-coa hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:adp-dependent short-chain-acyl-coa hydrolase | rel=r_associated | relid=0 | w=15
  552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adp-ribosyl cyclase 1
    n1=Hyde (prurigo nodulaire de) | n2=en:adp-ribosyl cyclase 1 | rel=r_associated | relid=0 | w=15
  553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adpribose pyrophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:adpribose pyrophosphatase | rel=r_associated | relid=0 | w=15
  554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adrenal insufficiency usually develops later (first decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:adrenal insufficiency usually develops later (first decade) | rel=r_associated | relid=0 | w=15
  555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult form is asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:adult form is asymptomatic | rel=r_associated | relid=0 | w=15
  556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult form onset has after 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:adult form onset has after 20 years | rel=r_associated | relid=0 | w=15
  557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult is an acronym for acro-dermato-ungual-lacrimal-tooth
    n1=Hyde (prurigo nodulaire de) | n2=en:adult is an acronym for acro-dermato-ungual-lacrimal-tooth | rel=r_associated | relid=0 | w=15
  558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset | rel=r_associated | relid=0 | w=15
  559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset - 100-1,000 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset - 100-1,000 repeats | rel=r_associated | relid=0 | w=15
  560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (18 to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (18 to 60 years) | rel=r_associated | relid=0 | w=15
  561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (20 to 40 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (20 to 40 years) | rel=r_associated | relid=0 | w=15
  562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (20 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (20 to 50 years) | rel=r_associated | relid=0 | w=15
  563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (25-45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (25-45 years) | rel=r_associated | relid=0 | w=15
  564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (27 to 48 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (27 to 48 years) | rel=r_associated | relid=0 | w=15
  565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (37 to 57 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (37 to 57 years) | rel=r_associated | relid=0 | w=15
  566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (40 to 60 years old)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (40 to 60 years old) | rel=r_associated | relid=0 | w=15
  567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (45 to 76 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (45 to 76 years) | rel=r_associated | relid=0 | w=15
  568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (after age 35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (after age 35 years) | rel=r_associated | relid=0 | w=15
  569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (before 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (before 50 years) | rel=r_associated | relid=0 | w=15
  570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (forties)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (forties) | rel=r_associated | relid=0 | w=15
  571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean 27 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean 27 years) | rel=r_associated | relid=0 | w=15
  572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean 30 years, range 10-65 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean 30 years, range 10-65 years) | rel=r_associated | relid=0 | w=15
  573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean 30 years, range 5-60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean 30 years, range 5-60 years) | rel=r_associated | relid=0 | w=15
  574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean 60 years) | rel=r_associated | relid=0 | w=15
  575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean age 37 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean age 37 years) | rel=r_associated | relid=0 | w=15
  576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mean of 30 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mean of 30 years) | rel=r_associated | relid=0 | w=15
  577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (mid-forties)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (mid-forties) | rel=r_associated | relid=0 | w=15
  578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 12 to 59 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 12 to 59 years) | rel=r_associated | relid=0 | w=15
  579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 14 to 70 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 14 to 70 years) | rel=r_associated | relid=0 | w=15
  580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 15 to 53 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 15 to 53 years) | rel=r_associated | relid=0 | w=15
  581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 28 to 55 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 28 to 55 years) | rel=r_associated | relid=0 | w=15
  582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 30 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 30 to 50 years) | rel=r_associated | relid=0 | w=15
  583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 34 to 66 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 34 to 66 years) | rel=r_associated | relid=0 | w=15
  584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 40 to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 40 to 60 years) | rel=r_associated | relid=0 | w=15
  585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (range 45 to 70 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (range 45 to 70 years) | rel=r_associated | relid=0 | w=15
  586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (second to sixth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (second to sixth decade) | rel=r_associated | relid=0 | w=15
  587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (sixth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (sixth decade) | rel=r_associated | relid=0 | w=15
  588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (third decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (third decade) | rel=r_associated | relid=0 | w=15
  589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (thirties to forties)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (thirties to forties) | rel=r_associated | relid=0 | w=15
  590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset (wide range of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset (wide range of age) | rel=r_associated | relid=0 | w=15
  591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset after puberty | rel=r_associated | relid=0 | w=15
  592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset form usually presents with psychiatric manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset form usually presents with psychiatric manifestations | rel=r_associated | relid=0 | w=15
  593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset from second to seventh decade
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset from second to seventh decade | rel=r_associated | relid=0 | w=15
  594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset has been rarely reported
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset has been rarely reported | rel=r_associated | relid=0 | w=15
  595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset has been reported | rel=r_associated | relid=0 | w=15
  596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset has been reported (age 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset has been reported (age 50 years) | rel=r_associated | relid=0 | w=15
  597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset may also occur
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset may also occur | rel=r_associated | relid=0 | w=15
  598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset may occur | rel=r_associated | relid=0 | w=15
  599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset of gait abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset of gait abnormalities | rel=r_associated | relid=0 | w=15
  600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset of muscle symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset of muscle symptoms | rel=r_associated | relid=0 | w=15
  601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset of neurologic symptoms has been reported in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset of neurologic symptoms has been reported in 1 family | rel=r_associated | relid=0 | w=15
  602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset of symptoms has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset of symptoms has been reported | rel=r_associated | relid=0 | w=15
  603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset rarely reported
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset rarely reported | rel=r_associated | relid=0 | w=15
  604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult onset, usually 30's to 40's, but up to early 60's
    n1=Hyde (prurigo nodulaire de) | n2=en:adult onset, usually 30's to 40's, but up to early 60's | rel=r_associated | relid=0 | w=15
  605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult patients have heterogeneous symptoms including some with relapsing-remitting symptoms similar to multiple sclerosis
    n1=Hyde (prurigo nodulaire de) | n2=en:adult patients have heterogeneous symptoms including some with relapsing-remitting symptoms similar to multiple sclerosis | rel=r_associated | relid=0 | w=15
  606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult-onset in third to fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:adult-onset in third to fourth decade | rel=r_associated | relid=0 | w=15
  607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adult-onset is referred to as small fiber neuropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:adult-onset is referred to as small fiber neuropathy | rel=r_associated | relid=0 | w=15
  608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adults may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:adults may be asymptomatic | rel=r_associated | relid=0 | w=15
  609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:adults may lose ability to walk
    n1=Hyde (prurigo nodulaire de) | n2=en:adults may lose ability to walk | rel=r_associated | relid=0 | w=15
  610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aestivalis prurigo
    n1=Hyde (prurigo nodulaire de) | n2=en:aestivalis prurigo | rel=r_associated | relid=0 | w=15
  611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected females are infertile
    n1=Hyde (prurigo nodulaire de) | n2=en:affected females are infertile | rel=r_associated | relid=0 | w=15
  612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected females have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:affected females have been reported | rel=r_associated | relid=0 | w=15
  613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected females may have increased spontaneous abortions
    n1=Hyde (prurigo nodulaire de) | n2=en:affected females may have increased spontaneous abortions | rel=r_associated | relid=0 | w=15
  614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected females report aggravation of symptoms during menstrual periods and pregnancy, with alleviation after menopause
    n1=Hyde (prurigo nodulaire de) | n2=en:affected females report aggravation of symptoms during menstrual periods and pregnancy, with alleviation after menopause | rel=r_associated | relid=0 | w=15
  615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals are highly prone to burn-related injuries
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals are highly prone to burn-related injuries | rel=r_associated | relid=0 | w=15
  616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals can pull hair from any part of the body, including eyelashes and eyebrows
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals can pull hair from any part of the body, including eyelashes and eyebrows | rel=r_associated | relid=0 | w=15
  617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals have amnesia for events
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals have amnesia for events | rel=r_associated | relid=0 | w=15
  618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals may have learning or behavioral problems during the period when seizures occur
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals may have learning or behavioral problems during the period when seizures occur | rel=r_associated | relid=0 | w=15
  619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals remain ambulatory
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals remain ambulatory | rel=r_associated | relid=0 | w=15
  620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected individuals remain ambulatory in old age
    n1=Hyde (prurigo nodulaire de) | n2=en:affected individuals remain ambulatory in old age | rel=r_associated | relid=0 | w=15
  621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected infants appear normal
    n1=Hyde (prurigo nodulaire de) | n2=en:affected infants appear normal | rel=r_associated | relid=0 | w=15
  622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected infants appear normal at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:affected infants appear normal at birth | rel=r_associated | relid=0 | w=15
  623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected infants die in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:affected infants die in neonatal period | rel=r_associated | relid=0 | w=15
  624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected infants often die in utero or in the postnatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:affected infants often die in utero or in the postnatal period | rel=r_associated | relid=0 | w=15
  625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males are all result of new mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males are all result of new mutation | rel=r_associated | relid=0 | w=15
  626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males are infertile, whereas affected females have recurrent pregnancy loss
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males are infertile, whereas affected females have recurrent pregnancy loss | rel=r_associated | relid=0 | w=15
  627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males are somatic mosaic for mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males are somatic mosaic for mutations | rel=r_associated | relid=0 | w=15
  628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males have normal pubertal development and are fertile
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males have normal pubertal development and are fertile | rel=r_associated | relid=0 | w=15
  629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males have onset of poor vision before the age of 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males have onset of poor vision before the age of 2 years | rel=r_associated | relid=0 | w=15
  630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males have serotonin-related disorders such as migraine headaches and diabetes
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males have serotonin-related disorders such as migraine headaches and diabetes | rel=r_associated | relid=0 | w=15
  631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males show onset of hematuria in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males show onset of hematuria in first year of life | rel=r_associated | relid=0 | w=15
  632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected males who survive are secondary to new mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:affected males who survive are secondary to new mutations | rel=r_associated | relid=0 | w=15
  633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected patients have various combinations of the main clinical features
    n1=Hyde (prurigo nodulaire de) | n2=en:affected patients have various combinations of the main clinical features | rel=r_associated | relid=0 | w=15
  634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affected, mild - 50-150 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:affected, mild - 50-150 repeats | rel=r_associated | relid=0 | w=15
  635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affects 1 in 250,000 to 1 million people worldwide
    n1=Hyde (prurigo nodulaire de) | n2=en:affects 1 in 250,000 to 1 million people worldwide | rel=r_associated | relid=0 | w=15
  636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affects 1 to 3% of the population
    n1=Hyde (prurigo nodulaire de) | n2=en:affects 1 to 3% of the population | rel=r_associated | relid=0 | w=15
  637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affects between 1 in 200 to 1 in 400 individuals of northern european descent
    n1=Hyde (prurigo nodulaire de) | n2=en:affects between 1 in 200 to 1 in 400 individuals of northern european descent | rel=r_associated | relid=0 | w=15
  638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affects up to 10% of the population
    n1=Hyde (prurigo nodulaire de) | n2=en:affects up to 10% of the population | rel=r_associated | relid=0 | w=15
  639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:affects up to 10% of women in their reproductive years
    n1=Hyde (prurigo nodulaire de) | n2=en:affects up to 10% of women in their reproductive years | rel=r_associated | relid=0 | w=15
  640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:agarase
    n1=Hyde (prurigo nodulaire de) | n2=en:agarase | rel=r_associated | relid=0 | w=15
  641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at death:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:age at death:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 2-4 months
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 2-4 months | rel=r_associated | relid=0 | w=15
  643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 24 +/- 18 years for dominant disease
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 24 +/- 18 years for dominant disease | rel=r_associated | relid=0 | w=15
  644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 26 +/- 14 years for recessive disease
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 26 +/- 14 years for recessive disease | rel=r_associated | relid=0 | w=15
  645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 28 +/- 18 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 28 +/- 18 years | rel=r_associated | relid=0 | w=15
  646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 36 +/- 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 36 +/- 20 years | rel=r_associated | relid=0 | w=15
  647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis 9 +/- 6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis 9 +/- 6 years | rel=r_associated | relid=0 | w=15
  648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at diagnosis of cataract may range up to 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at diagnosis of cataract may range up to 40 years | rel=r_associated | relid=0 | w=15
  649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at first pregnancy:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:age at first pregnancy:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at menarche:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:age at menarche:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at menopause:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:age at menopause:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset 14 to 44 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset 14 to 44 years | rel=r_associated | relid=0 | w=15
  653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset 15 to 25 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset 15 to 25 years | rel=r_associated | relid=0 | w=15
  654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset 15 to 33 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset 15 to 33 years | rel=r_associated | relid=0 | w=15
  655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset 3 to 23 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset 3 to 23 years | rel=r_associated | relid=0 | w=15
  656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset 8 to 55 years (mean 40 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset 8 to 55 years (mean 40 years) | rel=r_associated | relid=0 | w=15
  657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset can range from infancy to childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset can range from infancy to childhood | rel=r_associated | relid=0 | w=15
  658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset from 3 to 51 years (mean 19.2 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset from 3 to 51 years (mean 19.2 years) | rel=r_associated | relid=0 | w=15
  659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset in females ranges from childhood to the fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset in females ranges from childhood to the fourth decade | rel=r_associated | relid=0 | w=15
  660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset in males ranges from 3 to 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset in males ranges from 3 to 7 years | rel=r_associated | relid=0 | w=15
  661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset most often in childhood (first decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset most often in childhood (first decade) | rel=r_associated | relid=0 | w=15
  662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset ranges from 16 years to 65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset ranges from 16 years to 65 years | rel=r_associated | relid=0 | w=15
  663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset ranges from 50 to 70 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset ranges from 50 to 70 years | rel=r_associated | relid=0 | w=15
  664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset ranges from childhood to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset ranges from childhood to adulthood | rel=r_associated | relid=0 | w=15
  665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset ranges from first to sixth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset ranges from first to sixth decade | rel=r_associated | relid=0 | w=15
  666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age at onset ranges from neonatal to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:age at onset ranges from neonatal to adulthood | rel=r_associated | relid=0 | w=15
  667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset - birth to 15 months
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset - birth to 15 months | rel=r_associated | relid=0 | w=15
  668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 1 to 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 1 to 2 years | rel=r_associated | relid=0 | w=15
  669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 17 to 68 years (mean 39)
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 17 to 68 years (mean 39) | rel=r_associated | relid=0 | w=15
  670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 2-8 months
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 2-8 months | rel=r_associated | relid=0 | w=15
  671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 20-65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 20-65 years | rel=r_associated | relid=0 | w=15
  672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 23-59 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 23-59 years | rel=r_associated | relid=0 | w=15
  673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 28 to 70 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 28 to 70 years | rel=r_associated | relid=0 | w=15
  674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 30 to 60 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 30 to 60 years | rel=r_associated | relid=0 | w=15
  675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 36 to 55 years (mean 47)
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 36 to 55 years (mean 47) | rel=r_associated | relid=0 | w=15
  676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 43-64 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 43-64 years | rel=r_associated | relid=0 | w=15
  677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 5 to 19 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 5 to 19 years | rel=r_associated | relid=0 | w=15
  678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 5 to 22 years (mean 6.9)
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 5 to 22 years (mean 6.9) | rel=r_associated | relid=0 | w=15
  679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 5 to 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 5 to 40 years | rel=r_associated | relid=0 | w=15
  680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset 6-10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset 6-10 years | rel=r_associated | relid=0 | w=15
  681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset between 20 to 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset between 20 to 30 years | rel=r_associated | relid=0 | w=15
  682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset earlier in familial cases than in sporadic cases
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset earlier in familial cases than in sporadic cases | rel=r_associated | relid=0 | w=15
  683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset from 18 to 45 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset from 18 to 45 years | rel=r_associated | relid=0 | w=15
  684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset of distal lower limb weakness 8-16 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset of distal lower limb weakness 8-16 years | rel=r_associated | relid=0 | w=15
  685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset of upper limb involvement 10-43 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset of upper limb involvement 10-43 years | rel=r_associated | relid=0 | w=15
  686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset ranges from 1 to 47 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset ranges from 1 to 47 years | rel=r_associated | relid=0 | w=15
  687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset ranges from infancy to young adulthood (6 months-19 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset ranges from infancy to young adulthood (6 months-19 years) | rel=r_associated | relid=0 | w=15
  688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset ranges from neonate to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset ranges from neonate to adulthood | rel=r_associated | relid=0 | w=15
  689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset third decade | rel=r_associated | relid=0 | w=15
  690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset usually 1 week to 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset usually 1 week to 2 years | rel=r_associated | relid=0 | w=15
  691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset varies between 18 years and 53 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset varies between 18 years and 53 years | rel=r_associated | relid=0 | w=15
  692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset within the first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset within the first years of life | rel=r_associated | relid=0 | w=15
  693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset, 6-20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset, 6-20 years | rel=r_associated | relid=0 | w=15
  694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age of onset/diagnosis 12-35 years
    n1=Hyde (prurigo nodulaire de) | n2=en:age of onset/diagnosis 12-35 years | rel=r_associated | relid=0 | w=15
  695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age on onset - adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:age on onset - adolescence | rel=r_associated | relid=0 | w=15
  696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age-dependent penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:age-dependent penetrance | rel=r_associated | relid=0 | w=15
  697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age-related clinical course
    n1=Hyde (prurigo nodulaire de) | n2=en:age-related clinical course | rel=r_associated | relid=0 | w=15
  698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:age:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age:time:pt:^egg donor:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:age:time:pt:^egg donor:qn | rel=r_associated | relid=0 | w=15
  700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age:time:pt:^patient:qn:calculated
    n1=Hyde (prurigo nodulaire de) | n2=en:age:time:pt:^patient:qn:calculated | rel=r_associated | relid=0 | w=15
  701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age:time:pt:^patient:qn:estimated
    n1=Hyde (prurigo nodulaire de) | n2=en:age:time:pt:^patient:qn:estimated | rel=r_associated | relid=0 | w=15
  702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:age:time:pt:^patient:qn:reported
    n1=Hyde (prurigo nodulaire de) | n2=en:age:time:pt:^patient:qn:reported | rel=r_associated | relid=0 | w=15
  703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aggravated by physical activity
    n1=Hyde (prurigo nodulaire de) | n2=en:aggravated by physical activity | rel=r_associated | relid=0 | w=15
  704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aggressive malignancies
    n1=Hyde (prurigo nodulaire de) | n2=en:aggressive malignancies | rel=r_associated | relid=0 | w=15
  705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:agmatine deiminase
    n1=Hyde (prurigo nodulaire de) | n2=en:agmatine deiminase | rel=r_associated | relid=0 | w=15
  706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:alcohol | rel=r_associated | relid=0 | w=15
  707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alcohol may alleviate symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:alcohol may alleviate symptoms | rel=r_associated | relid=0 | w=15
  708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alkaline ceramidase 2
    n1=Hyde (prurigo nodulaire de) | n2=en:alkaline ceramidase 2 | rel=r_associated | relid=0 | w=15
  709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alkenylglycerophosphocholine hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:alkenylglycerophosphocholine hydrolase | rel=r_associated | relid=0 | w=15
  710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alkylacetylglycerophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:alkylacetylglycerophosphatase | rel=r_associated | relid=0 | w=15
  711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alkylglycerophosphoethanolamine phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:alkylglycerophosphoethanolamine phosphodiesterase | rel=r_associated | relid=0 | w=15
  712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all affected individuals have been stillborn or died in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:all affected individuals have been stillborn or died in the neonatal period | rel=r_associated | relid=0 | w=15
  713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases are de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases are de novo | rel=r_associated | relid=0 | w=15
  714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases due to de novo mutation (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases due to de novo mutation (last curated february 2014) | rel=r_associated | relid=0 | w=15
  715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases from a remote village, sabinas, in northern mexico
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases from a remote village, sabinas, in northern mexico | rel=r_associated | relid=0 | w=15
  716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases have been sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases have been sporadic | rel=r_associated | relid=0 | w=15
  717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases have been stillborn or immediate neonatal death
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases have been stillborn or immediate neonatal death | rel=r_associated | relid=0 | w=15
  718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases occur in a jewish religious isolate originally from cochin, india
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases occur in a jewish religious isolate originally from cochin, india | rel=r_associated | relid=0 | w=15
  719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases occur in old order amish, lancaster county, pennsylvania
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases occur in old order amish, lancaster county, pennsylvania | rel=r_associated | relid=0 | w=15
  720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases presumed de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases presumed de novo mutation | rel=r_associated | relid=0 | w=15
  721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all cases sporadic (18 males, 7 females)
    n1=Hyde (prurigo nodulaire de) | n2=en:all cases sporadic (18 males, 7 females) | rel=r_associated | relid=0 | w=15
  722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:all de novo mutations | rel=r_associated | relid=0 | w=15
  723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all features are unilateral
    n1=Hyde (prurigo nodulaire de) | n2=en:all features are unilateral | rel=r_associated | relid=0 | w=15
  724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all known cases are caused by a finnish founder mutation in the cln8 gene (607837.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:all known cases are caused by a finnish founder mutation in the cln8 gene (607837.0001) | rel=r_associated | relid=0 | w=15
  725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all patients have duplication of at least the crebbp gene (600140)
    n1=Hyde (prurigo nodulaire de) | n2=en:all patients have duplication of at least the crebbp gene (600140) | rel=r_associated | relid=0 | w=15
  726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all patients have severe hearing loss 10 to 15 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:all patients have severe hearing loss 10 to 15 years after onset | rel=r_associated | relid=0 | w=15
  727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported cases have de novo mutations (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported cases have de novo mutations (last curated october 2014) | rel=r_associated | relid=0 | w=15
  728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported cases have occurred de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported cases have occurred de novo | rel=r_associated | relid=0 | w=15
  729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported cases have occurred sporadically
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported cases have occurred sporadically | rel=r_associated | relid=0 | w=15
  730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported cases have resulted from de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported cases have resulted from de novo mutations | rel=r_associated | relid=0 | w=15
  731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported cases result from de novo mutation (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported cases result from de novo mutation (last curated july 2014) | rel=r_associated | relid=0 | w=15
  732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported mutations have occurred de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported mutations have occurred de novo | rel=r_associated | relid=0 | w=15
  733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported mutations have occurred de novo (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported mutations have occurred de novo (last curated december 2014) | rel=r_associated | relid=0 | w=15
  734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all reported patients are female
    n1=Hyde (prurigo nodulaire de) | n2=en:all reported patients are female | rel=r_associated | relid=0 | w=15
  735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:all-trans-retinyl-palmitate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:all-trans-retinyl-palmitate hydrolase | rel=r_associated | relid=0 | w=15
  736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allantoicase
    n1=Hyde (prurigo nodulaire de) | n2=en:allantoicase | rel=r_associated | relid=0 | w=15
  737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic corneal dystrophy groenow type (121900), thiel-behnke type (602082), lattice type i (122200), avellino type (607541), reis-bucklers type (608470) and epithelial basement membrane (121820)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic corneal dystrophy groenow type (121900), thiel-behnke type (602082), lattice type i (122200), avellino type (607541), reis-bucklers type (608470) and epithelial basement membrane (121820) | rel=r_associated | relid=0 | w=15
  738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder is brugada syndrome (601144)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder is brugada syndrome (601144) | rel=r_associated | relid=0 | w=15
  739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder is long qt syndrome-3 (lqt3, 603830)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder is long qt syndrome-3 (lqt3, 603830) | rel=r_associated | relid=0 | w=15
  740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to a form of dilated cardiomyopathy (cmd1g, 604145)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to a form of dilated cardiomyopathy (cmd1g, 604145) | rel=r_associated | relid=0 | w=15
  741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to adult polyglucosan body disease (263570)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to adult polyglucosan body disease (263570) | rel=r_associated | relid=0 | w=15
  742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to androgen insensitivity syndrome (ais, 300068)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to androgen insensitivity syndrome (ais, 300068) | rel=r_associated | relid=0 | w=15
  743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to ankyloblepharon-ectodermal defects, cleft lip/palate syndrome (aec, 106260)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to ankyloblepharon-ectodermal defects, cleft lip/palate syndrome (aec, 106260) | rel=r_associated | relid=0 | w=15
  744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal dominant form (129490)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal dominant form (129490) | rel=r_associated | relid=0 | w=15
  745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal dominant nonsyndromic sensorineural deafness (dfna11, 601317) and usher syndrome type ib (276900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal dominant nonsyndromic sensorineural deafness (dfna11, 601317) and usher syndrome type ib (276900) | rel=r_associated | relid=0 | w=15
  746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal dominant optic atrophy and cataract (165300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal dominant optic atrophy and cataract (165300) | rel=r_associated | relid=0 | w=15
  747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal dominant spg13 (605280)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal dominant spg13 (605280) | rel=r_associated | relid=0 | w=15
  748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal recessive charcot-marie-tooth disease type 4c (601596)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal recessive charcot-marie-tooth disease type 4c (601596) | rel=r_associated | relid=0 | w=15
  749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal recessive deafness 21 (dfnb21, 603629)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal recessive deafness 21 (dfnb21, 603629) | rel=r_associated | relid=0 | w=15
  750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal recessive form (224900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal recessive form (224900) | rel=r_associated | relid=0 | w=15
  751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal recessive hearing loss (dfnb2, 600060) and usher syndrome type ib (276900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal recessive hearing loss (dfnb2, 600060) and usher syndrome type ib (276900) | rel=r_associated | relid=0 | w=15
  752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to autosomal recessive inclusion body myopathy-2 (ibm2, 600737)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to autosomal recessive inclusion body myopathy-2 (ibm2, 600737) | rel=r_associated | relid=0 | w=15
  753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to benign hereditary chorea (118700), which is less severe
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to benign hereditary chorea (118700), which is less severe | rel=r_associated | relid=0 | w=15
  754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to benign recurrent intrahepatic cholestasis (bric1, 243300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to benign recurrent intrahepatic cholestasis (bric1, 243300) | rel=r_associated | relid=0 | w=15
  755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to brachydactyly type b (113000)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to brachydactyly type b (113000) | rel=r_associated | relid=0 | w=15
  756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to branchiootic syndrome (bos1, 602588) and otofaciocervical syndrome (166780)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to branchiootic syndrome (bos1, 602588) and otofaciocervical syndrome (166780) | rel=r_associated | relid=0 | w=15
  757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to branchiootorenal syndrome (bor, 113650) and otofaciocervical syndrome (166780)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to branchiootorenal syndrome (bor, 113650) and otofaciocervical syndrome (166780) | rel=r_associated | relid=0 | w=15
  758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to charcot-marie-tooth disease 2f (cmt2f, 606595)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to charcot-marie-tooth disease 2f (cmt2f, 606595) | rel=r_associated | relid=0 | w=15
  759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to charcot-marie-tooth disease type 1a (118220)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to charcot-marie-tooth disease type 1a (118220) | rel=r_associated | relid=0 | w=15
  760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to charcot-marie-tooth disease type 2a2 (cmt2a2, 609260)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to charcot-marie-tooth disease type 2a2 (cmt2a2, 609260) | rel=r_associated | relid=0 | w=15
  761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to charcot-marie-tooth disease type 2d (cmt2d, 601472), but distinguished by less severe distal sensory involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to charcot-marie-tooth disease type 2d (cmt2d, 601472), but distinguished by less severe distal sensory involvement | rel=r_associated | relid=0 | w=15
  762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to child syndrome (308050)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to child syndrome (308050) | rel=r_associated | relid=0 | w=15
  763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (610978), which is a more severe disorder | rel=r_associated | relid=0 | w=15
  764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to cln8 (600143)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to cln8 (600143) | rel=r_associated | relid=0 | w=15
  765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to cmt4a (214400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to cmt4a (214400) | rel=r_associated | relid=0 | w=15
  766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to corticosterone methyloxidase type i deficiency (203400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to corticosterone methyloxidase type i deficiency (203400) | rel=r_associated | relid=0 | w=15
  767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to corticosterone methyloxidase type ii deficiency (610600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to corticosterone methyloxidase type ii deficiency (610600) | rel=r_associated | relid=0 | w=15
  768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to dilated cardiomyopathy 1n (cmd1n, 607487)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to dilated cardiomyopathy 1n (cmd1n, 607487) | rel=r_associated | relid=0 | w=15
  769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to distal spinal muscular atrophy type v (dsmav, 600794), but distinguished by more severe distal sensory involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to distal spinal muscular atrophy type v (dsmav, 600794), but distinguished by more severe distal sensory involvement | rel=r_associated | relid=0 | w=15
  770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to distal spinal muscular atrophy, type v (dsmav, 600794), but distinguished by the presence of spasticity
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to distal spinal muscular atrophy, type v (dsmav, 600794), but distinguished by the presence of spasticity | rel=r_associated | relid=0 | w=15
  771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to duane-radial ray syndrome (drrs, 607323)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to duane-radial ray syndrome (drrs, 607323) | rel=r_associated | relid=0 | w=15
  772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to dunnigan-type familial partial lipodystrophy (151660)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to dunnigan-type familial partial lipodystrophy (151660) | rel=r_associated | relid=0 | w=15
  773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to early-onset sarcoidosis (609464)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to early-onset sarcoidosis (609464) | rel=r_associated | relid=0 | w=15
  774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to ebs dowling-meara (131760), ebs koebner (131900), and ebs weber-cockayne (131800)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to ebs dowling-meara (131760), ebs koebner (131900), and ebs weber-cockayne (131800) | rel=r_associated | relid=0 | w=15
  775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (eec3, 604292)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (eec3, 604292) | rel=r_associated | relid=0 | w=15
  776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to episodic ataxia-2 (ea2, 108500) and spinocerebellar ataxia-6 (sca6, 183086)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to episodic ataxia-2 (ea2, 108500) and spinocerebellar ataxia-6 (sca6, 183086) | rel=r_associated | relid=0 | w=15
  777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to familial cylindromatosis (132700) and brooke-spielger syndrome (bss, 605041)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to familial cylindromatosis (132700) and brooke-spielger syndrome (bss, 605041) | rel=r_associated | relid=0 | w=15
  778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to familial hypertrophic cardiomyopathy (cmh, 192600) and laing distal myopathy (160500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to familial hypertrophic cardiomyopathy (cmh, 192600) and laing distal myopathy (160500) | rel=r_associated | relid=0 | w=15
  779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to generalized epilepsy with seizures-plus (gefs+, 604233)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to generalized epilepsy with seizures-plus (gefs+, 604233) | rel=r_associated | relid=0 | w=15
  780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to glut1 deficiency syndrome 1 (606777)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to glut1 deficiency syndrome 1 (606777) | rel=r_associated | relid=0 | w=15
  781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to hyperkalemic periodic paralysis (hypp, 170500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to hyperkalemic periodic paralysis (hypp, 170500) | rel=r_associated | relid=0 | w=15
  782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to hyperkalemic periodic paralysis (hypp, 608390)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to hyperkalemic periodic paralysis (hypp, 608390) | rel=r_associated | relid=0 | w=15
  783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to hypokalemic periodic paralysis (hokpp, 170400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to hypokalemic periodic paralysis (hokpp, 170400) | rel=r_associated | relid=0 | w=15
  784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to ifap syndrome (308205)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to ifap syndrome (308205) | rel=r_associated | relid=0 | w=15
  785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to infantile neuroaxonal dystrophy (256600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to infantile neuroaxonal dystrophy (256600) | rel=r_associated | relid=0 | w=15
  786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to infantile-onset ascending spastic paralysis (iahsp, 607225)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to infantile-onset ascending spastic paralysis (iahsp, 607225) | rel=r_associated | relid=0 | w=15
  787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to intrahepatic cholestasis of pregnancy (icp, 147480)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to intrahepatic cholestasis of pregnancy (icp, 147480) | rel=r_associated | relid=0 | w=15
  788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to juvenile amyotrophic lateral sclerosis 2 (als2, 205100)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to juvenile amyotrophic lateral sclerosis 2 (als2, 205100) | rel=r_associated | relid=0 | w=15
  789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to juvenile nephronophthisis-1 (256100)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to juvenile nephronophthisis-1 (256100) | rel=r_associated | relid=0 | w=15
  790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to juvenile primary lateral sclerosis (plsj, 606353)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to juvenile primary lateral sclerosis (plsj, 606353) | rel=r_associated | relid=0 | w=15
  791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to juvenile-onset amyotrophic lateral sclerosis (als2, 205100)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to juvenile-onset amyotrophic lateral sclerosis (als2, 205100) | rel=r_associated | relid=0 | w=15
  792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to limb girdle muscular dystrophy type 1c (lgmd1c, 607801)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to limb girdle muscular dystrophy type 1c (lgmd1c, 607801) | rel=r_associated | relid=0 | w=15
  793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to limb-girdle muscular dystrophy type 2b (lgmd2b, 253601)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to limb-girdle muscular dystrophy type 2b (lgmd2b, 253601) | rel=r_associated | relid=0 | w=15
  794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to limb-mammary syndrome (lms, 603543)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to limb-mammary syndrome (lms, 603543) | rel=r_associated | relid=0 | w=15
  795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to long qt syndrome-1 (lqt1, 192500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to long qt syndrome-1 (lqt1, 192500) | rel=r_associated | relid=0 | w=15
  796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to margarita island type of ectodermal dysplasia (225060)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to margarita island type of ectodermal dysplasia (225060) | rel=r_associated | relid=0 | w=15
  797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to miyoshi muscular dystrophy 3 (mmd3, 613319)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to miyoshi muscular dystrophy 3 (mmd3, 613319) | rel=r_associated | relid=0 | w=15
  798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to miyoshi myopathy (254130) and distal myopathy with anterior tibial onset (606768)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to miyoshi myopathy (254130) and distal myopathy with anterior tibial onset (606768) | rel=r_associated | relid=0 | w=15
  799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to multiple familial trichoepithelioma 1 (mft1, 601606) and brooke-spiegler syndrome (bss, 605041)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to multiple familial trichoepithelioma 1 (mft1, 601606) and brooke-spiegler syndrome (bss, 605041) | rel=r_associated | relid=0 | w=15
  800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to multiple familial trichoepithelioma 1 (mft1, 601606) and familial cylindromatosis (fc, 132700)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to multiple familial trichoepithelioma 1 (mft1, 601606) and familial cylindromatosis (fc, 132700) | rel=r_associated | relid=0 | w=15
  801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to neurodegeneration with brain iron accumulation 2b (nbia2b, 610217)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to neurodegeneration with brain iron accumulation 2b (nbia2b, 610217) | rel=r_associated | relid=0 | w=15
  802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to nf1
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to nf1 | rel=r_associated | relid=0 | w=15
  803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to nieman-pick disease type b (607616)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to nieman-pick disease type b (607616) | rel=r_associated | relid=0 | w=15
  804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to niemann-pick disease type a (257200)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to niemann-pick disease type a (257200) | rel=r_associated | relid=0 | w=15
  805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to nonaka myopathy (605820)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to nonaka myopathy (605820) | rel=r_associated | relid=0 | w=15
  806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to northern epilepsy (610003)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to northern epilepsy (610003) | rel=r_associated | relid=0 | w=15
  807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to opitz-kaveggia syndrome (305450)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to opitz-kaveggia syndrome (305450) | rel=r_associated | relid=0 | w=15
  808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to orofaciodigital syndrome 1 (ofd1, 311200)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to orofaciodigital syndrome 1 (ofd1, 311200) | rel=r_associated | relid=0 | w=15
  809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to osmed (215150) allelic disorder to weissenbacher-zweymuller syndrome (277610)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to osmed (215150) allelic disorder to weissenbacher-zweymuller syndrome (277610) | rel=r_associated | relid=0 | w=15
  810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to osteoporosis-pseudoglioma syndrome (oppg, 259770)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to osteoporosis-pseudoglioma syndrome (oppg, 259770) | rel=r_associated | relid=0 | w=15
  811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to paramyotonia congenita (168300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to paramyotonia congenita (168300) | rel=r_associated | relid=0 | w=15
  812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to parkinson disease-1 (park1, 168601)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to parkinson disease-1 (park1, 168601) | rel=r_associated | relid=0 | w=15
  813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to potassium-aggravated myotonia (608390)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to potassium-aggravated myotonia (608390) | rel=r_associated | relid=0 | w=15
  814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to primary erythermalgia (133020)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to primary erythermalgia (133020) | rel=r_associated | relid=0 | w=15
  815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to progressive familial intrahepatic cholestasis-1 (pfic1, 211600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to progressive familial intrahepatic cholestasis-1 (pfic1, 211600) | rel=r_associated | relid=0 | w=15
  816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to progressive familial intrahepatic cholestasis-2 (pfic2, 601847)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to progressive familial intrahepatic cholestasis-2 (pfic2, 601847) | rel=r_associated | relid=0 | w=15
  817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to rapp-hodgkin syndrome (rhs, 129400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to rapp-hodgkin syndrome (rhs, 129400) | rel=r_associated | relid=0 | w=15
  818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to rett syndrome (312750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to rett syndrome (312750) | rel=r_associated | relid=0 | w=15
  819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to rigid spine muscular dystrophy (rsmd1, 602771)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to rigid spine muscular dystrophy (rsmd1, 602771) | rel=r_associated | relid=0 | w=15
  820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to rippling muscle disease (rmd, 606072)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to rippling muscle disease (rmd, 606072) | rel=r_associated | relid=0 | w=15
  821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to schindler disease (609241)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to schindler disease (609241) | rel=r_associated | relid=0 | w=15
  822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to silver syndrome (270685), but distinguished by lack of spasticity
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to silver syndrome (270685), but distinguished by lack of spasticity | rel=r_associated | relid=0 | w=15
  823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to spastic paraplegia-3 (spg3, 182600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to spastic paraplegia-3 (spg3, 182600) | rel=r_associated | relid=0 | w=15
  824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to spinal muscular atrophy type i (253300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to spinal muscular atrophy type i (253300) | rel=r_associated | relid=0 | w=15
  825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to split-hand/foot malformation 4 (shfm4, 605289)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to split-hand/foot malformation 4 (shfm4, 605289) | rel=r_associated | relid=0 | w=15
  826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to stickler syndrome 3 (184840)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to stickler syndrome 3 (184840) | rel=r_associated | relid=0 | w=15
  827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to t cell-negative, b cell-negative, nk cell- negative scid (601457), which is more severe
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to t cell-negative, b cell-negative, nk cell- negative scid (601457), which is more severe | rel=r_associated | relid=0 | w=15
  828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to the ivic syndrome (147750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to the ivic syndrome (147750) | rel=r_associated | relid=0 | w=15
  829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to the zlotogora-ogur syndrome (225000)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to the zlotogora-ogur syndrome (225000) | rel=r_associated | relid=0 | w=15
  830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to type iv glycogen storage disease (232500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to type iv glycogen storage disease (232500) | rel=r_associated | relid=0 | w=15
  831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to usher syndrome type 1f (602083)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to usher syndrome type 1f (602083) | rel=r_associated | relid=0 | w=15
  832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorder to van der woude syndrome (vws, 119300) and popliteal pterygium syndrome (pps, 119500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorder to van der woude syndrome (vws, 119300) and popliteal pterygium syndrome (pps, 119500) | rel=r_associated | relid=0 | w=15
  833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with clinical overlap include dss and cmt1b (118200)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with clinical overlap include dss and cmt1b (118200) | rel=r_associated | relid=0 | w=15
  834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include autosomal dominant emery-dreifuss muscular dystrophy (181350), dilated cardiomyopathy type 1a (115200), and congenital muscular dystrophy (613205).
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include autosomal dominant emery-dreifuss muscular dystrophy (181350), dilated cardiomyopathy type 1a (115200), and congenital muscular dystrophy (613205). | rel=r_associated | relid=0 | w=15
  835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include charcot-marie-tooth disease type 1 (cmt1b, 118200 and cmt1a, 118220) and dejerine-sottas syndrome (dss, 145900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include charcot-marie-tooth disease type 1 (cmt1b, 118200 and cmt1a, 118220) and dejerine-sottas syndrome (dss, 145900) | rel=r_associated | relid=0 | w=15
  836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include cmt1a (118220), hereditary neuropathy with liability to pressure palsies (hnpp, 162500), and dejerine-sottas syndrome (dss, 145900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include cmt1a (118220), hereditary neuropathy with liability to pressure palsies (hnpp, 162500), and dejerine-sottas syndrome (dss, 145900) | rel=r_associated | relid=0 | w=15
  837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include congenital hypomyelinating neuropathy (chn, 605253) and dejerine-sottas syndrome (dss, 145900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include congenital hypomyelinating neuropathy (chn, 605253) and dejerine-sottas syndrome (dss, 145900) | rel=r_associated | relid=0 | w=15
  838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include dejerine-sottas syndrome (dss, 145900), hereditary neuropathy with liability to pressure palsies (hnpp, 162500), and cmt with deafness (118300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include dejerine-sottas syndrome (dss, 145900), hereditary neuropathy with liability to pressure palsies (hnpp, 162500), and cmt with deafness (118300) | rel=r_associated | relid=0 | w=15
  839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include dss, congenital hypomyelination (chn, 605253), and some forms of axonal cmt2 (see 607677)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include dss, congenital hypomyelination (chn, 605253), and some forms of axonal cmt2 (see 607677) | rel=r_associated | relid=0 | w=15
  840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include hereditary lymphedema type ii (153200), lymphedema and ptosis (153000), and the lymphedema-distichiasis syndrome (153400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include hereditary lymphedema type ii (153200), lymphedema and ptosis (153000), and the lymphedema-distichiasis syndrome (153400) | rel=r_associated | relid=0 | w=15
  841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic disorders with overlapping phenotypes include hereditary lymphedema type ii (153200), lymphedema and ptosis (153000), and yellow nail and lymphedema syndrome (153300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic disorders with overlapping phenotypes include hereditary lymphedema type ii (153200), lymphedema and ptosis (153000), and yellow nail and lymphedema syndrome (153300) | rel=r_associated | relid=0 | w=15
  842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to acrocapitofemoral dysplasia (607778)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to acrocapitofemoral dysplasia (607778) | rel=r_associated | relid=0 | w=15
  843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to acrokeratosis verruciformis (101900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to acrokeratosis verruciformis (101900) | rel=r_associated | relid=0 | w=15
  844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to acromesomelic dysplasia, hunter-thompson type (201250), brachydactyly, type c (113100), and fibular hypoplasia nd complex brachydactyly (228900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to acromesomelic dysplasia, hunter-thompson type (201250), brachydactyly, type c (113100), and fibular hypoplasia nd complex brachydactyly (228900) | rel=r_associated | relid=0 | w=15
  845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to adult syndrome (103285), shfm4 (605289), hay-wells syndrome (106260), and limb-mammary syndrome (603543)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to adult syndrome (103285), shfm4 (605289), hay-wells syndrome (106260), and limb-mammary syndrome (603543) | rel=r_associated | relid=0 | w=15
  846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to adult syndrome (103285), split hand/foot malformation 4 (605289), rapp-hodgkin syndrome (129400), hay-wells syndrome (106260), and limb-mammary syndrome (603543)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to adult syndrome (103285), split hand/foot malformation 4 (605289), rapp-hodgkin syndrome (129400), hay-wells syndrome (106260), and limb-mammary syndrome (603543) | rel=r_associated | relid=0 | w=15
  847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to aicardi-goutieres syndrome (225750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to aicardi-goutieres syndrome (225750) | rel=r_associated | relid=0 | w=15
  848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to anterior segment mesenchymal dysgenesis (107250)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to anterior segment mesenchymal dysgenesis (107250) | rel=r_associated | relid=0 | w=15
  849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to atelosteogenesis, type ii (256050), achondrogenesis, type ib (600972), and multiple epiphyseal dysplasia, type 4 (226900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to atelosteogenesis, type ii (256050), achondrogenesis, type ib (600972), and multiple epiphyseal dysplasia, type 4 (226900) | rel=r_associated | relid=0 | w=15
  850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to autosomal recessive pxe (264800)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to autosomal recessive pxe (264800) | rel=r_associated | relid=0 | w=15
  851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to bannayan-riley-ruvalcaba syndrome (153480), which has an earlier age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to bannayan-riley-ruvalcaba syndrome (153480), which has an earlier age at onset | rel=r_associated | relid=0 | w=15
  852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to bardet-biedl syndrome 6 (209900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to bardet-biedl syndrome 6 (209900) | rel=r_associated | relid=0 | w=15
  853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to birt-hogg-dube syndrome (135150)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to birt-hogg-dube syndrome (135150) | rel=r_associated | relid=0 | w=15
  854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to brachydactyly, type a1 (112500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to brachydactyly, type a1 (112500) | rel=r_associated | relid=0 | w=15
  855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to brachydactyly, type a2 (112600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to brachydactyly, type a2 (112600) | rel=r_associated | relid=0 | w=15
  856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to cartilage-hair hypoplasia (250250)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to cartilage-hair hypoplasia (250250) | rel=r_associated | relid=0 | w=15
  857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to cowden disease (158350), which has a later age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to cowden disease (158350), which has a later age at onset | rel=r_associated | relid=0 | w=15
  858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to craniometaphyseal dysplasia (123000)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to craniometaphyseal dysplasia (123000) | rel=r_associated | relid=0 | w=15
  859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to deafness, autosomal recessive 12 (601386)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to deafness, autosomal recessive 12 (601386) | rel=r_associated | relid=0 | w=15
  860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to deafness, autosomal recessive 23 (609533)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to deafness, autosomal recessive 23 (609533) | rel=r_associated | relid=0 | w=15
  861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to deafness, neurosensory, autosomal recessive 18 (602092)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to deafness, neurosensory, autosomal recessive 18 (602092) | rel=r_associated | relid=0 | w=15
  862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to dentin dysplasia, type 2 (125420)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to dentin dysplasia, type 2 (125420) | rel=r_associated | relid=0 | w=15
  863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to dentinogenesis imperfecta 1 (125490)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to dentinogenesis imperfecta 1 (125490) | rel=r_associated | relid=0 | w=15
  864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to diastrophic dysplasia (222600), achondrogenesis, type 1b (600972), and multiple epiphyseal dysplasia, type 4 (226900) | rel=r_associated | relid=0 | w=15
  865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to diastrophic dysplasia (222600), atelosteogenesis, type ii (256050), and achondrogenesis, type ib (600972)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to diastrophic dysplasia (222600), atelosteogenesis, type ii (256050), and achondrogenesis, type ib (600972) | rel=r_associated | relid=0 | w=15
  866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to dyggve-melchior-clausen disease (223800)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to dyggve-melchior-clausen disease (223800) | rel=r_associated | relid=0 | w=15
  867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to early-onset familial alzheimer disease (ad1, 104300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to early-onset familial alzheimer disease (ad1, 104300) | rel=r_associated | relid=0 | w=15
  868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to eec3 (604292), shfm4 (605289), adult syndrome (103285), limb-mammary syndrome (603543), and rapp-hodgkin syndrome (129400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to eec3 (604292), shfm4 (605289), adult syndrome (103285), limb-mammary syndrome (603543), and rapp-hodgkin syndrome (129400) | rel=r_associated | relid=0 | w=15
  869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to eec3 (604292), shfm4 (605289), rapp-hodgkin syndrome (129400), hay-wells syndrome (106260), and adult syndrome (103285)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to eec3 (604292), shfm4 (605289), rapp-hodgkin syndrome (129400), hay-wells syndrome (106260), and adult syndrome (103285) | rel=r_associated | relid=0 | w=15
  870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to ellis-van creveld syndrome (225500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to ellis-van creveld syndrome (225500) | rel=r_associated | relid=0 | w=15
  871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to enhanced s-cone syndrome (268100)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to enhanced s-cone syndrome (268100) | rel=r_associated | relid=0 | w=15
  872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to fechtner syndrome (153640), may-hegglin anomaly (155100), sebastian syndrome (605249), and epstein syndrome (153650)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to fechtner syndrome (153640), may-hegglin anomaly (155100), sebastian syndrome (605249), and epstein syndrome (153650) | rel=r_associated | relid=0 | w=15
  873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to fibular aplasia or hypoplasia, femoral bowing, and poly-, syn-, and oligodactyly (fuhrmann syndrome, 228930)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to fibular aplasia or hypoplasia, femoral bowing, and poly-, syn-, and oligodactyly (fuhrmann syndrome, 228930) | rel=r_associated | relid=0 | w=15
  874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to giant platelet syndrome (231200) and bernard-soulier syndrome, benign, autosomal dominant (153670)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to giant platelet syndrome (231200) and bernard-soulier syndrome, benign, autosomal dominant (153670) | rel=r_associated | relid=0 | w=15
  875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to grebe syndrome (200700), brachydactyly type c (113100), and acromesomelic dysplasia, hunter-thompson type (201250)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to grebe syndrome (200700), brachydactyly type c (113100), and acromesomelic dysplasia, hunter-thompson type (201250) | rel=r_associated | relid=0 | w=15
  876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to grebe syndrome (200700), brachydactyly, type c (113100), fibular hypoplasia and complex brachydactyly (228900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to grebe syndrome (200700), brachydactyly, type c (113100), fibular hypoplasia and complex brachydactyly (228900) | rel=r_associated | relid=0 | w=15
  877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to grebe syndrome (200700), du pan syndrome (228900), and acromesomelic dysplasia, hunter thompson type (201250)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to grebe syndrome (200700), du pan syndrome (228900), and acromesomelic dysplasia, hunter thompson type (201250) | rel=r_associated | relid=0 | w=15
  878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to groenouw type 1 corneal dystrophy (121900), thiel-behnke corneal dystrophy (602082), lattice type 1 corneal dystrophy (122200), lattice type iiia corneal dystrophy (608471), and reis-bucklers type corneal dystrophy (608470)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to groenouw type 1 corneal dystrophy (121900), thiel-behnke corneal dystrophy (602082), lattice type 1 corneal dystrophy (122200), lattice type iiia corneal dystrophy (608471), and reis-bucklers type corneal dystrophy (608470) | rel=r_associated | relid=0 | w=15
  879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hand osteoarthritis (607850)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hand osteoarthritis (607850) | rel=r_associated | relid=0 | w=15
  880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hawkinsinuria (140350)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hawkinsinuria (140350) | rel=r_associated | relid=0 | w=15
  881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hereditary multiple leiomyoma of skin (see 150800) and hereditary leiomyomatosis and renal cell cancer (150800)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hereditary multiple leiomyoma of skin (see 150800) and hereditary leiomyomatosis and renal cell cancer (150800) | rel=r_associated | relid=0 | w=15
  882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hydropic and prenatally lethal chondrodystrophy (215140)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hydropic and prenatally lethal chondrodystrophy (215140) | rel=r_associated | relid=0 | w=15
  883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hyperimmunoglobulinemia d syndrome (hids, 260920)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hyperimmunoglobulinemia d syndrome (hids, 260920) | rel=r_associated | relid=0 | w=15
  884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to hypoparathyroidism-retardation-dysmorphism syndrome (241410) | rel=r_associated | relid=0 | w=15
  885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to infantile sialic acid storage disorder (269920)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to infantile sialic acid storage disorder (269920) | rel=r_associated | relid=0 | w=15
  886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to joubert syndrome 5 (610188) and leber congenital amaurosis type x (610142)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to joubert syndrome 5 (610188) and leber congenital amaurosis type x (610142) | rel=r_associated | relid=0 | w=15
  887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to kenny-caffey syndrome type 1 (244460)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to kenny-caffey syndrome type 1 (244460) | rel=r_associated | relid=0 | w=15
  888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to kid syndrome (148210), dfna3 (601544), dfnb1 (220290), vohwinkel syndrome (124500), keratoderma, palmoplantar with deafness (148350)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to kid syndrome (148210), dfna3 (601544), dfnb1 (220290), vohwinkel syndrome (124500), keratoderma, palmoplantar with deafness (148350) | rel=r_associated | relid=0 | w=15
  889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to leopard syndrome (151100)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to leopard syndrome (151100) | rel=r_associated | relid=0 | w=15
  890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to leprechaunism (246200) and insulin-resistant diabetes mellitus with acanthosis nigricans (147670)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to leprechaunism (246200) and insulin-resistant diabetes mellitus with acanthosis nigricans (147670) | rel=r_associated | relid=0 | w=15
  891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to marshall syndrome (154780)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to marshall syndrome (154780) | rel=r_associated | relid=0 | w=15
  892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to may-hegglin anomaly (155100), fechtner syndrome (153640), epstein syndrome (153650) and deafness, autosomal dominant 17 (603622)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to may-hegglin anomaly (155100), fechtner syndrome (153640), epstein syndrome (153650) and deafness, autosomal dominant 17 (603622) | rel=r_associated | relid=0 | w=15
  893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to may-heglin anomaly (155100), sebastian syndrome (605249), epstein syndrome (153650), and deafness, autosomal dominant 17 (603622)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to may-heglin anomaly (155100), sebastian syndrome (605249), epstein syndrome (153650), and deafness, autosomal dominant 17 (603622) | rel=r_associated | relid=0 | w=15
  894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to metaphyseal dysplasia without hypotrichosis (250460)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to metaphyseal dysplasia without hypotrichosis (250460) | rel=r_associated | relid=0 | w=15
  895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to mevalonic aciduria (610377)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to mevalonic aciduria (610377) | rel=r_associated | relid=0 | w=15
  896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to mucolipidosis ii (252500)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to mucolipidosis ii (252500) | rel=r_associated | relid=0 | w=15
  897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to mucopolysaccharidosis ivb
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to mucopolysaccharidosis ivb | rel=r_associated | relid=0 | w=15
  898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to multiple epiphyseal dysplasia, type 5 (607078) and hand osteoarthritis (607850)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to multiple epiphyseal dysplasia, type 5 (607078) and hand osteoarthritis (607850) | rel=r_associated | relid=0 | w=15
  899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to multiple pterygium syndrome, lethal type (253290)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to multiple pterygium syndrome, lethal type (253290) | rel=r_associated | relid=0 | w=15
  900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to multiple synostoses syndrome 1 (186500), tarsal-carpal coalition syndrome (186570), and stapes ankylosis syndrome without symphalangism (184460)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to multiple synostoses syndrome 1 (186500), tarsal-carpal coalition syndrome (186570), and stapes ankylosis syndrome without symphalangism (184460) | rel=r_associated | relid=0 | w=15
  901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to myosin storage myopathy (608358)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to myosin storage myopathy (608358) | rel=r_associated | relid=0 | w=15
  902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to naxos disease (601214)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to naxos disease (601214) | rel=r_associated | relid=0 | w=15
  903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to nephronophthisis 4 (606966)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to nephronophthisis 4 (606966) | rel=r_associated | relid=0 | w=15
  904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to neurofibromatosis-1 (nf1, 162200)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to neurofibromatosis-1 (nf1, 162200) | rel=r_associated | relid=0 | w=15
  905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to noonan syndrome (163950)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to noonan syndrome (163950) | rel=r_associated | relid=0 | w=15
  906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to osmed (215150) and weissenbacher-zweymuller syndrome (277610)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to osmed (215150) and weissenbacher-zweymuller syndrome (277610) | rel=r_associated | relid=0 | w=15
  907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to osteopetrosis (259700)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to osteopetrosis (259700) | rel=r_associated | relid=0 | w=15
  908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to osteoporosis-pseudoglioma syndrome (259770), van buchem type 2 (607636), autosomal dominant osteosclerosis (144750), type i osteopetrosis (607634)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to osteoporosis-pseudoglioma syndrome (259770), van buchem type 2 (607636), autosomal dominant osteosclerosis (144750), type i osteopetrosis (607634) | rel=r_associated | relid=0 | w=15
  909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to osteoporosis-pseudoglioma syndrome (259770), van buchem type 2 (607636), high bone mass (601884), autosomal dominant endosteal hyperostosis (144750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to osteoporosis-pseudoglioma syndrome (259770), van buchem type 2 (607636), high bone mass (601884), autosomal dominant endosteal hyperostosis (144750) | rel=r_associated | relid=0 | w=15
  910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to pachyonychia congenita jackson-lawler type (167210)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to pachyonychia congenita jackson-lawler type (167210) | rel=r_associated | relid=0 | w=15
  911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to papillon-lefevre syndrome (245000) and haim-munk syndrome (245010)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to papillon-lefevre syndrome (245000) and haim-munk syndrome (245010) | rel=r_associated | relid=0 | w=15
  912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to papillon-lefevre syndrome (245000) and juvenile periodontitis (170650)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to papillon-lefevre syndrome (245000) and juvenile periodontitis (170650) | rel=r_associated | relid=0 | w=15
  913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to pendred syndrome, deafness with goiter (274600)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to pendred syndrome, deafness with goiter (274600) | rel=r_associated | relid=0 | w=15
  914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to proximal symphalangism (185800), multiple synostoses syndrome (186500), and stapes ankylosis syndrome without symphalangism (184460)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to proximal symphalangism (185800), multiple synostoses syndrome (186500), and stapes ankylosis syndrome without symphalangism (184460) | rel=r_associated | relid=0 | w=15
  915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to proximal symphalangism (185800), multiple synostoses syndrome (186500), and tarsal-carpal coalition syndrome (186570)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to proximal symphalangism (185800), multiple synostoses syndrome (186500), and tarsal-carpal coalition syndrome (186570) | rel=r_associated | relid=0 | w=15
  916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to proximal symphalangism (185800), multiple synostoses syndrome 1 (186500), tarsal-carpal coalition syndrome (186570), and stapes ankylosis syndrome without symphalangism (184460)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to proximal symphalangism (185800), multiple synostoses syndrome 1 (186500), tarsal-carpal coalition syndrome (186570), and stapes ankylosis syndrome without symphalangism (184460) | rel=r_associated | relid=0 | w=15
  917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to proximal symphalangism (185800), stapes ankylosis syndrome without symphalangism (184460), and tarsal-carpal coalition syndrome (186570)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to proximal symphalangism (185800), stapes ankylosis syndrome without symphalangism (184460), and tarsal-carpal coalition syndrome (186570) | rel=r_associated | relid=0 | w=15
  918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to pseudoachondroplasia (177170)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to pseudoachondroplasia (177170) | rel=r_associated | relid=0 | w=15
  919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to retinitis punctata albescens (136880), fundus albipunctatus (136880), autosomal recessive retinitis pigmentosa (268000), newfoundland rod-cone dystrophy (607476)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to retinitis punctata albescens (136880), fundus albipunctatus (136880), autosomal recessive retinitis pigmentosa (268000), newfoundland rod-cone dystrophy (607476) | rel=r_associated | relid=0 | w=15
  920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to rett syndrome (312750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to rett syndrome (312750) | rel=r_associated | relid=0 | w=15
  921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to roberts syndrome (268300)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to roberts syndrome (268300) | rel=r_associated | relid=0 | w=15
  922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to robinow syndrome, autosomal recessive (268310)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to robinow syndrome, autosomal recessive (268310) | rel=r_associated | relid=0 | w=15
  923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to senior-loken syndrome 1 (266900) and joubert syndrome 4 (609583)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to senior-loken syndrome 1 (266900) and joubert syndrome 4 (609583) | rel=r_associated | relid=0 | w=15
  924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to senior-loken syndrome 4 (606996)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to senior-loken syndrome 4 (606996) | rel=r_associated | relid=0 | w=15
  925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to senior-loken syndrome 6 (610189) and leber congenital amaurosis type x (610142)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to senior-loken syndrome 6 (610189) and leber congenital amaurosis type x (610142) | rel=r_associated | relid=0 | w=15
  926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to several forms of autosomal recessive cmt (see 214400)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to several forms of autosomal recessive cmt (see 214400) | rel=r_associated | relid=0 | w=15
  927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to sialuria, finnish type (604369)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to sialuria, finnish type (604369) | rel=r_associated | relid=0 | w=15
  928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to spondyloepimetaphyseal dysplasia, matn-3 related (608728)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to spondyloepimetaphyseal dysplasia, matn-3 related (608728) | rel=r_associated | relid=0 | w=15
  929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to stickler syndrome, type 3 (184840) and osmed (215150)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to stickler syndrome, type 3 (184840) and osmed (215150) | rel=r_associated | relid=0 | w=15
  930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to stickler syndrome, type 3 (184840) and weissenbacher-zweymuller syndrome (277610)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to stickler syndrome, type 3 (184840) and weissenbacher-zweymuller syndrome (277610) | rel=r_associated | relid=0 | w=15
  931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to the less severe harp syndrome (607236), which is distinguished by the presence of hypobetalipoproteinemia and acanthocytosis
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to the less severe harp syndrome (607236), which is distinguished by the presence of hypobetalipoproteinemia and acanthocytosis | rel=r_associated | relid=0 | w=15
  932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to the more severe pantothenate kinase-associated neurodegeneration (nbia1, 234200)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to the more severe pantothenate kinase-associated neurodegeneration (nbia1, 234200) | rel=r_associated | relid=0 | w=15
  933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to trichorhinophalangeal syndrome, type iii (trps3, 190351)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to trichorhinophalangeal syndrome, type iii (trps3, 190351) | rel=r_associated | relid=0 | w=15
  934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to trp1 (190350)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to trp1 (190350) | rel=r_associated | relid=0 | w=15
  935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to type i osteopetrosis (607634), osteoporosis-pseudoglioma (259770), high bone mass (601884), autosomal dominant endosteal hyperostosis (144750)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to type i osteopetrosis (607634), osteoporosis-pseudoglioma (259770), high bone mass (601884), autosomal dominant endosteal hyperostosis (144750) | rel=r_associated | relid=0 | w=15
  936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to type i osteopetrosis (607634), osteoporosis-pseudoglioma (259770), type ii van buchem disease (607636), and high bone mass (601884)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to type i osteopetrosis (607634), osteoporosis-pseudoglioma (259770), type ii van buchem disease (607636), and high bone mass (601884) | rel=r_associated | relid=0 | w=15
  937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to tyrosinemia, type iii (276720)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to tyrosinemia, type iii (276720) | rel=r_associated | relid=0 | w=15
  938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to ulnar and fibula, absence of, with severe limb deficiency (al-awadi/raas-rothschild/schinzel phocomelia syndrome 276820)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to ulnar and fibula, absence of, with severe limb deficiency (al-awadi/raas-rothschild/schinzel phocomelia syndrome 276820) | rel=r_associated | relid=0 | w=15
  939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to usher syndrome, type id (601067)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to usher syndrome, type id (601067) | rel=r_associated | relid=0 | w=15
  940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to waardenburg syndrome, type iia (193510)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to waardenburg syndrome, type iia (193510) | rel=r_associated | relid=0 | w=15
  941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to wiskott-aldrich syndrome (301000) and severe congenital x-linked neutropenia (300299)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to wiskott-aldrich syndrome (301000) and severe congenital x-linked neutropenia (300299) | rel=r_associated | relid=0 | w=15
  942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic to wiskott-aldrich syndrome (301000) and x-linked thrombocytopenia (313900)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic to wiskott-aldrich syndrome (301000) and x-linked thrombocytopenia (313900) | rel=r_associated | relid=0 | w=15
  943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic with cone-rod dystrophy 10 (610283)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic with cone-rod dystrophy 10 (610283) | rel=r_associated | relid=0 | w=15
  944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic with dentinogenesis imperfecta 1 (125490) and dentin dysplasia, type ii (125420)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic with dentinogenesis imperfecta 1 (125490) and dentin dysplasia, type ii (125420) | rel=r_associated | relid=0 | w=15
  945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic with retinitis pigmentosa 35 (610282)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic with retinitis pigmentosa 35 (610282) | rel=r_associated | relid=0 | w=15
  946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allelic with smith-mccort dysplasia (607326)
    n1=Hyde (prurigo nodulaire de) | n2=en:allelic with smith-mccort dysplasia (607326) | rel=r_associated | relid=0 | w=15
  947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:allophanate hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:allophanate hydrolase | rel=r_associated | relid=0 | w=15
  948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:almost all patients require total parenteral nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:almost all patients require total parenteral nutrition | rel=r_associated | relid=0 | w=15
  949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alopecia may spontaneously regress, become chronic, or spread diffusely
    n1=Hyde (prurigo nodulaire de) | n2=en:alopecia may spontaneously regress, become chronic, or spread diffusely | rel=r_associated | relid=0 | w=15
  950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alopecia usually occurs around puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:alopecia usually occurs around puberty | rel=r_associated | relid=0 | w=15
  951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha fetoprotein increased
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=15
  952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha thalassemia-mental retardation syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha thalassemia-mental retardation syndrome | rel=r_associated | relid=0 | w=15
  953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha-aminoacylpeptide hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-aminoacylpeptide hydrolase | rel=r_associated | relid=0 | w=15
  954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha-glutamyl-glutamate dipeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-glutamyl-glutamate dipeptidase | rel=r_associated | relid=0 | w=15
  955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha-l-iduronidase
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-l-iduronidase | rel=r_associated | relid=0 | w=15
  956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha-l-iduronidase activity is <1% for all forms of mps1
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-l-iduronidase activity is <1% for all forms of mps1 | rel=r_associated | relid=0 | w=15
  957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alpha-n-acetylglucosaminidase
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha-n-acetylglucosaminidase | rel=r_associated | relid=0 | w=15
  958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:also called 'heterozygous osmed' and 'autosomal dominant osmed'
    n1=Hyde (prurigo nodulaire de) | n2=en:also called 'heterozygous osmed' and 'autosomal dominant osmed' | rel=r_associated | relid=0 | w=15
  959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:alternating hemiplegia of childhood (104290) is an allelic disorder with an overlapping phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:alternating hemiplegia of childhood (104290) is an allelic disorder with an overlapping phenotype | rel=r_associated | relid=0 | w=15
  960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ambulation difficulty
    n1=Hyde (prurigo nodulaire de) | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=15
  961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ambulation is preserved
    n1=Hyde (prurigo nodulaire de) | n2=en:ambulation is preserved | rel=r_associated | relid=0 | w=15
  962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ambulation is usually maintained during adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:ambulation is usually maintained during adulthood | rel=r_associated | relid=0 | w=15
  963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ambulation usually not achieved
    n1=Hyde (prurigo nodulaire de) | n2=en:ambulation usually not achieved | rel=r_associated | relid=0 | w=15
  964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amelioration with age
    n1=Hyde (prurigo nodulaire de) | n2=en:amelioration with age | rel=r_associated | relid=0 | w=15
  965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amidase
    n1=Hyde (prurigo nodulaire de) | n2=en:amidase | rel=r_associated | relid=0 | w=15
  966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amidohydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:amidohydrolases | rel=r_associated | relid=0 | w=15
  967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amino acid injection solution
    n1=Hyde (prurigo nodulaire de) | n2=en:amino acid injection solution | rel=r_associated | relid=0 | w=15
  968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amino acids+glycerin
    n1=Hyde (prurigo nodulaire de) | n2=en:amino acids+glycerin | rel=r_associated | relid=0 | w=15
  969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amino sugars
    n1=Hyde (prurigo nodulaire de) | n2=en:amino sugars | rel=r_associated | relid=0 | w=15
  970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aminoacyl-histidine dipeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:aminoacyl-histidine dipeptidase | rel=r_associated | relid=0 | w=15
  971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aminoacyl-methylhistidine dipeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:aminoacyl-methylhistidine dipeptidase | rel=r_associated | relid=0 | w=15
  972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aminoacylase
    n1=Hyde (prurigo nodulaire de) | n2=en:aminoacylase | rel=r_associated | relid=0 | w=15
  973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aminohydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:aminohydrolases | rel=r_associated | relid=0 | w=15
  974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aminopeptidase ey
    n1=Hyde (prurigo nodulaire de) | n2=en:aminopeptidase ey | rel=r_associated | relid=0 | w=15
  975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amnionitis
    n1=Hyde (prurigo nodulaire de) | n2=en:amnionitis | rel=r_associated | relid=0 | w=15
  976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic band syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic band syndrome | rel=r_associated | relid=0 | w=15
  977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic cavity and membrane problem
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic cavity and membrane problem | rel=r_associated | relid=0 | w=15
  978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic cavity disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic cavity disorder | rel=r_associated | relid=0 | w=15
  979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic cyst
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic cyst | rel=r_associated | relid=0 | w=15
  980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic fluid | rel=r_associated | relid=0 | w=15
  981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic fluid and cavity disorders of pregnancy nec
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic fluid and cavity disorders of pregnancy nec | rel=r_associated | relid=0 | w=15
  982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic fluid leak
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic fluid leak | rel=r_associated | relid=0 | w=15
  983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic infection syndrome of blane
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic infection syndrome of blane | rel=r_associated | relid=0 | w=15
  984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amniotic membrane finding
    n1=Hyde (prurigo nodulaire de) | n2=en:amniotic membrane finding | rel=r_associated | relid=0 | w=15
  985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amp nucleosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:amp nucleosidase | rel=r_associated | relid=0 | w=15
  986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:amylo-1,6-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:amylo-1,6-glucosidase | rel=r_associated | relid=0 | w=15
  987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:an autosomal recessive form has been reported (269720)
    n1=Hyde (prurigo nodulaire de) | n2=en:an autosomal recessive form has been reported (269720) | rel=r_associated | relid=0 | w=15
  988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia does not respond to alpha-interferon treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia does not respond to alpha-interferon treatment | rel=r_associated | relid=0 | w=15
  989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia is responsive to corticosteroid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia is responsive to corticosteroid treatment | rel=r_associated | relid=0 | w=15
  990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia is transfusion-dependent
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia is transfusion-dependent | rel=r_associated | relid=0 | w=15
  991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia may show favorable response to alpha-interferon treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia may show favorable response to alpha-interferon treatment | rel=r_associated | relid=0 | w=15
  992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia may show onset in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia may show onset in infancy | rel=r_associated | relid=0 | w=15
  993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anemia, diabetes, and deafness often show onset at different ages
    n1=Hyde (prurigo nodulaire de) | n2=en:anemia, diabetes, and deafness often show onset at different ages | rel=r_associated | relid=0 | w=15
  994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anesthesia complications include difficult intubation secondary to microstomia and risk of malignant hyperthermia
    n1=Hyde (prurigo nodulaire de) | n2=en:anesthesia complications include difficult intubation secondary to microstomia and risk of malignant hyperthermia | rel=r_associated | relid=0 | w=15
  995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:angiotensin-converting enzyme
    n1=Hyde (prurigo nodulaire de) | n2=en:angiotensin-converting enzyme | rel=r_associated | relid=0 | w=15
  996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:angular pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:angular pregnancy | rel=r_associated | relid=0 | w=15
  997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:anhydramnios | rel=r_associated | relid=0 | w=15
  998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:annular protein subunit
    n1=Hyde (prurigo nodulaire de) | n2=en:annular protein subunit | rel=r_associated | relid=0 | w=15
  999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antenatal onset
    n1=Hyde (prurigo nodulaire de) | n2=en:antenatal onset | rel=r_associated | relid=0 | w=15
  1000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antepartum hemorrhage
    n1=Hyde (prurigo nodulaire de) | n2=en:antepartum hemorrhage | rel=r_associated | relid=0 | w=15
  1001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antepartum hemorrhage, not elsewhere classified in icd10cm
    n1=Hyde (prurigo nodulaire de) | n2=en:antepartum hemorrhage, not elsewhere classified in icd10cm | rel=r_associated | relid=0 | w=15
  1002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antepartum uterine rupture
    n1=Hyde (prurigo nodulaire de) | n2=en:antepartum uterine rupture | rel=r_associated | relid=0 | w=15
  1003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antibodies can develop after pregnancy or transfusion
    n1=Hyde (prurigo nodulaire de) | n2=en:antibodies can develop after pregnancy or transfusion | rel=r_associated | relid=0 | w=15
  1004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anticonvulsants are effective (phenobarbital, valproic acid, benzodiazepines)
    n1=Hyde (prurigo nodulaire de) | n2=en:anticonvulsants are effective (phenobarbital, valproic acid, benzodiazepines) | rel=r_associated | relid=0 | w=15
  1005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:anticonvulsants are effective one family of thai origin has been reported (last curated march 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:anticonvulsants are effective one family of thai origin has been reported (last curated march 2013) | rel=r_associated | relid=0 | w=15
  1006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:antioxidant
    n1=Hyde (prurigo nodulaire de) | n2=en:antioxidant | rel=r_associated | relid=0 | w=15
  1007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aortic dissection may occur in second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:aortic dissection may occur in second decade of life | rel=r_associated | relid=0 | w=15
  1008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:apparent at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:apparent at birth | rel=r_associated | relid=0 | w=15
  1009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:apparent in newborn at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:apparent in newborn at birth | rel=r_associated | relid=0 | w=15
  1010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:appear normal at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:appear normal at birth | rel=r_associated | relid=0 | w=15
  1011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 10% of als cases are familial
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 10% of als cases are familial | rel=r_associated | relid=0 | w=15
  1012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 12 patients have been reported (as of march 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 12 patients have been reported (as of march 2010) | rel=r_associated | relid=0 | w=15
  1013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 25% have a severe course and die of respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 25% have a severe course and die of respiratory failure | rel=r_associated | relid=0 | w=15
  1014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 35% of patients die during the first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 35% of patients die during the first 2 years of life | rel=r_associated | relid=0 | w=15
  1015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 40% of cases are inherited or new germline mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 40% of cases are inherited or new germline mutations | rel=r_associated | relid=0 | w=15
  1016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 40% of patients die within newborn period
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 40% of patients die within newborn period | rel=r_associated | relid=0 | w=15
  1017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 45% of sma1 patients also are missing both homologs of neuronal apoptosis inhibitory protein (naip, 600355), which may play a role in modifying disease severity
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 45% of sma1 patients also are missing both homologs of neuronal apoptosis inhibitory protein (naip, 600355), which may play a role in modifying disease severity | rel=r_associated | relid=0 | w=15
  1018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 50% of cases are acute, severe neonatal illness often with rapid death and 50% are chronic episodic with asymptomatic intervals
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 50% of cases are acute, severe neonatal illness often with rapid death and 50% are chronic episodic with asymptomatic intervals | rel=r_associated | relid=0 | w=15
  1019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 50% of patients have situs inversus
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 50% of patients have situs inversus | rel=r_associated | relid=0 | w=15
  1020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 50db loss in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 50db loss in adulthood | rel=r_associated | relid=0 | w=15
  1021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 60% of brrs patients have pten mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 60% of brrs patients have pten mutations | rel=r_associated | relid=0 | w=15
  1022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 60% of cases are due to somatic mutations and are unilateral
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 60% of cases are due to somatic mutations and are unilateral | rel=r_associated | relid=0 | w=15
  1023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 70-80% of cases are de novo and sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 70-80% of cases are de novo and sporadic | rel=r_associated | relid=0 | w=15
  1024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 80% of cs patients have pten mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 80% of cs patients have pten mutations | rel=r_associated | relid=0 | w=15
  1025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately 85% of type ii patients are homozygous for a missense mutation m136t (102600.0003)
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately 85% of type ii patients are homozygous for a missense mutation m136t (102600.0003) | rel=r_associated | relid=0 | w=15
  1026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately half of cases are due to de novo deletions
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately half of cases are due to de novo deletions | rel=r_associated | relid=0 | w=15
  1027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately half of cases are due to unbalanced rearrangements, which may be familial
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately half of cases are due to unbalanced rearrangements, which may be familial | rel=r_associated | relid=0 | w=15
  1028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately half of patients need ambulatory support after the fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately half of patients need ambulatory support after the fifth decade | rel=r_associated | relid=0 | w=15
  1029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately half of the mutations are de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately half of the mutations are de novo | rel=r_associated | relid=0 | w=15
  1030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately one-third of patients become seizure-free with age
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately one-third of patients become seizure-free with age | rel=r_associated | relid=0 | w=15
  1031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:approximately one-third of patients eventually lose outer hair cell function and have profound sensorineural deafness (after 10 to 20 years) | rel=r_associated | relid=0 | w=15
  1032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:apyrase
    n1=Hyde (prurigo nodulaire de) | n2=en:apyrase | rel=r_associated | relid=0 | w=15
  1033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aquired delta-spd seen in myeloproliferative disorders, myelodysplasia, and acute leukemia
    n1=Hyde (prurigo nodulaire de) | n2=en:aquired delta-spd seen in myeloproliferative disorders, myelodysplasia, and acute leukemia | rel=r_associated | relid=0 | w=15
  1034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arginine deiminase
    n1=Hyde (prurigo nodulaire de) | n2=en:arginine deiminase | rel=r_associated | relid=0 | w=15
  1035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arginine hydrochloride 100mg/ml injection solution 100ml vial
    n1=Hyde (prurigo nodulaire de) | n2=en:arginine hydrochloride 100mg/ml injection solution 100ml vial | rel=r_associated | relid=0 | w=15
  1036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arrhythmias detected prenatally (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:arrhythmias detected prenatally (in some patients) | rel=r_associated | relid=0 | w=15
  1037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arteriovenous malformations can occur throughout the body
    n1=Hyde (prurigo nodulaire de) | n2=en:arteriovenous malformations can occur throughout the body | rel=r_associated | relid=0 | w=15
  1038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arthralgia
    n1=Hyde (prurigo nodulaire de) | n2=en:arthralgia | rel=r_associated | relid=0 | w=15
  1039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:artificial sweetener
    n1=Hyde (prurigo nodulaire de) | n2=en:artificial sweetener | rel=r_associated | relid=0 | w=15
  1040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aryl acylamidase
    n1=Hyde (prurigo nodulaire de) | n2=en:aryl acylamidase | rel=r_associated | relid=0 | w=15
  1041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arylalkyl acylamidase
    n1=Hyde (prurigo nodulaire de) | n2=en:arylalkyl acylamidase | rel=r_associated | relid=0 | w=15
  1042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:arylesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:arylesterase | rel=r_associated | relid=0 | w=15
  1043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:as of 2009, one family has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:as of 2009, one family has been reported | rel=r_associated | relid=0 | w=15
  1044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:as of 4/2011, 2 patients have been described in detail
    n1=Hyde (prurigo nodulaire de) | n2=en:as of 4/2011, 2 patients have been described in detail | rel=r_associated | relid=0 | w=15
  1045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ascorbic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:ascorbic acid | rel=r_associated | relid=0 | w=15
  1046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asparaginylendopeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:asparaginylendopeptidase | rel=r_associated | relid=0 | w=15
  1047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aspects of mortality statistics
    n1=Hyde (prurigo nodulaire de) | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=15
  1048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aspects of radionuclide imaging
    n1=Hyde (prurigo nodulaire de) | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=15
  1049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aspergillopepsin i
    n1=Hyde (prurigo nodulaire de) | n2=en:aspergillopepsin i | rel=r_associated | relid=0 | w=15
  1050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated specifically with the gba d409h mutation (606463.0006)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated specifically with the gba d409h mutation (606463.0006) | rel=r_associated | relid=0 | w=15
  1051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with a balanced translocation t(12,22)(p11.2,q13.3)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with a balanced translocation t(12,22)(p11.2,q13.3) | rel=r_associated | relid=0 | w=15
  1052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with a disease-specific sequence change, referred to as 'dsc3,' within an open-reading frame (orf) of a 'multiple transcript system' known as dyt3
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with a disease-specific sequence change, referred to as 'dsc3,' within an open-reading frame (orf) of a 'multiple transcript system' known as dyt3 | rel=r_associated | relid=0 | w=15
  1053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with advanced paternal age
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with advanced paternal age | rel=r_associated | relid=0 | w=15
  1054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with deletion at chromosome 2q37
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with deletion at chromosome 2q37 | rel=r_associated | relid=0 | w=15
  1055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with fragile x syndrome (300624)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with fragile x syndrome (300624) | rel=r_associated | relid=0 | w=15
  1056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with fragile x syndrome (309550)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with fragile x syndrome (309550) | rel=r_associated | relid=0 | w=15
  1057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with hemodialysis
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with hemodialysis | rel=r_associated | relid=0 | w=15
  1058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with hla-dqa1*01, hla-dqb1*05, and hla-dqa1*01/dqb1*05 high association with hla-drb1*0102 (relative risk 167.1)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with hla-dqa1*01, hla-dqb1*05, and hla-dqa1*01/dqb1*05 high association with hla-drb1*0102 (relative risk 167.1) | rel=r_associated | relid=0 | w=15
  1059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with idiopathic generalized epilepsy (ige, 600669)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with idiopathic generalized epilepsy (ige, 600669) | rel=r_associated | relid=0 | w=15
  1060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with imprinting and epigenetic defects in the g-protein, alpha-stimulating 1 gene (gnas1, 139320)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with imprinting and epigenetic defects in the g-protein, alpha-stimulating 1 gene (gnas1, 139320) | rel=r_associated | relid=0 | w=15
  1061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with increased frequency of autoimmune diseases
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with increased frequency of autoimmune diseases | rel=r_associated | relid=0 | w=15
  1062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with increased paternal age
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with increased paternal age | rel=r_associated | relid=0 | w=15
  1063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with increasing age
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with increasing age | rel=r_associated | relid=0 | w=15
  1064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with iron deficiency anemia
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with iron deficiency anemia | rel=r_associated | relid=0 | w=15
  1065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with malignant hyperthermia (mhs, 145600)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with malignant hyperthermia (mhs, 145600) | rel=r_associated | relid=0 | w=15
  1066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with myoclonic epilepsy
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with myoclonic epilepsy | rel=r_associated | relid=0 | w=15
  1067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with several congenital malformation syndromes (wagr 194072, beckwith-wiedemann syndrome 130650, abnormal urogenital development syndromes)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with several congenital malformation syndromes (wagr 194072, beckwith-wiedemann syndrome 130650, abnormal urogenital development syndromes) | rel=r_associated | relid=0 | w=15
  1068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with several loci on chromosomes 11p15 (wt2, 194071), 16 (wt3, 194090), 17 (wt4, 601363), and 7 (wt5, 601583).
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with several loci on chromosomes 11p15 (wt2, 194071), 16 (wt3, 194090), 17 (wt4, 601363), and 7 (wt5, 601583). | rel=r_associated | relid=0 | w=15
  1069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with smoking
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with smoking | rel=r_associated | relid=0 | w=15
  1070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with susceptibility loci on chromosome 11p11 (clls1, 609630), 13q14 (clls2, 109543), 9q34.1 (clls3, 612557), 6p25.3 (clls4, 612558), and 11q24.1 (clls5, 612559)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with susceptibility loci on chromosome 11p11 (clls1, 609630), 13q14 (clls2, 109543), 9q34.1 (clls3, 612557), 6p25.3 (clls4, 612558), and 11q24.1 (clls5, 612559) | rel=r_associated | relid=0 | w=15
  1071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with the tau (157140) h1 haplotype
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with the tau (157140) h1 haplotype | rel=r_associated | relid=0 | w=15
  1072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with trauma and impaired wound repair (alcoholism, diabetes, substance abuse, liver disease)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with trauma and impaired wound repair (alcoholism, diabetes, substance abuse, liver disease) | rel=r_associated | relid=0 | w=15
  1073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with tuberous sclerosis (191100)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with tuberous sclerosis (191100) | rel=r_associated | relid=0 | w=15
  1074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:associated with untreated phenylketonuria (261600)
    n1=Hyde (prurigo nodulaire de) | n2=en:associated with untreated phenylketonuria (261600) | rel=r_associated | relid=0 | w=15
  1075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:association between hla class ii alleles and presence of autoantibodies
    n1=Hyde (prurigo nodulaire de) | n2=en:association between hla class ii alleles and presence of autoantibodies | rel=r_associated | relid=0 | w=15
  1076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:association of cardiac events with exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:association of cardiac events with exercise | rel=r_associated | relid=0 | w=15
  1077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:association with autoimmune diseases
    n1=Hyde (prurigo nodulaire de) | n2=en:association with autoimmune diseases | rel=r_associated | relid=0 | w=15
  1078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:association with the hla-drb1*1501-dqb1*0602 haplotype has been repeatedly demonstrated in high-risk (northern european) populations.
    n1=Hyde (prurigo nodulaire de) | n2=en:association with the hla-drb1*1501-dqb1*0602 haplotype has been repeatedly demonstrated in high-risk (northern european) populations. | rel=r_associated | relid=0 | w=15
  1079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asymptomatic carriers of a pericentric chromosome 8 inversion, inv(8), have a 6.2% risk of having an affected child with an unbalanced recombinant chromosome 8, rec(8).
    n1=Hyde (prurigo nodulaire de) | n2=en:asymptomatic carriers of a pericentric chromosome 8 inversion, inv(8), have a 6.2% risk of having an affected child with an unbalanced recombinant chromosome 8, rec(8). | rel=r_associated | relid=0 | w=15
  1080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asymptomatic heterozygotes susceptible to lead toxicity
    n1=Hyde (prurigo nodulaire de) | n2=en:asymptomatic heterozygotes susceptible to lead toxicity | rel=r_associated | relid=0 | w=15
  1081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asymptomatic if papillary zone is spared
    n1=Hyde (prurigo nodulaire de) | n2=en:asymptomatic if papillary zone is spared | rel=r_associated | relid=0 | w=15
  1082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asymptomatic skin lesions begin on neck in third decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:asymptomatic skin lesions begin on neck in third decade of life | rel=r_associated | relid=0 | w=15
  1083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:asymptomatic younger patients show characteristic basal ganglia calcifications
    n1=Hyde (prurigo nodulaire de) | n2=en:asymptomatic younger patients show characteristic basal ganglia calcifications | rel=r_associated | relid=0 | w=15
  1084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:at birth, there is generalized red scaly skin
    n1=Hyde (prurigo nodulaire de) | n2=en:at birth, there is generalized red scaly skin | rel=r_associated | relid=0 | w=15
  1085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ataxia becomes evident at the end of the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:ataxia becomes evident at the end of the first year of life | rel=r_associated | relid=0 | w=15
  1086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ataxia is nonprogressive
    n1=Hyde (prurigo nodulaire de) | n2=en:ataxia is nonprogressive | rel=r_associated | relid=0 | w=15
  1087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ataxia is slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:ataxia is slowly progressive | rel=r_associated | relid=0 | w=15
  1088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atelosteogenesis, type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:atelosteogenesis, type 1 | rel=r_associated | relid=0 | w=15
  1089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atpase
    n1=Hyde (prurigo nodulaire de) | n2=en:atpase | rel=r_associated | relid=0 | w=15
  1090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atpase wrnip1
    n1=Hyde (prurigo nodulaire de) | n2=en:atpase wrnip1 | rel=r_associated | relid=0 | w=15
  1091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atrolysin b
    n1=Hyde (prurigo nodulaire de) | n2=en:atrolysin b | rel=r_associated | relid=0 | w=15
  1092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atrolysin e
    n1=Hyde (prurigo nodulaire de) | n2=en:atrolysin e | rel=r_associated | relid=0 | w=15
  1093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atroxase
    n1=Hyde (prurigo nodulaire de) | n2=en:atroxase | rel=r_associated | relid=0 | w=15
  1094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attack frequency may occur several times per week to once per year
    n1=Hyde (prurigo nodulaire de) | n2=en:attack frequency may occur several times per week to once per year | rel=r_associated | relid=0 | w=15
  1095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks are not responsive to acetazolamide
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks are not responsive to acetazolamide | rel=r_associated | relid=0 | w=15
  1096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks may present during or after sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks may present during or after sleep | rel=r_associated | relid=0 | w=15
  1097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks more common in women
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks more common in women | rel=r_associated | relid=0 | w=15
  1098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks often drug-induced
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks often drug-induced | rel=r_associated | relid=0 | w=15
  1099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks precipitated by drugs (e.g. barbiturates, sulfonamides), alcohol, infection, starvation, and hormonal changes
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks precipitated by drugs (e.g. barbiturates, sulfonamides), alcohol, infection, starvation, and hormonal changes | rel=r_associated | relid=0 | w=15
  1100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks precipitated by drugs, alcohol, and endocrine factors (hcp)
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks precipitated by drugs, alcohol, and endocrine factors (hcp) | rel=r_associated | relid=0 | w=15
  1101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | rel=r_associated | relid=0 | w=15
  1102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks rarely occur before puberty (hcp)
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks rarely occur before puberty (hcp) | rel=r_associated | relid=0 | w=15
  1103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks tend to decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks tend to decrease with age | rel=r_associated | relid=0 | w=15
  1104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks triggered by catabolic stress, such as fever or illness
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks triggered by catabolic stress, such as fever or illness | rel=r_associated | relid=0 | w=15
  1105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:attacks typically last for minutes
    n1=Hyde (prurigo nodulaire de) | n2=en:attacks typically last for minutes | rel=r_associated | relid=0 | w=15
  1106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atypical affected males, 'cardiac variants' 301500.0005 exist
    n1=Hyde (prurigo nodulaire de) | n2=en:atypical affected males, 'cardiac variants' 301500.0005 exist | rel=r_associated | relid=0 | w=15
  1107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atypical hemolytic-uremic syndrome shows onset in first 12 months
    n1=Hyde (prurigo nodulaire de) | n2=en:atypical hemolytic-uremic syndrome shows onset in first 12 months | rel=r_associated | relid=0 | w=15
  1108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:atypical: onset in second decade, slow progression, maintenance of independent ambulation up to 40 years later
    n1=Hyde (prurigo nodulaire de) | n2=en:atypical: onset in second decade, slow progression, maintenance of independent ambulation up to 40 years later | rel=r_associated | relid=0 | w=15
  1109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:aura may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:aura may occur | rel=r_associated | relid=0 | w=15
  1110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autonomic dysfunction usually precedes obvious neurologic deterioration
    n1=Hyde (prurigo nodulaire de) | n2=en:autonomic dysfunction usually precedes obvious neurologic deterioration | rel=r_associated | relid=0 | w=15
  1111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autonomic symptoms occur with headaches
    n1=Hyde (prurigo nodulaire de) | n2=en:autonomic symptoms occur with headaches | rel=r_associated | relid=0 | w=15
  1112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant (177000.0003)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant (177000.0003) | rel=r_associated | relid=0 | w=15
  1113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant and autosomal recessive forms
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant and autosomal recessive forms | rel=r_associated | relid=0 | w=15
  1114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant dopa-responsive dystonia (dyt5, 128230) is an allelic disorder with overlapping features
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant dopa-responsive dystonia (dyt5, 128230) is an allelic disorder with overlapping features | rel=r_associated | relid=0 | w=15
  1115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant inheritance has been rarely reported (187800)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant inheritance has been rarely reported (187800) | rel=r_associated | relid=0 | w=15
  1116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant inheritance has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant inheritance has been reported | rel=r_associated | relid=0 | w=15
  1117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant inheritance has been reported in a single family
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant inheritance has been reported in a single family | rel=r_associated | relid=0 | w=15
  1118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant inheritance is more common
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant inheritance is more common | rel=r_associated | relid=0 | w=15
  1119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant omodysplasia has also been described (164745)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant omodysplasia has also been described (164745) | rel=r_associated | relid=0 | w=15
  1120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant transmission has been rarely reported
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant transmission has been rarely reported | rel=r_associated | relid=0 | w=15
  1121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant with complete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant with complete penetrance | rel=r_associated | relid=0 | w=15
  1122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal dominant with incomplete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant with incomplete penetrance | rel=r_associated | relid=0 | w=15
  1123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive (177000.0006)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive (177000.0006) | rel=r_associated | relid=0 | w=15
  1124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive and dominant pedigrees described
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive and dominant pedigrees described | rel=r_associated | relid=0 | w=15
  1125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cases have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cases have been reported | rel=r_associated | relid=0 | w=15
  1126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cases tend to have a more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cases tend to have a more severe phenotype | rel=r_associated | relid=0 | w=15
  1127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cytochrome b-negative cgd (233690)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cytochrome b-negative cgd (233690) | rel=r_associated | relid=0 | w=15
  1128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cytochrome b-positive cgd, type i
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cytochrome b-positive cgd, type i | rel=r_associated | relid=0 | w=15
  1129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cytochrome b-positive cgd, type i (233700)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cytochrome b-positive cgd, type i (233700) | rel=r_associated | relid=0 | w=15
  1130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cytochrome b-positive cgd, type ii
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cytochrome b-positive cgd, type ii | rel=r_associated | relid=0 | w=15
  1131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive cytochrome b-positive cgd, type ii (233710)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive cytochrome b-positive cgd, type ii (233710) | rel=r_associated | relid=0 | w=15
  1132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive disorder tends to be more severe
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive disorder tends to be more severe | rel=r_associated | relid=0 | w=15
  1133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive form (240220)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive form (240220) | rel=r_associated | relid=0 | w=15
  1134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive form (277720) has also been described
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive form (277720) has also been described | rel=r_associated | relid=0 | w=15
  1135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance (245600) has also been suggested
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance (245600) has also been suggested | rel=r_associated | relid=0 | w=15
  1136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance can occur
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance can occur | rel=r_associated | relid=0 | w=15
  1137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has also been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has also been reported | rel=r_associated | relid=0 | w=15
  1138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been described in 2 families
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been described in 2 families | rel=r_associated | relid=0 | w=15
  1139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been reported | rel=r_associated | relid=0 | w=15
  1140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been reported (see 601253.0010)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been reported (see 601253.0010) | rel=r_associated | relid=0 | w=15
  1141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been reported in 1 case
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been reported in 1 case | rel=r_associated | relid=0 | w=15
  1142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been reported in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been reported in 1 family | rel=r_associated | relid=0 | w=15
  1143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been reported in 1 family (as of april 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been reported in 1 family (as of april 2011) | rel=r_associated | relid=0 | w=15
  1144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance has been suggested
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance has been suggested | rel=r_associated | relid=0 | w=15
  1145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance in one family (see 603342.0010)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance in one family (see 603342.0010) | rel=r_associated | relid=0 | w=15
  1146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance is most common
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance is most common | rel=r_associated | relid=0 | w=15
  1147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance with decreased penetrance (50%) is associated with a susceptibility locus on chromosome 10q26
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance with decreased penetrance (50%) is associated with a susceptibility locus on chromosome 10q26 | rel=r_associated | relid=0 | w=15
  1148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance with earlier onset has been reported in 3 patients
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance with earlier onset has been reported in 3 patients | rel=r_associated | relid=0 | w=15
  1149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive inheritance with earlier onset has been suggested
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive inheritance with earlier onset has been suggested | rel=r_associated | relid=0 | w=15
  1150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:autosomal recessive omodysplasia has also been described (258315)
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal recessive omodysplasia has also been described (258315) | rel=r_associated | relid=0 | w=15
  1151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:av119
    n1=Hyde (prurigo nodulaire de) | n2=en:av119 | rel=r_associated | relid=0 | w=15
  1152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at death is 37 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at death is 37 years | rel=r_associated | relid=0 | w=15
  1153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at diagnosis 17.8 years (range 2-35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at diagnosis 17.8 years (range 2-35 years) | rel=r_associated | relid=0 | w=15
  1154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 16.6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 16.6 years | rel=r_associated | relid=0 | w=15
  1155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 18 years (range 15 to 25 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 18 years (range 15 to 25 years) | rel=r_associated | relid=0 | w=15
  1156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 18.6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 18.6 years | rel=r_associated | relid=0 | w=15
  1157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 19 years (range 5 to 38)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 19 years (range 5 to 38) | rel=r_associated | relid=0 | w=15
  1158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 31 years (range 7 to 54)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 31 years (range 7 to 54) | rel=r_associated | relid=0 | w=15
  1159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 38 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 38 years | rel=r_associated | relid=0 | w=15
  1160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset 66 years although earlier onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset 66 years although earlier onset may occur | rel=r_associated | relid=0 | w=15
  1161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset between 40 and 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset between 40 and 50 years | rel=r_associated | relid=0 | w=15
  1162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age at onset is 24 years (range 4 to 58 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age at onset is 24 years (range 4 to 58 years) | rel=r_associated | relid=0 | w=15
  1163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age of onset 13 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age of onset 13 years | rel=r_associated | relid=0 | w=15
  1164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age of onset 15 years (range 4 to 40)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age of onset 15 years (range 4 to 40) | rel=r_associated | relid=0 | w=15
  1165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age of onset 57 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average age of onset 57 years | rel=r_associated | relid=0 | w=15
  1166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average age of onset 6 months (range birth - 2 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:average age of onset 6 months (range birth - 2 years) | rel=r_associated | relid=0 | w=15
  1167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average disease duration of 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average disease duration of 7 years | rel=r_associated | relid=0 | w=15
  1168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average duration of illness 8 years
    n1=Hyde (prurigo nodulaire de) | n2=en:average duration of illness 8 years | rel=r_associated | relid=0 | w=15
  1169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average onset 6 months (range 3-9)
    n1=Hyde (prurigo nodulaire de) | n2=en:average onset 6 months (range 3-9) | rel=r_associated | relid=0 | w=15
  1170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average onset 6-10 months (range 3-24)
    n1=Hyde (prurigo nodulaire de) | n2=en:average onset 6-10 months (range 3-24) | rel=r_associated | relid=0 | w=15
  1171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:average onset of seizures 6 months (range 3-12)
    n1=Hyde (prurigo nodulaire de) | n2=en:average onset of seizures 6 months (range 3-12) | rel=r_associated | relid=0 | w=15
  1172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bacillus subtilis ribonuclease
    n1=Hyde (prurigo nodulaire de) | n2=en:bacillus subtilis ribonuclease | rel=r_associated | relid=0 | w=15
  1173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:barrierpepsin
    n1=Hyde (prurigo nodulaire de) | n2=en:barrierpepsin | rel=r_associated | relid=0 | w=15
  1174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bartter syndrome, antenatal type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:bartter syndrome, antenatal type 1 | rel=r_associated | relid=0 | w=15
  1175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bartter syndrome, antenatal, type 2
    n1=Hyde (prurigo nodulaire de) | n2=en:bartter syndrome, antenatal, type 2 | rel=r_associated | relid=0 | w=15
  1176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bartter syndrome, type 4a
    n1=Hyde (prurigo nodulaire de) | n2=en:bartter syndrome, type 4a | rel=r_associated | relid=0 | w=15
  1177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bartter syndrome, type 4b
    n1=Hyde (prurigo nodulaire de) | n2=en:bartter syndrome, type 4b | rel=r_associated | relid=0 | w=15
  1178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:basal cell neoplasms develop after second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:basal cell neoplasms develop after second decade | rel=r_associated | relid=0 | w=15
  1179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:basal metabolic rate index:arbitrary concentration:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:basal metabolic rate index:arbitrary concentration:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  1180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 5-generation family (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 5-generation family (last curated january 2015) | rel=r_associated | relid=0 | w=15
  1181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 family (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 family (last curated september 2012) | rel=r_associated | relid=0 | w=15
  1182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 patient with compound heterozygous mutation in ttc21b (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 patient with compound heterozygous mutation in ttc21b (last curated february 2014) | rel=r_associated | relid=0 | w=15
  1183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 report of monozygotic twins (last curated may 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 report of monozygotic twins (last curated may 2014) | rel=r_associated | relid=0 | w=15
  1184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 reported family (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 reported family (last curated december 2013) | rel=r_associated | relid=0 | w=15
  1185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 reported family with oca6
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 reported family with oca6 | rel=r_associated | relid=0 | w=15
  1186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 reported patient (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 reported patient (last curated november 2013) | rel=r_associated | relid=0 | w=15
  1187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 1 uruguayan family (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 1 uruguayan family (last curated april 2014) | rel=r_associated | relid=0 | w=15
  1188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 families described with no mutations in the vitamin d receptor gene (vdr, 601769)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 families described with no mutations in the vitamin d receptor gene (vdr, 601769) | rel=r_associated | relid=0 | w=15
  1189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 patients from 1 consanguineous lebanese family (as of april 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 patients from 1 consanguineous lebanese family (as of april 2010) | rel=r_associated | relid=0 | w=15
  1190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 reported patients (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 reported patients (last curated january 2013) | rel=r_associated | relid=0 | w=15
  1191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 reported patients, 1 male and 1 female (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 reported patients, 1 male and 1 female (last curated august 2013) | rel=r_associated | relid=0 | w=15
  1192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 reports of 3 patients (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 reports of 3 patients (last curated september 2012) | rel=r_associated | relid=0 | w=15
  1193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 siblings in 1 family (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 siblings in 1 family (last curated september 2012) | rel=r_associated | relid=0 | w=15
  1194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 2 unrelated chinese families (last curated july 2014).
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 2 unrelated chinese families (last curated july 2014). | rel=r_associated | relid=0 | w=15
  1195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 3 patients from 2 families (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 3 patients from 2 families (last curated january 2015) | rel=r_associated | relid=0 | w=15
  1196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 4 patients in one family
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 4 patients in one family | rel=r_associated | relid=0 | w=15
  1197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on 4 reported patients (last curated april 2013) repeated first-trimester abortions in mothers of 2 probands
    n1=Hyde (prurigo nodulaire de) | n2=en:based on 4 reported patients (last curated april 2013) repeated first-trimester abortions in mothers of 2 probands | rel=r_associated | relid=0 | w=15
  1198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on description of 1 family (last curated april 2006)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on description of 1 family (last curated april 2006) | rel=r_associated | relid=0 | w=15
  1199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on four patients in a four generation family
    n1=Hyde (prurigo nodulaire de) | n2=en:based on four patients in a four generation family | rel=r_associated | relid=0 | w=15
  1200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on one finnish family
    n1=Hyde (prurigo nodulaire de) | n2=en:based on one finnish family | rel=r_associated | relid=0 | w=15
  1201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on one patient (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on one patient (last curated february 2015) | rel=r_associated | relid=0 | w=15
  1202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on one report of a 4-generation family with 4 affected males and 6 affected females
    n1=Hyde (prurigo nodulaire de) | n2=en:based on one report of a 4-generation family with 4 affected males and 6 affected females | rel=r_associated | relid=0 | w=15
  1203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on one report of brother and sister
    n1=Hyde (prurigo nodulaire de) | n2=en:based on one report of brother and sister | rel=r_associated | relid=0 | w=15
  1204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 3-generation family (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 3-generation family (last curated november 2014) | rel=r_associated | relid=0 | w=15
  1205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 consanguineous kurdish family with 4 affected sisters (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 consanguineous kurdish family with 4 affected sisters (last curated october 2014) | rel=r_associated | relid=0 | w=15
  1206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 consanguineous turkish family (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 consanguineous turkish family (last curated june 2014) | rel=r_associated | relid=0 | w=15
  1207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 family (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 family (last curated february 2015) | rel=r_associated | relid=0 | w=15
  1208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 family (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 family (last curated january 2014) | rel=r_associated | relid=0 | w=15
  1209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 family (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 family (last curated october 2014) | rel=r_associated | relid=0 | w=15
  1210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 japanese family (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 japanese family (last curated november 2013) | rel=r_associated | relid=0 | w=15
  1211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 1 saudi arabian family (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 1 saudi arabian family (last curated february 2015) | rel=r_associated | relid=0 | w=15
  1212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 consanguineous arab families (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 consanguineous arab families (last curated november 2014) | rel=r_associated | relid=0 | w=15
  1213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 families (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 families (last curated january 2014) | rel=r_associated | relid=0 | w=15
  1214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 individuals in 1 consanguineous family (last curated may 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 individuals in 1 consanguineous family (last curated may 2014) | rel=r_associated | relid=0 | w=15
  1215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 patients with dhtkd1 mutation (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 patients with dhtkd1 mutation (last curated november 2014) | rel=r_associated | relid=0 | w=15
  1216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 siblings and 1 patient (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 siblings and 1 patient (last curated december 2014) | rel=r_associated | relid=0 | w=15
  1217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 sibs in 2008
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 sibs in 2008 | rel=r_associated | relid=0 | w=15
  1218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 2 sisters (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 2 sisters (last curated october 2012) | rel=r_associated | relid=0 | w=15
  1219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of 5 brothers of arab-moslem descent (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of 5 brothers of arab-moslem descent (last curated february 2015) | rel=r_associated | relid=0 | w=15
  1220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of one consanguineous kuwaiti family (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of one consanguineous kuwaiti family (last curated december 2014) | rel=r_associated | relid=0 | w=15
  1221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on report of one polish roma patient (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on report of one polish roma patient (last curated november 2014) | rel=r_associated | relid=0 | w=15
  1222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on reports of one consanguineous saudi family and one consanguineous turkish family (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on reports of one consanguineous saudi family and one consanguineous turkish family (last curated december 2014) | rel=r_associated | relid=0 | w=15
  1223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:based on the report of one lebanese family (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:based on the report of one lebanese family (last curated october 2014) | rel=r_associated | relid=0 | w=15
  1224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:because of overlap with bardet-biedl syndrome (209900), patients should be followed by ophthalmology for development of cone-rod dystrophy until at least 10 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:because of overlap with bardet-biedl syndrome (209900), patients should be followed by ophthalmology for development of cone-rod dystrophy until at least 10 years of age | rel=r_associated | relid=0 | w=15
  1225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:begins as focal dystonia, later becomes segmental or generalized
    n1=Hyde (prurigo nodulaire de) | n2=en:begins as focal dystonia, later becomes segmental or generalized | rel=r_associated | relid=0 | w=15
  1226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:begins in feet and legs (peroneal distribution)
    n1=Hyde (prurigo nodulaire de) | n2=en:begins in feet and legs (peroneal distribution) | rel=r_associated | relid=0 | w=15
  1227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:begins in hands or feet, later generalized
    n1=Hyde (prurigo nodulaire de) | n2=en:begins in hands or feet, later generalized | rel=r_associated | relid=0 | w=15
  1228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:behavioral problems including stubbornness and rage
    n1=Hyde (prurigo nodulaire de) | n2=en:behavioral problems including stubbornness and rage | rel=r_associated | relid=0 | w=15
  1229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:benign condition
    n1=Hyde (prurigo nodulaire de) | n2=en:benign condition | rel=r_associated | relid=0 | w=15
  1230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:benign neonatal familial convulsions (see 601764, 121200, 121201, and 269720)
    n1=Hyde (prurigo nodulaire de) | n2=en:benign neonatal familial convulsions (see 601764, 121200, 121201, and 269720) | rel=r_associated | relid=0 | w=15
  1231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:benign trait
    n1=Hyde (prurigo nodulaire de) | n2=en:benign trait | rel=r_associated | relid=0 | w=15
  1232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:benign, asymptomatic defect
    n1=Hyde (prurigo nodulaire de) | n2=en:benign, asymptomatic defect | rel=r_associated | relid=0 | w=15
  1233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-aspartyl-n-acetylglucosaminidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-aspartyl-n-acetylglucosaminidase | rel=r_associated | relid=0 | w=15
  1234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-carotene
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-carotene | rel=r_associated | relid=0 | w=15
  1235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-galactosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-galactosidase | rel=r_associated | relid=0 | w=15
  1236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-glucuronidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-glucuronidase | rel=r_associated | relid=0 | w=15
  1237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-l-rhamnosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-l-rhamnosidase | rel=r_associated | relid=0 | w=15
  1238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-lytic metalloendopeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-lytic metalloendopeptidase | rel=r_associated | relid=0 | w=15
  1239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-n-acetylhexosaminidase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-n-acetylhexosaminidase | rel=r_associated | relid=0 | w=15
  1240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:beta-ureidopropionase
    n1=Hyde (prurigo nodulaire de) | n2=en:beta-ureidopropionase | rel=r_associated | relid=0 | w=15
  1241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bethlem myopathy (158810) is an allelic disorder with a milder phenotype and autosomal dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:bethlem myopathy (158810) is an allelic disorder with a milder phenotype and autosomal dominant inheritance | rel=r_associated | relid=0 | w=15
  1242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:between 2 and 7% of children will develop afebrile seizure disorders later in life
    n1=Hyde (prurigo nodulaire de) | n2=en:between 2 and 7% of children will develop afebrile seizure disorders later in life | rel=r_associated | relid=0 | w=15
  1243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bifunctional purine biosynthesis protein purh
    n1=Hyde (prurigo nodulaire de) | n2=en:bifunctional purine biosynthesis protein purh | rel=r_associated | relid=0 | w=15
  1244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bilateral involvement in 10% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:bilateral involvement in 10% of cases | rel=r_associated | relid=0 | w=15
  1245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bile salt hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:bile salt hydrolase | rel=r_associated | relid=0 | w=15
  1246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bimodal age of onset
    n1=Hyde (prurigo nodulaire de) | n2=en:bimodal age of onset | rel=r_associated | relid=0 | w=15
  1247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bimodal onset in early childhood (median 5 years) and young adulthood (21 to 30 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:bimodal onset in early childhood (median 5 years) and young adulthood (21 to 30 years) | rel=r_associated | relid=0 | w=15
  1248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bioformation
    n1=Hyde (prurigo nodulaire de) | n2=en:bioformation | rel=r_associated | relid=0 | w=15
  1249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biogenic amines
    n1=Hyde (prurigo nodulaire de) | n2=en:biogenic amines | rel=r_associated | relid=0 | w=15
  1250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biogenic peptide
    n1=Hyde (prurigo nodulaire de) | n2=en:biogenic peptide | rel=r_associated | relid=0 | w=15
  1251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biological factors
    n1=Hyde (prurigo nodulaire de) | n2=en:biological factors | rel=r_associated | relid=0 | w=15
  1252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biological macromolecular activity [moa]
    n1=Hyde (prurigo nodulaire de) | n2=en:biological macromolecular activity [moa] | rel=r_associated | relid=0 | w=15
  1253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biological molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:biological molecule | rel=r_associated | relid=0 | w=15
  1254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:biomedical and dental materials
    n1=Hyde (prurigo nodulaire de) | n2=en:biomedical and dental materials | rel=r_associated | relid=0 | w=15
  1255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:birth date:time stamp -- date and time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:birth date:time stamp -- date and time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  1256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:birth rate of 7.6 per 1,000,000
    n1=Hyde (prurigo nodulaire de) | n2=en:birth rate of 7.6 per 1,000,000 | rel=r_associated | relid=0 | w=15
  1257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bis(2-ethylhexyl)phthalate esterase
    n1=Hyde (prurigo nodulaire de) | n2=en:bis(2-ethylhexyl)phthalate esterase | rel=r_associated | relid=0 | w=15
  1258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bis(5'-nucleosyl)tetraphosphatase (asymmetrical)
    n1=Hyde (prurigo nodulaire de) | n2=en:bis(5'-nucleosyl)tetraphosphatase (asymmetrical) | rel=r_associated | relid=0 | w=15
  1259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bleeding after trauma or surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:bleeding after trauma or surgery | rel=r_associated | relid=0 | w=15
  1260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bleeding episodes occur early in life and may disappear with age
    n1=Hyde (prurigo nodulaire de) | n2=en:bleeding episodes occur early in life and may disappear with age | rel=r_associated | relid=0 | w=15
  1261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bleeding is usually delayed-onset after challenge
    n1=Hyde (prurigo nodulaire de) | n2=en:bleeding is usually delayed-onset after challenge | rel=r_associated | relid=0 | w=15
  1262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bleeding meckel's diverticulum
    n1=Hyde (prurigo nodulaire de) | n2=en:bleeding meckel's diverticulum | rel=r_associated | relid=0 | w=15
  1263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blindness episodes are not associated with fhm episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:blindness episodes are not associated with fhm episodes | rel=r_associated | relid=0 | w=15
  1264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blistering and erosions tend to occur on extensor surfaces or over bony prominences
    n1=Hyde (prurigo nodulaire de) | n2=en:blistering and erosions tend to occur on extensor surfaces or over bony prominences | rel=r_associated | relid=0 | w=15
  1265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blistering becomes confined to the palms and soles with age
    n1=Hyde (prurigo nodulaire de) | n2=en:blistering becomes confined to the palms and soles with age | rel=r_associated | relid=0 | w=15
  1266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blistering frequency may decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:blistering frequency may decrease with age | rel=r_associated | relid=0 | w=15
  1267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blistering may worsen during the summer
    n1=Hyde (prurigo nodulaire de) | n2=en:blistering may worsen during the summer | rel=r_associated | relid=0 | w=15
  1268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blistering tends to improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:blistering tends to improve with age | rel=r_associated | relid=0 | w=15
  1269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blisters are precipitated by minor skin trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:blisters are precipitated by minor skin trauma | rel=r_associated | relid=0 | w=15
  1270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blood clots in membranes
    n1=Hyde (prurigo nodulaire de) | n2=en:blood clots in membranes | rel=r_associated | relid=0 | w=15
  1271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blood glucose measurement
    n1=Hyde (prurigo nodulaire de) | n2=en:blood glucose measurement | rel=r_associated | relid=0 | w=15
  1272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blood glucose monitor with integrated lancing/blood sample
    n1=Hyde (prurigo nodulaire de) | n2=en:blood glucose monitor with integrated lancing/blood sample | rel=r_associated | relid=0 | w=15
  1273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:blood glucose monitor with integrated voice synthesizer
    n1=Hyde (prurigo nodulaire de) | n2=en:blood glucose monitor with integrated voice synthesizer | rel=r_associated | relid=0 | w=15
  1274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:body habitus becomes apparent in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:body habitus becomes apparent in childhood | rel=r_associated | relid=0 | w=15
  1275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:body weight
    n1=Hyde (prurigo nodulaire de) | n2=en:body weight | rel=r_associated | relid=0 | w=15
  1276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bohring syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:bohring syndrome | rel=r_associated | relid=0 | w=15
  1277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bone abnormalities improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:bone abnormalities improve with age | rel=r_associated | relid=0 | w=15
  1278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bone changes tend to develop after first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:bone changes tend to develop after first decade | rel=r_associated | relid=0 | w=15
  1279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bone morphogenetic protein 1
    n1=Hyde (prurigo nodulaire de) | n2=en:bone morphogenetic protein 1 | rel=r_associated | relid=0 | w=15
  1280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bonneau syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:bonneau syndrome | rel=r_associated | relid=0 | w=15
  1281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both autosomal dominant and autosomal recessive inheritance has been described
    n1=Hyde (prurigo nodulaire de) | n2=en:both autosomal dominant and autosomal recessive inheritance has been described | rel=r_associated | relid=0 | w=15
  1282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both autosomal dominant and autosomal recessive inheritance have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:both autosomal dominant and autosomal recessive inheritance have been reported | rel=r_associated | relid=0 | w=15
  1283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both contiguous gene syndromes show similar features such as cystinuria, growth impairment, and hypotonia
    n1=Hyde (prurigo nodulaire de) | n2=en:both contiguous gene syndromes show similar features such as cystinuria, growth impairment, and hypotonia | rel=r_associated | relid=0 | w=15
  1284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both demyelinating and axonal features
    n1=Hyde (prurigo nodulaire de) | n2=en:both demyelinating and axonal features | rel=r_associated | relid=0 | w=15
  1285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both germline (familial) and somatic (sporadic) mutation in kit (164920) and pdgfra (173490) have been found
    n1=Hyde (prurigo nodulaire de) | n2=en:both germline (familial) and somatic (sporadic) mutation in kit (164920) and pdgfra (173490) have been found | rel=r_associated | relid=0 | w=15
  1286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both heterozygous and homozygous mutations have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:both heterozygous and homozygous mutations have been reported | rel=r_associated | relid=0 | w=15
  1287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both heterozygous and homozygous pax3 mutations have been found
    n1=Hyde (prurigo nodulaire de) | n2=en:both heterozygous and homozygous pax3 mutations have been found | rel=r_associated | relid=0 | w=15
  1288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both homozygous and heterozygous edn3 mutations have been found
    n1=Hyde (prurigo nodulaire de) | n2=en:both homozygous and heterozygous edn3 mutations have been found | rel=r_associated | relid=0 | w=15
  1289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both homozygous and heterozygous ednrb mutations have been found
    n1=Hyde (prurigo nodulaire de) | n2=en:both homozygous and heterozygous ednrb mutations have been found | rel=r_associated | relid=0 | w=15
  1290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both homozygous and heterozygous mutations in lrsam1 have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:both homozygous and heterozygous mutations in lrsam1 have been reported | rel=r_associated | relid=0 | w=15
  1291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both recessive and dominant inheritance have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:both recessive and dominant inheritance have been reported | rel=r_associated | relid=0 | w=15
  1292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:both reported cases survived beyond infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:both reported cases survived beyond infancy | rel=r_associated | relid=0 | w=15
  1293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bothrolysin
    n1=Hyde (prurigo nodulaire de) | n2=en:bothrolysin | rel=r_associated | relid=0 | w=15
  1294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:boys are more often affected than girls (3:2)
    n1=Hyde (prurigo nodulaire de) | n2=en:boys are more often affected than girls (3:2) | rel=r_associated | relid=0 | w=15
  1295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:brain anomalies variable
    n1=Hyde (prurigo nodulaire de) | n2=en:brain anomalies variable | rel=r_associated | relid=0 | w=15
  1296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:brain mri abnormalities show improvement with time
    n1=Hyde (prurigo nodulaire de) | n2=en:brain mri abnormalities show improvement with time | rel=r_associated | relid=0 | w=15
  1297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:brainstem, cerebellum, anterior inner rim of the corpus callosum, posterior limb of the internal capsule and the external capsule, and anterior inner rim of the corpus callosum may show disease involvement on mri
    n1=Hyde (prurigo nodulaire de) | n2=en:brainstem, cerebellum, anterior inner rim of the corpus callosum, posterior limb of the internal capsule and the external capsule, and anterior inner rim of the corpus callosum may show disease involvement on mri | rel=r_associated | relid=0 | w=15
  1298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:brainstem, cerebellum, internal and external capsule, inner rim of the corpus callosum may show disease involvement on mri
    n1=Hyde (prurigo nodulaire de) | n2=en:brainstem, cerebellum, internal and external capsule, inner rim of the corpus callosum may show disease involvement on mri | rel=r_associated | relid=0 | w=15
  1299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:breast feeding
    n1=Hyde (prurigo nodulaire de) | n2=en:breast feeding | rel=r_associated | relid=0 | w=15
  1300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:breech position
    n1=Hyde (prurigo nodulaire de) | n2=en:breech position | rel=r_associated | relid=0 | w=15
  1301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:breech presentation
    n1=Hyde (prurigo nodulaire de) | n2=en:breech presentation | rel=r_associated | relid=0 | w=15
  1302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:broad range in severity of presentation in sibships
    n1=Hyde (prurigo nodulaire de) | n2=en:broad range in severity of presentation in sibships | rel=r_associated | relid=0 | w=15
  1303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:broad-based gait
    n1=Hyde (prurigo nodulaire de) | n2=en:broad-based gait | rel=r_associated | relid=0 | w=15
  1304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bromoxynil nitrilase
    n1=Hyde (prurigo nodulaire de) | n2=en:bromoxynil nitrilase | rel=r_associated | relid=0 | w=15
  1305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:bullae are located randomly in familial cases and apical in sporadic cases
    n1=Hyde (prurigo nodulaire de) | n2=en:bullae are located randomly in familial cases and apical in sporadic cases | rel=r_associated | relid=0 | w=15
  1306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:c [preparations]
    n1=Hyde (prurigo nodulaire de) | n2=en:c [preparations] | rel=r_associated | relid=0 | w=15
  1307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:c-1-tetrahydrofolate synthase, cytoplasmic
    n1=Hyde (prurigo nodulaire de) | n2=en:c-1-tetrahydrofolate synthase, cytoplasmic | rel=r_associated | relid=0 | w=15
  1308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:c10orf2 mutations account for approximately 35% of all peo cases
    n1=Hyde (prurigo nodulaire de) | n2=en:c10orf2 mutations account for approximately 35% of all peo cases | rel=r_associated | relid=0 | w=15
  1309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:c12-15 alcohols benzoate
    n1=Hyde (prurigo nodulaire de) | n2=en:c12-15 alcohols benzoate | rel=r_associated | relid=0 | w=15
  1310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:c3hex (cis-3-hexen-1-ol) is commonly associated with sensory characteristics such as 'green' and 'grassy'
    n1=Hyde (prurigo nodulaire de) | n2=en:c3hex (cis-3-hexen-1-ol) is commonly associated with sensory characteristics such as 'green' and 'grassy' | rel=r_associated | relid=0 | w=15
  1311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cabergoline
    n1=Hyde (prurigo nodulaire de) | n2=en:cabergoline | rel=r_associated | relid=0 | w=15
  1312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cabozantinib
    n1=Hyde (prurigo nodulaire de) | n2=en:cabozantinib | rel=r_associated | relid=0 | w=15
  1313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cadexomer iodine
    n1=Hyde (prurigo nodulaire de) | n2=en:cadexomer iodine | rel=r_associated | relid=0 | w=15
  1314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine | rel=r_associated | relid=0 | w=15
  1315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine / magnesium salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine / magnesium salicylate | rel=r_associated | relid=0 | w=15
  1316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine / phenacetin / salicylamide / styramate
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine / phenacetin / salicylamide / styramate | rel=r_associated | relid=0 | w=15
  1317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine, ergotamine drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine, ergotamine drug combination | rel=r_associated | relid=0 | w=15
  1318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine, sodium benzoate drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine, sodium benzoate drug combination | rel=r_associated | relid=0 | w=15
  1319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine/codeine/menthol/pheniramine/phenylephrine/sodium/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine/codeine/menthol/pheniramine/phenylephrine/sodium/sodium | rel=r_associated | relid=0 | w=15
  1320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caffeine/pheniramine/phenylephrine/sodium citrate/sodium salicyl
    n1=Hyde (prurigo nodulaire de) | n2=en:caffeine/pheniramine/phenylephrine/sodium citrate/sodium salicyl | rel=r_associated | relid=0 | w=15
  1321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cajuput oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cajuput oil | rel=r_associated | relid=0 | w=15
  1322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine | rel=r_associated | relid=0 | w=15
  1323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine / camphor / diphenhydramine
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine / camphor / diphenhydramine | rel=r_associated | relid=0 | w=15
  1324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine / camphor / pramoxine
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine / camphor / pramoxine | rel=r_associated | relid=0 | w=15
  1325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine / diphenhydramine
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine / diphenhydramine | rel=r_associated | relid=0 | w=15
  1326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine / phenol / zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine / phenol / zinc oxide | rel=r_associated | relid=0 | w=15
  1327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine / pramoxine
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine / pramoxine | rel=r_associated | relid=0 | w=15
  1328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine + zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine + zinc oxide | rel=r_associated | relid=0 | w=15
  1329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine/glycerin/phenol/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine/glycerin/phenol/zinc oxide | rel=r_associated | relid=0 | w=15
  1330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine/lanolin/menthol/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine/lanolin/menthol/zinc oxide | rel=r_associated | relid=0 | w=15
  1331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine/metacresyl acetate/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine/metacresyl acetate/zinc oxide | rel=r_associated | relid=0 | w=15
  1332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calamine/resorcinol/sulfur
    n1=Hyde (prurigo nodulaire de) | n2=en:calamine/resorcinol/sulfur | rel=r_associated | relid=0 | w=15
  1333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calanus oil
    n1=Hyde (prurigo nodulaire de) | n2=en:calanus oil | rel=r_associated | relid=0 | w=15
  1334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcifediol
    n1=Hyde (prurigo nodulaire de) | n2=en:calcifediol | rel=r_associated | relid=0 | w=15
  1335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcipotriene
    n1=Hyde (prurigo nodulaire de) | n2=en:calcipotriene | rel=r_associated | relid=0 | w=15
  1336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcitonin
    n1=Hyde (prurigo nodulaire de) | n2=en:calcitonin | rel=r_associated | relid=0 | w=15
  1337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calciuim lactate/thiamine
    n1=Hyde (prurigo nodulaire de) | n2=en:calciuim lactate/thiamine | rel=r_associated | relid=0 | w=15
  1338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium + magnesium
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium + magnesium | rel=r_associated | relid=0 | w=15
  1339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium + vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium + vitamin d | rel=r_associated | relid=0 | w=15
  1340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium ascorbate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium ascorbate | rel=r_associated | relid=0 | w=15
  1341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / ferrous fumarate / vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / ferrous fumarate / vitamin d | rel=r_associated | relid=0 | w=15
  1342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / folic acid / magnesium carbonate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / folic acid / magnesium carbonate | rel=r_associated | relid=0 | w=15
  1343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / glycine
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / glycine | rel=r_associated | relid=0 | w=15
  1344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / magnesium carbonate / magnesium oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / magnesium carbonate / magnesium oxide | rel=r_associated | relid=0 | w=15
  1345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / magnesium carbonate / vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / magnesium carbonate / vitamin d | rel=r_associated | relid=0 | w=15
  1346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / magnesium hydroxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / magnesium hydroxide | rel=r_associated | relid=0 | w=15
  1347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / magnesium hydroxide / phenobarbital
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / magnesium hydroxide / phenobarbital | rel=r_associated | relid=0 | w=15
  1348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / magnesium hydroxide / simethicone
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / magnesium hydroxide / simethicone | rel=r_associated | relid=0 | w=15
  1349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / pectin
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / pectin | rel=r_associated | relid=0 | w=15
  1350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / phenobarbital
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / phenobarbital | rel=r_associated | relid=0 | w=15
  1351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / sodium fluoride
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / sodium fluoride | rel=r_associated | relid=0 | w=15
  1352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate / vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate / vitamin d | rel=r_associated | relid=0 | w=15
  1353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate + famotidine + magnesium hydroxide
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate + famotidine + magnesium hydroxide | rel=r_associated | relid=0 | w=15
  1354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate + simethicone
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate + simethicone | rel=r_associated | relid=0 | w=15
  1355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate/calcium gluconate/calciucm lactate/vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate/calcium gluconate/calciucm lactate/vitamin d | rel=r_associated | relid=0 | w=15
  1356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate/calcium phosphate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate/calcium phosphate | rel=r_associated | relid=0 | w=15
  1357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate/magnesium carbonate/sodium alginate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate/magnesium carbonate/sodium alginate | rel=r_associated | relid=0 | w=15
  1358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate/minerals/vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate/minerals/vitamin d | rel=r_associated | relid=0 | w=15
  1359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate/nux vomica/phenobarbital
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate/nux vomica/phenobarbital | rel=r_associated | relid=0 | w=15
  1360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carbonate+magnesium carbonate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carbonate+magnesium carbonate | rel=r_associated | relid=0 | w=15
  1361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium carrageenan
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium carrageenan | rel=r_associated | relid=0 | w=15
  1362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium caseinate/cod liver oil/lanolin/lanolin alcohol/methylbe
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium caseinate/cod liver oil/lanolin/lanolin alcohol/methylbe | rel=r_associated | relid=0 | w=15
  1363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium chloride/dextrose/magnesium chloride/sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium chloride/dextrose/magnesium chloride/sodium chloride | rel=r_associated | relid=0 | w=15
  1364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium citrate / vitamin a / vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium citrate / vitamin a / vitamin d | rel=r_associated | relid=0 | w=15
  1365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium citrate / vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium citrate / vitamin d | rel=r_associated | relid=0 | w=15
  1366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium citrate/glutamic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium citrate/glutamic acid | rel=r_associated | relid=0 | w=15
  1367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium creosotate / iodine
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium creosotate / iodine | rel=r_associated | relid=0 | w=15
  1368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium gluconate / niacinamide / phenobarbital
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium gluconate / niacinamide / phenobarbital | rel=r_associated | relid=0 | w=15
  1369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium glycerophosphate / calcium lactate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium glycerophosphate / calcium lactate | rel=r_associated | relid=0 | w=15
  1370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium glycerophosphate / calcium levulinate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium glycerophosphate / calcium levulinate | rel=r_associated | relid=0 | w=15
  1371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium glycerophosphate/phosphoric acid/sodium glycerophosphate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium glycerophosphate/phosphoric acid/sodium glycerophosphate | rel=r_associated | relid=0 | w=15
  1372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium iodate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium iodate | rel=r_associated | relid=0 | w=15
  1373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium iodide
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium iodide | rel=r_associated | relid=0 | w=15
  1374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium iodide / codeine
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium iodide / codeine | rel=r_associated | relid=0 | w=15
  1375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium iodide / isoproterenol
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium iodide / isoproterenol | rel=r_associated | relid=0 | w=15
  1376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium iodized/peptone/thyroid
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium iodized/peptone/thyroid | rel=r_associated | relid=0 | w=15
  1377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium lactate/guaifenesin/hyoscyamus/phenobarbital/terpin hydr
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium lactate/guaifenesin/hyoscyamus/phenobarbital/terpin hydr | rel=r_associated | relid=0 | w=15
  1378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium pantothenate/danthron
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium pantothenate/danthron | rel=r_associated | relid=0 | w=15
  1379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium pantothenate/danthron/docusate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium pantothenate/danthron/docusate | rel=r_associated | relid=0 | w=15
  1380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium silicate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium silicate | rel=r_associated | relid=0 | w=15
  1381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium sodium polyvinylmethyl ether maleate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium sodium polyvinylmethyl ether maleate | rel=r_associated | relid=0 | w=15
  1382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium stearate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium stearate | rel=r_associated | relid=0 | w=15
  1383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium sulfate | rel=r_associated | relid=0 | w=15
  1384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium undecylenate / zinc undecylenate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium undecylenate / zinc undecylenate | rel=r_associated | relid=0 | w=15
  1385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium-transporting atpase type 2c member 2
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium-transporting atpase type 2c member 2 | rel=r_associated | relid=0 | w=15
  1386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/chloride/gluconate/magnesium/potassium/sodium/sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/chloride/gluconate/magnesium/potassium/sodium/sulfate | rel=r_associated | relid=0 | w=15
  1387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/ergocalciferol/salicylamide
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/ergocalciferol/salicylamide | rel=r_associated | relid=0 | w=15
  1388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/iodine
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/iodine | rel=r_associated | relid=0 | w=15
  1389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/phosphorus
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/phosphorus | rel=r_associated | relid=0 | w=15
  1390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/potassium/sodium/sodium/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/potassium/sodium/sodium/sodium | rel=r_associated | relid=0 | w=15
  1391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/vitamin d | rel=r_associated | relid=0 | w=15
  1392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/vitamin d/vitamin k
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/vitamin d/vitamin k | rel=r_associated | relid=0 | w=15
  1393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/vitamin d/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/vitamin d/zinc | rel=r_associated | relid=0 | w=15
  1394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/magnesium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/magnesium/zinc | rel=r_associated | relid=0 | w=15
  1395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/phosphorus/vitamin d
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/phosphorus/vitamin d | rel=r_associated | relid=0 | w=15
  1396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calcium/vitamin d/vitamin k
    n1=Hyde (prurigo nodulaire de) | n2=en:calcium/vitamin d/vitamin k | rel=r_associated | relid=0 | w=15
  1397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caldesmon-phosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:caldesmon-phosphatase | rel=r_associated | relid=0 | w=15
  1398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caldiamide sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:caldiamide sodium | rel=r_associated | relid=0 | w=15
  1399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caldiamide/gadodiamide
    n1=Hyde (prurigo nodulaire de) | n2=en:caldiamide/gadodiamide | rel=r_associated | relid=0 | w=15
  1400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calendula preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:calendula preparation | rel=r_associated | relid=0 | w=15
  1401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calfactant
    n1=Hyde (prurigo nodulaire de) | n2=en:calfactant | rel=r_associated | relid=0 | w=15
  1402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calibrator
    n1=Hyde (prurigo nodulaire de) | n2=en:calibrator | rel=r_associated | relid=0 | w=15
  1403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:calteridol calcium
    n1=Hyde (prurigo nodulaire de) | n2=en:calteridol calcium | rel=r_associated | relid=0 | w=15
  1404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor | rel=r_associated | relid=0 | w=15
  1405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor / eucalyptus oil / menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor / eucalyptus oil / menthol | rel=r_associated | relid=0 | w=15
  1406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor / eucalyptus oil / menthol / methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor / eucalyptus oil / menthol / methyl salicylate | rel=r_associated | relid=0 | w=15
  1407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor / parachlorophenol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor / parachlorophenol | rel=r_associated | relid=0 | w=15
  1408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor / phenol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor / phenol | rel=r_associated | relid=0 | w=15
  1409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor + menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor + menthol | rel=r_associated | relid=0 | w=15
  1410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor + menthol + methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor + menthol + methyl salicylate | rel=r_associated | relid=0 | w=15
  1411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor + menthol + phenol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor + menthol + phenol | rel=r_associated | relid=0 | w=15
  1412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/capsicum oleoresin/methyl salicylate/pine oil/turpentine
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/capsicum oleoresin/methyl salicylate/pine oil/turpentine | rel=r_associated | relid=0 | w=15
  1413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/chloroxylenol/eucalyptus/menthol/methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/chloroxylenol/eucalyptus/menthol/methyl salicylate | rel=r_associated | relid=0 | w=15
  1414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/corn starch/eucalyptus/kaolin/triclosan/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/corn starch/eucalyptus/kaolin/triclosan/zinc oxide | rel=r_associated | relid=0 | w=15
  1415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/diperodon/menthol/phenyltoloxamine/pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/diperodon/menthol/phenyltoloxamine/pyrilamine | rel=r_associated | relid=0 | w=15
  1416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/ephedrine/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/ephedrine/zinc oxide | rel=r_associated | relid=0 | w=15
  1417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/eucalyptus oil/menthol/phenol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/eucalyptus oil/menthol/phenol | rel=r_associated | relid=0 | w=15
  1418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/eucalyptus oil/menthol/turpentine spirits
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/eucalyptus oil/menthol/turpentine spirits | rel=r_associated | relid=0 | w=15
  1419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/eucalyptus/menthol/methyl salicylate/turpentine
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/eucalyptus/menthol/methyl salicylate/turpentine | rel=r_associated | relid=0 | w=15
  1420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/glycerin/mineral oil/phenol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/glycerin/mineral oil/phenol | rel=r_associated | relid=0 | w=15
  1421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/hyoscyamus/passion flower/phenobarbital/valerian
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/hyoscyamus/passion flower/phenobarbital/valerian | rel=r_associated | relid=0 | w=15
  1422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/isopropanol/menthol/propylene glycol
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/isopropanol/menthol/propylene glycol | rel=r_associated | relid=0 | w=15
  1423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/menthol/methyl nicotinate/methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/menthol/methyl nicotinate/methyl salicylate | rel=r_associated | relid=0 | w=15
  1424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/menthol/methyl salicylate/peppermint oil
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/menthol/methyl salicylate/peppermint oil | rel=r_associated | relid=0 | w=15
  1425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/menthol/methyl salicylate/tartrazine
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/menthol/methyl salicylate/tartrazine | rel=r_associated | relid=0 | w=15
  1426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/pramoxine/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/pramoxine/zinc | rel=r_associated | relid=0 | w=15
  1427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:camphor/soap
    n1=Hyde (prurigo nodulaire de) | n2=en:camphor/soap | rel=r_associated | relid=0 | w=15
  1428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:can be asymptomatic | rel=r_associated | relid=0 | w=15
  1429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be categorized into 3 groups
    n1=Hyde (prurigo nodulaire de) | n2=en:can be categorized into 3 groups | rel=r_associated | relid=0 | w=15
  1430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be caused by mutations in nuclear-encoded or mitochondrial-encoded genes
    n1=Hyde (prurigo nodulaire de) | n2=en:can be caused by mutations in nuclear-encoded or mitochondrial-encoded genes | rel=r_associated | relid=0 | w=15
  1431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be effectively treated with n-carbamylglutamate
    n1=Hyde (prurigo nodulaire de) | n2=en:can be effectively treated with n-carbamylglutamate | rel=r_associated | relid=0 | w=15
  1432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be slowly or rapidly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:can be slowly or rapidly progressive | rel=r_associated | relid=0 | w=15
  1433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be treated by bone marrow transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:can be treated by bone marrow transplantation | rel=r_associated | relid=0 | w=15
  1434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:can be treated with physiologic levels of 1,25-dihydroxyvitamin d3 or 1-alpha-hydroxyvitamin d3
    n1=Hyde (prurigo nodulaire de) | n2=en:can be treated with physiologic levels of 1,25-dihydroxyvitamin d3 or 1-alpha-hydroxyvitamin d3 | rel=r_associated | relid=0 | w=15
  1435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:canagliflozin
    n1=Hyde (prurigo nodulaire de) | n2=en:canagliflozin | rel=r_associated | relid=0 | w=15
  1436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:canagliflozin + metformin
    n1=Hyde (prurigo nodulaire de) | n2=en:canagliflozin + metformin | rel=r_associated | relid=0 | w=15
  1437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:canakinumab
    n1=Hyde (prurigo nodulaire de) | n2=en:canakinumab | rel=r_associated | relid=0 | w=15
  1438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cananga odorata extract
    n1=Hyde (prurigo nodulaire de) | n2=en:cananga odorata extract | rel=r_associated | relid=0 | w=15
  1439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candelilla wax
    n1=Hyde (prurigo nodulaire de) | n2=en:candelilla wax | rel=r_associated | relid=0 | w=15
  1440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candesartan
    n1=Hyde (prurigo nodulaire de) | n2=en:candesartan | rel=r_associated | relid=0 | w=15
  1441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candesartan / hydrochlorothiazide
    n1=Hyde (prurigo nodulaire de) | n2=en:candesartan / hydrochlorothiazide | rel=r_associated | relid=0 | w=15
  1442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candida albicans test
    n1=Hyde (prurigo nodulaire de) | n2=en:candida albicans test | rel=r_associated | relid=0 | w=15
  1443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candida/coccidioidin
    n1=Hyde (prurigo nodulaire de) | n2=en:candida/coccidioidin | rel=r_associated | relid=0 | w=15
  1444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candida/diphtheria/proteus/streptococcus/tetanus/tricophyton/tub
    n1=Hyde (prurigo nodulaire de) | n2=en:candida/diphtheria/proteus/streptococcus/tetanus/tricophyton/tub | rel=r_associated | relid=0 | w=15
  1445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candida/histoplasmin
    n1=Hyde (prurigo nodulaire de) | n2=en:candida/histoplasmin | rel=r_associated | relid=0 | w=15
  1446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candida/mumps
    n1=Hyde (prurigo nodulaire de) | n2=en:candida/mumps | rel=r_associated | relid=0 | w=15
  1447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candidiasis is restricted to nails of hands and feet
    n1=Hyde (prurigo nodulaire de) | n2=en:candidiasis is restricted to nails of hands and feet | rel=r_associated | relid=0 | w=15
  1448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:candidiasis is usually the first symptom
    n1=Hyde (prurigo nodulaire de) | n2=en:candidiasis is usually the first symptom | rel=r_associated | relid=0 | w=15
  1449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:canola oil
    n1=Hyde (prurigo nodulaire de) | n2=en:canola oil | rel=r_associated | relid=0 | w=15
  1450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cantharidin
    n1=Hyde (prurigo nodulaire de) | n2=en:cantharidin | rel=r_associated | relid=0 | w=15
  1451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cantharidin / podophyllin / salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:cantharidin / podophyllin / salicylic acid | rel=r_associated | relid=0 | w=15
  1452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capecitabine
    n1=Hyde (prurigo nodulaire de) | n2=en:capecitabine | rel=r_associated | relid=0 | w=15
  1453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capillary malformation are apparent at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:capillary malformation are apparent at birth | rel=r_associated | relid=0 | w=15
  1454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capreomycin
    n1=Hyde (prurigo nodulaire de) | n2=en:capreomycin | rel=r_associated | relid=0 | w=15
  1455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capric triglyceride
    n1=Hyde (prurigo nodulaire de) | n2=en:capric triglyceride | rel=r_associated | relid=0 | w=15
  1456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caprylic triglyceride
    n1=Hyde (prurigo nodulaire de) | n2=en:caprylic triglyceride | rel=r_associated | relid=0 | w=15
  1457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin | rel=r_associated | relid=0 | w=15
  1458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin / histamine / menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin / histamine / menthol | rel=r_associated | relid=0 | w=15
  1459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin / lidocaine / menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin / lidocaine / menthol | rel=r_associated | relid=0 | w=15
  1460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin / lidocaine / menthol / methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin / lidocaine / menthol / methyl salicylate | rel=r_associated | relid=0 | w=15
  1461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin / menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin / menthol | rel=r_associated | relid=0 | w=15
  1462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin / menthol / methyl salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin / menthol / methyl salicylate | rel=r_associated | relid=0 | w=15
  1463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsaicin/methyl nicotinate
    n1=Hyde (prurigo nodulaire de) | n2=en:capsaicin/methyl nicotinate | rel=r_associated | relid=0 | w=15
  1464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsella preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:capsella preparation | rel=r_associated | relid=0 | w=15
  1465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsicum/cascara sagrada/ginger/nux vomica
    n1=Hyde (prurigo nodulaire de) | n2=en:capsicum/cascara sagrada/ginger/nux vomica | rel=r_associated | relid=0 | w=15
  1466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:capsular polysaccharide,purified
    n1=Hyde (prurigo nodulaire de) | n2=en:capsular polysaccharide,purified | rel=r_associated | relid=0 | w=15
  1467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:captopril
    n1=Hyde (prurigo nodulaire de) | n2=en:captopril | rel=r_associated | relid=0 | w=15
  1468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:captopril, hydrochlorothiazide drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:captopril, hydrochlorothiazide drug combination | rel=r_associated | relid=0 | w=15
  1469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cara-klenz
    n1=Hyde (prurigo nodulaire de) | n2=en:cara-klenz | rel=r_associated | relid=0 | w=15
  1470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caralluma fimbriata
    n1=Hyde (prurigo nodulaire de) | n2=en:caralluma fimbriata | rel=r_associated | relid=0 | w=15
  1471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caralluma fimbriata extract
    n1=Hyde (prurigo nodulaire de) | n2=en:caralluma fimbriata extract | rel=r_associated | relid=0 | w=15
  1472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caramel color
    n1=Hyde (prurigo nodulaire de) | n2=en:caramel color | rel=r_associated | relid=0 | w=15
  1473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caramiphen
    n1=Hyde (prurigo nodulaire de) | n2=en:caramiphen | rel=r_associated | relid=0 | w=15
  1474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caramiphen / chlorpheniramine / isopropamide / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:caramiphen / chlorpheniramine / isopropamide / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caramiphen / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:caramiphen / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caraway extract
    n1=Hyde (prurigo nodulaire de) | n2=en:caraway extract | rel=r_associated | relid=0 | w=15
  1477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carb
    n1=Hyde (prurigo nodulaire de) | n2=en:carb | rel=r_associated | relid=0 | w=15
  1478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbachol
    n1=Hyde (prurigo nodulaire de) | n2=en:carbachol | rel=r_associated | relid=0 | w=15
  1479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbamide peroxide
    n1=Hyde (prurigo nodulaire de) | n2=en:carbamide peroxide | rel=r_associated | relid=0 | w=15
  1480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbamide peroxide/glycerin
    n1=Hyde (prurigo nodulaire de) | n2=en:carbamide peroxide/glycerin | rel=r_associated | relid=0 | w=15
  1481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbamide peroxide/glycerol
    n1=Hyde (prurigo nodulaire de) | n2=en:carbamide peroxide/glycerol | rel=r_associated | relid=0 | w=15
  1482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbenicillin
    n1=Hyde (prurigo nodulaire de) | n2=en:carbenicillin | rel=r_associated | relid=0 | w=15
  1483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbetapentane / guaifenesin
    n1=Hyde (prurigo nodulaire de) | n2=en:carbetapentane / guaifenesin | rel=r_associated | relid=0 | w=15
  1484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbetapentane / phenylephrine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:carbetapentane / phenylephrine / pyrilamine | rel=r_associated | relid=0 | w=15
  1485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbetapentane/chlorpheniramine/citric/codeine/guaifenesin/sodiu
    n1=Hyde (prurigo nodulaire de) | n2=en:carbetapentane/chlorpheniramine/citric/codeine/guaifenesin/sodiu | rel=r_associated | relid=0 | w=15
  1486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbetapentane/phenylephrine/phenylpropanolamine/potassium
    n1=Hyde (prurigo nodulaire de) | n2=en:carbetapentane/phenylephrine/phenylpropanolamine/potassium | rel=r_associated | relid=0 | w=15
  1487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbidopa + entacapone + levodopa
    n1=Hyde (prurigo nodulaire de) | n2=en:carbidopa + entacapone + levodopa | rel=r_associated | relid=0 | w=15
  1488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbidopa, levodopa drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:carbidopa, levodopa drug combination | rel=r_associated | relid=0 | w=15
  1489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbinoxamine / methscopolamine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:carbinoxamine / methscopolamine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbinoxamine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:carbinoxamine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:carbinoxamine, dextromethorphan, pseudoephedrine drug combination | rel=r_associated | relid=0 | w=15
  1492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbinoxamine/gauifenesin/pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:carbinoxamine/gauifenesin/pseudoephedrine | rel=r_associated | relid=0 | w=15
  1493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate dehydrogenases
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate dehydrogenases | rel=r_associated | relid=0 | w=15
  1494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate epimerases
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate epimerases | rel=r_associated | relid=0 | w=15
  1495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate identification
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate identification | rel=r_associated | relid=0 | w=15
  1496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate measurement
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate measurement | rel=r_associated | relid=0 | w=15
  1497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate metabolic process
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate metabolic process | rel=r_associated | relid=0 | w=15
  1498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate metabolism disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate metabolism disorder | rel=r_associated | relid=0 | w=15
  1499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate modified diet
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate modified diet | rel=r_associated | relid=0 | w=15
  1500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate-coated nanoparticle
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate-coated nanoparticle | rel=r_associated | relid=0 | w=15
  1501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate-deficient transferrin
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate-deficient transferrin | rel=r_associated | relid=0 | w=15
  1502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate-related compounds
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate-related compounds | rel=r_associated | relid=0 | w=15
  1503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate/electrolyte/fat/mineral/protein/vitamin
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate/electrolyte/fat/mineral/protein/vitamin | rel=r_associated | relid=0 | w=15
  1504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrate/electrolytes
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate/electrolytes | rel=r_associated | relid=0 | w=15
  1505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates | rel=r_associated | relid=0 | w=15
  1506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates:acnc:pt:stool:ord
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates:acnc:pt:stool:ord | rel=r_associated | relid=0 | w=15
  1507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates:acnc:pt:xxx:ord
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates:acnc:pt:xxx:ord | rel=r_associated | relid=0 | w=15
  1508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates:mcnt:pt:stool:qn:infrared spectroscopy
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates:mcnt:pt:stool:qn:infrared spectroscopy | rel=r_associated | relid=0 | w=15
  1509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates:prid:pt:urine:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates:prid:pt:urine:nom | rel=r_associated | relid=0 | w=15
  1510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbohydrates/fats/proteins
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrates/fats/proteins | rel=r_associated | relid=0 | w=15
  1511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbomer
    n1=Hyde (prurigo nodulaire de) | n2=en:carbomer | rel=r_associated | relid=0 | w=15
  1512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbon dioxide / nitrogen
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon dioxide / nitrogen | rel=r_associated | relid=0 | w=15
  1513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbon hydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon hydrate | rel=r_associated | relid=0 | w=15
  1514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbon monoxide
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon monoxide | rel=r_associated | relid=0 | w=15
  1515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbon monoxide / helium / nitrogen / oxygen
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon monoxide / helium / nitrogen / oxygen | rel=r_associated | relid=0 | w=15
  1516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carbon nitrogen hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:carbon nitrogen hydrolase | rel=r_associated | relid=0 | w=15
  1517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboprost tromethamine
    n1=Hyde (prurigo nodulaire de) | n2=en:carboprost tromethamine | rel=r_associated | relid=0 | w=15
  1518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxylesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxylesterase | rel=r_associated | relid=0 | w=15
  1519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose | rel=r_associated | relid=0 | w=15
  1520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose / casanthranol / docusate
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose / casanthranol / docusate | rel=r_associated | relid=0 | w=15
  1521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose / docusate
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose / docusate | rel=r_associated | relid=0 | w=15
  1522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose / docusate / phenolphthalein
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose / docusate / phenolphthalein | rel=r_associated | relid=0 | w=15
  1523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose / glycerin
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose / glycerin | rel=r_associated | relid=0 | w=15
  1524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose / hypromellose
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose / hypromellose | rel=r_associated | relid=0 | w=15
  1525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylcellulose/methylparaben/sorbitol
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylcellulose/methylparaben/sorbitol | rel=r_associated | relid=0 | w=15
  1526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxymethylhydantoinase
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxymethylhydantoinase | rel=r_associated | relid=0 | w=15
  1527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxypeptidase b2
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxypeptidase b2 | rel=r_associated | relid=0 | w=15
  1528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxypeptidase d
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxypeptidase d | rel=r_associated | relid=0 | w=15
  1529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxypeptidase m
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxypeptidase m | rel=r_associated | relid=0 | w=15
  1530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carboxypolymethylene
    n1=Hyde (prurigo nodulaire de) | n2=en:carboxypolymethylene | rel=r_associated | relid=0 | w=15
  1531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carcinia mangostana
    n1=Hyde (prurigo nodulaire de) | n2=en:carcinia mangostana | rel=r_associated | relid=0 | w=15
  1532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiac arrest and sudden death may occur, even in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiac arrest and sudden death may occur, even in early childhood | rel=r_associated | relid=0 | w=15
  1533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiac failure at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiac failure at birth | rel=r_associated | relid=0 | w=15
  1534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiac features are observed in ~3% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiac features are observed in ~3% of cases | rel=r_associated | relid=0 | w=15
  1535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiac involvement occurs between 5 and 12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiac involvement occurs between 5 and 12 years | rel=r_associated | relid=0 | w=15
  1536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiac manifestations are often fatal
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiac manifestations are often fatal | rel=r_associated | relid=0 | w=15
  1537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiofaciocutaneous syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiofaciocutaneous syndrome | rel=r_associated | relid=0 | w=15
  1538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cardiomyopathy may develop later in the disease
    n1=Hyde (prurigo nodulaire de) | n2=en:cardiomyopathy may develop later in the disease | rel=r_associated | relid=0 | w=15
  1539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carfilzomib
    n1=Hyde (prurigo nodulaire de) | n2=en:carfilzomib | rel=r_associated | relid=0 | w=15
  1540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carglumic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:carglumic acid | rel=r_associated | relid=0 | w=15
  1541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caricain
    n1=Hyde (prurigo nodulaire de) | n2=en:caricain | rel=r_associated | relid=0 | w=15
  1542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carisoprodol
    n1=Hyde (prurigo nodulaire de) | n2=en:carisoprodol | rel=r_associated | relid=0 | w=15
  1543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carmex
    n1=Hyde (prurigo nodulaire de) | n2=en:carmex | rel=r_associated | relid=0 | w=15
  1544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carmustine
    n1=Hyde (prurigo nodulaire de) | n2=en:carmustine | rel=r_associated | relid=0 | w=15
  1545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnation instant
    n1=Hyde (prurigo nodulaire de) | n2=en:carnation instant | rel=r_associated | relid=0 | w=15
  1546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnation oil
    n1=Hyde (prurigo nodulaire de) | n2=en:carnation oil | rel=r_associated | relid=0 | w=15
  1547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnauba wax
    n1=Hyde (prurigo nodulaire de) | n2=en:carnauba wax | rel=r_associated | relid=0 | w=15
  1548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnitine
    n1=Hyde (prurigo nodulaire de) | n2=en:carnitine | rel=r_associated | relid=0 | w=15
  1549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnitine supplementation can prevent further episodes and declines in cardiac function
    n1=Hyde (prurigo nodulaire de) | n2=en:carnitine supplementation can prevent further episodes and declines in cardiac function | rel=r_associated | relid=0 | w=15
  1550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carnosine
    n1=Hyde (prurigo nodulaire de) | n2=en:carnosine | rel=r_associated | relid=0 | w=15
  1551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carprofen
    n1=Hyde (prurigo nodulaire de) | n2=en:carprofen | rel=r_associated | relid=0 | w=15
  1552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrageenan
    n1=Hyde (prurigo nodulaire de) | n2=en:carrageenan | rel=r_associated | relid=0 | w=15
  1553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier female phenotype ranges from normal bone density with no fractures to early-onset osteoporosis and fractures
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier female phenotype ranges from normal bone density with no fractures to early-onset osteoporosis and fractures | rel=r_associated | relid=0 | w=15
  1554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females are less affected (short stature with rhizomelic shortening of limbs, mild body asymmetry, and mild mental retardation)
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females are less affected (short stature with rhizomelic shortening of limbs, mild body asymmetry, and mild mental retardation) | rel=r_associated | relid=0 | w=15
  1555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females are normal
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females are normal | rel=r_associated | relid=0 | w=15
  1556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females are unaffected
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females are unaffected | rel=r_associated | relid=0 | w=15
  1557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females exhibit less severe phenotype attributed to random inactivation of the x chromosome
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females exhibit less severe phenotype attributed to random inactivation of the x chromosome | rel=r_associated | relid=0 | w=15
  1558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females have arthralgias in middle age
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females have arthralgias in middle age | rel=r_associated | relid=0 | w=15
  1559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females have normal funduscopic examinations and normal waveforms on electroretinography.
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females have normal funduscopic examinations and normal waveforms on electroretinography. | rel=r_associated | relid=0 | w=15
  1560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may develop intrahepatic cholestasis of pregnancy (icp, 147480)
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may develop intrahepatic cholestasis of pregnancy (icp, 147480) | rel=r_associated | relid=0 | w=15
  1561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may have mild features
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may have mild features | rel=r_associated | relid=0 | w=15
  1562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may present with postpartum hyperammonemia
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may present with postpartum hyperammonemia | rel=r_associated | relid=0 | w=15
  1563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may show mild features, such as mild contractures, club feet, and intellectual disability
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may show mild features, such as mild contractures, club feet, and intellectual disability | rel=r_associated | relid=0 | w=15
  1564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may show mild mental retardation or learning disabilities
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may show mild mental retardation or learning disabilities | rel=r_associated | relid=0 | w=15
  1565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females may show neuropsychologic impairment
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females may show neuropsychologic impairment | rel=r_associated | relid=0 | w=15
  1566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females show no clinical phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females show no clinical phenotype | rel=r_associated | relid=0 | w=15
  1567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier females show no phenotypic abnormalities, but may have learning difficulties
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier females show no phenotypic abnormalities, but may have learning difficulties | rel=r_associated | relid=0 | w=15
  1568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier frequency 1:1,000 in french-canadians in quebec
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier frequency 1:1,000 in french-canadians in quebec | rel=r_associated | relid=0 | w=15
  1569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier frequency 1:200,000 in france
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier frequency 1:200,000 in france | rel=r_associated | relid=0 | w=15
  1570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier frequency 1:700 in bukhara jewish populations
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier frequency 1:700 in bukhara jewish populations | rel=r_associated | relid=0 | w=15
  1571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier frequency in finland 1/40
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier frequency in finland 1/40 | rel=r_associated | relid=0 | w=15
  1572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier frequency in finland is 1 in 230
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier frequency in finland is 1 in 230 | rel=r_associated | relid=0 | w=15
  1573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier males are unaffected except for psychiatric/behavioral abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier males are unaffected except for psychiatric/behavioral abnormalities | rel=r_associated | relid=0 | w=15
  1574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier mothers have urine biochemistry profiles identical to those of their sons
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier mothers have urine biochemistry profiles identical to those of their sons | rel=r_associated | relid=0 | w=15
  1575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier rate of 1 in 11 among old order amish
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier rate of 1 in 11 among old order amish | rel=r_associated | relid=0 | w=15
  1576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrier rate of 1 in 39 in the saguenay-lac-saint-jean region of quebec
    n1=Hyde (prurigo nodulaire de) | n2=en:carrier rate of 1 in 39 in the saguenay-lac-saint-jean region of quebec | rel=r_associated | relid=0 | w=15
  1577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrington
    n1=Hyde (prurigo nodulaire de) | n2=en:carrington | rel=r_associated | relid=0 | w=15
  1578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carrington gel
    n1=Hyde (prurigo nodulaire de) | n2=en:carrington gel | rel=r_associated | relid=0 | w=15
  1579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:carum (caraway)
    n1=Hyde (prurigo nodulaire de) | n2=en:carum (caraway) | rel=r_associated | relid=0 | w=15
  1580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:casanthranol
    n1=Hyde (prurigo nodulaire de) | n2=en:casanthranol | rel=r_associated | relid=0 | w=15
  1581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:casanthranol/docusate
    n1=Hyde (prurigo nodulaire de) | n2=en:casanthranol/docusate | rel=r_associated | relid=0 | w=15
  1582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cascara/magnesium hydroxide
    n1=Hyde (prurigo nodulaire de) | n2=en:cascara/magnesium hydroxide | rel=r_associated | relid=0 | w=15
  1583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cascara/mineral oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cascara/mineral oil | rel=r_associated | relid=0 | w=15
  1584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:casec
    n1=Hyde (prurigo nodulaire de) | n2=en:casec | rel=r_associated | relid=0 | w=15
  1585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:casein
    n1=Hyde (prurigo nodulaire de) | n2=en:casein | rel=r_associated | relid=0 | w=15
  1586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caseinate/dextrose/lactose/milk/minerals/multivitamins
    n1=Hyde (prurigo nodulaire de) | n2=en:caseinate/dextrose/lactose/milk/minerals/multivitamins | rel=r_associated | relid=0 | w=15
  1587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caseinate/minerals/multivitamins/soy oil/sucrose
    n1=Hyde (prurigo nodulaire de) | n2=en:caseinate/minerals/multivitamins/soy oil/sucrose | rel=r_associated | relid=0 | w=15
  1588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cases reported in the old order amish and one japanese family (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:cases reported in the old order amish and one japanese family (last curated april 2014) | rel=r_associated | relid=0 | w=15
  1589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cases reported include de novo deletions, interstitial deletions, and translocations involving only the terminal band of the reciprocal chromosome
    n1=Hyde (prurigo nodulaire de) | n2=en:cases reported include de novo deletions, interstitial deletions, and translocations involving only the terminal band of the reciprocal chromosome | rel=r_associated | relid=0 | w=15
  1590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caspase-1
    n1=Hyde (prurigo nodulaire de) | n2=en:caspase-1 | rel=r_associated | relid=0 | w=15
  1591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castellani paint
    n1=Hyde (prurigo nodulaire de) | n2=en:castellani paint | rel=r_associated | relid=0 | w=15
  1592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil | rel=r_associated | relid=0 | w=15
  1593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil / peruvian balsam
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil / peruvian balsam | rel=r_associated | relid=0 | w=15
  1594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil / peruvian balsam / trypsin
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil / peruvian balsam / trypsin | rel=r_associated | relid=0 | w=15
  1595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil/collodion/podophyllin/salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil/collodion/podophyllin/salicylic acid | rel=r_associated | relid=0 | w=15
  1596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil/dimethicone/nitrocellulose
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil/dimethicone/nitrocellulose | rel=r_associated | relid=0 | w=15
  1597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor oil/silicone
    n1=Hyde (prurigo nodulaire de) | n2=en:castor oil/silicone | rel=r_associated | relid=0 | w=15
  1598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:castor/mercury/mineral/polyoxyl/polysorbate/salicylic
    n1=Hyde (prurigo nodulaire de) | n2=en:castor/mercury/mineral/polyoxyl/polysorbate/salicylic | rel=r_associated | relid=0 | w=15
  1599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catalase
    n1=Hyde (prurigo nodulaire de) | n2=en:catalase | rel=r_associated | relid=0 | w=15
  1600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catalytic formula
    n1=Hyde (prurigo nodulaire de) | n2=en:catalytic formula | rel=r_associated | relid=0 | w=15
  1601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cataracts are progressive but may vary between eyes of an individual
    n1=Hyde (prurigo nodulaire de) | n2=en:cataracts are progressive but may vary between eyes of an individual | rel=r_associated | relid=0 | w=15
  1602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cataracts may be subclinical in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:cataracts may be subclinical in some patients | rel=r_associated | relid=0 | w=15
  1603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cataracts present at birth or develop in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:cataracts present at birth or develop in infancy | rel=r_associated | relid=0 | w=15
  1604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cataracts variably present at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:cataracts variably present at birth | rel=r_associated | relid=0 | w=15
  1605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catechol
    n1=Hyde (prurigo nodulaire de) | n2=en:catechol | rel=r_associated | relid=0 | w=15
  1606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catgut
    n1=Hyde (prurigo nodulaire de) | n2=en:catgut | rel=r_associated | relid=0 | w=15
  1607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cathepsin c
    n1=Hyde (prurigo nodulaire de) | n2=en:cathepsin c | rel=r_associated | relid=0 | w=15
  1608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cathepsin e
    n1=Hyde (prurigo nodulaire de) | n2=en:cathepsin e | rel=r_associated | relid=0 | w=15
  1609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cathepsin h
    n1=Hyde (prurigo nodulaire de) | n2=en:cathepsin h | rel=r_associated | relid=0 | w=15
  1610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cathepsin l1
    n1=Hyde (prurigo nodulaire de) | n2=en:cathepsin l1 | rel=r_associated | relid=0 | w=15
  1611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cathepsin s
    n1=Hyde (prurigo nodulaire de) | n2=en:cathepsin s | rel=r_associated | relid=0 | w=15
  1612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catnip preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:catnip preparation | rel=r_associated | relid=0 | w=15
  1613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catshl is an acronym for camptodactyly, tall stature, scoliosis, and hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:catshl is an acronym for camptodactyly, tall stature, scoliosis, and hearing loss | rel=r_associated | relid=0 | w=15
  1614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:catuaba bark
    n1=Hyde (prurigo nodulaire de) | n2=en:catuaba bark | rel=r_associated | relid=0 | w=15
  1615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caulophyllum extract
    n1=Hyde (prurigo nodulaire de) | n2=en:caulophyllum extract | rel=r_associated | relid=0 | w=15
  1616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cause of death usually due to respiratory failure before adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:cause of death usually due to respiratory failure before adulthood | rel=r_associated | relid=0 | w=15
  1617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by 55-200 expanded trinucleotide repeats in the fmr1 gene (309550) referred to as a 'premutation'
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by 55-200 expanded trinucleotide repeats in the fmr1 gene (309550) referred to as a 'premutation' | rel=r_associated | relid=0 | w=15
  1618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by a de novo heterozygous gene deletion syndrome at chromosome 15q24
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by a de novo heterozygous gene deletion syndrome at chromosome 15q24 | rel=r_associated | relid=0 | w=15
  1619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by a defect in bile acid transport
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by a defect in bile acid transport | rel=r_associated | relid=0 | w=15
  1620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by constitutive activation of the avpr2 receptor
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by constitutive activation of the avpr2 receptor | rel=r_associated | relid=0 | w=15
  1621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by heterozygous germline mutation and second-hit somatic mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by heterozygous germline mutation and second-hit somatic mutation | rel=r_associated | relid=0 | w=15
  1622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by inactivating mutations in the parathyroid hormone receptor 1 gene, in contrast to jansen type metaphyseal chondrodysplasia, 156400
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by inactivating mutations in the parathyroid hormone receptor 1 gene, in contrast to jansen type metaphyseal chondrodysplasia, 156400 | rel=r_associated | relid=0 | w=15
  1623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by inborn error in bile acid synthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by inborn error in bile acid synthesis | rel=r_associated | relid=0 | w=15
  1624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by inheritance of the mutation on the maternal allele (imprinting)
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by inheritance of the mutation on the maternal allele (imprinting) | rel=r_associated | relid=0 | w=15
  1625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by inheritance of the mutation on the paternal allele (imprinting)
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by inheritance of the mutation on the paternal allele (imprinting) | rel=r_associated | relid=0 | w=15
  1626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by paternally-inherited inactivating gnas1 mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by paternally-inherited inactivating gnas1 mutations | rel=r_associated | relid=0 | w=15
  1627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:caused by somatic mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:caused by somatic mutations | rel=r_associated | relid=0 | w=15
  1628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cayler cardiofacial syndrome was classically described as hypoplasia of the depressor anguli oris muscle and congenital heart defects
    n1=Hyde (prurigo nodulaire de) | n2=en:cayler cardiofacial syndrome was classically described as hypoplasia of the depressor anguli oris muscle and congenital heart defects | rel=r_associated | relid=0 | w=15
  1629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cc-preferring endodeoxyribonuclease
    n1=Hyde (prurigo nodulaire de) | n2=en:cc-preferring endodeoxyribonuclease | rel=r_associated | relid=0 | w=15
  1630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cdags is an acronym - craniosynostosis and clavicular hypoplasia, delayed closure of fontanel, anal anomalies, genitourinary malformations, and skin eruption
    n1=Hyde (prurigo nodulaire de) | n2=en:cdags is an acronym - craniosynostosis and clavicular hypoplasia, delayed closure of fontanel, anal anomalies, genitourinary malformations, and skin eruption | rel=r_associated | relid=0 | w=15
  1631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cdisc send fetal pathology findings result terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:cdisc send fetal pathology findings result terminology | rel=r_associated | relid=0 | w=15
  1632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cdisc send terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=15
  1633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cdpglycerol pyrophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:cdpglycerol pyrophosphatase | rel=r_associated | relid=0 | w=15
  1634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cedar leaf oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cedar leaf oil | rel=r_associated | relid=0 | w=15
  1635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefamandole
    n1=Hyde (prurigo nodulaire de) | n2=en:cefamandole | rel=r_associated | relid=0 | w=15
  1636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefazolin
    n1=Hyde (prurigo nodulaire de) | n2=en:cefazolin | rel=r_associated | relid=0 | w=15
  1637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefazolin/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cefazolin/dextrose | rel=r_associated | relid=0 | w=15
  1638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefazolin/sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:cefazolin/sodium chloride | rel=r_associated | relid=0 | w=15
  1639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefditoren
    n1=Hyde (prurigo nodulaire de) | n2=en:cefditoren | rel=r_associated | relid=0 | w=15
  1640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefepime
    n1=Hyde (prurigo nodulaire de) | n2=en:cefepime | rel=r_associated | relid=0 | w=15
  1641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefmetazole
    n1=Hyde (prurigo nodulaire de) | n2=en:cefmetazole | rel=r_associated | relid=0 | w=15
  1642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefonicid
    n1=Hyde (prurigo nodulaire de) | n2=en:cefonicid | rel=r_associated | relid=0 | w=15
  1643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefoperazone
    n1=Hyde (prurigo nodulaire de) | n2=en:cefoperazone | rel=r_associated | relid=0 | w=15
  1644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefoperazone/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cefoperazone/dextrose | rel=r_associated | relid=0 | w=15
  1645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceforanide
    n1=Hyde (prurigo nodulaire de) | n2=en:ceforanide | rel=r_associated | relid=0 | w=15
  1646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefotaxime
    n1=Hyde (prurigo nodulaire de) | n2=en:cefotaxime | rel=r_associated | relid=0 | w=15
  1647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefotetan
    n1=Hyde (prurigo nodulaire de) | n2=en:cefotetan | rel=r_associated | relid=0 | w=15
  1648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefoxitin
    n1=Hyde (prurigo nodulaire de) | n2=en:cefoxitin | rel=r_associated | relid=0 | w=15
  1649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefoxitin/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cefoxitin/dextrose | rel=r_associated | relid=0 | w=15
  1650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefpodoxime proxetil
    n1=Hyde (prurigo nodulaire de) | n2=en:cefpodoxime proxetil | rel=r_associated | relid=0 | w=15
  1651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftaroline
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftaroline | rel=r_associated | relid=0 | w=15
  1652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftazidime/sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftazidime/sodium chloride | rel=r_associated | relid=0 | w=15
  1653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftizoxime
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftizoxime | rel=r_associated | relid=0 | w=15
  1654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftizoxime/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftizoxime/dextrose | rel=r_associated | relid=0 | w=15
  1655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftolozane, tazobactam drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftolozane, tazobactam drug combination | rel=r_associated | relid=0 | w=15
  1656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftriaxone
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftriaxone | rel=r_associated | relid=0 | w=15
  1657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftriaxone/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftriaxone/dextrose | rel=r_associated | relid=0 | w=15
  1658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceftriaxone/lidocaine
    n1=Hyde (prurigo nodulaire de) | n2=en:ceftriaxone/lidocaine | rel=r_associated | relid=0 | w=15
  1659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefuroxime/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cefuroxime/dextrose | rel=r_associated | relid=0 | w=15
  1660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cefuroxime/sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:cefuroxime/sodium chloride | rel=r_associated | relid=0 | w=15
  1661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:celery extract
    n1=Hyde (prurigo nodulaire de) | n2=en:celery extract | rel=r_associated | relid=0 | w=15
  1662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:celiprolol
    n1=Hyde (prurigo nodulaire de) | n2=en:celiprolol | rel=r_associated | relid=0 | w=15
  1663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cells of origin are part of the diffuse neuroendocrine system (dnes)
    n1=Hyde (prurigo nodulaire de) | n2=en:cells of origin are part of the diffuse neuroendocrine system (dnes) | rel=r_associated | relid=0 | w=15
  1664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellular secretion
    n1=Hyde (prurigo nodulaire de) | n2=en:cellular secretion | rel=r_associated | relid=0 | w=15
  1665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellulase
    n1=Hyde (prurigo nodulaire de) | n2=en:cellulase | rel=r_associated | relid=0 | w=15
  1666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellulose
    n1=Hyde (prurigo nodulaire de) | n2=en:cellulose | rel=r_associated | relid=0 | w=15
  1667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellulose sodium phosphate
    n1=Hyde (prurigo nodulaire de) | n2=en:cellulose sodium phosphate | rel=r_associated | relid=0 | w=15
  1668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellulose, oxidized
    n1=Hyde (prurigo nodulaire de) | n2=en:cellulose, oxidized | rel=r_associated | relid=0 | w=15
  1669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cellulose/talc
    n1=Hyde (prurigo nodulaire de) | n2=en:cellulose/talc | rel=r_associated | relid=0 | w=15
  1670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:centaury preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:centaury preparation | rel=r_associated | relid=0 | w=15
  1671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:central apneic episodes may be fatal
    n1=Hyde (prurigo nodulaire de) | n2=en:central apneic episodes may be fatal | rel=r_associated | relid=0 | w=15
  1672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:central hypoventilation occurs late in the disease and is often fatal
    n1=Hyde (prurigo nodulaire de) | n2=en:central hypoventilation occurs late in the disease and is often fatal | rel=r_associated | relid=0 | w=15
  1673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:centromeric instability of chromosomes 1, 9 and 16 with increased somatic recombination and formation of multibranched configurations
    n1=Hyde (prurigo nodulaire de) | n2=en:centromeric instability of chromosomes 1, 9 and 16 with increased somatic recombination and formation of multibranched configurations | rel=r_associated | relid=0 | w=15
  1674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:centruroides antivenin
    n1=Hyde (prurigo nodulaire de) | n2=en:centruroides antivenin | rel=r_associated | relid=0 | w=15
  1675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cephalosporin-c deacetylase
    n1=Hyde (prurigo nodulaire de) | n2=en:cephalosporin-c deacetylase | rel=r_associated | relid=0 | w=15
  1676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cephalothin
    n1=Hyde (prurigo nodulaire de) | n2=en:cephalothin | rel=r_associated | relid=0 | w=15
  1677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cephalothin/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cephalothin/dextrose | rel=r_associated | relid=0 | w=15
  1678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cephapirin
    n1=Hyde (prurigo nodulaire de) | n2=en:cephapirin | rel=r_associated | relid=0 | w=15
  1679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cephradine
    n1=Hyde (prurigo nodulaire de) | n2=en:cephradine | rel=r_associated | relid=0 | w=15
  1680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceraphyl 140a
    n1=Hyde (prurigo nodulaire de) | n2=en:ceraphyl 140a | rel=r_associated | relid=0 | w=15
  1681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceraphyl 230
    n1=Hyde (prurigo nodulaire de) | n2=en:ceraphyl 230 | rel=r_associated | relid=0 | w=15
  1682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerasynt-sd
    n1=Hyde (prurigo nodulaire de) | n2=en:cerasynt-sd | rel=r_associated | relid=0 | w=15
  1683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerave
    n1=Hyde (prurigo nodulaire de) | n2=en:cerave | rel=r_associated | relid=0 | w=15
  1684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerebellar ataxia shows onset in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:cerebellar ataxia shows onset in young adulthood | rel=r_associated | relid=0 | w=15
  1685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerebrocostomandibular syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:cerebrocostomandibular syndrome | rel=r_associated | relid=0 | w=15
  1686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceresin
    n1=Hyde (prurigo nodulaire de) | n2=en:ceresin | rel=r_associated | relid=0 | w=15
  1687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceresin wax
    n1=Hyde (prurigo nodulaire de) | n2=en:ceresin wax | rel=r_associated | relid=0 | w=15
  1688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerium oxalate
    n1=Hyde (prurigo nodulaire de) | n2=en:cerium oxalate | rel=r_associated | relid=0 | w=15
  1689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cerivastatin
    n1=Hyde (prurigo nodulaire de) | n2=en:cerivastatin | rel=r_associated | relid=0 | w=15
  1690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetalkonium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:cetalkonium chloride | rel=r_associated | relid=0 | w=15
  1691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetaphil
    n1=Hyde (prurigo nodulaire de) | n2=en:cetaphil | rel=r_associated | relid=0 | w=15
  1692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetaphil cleanser
    n1=Hyde (prurigo nodulaire de) | n2=en:cetaphil cleanser | rel=r_associated | relid=0 | w=15
  1693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceteareth 20
    n1=Hyde (prurigo nodulaire de) | n2=en:ceteareth 20 | rel=r_associated | relid=0 | w=15
  1694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ceteareth-6
    n1=Hyde (prurigo nodulaire de) | n2=en:ceteareth-6 | rel=r_associated | relid=0 | w=15
  1695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetearyl alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:cetearyl alcohol | rel=r_associated | relid=0 | w=15
  1696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetearyl alcohol/glycerin/mineral oil/petrolatum/propylene glyco
    n1=Hyde (prurigo nodulaire de) | n2=en:cetearyl alcohol/glycerin/mineral oil/petrolatum/propylene glyco | rel=r_associated | relid=0 | w=15
  1697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetearyl octaneoate
    n1=Hyde (prurigo nodulaire de) | n2=en:cetearyl octaneoate | rel=r_associated | relid=0 | w=15
  1698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetearyl sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:cetearyl sulfate | rel=r_associated | relid=0 | w=15
  1699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetearyl-20
    n1=Hyde (prurigo nodulaire de) | n2=en:cetearyl-20 | rel=r_associated | relid=0 | w=15
  1700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetirizine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:cetirizine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetostearyl alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:cetostearyl alcohol | rel=r_associated | relid=0 | w=15
  1702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetraxate benzylesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:cetraxate benzylesterase | rel=r_associated | relid=0 | w=15
  1703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetrimonium bromide
    n1=Hyde (prurigo nodulaire de) | n2=en:cetrimonium bromide | rel=r_associated | relid=0 | w=15
  1704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetrorelix
    n1=Hyde (prurigo nodulaire de) | n2=en:cetrorelix | rel=r_associated | relid=0 | w=15
  1705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl acid
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl acid | rel=r_associated | relid=0 | w=15
  1706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl alcohol | rel=r_associated | relid=0 | w=15
  1707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl alcohol/colfosceril palmitate/tyloxapol
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl alcohol/colfosceril palmitate/tyloxapol | rel=r_associated | relid=0 | w=15
  1708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl alcohol/propylene glycol/stearyl alcohol/wax
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl alcohol/propylene glycol/stearyl alcohol/wax | rel=r_associated | relid=0 | w=15
  1709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl esters wax
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl esters wax | rel=r_associated | relid=0 | w=15
  1710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl esters wax/mineral oil/sodium borate/white wax
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl esters wax/mineral oil/sodium borate/white wax | rel=r_associated | relid=0 | w=15
  1711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetyl palmitate
    n1=Hyde (prurigo nodulaire de) | n2=en:cetyl palmitate | rel=r_associated | relid=0 | w=15
  1712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium | rel=r_associated | relid=0 | w=15
  1713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium / chloroxylenol / triacetin
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium / chloroxylenol / triacetin | rel=r_associated | relid=0 | w=15
  1714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium chloride/chlorophyl copper complex
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium chloride/chlorophyl copper complex | rel=r_associated | relid=0 | w=15
  1715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium chloride/chloroxylenol/hydrocortisone/triacetin
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium chloride/chloroxylenol/hydrocortisone/triacetin | rel=r_associated | relid=0 | w=15
  1716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium chloride/dyclonine hcl
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium chloride/dyclonine hcl | rel=r_associated | relid=0 | w=15
  1717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cetylpyridinium+menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:cetylpyridinium+menthol | rel=r_associated | relid=0 | w=15
  1718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chamaelirium luteum extract
    n1=Hyde (prurigo nodulaire de) | n2=en:chamaelirium luteum extract | rel=r_associated | relid=0 | w=15
  1719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chamomile flowers
    n1=Hyde (prurigo nodulaire de) | n2=en:chamomile flowers | rel=r_associated | relid=0 | w=15
  1720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chands is an acronym for curly hair, ankyloblepharon filiform, nail dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:chands is an acronym for curly hair, ankyloblepharon filiform, nail dysplasia | rel=r_associated | relid=0 | w=15
  1721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:changes more marked in hands than feet
    n1=Hyde (prurigo nodulaire de) | n2=en:changes more marked in hands than feet | rel=r_associated | relid=0 | w=15
  1722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:characteristic face and body by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:characteristic face and body by age 2 years | rel=r_associated | relid=0 | w=15
  1723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:characteristic facial features become more apparent with age
    n1=Hyde (prurigo nodulaire de) | n2=en:characteristic facial features become more apparent with age | rel=r_associated | relid=0 | w=15
  1724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:characterized by calf weakness at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:characterized by calf weakness at onset | rel=r_associated | relid=0 | w=15
  1725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charcoal
    n1=Hyde (prurigo nodulaire de) | n2=en:charcoal | rel=r_associated | relid=0 | w=15
  1726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charcoal / simethicone
    n1=Hyde (prurigo nodulaire de) | n2=en:charcoal / simethicone | rel=r_associated | relid=0 | w=15
  1727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charcoal/ipecac
    n1=Hyde (prurigo nodulaire de) | n2=en:charcoal/ipecac | rel=r_associated | relid=0 | w=15
  1728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charcoal/sorbitol
    n1=Hyde (prurigo nodulaire de) | n2=en:charcoal/sorbitol | rel=r_associated | relid=0 | w=15
  1729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charcot-marie-tooth disease type 2l (cmt2l, 608673) is an allelic disorder with an overlapping phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:charcot-marie-tooth disease type 2l (cmt2l, 608673) is an allelic disorder with an overlapping phenotype | rel=r_associated | relid=0 | w=15
  1730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:charge acronym (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness, extremity abnormalities)
    n1=Hyde (prurigo nodulaire de) | n2=en:charge acronym (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness, extremity abnormalities) | rel=r_associated | relid=0 | w=15
  1731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chaste berry extract
    n1=Hyde (prurigo nodulaire de) | n2=en:chaste berry extract | rel=r_associated | relid=0 | w=15
  1732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cheerful disposition
    n1=Hyde (prurigo nodulaire de) | n2=en:cheerful disposition | rel=r_associated | relid=0 | w=15
  1733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chelation therapy can result in clinical improvement
    n1=Hyde (prurigo nodulaire de) | n2=en:chelation therapy can result in clinical improvement | rel=r_associated | relid=0 | w=15
  1734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemical actions and uses
    n1=Hyde (prurigo nodulaire de) | n2=en:chemical actions and uses | rel=r_associated | relid=0 | w=15
  1735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemical classes for pharmacologic classification [chemical/ingredient]
    n1=Hyde (prurigo nodulaire de) | n2=en:chemical classes for pharmacologic classification [chemical/ingredient] | rel=r_associated | relid=0 | w=15
  1736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemical ingredients [chemical/ingredient]
    n1=Hyde (prurigo nodulaire de) | n2=en:chemical ingredients [chemical/ingredient] | rel=r_associated | relid=0 | w=15
  1737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemically induced
    n1=Hyde (prurigo nodulaire de) | n2=en:chemically induced | rel=r_associated | relid=0 | w=15
  1738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemicals and drugs (mesh category)
    n1=Hyde (prurigo nodulaire de) | n2=en:chemicals and drugs (mesh category) | rel=r_associated | relid=0 | w=15
  1739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chemstrip
    n1=Hyde (prurigo nodulaire de) | n2=en:chemstrip | rel=r_associated | relid=0 | w=15
  1740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chenodiol
    n1=Hyde (prurigo nodulaire de) | n2=en:chenodiol | rel=r_associated | relid=0 | w=15
  1741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cherry extract
    n1=Hyde (prurigo nodulaire de) | n2=en:cherry extract | rel=r_associated | relid=0 | w=15
  1742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cherry flavor
    n1=Hyde (prurigo nodulaire de) | n2=en:cherry flavor | rel=r_associated | relid=0 | w=15
  1743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chickweed extract
    n1=Hyde (prurigo nodulaire de) | n2=en:chickweed extract | rel=r_associated | relid=0 | w=15
  1744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:child is an acronym for congenital hemidysplasia with ichthyosiform erythroderma and limb defects
    n1=Hyde (prurigo nodulaire de) | n2=en:child is an acronym for congenital hemidysplasia with ichthyosiform erythroderma and limb defects | rel=r_associated | relid=0 | w=15
  1745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:child nutritional physiological phenomena
    n1=Hyde (prurigo nodulaire de) | n2=en:child nutritional physiological phenomena | rel=r_associated | relid=0 | w=15
  1746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:child often can sit unsupported but never ambulates
    n1=Hyde (prurigo nodulaire de) | n2=en:child often can sit unsupported but never ambulates | rel=r_associated | relid=0 | w=15
  1747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood absence epilepsy (eca1 600131, eca2 607681, eca3 607682)
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood absence epilepsy (eca1 600131, eca2 607681, eca3 607682) | rel=r_associated | relid=0 | w=15
  1748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood obesity
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood obesity | rel=r_associated | relid=0 | w=15
  1749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset | rel=r_associated | relid=0 | w=15
  1750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset (average 4 to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset (average 4 to 6 years) | rel=r_associated | relid=0 | w=15
  1751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset (range birth to 12 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset (range birth to 12 years) | rel=r_associated | relid=0 | w=15
  1752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset has been reported | rel=r_associated | relid=0 | w=15
  1753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset has been reported in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset has been reported in 1 family | rel=r_associated | relid=0 | w=15
  1754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset may occur | rel=r_associated | relid=0 | w=15
  1755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood onset rarely occurs
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood onset rarely occurs | rel=r_associated | relid=0 | w=15
  1756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood or adolescent onset (usually less than 25 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood or adolescent onset (usually less than 25 years) | rel=r_associated | relid=0 | w=15
  1757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood or adolescent onset, protracted, with myopathy and neuropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood or adolescent onset, protracted, with myopathy and neuropathy | rel=r_associated | relid=0 | w=15
  1758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:childhood or young adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:childhood or young adult onset | rel=r_associated | relid=0 | w=15
  1759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:children rarely develop the disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:children rarely develop the disorder | rel=r_associated | relid=0 | w=15
  1760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chime is an acronym - ocular colobomas, heart defect, ichthyosiform dermatosis, mental retardation, ear anomalies
    n1=Hyde (prurigo nodulaire de) | n2=en:chime is an acronym - ocular colobomas, heart defect, ichthyosiform dermatosis, mental retardation, ear anomalies | rel=r_associated | relid=0 | w=15
  1761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chimeric cyp11b1/cyp11b2 gene is an anti-lepore-like fusion product
    n1=Hyde (prurigo nodulaire de) | n2=en:chimeric cyp11b1/cyp11b2 gene is an anti-lepore-like fusion product | rel=r_associated | relid=0 | w=15
  1762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chitinase
    n1=Hyde (prurigo nodulaire de) | n2=en:chitinase | rel=r_associated | relid=0 | w=15
  1763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chitosan
    n1=Hyde (prurigo nodulaire de) | n2=en:chitosan | rel=r_associated | relid=0 | w=15
  1764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chitosanase
    n1=Hyde (prurigo nodulaire de) | n2=en:chitosanase | rel=r_associated | relid=0 | w=15
  1765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlophedianol
    n1=Hyde (prurigo nodulaire de) | n2=en:chlophedianol | rel=r_associated | relid=0 | w=15
  1766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlophedianol / chlorpheniramine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlophedianol / chlorpheniramine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloral hydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:chloral hydrate | rel=r_associated | relid=0 | w=15
  1768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloral hydrate/salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:chloral hydrate/salicylic acid | rel=r_associated | relid=0 | w=15
  1769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorambucil
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorambucil | rel=r_associated | relid=0 | w=15
  1770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloramphenicol / hydrocortisone / polymyxin b
    n1=Hyde (prurigo nodulaire de) | n2=en:chloramphenicol / hydrocortisone / polymyxin b | rel=r_associated | relid=0 | w=15
  1771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloramphenicol/desoxyribonuclease/fibrinolysin
    n1=Hyde (prurigo nodulaire de) | n2=en:chloramphenicol/desoxyribonuclease/fibrinolysin | rel=r_associated | relid=0 | w=15
  1772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorcyclizine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorcyclizine | rel=r_associated | relid=0 | w=15
  1773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorcyclizine / hydrocortisone
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorcyclizine / hydrocortisone | rel=r_associated | relid=0 | w=15
  1774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlordiazepoxide / methscopolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlordiazepoxide / methscopolamine | rel=r_associated | relid=0 | w=15
  1775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlordiazepoxide, clidinium drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:chlordiazepoxide, clidinium drug combination | rel=r_associated | relid=0 | w=15
  1776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlordiazepoxide/estrogens
    n1=Hyde (prurigo nodulaire de) | n2=en:chlordiazepoxide/estrogens | rel=r_associated | relid=0 | w=15
  1777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorella (pharmacologic substance)
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorella (pharmacologic substance) | rel=r_associated | relid=0 | w=15
  1778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorhexidine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorhexidine | rel=r_associated | relid=0 | w=15
  1779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorhexidine gluconate/glycerin/hydroxyethyl cellulose
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorhexidine gluconate/glycerin/hydroxyethyl cellulose | rel=r_associated | relid=0 | w=15
  1780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorhexidine gluconate/ispropyl alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorhexidine gluconate/ispropyl alcohol | rel=r_associated | relid=0 | w=15
  1781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorhexidine/edetate
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorhexidine/edetate | rel=r_associated | relid=0 | w=15
  1782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloride hexahydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:chloride hexahydrate | rel=r_associated | relid=0 | w=15
  1783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloride ion
    n1=Hyde (prurigo nodulaire de) | n2=en:chloride ion | rel=r_associated | relid=0 | w=15
  1784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloride/chromium/copper/manganese/sodium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chloride/chromium/copper/manganese/sodium/zinc | rel=r_associated | relid=0 | w=15
  1785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloride/potassium/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:chloride/potassium/sodium | rel=r_associated | relid=0 | w=15
  1786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorine | rel=r_associated | relid=0 | w=15
  1787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlormezanone
    n1=Hyde (prurigo nodulaire de) | n2=en:chlormezanone | rel=r_associated | relid=0 | w=15
  1788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroacetic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroacetic acid | rel=r_associated | relid=0 | w=15
  1789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorobutanol
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorobutanol | rel=r_associated | relid=0 | w=15
  1790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorobutanol/edta/polyvinyl alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorobutanol/edta/polyvinyl alcohol | rel=r_associated | relid=0 | w=15
  1791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroform
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroform | rel=r_associated | relid=0 | w=15
  1792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorohexidine gluconate/glycerin/hydroxyethyl cellulose
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorohexidine gluconate/glycerin/hydroxyethyl cellulose | rel=r_associated | relid=0 | w=15
  1793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorophyll
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorophyll | rel=r_associated | relid=0 | w=15
  1794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorophyll / papain / urea
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorophyll / papain / urea | rel=r_associated | relid=0 | w=15
  1795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorophyllase
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorophyllase | rel=r_associated | relid=0 | w=15
  1796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorophyllin copper complex / sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorophyllin copper complex / sodium chloride | rel=r_associated | relid=0 | w=15
  1797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorophyllin copper complex / sodium propionate
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorophyllin copper complex / sodium propionate | rel=r_associated | relid=0 | w=15
  1798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroquine / primaquine
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroquine / primaquine | rel=r_associated | relid=0 | w=15
  1799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorothen / methapyrilene / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorothen / methapyrilene / pyrilamine | rel=r_associated | relid=0 | w=15
  1800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorothen maleate
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorothen maleate | rel=r_associated | relid=0 | w=15
  1801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorothiazide
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorothiazide | rel=r_associated | relid=0 | w=15
  1802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorothiazide + methyldopa
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorothiazide + methyldopa | rel=r_associated | relid=0 | w=15
  1803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorothiazide + reserpine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorothiazide + reserpine | rel=r_associated | relid=0 | w=15
  1804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorotrianisene
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorotrianisene | rel=r_associated | relid=0 | w=15
  1805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxine
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxine | rel=r_associated | relid=0 | w=15
  1806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol | rel=r_associated | relid=0 | w=15
  1807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol / hydrocortisone / pramoxine
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol / hydrocortisone / pramoxine | rel=r_associated | relid=0 | w=15
  1808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol / pramoxine
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol / pramoxine | rel=r_associated | relid=0 | w=15
  1809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol / resorcinol / sulfur
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol / resorcinol / sulfur | rel=r_associated | relid=0 | w=15
  1810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol/domiphen/hydrocortisone/pramoxine
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol/domiphen/hydrocortisone/pramoxine | rel=r_associated | relid=0 | w=15
  1811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol/iodine/menthol/potassium iodide/thymol
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol/iodine/menthol/potassium iodide/thymol | rel=r_associated | relid=0 | w=15
  1812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol/isopropyl myristate/undecylenic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol/isopropyl myristate/undecylenic acid | rel=r_associated | relid=0 | w=15
  1813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chloroxylenol/undecylenic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:chloroxylenol/undecylenic acid | rel=r_associated | relid=0 | w=15
  1814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorphenesin
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorphenesin | rel=r_associated | relid=0 | w=15
  1815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine | rel=r_associated | relid=0 | w=15
  1816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / codeine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / codeine | rel=r_associated | relid=0 | w=15
  1817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / codeine / iodinated glycerol
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / codeine / iodinated glycerol | rel=r_associated | relid=0 | w=15
  1818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / codeine / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / codeine / phenylephrine | rel=r_associated | relid=0 | w=15
  1819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / codeine / phenylephrine / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / codeine / phenylephrine / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / codeine / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / codeine / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / dextromethorphan
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / dextromethorphan | rel=r_associated | relid=0 | w=15
  1822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine | rel=r_associated | relid=0 | w=15
  1823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / dextromethorphan / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / dextromethorphan / phenylephrine | rel=r_associated | relid=0 | w=15
  1824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / dextromethorphan / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / dextromethorphan / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / ephedrine / guaifenesin / hydroiodic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / ephedrine / guaifenesin / hydroiodic acid | rel=r_associated | relid=0 | w=15
  1826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / ephedrine / guaifenesin / phenobarbital / theophylline
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / ephedrine / guaifenesin / phenobarbital / theophylline | rel=r_associated | relid=0 | w=15
  1827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / guaifenesin / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / guaifenesin / phenylephrine | rel=r_associated | relid=0 | w=15
  1828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / guaifenesin / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / guaifenesin / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / guaifenesin / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / guaifenesin / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / hydrocodone / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / hydrocodone / phenylephrine | rel=r_associated | relid=0 | w=15
  1831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / hydrocortisone / pheniramine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / hydrocortisone / pheniramine / pyrilamine | rel=r_associated | relid=0 | w=15
  1832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / methscopolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / methscopolamine | rel=r_associated | relid=0 | w=15
  1833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / methscopolamine / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / methscopolamine / phenylephrine | rel=r_associated | relid=0 | w=15
  1834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / methscopolamine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / methscopolamine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / phenindamine / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / phenindamine / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / phenylephrine / phenylpropanolamine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / phenylephrine / phenylpropanolamine / pyrilamine | rel=r_associated | relid=0 | w=15
  1837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / phenylephrine / phenyltoloxamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / phenylephrine / phenyltoloxamine | rel=r_associated | relid=0 | w=15
  1838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / phenylpropanolamine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / phenylpropanolamine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  1839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine / phenylpropanolamine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine / phenylpropanolamine / pyrilamine | rel=r_associated | relid=0 | w=15
  1840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + carbetapentane
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + carbetapentane | rel=r_associated | relid=0 | w=15
  1841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + ibuprofen + pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + ibuprofen + pseudoephedrine | rel=r_associated | relid=0 | w=15
  1842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + phenylephrine | rel=r_associated | relid=0 | w=15
  1843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + pseudoephedrine | rel=r_associated | relid=0 | w=15
  1844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + pseudoephedrine + codeine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + pseudoephedrine + codeine | rel=r_associated | relid=0 | w=15
  1845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + pseudoephedrine + dextromethorphan
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + pseudoephedrine + dextromethorphan | rel=r_associated | relid=0 | w=15
  1846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + pseudoephedrine + hydrocodone
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + pseudoephedrine + hydrocodone | rel=r_associated | relid=0 | w=15
  1847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine + pyrilamine + phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine + pyrilamine + phenylephrine | rel=r_associated | relid=0 | w=15
  1848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine, ephedrine drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine, ephedrine drug combination | rel=r_associated | relid=0 | w=15
  1849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination | rel=r_associated | relid=0 | w=15
  1850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine, phenylpropanolamine drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine, phenylpropanolamine drug combination | rel=r_associated | relid=0 | w=15
  1851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/citric acid/guaifenesin/phenylpropanolamine/sod
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/citric acid/guaifenesin/phenylpropanolamine/sod | rel=r_associated | relid=0 | w=15
  1852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/dextromethorphan/glycerol,iodinated
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/dextromethorphan/glycerol,iodinated | rel=r_associated | relid=0 | w=15
  1853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/dextromethorphan/guaifenesin/phenylephrine/sodi
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/dextromethorphan/guaifenesin/phenylephrine/sodi | rel=r_associated | relid=0 | w=15
  1854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/dextromethorphan/phenylephrine/phenylpropanolam
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/dextromethorphan/phenylephrine/phenylpropanolam | rel=r_associated | relid=0 | w=15
  1855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/dihydrocodeine/phenylephrine/phenylpropanolamin
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/dihydrocodeine/phenylephrine/phenylpropanolamin | rel=r_associated | relid=0 | w=15
  1856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine/p
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine/p | rel=r_associated | relid=0 | w=15
  1858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/hydrocodone/menthol/pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/hydrocodone/menthol/pseudoephedrine | rel=r_associated | relid=0 | w=15
  1859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyri
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyri | rel=r_associated | relid=0 | w=15
  1860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/hydrocodone/phenindamine/phenylephrine/pyrilami
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/hydrocodone/phenindamine/phenylephrine/pyrilami | rel=r_associated | relid=0 | w=15
  1861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/hydrocortisone/isopropyl alcohol/pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/hydrocortisone/isopropyl alcohol/pyrilamine | rel=r_associated | relid=0 | w=15
  1862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/isopropyl alcohol/pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/isopropyl alcohol/pyrilamine | rel=r_associated | relid=0 | w=15
  1863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpheniramine/phenylephrine/phenylpropanolamine/phenyltoloxam
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpheniramine/phenylephrine/phenylpropanolamine/phenyltoloxam | rel=r_associated | relid=0 | w=15
  1864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpromazine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpromazine | rel=r_associated | relid=0 | w=15
  1865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorpropamide
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorpropamide | rel=r_associated | relid=0 | w=15
  1866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorprothixene
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorprothixene | rel=r_associated | relid=0 | w=15
  1867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlortetracycline
    n1=Hyde (prurigo nodulaire de) | n2=en:chlortetracycline | rel=r_associated | relid=0 | w=15
  1868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorthalidone
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorthalidone | rel=r_associated | relid=0 | w=15
  1869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorthalidone / clonidine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorthalidone / clonidine | rel=r_associated | relid=0 | w=15
  1870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorthalidone / reserpine
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorthalidone / reserpine | rel=r_associated | relid=0 | w=15
  1871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chlorzoxazone
    n1=Hyde (prurigo nodulaire de) | n2=en:chlorzoxazone | rel=r_associated | relid=0 | w=15
  1872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chocolate flavoring
    n1=Hyde (prurigo nodulaire de) | n2=en:chocolate flavoring | rel=r_associated | relid=0 | w=15
  1873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choice dm
    n1=Hyde (prurigo nodulaire de) | n2=en:choice dm | rel=r_associated | relid=0 | w=15
  1874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholecalciferol
    n1=Hyde (prurigo nodulaire de) | n2=en:cholecalciferol | rel=r_associated | relid=0 | w=15
  1875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholecalciferol / folic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:cholecalciferol / folic acid | rel=r_associated | relid=0 | w=15
  1876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholecalciferol/fish liver oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cholecalciferol/fish liver oil | rel=r_associated | relid=0 | w=15
  1877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholecalciferol/fish oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cholecalciferol/fish oil | rel=r_associated | relid=0 | w=15
  1878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholest off
    n1=Hyde (prurigo nodulaire de) | n2=en:cholest off | rel=r_associated | relid=0 | w=15
  1879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholesterol
    n1=Hyde (prurigo nodulaire de) | n2=en:cholesterol | rel=r_associated | relid=0 | w=15
  1880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholesterol test kit
    n1=Hyde (prurigo nodulaire de) | n2=en:cholesterol test kit | rel=r_associated | relid=0 | w=15
  1881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholesterol/petrolatum/stearyl alcohol/wax
    n1=Hyde (prurigo nodulaire de) | n2=en:cholesterol/petrolatum/stearyl alcohol/wax | rel=r_associated | relid=0 | w=15
  1882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholestyramine
    n1=Hyde (prurigo nodulaire de) | n2=en:cholestyramine | rel=r_associated | relid=0 | w=15
  1883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cholestyramine/sorbitol
    n1=Hyde (prurigo nodulaire de) | n2=en:cholestyramine/sorbitol | rel=r_associated | relid=0 | w=15
  1884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline
    n1=Hyde (prurigo nodulaire de) | n2=en:choline | rel=r_associated | relid=0 | w=15
  1885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline / dexpanthenol
    n1=Hyde (prurigo nodulaire de) | n2=en:choline / dexpanthenol | rel=r_associated | relid=0 | w=15
  1886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline bitartrate
    n1=Hyde (prurigo nodulaire de) | n2=en:choline bitartrate | rel=r_associated | relid=0 | w=15
  1887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:choline chloride | rel=r_associated | relid=0 | w=15
  1888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:choline salicylate | rel=r_associated | relid=0 | w=15
  1889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choline salicylate/magnesium salicylate
    n1=Hyde (prurigo nodulaire de) | n2=en:choline salicylate/magnesium salicylate | rel=r_associated | relid=0 | w=15
  1890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondrodysplasia punctata, x-linked dominant type
    n1=Hyde (prurigo nodulaire de) | n2=en:chondrodysplasia punctata, x-linked dominant type | rel=r_associated | relid=0 | w=15
  1891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondrodysplasia, blomstrand type
    n1=Hyde (prurigo nodulaire de) | n2=en:chondrodysplasia, blomstrand type | rel=r_associated | relid=0 | w=15
  1892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondroitin
    n1=Hyde (prurigo nodulaire de) | n2=en:chondroitin | rel=r_associated | relid=0 | w=15
  1893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondroitin/glucosamine
    n1=Hyde (prurigo nodulaire de) | n2=en:chondroitin/glucosamine | rel=r_associated | relid=0 | w=15
  1894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondroitin/glucosamine/hyaluronate
    n1=Hyde (prurigo nodulaire de) | n2=en:chondroitin/glucosamine/hyaluronate | rel=r_associated | relid=0 | w=15
  1895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondroitin/glucosamine/methylsulfonylmethane
    n1=Hyde (prurigo nodulaire de) | n2=en:chondroitin/glucosamine/methylsulfonylmethane | rel=r_associated | relid=0 | w=15
  1896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chondroitin/hyaluronate
    n1=Hyde (prurigo nodulaire de) | n2=en:chondroitin/hyaluronate | rel=r_associated | relid=0 | w=15
  1897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chorea gravidarum
    n1=Hyde (prurigo nodulaire de) | n2=en:chorea gravidarum | rel=r_associated | relid=0 | w=15
  1898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chorioamnionitis
    n1=Hyde (prurigo nodulaire de) | n2=en:chorioamnionitis | rel=r_associated | relid=0 | w=15
  1899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:choriolysin l
    n1=Hyde (prurigo nodulaire de) | n2=en:choriolysin l | rel=r_associated | relid=0 | w=15
  1900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromagen ob
    n1=Hyde (prurigo nodulaire de) | n2=en:chromagen ob | rel=r_associated | relid=0 | w=15
  1901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromates
    n1=Hyde (prurigo nodulaire de) | n2=en:chromates | rel=r_associated | relid=0 | w=15
  1902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic chloride/cupric chloride/manganese chloride/selenium/zin
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic chloride/cupric chloride/manganese chloride/selenium/zin | rel=r_associated | relid=0 | w=15
  1903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic chloride/cupric chloride/manganese chloride/zinc chlorid
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic chloride/cupric chloride/manganese chloride/zinc chlorid | rel=r_associated | relid=0 | w=15
  1904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic chloride/cupric chloride/manganese sulfate/selenium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic chloride/cupric chloride/manganese sulfate/selenium/zinc | rel=r_associated | relid=0 | w=15
  1905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic chloride/cupric sulfate/manganese sulfate/selenium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic chloride/cupric sulfate/manganese sulfate/selenium/zinc | rel=r_associated | relid=0 | w=15
  1906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic chloride/cupric sulfate/manganese sulfate/zinc sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic chloride/cupric sulfate/manganese sulfate/zinc sulfate | rel=r_associated | relid=0 | w=15
  1907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic sulfate/cupric sulfate/manganese sulfate/selenium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic sulfate/cupric sulfate/manganese sulfate/selenium/zinc | rel=r_associated | relid=0 | w=15
  1908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromic sulfate/cupric sulfate/manganese sulfate/zinc sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:chromic sulfate/cupric sulfate/manganese sulfate/zinc sulfate | rel=r_associated | relid=0 | w=15
  1909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromium amino acid chelate
    n1=Hyde (prurigo nodulaire de) | n2=en:chromium amino acid chelate | rel=r_associated | relid=0 | w=15
  1910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromium/cinnamon
    n1=Hyde (prurigo nodulaire de) | n2=en:chromium/cinnamon | rel=r_associated | relid=0 | w=15
  1911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromium/copper/iodide/manganese/molybdenum/selenium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chromium/copper/iodide/manganese/molybdenum/selenium/zinc | rel=r_associated | relid=0 | w=15
  1912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromium/copper/iodide/manganese/selenium/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:chromium/copper/iodide/manganese/selenium/zinc | rel=r_associated | relid=0 | w=15
  1913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromosomal hypersensitivity to ionizing radiation and alkylating agents
    n1=Hyde (prurigo nodulaire de) | n2=en:chromosomal hypersensitivity to ionizing radiation and alkylating agents | rel=r_associated | relid=0 | w=15
  1914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chromosome rearrangements gave been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:chromosome rearrangements gave been reported | rel=r_associated | relid=0 | w=15
  1915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chronic course with exacerbations and remissions
    n1=Hyde (prurigo nodulaire de) | n2=en:chronic course with exacerbations and remissions | rel=r_associated | relid=0 | w=15
  1916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chronic disease
    n1=Hyde (prurigo nodulaire de) | n2=en:chronic disease | rel=r_associated | relid=0 | w=15
  1917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chronic polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:chronic polyhydramnios | rel=r_associated | relid=0 | w=15
  1918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chronic, relapsing condition
    n1=Hyde (prurigo nodulaire de) | n2=en:chronic, relapsing condition | rel=r_associated | relid=0 | w=15
  1919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chylothorax
    n1=Hyde (prurigo nodulaire de) | n2=en:chylothorax | rel=r_associated | relid=0 | w=15
  1920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chymopapain
    n1=Hyde (prurigo nodulaire de) | n2=en:chymopapain | rel=r_associated | relid=0 | w=15
  1921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:chymotrypsin
    n1=Hyde (prurigo nodulaire de) | n2=en:chymotrypsin | rel=r_associated | relid=0 | w=15
  1922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cianidanol
    n1=Hyde (prurigo nodulaire de) | n2=en:cianidanol | rel=r_associated | relid=0 | w=15
  1923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ciclesonide
    n1=Hyde (prurigo nodulaire de) | n2=en:ciclesonide | rel=r_associated | relid=0 | w=15
  1924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ciclopirox
    n1=Hyde (prurigo nodulaire de) | n2=en:ciclopirox | rel=r_associated | relid=0 | w=15
  1925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cidofovir
    n1=Hyde (prurigo nodulaire de) | n2=en:cidofovir | rel=r_associated | relid=0 | w=15
  1926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cilastatin, imipenem drug combination
    n1=Hyde (prurigo nodulaire de) | n2=en:cilastatin, imipenem drug combination | rel=r_associated | relid=0 | w=15
  1927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cilazapril monohydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:cilazapril monohydrate | rel=r_associated | relid=0 | w=15
  1928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cilomilast
    n1=Hyde (prurigo nodulaire de) | n2=en:cilomilast | rel=r_associated | relid=0 | w=15
  1929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cimetidine
    n1=Hyde (prurigo nodulaire de) | n2=en:cimetidine | rel=r_associated | relid=0 | w=15
  1930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cimetidine/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:cimetidine/dextrose | rel=r_associated | relid=0 | w=15
  1931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cimetidine/sodium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:cimetidine/sodium chloride | rel=r_associated | relid=0 | w=15
  1932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinchona
    n1=Hyde (prurigo nodulaire de) | n2=en:cinchona | rel=r_associated | relid=0 | w=15
  1933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinnamedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:cinnamedrine | rel=r_associated | relid=0 | w=15
  1934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinoxacin
    n1=Hyde (prurigo nodulaire de) | n2=en:cinoxacin | rel=r_associated | relid=0 | w=15
  1935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinoxate
    n1=Hyde (prurigo nodulaire de) | n2=en:cinoxate | rel=r_associated | relid=0 | w=15
  1936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinoxate/methyl anthranilate
    n1=Hyde (prurigo nodulaire de) | n2=en:cinoxate/methyl anthranilate | rel=r_associated | relid=0 | w=15
  1937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cinoxate/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:cinoxate/zinc oxide | rel=r_associated | relid=0 | w=15
  1938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ciprofloxacin / hydrocortisone
    n1=Hyde (prurigo nodulaire de) | n2=en:ciprofloxacin / hydrocortisone | rel=r_associated | relid=0 | w=15
  1939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ciprofloxacin/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:ciprofloxacin/dextrose | rel=r_associated | relid=0 | w=15
  1940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ciprofloxacin+dexamethasone
    n1=Hyde (prurigo nodulaire de) | n2=en:ciprofloxacin+dexamethasone | rel=r_associated | relid=0 | w=15
  1941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:circumvallate placenta syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:circumvallate placenta syndrome | rel=r_associated | relid=0 | w=15
  1942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cisapride
    n1=Hyde (prurigo nodulaire de) | n2=en:cisapride | rel=r_associated | relid=0 | w=15
  1943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cisatracurium
    n1=Hyde (prurigo nodulaire de) | n2=en:cisatracurium | rel=r_associated | relid=0 | w=15
  1944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citalopram
    n1=Hyde (prurigo nodulaire de) | n2=en:citalopram | rel=r_associated | relid=0 | w=15
  1945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citation:bib:pt:reference lab test:nar
    n1=Hyde (prurigo nodulaire de) | n2=en:citation:bib:pt:reference lab test:nar | rel=r_associated | relid=0 | w=15
  1946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citicoline
    n1=Hyde (prurigo nodulaire de) | n2=en:citicoline | rel=r_associated | relid=0 | w=15
  1947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrate
    n1=Hyde (prurigo nodulaire de) | n2=en:citrate | rel=r_associated | relid=0 | w=15
  1948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrate ester
    n1=Hyde (prurigo nodulaire de) | n2=en:citrate ester | rel=r_associated | relid=0 | w=15
  1949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrate/sulfate magnesia
    n1=Hyde (prurigo nodulaire de) | n2=en:citrate/sulfate magnesia | rel=r_associated | relid=0 | w=15
  1950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid | rel=r_associated | relid=0 | w=15
  1951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid / magnesium oxide / sodium carbonate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid / magnesium oxide / sodium carbonate | rel=r_associated | relid=0 | w=15
  1952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid / potassium citrate / sodium citrate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid / potassium citrate / sodium citrate | rel=r_associated | relid=0 | w=15
  1953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid / simethicone / sodium bicarbonate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid / simethicone / sodium bicarbonate | rel=r_associated | relid=0 | w=15
  1954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid + magnesium oxide + sodium picosulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid + magnesium oxide + sodium picosulfate | rel=r_associated | relid=0 | w=15
  1955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid/dextrose/fructose/glycerin
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid/dextrose/fructose/glycerin | rel=r_associated | relid=0 | w=15
  1956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid/gluconic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid/gluconic acid | rel=r_associated | relid=0 | w=15
  1957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid/glucono-delta-lactone/magnesium carbonate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid/glucono-delta-lactone/magnesium carbonate | rel=r_associated | relid=0 | w=15
  1958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric acid/sodium laureth sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric acid/sodium laureth sulfate | rel=r_associated | relid=0 | w=15
  1959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric/codeine/ipecac/potassium/promethazine/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:citric/codeine/ipecac/potassium/promethazine/sodium | rel=r_associated | relid=0 | w=15
  1960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric/codeine/ipecac/potassium/promethazine/sodium citrate
    n1=Hyde (prurigo nodulaire de) | n2=en:citric/codeine/ipecac/potassium/promethazine/sodium citrate | rel=r_associated | relid=0 | w=15
  1961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric/dextromethorphan/ipecac/potassium/promethazine/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:citric/dextromethorphan/ipecac/potassium/promethazine/sodium | rel=r_associated | relid=0 | w=15
  1962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric/ipecac/phenylephrine/potassium/promethazine/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:citric/ipecac/phenylephrine/potassium/promethazine/sodium | rel=r_associated | relid=0 | w=15
  1963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citric/ipecac/potassium/promethazine/sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:citric/ipecac/potassium/promethazine/sodium | rel=r_associated | relid=0 | w=15
  1964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citronella preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:citronella preparation | rel=r_associated | relid=0 | w=15
  1965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrotein
    n1=Hyde (prurigo nodulaire de) | n2=en:citrotein | rel=r_associated | relid=0 | w=15
  1966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrullinase
    n1=Hyde (prurigo nodulaire de) | n2=en:citrullinase | rel=r_associated | relid=0 | w=15
  1967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:citrulline
    n1=Hyde (prurigo nodulaire de) | n2=en:citrulline | rel=r_associated | relid=0 | w=15
  1968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cladosporium
    n1=Hyde (prurigo nodulaire de) | n2=en:cladosporium | rel=r_associated | relid=0 | w=15
  1969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clarithromycin
    n1=Hyde (prurigo nodulaire de) | n2=en:clarithromycin | rel=r_associated | relid=0 | w=15
  1970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic hepatic form begins in first months of life with hepatic failure and death by age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:classic hepatic form begins in first months of life with hepatic failure and death by age 5 years | rel=r_associated | relid=0 | w=15
  1971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic lesch-nyhan, < 1.5% hypoxanthine phosphoribosyltransferase (hprt) activity
    n1=Hyde (prurigo nodulaire de) | n2=en:classic lesch-nyhan, < 1.5% hypoxanthine phosphoribosyltransferase (hprt) activity | rel=r_associated | relid=0 | w=15
  1972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic severe form shows onset at 2 to 3 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:classic severe form shows onset at 2 to 3 months of age | rel=r_associated | relid=0 | w=15
  1973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic triad consists of nail dystrophy, skin hyperpigmentation, and mucosal leukoplakia
    n1=Hyde (prurigo nodulaire de) | n2=en:classic triad consists of nail dystrophy, skin hyperpigmentation, and mucosal leukoplakia | rel=r_associated | relid=0 | w=15
  1974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic triad is megaloblastic anemia, diabetes, and deafness, but some patients may not have this triad
    n1=Hyde (prurigo nodulaire de) | n2=en:classic triad is megaloblastic anemia, diabetes, and deafness, but some patients may not have this triad | rel=r_associated | relid=0 | w=15
  1975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classic: onset in first decade, rapid progression, loss of independent ambulation within 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:classic: onset in first decade, rapid progression, loss of independent ambulation within 15 years | rel=r_associated | relid=0 | w=15
  1976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:classical form (type i), less severe with survival into adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:classical form (type i), less severe with survival into adulthood | rel=r_associated | relid=0 | w=15
  1977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clavulanate
    n1=Hyde (prurigo nodulaire de) | n2=en:clavulanate | rel=r_associated | relid=0 | w=15
  1978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clavulanate / ticarcillin
    n1=Hyde (prurigo nodulaire de) | n2=en:clavulanate / ticarcillin | rel=r_associated | relid=0 | w=15
  1979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cleanser
    n1=Hyde (prurigo nodulaire de) | n2=en:cleanser | rel=r_associated | relid=0 | w=15
  1980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cleansing bar
    n1=Hyde (prurigo nodulaire de) | n2=en:cleansing bar | rel=r_associated | relid=0 | w=15
  1981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cleansing shampoo
    n1=Hyde (prurigo nodulaire de) | n2=en:cleansing shampoo | rel=r_associated | relid=0 | w=15
  1982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clearclenz
    n1=Hyde (prurigo nodulaire de) | n2=en:clearclenz | rel=r_associated | relid=0 | w=15
  1983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clemastine
    n1=Hyde (prurigo nodulaire de) | n2=en:clemastine | rel=r_associated | relid=0 | w=15
  1984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clemastine+phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:clemastine+phenylpropanolamine | rel=r_associated | relid=0 | w=15
  1985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clevidepine
    n1=Hyde (prurigo nodulaire de) | n2=en:clevidepine | rel=r_associated | relid=0 | w=15
  1986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clevidipine
    n1=Hyde (prurigo nodulaire de) | n2=en:clevidipine | rel=r_associated | relid=0 | w=15
  1987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clidinium
    n1=Hyde (prurigo nodulaire de) | n2=en:clidinium | rel=r_associated | relid=0 | w=15
  1988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clindamycin
    n1=Hyde (prurigo nodulaire de) | n2=en:clindamycin | rel=r_associated | relid=0 | w=15
  1989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clindamycin phosphate/tretinoin
    n1=Hyde (prurigo nodulaire de) | n2=en:clindamycin phosphate/tretinoin | rel=r_associated | relid=0 | w=15
  1990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clindamycin/dextrose
    n1=Hyde (prurigo nodulaire de) | n2=en:clindamycin/dextrose | rel=r_associated | relid=0 | w=15
  1991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical and biochemical abnormalities disappear with age
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical and biochemical abnormalities disappear with age | rel=r_associated | relid=0 | w=15
  1992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical and biochemical abnormalities improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical and biochemical abnormalities improve with age | rel=r_associated | relid=0 | w=15
  1993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical and biochemical symptoms improved with oral administration of creatine monohydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical and biochemical symptoms improved with oral administration of creatine monohydrate | rel=r_associated | relid=0 | w=15
  1994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical and pathologic features of both demyelinating and axonal cmt
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical and pathologic features of both demyelinating and axonal cmt | rel=r_associated | relid=0 | w=15
  1995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical data interchange standards consortium terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=15
  1996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical details not provided beyond a statement that the phenotype is 'identical to that of lccs3' (611369)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical details not provided beyond a statement that the phenotype is 'identical to that of lccs3' (611369) | rel=r_associated | relid=0 | w=15
  1997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical features based on 1 reported family (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical features based on 1 reported family (last curated august 2013) | rel=r_associated | relid=0 | w=15
  1998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical features in females include mild mental retardation (80%), short stature (50%), prominent forehead, and coarse facies
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical features in females include mild mental retardation (80%), short stature (50%), prominent forehead, and coarse facies | rel=r_associated | relid=0 | w=15
  1999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical features may vary
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical features may vary | rel=r_associated | relid=0 | w=15
  2000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical heterogeneity of multiminicore disease (see 255320 and 607552)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical heterogeneity of multiminicore disease (see 255320 and 607552) | rel=r_associated | relid=0 | w=15
  2001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical improvement after 2 to 3 weeks of supportive care
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical improvement after 2 to 3 weeks of supportive care | rel=r_associated | relid=0 | w=15
  2002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical manifestation of some forms of bardet-biedl syndrome requires recessive mutation in 1 of the 6 loci plus an additional mutation in a second locus, or triallelic inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical manifestation of some forms of bardet-biedl syndrome requires recessive mutation in 1 of the 6 loci plus an additional mutation in a second locus, or triallelic inheritance | rel=r_associated | relid=0 | w=15
  2003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical manifestation ranges from mild, transient hypertension to hellp syndrome (hemolysis, elevated liver enzymes, and low platelets)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical manifestation ranges from mild, transient hypertension to hellp syndrome (hemolysis, elevated liver enzymes, and low platelets) | rel=r_associated | relid=0 | w=15
  2004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical manifestations only occur if vel-negative individuals have anti-vel antibodies and are transfused with vel-positive blood
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical manifestations only occur if vel-negative individuals have anti-vel antibodies and are transfused with vel-positive blood | rel=r_associated | relid=0 | w=15
  2005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical onset within first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical onset within first 2 years of life | rel=r_associated | relid=0 | w=15
  2006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical overlap with charcot-marie-tooth disease type 2c (606071)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical overlap with charcot-marie-tooth disease type 2c (606071) | rel=r_associated | relid=0 | w=15
  2007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical overlap with congenital hypomyelinating neuropathy (chn, 605253)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical overlap with congenital hypomyelinating neuropathy (chn, 605253) | rel=r_associated | relid=0 | w=15
  2008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical overlap with dejerine-sottas syndrome (dss, 145900)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical overlap with dejerine-sottas syndrome (dss, 145900) | rel=r_associated | relid=0 | w=15
  2009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical overlap with demyelinating charcot-marie-tooth disease type 1 (see cmt1b, 118200), but much more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical overlap with demyelinating charcot-marie-tooth disease type 1 (see cmt1b, 118200), but much more severe phenotype | rel=r_associated | relid=0 | w=15
  2010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical overlap with distal hereditary motor neuropathy type vii (dhmn vii, 158580)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical overlap with distal hereditary motor neuropathy type vii (dhmn vii, 158580) | rel=r_associated | relid=0 | w=15
  2011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical presentation varies
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical presentation varies | rel=r_associated | relid=0 | w=15
  2012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical presentation varies from asymptomatic to fulminant course
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical presentation varies from asymptomatic to fulminant course | rel=r_associated | relid=0 | w=15
  2013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical severity varies
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical severity varies | rel=r_associated | relid=0 | w=15
  2014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical spectrum in males ranges from lethal neonatal onset to milder forms with first recognized episode in late childhood or even in adulthood | rel=r_associated | relid=0 | w=15
  2015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical triad - dysmorphic features, cardiac arrhythmia, and potassium-sensitive periodic paralysis
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical triad - dysmorphic features, cardiac arrhythmia, and potassium-sensitive periodic paralysis | rel=r_associated | relid=0 | w=15
  2016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical variability
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical variability | rel=r_associated | relid=0 | w=15
  2017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical variability seen in waardenburg syndrome type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical variability seen in waardenburg syndrome type 1 | rel=r_associated | relid=0 | w=15
  2018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinical variation
    n1=Hyde (prurigo nodulaire de) | n2=en:clinical variation | rel=r_associated | relid=0 | w=15
  2019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically 'silent' nystagmus evident on eye movement recording in carrier females
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically 'silent' nystagmus evident on eye movement recording in carrier females | rel=r_associated | relid=0 | w=15
  2020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically classified into classic, atypical, and intermediate phenotypes
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically classified into classic, atypical, and intermediate phenotypes | rel=r_associated | relid=0 | w=15
  2021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically mimics congenital torch infections (see 251290)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically mimics congenital torch infections (see 251290) | rel=r_associated | relid=0 | w=15
  2022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically resembles essential tremor, but not responsive to beta-adrenergic blockers | rel=r_associated | relid=0 | w=15
  2023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically resembles spinal muscular atrophy-1 (sma1, 253300)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically resembles spinal muscular atrophy-1 (sma1, 253300) | rel=r_associated | relid=0 | w=15
  2024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically similar to torsion dystonia-1 (dyt1, 128100)
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically similar to torsion dystonia-1 (dyt1, 128100) | rel=r_associated | relid=0 | w=15
  2025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clinically unaffected heterozygotes may show changes on electroretinography
    n1=Hyde (prurigo nodulaire de) | n2=en:clinically unaffected heterozygotes may show changes on electroretinography | rel=r_associated | relid=0 | w=15
  2026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clioquinol / coal tar / hydrocortisone
    n1=Hyde (prurigo nodulaire de) | n2=en:clioquinol / coal tar / hydrocortisone | rel=r_associated | relid=0 | w=15
  2027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clioquinol + hydrocortisone + pramoxine hydrochloride
    n1=Hyde (prurigo nodulaire de) | n2=en:clioquinol + hydrocortisone + pramoxine hydrochloride | rel=r_associated | relid=0 | w=15
  2028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clobazam
    n1=Hyde (prurigo nodulaire de) | n2=en:clobazam | rel=r_associated | relid=0 | w=15
  2029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clocortolone
    n1=Hyde (prurigo nodulaire de) | n2=en:clocortolone | rel=r_associated | relid=0 | w=15
  2030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clofarabine
    n1=Hyde (prurigo nodulaire de) | n2=en:clofarabine | rel=r_associated | relid=0 | w=15
  2031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clofazimine
    n1=Hyde (prurigo nodulaire de) | n2=en:clofazimine | rel=r_associated | relid=0 | w=15
  2032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clofibrate
    n1=Hyde (prurigo nodulaire de) | n2=en:clofibrate | rel=r_associated | relid=0 | w=15
  2033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clomiphene
    n1=Hyde (prurigo nodulaire de) | n2=en:clomiphene | rel=r_associated | relid=0 | w=15
  2034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clonazepam and diazepam may be effective in preventing or lessening severity
    n1=Hyde (prurigo nodulaire de) | n2=en:clonazepam and diazepam may be effective in preventing or lessening severity | rel=r_associated | relid=0 | w=15
  2035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clonidine
    n1=Hyde (prurigo nodulaire de) | n2=en:clonidine | rel=r_associated | relid=0 | w=15
  2036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clonidine can alleviate hyperhidrosis
    n1=Hyde (prurigo nodulaire de) | n2=en:clonidine can alleviate hyperhidrosis | rel=r_associated | relid=0 | w=15
  2037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clorazepate
    n1=Hyde (prurigo nodulaire de) | n2=en:clorazepate | rel=r_associated | relid=0 | w=15
  2038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clotrimazole
    n1=Hyde (prurigo nodulaire de) | n2=en:clotrimazole | rel=r_associated | relid=0 | w=15
  2039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clove - congenital lipomatous overgrowth, vascular malformations, and epidermal nevi
    n1=Hyde (prurigo nodulaire de) | n2=en:clove - congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | rel=r_associated | relid=0 | w=15
  2040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cloxacillin
    n1=Hyde (prurigo nodulaire de) | n2=en:cloxacillin | rel=r_associated | relid=0 | w=15
  2041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clozapine
    n1=Hyde (prurigo nodulaire de) | n2=en:clozapine | rel=r_associated | relid=0 | w=15
  2042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:clubfoot is bilateral in most patients
    n1=Hyde (prurigo nodulaire de) | n2=en:clubfoot is bilateral in most patients | rel=r_associated | relid=0 | w=15
  2043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cluster of differentiation transmembrane protein
    n1=Hyde (prurigo nodulaire de) | n2=en:cluster of differentiation transmembrane protein | rel=r_associated | relid=0 | w=15
  2044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coa hydrolase, acyl
    n1=Hyde (prurigo nodulaire de) | n2=en:coa hydrolase, acyl | rel=r_associated | relid=0 | w=15
  2045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coagulation specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:coagulation specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  2046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar | rel=r_associated | relid=0 | w=15
  2047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar / menthol
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar / menthol | rel=r_associated | relid=0 | w=15
  2048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar / menthol / salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar / menthol / salicylic acid | rel=r_associated | relid=0 | w=15
  2049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar / polysorbate 80
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar / polysorbate 80 | rel=r_associated | relid=0 | w=15
  2050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar / salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar / salicylic acid | rel=r_associated | relid=0 | w=15
  2051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar/lactic acid/salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar/lactic acid/salicylic acid | rel=r_associated | relid=0 | w=15
  2052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar/lanolin/mineral oil
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar/lanolin/mineral oil | rel=r_associated | relid=0 | w=15
  2053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar/lauramide dea/sodium lauryl sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar/lauramide dea/sodium lauryl sulfate | rel=r_associated | relid=0 | w=15
  2054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar/salicylic acid/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar/salicylic acid/zinc oxide | rel=r_associated | relid=0 | w=15
  2055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coal tar/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:coal tar/zinc oxide | rel=r_associated | relid=0 | w=15
  2056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobalamin
    n1=Hyde (prurigo nodulaire de) | n2=en:cobalamin | rel=r_associated | relid=0 | w=15
  2057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobalamins
    n1=Hyde (prurigo nodulaire de) | n2=en:cobalamins | rel=r_associated | relid=0 | w=15
  2058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobalt
    n1=Hyde (prurigo nodulaire de) | n2=en:cobalt | rel=r_associated | relid=0 | w=15
  2059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobalt co-57
    n1=Hyde (prurigo nodulaire de) | n2=en:cobalt co-57 | rel=r_associated | relid=0 | w=15
  2060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobicistat
    n1=Hyde (prurigo nodulaire de) | n2=en:cobicistat | rel=r_associated | relid=0 | w=15
  2061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobicistat + darunavir
    n1=Hyde (prurigo nodulaire de) | n2=en:cobicistat + darunavir | rel=r_associated | relid=0 | w=15
  2062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cobicistat/elvitegravir/emtricitabine/tenofovir
    n1=Hyde (prurigo nodulaire de) | n2=en:cobicistat/elvitegravir/emtricitabine/tenofovir | rel=r_associated | relid=0 | w=15
  2063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocaine
    n1=Hyde (prurigo nodulaire de) | n2=en:cocaine | rel=r_associated | relid=0 | w=15
  2064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocamide dea
    n1=Hyde (prurigo nodulaire de) | n2=en:cocamide dea | rel=r_associated | relid=0 | w=15
  2065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocamide mea
    n1=Hyde (prurigo nodulaire de) | n2=en:cocamide mea | rel=r_associated | relid=0 | w=15
  2066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocamidopropyl betaine
    n1=Hyde (prurigo nodulaire de) | n2=en:cocamidopropyl betaine | rel=r_associated | relid=0 | w=15
  2067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coccidiodin
    n1=Hyde (prurigo nodulaire de) | n2=en:coccidiodin | rel=r_associated | relid=0 | w=15
  2068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coccidioides immitis
    n1=Hyde (prurigo nodulaire de) | n2=en:coccidioides immitis | rel=r_associated | relid=0 | w=15
  2069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coccidioides immitis antigen
    n1=Hyde (prurigo nodulaire de) | n2=en:coccidioides immitis antigen | rel=r_associated | relid=0 | w=15
  2070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coco-caprylate
    n1=Hyde (prurigo nodulaire de) | n2=en:coco-caprylate | rel=r_associated | relid=0 | w=15
  2071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocoa butter / zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:cocoa butter / zinc oxide | rel=r_associated | relid=0 | w=15
  2072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cocoa extract
    n1=Hyde (prurigo nodulaire de) | n2=en:cocoa extract | rel=r_associated | relid=0 | w=15
  2073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coconut oil
    n1=Hyde (prurigo nodulaire de) | n2=en:coconut oil | rel=r_associated | relid=0 | w=15
  2074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coconut oil/palm kernel oil
    n1=Hyde (prurigo nodulaire de) | n2=en:coconut oil/palm kernel oil | rel=r_associated | relid=0 | w=15
  2075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cod liver oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cod liver oil | rel=r_associated | relid=0 | w=15
  2076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cod liver oil/talc/zinc oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:cod liver oil/talc/zinc oxide | rel=r_associated | relid=0 | w=15
  2077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codas is an acronym for cerebral ocular dental auricular skeletal syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:codas is an acronym for cerebral ocular dental auricular skeletal syndrome | rel=r_associated | relid=0 | w=15
  2078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codas syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:codas syndrome | rel=r_associated | relid=0 | w=15
  2079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / ephedrine / guaifenesin
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / ephedrine / guaifenesin | rel=r_associated | relid=0 | w=15
  2080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / guaifenesin / pheniramine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / guaifenesin / pheniramine | rel=r_associated | relid=0 | w=15
  2081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / guaifenesin / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / guaifenesin / phenylephrine | rel=r_associated | relid=0 | w=15
  2082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / guaifenesin / phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / guaifenesin / phenylpropanolamine | rel=r_associated | relid=0 | w=15
  2083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / guaifenesin / pseudoephedrine / triprolidine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / guaifenesin / pseudoephedrine / triprolidine | rel=r_associated | relid=0 | w=15
  2084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / iodinated glycerol
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / iodinated glycerol | rel=r_associated | relid=0 | w=15
  2085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / menthol / pheniramine / phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / menthol / pheniramine / phenylephrine | rel=r_associated | relid=0 | w=15
  2086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / papaverine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / papaverine | rel=r_associated | relid=0 | w=15
  2087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / phenylephrine / pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / phenylephrine / pseudoephedrine | rel=r_associated | relid=0 | w=15
  2088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / phenylephrine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / phenylephrine / pyrilamine | rel=r_associated | relid=0 | w=15
  2089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / phenylephrine / triprolidine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / phenylephrine / triprolidine | rel=r_associated | relid=0 | w=15
  2090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / phenylpropanolamine / promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / phenylpropanolamine / promethazine | rel=r_associated | relid=0 | w=15
  2091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / potassium citrate
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / potassium citrate | rel=r_associated | relid=0 | w=15
  2092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / promethazine | rel=r_associated | relid=0 | w=15
  2093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / pseudoephedrine / triprolidine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / pseudoephedrine / triprolidine | rel=r_associated | relid=0 | w=15
  2094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / pyrilamine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / pyrilamine | rel=r_associated | relid=0 | w=15
  2095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine / terpin hydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine / terpin hydrate | rel=r_associated | relid=0 | w=15
  2096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine + pseudoephedrine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine + pseudoephedrine | rel=r_associated | relid=0 | w=15
  2097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine/ipecac/phenylephrine/potassium/promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine/ipecac/phenylephrine/potassium/promethazine | rel=r_associated | relid=0 | w=15
  2098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine/ipecac/potassium guaiacolsulfonate/promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine/ipecac/potassium guaiacolsulfonate/promethazine | rel=r_associated | relid=0 | w=15
  2099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine/phenylephrine/phenylpropanolamine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine/phenylephrine/phenylpropanolamine | rel=r_associated | relid=0 | w=15
  2100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine/phenylephrine/potassium guaiacolsulfonate/promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine/phenylephrine/potassium guaiacolsulfonate/promethazine | rel=r_associated | relid=0 | w=15
  2101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codeine/potassium guaiacolsulfonate/promethazine
    n1=Hyde (prurigo nodulaire de) | n2=en:codeine/potassium guaiacolsulfonate/promethazine | rel=r_associated | relid=0 | w=15
  2102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codominant inheritance has been suggested
    n1=Hyde (prurigo nodulaire de) | n2=en:codominant inheritance has been suggested | rel=r_associated | relid=0 | w=15
  2103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:codonopsis extract
    n1=Hyde (prurigo nodulaire de) | n2=en:codonopsis extract | rel=r_associated | relid=0 | w=15
  2104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coenzyme q10
    n1=Hyde (prurigo nodulaire de) | n2=en:coenzyme q10 | rel=r_associated | relid=0 | w=15
  2105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coenzyme q10 / levocarnitine
    n1=Hyde (prurigo nodulaire de) | n2=en:coenzyme q10 / levocarnitine | rel=r_associated | relid=0 | w=15
  2106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cola
    n1=Hyde (prurigo nodulaire de) | n2=en:cola | rel=r_associated | relid=0 | w=15
  2107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colchicine
    n1=Hyde (prurigo nodulaire de) | n2=en:colchicine | rel=r_associated | relid=0 | w=15
  2108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colchicine treatment is not effective
    n1=Hyde (prurigo nodulaire de) | n2=en:colchicine treatment is not effective | rel=r_associated | relid=0 | w=15
  2109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cold cream
    n1=Hyde (prurigo nodulaire de) | n2=en:cold cream | rel=r_associated | relid=0 | w=15
  2110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cold temeratures exacerbate symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:cold temeratures exacerbate symptoms | rel=r_associated | relid=0 | w=15
  2111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cold-induced sweating develops late in the first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:cold-induced sweating develops late in the first decade | rel=r_associated | relid=0 | w=15
  2112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colesevelam
    n1=Hyde (prurigo nodulaire de) | n2=en:colesevelam | rel=r_associated | relid=0 | w=15
  2113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colfosceril
    n1=Hyde (prurigo nodulaire de) | n2=en:colfosceril | rel=r_associated | relid=0 | w=15
  2114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colistimethate
    n1=Hyde (prurigo nodulaire de) | n2=en:colistimethate | rel=r_associated | relid=0 | w=15
  2115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colistin
    n1=Hyde (prurigo nodulaire de) | n2=en:colistin | rel=r_associated | relid=0 | w=15
  2116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colistin / hydrocortisone / neomycin / thonzonium
    n1=Hyde (prurigo nodulaire de) | n2=en:colistin / hydrocortisone / neomycin / thonzonium | rel=r_associated | relid=0 | w=15
  2117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colistin/hydrocortisone/neomycin
    n1=Hyde (prurigo nodulaire de) | n2=en:colistin/hydrocortisone/neomycin | rel=r_associated | relid=0 | w=15
  2118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colladerm
    n1=Hyde (prurigo nodulaire de) | n2=en:colladerm | rel=r_associated | relid=0 | w=15
  2119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collagen
    n1=Hyde (prurigo nodulaire de) | n2=en:collagen | rel=r_associated | relid=0 | w=15
  2120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collagen hemostat
    n1=Hyde (prurigo nodulaire de) | n2=en:collagen hemostat | rel=r_associated | relid=0 | w=15
  2121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collagen,microfibrillar
    n1=Hyde (prurigo nodulaire de) | n2=en:collagen,microfibrillar | rel=r_associated | relid=0 | w=15
  2122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collagen,soluble
    n1=Hyde (prurigo nodulaire de) | n2=en:collagen,soluble | rel=r_associated | relid=0 | w=15
  2123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collagen/elastin/glycerin
    n1=Hyde (prurigo nodulaire de) | n2=en:collagen/elastin/glycerin | rel=r_associated | relid=0 | w=15
  2124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collodion
    n1=Hyde (prurigo nodulaire de) | n2=en:collodion | rel=r_associated | relid=0 | w=15
  2125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:collodion,flexible/lactic acid/salicylic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:collodion,flexible/lactic acid/salicylic acid | rel=r_associated | relid=0 | w=15
  2126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coloboma is associated with larger microdeletion (490kb) of 11q13
    n1=Hyde (prurigo nodulaire de) | n2=en:coloboma is associated with larger microdeletion (490kb) of 11q13 | rel=r_associated | relid=0 | w=15
  2127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:color vision defects may not be part of the phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:color vision defects may not be part of the phenotype | rel=r_associated | relid=0 | w=15
  2128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:color,artificial
    n1=Hyde (prurigo nodulaire de) | n2=en:color,artificial | rel=r_associated | relid=0 | w=15
  2129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colorectal cancer develops by fourth decade in untreated patients
    n1=Hyde (prurigo nodulaire de) | n2=en:colorectal cancer develops by fourth decade in untreated patients | rel=r_associated | relid=0 | w=15
  2130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:colostrum preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:colostrum preparation | rel=r_associated | relid=0 | w=15
  2131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:column protein subunit
    n1=Hyde (prurigo nodulaire de) | n2=en:column protein subunit | rel=r_associated | relid=0 | w=15
  2132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:comfeel ulcer care
    n1=Hyde (prurigo nodulaire de) | n2=en:comfeel ulcer care | rel=r_associated | relid=0 | w=15
  2133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:commiphora mukul (guggul)
    n1=Hyde (prurigo nodulaire de) | n2=en:commiphora mukul (guggul) | rel=r_associated | relid=0 | w=15
  2134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:common (up to 7% of the population)
    n1=Hyde (prurigo nodulaire de) | n2=en:common (up to 7% of the population) | rel=r_associated | relid=0 | w=15
  2135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:common in afrikaan population, south africa
    n1=Hyde (prurigo nodulaire de) | n2=en:common in afrikaan population, south africa | rel=r_associated | relid=0 | w=15
  2136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:common in japan and other asian populations
    n1=Hyde (prurigo nodulaire de) | n2=en:common in japan and other asian populations | rel=r_associated | relid=0 | w=15
  2137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:common in south african whites
    n1=Hyde (prurigo nodulaire de) | n2=en:common in south african whites | rel=r_associated | relid=0 | w=15
  2138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:common rue preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:common rue preparation | rel=r_associated | relid=0 | w=15
  2139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:communication board, non-electronic augmentative or alternative communication device
    n1=Hyde (prurigo nodulaire de) | n2=en:communication board, non-electronic augmentative or alternative communication device | rel=r_associated | relid=0 | w=15
  2140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:compleat liquid nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:compleat liquid nutrition | rel=r_associated | relid=0 | w=15
  2141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complement activating enzymes
    n1=Hyde (prurigo nodulaire de) | n2=en:complement activating enzymes | rel=r_associated | relid=0 | w=15
  2142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complement deficiency (e.g. c2 and c4 null alleles) are susceptible to developing sle
    n1=Hyde (prurigo nodulaire de) | n2=en:complement deficiency (e.g. c2 and c4 null alleles) are susceptible to developing sle | rel=r_associated | relid=0 | w=15
  2143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complementation group b (represented by single atypical patient)
    n1=Hyde (prurigo nodulaire de) | n2=en:complementation group b (represented by single atypical patient) | rel=r_associated | relid=0 | w=15
  2144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complementation group c (variant mliii, 252605)
    n1=Hyde (prurigo nodulaire de) | n2=en:complementation group c (variant mliii, 252605) | rel=r_associated | relid=0 | w=15
  2145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complementation groups - complementation group a (classic mliii, 252600)
    n1=Hyde (prurigo nodulaire de) | n2=en:complementation groups - complementation group a (classic mliii, 252600) | rel=r_associated | relid=0 | w=15
  2146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete absence of melanin synthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:complete absence of melanin synthesis | rel=r_associated | relid=0 | w=15
  2147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete manifestation in males
    n1=Hyde (prurigo nodulaire de) | n2=en:complete manifestation in males | rel=r_associated | relid=0 | w=15
  2148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:complete penetrance | rel=r_associated | relid=0 | w=15
  2149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete penetrance but extreme variability of phenotypic expression
    n1=Hyde (prurigo nodulaire de) | n2=en:complete penetrance but extreme variability of phenotypic expression | rel=r_associated | relid=0 | w=15
  2150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete penetrance with variable expressivity
    n1=Hyde (prurigo nodulaire de) | n2=en:complete penetrance with variable expressivity | rel=r_associated | relid=0 | w=15
  2151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complete recovery upon treatment of hyperthyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:complete recovery upon treatment of hyperthyroidism | rel=r_associated | relid=0 | w=15
  2152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complex mixtures
    n1=Hyde (prurigo nodulaire de) | n2=en:complex mixtures | rel=r_associated | relid=0 | w=15
  2153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complicated and pure forms
    n1=Hyde (prurigo nodulaire de) | n2=en:complicated and pure forms | rel=r_associated | relid=0 | w=15
  2154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:complications specific to multiple gestation
    n1=Hyde (prurigo nodulaire de) | n2=en:complications specific to multiple gestation | rel=r_associated | relid=0 | w=15
  2155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:component of protein complex
    n1=Hyde (prurigo nodulaire de) | n2=en:component of protein complex | rel=r_associated | relid=0 | w=15
  2156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:compound heterozygosity common
    n1=Hyde (prurigo nodulaire de) | n2=en:compound heterozygosity common | rel=r_associated | relid=0 | w=15
  2157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:comprises several subtypes, including
    n1=Hyde (prurigo nodulaire de) | n2=en:comprises several subtypes, including | rel=r_associated | relid=0 | w=15
  2158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:condition is experienced by patients as harmless and is often discovered incidentally
    n1=Hyde (prurigo nodulaire de) | n2=en:condition is experienced by patients as harmless and is often discovered incidentally | rel=r_associated | relid=0 | w=15
  2159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:condition of membranes at delivery
    n1=Hyde (prurigo nodulaire de) | n2=en:condition of membranes at delivery | rel=r_associated | relid=0 | w=15
  2160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:conduction defect is progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:conduction defect is progressive | rel=r_associated | relid=0 | w=15
  2161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:cone-shaped epiphyses appear in early childhood and disappear with premature fusion of growth plate before puberty | rel=r_associated | relid=0 | w=15
  2162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cone-shaped epiphyses usually not present before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:cone-shaped epiphyses usually not present before age 2 years | rel=r_associated | relid=0 | w=15
  2163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congener
    n1=Hyde (prurigo nodulaire de) | n2=en:congener | rel=r_associated | relid=0 | w=15
  2164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital - over 2,000 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital - over 2,000 repeats | rel=r_associated | relid=0 | w=15
  2165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital abnormality
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=15
  2166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital and peripartum cerebral disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital and peripartum cerebral disorders | rel=r_associated | relid=0 | w=15
  2167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital cataracts, sometimes requiring extraction in childhood due to impairment of vision
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital cataracts, sometimes requiring extraction in childhood due to impairment of vision | rel=r_associated | relid=0 | w=15
  2168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital chloride diarrhea
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital chloride diarrhea | rel=r_associated | relid=0 | w=15
  2169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital disorders | rel=r_associated | relid=0 | w=15
  2170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital hypotonia from 8 to 12 months, then progressive spasticity resulting in contractures and spastic quadriplegia
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital hypotonia from 8 to 12 months, then progressive spasticity resulting in contractures and spastic quadriplegia | rel=r_associated | relid=0 | w=15
  2171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital onset
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital onset | rel=r_associated | relid=0 | w=15
  2172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital onset or onset before 2 years (prelingual)
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital onset or onset before 2 years (prelingual) | rel=r_associated | relid=0 | w=15
  2173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital pulmonary lymphangiectasia
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital pulmonary lymphangiectasia | rel=r_associated | relid=0 | w=15
  2174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:congenital secretory diarrhea, sodium type (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital secretory diarrhea, sodium type (disorder) | rel=r_associated | relid=0 | w=15
  2175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:connatal form (type ii), most severe with death in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:connatal form (type ii), most severe with death in first decade | rel=r_associated | relid=0 | w=15
  2176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered a benign disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:considered a benign disorder | rel=r_associated | relid=0 | w=15
  2177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered a myeloproliferative disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:considered a myeloproliferative disorder | rel=r_associated | relid=0 | w=15
  2178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered a normal variant
    n1=Hyde (prurigo nodulaire de) | n2=en:considered a normal variant | rel=r_associated | relid=0 | w=15
  2179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered part of a spectrum of leber hereditary optic atrophy (lhon, 535000)
    n1=Hyde (prurigo nodulaire de) | n2=en:considered part of a spectrum of leber hereditary optic atrophy (lhon, 535000) | rel=r_associated | relid=0 | w=15
  2180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered to be a manifestation of the caudal regression syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:considered to be a manifestation of the caudal regression syndrome | rel=r_associated | relid=0 | w=15
  2181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered to be a severe form of gaucher disease type ii (230900)
    n1=Hyde (prurigo nodulaire de) | n2=en:considered to be a severe form of gaucher disease type ii (230900) | rel=r_associated | relid=0 | w=15
  2182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered to be a variant of gaucher disease type iii (231000)
    n1=Hyde (prurigo nodulaire de) | n2=en:considered to be a variant of gaucher disease type iii (231000) | rel=r_associated | relid=0 | w=15
  2183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:considered to be part of the spectrum of joubert syndrome (213300) and meckel syndrome (249000)
    n1=Hyde (prurigo nodulaire de) | n2=en:considered to be part of the spectrum of joubert syndrome (213300) and meckel syndrome (249000) | rel=r_associated | relid=0 | w=15
  2184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:consistent carbohydrate diet
    n1=Hyde (prurigo nodulaire de) | n2=en:consistent carbohydrate diet | rel=r_associated | relid=0 | w=15
  2185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:constriction band abnormality of placental amnion
    n1=Hyde (prurigo nodulaire de) | n2=en:constriction band abnormality of placental amnion | rel=r_associated | relid=0 | w=15
  2186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contact lens cleaning solutions
    n1=Hyde (prurigo nodulaire de) | n2=en:contact lens cleaning solutions | rel=r_associated | relid=0 | w=15
  2187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contact lens saline,preserved
    n1=Hyde (prurigo nodulaire de) | n2=en:contact lens saline,preserved | rel=r_associated | relid=0 | w=15
  2188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contact lens wetting soln
    n1=Hyde (prurigo nodulaire de) | n2=en:contact lens wetting soln | rel=r_associated | relid=0 | w=15
  2189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene deletion of 17q21.3 involves a region which harbors a 900kb inversion polymorphism
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene deletion of 17q21.3 involves a region which harbors a 900kb inversion polymorphism | rel=r_associated | relid=0 | w=15
  2190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene deletion syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene deletion syndrome | rel=r_associated | relid=0 | w=15
  2191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene deletion syndrome (in most patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene deletion syndrome (in most patients) | rel=r_associated | relid=0 | w=15
  2192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene deletion syndrome at chromosome 6p
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene deletion syndrome at chromosome 6p | rel=r_associated | relid=0 | w=15
  2193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene deletion syndrome of 5q31
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene deletion syndrome of 5q31 | rel=r_associated | relid=0 | w=15
  2194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene duplication syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene duplication syndrome | rel=r_associated | relid=0 | w=15
  2195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene syndrome | rel=r_associated | relid=0 | w=15
  2196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contiguous gene syndrome caused by deletion, duplication, or rearrangement of chromosome 7q21.3 involving the dss1 (601285), dlx5 (600028), and dlx6 (600030) genes and possible regulatory elements in the region
    n1=Hyde (prurigo nodulaire de) | n2=en:contiguous gene syndrome caused by deletion, duplication, or rearrangement of chromosome 7q21.3 involving the dss1 (601285), dlx5 (600028), and dlx6 (600030) genes and possible regulatory elements in the region | rel=r_associated | relid=0 | w=15
  2197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contractures most severe by midadolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:contractures most severe by midadolescence | rel=r_associated | relid=0 | w=15
  2198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:contractures other than plantar are less common and less severe
    n1=Hyde (prurigo nodulaire de) | n2=en:contractures other than plantar are less common and less severe | rel=r_associated | relid=0 | w=15
  2199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:converting enzyme, pro-opiomelanocortin
    n1=Hyde (prurigo nodulaire de) | n2=en:converting enzyme, pro-opiomelanocortin | rel=r_associated | relid=0 | w=15
  2200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cophene
    n1=Hyde (prurigo nodulaire de) | n2=en:cophene | rel=r_associated | relid=0 | w=15
  2201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:copper amino acid chelate
    n1=Hyde (prurigo nodulaire de) | n2=en:copper amino acid chelate | rel=r_associated | relid=0 | w=15
  2202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:copper gluconate
    n1=Hyde (prurigo nodulaire de) | n2=en:copper gluconate | rel=r_associated | relid=0 | w=15
  2203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:copper-transporting atpase 1
    n1=Hyde (prurigo nodulaire de) | n2=en:copper-transporting atpase 1 | rel=r_associated | relid=0 | w=15
  2204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:copper/folic/niacinamide/zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:copper/folic/niacinamide/zinc | rel=r_associated | relid=0 | w=15
  2205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coprinus micaceus
    n1=Hyde (prurigo nodulaire de) | n2=en:coprinus micaceus | rel=r_associated | relid=0 | w=15
  2206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coptis extract
    n1=Hyde (prurigo nodulaire de) | n2=en:coptis extract | rel=r_associated | relid=0 | w=15
  2207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cordyceps sinensis preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:cordyceps sinensis preparation | rel=r_associated | relid=0 | w=15
  2208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coriander oil
    n1=Hyde (prurigo nodulaire de) | n2=en:coriander oil | rel=r_associated | relid=0 | w=15
  2209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corn oil
    n1=Hyde (prurigo nodulaire de) | n2=en:corn oil | rel=r_associated | relid=0 | w=15
  2210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corn starch/methylbenzethonium chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:corn starch/methylbenzethonium chloride | rel=r_associated | relid=0 | w=15
  2211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corn syrup
    n1=Hyde (prurigo nodulaire de) | n2=en:corn syrup | rel=r_associated | relid=0 | w=15
  2212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corneal diameter decreases with decreasing axial length
    n1=Hyde (prurigo nodulaire de) | n2=en:corneal diameter decreases with decreasing axial length | rel=r_associated | relid=0 | w=15
  2213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corneal hydration
    n1=Hyde (prurigo nodulaire de) | n2=en:corneal hydration | rel=r_associated | relid=0 | w=15
  2214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corneal steepening is proportional to the degree of axial foreshortening
    n1=Hyde (prurigo nodulaire de) | n2=en:corneal steepening is proportional to the degree of axial foreshortening | rel=r_associated | relid=0 | w=15
  2215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cornsilk
    n1=Hyde (prurigo nodulaire de) | n2=en:cornsilk | rel=r_associated | relid=0 | w=15
  2216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:coronary artery disease or myocardial infarction in fifth or sixth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:coronary artery disease or myocardial infarction in fifth or sixth decade of life | rel=r_associated | relid=0 | w=15
  2217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corpak pro-mix
    n1=Hyde (prurigo nodulaire de) | n2=en:corpak pro-mix | rel=r_associated | relid=0 | w=15
  2218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corrected by bone marrow transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:corrected by bone marrow transplantation | rel=r_associated | relid=0 | w=15
  2219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corticorelin ovine
    n1=Hyde (prurigo nodulaire de) | n2=en:corticorelin ovine | rel=r_associated | relid=0 | w=15
  2220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corticotropin
    n1=Hyde (prurigo nodulaire de) | n2=en:corticotropin | rel=r_associated | relid=0 | w=15
  2221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:corticotropin zinc hydroxide preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:corticotropin zinc hydroxide preparation | rel=r_associated | relid=0 | w=15
  2222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cortisone
    n1=Hyde (prurigo nodulaire de) | n2=en:cortisone | rel=r_associated | relid=0 | w=15
  2223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:costamere
    n1=Hyde (prurigo nodulaire de) | n2=en:costamere | rel=r_associated | relid=0 | w=15
  2224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:costello syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:costello syndrome | rel=r_associated | relid=0 | w=15
  2225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cosyntropin
    n1=Hyde (prurigo nodulaire de) | n2=en:cosyntropin | rel=r_associated | relid=0 | w=15
  2226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cosyntropin/mannitol
    n1=Hyde (prurigo nodulaire de) | n2=en:cosyntropin/mannitol | rel=r_associated | relid=0 | w=15
  2227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cottonseed oil
    n1=Hyde (prurigo nodulaire de) | n2=en:cottonseed oil | rel=r_associated | relid=0 | w=15
  2228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:course characterized by repeated relapses precipitated by excessive protein intake, intercurrent infection, or constipation
    n1=Hyde (prurigo nodulaire de) | n2=en:course characterized by repeated relapses precipitated by excessive protein intake, intercurrent infection, or constipation | rel=r_associated | relid=0 | w=15
  2229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:covangesic
    n1=Hyde (prurigo nodulaire de) | n2=en:covangesic | rel=r_associated | relid=0 | w=15
  2230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cranberry preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:cranberry preparation | rel=r_associated | relid=0 | w=15
  2231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crash is an acronym for corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus which encompasses all l1cam diseases
    n1=Hyde (prurigo nodulaire de) | n2=en:crash is an acronym for corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus which encompasses all l1cam diseases | rel=r_associated | relid=0 | w=15
  2232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:creatinase
    n1=Hyde (prurigo nodulaire de) | n2=en:creatinase | rel=r_associated | relid=0 | w=15
  2233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:creatine
    n1=Hyde (prurigo nodulaire de) | n2=en:creatine | rel=r_associated | relid=0 | w=15
  2234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cresol
    n1=Hyde (prurigo nodulaire de) | n2=en:cresol | rel=r_associated | relid=0 | w=15
  2235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cresol / formaldehyde
    n1=Hyde (prurigo nodulaire de) | n2=en:cresol / formaldehyde | rel=r_associated | relid=0 | w=15
  2236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crisis precipitated by high altitude exposure
    n1=Hyde (prurigo nodulaire de) | n2=en:crisis precipitated by high altitude exposure | rel=r_associated | relid=0 | w=15
  2237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:criticare hn
    n1=Hyde (prurigo nodulaire de) | n2=en:criticare hn | rel=r_associated | relid=0 | w=15
  2238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crm-197 protein conjugate
    n1=Hyde (prurigo nodulaire de) | n2=en:crm-197 protein conjugate | rel=r_associated | relid=0 | w=15
  2239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cromolyn
    n1=Hyde (prurigo nodulaire de) | n2=en:cromolyn | rel=r_associated | relid=0 | w=15
  2240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:croscarmellose sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:croscarmellose sodium | rel=r_associated | relid=0 | w=15
  2241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crospovidone
    n1=Hyde (prurigo nodulaire de) | n2=en:crospovidone | rel=r_associated | relid=0 | w=15
  2242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crossover junction endoribonuclease
    n1=Hyde (prurigo nodulaire de) | n2=en:crossover junction endoribonuclease | rel=r_associated | relid=0 | w=15
  2243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crotaline antivenin
    n1=Hyde (prurigo nodulaire de) | n2=en:crotaline antivenin | rel=r_associated | relid=0 | w=15
  2244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:crotamiton
    n1=Hyde (prurigo nodulaire de) | n2=en:crotamiton | rel=r_associated | relid=0 | w=15
  2245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cryptenamine
    n1=Hyde (prurigo nodulaire de) | n2=en:cryptenamine | rel=r_associated | relid=0 | w=15
  2246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cryptenamine / methyclothiazide
    n1=Hyde (prurigo nodulaire de) | n2=en:cryptenamine / methyclothiazide | rel=r_associated | relid=0 | w=15
  2247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cupric chloride
    n1=Hyde (prurigo nodulaire de) | n2=en:cupric chloride | rel=r_associated | relid=0 | w=15
  2248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cupric oxide
    n1=Hyde (prurigo nodulaire de) | n2=en:cupric oxide | rel=r_associated | relid=0 | w=15
  2249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cupric sulfate
    n1=Hyde (prurigo nodulaire de) | n2=en:cupric sulfate | rel=r_associated | relid=0 | w=15
  2250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:curafil
    n1=Hyde (prurigo nodulaire de) | n2=en:curafil | rel=r_associated | relid=0 | w=15
  2251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:curasol
    n1=Hyde (prurigo nodulaire de) | n2=en:curasol | rel=r_associated | relid=0 | w=15
  2252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:currarino triad includes - hemisacrum, presacral mass (anterior meningocele, enteric cyst, and/or presacral teratoma) and anorectal anomalies
    n1=Hyde (prurigo nodulaire de) | n2=en:currarino triad includes - hemisacrum, presacral mass (anterior meningocele, enteric cyst, and/or presacral teratoma) and anorectal anomalies | rel=r_associated | relid=0 | w=15
  2253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cutaneous leiomyomas increase in number over time
    n1=Hyde (prurigo nodulaire de) | n2=en:cutaneous leiomyomas increase in number over time | rel=r_associated | relid=0 | w=15
  2254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cutaneous symptoms induced by cold exposure or cooling
    n1=Hyde (prurigo nodulaire de) | n2=en:cutaneous symptoms induced by cold exposure or cooling | rel=r_associated | relid=0 | w=15
  2255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cutaneous telangiectases often not evident until 20-30 years of age incidence 1 in 5,000-8,000
    n1=Hyde (prurigo nodulaire de) | n2=en:cutaneous telangiectases often not evident until 20-30 years of age incidence 1 in 5,000-8,000 | rel=r_associated | relid=0 | w=15
  2256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cutemol
    n1=Hyde (prurigo nodulaire de) | n2=en:cutemol | rel=r_associated | relid=0 | w=15
  2257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cuvettes
    n1=Hyde (prurigo nodulaire de) | n2=en:cuvettes | rel=r_associated | relid=0 | w=15
  2258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanase
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanase | rel=r_associated | relid=0 | w=15
  2259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin + folic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin + folic acid | rel=r_associated | relid=0 | w=15
  2260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin co-57
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin co-57 | rel=r_associated | relid=0 | w=15
  2261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/estrogens/methamphetamine/methyltestosterone/thia
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/estrogens/methamphetamine/methyltestosterone/thia | rel=r_associated | relid=0 | w=15
  2262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/folic acid/iron
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/folic acid/iron | rel=r_associated | relid=0 | w=15
  2263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/folic acid/liver
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/folic acid/liver | rel=r_associated | relid=0 | w=15
  2264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/intrinsic factor
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/intrinsic factor | rel=r_associated | relid=0 | w=15
  2265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/iron/liver
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/iron/liver | rel=r_associated | relid=0 | w=15
  2266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyanocobalamin/thiamine
    n1=Hyde (prurigo nodulaire de) | n2=en:cyanocobalamin/thiamine | rel=r_associated | relid=0 | w=15
  2267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclacillin
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclacillin | rel=r_associated | relid=0 | w=15
  2268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclafem
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclafem | rel=r_associated | relid=0 | w=15
  2269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclamate sulfamatase
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclamate sulfamatase | rel=r_associated | relid=0 | w=15
  2270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclandelate
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclandelate | rel=r_associated | relid=0 | w=15
  2271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclic vomiting syndrome plus (cvs+) is characterized by additional neuromuscular and/or visceral organ manifestations (as indicated above)
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclic vomiting syndrome plus (cvs+) is characterized by additional neuromuscular and/or visceral organ manifestations (as indicated above) | rel=r_associated | relid=0 | w=15
  2272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclizine
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclizine | rel=r_associated | relid=0 | w=15
  2273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclobenzaprine
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclobenzaprine | rel=r_associated | relid=0 | w=15
  2274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclomaltodextrinase
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclomaltodextrinase | rel=r_associated | relid=0 | w=15
  2275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclomethicone
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclomethicone | rel=r_associated | relid=0 | w=15
  2276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclopentolate
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclopentolate | rel=r_associated | relid=0 | w=15
  2277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclopentolate+phenylephrine
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclopentolate+phenylephrine | rel=r_associated | relid=0 | w=15
  2278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclophosphamide / mannitol
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclophosphamide / mannitol | rel=r_associated | relid=0 | w=15
  2279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cycloserine
    n1=Hyde (prurigo nodulaire de) | n2=en:cycloserine | rel=r_associated | relid=0 | w=15
  2280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyclothiazide
    n1=Hyde (prurigo nodulaire de) | n2=en:cyclothiazide | rel=r_associated | relid=0 | w=15
  2281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cylindrical embryo
    n1=Hyde (prurigo nodulaire de) | n2=en:cylindrical embryo | rel=r_associated | relid=0 | w=15
  2282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyp2d6 enzyme is located in the endoplasmic reticulum of the liver
    n1=Hyde (prurigo nodulaire de) | n2=en:cyp2d6 enzyme is located in the endoplasmic reticulum of the liver | rel=r_associated | relid=0 | w=15
  2283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyp2d6 represents about 1% of total liver cytochrome p450 content
    n1=Hyde (prurigo nodulaire de) | n2=en:cyp2d6 represents about 1% of total liver cytochrome p450 content | rel=r_associated | relid=0 | w=15
  2284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyperus
    n1=Hyde (prurigo nodulaire de) | n2=en:cyperus | rel=r_associated | relid=0 | w=15
  2285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cyproheptadine
    n1=Hyde (prurigo nodulaire de) | n2=en:cyproheptadine | rel=r_associated | relid=0 | w=15
  2286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cysteine
    n1=Hyde (prurigo nodulaire de) | n2=en:cysteine | rel=r_associated | relid=0 | w=15
  2287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cystic kidney disease with ventriculomegaly
    n1=Hyde (prurigo nodulaire de) | n2=en:cystic kidney disease with ventriculomegaly | rel=r_associated | relid=0 | w=15
  2288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cystine
    n1=Hyde (prurigo nodulaire de) | n2=en:cystine | rel=r_associated | relid=0 | w=15
  2289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cystine/inositol/methionine/sodium propionate/urea
    n1=Hyde (prurigo nodulaire de) | n2=en:cystine/inositol/methionine/sodium propionate/urea | rel=r_associated | relid=0 | w=15
  2290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:cytosine deaminase
    n1=Hyde (prurigo nodulaire de) | n2=en:cytosine deaminase | rel=r_associated | relid=0 | w=15
  2291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d vitamin
    n1=Hyde (prurigo nodulaire de) | n2=en:d vitamin | rel=r_associated | relid=0 | w=15
  2292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d-arabinonolactonase
    n1=Hyde (prurigo nodulaire de) | n2=en:d-arabinonolactonase | rel=r_associated | relid=0 | w=15
  2293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d-benzoylarginine-4-nitroanilide amidase
    n1=Hyde (prurigo nodulaire de) | n2=en:d-benzoylarginine-4-nitroanilide amidase | rel=r_associated | relid=0 | w=15
  2294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d-hus is usually familial
    n1=Hyde (prurigo nodulaire de) | n2=en:d-hus is usually familial | rel=r_associated | relid=0 | w=15
  2295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d-stereospecific aminopeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:d-stereospecific aminopeptidase | rel=r_associated | relid=0 | w=15
  2296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:d+hus (typical hus) is usually sporadic, limited to 1 event, and has a good prognosis
    n1=Hyde (prurigo nodulaire de) | n2=en:d+hus (typical hus) is usually sporadic, limited to 1 event, and has a good prognosis | rel=r_associated | relid=0 | w=15
  2297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date of analysis:tmstp:pt:xxx:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:date of analysis:tmstp:pt:xxx:qn | rel=r_associated | relid=0 | w=15
  2298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date of autopsy:date:pt:^patient:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:date of autopsy:date:pt:^patient:qn | rel=r_associated | relid=0 | w=15
  2299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date of observation:time stamp -- date and time:point in time:to be specified in another part of the message:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:date of observation:time stamp -- date and time:point in time:to be specified in another part of the message:quantitative | rel=r_associated | relid=0 | w=15
  2300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date reference lab test received:time stamp -- date and time:time reported elsewhere:reference lab test:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:date reference lab test received:time stamp -- date and time:time reported elsewhere:reference lab test:quantitative | rel=r_associated | relid=0 | w=15
  2301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date reference lab test sent:time stamp -- date and time:time reported elsewhere:reference lab test:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:date reference lab test sent:time stamp -- date and time:time reported elsewhere:reference lab test:quantitative | rel=r_associated | relid=0 | w=15
  2302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:date ultrasound:date:pt:^patient:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:date ultrasound:date:pt:^patient:qn | rel=r_associated | relid=0 | w=15
  2303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:de novo deletions in 8% of patients (preferentially paternally derived)
    n1=Hyde (prurigo nodulaire de) | n2=en:de novo deletions in 8% of patients (preferentially paternally derived) | rel=r_associated | relid=0 | w=15
  2304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:de novo mutation | rel=r_associated | relid=0 | w=15
  2305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:de novo mutation identified in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:de novo mutation identified in some patients | rel=r_associated | relid=0 | w=15
  2306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:de novo mutation resulting in haploinsufficiency of eftud2 (603892)
    n1=Hyde (prurigo nodulaire de) | n2=en:de novo mutation resulting in haploinsufficiency of eftud2 (603892) | rel=r_associated | relid=0 | w=15
  2307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:de novo mutations occur almost exclusively on the paternally derived x chromosome
    n1=Hyde (prurigo nodulaire de) | n2=en:de novo mutations occur almost exclusively on the paternally derived x chromosome | rel=r_associated | relid=0 | w=15
  2308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deacetylase
    n1=Hyde (prurigo nodulaire de) | n2=en:deacetylase | rel=r_associated | relid=0 | w=15
  2309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deafness is presenting symptom
    n1=Hyde (prurigo nodulaire de) | n2=en:deafness is presenting symptom | rel=r_associated | relid=0 | w=15
  2310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deafness tends to occur before other neurologic signs, except in patients with very early onset
    n1=Hyde (prurigo nodulaire de) | n2=en:deafness tends to occur before other neurologic signs, except in patients with very early onset | rel=r_associated | relid=0 | w=15
  2311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deaminase
    n1=Hyde (prurigo nodulaire de) | n2=en:deaminase | rel=r_associated | relid=0 | w=15
  2312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death about 20 years after symptom onset
    n1=Hyde (prurigo nodulaire de) | n2=en:death about 20 years after symptom onset | rel=r_associated | relid=0 | w=15
  2313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death at 10 to 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death at 10 to 15 years | rel=r_associated | relid=0 | w=15
  2314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death at 13 to 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death at 13 to 30 years | rel=r_associated | relid=0 | w=15
  2315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death at 20 to 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death at 20 to 40 years | rel=r_associated | relid=0 | w=15
  2316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death at birth or within first 2 years of life (severe form)
    n1=Hyde (prurigo nodulaire de) | n2=en:death at birth or within first 2 years of life (severe form) | rel=r_associated | relid=0 | w=15
  2317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death before age 15 in iia
    n1=Hyde (prurigo nodulaire de) | n2=en:death before age 15 in iia | rel=r_associated | relid=0 | w=15
  2318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death before age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death before age 3 years | rel=r_associated | relid=0 | w=15
  2319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death before age 40
    n1=Hyde (prurigo nodulaire de) | n2=en:death before age 40 | rel=r_associated | relid=0 | w=15
  2320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death between 2 years of age and young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:death between 2 years of age and young adulthood | rel=r_associated | relid=0 | w=15
  2321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death by age 15 months
    n1=Hyde (prurigo nodulaire de) | n2=en:death by age 15 months | rel=r_associated | relid=0 | w=15
  2322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death by age 2 years | rel=r_associated | relid=0 | w=15
  2323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death by age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death by age 3 years | rel=r_associated | relid=0 | w=15
  2324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death by age 5 (infantile form)
    n1=Hyde (prurigo nodulaire de) | n2=en:death by age 5 (infantile form) | rel=r_associated | relid=0 | w=15
  2325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death by age 6-7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death by age 6-7 years | rel=r_associated | relid=0 | w=15
  2326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death can occur in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death can occur in infancy | rel=r_associated | relid=0 | w=15
  2327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death due to rapidly progressive pulmonary fibrosis in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death due to rapidly progressive pulmonary fibrosis in infancy | rel=r_associated | relid=0 | w=15
  2328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death due to respiratory failure or infection
    n1=Hyde (prurigo nodulaire de) | n2=en:death due to respiratory failure or infection | rel=r_associated | relid=0 | w=15
  2329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death due to respiratory insufficiency within minutes to hours after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:death due to respiratory insufficiency within minutes to hours after birth | rel=r_associated | relid=0 | w=15
  2330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death frequent in severe infantile form
    n1=Hyde (prurigo nodulaire de) | n2=en:death frequent in severe infantile form | rel=r_associated | relid=0 | w=15
  2331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death from pneumonia
    n1=Hyde (prurigo nodulaire de) | n2=en:death from pneumonia | rel=r_associated | relid=0 | w=15
  2332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood | rel=r_associated | relid=0 | w=15
  2333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood is frequent due to respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood is frequent due to respiratory failure | rel=r_associated | relid=0 | w=15
  2334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood may occur | rel=r_associated | relid=0 | w=15
  2335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood may occur due to end-stage renal disease
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood may occur due to end-stage renal disease | rel=r_associated | relid=0 | w=15
  2336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood may occur due to infection
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood may occur due to infection | rel=r_associated | relid=0 | w=15
  2337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood often results from respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood often results from respiratory insufficiency | rel=r_associated | relid=0 | w=15
  2338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in childhood secondary to malabsorption
    n1=Hyde (prurigo nodulaire de) | n2=en:death in childhood secondary to malabsorption | rel=r_associated | relid=0 | w=15
  2339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death in early childhood | rel=r_associated | relid=0 | w=15
  2340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in early childhood has been reported in some presumed homozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:death in early childhood has been reported in some presumed homozygotes | rel=r_associated | relid=0 | w=15
  2341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in early childhood may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:death in early childhood may occur | rel=r_associated | relid=0 | w=15
  2342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death in early infancy | rel=r_associated | relid=0 | w=15
  2343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in early infancy (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:death in early infancy (in some patients) | rel=r_associated | relid=0 | w=15
  2344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death in first months of life | rel=r_associated | relid=0 | w=15
  2345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in first weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death in first weeks of life | rel=r_associated | relid=0 | w=15
  2346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in first-second decade of life secondary to cardio-respiratory compromise
    n1=Hyde (prurigo nodulaire de) | n2=en:death in first-second decade of life secondary to cardio-respiratory compromise | rel=r_associated | relid=0 | w=15
  2347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in fourth to fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death in fourth to fifth decade | rel=r_associated | relid=0 | w=15
  2348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy | rel=r_associated | relid=0 | w=15
  2349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy (1 patient)
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy (1 patient) | rel=r_associated | relid=0 | w=15
  2350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy common for patients with the classic neonatal form
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy common for patients with the classic neonatal form | rel=r_associated | relid=0 | w=15
  2351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy due to hyperthermia or apnea
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy due to hyperthermia or apnea | rel=r_associated | relid=0 | w=15
  2352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy in 2 patients
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy in 2 patients | rel=r_associated | relid=0 | w=15
  2353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy in majority of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy in majority of patients | rel=r_associated | relid=0 | w=15
  2354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy secondary to kernicterus
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy secondary to kernicterus | rel=r_associated | relid=0 | w=15
  2355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy secondary to pulmonary insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy secondary to pulmonary insufficiency | rel=r_associated | relid=0 | w=15
  2356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy secondary to respiratory insufficiency/pneumonia
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy secondary to respiratory insufficiency/pneumonia | rel=r_associated | relid=0 | w=15
  2357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy without bone marrow transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy without bone marrow transplantation | rel=r_associated | relid=0 | w=15
  2358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in infancy, usually from sepsis, dehydration, or acidosis
    n1=Hyde (prurigo nodulaire de) | n2=en:death in infancy, usually from sepsis, dehydration, or acidosis | rel=r_associated | relid=0 | w=15
  2359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in majority of infants soon after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:death in majority of infants soon after birth | rel=r_associated | relid=0 | w=15
  2360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:death in neonatal period | rel=r_associated | relid=0 | w=15
  2361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in perinatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:death in perinatal period | rel=r_associated | relid=0 | w=15
  2362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in teens secondary to cardiac failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death in teens secondary to cardiac failure | rel=r_associated | relid=0 | w=15
  2363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in the fifth or sixth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death in the fifth or sixth decade | rel=r_associated | relid=0 | w=15
  2364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in the first decade, usually from liver failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death in the first decade, usually from liver failure | rel=r_associated | relid=0 | w=15
  2365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in the first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death in the first years of life | rel=r_associated | relid=0 | w=15
  2366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in the mid-twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:death in the mid-twenties | rel=r_associated | relid=0 | w=15
  2367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in third or fourth decades, usually due to respiratory infection
    n1=Hyde (prurigo nodulaire de) | n2=en:death in third or fourth decades, usually due to respiratory infection | rel=r_associated | relid=0 | w=15
  2368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in untreated children
    n1=Hyde (prurigo nodulaire de) | n2=en:death in untreated children | rel=r_associated | relid=0 | w=15
  2369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero | rel=r_associated | relid=0 | w=15
  2370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero (30%)
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero (30%) | rel=r_associated | relid=0 | w=15
  2371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero or as neonate
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero or as neonate | rel=r_associated | relid=0 | w=15
  2372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero or early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero or early infancy | rel=r_associated | relid=0 | w=15
  2373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero or in early infancy is common
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero or in early infancy is common | rel=r_associated | relid=0 | w=15
  2374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death in utero or in the perinatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:death in utero or in the perinatal period | rel=r_associated | relid=0 | w=15
  2375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death may occur in childhood due to respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death may occur in childhood due to respiratory failure | rel=r_associated | relid=0 | w=15
  2376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death may occur in early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death may occur in early infancy | rel=r_associated | relid=0 | w=15
  2377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death may occur in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death may occur in infancy | rel=r_associated | relid=0 | w=15
  2378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death may occur in late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death may occur in late childhood | rel=r_associated | relid=0 | w=15
  2379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death may occur in the first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death may occur in the first decade | rel=r_associated | relid=0 | w=15
  2380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death occurs 10 to 20 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:death occurs 10 to 20 years after onset | rel=r_associated | relid=0 | w=15
  2381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death occurs 5 to 10 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:death occurs 5 to 10 years after onset | rel=r_associated | relid=0 | w=15
  2382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death occurs before 12 months of age due to cardiorespiratory arrest
    n1=Hyde (prurigo nodulaire de) | n2=en:death occurs before 12 months of age due to cardiorespiratory arrest | rel=r_associated | relid=0 | w=15
  2383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death occurs in second or third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death occurs in second or third decade | rel=r_associated | relid=0 | w=15
  2384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often before age 2
    n1=Hyde (prurigo nodulaire de) | n2=en:death often before age 2 | rel=r_associated | relid=0 | w=15
  2385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death often by age 2 years | rel=r_associated | relid=0 | w=15
  2386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often in early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death often in early infancy | rel=r_associated | relid=0 | w=15
  2387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death often in first months of life | rel=r_associated | relid=0 | w=15
  2388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death often in infancy | rel=r_associated | relid=0 | w=15
  2389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often in the teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:death often in the teenage years | rel=r_associated | relid=0 | w=15
  2390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often occurs during metabolic/acidotic crisis
    n1=Hyde (prurigo nodulaire de) | n2=en:death often occurs during metabolic/acidotic crisis | rel=r_associated | relid=0 | w=15
  2391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often occurs in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death often occurs in childhood | rel=r_associated | relid=0 | w=15
  2392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often occurs in the first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death often occurs in the first decade | rel=r_associated | relid=0 | w=15
  2393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often secondary to infectious disease
    n1=Hyde (prurigo nodulaire de) | n2=en:death often secondary to infectious disease | rel=r_associated | relid=0 | w=15
  2394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death often secondary to pneumonia or congestive heart failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death often secondary to pneumonia or congestive heart failure | rel=r_associated | relid=0 | w=15
  2395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death secondary to renal failure, cardiac or cerebrovascular disease
    n1=Hyde (prurigo nodulaire de) | n2=en:death secondary to renal failure, cardiac or cerebrovascular disease | rel=r_associated | relid=0 | w=15
  2396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death secondary to respiratory infection or failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death secondary to respiratory infection or failure | rel=r_associated | relid=0 | w=15
  2397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death secondary to respiratory infection or failure before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death secondary to respiratory infection or failure before age 2 years | rel=r_associated | relid=0 | w=15
  2398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death secondary to respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:death secondary to respiratory insufficiency | rel=r_associated | relid=0 | w=15
  2399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually associated with cardiogenic shock preceded by arrhythmia
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually associated with cardiogenic shock preceded by arrhythmia | rel=r_associated | relid=0 | w=15
  2400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually by 1 year of age
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually by 1 year of age | rel=r_associated | relid=0 | w=15
  2401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually by age 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually by age 10 years | rel=r_associated | relid=0 | w=15
  2402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually by age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually by age 3 years | rel=r_associated | relid=0 | w=15
  2403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually due to renal failure by average age 3
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually due to renal failure by average age 3 | rel=r_associated | relid=0 | w=15
  2404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually due to respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually due to respiratory failure | rel=r_associated | relid=0 | w=15
  2405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in childhood | rel=r_associated | relid=0 | w=15
  2406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in early childhood | rel=r_associated | relid=0 | w=15
  2407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in first year of life | rel=r_associated | relid=0 | w=15
  2408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in infancy | rel=r_associated | relid=0 | w=15
  2409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in infancy due to respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in infancy due to respiratory failure | rel=r_associated | relid=0 | w=15
  2410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in infancy or early childhood | rel=r_associated | relid=0 | w=15
  2411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in newborn period or infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in newborn period or infancy | rel=r_associated | relid=0 | w=15
  2412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in sixth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in sixth decade | rel=r_associated | relid=0 | w=15
  2413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in teenage years | rel=r_associated | relid=0 | w=15
  2414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in the first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in the first 2 years of life | rel=r_associated | relid=0 | w=15
  2415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually in the perinatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually in the perinatal period | rel=r_associated | relid=0 | w=15
  2416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs before 5th decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs before 5th decade | rel=r_associated | relid=0 | w=15
  2417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs by 12 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs by 12 months of life | rel=r_associated | relid=0 | w=15
  2418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs by age 2 years | rel=r_associated | relid=0 | w=15
  2419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs in childhood | rel=r_associated | relid=0 | w=15
  2420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs in early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs in early infancy | rel=r_associated | relid=0 | w=15
  2421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs in first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs in first decade of life | rel=r_associated | relid=0 | w=15
  2422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs in infancy or childhood if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs in infancy or childhood if untreated | rel=r_associated | relid=0 | w=15
  2423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually occurs in the first weeks to months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually occurs in the first weeks to months of life | rel=r_associated | relid=0 | w=15
  2424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually within first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually within first 2 years of life | rel=r_associated | relid=0 | w=15
  2425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually within first weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually within first weeks of life | rel=r_associated | relid=0 | w=15
  2426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death usually within first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death usually within first year of life | rel=r_associated | relid=0 | w=15
  2427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within 12 months
    n1=Hyde (prurigo nodulaire de) | n2=en:death within 12 months | rel=r_associated | relid=0 | w=15
  2428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within 6 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:death within 6 years after onset | rel=r_associated | relid=0 | w=15
  2429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:death within first decade | rel=r_associated | relid=0 | w=15
  2430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within first months or years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death within first months or years of life | rel=r_associated | relid=0 | w=15
  2431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:death within first year of life | rel=r_associated | relid=0 | w=15
  2432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within first year of life in 25%
    n1=Hyde (prurigo nodulaire de) | n2=en:death within first year of life in 25% | rel=r_associated | relid=0 | w=15
  2433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:death within several months if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:death within several months if untreated | rel=r_associated | relid=0 | w=15
  2434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:decrease in seizure frequency in middle age
    n1=Hyde (prurigo nodulaire de) | n2=en:decrease in seizure frequency in middle age | rel=r_associated | relid=0 | w=15
  2435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:decreased bilirubin concentration with phenobarbital administration
    n1=Hyde (prurigo nodulaire de) | n2=en:decreased bilirubin concentration with phenobarbital administration | rel=r_associated | relid=0 | w=15
  2436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:decreased fertility
    n1=Hyde (prurigo nodulaire de) | n2=en:decreased fertility | rel=r_associated | relid=0 | w=15
  2437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:decreased life expectancy
    n1=Hyde (prurigo nodulaire de) | n2=en:decreased life expectancy | rel=r_associated | relid=0 | w=15
  2438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:decreased penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:decreased penetrance | rel=r_associated | relid=0 | w=15
  2439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:defect in tetrahydrobiopterin (bh4) synthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:defect in tetrahydrobiopterin (bh4) synthesis | rel=r_associated | relid=0 | w=15
  2440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:defect in urocanic acid conversion to formiminoglutamic acid (figlu)
    n1=Hyde (prurigo nodulaire de) | n2=en:defect in urocanic acid conversion to formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=15
  2441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deficiency aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=15
  2442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deficient food intake
    n1=Hyde (prurigo nodulaire de) | n2=en:deficient food intake | rel=r_associated | relid=0 | w=15
  2443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:definite diagnosis if 3/4 criteria present (epistaxis, telangiectasia, visceral lesion, or family history)
    n1=Hyde (prurigo nodulaire de) | n2=en:definite diagnosis if 3/4 criteria present (epistaxis, telangiectasia, visceral lesion, or family history) | rel=r_associated | relid=0 | w=15
  2444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:delayed psychomotor development apparent in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:delayed psychomotor development apparent in infancy | rel=r_associated | relid=0 | w=15
  2445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:delayed separation of umbilical cord
    n1=Hyde (prurigo nodulaire de) | n2=en:delayed separation of umbilical cord | rel=r_associated | relid=0 | w=15
  2446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deleted region contains 4 genes that are not imprinted, tubgcp2 (608147), nipa1 (608145), nipa2 (608146), and cyfip1 (606322)
    n1=Hyde (prurigo nodulaire de) | n2=en:deleted region contains 4 genes that are not imprinted, tubgcp2 (608147), nipa1 (608145), nipa2 (608146), and cyfip1 (606322) | rel=r_associated | relid=0 | w=15
  2447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deletion sizes range from 287kb to 4.4mb
    n1=Hyde (prurigo nodulaire de) | n2=en:deletion sizes range from 287kb to 4.4mb | rel=r_associated | relid=0 | w=15
  2448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deletions in naip gene (600355) found in 18% of sma2 patients
    n1=Hyde (prurigo nodulaire de) | n2=en:deletions in naip gene (600355) found in 18% of sma2 patients | rel=r_associated | relid=0 | w=15
  2449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deletions in naip gene (600355) found in 18% of smaii patients
    n1=Hyde (prurigo nodulaire de) | n2=en:deletions in naip gene (600355) found in 18% of smaii patients | rel=r_associated | relid=0 | w=15
  2450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:delta-f508 present in 70% of alleles
    n1=Hyde (prurigo nodulaire de) | n2=en:delta-f508 present in 70% of alleles | rel=r_associated | relid=0 | w=15
  2451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deoxy sugars
    n1=Hyde (prurigo nodulaire de) | n2=en:deoxy sugars | rel=r_associated | relid=0 | w=15
  2452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deoxyribonuclease
    n1=Hyde (prurigo nodulaire de) | n2=en:deoxyribonuclease | rel=r_associated | relid=0 | w=15
  2453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deoxyribopyrimidine endonucleosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:deoxyribopyrimidine endonucleosidase | rel=r_associated | relid=0 | w=15
  2454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deposits may recur in graft after corneal transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:deposits may recur in graft after corneal transplantation | rel=r_associated | relid=0 | w=15
  2455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dermatitis resolves in offspring after zinc supplementation and/or weaning
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis resolves in offspring after zinc supplementation and/or weaning | rel=r_associated | relid=0 | w=15
  2456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in 3 unrelated infants (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:described in 3 unrelated infants (last curated january 2013) | rel=r_associated | relid=0 | w=15
  2457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in 6 japanese families
    n1=Hyde (prurigo nodulaire de) | n2=en:described in 6 japanese families | rel=r_associated | relid=0 | w=15
  2458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in families from galicia, spain
    n1=Hyde (prurigo nodulaire de) | n2=en:described in families from galicia, spain | rel=r_associated | relid=0 | w=15
  2459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in families from western japan
    n1=Hyde (prurigo nodulaire de) | n2=en:described in families from western japan | rel=r_associated | relid=0 | w=15
  2460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in individuals of jewish bukharian descent
    n1=Hyde (prurigo nodulaire de) | n2=en:described in individuals of jewish bukharian descent | rel=r_associated | relid=0 | w=15
  2461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in individuals of roma gypsy origin (founder mutation)
    n1=Hyde (prurigo nodulaire de) | n2=en:described in individuals of roma gypsy origin (founder mutation) | rel=r_associated | relid=0 | w=15
  2462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in one 5-generation pakistani family (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:described in one 5-generation pakistani family (last curated april 2013) | rel=r_associated | relid=0 | w=15
  2463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described in single afrikaner family
    n1=Hyde (prurigo nodulaire de) | n2=en:described in single afrikaner family | rel=r_associated | relid=0 | w=15
  2464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:described predominantly in families from the philippines
    n1=Hyde (prurigo nodulaire de) | n2=en:described predominantly in families from the philippines | rel=r_associated | relid=0 | w=15
  2465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:despite voluminous steatorrhea, patients' growth and overall state of health is good
    n1=Hyde (prurigo nodulaire de) | n2=en:despite voluminous steatorrhea, patients' growth and overall state of health is good | rel=r_associated | relid=0 | w=15
  2466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:detached trophoblast
    n1=Hyde (prurigo nodulaire de) | n2=en:detached trophoblast | rel=r_associated | relid=0 | w=15
  2467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:detected in 1/50,000 in neonatal screening programs
    n1=Hyde (prurigo nodulaire de) | n2=en:detected in 1/50,000 in neonatal screening programs | rel=r_associated | relid=0 | w=15
  2468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:deubiquitinating enzyme
    n1=Hyde (prurigo nodulaire de) | n2=en:deubiquitinating enzyme | rel=r_associated | relid=0 | w=15
  2469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:development of afebrile seizures later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:development of afebrile seizures later in childhood | rel=r_associated | relid=0 | w=15
  2470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:developmental anomaly of vitelline duct
    n1=Hyde (prurigo nodulaire de) | n2=en:developmental anomaly of vitelline duct | rel=r_associated | relid=0 | w=15
  2471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dextran 1,6-alpha-isomaltotriosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:dextran 1,6-alpha-isomaltotriosidase | rel=r_associated | relid=0 | w=15
  2472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dgtpase
    n1=Hyde (prurigo nodulaire de) | n2=en:dgtpase | rel=r_associated | relid=0 | w=15
  2473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diabetes and anemia respond to high doses of thiamine supplementation
    n1=Hyde (prurigo nodulaire de) | n2=en:diabetes and anemia respond to high doses of thiamine supplementation | rel=r_associated | relid=0 | w=15
  2474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diabetes mellitus develops in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:diabetes mellitus develops in adolescence | rel=r_associated | relid=0 | w=15
  2475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diabetes status:prid:pt:^patient:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:diabetes status:prid:pt:^patient:nom | rel=r_associated | relid=0 | w=15
  2476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diabetic diet
    n1=Hyde (prurigo nodulaire de) | n2=en:diabetic diet | rel=r_associated | relid=0 | w=15
  2477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosed in second or third decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosed in second or third decade of life | rel=r_associated | relid=0 | w=15
  2478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis aspect
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=15
  2479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis in early childhood | rel=r_associated | relid=0 | w=15
  2480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis in the second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis in the second decade of life | rel=r_associated | relid=0 | w=15
  2481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis made if 3/7 defects are present
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis made if 3/7 defects are present | rel=r_associated | relid=0 | w=15
  2482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects)
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis made when at least 2/3 features present (optic nerve hypoplasia, hypopituitarism with pituitary hypoplasia, midline forebrain defects) | rel=r_associated | relid=0 | w=15
  2483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis occurs between 23 and 33 weeks' gestation
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis occurs between 23 and 33 weeks' gestation | rel=r_associated | relid=0 | w=15
  2484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis requires 3 major features (a positive family history is also considered a major feature) and at least 3 minor features | rel=r_associated | relid=0 | w=15
  2485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis typically between age 10-20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis typically between age 10-20 years | rel=r_associated | relid=0 | w=15
  2486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diagnosis within the first 3 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:diagnosis within the first 3 months of life | rel=r_associated | relid=0 | w=15
  2487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diaminobutane
    n1=Hyde (prurigo nodulaire de) | n2=en:diaminobutane | rel=r_associated | relid=0 | w=15
  2488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diarrhea persists even with vigorous nursing
    n1=Hyde (prurigo nodulaire de) | n2=en:diarrhea persists even with vigorous nursing | rel=r_associated | relid=0 | w=15
  2489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diarrhea worsens in parallel with increases in severity of skin disease
    n1=Hyde (prurigo nodulaire de) | n2=en:diarrhea worsens in parallel with increases in severity of skin disease | rel=r_associated | relid=0 | w=15
  2490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diarrhea-associated (d+hus), occurs in children younger than 3 years, associated with verotoxin-producing e. coli (90% of patients) (typical hus)
    n1=Hyde (prurigo nodulaire de) | n2=en:diarrhea-associated (d+hus), occurs in children younger than 3 years, associated with verotoxin-producing e. coli (90% of patients) (typical hus) | rel=r_associated | relid=0 | w=15
  2491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diarrhea-negative subtype (d-hus), or atypical hus, is more severe and often relapses
    n1=Hyde (prurigo nodulaire de) | n2=en:diarrhea-negative subtype (d-hus), or atypical hus, is more severe and often relapses | rel=r_associated | relid=0 | w=15
  2492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:die at birth or shortly after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:die at birth or shortly after birth | rel=r_associated | relid=0 | w=15
  2493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diet
    n1=Hyde (prurigo nodulaire de) | n2=en:diet | rel=r_associated | relid=0 | w=15
  2494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diet, carbohydrate-restricted
    n1=Hyde (prurigo nodulaire de) | n2=en:diet, carbohydrate-restricted | rel=r_associated | relid=0 | w=15
  2495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary approaches to stop hypertension diet
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary approaches to stop hypertension diet | rel=r_associated | relid=0 | w=15
  2496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary calcium
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary calcium | rel=r_associated | relid=0 | w=15
  2497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary carbohydrate
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary carbohydrate | rel=r_associated | relid=0 | w=15
  2498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary fiber
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary fiber | rel=r_associated | relid=0 | w=15
  2499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary lipid
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary lipid | rel=r_associated | relid=0 | w=15
  2500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary mineral
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary mineral | rel=r_associated | relid=0 | w=15
  2501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary potassium
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary potassium | rel=r_associated | relid=0 | w=15
  2502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary protein
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary protein | rel=r_associated | relid=0 | w=15
  2503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dietary supplement
    n1=Hyde (prurigo nodulaire de) | n2=en:dietary supplement | rel=r_associated | relid=0 | w=15
  2504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:digenic form caused by heterozygous mutations in both nek1 (604588) and dyn2ch1 (603297)
    n1=Hyde (prurigo nodulaire de) | n2=en:digenic form caused by heterozygous mutations in both nek1 (604588) and dyn2ch1 (603297) | rel=r_associated | relid=0 | w=15
  2505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:digenic form caused by heterozygous mutations in the gpr98 (602851.0010) and pdzd7 (612971.0002) genes
    n1=Hyde (prurigo nodulaire de) | n2=en:digenic form caused by heterozygous mutations in the gpr98 (602851.0010) and pdzd7 (612971.0002) genes | rel=r_associated | relid=0 | w=15
  2506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:digenic form type id/f caused by digenic mutation in the cdh23 (605516) and pcdh15 genes
    n1=Hyde (prurigo nodulaire de) | n2=en:digenic form type id/f caused by digenic mutation in the cdh23 (605516) and pcdh15 genes | rel=r_associated | relid=0 | w=15
  2507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:digenic form type id/f caused by digenic mutation in the cdh23 and pcdh15 (605514) genes
    n1=Hyde (prurigo nodulaire de) | n2=en:digenic form type id/f caused by digenic mutation in the cdh23 and pcdh15 (605514) genes | rel=r_associated | relid=0 | w=15
  2508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diguanidinobutanase
    n1=Hyde (prurigo nodulaire de) | n2=en:diguanidinobutanase | rel=r_associated | relid=0 | w=15
  2509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dihydroorotase
    n1=Hyde (prurigo nodulaire de) | n2=en:dihydroorotase | rel=r_associated | relid=0 | w=15
  2510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diisopropyl-fluorophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:diisopropyl-fluorophosphatase | rel=r_associated | relid=0 | w=15
  2511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dip is a pathologic diagnosis that may represent other disease entities
    n1=Hyde (prurigo nodulaire de) | n2=en:dip is a pathologic diagnosis that may represent other disease entities | rel=r_associated | relid=0 | w=15
  2512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dipeptidylpeptide hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:dipeptidylpeptide hydrolase | rel=r_associated | relid=0 | w=15
  2513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disability by end of first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:disability by end of first decade | rel=r_associated | relid=0 | w=15
  2514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disaccharidases
    n1=Hyde (prurigo nodulaire de) | n2=en:disaccharidases | rel=r_associated | relid=0 | w=15
  2515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disaccharide
    n1=Hyde (prurigo nodulaire de) | n2=en:disaccharide | rel=r_associated | relid=0 | w=15
  2516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:discordant phenotype among monozygotic twins has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:discordant phenotype among monozygotic twins has been reported | rel=r_associated | relid=0 | w=15
  2517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:discordant twin
    n1=Hyde (prurigo nodulaire de) | n2=en:discordant twin | rel=r_associated | relid=0 | w=15
  2518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease complicated by recurrent sepsis in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:disease complicated by recurrent sepsis in some patients | rel=r_associated | relid=0 | w=15
  2519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease course depends on age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:disease course depends on age at onset | rel=r_associated | relid=0 | w=15
  2520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease exacerbation during summer due to heat
    n1=Hyde (prurigo nodulaire de) | n2=en:disease exacerbation during summer due to heat | rel=r_associated | relid=0 | w=15
  2521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease is life-threatening if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:disease is life-threatening if untreated | rel=r_associated | relid=0 | w=15
  2522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease usually progresses in a cephalocaudal direction
    n1=Hyde (prurigo nodulaire de) | n2=en:disease usually progresses in a cephalocaudal direction | rel=r_associated | relid=0 | w=15
  2523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disease-free intervals can last weeks to years during which there is no clinical or biochemical evidence of cholestasis
    n1=Hyde (prurigo nodulaire de) | n2=en:disease-free intervals can last weeks to years during which there is no clinical or biochemical evidence of cholestasis | rel=r_associated | relid=0 | w=15
  2524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder is static for first 2 decades and then shows progression of movement disorders and further cognitive decline
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder is static for first 2 decades and then shows progression of movement disorders and further cognitive decline | rel=r_associated | relid=0 | w=15
  2525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder may progress to involve a larger body area
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder may progress to involve a larger body area | rel=r_associated | relid=0 | w=15
  2526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder of amniotic fluid production
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder of amniotic fluid production | rel=r_associated | relid=0 | w=15
  2527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder of amniotic fluid turnover
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder of amniotic fluid turnover | rel=r_associated | relid=0 | w=15
  2528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder of umbilical cord
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder of umbilical cord | rel=r_associated | relid=0 | w=15
  2529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorder usually remains stable over time
    n1=Hyde (prurigo nodulaire de) | n2=en:disorder usually remains stable over time | rel=r_associated | relid=0 | w=15
  2530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disorders with overlapping phenotypes can be caused by mutation in the keratin-14 gene (148066)
    n1=Hyde (prurigo nodulaire de) | n2=en:disorders with overlapping phenotypes can be caused by mutation in the keratin-14 gene (148066) | rel=r_associated | relid=0 | w=15
  2531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disproportion in pregnancy, labor, and delivery
    n1=Hyde (prurigo nodulaire de) | n2=en:disproportion in pregnancy, labor, and delivery | rel=r_associated | relid=0 | w=15
  2532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:disproportionately short limbs often noted at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:disproportionately short limbs often noted at birth | rel=r_associated | relid=0 | w=15
  2533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distal tapering of the carotid, cerebellar, and meningeal arteries
    n1=Hyde (prurigo nodulaire de) | n2=en:distal tapering of the carotid, cerebellar, and meningeal arteries | rel=r_associated | relid=0 | w=15
  2534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from acquired limb-girdle myasthenia (159400) and congenital limb-girdle myasthenia (254300)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from acquired limb-girdle myasthenia (159400) and congenital limb-girdle myasthenia (254300) | rel=r_associated | relid=0 | w=15
  2535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from acquired limb-girdle myasthenia (159400) and limb-girdle myasthenia with tubular aggregates (610542)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from acquired limb-girdle myasthenia (159400) and limb-girdle myasthenia with tubular aggregates (610542) | rel=r_associated | relid=0 | w=15
  2536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from autosomal dominant hyper ige syndrome (147060)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from autosomal dominant hyper ige syndrome (147060) | rel=r_associated | relid=0 | w=15
  2537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from familial erythrocytosis (ecyt1, 133100)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from familial erythrocytosis (ecyt1, 133100) | rel=r_associated | relid=0 | w=15
  2538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from familial limb-girdle myasthenia (254200)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from familial limb-girdle myasthenia (254200) | rel=r_associated | relid=0 | w=15
  2539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from galactosemia (230400)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from galactosemia (230400) | rel=r_associated | relid=0 | w=15
  2540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from hereditary neuropathy with liability to pressure palsies (hnpp, 162500)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from hereditary neuropathy with liability to pressure palsies (hnpp, 162500) | rel=r_associated | relid=0 | w=15
  2541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from marinesco-sjogren syndrome (mss, 248800)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from marinesco-sjogren syndrome (mss, 248800) | rel=r_associated | relid=0 | w=15
  2542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from myasthenia gravis (mg, 254200)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from myasthenia gravis (mg, 254200) | rel=r_associated | relid=0 | w=15
  2543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from parkinson disease (168600)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from parkinson disease (168600) | rel=r_associated | relid=0 | w=15
  2544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from reduced zinc in breast milk (608118)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from reduced zinc in breast milk (608118) | rel=r_associated | relid=0 | w=15
  2545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct disorder from transient neonatal hyperthyroidism due to maternal graves disease (see 275000)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct disorder from transient neonatal hyperthyroidism due to maternal graves disease (see 275000) | rel=r_associated | relid=0 | w=15
  2546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct from pili annulati (180600)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct from pili annulati (180600) | rel=r_associated | relid=0 | w=15
  2547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinct from pseudopili annulati (613241)
    n1=Hyde (prurigo nodulaire de) | n2=en:distinct from pseudopili annulati (613241) | rel=r_associated | relid=0 | w=15
  2548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinctive and stereotyped sequence of events
    n1=Hyde (prurigo nodulaire de) | n2=en:distinctive and stereotyped sequence of events | rel=r_associated | relid=0 | w=15
  2549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distinguished from nbia1 by the presence of hypobetalipoproteinemia and acanthocytosis
    n1=Hyde (prurigo nodulaire de) | n2=en:distinguished from nbia1 by the presence of hypobetalipoproteinemia and acanthocytosis | rel=r_associated | relid=0 | w=15
  2550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distribution of involvement is variable and may include craniofacial, thoracic, abdominal, and extremity structures
    n1=Hyde (prurigo nodulaire de) | n2=en:distribution of involvement is variable and may include craniofacial, thoracic, abdominal, and extremity structures | rel=r_associated | relid=0 | w=15
  2551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:distribution of lesions may be generalized, palmoplantar, or acral
    n1=Hyde (prurigo nodulaire de) | n2=en:distribution of lesions may be generalized, palmoplantar, or acral | rel=r_associated | relid=0 | w=15
  2552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diurnal fluctuation
    n1=Hyde (prurigo nodulaire de) | n2=en:diurnal fluctuation | rel=r_associated | relid=0 | w=15
  2553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diurnal fluctuation of neurologic symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:diurnal fluctuation of neurologic symptoms | rel=r_associated | relid=0 | w=15
  2554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diurnal fluctuation of symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:diurnal fluctuation of symptoms | rel=r_associated | relid=0 | w=15
  2555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:diurnal fluctuation, more apparent in earlier years, later subsides
    n1=Hyde (prurigo nodulaire de) | n2=en:diurnal fluctuation, more apparent in earlier years, later subsides | rel=r_associated | relid=0 | w=15
  2556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%)
    n1=Hyde (prurigo nodulaire de) | n2=en:divided into isolated cases (75-80%), familial (10-15%), and syndromal (1-5%) | rel=r_associated | relid=0 | w=15
  2557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dna
    n1=Hyde (prurigo nodulaire de) | n2=en:dna | rel=r_associated | relid=0 | w=15
  2558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dna dc to du-editing enzyme apobec-3a
    n1=Hyde (prurigo nodulaire de) | n2=en:dna dc to du-editing enzyme apobec-3a | rel=r_associated | relid=0 | w=15
  2559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dna dc to du-editing enzyme apobec-3f
    n1=Hyde (prurigo nodulaire de) | n2=en:dna dc to du-editing enzyme apobec-3f | rel=r_associated | relid=0 | w=15
  2560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dna molecule region
    n1=Hyde (prurigo nodulaire de) | n2=en:dna molecule region | rel=r_associated | relid=0 | w=15
  2561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dodecanoyl-[acyl-carrier protein] hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:dodecanoyl-[acyl-carrier protein] hydrolase | rel=r_associated | relid=0 | w=15
  2562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:does not lead to hepatic failure
    n1=Hyde (prurigo nodulaire de) | n2=en:does not lead to hepatic failure | rel=r_associated | relid=0 | w=15
  2563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:does not result in renal failure
    n1=Hyde (prurigo nodulaire de) | n2=en:does not result in renal failure | rel=r_associated | relid=0 | w=15
  2564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dolichyl-phosphate-mannose phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:dolichyl-phosphate-mannose phosphodiesterase | rel=r_associated | relid=0 | w=15
  2565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:door is acronym for deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:door is acronym for deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures | rel=r_associated | relid=0 | w=15
  2566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dopa-responsive rigidity
    n1=Hyde (prurigo nodulaire de) | n2=en:dopa-responsive rigidity | rel=r_associated | relid=0 | w=15
  2567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dopa-unresponsive
    n1=Hyde (prurigo nodulaire de) | n2=en:dopa-unresponsive | rel=r_associated | relid=0 | w=15
  2568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dramatic improvement with proper treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:dramatic improvement with proper treatment | rel=r_associated | relid=0 | w=15
  2569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dramatic late catch-up growth occurs in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:dramatic late catch-up growth occurs in adolescence | rel=r_associated | relid=0 | w=15
  2570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:drinking water
    n1=Hyde (prurigo nodulaire de) | n2=en:drinking water | rel=r_associated | relid=0 | w=15
  2571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:drop attack
    n1=Hyde (prurigo nodulaire de) | n2=en:drop attack | rel=r_associated | relid=0 | w=15
  2572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:drug-induced dyskinesias occur in a subset of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:drug-induced dyskinesias occur in a subset of patients | rel=r_associated | relid=0 | w=15
  2573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:duane anomaly is not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:duane anomaly is not always present | rel=r_associated | relid=0 | w=15
  2574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:due to lack of epidermal ridging, patients lack fingerprints
    n1=Hyde (prurigo nodulaire de) | n2=en:due to lack of epidermal ridging, patients lack fingerprints | rel=r_associated | relid=0 | w=15
  2575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:duplication of lmnb1 is sufficient for the disorder, although patients may also have larger duplications
    n1=Hyde (prurigo nodulaire de) | n2=en:duplication of lmnb1 is sufficient for the disorder, although patients may also have larger duplications | rel=r_associated | relid=0 | w=15
  2576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dutp pyrophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:dutp pyrophosphatase | rel=r_associated | relid=0 | w=15
  2577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dwarfism not detectable at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:dwarfism not detectable at birth | rel=r_associated | relid=0 | w=15
  2578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dynamin-1-like protein
    n1=Hyde (prurigo nodulaire de) | n2=en:dynamin-1-like protein | rel=r_associated | relid=0 | w=15
  2579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysarthria, dysphonia, or cough precede onset of ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:dysarthria, dysphonia, or cough precede onset of ataxia | rel=r_associated | relid=0 | w=15
  2580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dyskinesia may be precipitated by alcohol, stress, or fatigue
    n1=Hyde (prurigo nodulaire de) | n2=en:dyskinesia may be precipitated by alcohol, stress, or fatigue | rel=r_associated | relid=0 | w=15
  2581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dyskinesia may occur in homozygotes (1 reported case)
    n1=Hyde (prurigo nodulaire de) | n2=en:dyskinesia may occur in homozygotes (1 reported case) | rel=r_associated | relid=0 | w=15
  2582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dyskinesias occur in a subset of patients later than seizures (6 to 12 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:dyskinesias occur in a subset of patients later than seizures (6 to 12 months) | rel=r_associated | relid=0 | w=15
  2583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic facial features are subtle
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic facial features are subtle | rel=r_associated | relid=0 | w=15
  2584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic facial features are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic facial features are variable | rel=r_associated | relid=0 | w=15
  2585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic facial features may not be present
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic facial features may not be present | rel=r_associated | relid=0 | w=15
  2586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic facial features reported in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic facial features reported in 1 family | rel=r_associated | relid=0 | w=15
  2587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic features are mild or variable
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic features are mild or variable | rel=r_associated | relid=0 | w=15
  2588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic features are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic features are variable | rel=r_associated | relid=0 | w=15
  2589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dysmorphic features were only reported in 1 patient
    n1=Hyde (prurigo nodulaire de) | n2=en:dysmorphic features were only reported in 1 patient | rel=r_associated | relid=0 | w=15
  2590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dystonia and seizures may persist after resolution of episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:dystonia and seizures may persist after resolution of episodes | rel=r_associated | relid=0 | w=15
  2591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:dystonia is usually focal or segmental
    n1=Hyde (prurigo nodulaire de) | n2=en:dystonia is usually focal or segmental | rel=r_associated | relid=0 | w=15
  2592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:e1a-binding protein p400
    n1=Hyde (prurigo nodulaire de) | n2=en:e1a-binding protein p400 | rel=r_associated | relid=0 | w=15
  2593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset associated with faster progression and shorter life span
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset associated with faster progression and shorter life span | rel=r_associated | relid=0 | w=15
  2594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset associated with increased severity
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset associated with increased severity | rel=r_associated | relid=0 | w=15
  2595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset is associated with a more severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset is associated with a more severe disorder | rel=r_associated | relid=0 | w=15
  2596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset is associated with more aggressive disease course
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset is associated with more aggressive disease course | rel=r_associated | relid=0 | w=15
  2597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset is associated with more rapid progression
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset is associated with more rapid progression | rel=r_associated | relid=0 | w=15
  2598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset is rare
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset is rare | rel=r_associated | relid=0 | w=15
  2599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:earlier onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:earlier onset may occur | rel=r_associated | relid=0 | w=15
  2600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early adult onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:early adult onset has been reported | rel=r_associated | relid=0 | w=15
  2601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early age of onset
    n1=Hyde (prurigo nodulaire de) | n2=en:early age of onset | rel=r_associated | relid=0 | w=15
  2602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early age of onset (approximately 45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:early age of onset (approximately 45 years) | rel=r_associated | relid=0 | w=15
  2603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early age of onset (mean age at diagnosis, 36 years) most patients have intraocular pressures within the normal range (21 mmhg or less)
    n1=Hyde (prurigo nodulaire de) | n2=en:early age of onset (mean age at diagnosis, 36 years) most patients have intraocular pressures within the normal range (21 mmhg or less) | rel=r_associated | relid=0 | w=15
  2604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early age of onset, usually less than 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:early age of onset, usually less than 3 years | rel=r_associated | relid=0 | w=15
  2605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early childhood onset (before age 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:early childhood onset (before age 5 years) | rel=r_associated | relid=0 | w=15
  2606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death
    n1=Hyde (prurigo nodulaire de) | n2=en:early death | rel=r_associated | relid=0 | w=15
  2607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:early death (in some patients) | rel=r_associated | relid=0 | w=15
  2608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death (mean age 13 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:early death (mean age 13 months) | rel=r_associated | relid=0 | w=15
  2609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death (usually by 3 years of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:early death (usually by 3 years of age) | rel=r_associated | relid=0 | w=15
  2610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death due to infection
    n1=Hyde (prurigo nodulaire de) | n2=en:early death due to infection | rel=r_associated | relid=0 | w=15
  2611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death due to sepsis
    n1=Hyde (prurigo nodulaire de) | n2=en:early death due to sepsis | rel=r_associated | relid=0 | w=15
  2612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death from infection may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:early death from infection may occur | rel=r_associated | relid=0 | w=15
  2613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death from respiratory failure may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:early death from respiratory failure may occur | rel=r_associated | relid=0 | w=15
  2614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death in early adulthood often associated with diverticulitis and intestinal perforation
    n1=Hyde (prurigo nodulaire de) | n2=en:early death in early adulthood often associated with diverticulitis and intestinal perforation | rel=r_associated | relid=0 | w=15
  2615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death in males
    n1=Hyde (prurigo nodulaire de) | n2=en:early death in males | rel=r_associated | relid=0 | w=15
  2616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death in patients with cloverleaf skull
    n1=Hyde (prurigo nodulaire de) | n2=en:early death in patients with cloverleaf skull | rel=r_associated | relid=0 | w=15
  2617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death in some patients due to cardiorespiratory involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:early death in some patients due to cardiorespiratory involvement | rel=r_associated | relid=0 | w=15
  2618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death in the first few weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:early death in the first few weeks of life | rel=r_associated | relid=0 | w=15
  2619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:early death may occur | rel=r_associated | relid=0 | w=15
  2620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death may occur due to infection
    n1=Hyde (prurigo nodulaire de) | n2=en:early death may occur due to infection | rel=r_associated | relid=0 | w=15
  2621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death occurs in affected infants (days to months after disease onset)
    n1=Hyde (prurigo nodulaire de) | n2=en:early death occurs in affected infants (days to months after disease onset) | rel=r_associated | relid=0 | w=15
  2622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death often due to respiratory complications
    n1=Hyde (prurigo nodulaire de) | n2=en:early death often due to respiratory complications | rel=r_associated | relid=0 | w=15
  2623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death often occurs from cardiac failure or infection
    n1=Hyde (prurigo nodulaire de) | n2=en:early death often occurs from cardiac failure or infection | rel=r_associated | relid=0 | w=15
  2624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death without bone marrow transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:early death without bone marrow transplantation | rel=r_associated | relid=0 | w=15
  2625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death without kidney transplant
    n1=Hyde (prurigo nodulaire de) | n2=en:early death without kidney transplant | rel=r_associated | relid=0 | w=15
  2626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early death, usually before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:early death, usually before age 2 years | rel=r_associated | relid=0 | w=15
  2627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early diagnosis and proper treatment with folate replacement therapy can avoid neurologic sequelae
    n1=Hyde (prurigo nodulaire de) | n2=en:early diagnosis and proper treatment with folate replacement therapy can avoid neurologic sequelae | rel=r_associated | relid=0 | w=15
  2628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early diagnosis and treatment prevent many complications
    n1=Hyde (prurigo nodulaire de) | n2=en:early diagnosis and treatment prevent many complications | rel=r_associated | relid=0 | w=15
  2629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early exhaustion on exertion
    n1=Hyde (prurigo nodulaire de) | n2=en:early exhaustion on exertion | rel=r_associated | relid=0 | w=15
  2630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early lethality
    n1=Hyde (prurigo nodulaire de) | n2=en:early lethality | rel=r_associated | relid=0 | w=15
  2631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early lethality in most cases
    n1=Hyde (prurigo nodulaire de) | n2=en:early lethality in most cases | rel=r_associated | relid=0 | w=15
  2632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset (1 month to 4 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset (1 month to 4 years) | rel=r_associated | relid=0 | w=15
  2633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset (9-48 years, but reported up to 68 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset (9-48 years, but reported up to 68 years) | rel=r_associated | relid=0 | w=15
  2634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset (average 1 year)
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset (average 1 year) | rel=r_associated | relid=0 | w=15
  2635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset has rarely been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset has rarely been reported | rel=r_associated | relid=0 | w=15
  2636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset in some patients | rel=r_associated | relid=0 | w=15
  2637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset of peripheral neuropathy (mean 2.1 years, range 1 to 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset of peripheral neuropathy (mean 2.1 years, range 1 to 10 years) | rel=r_associated | relid=0 | w=15
  2638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset patients are indistinguishable from those with carbamoyl phosphate synthetase i (cps1) deficiency (237300)
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset patients are indistinguishable from those with carbamoyl phosphate synthetase i (cps1) deficiency (237300) | rel=r_associated | relid=0 | w=15
  2639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early onset, between 35-60 years
    n1=Hyde (prurigo nodulaire de) | n2=en:early onset, between 35-60 years | rel=r_associated | relid=0 | w=15
  2640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early treatment can reduce neurologic symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:early treatment can reduce neurologic symptoms | rel=r_associated | relid=0 | w=15
  2641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early-onset
    n1=Hyde (prurigo nodulaire de) | n2=en:early-onset | rel=r_associated | relid=0 | w=15
  2642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early-onset associated with more severe course and early death
    n1=Hyde (prurigo nodulaire de) | n2=en:early-onset associated with more severe course and early death | rel=r_associated | relid=0 | w=15
  2643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:early-onset severe renal disease
    n1=Hyde (prurigo nodulaire de) | n2=en:early-onset severe renal disease | rel=r_associated | relid=0 | w=15
  2644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:eating disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:eating disorder | rel=r_associated | relid=0 | w=15
  2645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:echocardiogram and ophthalmologic examination normal
    n1=Hyde (prurigo nodulaire de) | n2=en:echocardiogram and ophthalmologic examination normal | rel=r_associated | relid=0 | w=15
  2646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ectopic pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:ectopic pregnancy | rel=r_associated | relid=0 | w=15
  2647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:edema
    n1=Hyde (prurigo nodulaire de) | n2=en:edema | rel=r_associated | relid=0 | w=15
  2648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ee57c protein, bacillus subtilis
    n1=Hyde (prurigo nodulaire de) | n2=en:ee57c protein, bacillus subtilis | rel=r_associated | relid=0 | w=15
  2649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:eight unrelated patients have been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:eight unrelated patients have been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  2650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:electrolyte imbalances can mimic renal bartter syndrome (601678)
    n1=Hyde (prurigo nodulaire de) | n2=en:electrolyte imbalances can mimic renal bartter syndrome (601678) | rel=r_associated | relid=0 | w=15
  2651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:electromyography may be normal in infancy, but shows myopathic pattern in adolescence and adulthood | rel=r_associated | relid=0 | w=15
  2652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:electroretinogram reduction as early as 4 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:electroretinogram reduction as early as 4 years of age | rel=r_associated | relid=0 | w=15
  2653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated afp can be seen in other disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated afp can be seen in other disorders | rel=r_associated | relid=0 | w=15
  2654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated amniotic alpha-fetoprotein in affected fetuses with encephalocele | rel=r_associated | relid=0 | w=15
  2655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated amniotic fluid alpha-fetoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated amniotic fluid alpha-fetoprotein | rel=r_associated | relid=0 | w=15
  2656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated body temperatures to 42 degrees celsius
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated body temperatures to 42 degrees celsius | rel=r_associated | relid=0 | w=15
  2657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated chloride levels
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated chloride levels | rel=r_associated | relid=0 | w=15
  2658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:elevated maternal serum alpha-fetoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:elevated maternal serum alpha-fetoprotein | rel=r_associated | relid=0 | w=15
  2659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:embryonic loss
    n1=Hyde (prurigo nodulaire de) | n2=en:embryonic loss | rel=r_associated | relid=0 | w=15
  2660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:emetrol
    n1=Hyde (prurigo nodulaire de) | n2=en:emetrol | rel=r_associated | relid=0 | w=15
  2661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:empiric risk for a sib of an affected child between 2 and 5%
    n1=Hyde (prurigo nodulaire de) | n2=en:empiric risk for a sib of an affected child between 2 and 5% | rel=r_associated | relid=0 | w=15
  2662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:empty flexible container
    n1=Hyde (prurigo nodulaire de) | n2=en:empty flexible container | rel=r_associated | relid=0 | w=15
  2663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:encephaloclastic proliferative vasculopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:encephaloclastic proliferative vasculopathy | rel=r_associated | relid=0 | w=15
  2664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:encephalopathic episodes associated with increased serum and csf lactate
    n1=Hyde (prurigo nodulaire de) | n2=en:encephalopathic episodes associated with increased serum and csf lactate | rel=r_associated | relid=0 | w=15
  2665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:end-stage renal disease (ckd stage 5) requiring kidney transplantation is commonly reported
    n1=Hyde (prurigo nodulaire de) | n2=en:end-stage renal disease (ckd stage 5) requiring kidney transplantation is commonly reported | rel=r_associated | relid=0 | w=15
  2666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:end-stage renal failure in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:end-stage renal failure in first decade | rel=r_associated | relid=0 | w=15
  2667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:end-stage renal failure in first or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:end-stage renal failure in first or second decade | rel=r_associated | relid=0 | w=15
  2668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:end-stage renal failure may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:end-stage renal failure may occur | rel=r_associated | relid=0 | w=15
  2669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endo-1,3-alpha-glucanase
    n1=Hyde (prurigo nodulaire de) | n2=en:endo-1,3-alpha-glucanase | rel=r_associated | relid=0 | w=15
  2670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endo-1,5-alpha-l-arabinanase
    n1=Hyde (prurigo nodulaire de) | n2=en:endo-1,5-alpha-l-arabinanase | rel=r_associated | relid=0 | w=15
  2671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endocrine abnormalities confined to kidney
    n1=Hyde (prurigo nodulaire de) | n2=en:endocrine abnormalities confined to kidney | rel=r_associated | relid=0 | w=15
  2672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endocrine defects evolve over time
    n1=Hyde (prurigo nodulaire de) | n2=en:endocrine defects evolve over time | rel=r_associated | relid=0 | w=15
  2673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endocrinologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:endocrinologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  2674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endogalactosaminidase
    n1=Hyde (prurigo nodulaire de) | n2=en:endogalactosaminidase | rel=r_associated | relid=0 | w=15
  2675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endopeptidase clp
    n1=Hyde (prurigo nodulaire de) | n2=en:endopeptidase clp | rel=r_associated | relid=0 | w=15
  2676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endopeptidase so
    n1=Hyde (prurigo nodulaire de) | n2=en:endopeptidase so | rel=r_associated | relid=0 | w=15
  2677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:endoproteinase asp-n
    n1=Hyde (prurigo nodulaire de) | n2=en:endoproteinase asp-n | rel=r_associated | relid=0 | w=15
  2678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enterobacter ribonuclease
    n1=Hyde (prurigo nodulaire de) | n2=en:enterobacter ribonuclease | rel=r_associated | relid=0 | w=15
  2679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enterocolitis tends to remit with age
    n1=Hyde (prurigo nodulaire de) | n2=en:enterocolitis tends to remit with age | rel=r_associated | relid=0 | w=15
  2680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:environmental triggers - cold and wet exposure
    n1=Hyde (prurigo nodulaire de) | n2=en:environmental triggers - cold and wet exposure | rel=r_associated | relid=0 | w=15
  2681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:environmental triggers include (koebner's phenomenon), sunburn, hiv infection, beta-hemolytic streptococcal infection, certain medications, stress, and alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:environmental triggers include (koebner's phenomenon), sunburn, hiv infection, beta-hemolytic streptococcal infection, certain medications, stress, and alcohol | rel=r_associated | relid=0 | w=15
  2682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enzyme
    n1=Hyde (prurigo nodulaire de) | n2=en:enzyme | rel=r_associated | relid=0 | w=15
  2683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enzyme replacement therapy will help visceral manifestations but cannot cross blood-brain barrier, so will not help neurodegeneration
    n1=Hyde (prurigo nodulaire de) | n2=en:enzyme replacement therapy will help visceral manifestations but cannot cross blood-brain barrier, so will not help neurodegeneration | rel=r_associated | relid=0 | w=15
  2684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enzymes and coenzymes
    n1=Hyde (prurigo nodulaire de) | n2=en:enzymes and coenzymes | rel=r_associated | relid=0 | w=15
  2685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:enzymology
    n1=Hyde (prurigo nodulaire de) | n2=en:enzymology | rel=r_associated | relid=0 | w=15
  2686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epidemiologic
    n1=Hyde (prurigo nodulaire de) | n2=en:epidemiologic | rel=r_associated | relid=0 | w=15
  2687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epidermolysis bullosa simplex with pyloric atresia
    n1=Hyde (prurigo nodulaire de) | n2=en:epidermolysis bullosa simplex with pyloric atresia | rel=r_associated | relid=0 | w=15
  2688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epidermolysis bullosa with pyloric atresia
    n1=Hyde (prurigo nodulaire de) | n2=en:epidermolysis bullosa with pyloric atresia | rel=r_associated | relid=0 | w=15
  2689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epilepsy with grand mal seizures on awakening (egma, 607628)
    n1=Hyde (prurigo nodulaire de) | n2=en:epilepsy with grand mal seizures on awakening (egma, 607628) | rel=r_associated | relid=0 | w=15
  2690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epinephrine + chlorpheniramine
    n1=Hyde (prurigo nodulaire de) | n2=en:epinephrine + chlorpheniramine | rel=r_associated | relid=0 | w=15
  2691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epiphyseal stippling is gone by 8 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:epiphyseal stippling is gone by 8 months of age | rel=r_associated | relid=0 | w=15
  2692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episode frequency is monthly to yearly, and decreases with age
    n1=Hyde (prurigo nodulaire de) | n2=en:episode frequency is monthly to yearly, and decreases with age | rel=r_associated | relid=0 | w=15
  2693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episode, syncopal
    n1=Hyde (prurigo nodulaire de) | n2=en:episode, syncopal | rel=r_associated | relid=0 | w=15
  2694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes are followed by exhaustion and sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes are followed by exhaustion and sleep | rel=r_associated | relid=0 | w=15
  2695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes are triggered by cold exposure
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes are triggered by cold exposure | rel=r_associated | relid=0 | w=15
  2696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes are triggered by fatigue, illness, or strenuous exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes are triggered by fatigue, illness, or strenuous exercise | rel=r_associated | relid=0 | w=15
  2697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes are triggered by hunger, fatigue, cold, stress
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes are triggered by hunger, fatigue, cold, stress | rel=r_associated | relid=0 | w=15
  2698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes are triggered by infection, immunization, surgery, strenuous exercise, cold, pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes are triggered by infection, immunization, surgery, strenuous exercise, cold, pregnancy | rel=r_associated | relid=0 | w=15
  2699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes brought on by fasting or infection
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes brought on by fasting or infection | rel=r_associated | relid=0 | w=15
  2700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes last 1 to 2 days
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes last 1 to 2 days | rel=r_associated | relid=0 | w=15
  2701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes last 2 days to 1 week
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes last 2 days to 1 week | rel=r_associated | relid=0 | w=15
  2702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes last about 1.5 hours
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes last about 1.5 hours | rel=r_associated | relid=0 | w=15
  2703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes last from several hours to days
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes last from several hours to days | rel=r_associated | relid=0 | w=15
  2704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes may be precipitated by fear, unexpected noises, emotional responses, movement
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes may be precipitated by fear, unexpected noises, emotional responses, movement | rel=r_associated | relid=0 | w=15
  2705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes may be triggered by exercise, emotional stress, head trauma, angiography, lack of sleep, heat | rel=r_associated | relid=0 | w=15
  2706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes not triggered by alcohol, caffeine, or stress
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes not triggered by alcohol, caffeine, or stress | rel=r_associated | relid=0 | w=15
  2707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes occur 30 minutes to 3 hours after exposure to cold
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes occur 30 minutes to 3 hours after exposure to cold | rel=r_associated | relid=0 | w=15
  2708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes of fatigue or weakness (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes of fatigue or weakness (in some patients) | rel=r_associated | relid=0 | w=15
  2709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes tend to decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes tend to decrease with age | rel=r_associated | relid=0 | w=15
  2710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes triggered by fasting, illness, fever
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes triggered by fasting, illness, fever | rel=r_associated | relid=0 | w=15
  2711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes typically last 2 to 5 minutes and occur daily or several times per month
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes typically last 2 to 5 minutes and occur daily or several times per month | rel=r_associated | relid=0 | w=15
  2712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodes usually last 1 to 2 days
    n1=Hyde (prurigo nodulaire de) | n2=en:episodes usually last 1 to 2 days | rel=r_associated | relid=0 | w=15
  2713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodic
    n1=Hyde (prurigo nodulaire de) | n2=en:episodic | rel=r_associated | relid=0 | w=15
  2714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodic decompensation is usually triggered by illness
    n1=Hyde (prurigo nodulaire de) | n2=en:episodic decompensation is usually triggered by illness | rel=r_associated | relid=0 | w=15
  2715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:episodic metabolic decompensation usually associated with illness
    n1=Hyde (prurigo nodulaire de) | n2=en:episodic metabolic decompensation usually associated with illness | rel=r_associated | relid=0 | w=15
  2716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:epoxide hydrolase 1
    n1=Hyde (prurigo nodulaire de) | n2=en:epoxide hydrolase 1 | rel=r_associated | relid=0 | w=15
  2717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:erythema often triggered by sudden temperature change or emotional stress
    n1=Hyde (prurigo nodulaire de) | n2=en:erythema often triggered by sudden temperature change or emotional stress | rel=r_associated | relid=0 | w=15
  2718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:essential amino acid
    n1=Hyde (prurigo nodulaire de) | n2=en:essential amino acid | rel=r_associated | relid=0 | w=15
  2719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:essential fatty acid product
    n1=Hyde (prurigo nodulaire de) | n2=en:essential fatty acid product | rel=r_associated | relid=0 | w=15
  2720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:esterase
    n1=Hyde (prurigo nodulaire de) | n2=en:esterase | rel=r_associated | relid=0 | w=15
  2721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated carrier frequency 1/100
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated carrier frequency 1/100 | rel=r_associated | relid=0 | w=15
  2722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated carrier frequency in charlevoix-saguenay region is 1/22
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated carrier frequency in charlevoix-saguenay region is 1/22 | rel=r_associated | relid=0 | w=15
  2723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated carrier frequency of 10-25% in yarmouth county, nova scotia
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated carrier frequency of 10-25% in yarmouth county, nova scotia | rel=r_associated | relid=0 | w=15
  2724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated frequence 1/3000 to 1/5000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated frequence 1/3000 to 1/5000 | rel=r_associated | relid=0 | w=15
  2725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated frequency 1.6 cases/10,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated frequency 1.6 cases/10,000 live births | rel=r_associated | relid=0 | w=15
  2726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated frequency 1/2000-1/4000 individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated frequency 1/2000-1/4000 individuals | rel=r_associated | relid=0 | w=15
  2727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated frequency of 1 in 40,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated frequency of 1 in 40,000 live births | rel=r_associated | relid=0 | w=15
  2728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated gene carrier frequency of 1 in 5,000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated gene carrier frequency of 1 in 5,000 | rel=r_associated | relid=0 | w=15
  2729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated incidence 1/20,000 - 1/40,000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated incidence 1/20,000 - 1/40,000 | rel=r_associated | relid=0 | w=15
  2730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated incidence of 1 in 17,000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated incidence of 1 in 17,000 | rel=r_associated | relid=0 | w=15
  2731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated incidence of 1-2 in 10,000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated incidence of 1-2 in 10,000 | rel=r_associated | relid=0 | w=15
  2732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated mutation carrier rate of 1 in 350
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated mutation carrier rate of 1 in 350 | rel=r_associated | relid=0 | w=15
  2733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated prevalence of 1 in 16,000
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated prevalence of 1 in 16,000 | rel=r_associated | relid=0 | w=15
  2734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:estimated prevalence of 1.6 in 1,000,000 individuals in the u.k.
    n1=Hyde (prurigo nodulaire de) | n2=en:estimated prevalence of 1.6 in 1,000,000 individuals in the u.k. | rel=r_associated | relid=0 | w=15
  2735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ether hydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:ether hydrolase | rel=r_associated | relid=0 | w=15
  2736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ethnologic
    n1=Hyde (prurigo nodulaire de) | n2=en:ethnologic | rel=r_associated | relid=0 | w=15
  2737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:etiology aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:etiology aspects | rel=r_associated | relid=0 | w=15
  2738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:etoposide
    n1=Hyde (prurigo nodulaire de) | n2=en:etoposide | rel=r_associated | relid=0 | w=15
  2739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:evacuated container
    n1=Hyde (prurigo nodulaire de) | n2=en:evacuated container | rel=r_associated | relid=0 | w=15
  2740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:evidence of incomplete penetrance in one family
    n1=Hyde (prurigo nodulaire de) | n2=en:evidence of incomplete penetrance in one family | rel=r_associated | relid=0 | w=15
  2741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:evidence of systemic iron overload seen in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:evidence of systemic iron overload seen in 1 family | rel=r_associated | relid=0 | w=15
  2742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exacerbation at puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:exacerbation at puberty | rel=r_associated | relid=0 | w=15
  2743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exacerbation during febrile episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:exacerbation during febrile episodes | rel=r_associated | relid=0 | w=15
  2744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exacerbation following stress, decreased food intake, or alcohol use
    n1=Hyde (prurigo nodulaire de) | n2=en:exacerbation following stress, decreased food intake, or alcohol use | rel=r_associated | relid=0 | w=15
  2745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exacerbation of symptoms during or after pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:exacerbation of symptoms during or after pregnancy | rel=r_associated | relid=0 | w=15
  2746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exacerbations during infection
    n1=Hyde (prurigo nodulaire de) | n2=en:exacerbations during infection | rel=r_associated | relid=0 | w=15
  2747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:excessive postsurgical blood loss
    n1=Hyde (prurigo nodulaire de) | n2=en:excessive postsurgical blood loss | rel=r_associated | relid=0 | w=15
  2748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:excessive posttraumatic blood loss
    n1=Hyde (prurigo nodulaire de) | n2=en:excessive posttraumatic blood loss | rel=r_associated | relid=0 | w=15
  2749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:excessive skin picking of sores
    n1=Hyde (prurigo nodulaire de) | n2=en:excessive skin picking of sores | rel=r_associated | relid=0 | w=15
  2750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exercise intolerance often evident in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:exercise intolerance often evident in childhood | rel=r_associated | relid=0 | w=15
  2751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:existence as a distinct entity is not confirmed
    n1=Hyde (prurigo nodulaire de) | n2=en:existence as a distinct entity is not confirmed | rel=r_associated | relid=0 | w=15
  2752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exo-1,3-alpha-glucanase
    n1=Hyde (prurigo nodulaire de) | n2=en:exo-1,3-alpha-glucanase | rel=r_associated | relid=0 | w=15
  2753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exo-1,6-alpha-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:exo-1,6-alpha-glucosidase | rel=r_associated | relid=0 | w=15
  2754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exodeoxyribonuclease (lambda-induced)
    n1=Hyde (prurigo nodulaire de) | n2=en:exodeoxyribonuclease (lambda-induced) | rel=r_associated | relid=0 | w=15
  2755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exodeoxyribonuclease iii
    n1=Hyde (prurigo nodulaire de) | n2=en:exodeoxyribonuclease iii | rel=r_associated | relid=0 | w=15
  2756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exodeoxyribonuclease vii
    n1=Hyde (prurigo nodulaire de) | n2=en:exodeoxyribonuclease vii | rel=r_associated | relid=0 | w=15
  2757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exon 7 of smn1 is absent in 95.6% of sma1 patients
    n1=Hyde (prurigo nodulaire de) | n2=en:exon 7 of smn1 is absent in 95.6% of sma1 patients | rel=r_associated | relid=0 | w=15
  2758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exopolyphosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:exopolyphosphatase | rel=r_associated | relid=0 | w=15
  2759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:exoribonuclease ii
    n1=Hyde (prurigo nodulaire de) | n2=en:exoribonuclease ii | rel=r_associated | relid=0 | w=15
  2760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:expression more severe in females than males, except for mosaic males
    n1=Hyde (prurigo nodulaire de) | n2=en:expression more severe in females than males, except for mosaic males | rel=r_associated | relid=0 | w=15
  2761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:extracutaneous manifestations are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:extracutaneous manifestations are variable | rel=r_associated | relid=0 | w=15
  2762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:extrapyramidal signs show a favorable response to levodopa
    n1=Hyde (prurigo nodulaire de) | n2=en:extrapyramidal signs show a favorable response to levodopa | rel=r_associated | relid=0 | w=15
  2763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:extreme clinical heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:extreme clinical heterogeneity | rel=r_associated | relid=0 | w=15
  2764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:extreme phenotypic variability
    n1=Hyde (prurigo nodulaire de) | n2=en:extreme phenotypic variability | rel=r_associated | relid=0 | w=15
  2765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:extremely variable phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:extremely variable phenotype | rel=r_associated | relid=0 | w=15
  2766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:eye involvement begins at birth, neurologic involvement begins later
    n1=Hyde (prurigo nodulaire de) | n2=en:eye involvement begins at birth, neurologic involvement begins later | rel=r_associated | relid=0 | w=15
  2767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:f syndrome (102510) has many overlapping features
    n1=Hyde (prurigo nodulaire de) | n2=en:f syndrome (102510) has many overlapping features | rel=r_associated | relid=0 | w=15
  2768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial appearance becomes more apparent with age
    n1=Hyde (prurigo nodulaire de) | n2=en:facial appearance becomes more apparent with age | rel=r_associated | relid=0 | w=15
  2769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial dysmorphic features are mild
    n1=Hyde (prurigo nodulaire de) | n2=en:facial dysmorphic features are mild | rel=r_associated | relid=0 | w=15
  2770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial dysmorphic features may not be present and may become less apparent in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:facial dysmorphic features may not be present and may become less apparent in adulthood | rel=r_associated | relid=0 | w=15
  2771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial dysmorphism is age-related and alters substantially over time
    n1=Hyde (prurigo nodulaire de) | n2=en:facial dysmorphism is age-related and alters substantially over time | rel=r_associated | relid=0 | w=15
  2772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial dysmorphism is uncommon
    n1=Hyde (prurigo nodulaire de) | n2=en:facial dysmorphism is uncommon | rel=r_associated | relid=0 | w=15
  2773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:facial palsy often transient in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:facial palsy often transient in infancy | rel=r_associated | relid=0 | w=15
  2774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fad pyrophosphatase
    n1=Hyde (prurigo nodulaire de) | n2=en:fad pyrophosphatase | rel=r_associated | relid=0 | w=15
  2775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial (10%) and isolated cases
    n1=Hyde (prurigo nodulaire de) | n2=en:familial (10%) and isolated cases | rel=r_associated | relid=0 | w=15
  2776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial cases are rare and show incomplete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:familial cases are rare and show incomplete penetrance | rel=r_associated | relid=0 | w=15
  2777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial form
    n1=Hyde (prurigo nodulaire de) | n2=en:familial form | rel=r_associated | relid=0 | w=15
  2778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial form - constitutional deficiency of vwf-cleaving protease
    n1=Hyde (prurigo nodulaire de) | n2=en:familial form - constitutional deficiency of vwf-cleaving protease | rel=r_associated | relid=0 | w=15
  2779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial hemiplegic migraine-2 (fhm2, 602481) is an allelic disorder with an overlapping phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:familial hemiplegic migraine-2 (fhm2, 602481) is an allelic disorder with an overlapping phenotype | rel=r_associated | relid=0 | w=15
  2780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:familial occurrence is rare
    n1=Hyde (prurigo nodulaire de) | n2=en:familial occurrence is rare | rel=r_associated | relid=0 | w=15
  2781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:family history of sudden death, as early as fourth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:family history of sudden death, as early as fourth decade of life | rel=r_associated | relid=0 | w=15
  2782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fasting status:acnc:pt:^patient:ord:reported
    n1=Hyde (prurigo nodulaire de) | n2=en:fasting status:acnc:pt:^patient:ord:reported | rel=r_associated | relid=0 | w=15
  2783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fat emulsion
    n1=Hyde (prurigo nodulaire de) | n2=en:fat emulsion | rel=r_associated | relid=0 | w=15
  2784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fat pads become less prominent with time
    n1=Hyde (prurigo nodulaire de) | n2=en:fat pads become less prominent with time | rel=r_associated | relid=0 | w=15
  2785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal before age 2 years | rel=r_associated | relid=0 | w=15
  2786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal if renal transplant is not performed
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal if renal transplant is not performed | rel=r_associated | relid=0 | w=15
  2787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal in first few months of life in most cases
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal in first few months of life in most cases | rel=r_associated | relid=0 | w=15
  2788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal in the neonatal period (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal in the neonatal period (in some patients) | rel=r_associated | relid=0 | w=15
  2789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal multiorgan failure due to severe inflammatory response in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal multiorgan failure due to severe inflammatory response in some patients | rel=r_associated | relid=0 | w=15
  2790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal outcome if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal outcome if untreated | rel=r_associated | relid=0 | w=15
  2791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal without bone marrow transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal without bone marrow transplantation | rel=r_associated | relid=0 | w=15
  2792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal without hematopoietic stem cell transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal without hematopoietic stem cell transplantation | rel=r_associated | relid=0 | w=15
  2793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatal without lung transplant
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal without lung transplant | rel=r_associated | relid=0 | w=15
  2794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatigue
    n1=Hyde (prurigo nodulaire de) | n2=en:fatigue | rel=r_associated | relid=0 | w=15
  2795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fatty acid
    n1=Hyde (prurigo nodulaire de) | n2=en:fatty acid | rel=r_associated | relid=0 | w=15
  2796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable initial response to l-dopa
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable initial response to l-dopa | rel=r_associated | relid=0 | w=15
  2797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable management with the fibrinolysis inhibitors (e.g., epsilon-aminocaproic acid and tranexamic acid)
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable management with the fibrinolysis inhibitors (e.g., epsilon-aminocaproic acid and tranexamic acid) | rel=r_associated | relid=0 | w=15
  2798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response of episodic attacks to acetazolamide
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response of episodic attacks to acetazolamide | rel=r_associated | relid=0 | w=15
  2799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to 3,4-diaminopyridine
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to 3,4-diaminopyridine | rel=r_associated | relid=0 | w=15
  2800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to a ketogenic diet
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to a ketogenic diet | rel=r_associated | relid=0 | w=15
  2801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to acetylcholinesterase inhibitors
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to acetylcholinesterase inhibitors | rel=r_associated | relid=0 | w=15
  2802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to alcohol | rel=r_associated | relid=0 | w=15
  2803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to alcohol in about 50%
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to alcohol in about 50% | rel=r_associated | relid=0 | w=15
  2804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to antibodies against tnf-alpha (tnfa, 191160)
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to antibodies against tnf-alpha (tnfa, 191160) | rel=r_associated | relid=0 | w=15
  2805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to anticholinesterase medication
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to anticholinesterase medication | rel=r_associated | relid=0 | w=15
  2806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to anticonvulsants
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to anticonvulsants | rel=r_associated | relid=0 | w=15
  2807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to bh4
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to bh4 | rel=r_associated | relid=0 | w=15
  2808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to bh4 therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to bh4 therapy | rel=r_associated | relid=0 | w=15
  2809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to clonazepam
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to clonazepam | rel=r_associated | relid=0 | w=15
  2810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to corticosteroid treatment (1 family)
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to corticosteroid treatment (1 family) | rel=r_associated | relid=0 | w=15
  2811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to ephedrine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to ephedrine treatment | rel=r_associated | relid=0 | w=15
  2812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to flunarizine
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to flunarizine | rel=r_associated | relid=0 | w=15
  2813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to high-dose steroids
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to high-dose steroids | rel=r_associated | relid=0 | w=15
  2814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to hydroxychloroquine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to hydroxychloroquine treatment | rel=r_associated | relid=0 | w=15
  2815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to immunotherapy
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to immunotherapy | rel=r_associated | relid=0 | w=15
  2816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to intermittent, low-dose steroid therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to intermittent, low-dose steroid therapy | rel=r_associated | relid=0 | w=15
  2817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to l-dopa
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to l-dopa | rel=r_associated | relid=0 | w=15
  2818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to l-dopa treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to l-dopa treatment | rel=r_associated | relid=0 | w=15
  2819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to l-dopa without side effects
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to l-dopa without side effects | rel=r_associated | relid=0 | w=15
  2820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to oral bile acid therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to oral bile acid therapy | rel=r_associated | relid=0 | w=15
  2821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to oral creatine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to oral creatine treatment | rel=r_associated | relid=0 | w=15
  2822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to rituxan (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to rituxan (in some patients) | rel=r_associated | relid=0 | w=15
  2823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to sodium chloride treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to sodium chloride treatment | rel=r_associated | relid=0 | w=15
  2824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to spironolactone
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to spironolactone | rel=r_associated | relid=0 | w=15
  2825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to treatment with minocycline or azithromycin
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to treatment with minocycline or azithromycin | rel=r_associated | relid=0 | w=15
  2826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to treatment with riboflavin
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to treatment with riboflavin | rel=r_associated | relid=0 | w=15
  2827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favorable response to ursodeoxycholic acid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:favorable response to ursodeoxycholic acid treatment | rel=r_associated | relid=0 | w=15
  2828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:favoring of fat and protein
    n1=Hyde (prurigo nodulaire de) | n2=en:favoring of fat and protein | rel=r_associated | relid=0 | w=15
  2829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:features are variable | rel=r_associated | relid=0 | w=15
  2830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features based on one australian/uk family with tmem98 mutation (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:features based on one australian/uk family with tmem98 mutation (last curated august 2014) | rel=r_associated | relid=0 | w=15
  2831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features in addition to mental retardation are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:features in addition to mental retardation are variable | rel=r_associated | relid=0 | w=15
  2832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features in typical patient include mental retardation, microcephaly, short stature, and lean body build
    n1=Hyde (prurigo nodulaire de) | n2=en:features in typical patient include mental retardation, microcephaly, short stature, and lean body build | rel=r_associated | relid=0 | w=15
  2833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features intermediate between demyelinating cmt and axonal cmt
    n1=Hyde (prurigo nodulaire de) | n2=en:features intermediate between demyelinating cmt and axonal cmt | rel=r_associated | relid=0 | w=15
  2834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features may be bilateral (15/24) or left side (9/24)
    n1=Hyde (prurigo nodulaire de) | n2=en:features may be bilateral (15/24) or left side (9/24) | rel=r_associated | relid=0 | w=15
  2835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features occur episodically
    n1=Hyde (prurigo nodulaire de) | n2=en:features occur episodically | rel=r_associated | relid=0 | w=15
  2836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features of aho may rarely be observed, including brachydactyly, short metacarpals, and obesity (see 103580)
    n1=Hyde (prurigo nodulaire de) | n2=en:features of aho may rarely be observed, including brachydactyly, short metacarpals, and obesity (see 103580) | rel=r_associated | relid=0 | w=15
  2837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features of pseudoxanthoma elasticum seen in later childhood in some surviving patients
    n1=Hyde (prurigo nodulaire de) | n2=en:features of pseudoxanthoma elasticum seen in later childhood in some surviving patients | rel=r_associated | relid=0 | w=15
  2838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:features usually appear during adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:features usually appear during adulthood | rel=r_associated | relid=0 | w=15
  2839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:febrile attacks disappear in adulthood in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:febrile attacks disappear in adulthood in some patients | rel=r_associated | relid=0 | w=15
  2840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:febrile crises decrease with age, with ataxia becoming the predominant symptom (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:febrile crises decrease with age, with ataxia becoming the predominant symptom (in some patients) | rel=r_associated | relid=0 | w=15
  2841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:febrile illness may precipitate attacks of weakness
    n1=Hyde (prurigo nodulaire de) | n2=en:febrile illness may precipitate attacks of weakness | rel=r_associated | relid=0 | w=15
  2842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:febrile seizures remit by age 5 or 6
    n1=Hyde (prurigo nodulaire de) | n2=en:febrile seizures remit by age 5 or 6 | rel=r_associated | relid=0 | w=15
  2843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:febrile seizures show onset between 6 months and 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:febrile seizures show onset between 6 months and 3 years | rel=r_associated | relid=0 | w=15
  2844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:feeding difficulties in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:feeding difficulties in infancy | rel=r_associated | relid=0 | w=15
  2845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:feeding difficulties, including aspiration, ameliorate with age
    n1=Hyde (prurigo nodulaire de) | n2=en:feeding difficulties, including aspiration, ameliorate with age | rel=r_associated | relid=0 | w=15
  2846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:feet are unaffected
    n1=Hyde (prurigo nodulaire de) | n2=en:feet are unaffected | rel=r_associated | relid=0 | w=15
  2847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:feet are unaffected in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:feet are unaffected in some patients | rel=r_associated | relid=0 | w=15
  2848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:feingold syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:feingold syndrome | rel=r_associated | relid=0 | w=15
  2849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers are unaffected or show neuropsychiatric features
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers are unaffected or show neuropsychiatric features | rel=r_associated | relid=0 | w=15
  2850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers experience significant clinical manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers experience significant clinical manifestations | rel=r_associated | relid=0 | w=15
  2851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may be affected
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may be affected | rel=r_associated | relid=0 | w=15
  2852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may be less severely affected
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may be less severely affected | rel=r_associated | relid=0 | w=15
  2853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may be mildly affected
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may be mildly affected | rel=r_associated | relid=0 | w=15
  2854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may develop mild hearing loss as adults
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may develop mild hearing loss as adults | rel=r_associated | relid=0 | w=15
  2855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have asymptomatic hypercalciuria or hypophosphatemia only | rel=r_associated | relid=0 | w=15
  2856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have asymptomatic proteinuria or hypercalciuria
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have asymptomatic proteinuria or hypercalciuria | rel=r_associated | relid=0 | w=15
  2857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have asymptomatic proteinuria, hypercalciuria, or hypophosphatemia only
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have asymptomatic proteinuria, hypercalciuria, or hypophosphatemia only | rel=r_associated | relid=0 | w=15
  2858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have cardiac defects
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have cardiac defects | rel=r_associated | relid=0 | w=15
  2859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have hearing loss | rel=r_associated | relid=0 | w=15
  2860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have mild hearing impairment
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have mild hearing impairment | rel=r_associated | relid=0 | w=15
  2861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have mild hearing impairment and/or mild signs of choroideremia
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have mild hearing impairment and/or mild signs of choroideremia | rel=r_associated | relid=0 | w=15
  2862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have mild mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have mild mental retardation | rel=r_associated | relid=0 | w=15
  2863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have short stature and premature ovarian failure
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have short stature and premature ovarian failure | rel=r_associated | relid=0 | w=15
  2864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may have subtle manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may have subtle manifestations | rel=r_associated | relid=0 | w=15
  2865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may show intermittent hematuria
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may show intermittent hematuria | rel=r_associated | relid=0 | w=15
  2866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may show mild learning disabilities
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may show mild learning disabilities | rel=r_associated | relid=0 | w=15
  2867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female carriers may show some manifestations, such as hearing impairment
    n1=Hyde (prurigo nodulaire de) | n2=en:female carriers may show some manifestations, such as hearing impairment | rel=r_associated | relid=0 | w=15
  2868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female mutation carriers have earlier age at onset compared to male mutation carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:female mutation carriers have earlier age at onset compared to male mutation carriers | rel=r_associated | relid=0 | w=15
  2869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female mutations carriers have a milder phenotype, with myalgia, calf hypertrophy, or isolated increased serum creatine kinase
    n1=Hyde (prurigo nodulaire de) | n2=en:female mutations carriers have a milder phenotype, with myalgia, calf hypertrophy, or isolated increased serum creatine kinase | rel=r_associated | relid=0 | w=15
  2870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female predominance (4:1)
    n1=Hyde (prurigo nodulaire de) | n2=en:female predominance (4:1) | rel=r_associated | relid=0 | w=15
  2871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female preponderance
    n1=Hyde (prurigo nodulaire de) | n2=en:female preponderance | rel=r_associated | relid=0 | w=15
  2872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female reproductive system disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:female reproductive system disorder | rel=r_associated | relid=0 | w=15
  2873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female to male ratio 5:1
    n1=Hyde (prurigo nodulaire de) | n2=en:female to male ratio 5:1 | rel=r_associated | relid=0 | w=15
  2874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female to male ratio 8-13:1
    n1=Hyde (prurigo nodulaire de) | n2=en:female to male ratio 8-13:1 | rel=r_associated | relid=0 | w=15
  2875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female to male ratio ranges from 2:1 to 4:1
    n1=Hyde (prurigo nodulaire de) | n2=en:female to male ratio ranges from 2:1 to 4:1 | rel=r_associated | relid=0 | w=15
  2876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:female to male ratio, 1:1
    n1=Hyde (prurigo nodulaire de) | n2=en:female to male ratio, 1:1 | rel=r_associated | relid=0 | w=15
  2877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females are more often affected
    n1=Hyde (prurigo nodulaire de) | n2=en:females are more often affected | rel=r_associated | relid=0 | w=15
  2878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females are most often affected, but rare male cases have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:females are most often affected, but rare male cases have been reported | rel=r_associated | relid=0 | w=15
  2879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females carriers have more variable age at onset and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:females carriers have more variable age at onset and severity | rel=r_associated | relid=0 | w=15
  2880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females demonstrate lyonization with corresponding phenotypic variation
    n1=Hyde (prurigo nodulaire de) | n2=en:females demonstrate lyonization with corresponding phenotypic variation | rel=r_associated | relid=0 | w=15
  2881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females have milder manifestations than males
    n1=Hyde (prurigo nodulaire de) | n2=en:females have milder manifestations than males | rel=r_associated | relid=0 | w=15
  2882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females may be unaffected or mildly affected
    n1=Hyde (prurigo nodulaire de) | n2=en:females may be unaffected or mildly affected | rel=r_associated | relid=0 | w=15
  2883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females more severely affected than males
    n1=Hyde (prurigo nodulaire de) | n2=en:females more severely affected than males | rel=r_associated | relid=0 | w=15
  2884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females often show milder phenotype with later onset of cardiac symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:females often show milder phenotype with later onset of cardiac symptoms | rel=r_associated | relid=0 | w=15
  2885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:females tend to have earlier onset
    n1=Hyde (prurigo nodulaire de) | n2=en:females tend to have earlier onset | rel=r_associated | relid=0 | w=15
  2886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal akinesia deformation sequence
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal akinesia deformation sequence | rel=r_associated | relid=0 | w=15
  2887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal anuria
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal anuria | rel=r_associated | relid=0 | w=15
  2888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal ascites
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal ascites | rel=r_associated | relid=0 | w=15
  2889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal death usually occurs
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal death usually occurs | rel=r_associated | relid=0 | w=15
  2890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal disorder | rel=r_associated | relid=0 | w=15
  2891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal hydrops (in perinatal or congenital neuromuscular forms)
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal hydrops (in perinatal or congenital neuromuscular forms) | rel=r_associated | relid=0 | w=15
  2892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal pleural effusion
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal pleural effusion | rel=r_associated | relid=0 | w=15
  2893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetal polyuria
    n1=Hyde (prurigo nodulaire de) | n2=en:fetal polyuria | rel=r_associated | relid=0 | w=15
  2894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fetus or newborn affected by polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:fetus or newborn affected by polyhydramnios | rel=r_associated | relid=0 | w=15
  2895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fever of unknown origin
    n1=Hyde (prurigo nodulaire de) | n2=en:fever of unknown origin | rel=r_associated | relid=0 | w=15
  2896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fever, muscle cramping, and poor feeding remit by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:fever, muscle cramping, and poor feeding remit by age 2 years | rel=r_associated | relid=0 | w=15
  2897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:few familial (parent offspring) cases reported
    n1=Hyde (prurigo nodulaire de) | n2=en:few familial (parent offspring) cases reported | rel=r_associated | relid=0 | w=15
  2898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:few patients with mild to moderate mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:few patients with mild to moderate mental retardation | rel=r_associated | relid=0 | w=15
  2899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ficain
    n1=Hyde (prurigo nodulaire de) | n2=en:ficain | rel=r_associated | relid=0 | w=15
  2900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fifty percent of cases are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:fifty percent of cases are sporadic | rel=r_associated | relid=0 | w=15
  2901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fifty percent of cases secondary to new mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:fifty percent of cases secondary to new mutations | rel=r_associated | relid=0 | w=15
  2902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fifty-percent of individuals responsive to pyridoxine (vitamin b6)
    n1=Hyde (prurigo nodulaire de) | n2=en:fifty-percent of individuals responsive to pyridoxine (vitamin b6) | rel=r_associated | relid=0 | w=15
  2903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:figure associated with report or note:-:point in time:^patient:-
    n1=Hyde (prurigo nodulaire de) | n2=en:figure associated with report or note:-:point in time:^patient:- | rel=r_associated | relid=0 | w=15
  2904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:finding of number of membranes
    n1=Hyde (prurigo nodulaire de) | n2=en:finding of number of membranes | rel=r_associated | relid=0 | w=15
  2905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:findings in muscle biopsy may be variable
    n1=Hyde (prurigo nodulaire de) | n2=en:findings in muscle biopsy may be variable | rel=r_associated | relid=0 | w=15
  2906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:first described in acadian population of louisiana
    n1=Hyde (prurigo nodulaire de) | n2=en:first described in acadian population of louisiana | rel=r_associated | relid=0 | w=15
  2907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:first described in gypsy group from bulgaria
    n1=Hyde (prurigo nodulaire de) | n2=en:first described in gypsy group from bulgaria | rel=r_associated | relid=0 | w=15
  2908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:first described in the geographically isolated saguenay-lac-saint-jean region of quebec, canada
    n1=Hyde (prurigo nodulaire de) | n2=en:first described in the geographically isolated saguenay-lac-saint-jean region of quebec, canada | rel=r_associated | relid=0 | w=15
  2909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:first identified in individuals of cypriot origin
    n1=Hyde (prurigo nodulaire de) | n2=en:first identified in individuals of cypriot origin | rel=r_associated | relid=0 | w=15
  2910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:first name:pn:pt:^guardian or legally authorized representative:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:first name:pn:pt:^guardian or legally authorized representative:nom | rel=r_associated | relid=0 | w=15
  2911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fish can be used to detect deletions of 4p16.3, the critical region for the phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:fish can be used to detect deletions of 4p16.3, the critical region for the phenotype | rel=r_associated | relid=0 | w=15
  2912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fishy body odor
    n1=Hyde (prurigo nodulaire de) | n2=en:fishy body odor | rel=r_associated | relid=0 | w=15
  2913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five clinical variants of msud unassociated with genotype
    n1=Hyde (prurigo nodulaire de) | n2=en:five clinical variants of msud unassociated with genotype | rel=r_associated | relid=0 | w=15
  2914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five patients have been reported (as of 8/2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:five patients have been reported (as of 8/2011) | rel=r_associated | relid=0 | w=15
  2915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five patients have been reported (as of april 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:five patients have been reported (as of april 2011) | rel=r_associated | relid=0 | w=15
  2916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five patients have been reported (as of june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:five patients have been reported (as of june 2011) | rel=r_associated | relid=0 | w=15
  2917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five patients have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:five patients have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  2918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five patients reported (as of march 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:five patients reported (as of march 2009) | rel=r_associated | relid=0 | w=15
  2919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five reported patients, all boys (as of july 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:five reported patients, all boys (as of july 2009) | rel=r_associated | relid=0 | w=15
  2920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five unrelated cases have been reported (as of march 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:five unrelated cases have been reported (as of march 2012) | rel=r_associated | relid=0 | w=15
  2921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five unrelated patients have been reported (as of december 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:five unrelated patients have been reported (as of december 2009) | rel=r_associated | relid=0 | w=15
  2922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five unrelated patients have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:five unrelated patients have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  2923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:five unrelated patients have been reported (nov. 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:five unrelated patients have been reported (nov. 2009) | rel=r_associated | relid=0 | w=15
  2924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:flares triggered by viral infection, overexertion, stress
    n1=Hyde (prurigo nodulaire de) | n2=en:flares triggered by viral infection, overexertion, stress | rel=r_associated | relid=0 | w=15
  2925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:flavirin
    n1=Hyde (prurigo nodulaire de) | n2=en:flavirin | rel=r_associated | relid=0 | w=15
  2926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:flow cytometry specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:flow cytometry specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  2927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fluid and electrolyte balance
    n1=Hyde (prurigo nodulaire de) | n2=en:fluid and electrolyte balance | rel=r_associated | relid=0 | w=15
  2928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:flunarizine treatment may be beneficial
    n1=Hyde (prurigo nodulaire de) | n2=en:flunarizine treatment may be beneficial | rel=r_associated | relid=0 | w=15
  2929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fluorescein isothiocyanate
    n1=Hyde (prurigo nodulaire de) | n2=en:fluorescein isothiocyanate | rel=r_associated | relid=0 | w=15
  2930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fluoxetine therapy is effective
    n1=Hyde (prurigo nodulaire de) | n2=en:fluoxetine therapy is effective | rel=r_associated | relid=0 | w=15
  2931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:focal or segmental onset in cranial-cervical area or upper limbs
    n1=Hyde (prurigo nodulaire de) | n2=en:focal or segmental onset in cranial-cervical area or upper limbs | rel=r_associated | relid=0 | w=15
  2932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:folic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:folic acid | rel=r_associated | relid=0 | w=15
  2933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:folic acid + pyridoxine + cyanocobalamin
    n1=Hyde (prurigo nodulaire de) | n2=en:folic acid + pyridoxine + cyanocobalamin | rel=r_associated | relid=0 | w=15
  2934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:following fever in infancy, muscular weakness and poor growth
    n1=Hyde (prurigo nodulaire de) | n2=en:following fever in infancy, muscular weakness and poor growth | rel=r_associated | relid=0 | w=15
  2935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food allergy
    n1=Hyde (prurigo nodulaire de) | n2=en:food allergy | rel=r_associated | relid=0 | w=15
  2936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food and nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:food and nutrition | rel=r_associated | relid=0 | w=15
  2937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food intolerance
    n1=Hyde (prurigo nodulaire de) | n2=en:food intolerance | rel=r_associated | relid=0 | w=15
  2938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food labeling
    n1=Hyde (prurigo nodulaire de) | n2=en:food labeling | rel=r_associated | relid=0 | w=15
  2939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food related behavioral problems include excessive appetite and obsession with eating
    n1=Hyde (prurigo nodulaire de) | n2=en:food related behavioral problems include excessive appetite and obsession with eating | rel=r_associated | relid=0 | w=15
  2940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:food safety
    n1=Hyde (prurigo nodulaire de) | n2=en:food safety | rel=r_associated | relid=0 | w=15
  2941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:foodborne disease
    n1=Hyde (prurigo nodulaire de) | n2=en:foodborne disease | rel=r_associated | relid=0 | w=15
  2942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:foot deformities are present in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:foot deformities are present in infancy or childhood | rel=r_associated | relid=0 | w=15
  2943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:foot dragging may appear in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:foot dragging may appear in childhood | rel=r_associated | relid=0 | w=15
  2944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:for a similar phenotype with genital anomalies and disordered steroidogenesis see por deficiency (201750)
    n1=Hyde (prurigo nodulaire de) | n2=en:for a similar phenotype with genital anomalies and disordered steroidogenesis see por deficiency (201750) | rel=r_associated | relid=0 | w=15
  2945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:for autosomal dominant forms of axonal neuropathy, see cmt2a (118210)
    n1=Hyde (prurigo nodulaire de) | n2=en:for autosomal dominant forms of axonal neuropathy, see cmt2a (118210) | rel=r_associated | relid=0 | w=15
  2946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:for autosomal recessive forms, see cmt2b1 605588 and cmt2b2 605589
    n1=Hyde (prurigo nodulaire de) | n2=en:for autosomal recessive forms, see cmt2b1 605588 and cmt2b2 605589 | rel=r_associated | relid=0 | w=15
  2947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:for similar autosomal dominant form, see 162350
    n1=Hyde (prurigo nodulaire de) | n2=en:for similar autosomal dominant form, see 162350 | rel=r_associated | relid=0 | w=15
  2948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:for similar autosomal recessive form, see cln4 (204300)
    n1=Hyde (prurigo nodulaire de) | n2=en:for similar autosomal recessive form, see cln4 (204300) | rel=r_associated | relid=0 | w=15
  2949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:forewater
    n1=Hyde (prurigo nodulaire de) | n2=en:forewater | rel=r_associated | relid=0 | w=15
  2950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:formamidopyrimidine-dna glycosylase
    n1=Hyde (prurigo nodulaire de) | n2=en:formamidopyrimidine-dna glycosylase | rel=r_associated | relid=0 | w=15
  2951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:formiminoglutamate deiminase
    n1=Hyde (prurigo nodulaire de) | n2=en:formiminoglutamate deiminase | rel=r_associated | relid=0 | w=15
  2952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:formose sugars
    n1=Hyde (prurigo nodulaire de) | n2=en:formose sugars | rel=r_associated | relid=0 | w=15
  2953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:formylaspartate deformylase
    n1=Hyde (prurigo nodulaire de) | n2=en:formylaspartate deformylase | rel=r_associated | relid=0 | w=15
  2954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:formyltetrahydrofolate deformylase
    n1=Hyde (prurigo nodulaire de) | n2=en:formyltetrahydrofolate deformylase | rel=r_associated | relid=0 | w=15
  2955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:forty percent of patients die in the first year
    n1=Hyde (prurigo nodulaire de) | n2=en:forty percent of patients die in the first year | rel=r_associated | relid=0 | w=15
  2956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:found predominantly in the amish population
    n1=Hyde (prurigo nodulaire de) | n2=en:found predominantly in the amish population | rel=r_associated | relid=0 | w=15
  2957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:founder effect in irish traveler population
    n1=Hyde (prurigo nodulaire de) | n2=en:founder effect in irish traveler population | rel=r_associated | relid=0 | w=15
  2958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:founder effect in turkish families
    n1=Hyde (prurigo nodulaire de) | n2=en:founder effect in turkish families | rel=r_associated | relid=0 | w=15
  2959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four cases have been reported, all female
    n1=Hyde (prurigo nodulaire de) | n2=en:four cases have been reported, all female | rel=r_associated | relid=0 | w=15
  2960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four clinical forms of krabbe disease
    n1=Hyde (prurigo nodulaire de) | n2=en:four clinical forms of krabbe disease | rel=r_associated | relid=0 | w=15
  2961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four clinical stages - stage i, early onset stagnation (onset 6 months-1.5 year)
    n1=Hyde (prurigo nodulaire de) | n2=en:four clinical stages - stage i, early onset stagnation (onset 6 months-1.5 year) | rel=r_associated | relid=0 | w=15
  2962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four clinically indistinguishable biochemically distinct forms
    n1=Hyde (prurigo nodulaire de) | n2=en:four clinically indistinguishable biochemically distinct forms | rel=r_associated | relid=0 | w=15
  2963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930)
    n1=Hyde (prurigo nodulaire de) | n2=en:four clinically indistinguishable biochemically distinct forms (see 252900, 252920, 252930) | rel=r_associated | relid=0 | w=15
  2964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four clinically indistinguishable biochemically distinct forms (see, e.g., type iiia, 252900)
    n1=Hyde (prurigo nodulaire de) | n2=en:four clinically indistinguishable biochemically distinct forms (see, e.g., type iiia, 252900) | rel=r_associated | relid=0 | w=15
  2965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four families have been reported (last curated june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:four families have been reported (last curated june 2011) | rel=r_associated | relid=0 | w=15
  2966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four families have been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:four families have been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  2967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four individual patients and 1 saudi family have been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:four individual patients and 1 saudi family have been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  2968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four major groups: early infantile, late infantile, juvenile, adult
    n1=Hyde (prurigo nodulaire de) | n2=en:four major groups: early infantile, late infantile, juvenile, adult | rel=r_associated | relid=0 | w=15
  2969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 2 unrelated families have been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 2 unrelated families have been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  2970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 3 families have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 3 families have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  2971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 3 families have been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 3 families have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  2972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 3 families have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 3 families have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  2973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 3 families have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 3 families have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  2974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients from 3 unrelated families have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients from 3 unrelated families have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  2975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients have been reported | rel=r_associated | relid=0 | w=15
  2976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients have been reported (as of december 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients have been reported (as of december 2009) | rel=r_associated | relid=0 | w=15
  2977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients have been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients have been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  2978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients have been reported (last curated june 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients have been reported (last curated june 2013) | rel=r_associated | relid=0 | w=15
  2979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients have been reported from pakistan (as of march 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients have been reported from pakistan (as of march 2011) | rel=r_associated | relid=0 | w=15
  2980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients of canadian cree origin and 1 patient of turkish origin have been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients of canadian cree origin and 1 patient of turkish origin have been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  2981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four patients reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:four patients reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  2982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form
    n1=Hyde (prurigo nodulaire de) | n2=en:four separate types - (1) severe perinatal ('lethal') form, (2) severe infantile form, (3) childhood form, and (4) adult form | rel=r_associated | relid=0 | w=15
  2983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four types of cgd with basically identical clinical phenotypes
    n1=Hyde (prurigo nodulaire de) | n2=en:four types of cgd with basically identical clinical phenotypes | rel=r_associated | relid=0 | w=15
  2984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four types of opll - segmental (39%), continuous (27%), mixed (29%), other (5%)
    n1=Hyde (prurigo nodulaire de) | n2=en:four types of opll - segmental (39%), continuous (27%), mixed (29%), other (5%) | rel=r_associated | relid=0 | w=15
  2985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated families have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated families have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  2986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated families of caucasian european descent have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated families of caucasian european descent have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  2987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated infants with the disorder and decreased expression of csf2rb in cells have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated infants with the disorder and decreased expression of csf2rb in cells have been reported | rel=r_associated | relid=0 | w=15
  2988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated patients have been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated patients have been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  2989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated patients have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated patients have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  2990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated patients have been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated patients have been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  2991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:four unrelated patients with zswim6 mutations have been described (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:four unrelated patients with zswim6 mutations have been described (last curated september 2014) | rel=r_associated | relid=0 | w=15
  2992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fracture frequency constant through childhood, decreases after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:fracture frequency constant through childhood, decreases after puberty | rel=r_associated | relid=0 | w=15
  2993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fracture frequency decreased post puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:fracture frequency decreased post puberty | rel=r_associated | relid=0 | w=15
  2994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fracture frequency increases after menopause and in men ages 60-80
    n1=Hyde (prurigo nodulaire de) | n2=en:fracture frequency increases after menopause and in men ages 60-80 | rel=r_associated | relid=0 | w=15
  2995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fractures and dental caries and premature secondary tooth loss occur in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:fractures and dental caries and premature secondary tooth loss occur in adulthood | rel=r_associated | relid=0 | w=15
  2996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fractures can occur in utero, during labor and delivery, or in newborn period
    n1=Hyde (prurigo nodulaire de) | n2=en:fractures can occur in utero, during labor and delivery, or in newborn period | rel=r_associated | relid=0 | w=15
  2997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fractures decrease after puberty but increase after menopause
    n1=Hyde (prurigo nodulaire de) | n2=en:fractures decrease after puberty but increase after menopause | rel=r_associated | relid=0 | w=15
  2998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fractures occur in first few months, then decrease in frequency and then occur with ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:fractures occur in first few months, then decrease in frequency and then occur with ambulation | rel=r_associated | relid=0 | w=15
  2999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fractures often heal without deformity
    n1=Hyde (prurigo nodulaire de) | n2=en:fractures often heal without deformity | rel=r_associated | relid=0 | w=15
  3000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frangula purshiana bark
    n1=Hyde (prurigo nodulaire de) | n2=en:frangula purshiana bark | rel=r_associated | relid=0 | w=15
  3001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency 1/100,000 - 1/130,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency 1/100,000 - 1/130,000 live births | rel=r_associated | relid=0 | w=15
  3002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency and severity of seizures tends to decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency and severity of seizures tends to decrease with age | rel=r_associated | relid=0 | w=15
  3003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency and severity of symptoms do not worsen with age
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency and severity of symptoms do not worsen with age | rel=r_associated | relid=0 | w=15
  3004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency between 1 in 58,000 to 1 in 1,000,000
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency between 1 in 58,000 to 1 in 1,000,000 | rel=r_associated | relid=0 | w=15
  3005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency increases with advancing age
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency increases with advancing age | rel=r_associated | relid=0 | w=15
  3006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency of attack, monthly - bimonthly
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency of attack, monthly - bimonthly | rel=r_associated | relid=0 | w=15
  3007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency of attacks may decrease with age or during pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency of attacks may decrease with age or during pregnancy | rel=r_associated | relid=0 | w=15
  3008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency of episodes ranges from several per week to several per year
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency of episodes ranges from several per week to several per year | rel=r_associated | relid=0 | w=15
  3009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequency of infections decreases after 3 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:frequency of infections decreases after 3 years of age | rel=r_associated | relid=0 | w=15
  3010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequent falls
    n1=Hyde (prurigo nodulaire de) | n2=en:frequent falls | rel=r_associated | relid=0 | w=15
  3011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequent neonatal sudden death
    n1=Hyde (prurigo nodulaire de) | n2=en:frequent neonatal sudden death | rel=r_associated | relid=0 | w=15
  3012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequent new mutations (~60%) and/or gonadal mosaicism in tsc2
    n1=Hyde (prurigo nodulaire de) | n2=en:frequent new mutations (~60%) and/or gonadal mosaicism in tsc2 | rel=r_associated | relid=0 | w=15
  3013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequent new mutations (~86%) and/or gonadal mosaicism in tsc1
    n1=Hyde (prurigo nodulaire de) | n2=en:frequent new mutations (~86%) and/or gonadal mosaicism in tsc1 | rel=r_associated | relid=0 | w=15
  3014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequently death in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:frequently death in infancy | rel=r_associated | relid=0 | w=15
  3015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequently fatal within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:frequently fatal within the first year of life | rel=r_associated | relid=0 | w=15
  3016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frequently occurs in navajo children, especially in western reservations
    n1=Hyde (prurigo nodulaire de) | n2=en:frequently occurs in navajo children, especially in western reservations | rel=r_associated | relid=0 | w=15
  3017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:frontometaphyseal dysplasia (fmd, 305620) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:frontometaphyseal dysplasia (fmd, 305620) is an allelic disorder | rel=r_associated | relid=0 | w=15
  3018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fructan beta-fructosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:fructan beta-fructosidase | rel=r_associated | relid=0 | w=15
  3019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fructose
    n1=Hyde (prurigo nodulaire de) | n2=en:fructose | rel=r_associated | relid=0 | w=15
  3020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fruit bromelain
    n1=Hyde (prurigo nodulaire de) | n2=en:fruit bromelain | rel=r_associated | relid=0 | w=15
  3021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fucosidases
    n1=Hyde (prurigo nodulaire de) | n2=en:fucosidases | rel=r_associated | relid=0 | w=15
  3022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:full mutations with expanded trinucleotide repeats greater than 200 result in fragile x mental retardation syndrome (300624)
    n1=Hyde (prurigo nodulaire de) | n2=en:full mutations with expanded trinucleotide repeats greater than 200 result in fragile x mental retardation syndrome (300624) | rel=r_associated | relid=0 | w=15
  3023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:full recovery after attacks
    n1=Hyde (prurigo nodulaire de) | n2=en:full recovery after attacks | rel=r_associated | relid=0 | w=15
  3024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:fullerene
    n1=Hyde (prurigo nodulaire de) | n2=en:fullerene | rel=r_associated | relid=0 | w=15
  3025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:furin
    n1=Hyde (prurigo nodulaire de) | n2=en:furin | rel=r_associated | relid=0 | w=15
  3026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:g/t mismatch-specific thymine dna glycosylase
    n1=Hyde (prurigo nodulaire de) | n2=en:g/t mismatch-specific thymine dna glycosylase | rel=r_associated | relid=0 | w=15
  3027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gabonase
    n1=Hyde (prurigo nodulaire de) | n2=en:gabonase | rel=r_associated | relid=0 | w=15
  3028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gadopentetate dimeglumine
    n1=Hyde (prurigo nodulaire de) | n2=en:gadopentetate dimeglumine | rel=r_associated | relid=0 | w=15
  3029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gait difficulties and beginning of cognitive decline in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:gait difficulties and beginning of cognitive decline in first decade | rel=r_associated | relid=0 | w=15
  3030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gait disturbance
    n1=Hyde (prurigo nodulaire de) | n2=en:gait disturbance | rel=r_associated | relid=0 | w=15
  3031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:galactosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:galactosidase | rel=r_associated | relid=0 | w=15
  3032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gamma-d-glutamyl-meso-diaminopimelate peptidase i
    n1=Hyde (prurigo nodulaire de) | n2=en:gamma-d-glutamyl-meso-diaminopimelate peptidase i | rel=r_associated | relid=0 | w=15
  3033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gapo is acronym for growth retardation, alopecia, pseudoanodontia, optic atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:gapo is acronym for growth retardation, alopecia, pseudoanodontia, optic atrophy | rel=r_associated | relid=0 | w=15
  3034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gastric suction pump, home model, portable or stationary, electric
    n1=Hyde (prurigo nodulaire de) | n2=en:gastric suction pump, home model, portable or stationary, electric | rel=r_associated | relid=0 | w=15
  3035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gastrointestinal anomalies are not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:gastrointestinal anomalies are not always present | rel=r_associated | relid=0 | w=15
  3036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gaucher disease, perinatal lethal
    n1=Hyde (prurigo nodulaire de) | n2=en:gaucher disease, perinatal lethal | rel=r_associated | relid=0 | w=15
  3037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gdpglucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:gdpglucosidase | rel=r_associated | relid=0 | w=15
  3038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gei (gene-environment interaction) - association of cardiac events with drug administration
    n1=Hyde (prurigo nodulaire de) | n2=en:gei (gene-environment interaction) - association of cardiac events with drug administration | rel=r_associated | relid=0 | w=15
  3039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gene frequency in northwest puerto rico 1 in 18
    n1=Hyde (prurigo nodulaire de) | n2=en:gene frequency in northwest puerto rico 1 in 18 | rel=r_associated | relid=0 | w=15
  3040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generalized dystonia in some cases
    n1=Hyde (prurigo nodulaire de) | n2=en:generalized dystonia in some cases | rel=r_associated | relid=0 | w=15
  3041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generalized fatigue
    n1=Hyde (prurigo nodulaire de) | n2=en:generalized fatigue | rel=r_associated | relid=0 | w=15
  3042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generally benign disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:generally benign disorder | rel=r_associated | relid=0 | w=15
  3043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generally considered to be a benign disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:generally considered to be a benign disorder | rel=r_associated | relid=0 | w=15
  3044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generally mild phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:generally mild phenotype | rel=r_associated | relid=0 | w=15
  3045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:generally static disease course
    n1=Hyde (prurigo nodulaire de) | n2=en:generally static disease course | rel=r_associated | relid=0 | w=15
  3046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic anticipation
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic anticipation | rel=r_associated | relid=0 | w=15
  3047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic anticipation associated with progressive telomere shortening
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic anticipation associated with progressive telomere shortening | rel=r_associated | relid=0 | w=15
  3048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic anticipation has been observed
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic anticipation has been observed | rel=r_associated | relid=0 | w=15
  3049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic anticipation occurs
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic anticipation occurs | rel=r_associated | relid=0 | w=15
  3050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity | rel=r_associated | relid=0 | w=15
  3051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (autosomal recessive form 224900 and autosomal dominant form 129490)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (autosomal recessive form 224900 and autosomal dominant form 129490) | rel=r_associated | relid=0 | w=15
  3052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (bor2, 610896)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (bor2, 610896) | rel=r_associated | relid=0 | w=15
  3053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (ccm2 603284, ccm3 603285)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (ccm2 603284, ccm3 603285) | rel=r_associated | relid=0 | w=15
  3054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) | rel=r_associated | relid=0 | w=15
  3055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 116800 for summary)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 116800 for summary) | rel=r_associated | relid=0 | w=15
  3056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 125800)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 125800) | rel=r_associated | relid=0 | w=15
  3057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 145410)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 145410) | rel=r_associated | relid=0 | w=15
  3058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 157640)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 157640) | rel=r_associated | relid=0 | w=15
  3059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 159900)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 159900) | rel=r_associated | relid=0 | w=15
  3060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 161400)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 161400) | rel=r_associated | relid=0 | w=15
  3061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 161800)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 161800) | rel=r_associated | relid=0 | w=15
  3062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 166600)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 166600) | rel=r_associated | relid=0 | w=15
  3063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 191100)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 191100) | rel=r_associated | relid=0 | w=15
  3064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 192600)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 192600) | rel=r_associated | relid=0 | w=15
  3065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 209850)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 209850) | rel=r_associated | relid=0 | w=15
  3066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 213300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 213300) | rel=r_associated | relid=0 | w=15
  3067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 214300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 214300) | rel=r_associated | relid=0 | w=15
  3068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 259700)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 259700) | rel=r_associated | relid=0 | w=15
  3069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 266900 for summary)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 266900 for summary) | rel=r_associated | relid=0 | w=15
  3070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 304800)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 304800) | rel=r_associated | relid=0 | w=15
  3071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 601680)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 601680) | rel=r_associated | relid=0 | w=15
  3072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 604559)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 604559) | rel=r_associated | relid=0 | w=15
  3073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 605407)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 605407) | rel=r_associated | relid=0 | w=15
  3074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 606215)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 606215) | rel=r_associated | relid=0 | w=15
  3075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 607634)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 607634) | rel=r_associated | relid=0 | w=15
  3076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 608638)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 608638) | rel=r_associated | relid=0 | w=15
  3077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 609192)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 609192) | rel=r_associated | relid=0 | w=15
  3078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 610168)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 610168) | rel=r_associated | relid=0 | w=15
  3079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see 613254)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see 613254) | rel=r_associated | relid=0 | w=15
  3080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see antenatal bartter syndrome type 1, 601678)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see antenatal bartter syndrome type 1, 601678) | rel=r_associated | relid=0 | w=15
  3081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see antenatal bartter syndrome type 2, 241200)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see antenatal bartter syndrome type 2, 241200) | rel=r_associated | relid=0 | w=15
  3082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see bafme1, 601068)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see bafme1, 601068) | rel=r_associated | relid=0 | w=15
  3083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see bafme2, 607876)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see bafme2, 607876) | rel=r_associated | relid=0 | w=15
  3084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see bfic2, 605751)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see bfic2, 605751) | rel=r_associated | relid=0 | w=15
  3085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see bscl1, 608594)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see bscl1, 608594) | rel=r_associated | relid=0 | w=15
  3086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see bscl2, 269700)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see bscl2, 269700) | rel=r_associated | relid=0 | w=15
  3087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cftd1, 255310)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cftd1, 255310) | rel=r_associated | relid=0 | w=15
  3088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cms1a1, 605809)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cms1a1, 605809) | rel=r_associated | relid=0 | w=15
  3089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cms1a2, 254210)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cms1a2, 254210) | rel=r_associated | relid=0 | w=15
  3090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt1a 118220, cmt1c 601098, cmt1d 607678, cmt1f 607734)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt1a 118220, cmt1c 601098, cmt1d 607678, cmt1f 607734) | rel=r_associated | relid=0 | w=15
  3091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt1b 118200)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt1b 118200) | rel=r_associated | relid=0 | w=15
  3092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt2a 118210)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt2a 118210) | rel=r_associated | relid=0 | w=15
  3093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt2a2 609260, cmt2b 600882, cmt2c 606071, cmt2d 601472, cmt2e 607684, cmt2f 606595, cmt2i 607677)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt2a2 609260, cmt2b 600882, cmt2c 606071, cmt2d 601472, cmt2e 607684, cmt2f 606595, cmt2i 607677) | rel=r_associated | relid=0 | w=15
  3094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt2b2, 605589)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt2b2, 605589) | rel=r_associated | relid=0 | w=15
  3095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt4a 214400)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt4a 214400) | rel=r_associated | relid=0 | w=15
  3096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt4b1, 601382)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt4b1, 601382) | rel=r_associated | relid=0 | w=15
  3097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmt4b2, 604563)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmt4b2, 604563) | rel=r_associated | relid=0 | w=15
  3098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cmtdia 606483)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cmtdia 606483) | rel=r_associated | relid=0 | w=15
  3099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see cnc2, 605244)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see cnc2, 605244) | rel=r_associated | relid=0 | w=15
  3100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see coxpd1, 609060)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see coxpd1, 609060) | rel=r_associated | relid=0 | w=15
  3101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see ebn2 121201, ebn3 608217)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see ebn2 121201, ebn3 608217) | rel=r_associated | relid=0 | w=15
  3102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see eca1, 600131 and eca3, 607682)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see eca1, 600131 and eca3, 607682) | rel=r_associated | relid=0 | w=15
  3103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see edm1 132400, edm2 600204, edm3 600969, edm4 226900)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see edm1 132400, edm2 600204, edm3 600969, edm4 226900) | rel=r_associated | relid=0 | w=15
  3104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see edm1 132400, edm2 600204, edm4 226900, edm5 607078)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see edm1 132400, edm2 600204, edm4 226900, edm5 607078) | rel=r_associated | relid=0 | w=15
  3105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see edm1 132400, edm3 600969, edm4 226900, edm5 607078)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see edm1 132400, edm3 600969, edm4 226900, edm5 607078) | rel=r_associated | relid=0 | w=15
  3106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see edm2 600204, edm3 600969, edm4 226900, edm5 607078)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see edm2 600204, edm3 600969, edm4 226900, edm5 607078) | rel=r_associated | relid=0 | w=15
  3107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see enfl1, 600513)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see enfl1, 600513) | rel=r_associated | relid=0 | w=15
  3108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see etl2, 608096)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see etl2, 608096) | rel=r_associated | relid=0 | w=15
  3109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see feb1 121210)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see feb1 121210) | rel=r_associated | relid=0 | w=15
  3110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see fhm1 141500 and mgr6 607516)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see fhm1 141500 and mgr6 607516) | rel=r_associated | relid=0 | w=15
  3111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see gefs+, 604233)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see gefs+, 604233) | rel=r_associated | relid=0 | w=15
  3112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see hcfp1, 601471)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see hcfp1, 601471) | rel=r_associated | relid=0 | w=15
  3113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see hcfp2, 604185)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see hcfp2, 604185) | rel=r_associated | relid=0 | w=15
  3114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see hhf1 256450)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see hhf1 256450) | rel=r_associated | relid=0 | w=15
  3115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see hht1, 187300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see hht1, 187300) | rel=r_associated | relid=0 | w=15
  3116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see jbts1 213300, jbts2 608091, jbts3 608629)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see jbts1 213300, jbts2 608091, jbts3 608629) | rel=r_associated | relid=0 | w=15
  3117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see lgmd1a 159000 for overview)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see lgmd1a 159000 for overview) | rel=r_associated | relid=0 | w=15
  3118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see lqt1 192500)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see lqt1 192500) | rel=r_associated | relid=0 | w=15
  3119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see mada, 248370)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see mada, 248370) | rel=r_associated | relid=0 | w=15
  3120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see madb, 608612)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see madb, 608612) | rel=r_associated | relid=0 | w=15
  3121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see mcc2 deficiency 210210)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see mcc2 deficiency 210210) | rel=r_associated | relid=0 | w=15
  3122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see mks2 603194 and mks3 607361)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see mks2 603194 and mks3 607361) | rel=r_associated | relid=0 | w=15
  3123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see npc1, 257220)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see npc1, 257220) | rel=r_associated | relid=0 | w=15
  3124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see npc2, 607625)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see npc2, 607625) | rel=r_associated | relid=0 | w=15
  3125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see ofc1, 119530)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see ofc1, 119530) | rel=r_associated | relid=0 | w=15
  3126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see peoa2 609283, peoa3 609286, and peoa4 610131)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see peoa2 609283, peoa3 609286, and peoa4 610131) | rel=r_associated | relid=0 | w=15
  3127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see pfic1, 211600)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see pfic1, 211600) | rel=r_associated | relid=0 | w=15
  3128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see pfm1, 168500)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see pfm1, 168500) | rel=r_associated | relid=0 | w=15
  3129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see ppr2, 609572 and ppr3, 609573)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see ppr2, 609572 and ppr3, 609573) | rel=r_associated | relid=0 | w=15
  3130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see psnp1 601104)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see psnp1 601104) | rel=r_associated | relid=0 | w=15
  3131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see psnp2 609454)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see psnp2 609454) | rel=r_associated | relid=0 | w=15
  3132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see rieg2, 601499)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see rieg2, 601499) | rel=r_associated | relid=0 | w=15
  3133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see rls2, 608831)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see rls2, 608831) | rel=r_associated | relid=0 | w=15
  3134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see rmd, 606072)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see rmd, 606072) | rel=r_associated | relid=0 | w=15
  3135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see rmd1, 600332)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see rmd1, 600332) | rel=r_associated | relid=0 | w=15
  3136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see sca1, 164000)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see sca1, 164000) | rel=r_associated | relid=0 | w=15
  3137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see spondyloarthropathy, susceptibility to, 2 183840)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see spondyloarthropathy, susceptibility to, 2 183840) | rel=r_associated | relid=0 | w=15
  3138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., 600795, 105550)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., 600795, 105550) | rel=r_associated | relid=0 | w=15
  3139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., 608631, 300494, 300497)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., 608631, 300494, 300497) | rel=r_associated | relid=0 | w=15
  3140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., 609378, 608636, 608049, 300425, 300495, 300496)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., 609378, 608636, 608049, 300425, 300495, 300496) | rel=r_associated | relid=0 | w=15
  3141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., atfb1, 608583)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., atfb1, 608583) | rel=r_associated | relid=0 | w=15
  3142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., atfb3, 607554)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., atfb3, 607554) | rel=r_associated | relid=0 | w=15
  3143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., cmtdib 606482, cmtdid 607791)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., cmtdib 606482, cmtdid 607791) | rel=r_associated | relid=0 | w=15
  3144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., cockayne syndrome type b, 133540)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., cockayne syndrome type b, 133540) | rel=r_associated | relid=0 | w=15
  3145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., nys1 310700, nys2 164100, nys4 193003)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., nys1 310700, nys2 164100, nys4 193003) | rel=r_associated | relid=0 | w=15
  3146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (see, e.g., sli1 606711 and sli3 607134)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (see, e.g., sli1 606711 and sli3 607134) | rel=r_associated | relid=0 | w=15
  3147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (sli2 606712, sli3 607134)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (sli2 606712, sli3 607134) | rel=r_associated | relid=0 | w=15
  3148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity (x-linked form 305100)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity (x-linked form 305100) | rel=r_associated | relid=0 | w=15
  3149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity for phenotypically similar disorders with specific language impairment (sli1 606711, sli2 606712, sli3 607134)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity for phenotypically similar disorders with specific language impairment (sli1 606711, sli2 606712, sli3 607134) | rel=r_associated | relid=0 | w=15
  3150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity of axonal cmt (see cmt2a 118210)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity of axonal cmt (see cmt2a 118210) | rel=r_associated | relid=0 | w=15
  3151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity of waardenburg syndrome type 2
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity of waardenburg syndrome type 2 | rel=r_associated | relid=0 | w=15
  3152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, probably determined by major and minor genes, environmental factors, and developmental threshold
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, probably determined by major and minor genes, environmental factors, and developmental threshold | rel=r_associated | relid=0 | w=15
  3153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see (203300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see (203300) | rel=r_associated | relid=0 | w=15
  3154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see ags2 (610181), ags3 (610329), and ags4 (610333)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see ags2 (610181), ags3 (610329), and ags4 (610333) | rel=r_associated | relid=0 | w=15
  3155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see also pfic2 (601847), pfic3 (602347)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see also pfic2 (601847), pfic3 (602347) | rel=r_associated | relid=0 | w=15
  3156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see apmr1 (203650)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see apmr1 (203650) | rel=r_associated | relid=0 | w=15
  3157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see aprm2 (610422)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see aprm2 (610422) | rel=r_associated | relid=0 | w=15
  3158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see autosomal recessive inheritance of the disorder (271930)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see autosomal recessive inheritance of the disorder (271930) | rel=r_associated | relid=0 | w=15
  3159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see bos2 (120502) and bos3 (608389)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see bos2 (120502) and bos3 (608389) | rel=r_associated | relid=0 | w=15
  3160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see cild1 (244400)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see cild1 (244400) | rel=r_associated | relid=0 | w=15
  3161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see edm1 (132400), edm2 (600204), edm3 (600969), and edm5 (607078)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see edm1 (132400), edm2 (600204), edm3 (600969), and edm5 (607078) | rel=r_associated | relid=0 | w=15
  3162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see ekd1 (128200)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see ekd1 (128200) | rel=r_associated | relid=0 | w=15
  3163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see evr1 (133780)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see evr1 (133780) | rel=r_associated | relid=0 | w=15
  3164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see evr2 (305390), evr3 (605750), and evr4 (601813)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see evr2 (305390), evr3 (605750), and evr4 (601813) | rel=r_associated | relid=0 | w=15
  3165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see fhm1 141500
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see fhm1 141500 | rel=r_associated | relid=0 | w=15
  3166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see fhm1, (141500) and mgr1, (157300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see fhm1, (141500) and mgr1, (157300) | rel=r_associated | relid=0 | w=15
  3167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see lgmd2a (253600)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see lgmd2a (253600) | rel=r_associated | relid=0 | w=15
  3168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see mgr1 (157300)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see mgr1 (157300) | rel=r_associated | relid=0 | w=15
  3169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see mitochondrial inheritance of the disorder (500003)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see mitochondrial inheritance of the disorder (500003) | rel=r_associated | relid=0 | w=15
  3170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see ppnad1 (610489)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see ppnad1 (610489) | rel=r_associated | relid=0 | w=15
  3171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see ppnad2 (610475)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see ppnad2 (610475) | rel=r_associated | relid=0 | w=15
  3172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see sca1 (164400)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see sca1 (164400) | rel=r_associated | relid=0 | w=15
  3173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see spg3a (182600)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see spg3a (182600) | rel=r_associated | relid=0 | w=15
  3174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see spg5a (270800)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see spg5a (270800) | rel=r_associated | relid=0 | w=15
  3175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see spg5a (270800) for overview of recessive spgs
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see spg5a (270800) for overview of recessive spgs | rel=r_associated | relid=0 | w=15
  3176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, see, e.g., mgr2 (300125), mgr3 (607498), mgr4 (607501), mgr5 (607508), mgr6 (607516)
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, see, e.g., mgr2 (300125), mgr3 (607498), mgr4 (607501), mgr5 (607508), mgr6 (607516) | rel=r_associated | relid=0 | w=15
  3177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genetic heterogeneity, some patients not linked to fgfr3
    n1=Hyde (prurigo nodulaire de) | n2=en:genetic heterogeneity, some patients not linked to fgfr3 | rel=r_associated | relid=0 | w=15
  3178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:geneticist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:geneticist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  3179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:genitopatellar syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:genitopatellar syndrome | rel=r_associated | relid=0 | w=15
  3180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:germline and somatic mutations contribute to this disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:germline and somatic mutations contribute to this disorder | rel=r_associated | relid=0 | w=15
  3181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:germline or somatic mutations may cause the disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:germline or somatic mutations may cause the disorder | rel=r_associated | relid=0 | w=15
  3182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gestational age:time:pt:^fetus:qn:amniocentesis
    n1=Hyde (prurigo nodulaire de) | n2=en:gestational age:time:pt:^fetus:qn:amniocentesis | rel=r_associated | relid=0 | w=15
  3183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gestational diabetes
    n1=Hyde (prurigo nodulaire de) | n2=en:gestational diabetes | rel=r_associated | relid=0 | w=15
  3184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gestational hypertension
    n1=Hyde (prurigo nodulaire de) | n2=en:gestational hypertension | rel=r_associated | relid=0 | w=15
  3185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gestational sac absent
    n1=Hyde (prurigo nodulaire de) | n2=en:gestational sac absent | rel=r_associated | relid=0 | w=15
  3186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glial cell
    n1=Hyde (prurigo nodulaire de) | n2=en:glial cell | rel=r_associated | relid=0 | w=15
  3187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gliomas may occur in association with other hereditary tumor syndromes (see 276300, 155755, 162200, 101000, 191100)
    n1=Hyde (prurigo nodulaire de) | n2=en:gliomas may occur in association with other hereditary tumor syndromes (see 276300, 155755, 162200, 101000, 191100) | rel=r_associated | relid=0 | w=15
  3188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:global developmental delay
    n1=Hyde (prurigo nodulaire de) | n2=en:global developmental delay | rel=r_associated | relid=0 | w=15
  3189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucan 1,3-beta-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucan 1,3-beta-glucosidase | rel=r_associated | relid=0 | w=15
  3190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucan 1,4-alpha-maltohydrolase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucan 1,4-alpha-maltohydrolase | rel=r_associated | relid=0 | w=15
  3191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucan 1,4-beta-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucan 1,4-beta-glucosidase | rel=r_associated | relid=0 | w=15
  3192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucan 1,6-alpha-isomaltosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucan 1,6-alpha-isomaltosidase | rel=r_associated | relid=0 | w=15
  3193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucan endo-1,3-beta-d-glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucan endo-1,3-beta-d-glucosidase | rel=r_associated | relid=0 | w=15
  3194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucocorticoid deficiency occurs in mid-childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:glucocorticoid deficiency occurs in mid-childhood | rel=r_associated | relid=0 | w=15
  3195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucola
    n1=Hyde (prurigo nodulaire de) | n2=en:glucola | rel=r_associated | relid=0 | w=15
  3196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gluconolactonase
    n1=Hyde (prurigo nodulaire de) | n2=en:gluconolactonase | rel=r_associated | relid=0 | w=15
  3197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucosidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucosidase | rel=r_associated | relid=0 | w=15
  3198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucosylceramidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucosylceramidase | rel=r_associated | relid=0 | w=15
  3199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glucuronoarabinoxylan endo-1,4-beta-xylanase
    n1=Hyde (prurigo nodulaire de) | n2=en:glucuronoarabinoxylan endo-1,4-beta-xylanase | rel=r_associated | relid=0 | w=15
  3200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glutamate carboxypeptidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glutamate carboxypeptidase | rel=r_associated | relid=0 | w=15
  3201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glutamin-(asparagin-)ase
    n1=Hyde (prurigo nodulaire de) | n2=en:glutamin-(asparagin-)ase | rel=r_associated | relid=0 | w=15
  3202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glutaminase liver isoform, mitochondrial
    n1=Hyde (prurigo nodulaire de) | n2=en:glutaminase liver isoform, mitochondrial | rel=r_associated | relid=0 | w=15
  3203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glutaminyl-peptide glutaminase
    n1=Hyde (prurigo nodulaire de) | n2=en:glutaminyl-peptide glutaminase | rel=r_associated | relid=0 | w=15
  3204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glutathione thiolesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:glutathione thiolesterase | rel=r_associated | relid=0 | w=15
  3205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycerol-1,2-cyclic-phosphate 2-phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:glycerol-1,2-cyclic-phosphate 2-phosphodiesterase | rel=r_associated | relid=0 | w=15
  3206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycerophosphocholine phosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:glycerophosphocholine phosphodiesterase | rel=r_associated | relid=0 | w=15
  3207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycerophosphoinositol glycerophosphodiesterase
    n1=Hyde (prurigo nodulaire de) | n2=en:glycerophosphoinositol glycerophosphodiesterase | rel=r_associated | relid=0 | w=15
  3208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycobiology
    n1=Hyde (prurigo nodulaire de) | n2=en:glycobiology | rel=r_associated | relid=0 | w=15
  3209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycoconjugates
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoconjugates | rel=r_associated | relid=0 | w=15
  3210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycolic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:glycolic acid | rel=r_associated | relid=0 | w=15
  3211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycopeptide alpha-n-acetylgalactosaminidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glycopeptide alpha-n-acetylgalactosaminidase | rel=r_associated | relid=0 | w=15
  3212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoprotein | rel=r_associated | relid=0 | w=15
  3213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycoprotein gp63, leishmania
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoprotein gp63, leishmania | rel=r_associated | relid=0 | w=15
  3214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycosaminoglycan
    n1=Hyde (prurigo nodulaire de) | n2=en:glycosaminoglycan | rel=r_associated | relid=0 | w=15
  3215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycoside hydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:glycoside hydrolases | rel=r_associated | relid=0 | w=15
  3216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:glycosylceramidase
    n1=Hyde (prurigo nodulaire de) | n2=en:glycosylceramidase | rel=r_associated | relid=0 | w=15
  3217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gms is goniodysgenesis, mental deficiency, and short stature
    n1=Hyde (prurigo nodulaire de) | n2=en:gms is goniodysgenesis, mental deficiency, and short stature | rel=r_associated | relid=0 | w=15
  3218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gonadal and somatic mosaicism reported in parent
    n1=Hyde (prurigo nodulaire de) | n2=en:gonadal and somatic mosaicism reported in parent | rel=r_associated | relid=0 | w=15
  3219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gonadal mosaicism may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:gonadal mosaicism may occur | rel=r_associated | relid=0 | w=15
  3220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gonadal mosaicism reported
    n1=Hyde (prurigo nodulaire de) | n2=en:gonadal mosaicism reported | rel=r_associated | relid=0 | w=15
  3221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to clonazepam
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to clonazepam | rel=r_associated | relid=0 | w=15
  3222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to fibrinolytic inhibitors
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to fibrinolytic inhibitors | rel=r_associated | relid=0 | w=15
  3223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to gaba-enhancing medications
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to gaba-enhancing medications | rel=r_associated | relid=0 | w=15
  3224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to immunotherapy (intravenous igg or plasmapheresis)
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to immunotherapy (intravenous igg or plasmapheresis) | rel=r_associated | relid=0 | w=15
  3225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to l-dopa initially
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to l-dopa initially | rel=r_associated | relid=0 | w=15
  3226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to medication
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to medication | rel=r_associated | relid=0 | w=15
  3227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to phosphate treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to phosphate treatment | rel=r_associated | relid=0 | w=15
  3228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to steroid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to steroid treatment | rel=r_associated | relid=0 | w=15
  3229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to vitamin b12 therapy 'variant 1' has isolated homocystinuria and decreased mecbl
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to vitamin b12 therapy 'variant 1' has isolated homocystinuria and decreased mecbl | rel=r_associated | relid=0 | w=15
  3230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good response to vitamin d treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:good response to vitamin d treatment | rel=r_associated | relid=0 | w=15
  3231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:good seizure control with medication
    n1=Hyde (prurigo nodulaire de) | n2=en:good seizure control with medication | rel=r_associated | relid=0 | w=15
  3232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gradual progression
    n1=Hyde (prurigo nodulaire de) | n2=en:gradual progression | rel=r_associated | relid=0 | w=15
  3233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gradual progression of hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:gradual progression of hearing loss | rel=r_associated | relid=0 | w=15
  3234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gradual spontaneous improvement in the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:gradual spontaneous improvement in the first year of life | rel=r_associated | relid=0 | w=15
  3235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:great variation in extent of hypertrophy in mutation-positive individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:great variation in extent of hypertrophy in mutation-positive individuals | rel=r_associated | relid=0 | w=15
  3236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:greater expression in females
    n1=Hyde (prurigo nodulaire de) | n2=en:greater expression in females | rel=r_associated | relid=0 | w=15
  3237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:green color resolves if cholestasis is treated
    n1=Hyde (prurigo nodulaire de) | n2=en:green color resolves if cholestasis is treated | rel=r_associated | relid=0 | w=15
  3238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:green jaundice occurs only in the context of liver failure or obstructive cholestasis
    n1=Hyde (prurigo nodulaire de) | n2=en:green jaundice occurs only in the context of liver failure or obstructive cholestasis | rel=r_associated | relid=0 | w=15
  3239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:griscelli syndrome type 3 (609227) for a similar disorder without neurologic or immunologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:griscelli syndrome type 3 (609227) for a similar disorder without neurologic or immunologic abnormalities | rel=r_associated | relid=0 | w=15
  3240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:group a patients die in the first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:group a patients die in the first years of life | rel=r_associated | relid=0 | w=15
  3241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:group a, found in north american indians, has lactic acidosis and psychomotor retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:group a, found in north american indians, has lactic acidosis and psychomotor retardation | rel=r_associated | relid=0 | w=15
  3242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:group b patients die by 3 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:group b patients die by 3 months of age | rel=r_associated | relid=0 | w=15
  3243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:group b, found in france and united kingdom, severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:group b, found in france and united kingdom, severe phenotype | rel=r_associated | relid=0 | w=15
  3244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:group c is relatively benign
    n1=Hyde (prurigo nodulaire de) | n2=en:group c is relatively benign | rel=r_associated | relid=0 | w=15
  3245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:growth retardation onset in utero
    n1=Hyde (prurigo nodulaire de) | n2=en:growth retardation onset in utero | rel=r_associated | relid=0 | w=15
  3246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gt 1043
    n1=Hyde (prurigo nodulaire de) | n2=en:gt 1043 | rel=r_associated | relid=0 | w=15
  3247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gt 1587
    n1=Hyde (prurigo nodulaire de) | n2=en:gt 1587 | rel=r_associated | relid=0 | w=15
  3248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:guaifenesin/codeine
    n1=Hyde (prurigo nodulaire de) | n2=en:guaifenesin/codeine | rel=r_associated | relid=0 | w=15
  3249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:gypsy groups demonstrate a founder effect (1267delg, 100725.0012)
    n1=Hyde (prurigo nodulaire de) | n2=en:gypsy groups demonstrate a founder effect (1267delg, 100725.0012) | rel=r_associated | relid=0 | w=15
  3250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair loss begins in first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:hair loss begins in first years of life | rel=r_associated | relid=0 | w=15
  3251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair may normalize at puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:hair may normalize at puberty | rel=r_associated | relid=0 | w=15
  3252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair phenotype present at birth and involves entire scalp region
    n1=Hyde (prurigo nodulaire de) | n2=en:hair phenotype present at birth and involves entire scalp region | rel=r_associated | relid=0 | w=15
  3253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair regrowth may occur later in life
    n1=Hyde (prurigo nodulaire de) | n2=en:hair regrowth may occur later in life | rel=r_associated | relid=0 | w=15
  3254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair tends to straighten by 2nd-3rd decade
    n1=Hyde (prurigo nodulaire de) | n2=en:hair tends to straighten by 2nd-3rd decade | rel=r_associated | relid=0 | w=15
  3255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hair, nails, and teeth are normal
    n1=Hyde (prurigo nodulaire de) | n2=en:hair, nails, and teeth are normal | rel=r_associated | relid=0 | w=15
  3256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hairy elbows become apparent in infancy and regress during adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:hairy elbows become apparent in infancy and regress during adolescence | rel=r_associated | relid=0 | w=15
  3257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:half (50%) of affected patients have a recurrent episode with worse outcome
    n1=Hyde (prurigo nodulaire de) | n2=en:half (50%) of affected patients have a recurrent episode with worse outcome | rel=r_associated | relid=0 | w=15
  3258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:half of cases show retarded head circumference equal to height retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:half of cases show retarded head circumference equal to height retardation | rel=r_associated | relid=0 | w=15
  3259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures)
    n1=Hyde (prurigo nodulaire de) | n2=en:hand and foot lesions can severely limit dexterity (due to flexion contractures) and mobility (due to painful fissures) | rel=r_associated | relid=0 | w=15
  3260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hand involvement improves with age
    n1=Hyde (prurigo nodulaire de) | n2=en:hand involvement improves with age | rel=r_associated | relid=0 | w=15
  3261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hands clenched at birth but loosen in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:hands clenched at birth but loosen in infancy | rel=r_associated | relid=0 | w=15
  3262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:haploinsufficiency of grn (138945)
    n1=Hyde (prurigo nodulaire de) | n2=en:haploinsufficiency of grn (138945) | rel=r_associated | relid=0 | w=15
  3263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:haploinsufficiency of rps14 (130620)
    n1=Hyde (prurigo nodulaire de) | n2=en:haploinsufficiency of rps14 (130620) | rel=r_associated | relid=0 | w=15
  3264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:has also been called 'distal hereditary motor neuronopathy' (dhmn) and 'distal spinal muscular atrophy' (dsma)
    n1=Hyde (prurigo nodulaire de) | n2=en:has also been called 'distal hereditary motor neuronopathy' (dhmn) and 'distal spinal muscular atrophy' (dsma) | rel=r_associated | relid=0 | w=15
  3265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:has been described in patients of caucasus jewish origin
    n1=Hyde (prurigo nodulaire de) | n2=en:has been described in patients of caucasus jewish origin | rel=r_associated | relid=0 | w=15
  3266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:headache duration 4-72 hours
    n1=Hyde (prurigo nodulaire de) | n2=en:headache duration 4-72 hours | rel=r_associated | relid=0 | w=15
  3267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:headaches last hours to days
    n1=Hyde (prurigo nodulaire de) | n2=en:headaches last hours to days | rel=r_associated | relid=0 | w=15
  3268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:health data repository:id:pt:repository:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:health data repository:id:pt:repository:nom | rel=r_associated | relid=0 | w=15
  3269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:health insurance plan benefits comment:finding:point in time:^patient:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:health insurance plan benefits comment:finding:point in time:^patient:narrative | rel=r_associated | relid=0 | w=15
  3270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing impairment may improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing impairment may improve with age | rel=r_associated | relid=0 | w=15
  3271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss affects all frequencies
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss affects all frequencies | rel=r_associated | relid=0 | w=15
  3272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss and hoarseness occur later
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss and hoarseness occur later | rel=r_associated | relid=0 | w=15
  3273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss and ocular findings are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss and ocular findings are variable | rel=r_associated | relid=0 | w=15
  3274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss is pre- or perilingual in onset
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss is pre- or perilingual in onset | rel=r_associated | relid=0 | w=15
  3275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss is usually severe by age 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss is usually severe by age 20 years | rel=r_associated | relid=0 | w=15
  3276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss is variable
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss is variable | rel=r_associated | relid=0 | w=15
  3277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss ma be fluctuating or progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss ma be fluctuating or progressive | rel=r_associated | relid=0 | w=15
  3278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss may be congenital or rapidly progressive leading to severe hearing loss by age 3 years | rel=r_associated | relid=0 | w=15
  3279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss may be stable or progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss may be stable or progressive | rel=r_associated | relid=0 | w=15
  3280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss occurs in late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss occurs in late childhood | rel=r_associated | relid=0 | w=15
  3281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss progresses to profound deafness
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss progresses to profound deafness | rel=r_associated | relid=0 | w=15
  3282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hearing loss typically begins between 3 and 4 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:hearing loss typically begins between 3 and 4 years of age | rel=r_associated | relid=0 | w=15
  3283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:helicase
    n1=Hyde (prurigo nodulaire de) | n2=en:helicase | rel=r_associated | relid=0 | w=15
  3284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hematuria may become apparent after respiratory infections (synpharyngitic)
    n1=Hyde (prurigo nodulaire de) | n2=en:hematuria may become apparent after respiratory infections (synpharyngitic) | rel=r_associated | relid=0 | w=15
  3285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hemihydranencephalies
    n1=Hyde (prurigo nodulaire de) | n2=en:hemihydranencephalies | rel=r_associated | relid=0 | w=15
  3286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hemolysis may be exercise-induced
    n1=Hyde (prurigo nodulaire de) | n2=en:hemolysis may be exercise-induced | rel=r_associated | relid=0 | w=15
  3287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hemorrhagic complication of pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:hemorrhagic complication of pregnancy | rel=r_associated | relid=0 | w=15
  3288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heparanase-2
    n1=Hyde (prurigo nodulaire de) | n2=en:heparanase-2 | rel=r_associated | relid=0 | w=15
  3289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hepatic failure develops in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:hepatic failure develops in first months of life | rel=r_associated | relid=0 | w=15
  3290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hepatic triacylglycerol lipase
    n1=Hyde (prurigo nodulaire de) | n2=en:hepatic triacylglycerol lipase | rel=r_associated | relid=0 | w=15
  3291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hepatoerythropoietic porphyria (hep, 176100.0005) is a severe infantile form due to homozygous pct
    n1=Hyde (prurigo nodulaire de) | n2=en:hepatoerythropoietic porphyria (hep, 176100.0005) is a severe infantile form due to homozygous pct | rel=r_associated | relid=0 | w=15
  3292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hepatomegaly improves with age and disappears around puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:hepatomegaly improves with age and disappears around puberty | rel=r_associated | relid=0 | w=15
  3293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hernia occurs in 22% of adults
    n1=Hyde (prurigo nodulaire de) | n2=en:hernia occurs in 22% of adults | rel=r_associated | relid=0 | w=15
  3294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterogeneous disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:heterogeneous disorder | rel=r_associated | relid=0 | w=15
  3295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heteroorganic compound
    n1=Hyde (prurigo nodulaire de) | n2=en:heteroorganic compound | rel=r_associated | relid=0 | w=15
  3296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygote individuals are average stature and can have mild skeletal abnormalities including brachydactyly, delayed bone age, metatarsus adductus, and finger flexion contractures
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygote individuals are average stature and can have mild skeletal abnormalities including brachydactyly, delayed bone age, metatarsus adductus, and finger flexion contractures | rel=r_associated | relid=0 | w=15
  3297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygote may have elevated serum phosphate and elevated serum 1,25-dihydroxycholecalciferol | rel=r_associated | relid=0 | w=15
  3298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes - 39% severe phenotype, 28% clinically symptomatic, 28% x-ray changes only, 4% non-penetrant
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes - 39% severe phenotype, 28% clinically symptomatic, 28% x-ray changes only, 4% non-penetrant | rel=r_associated | relid=0 | w=15
  3299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes are not affected
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes are not affected | rel=r_associated | relid=0 | w=15
  3300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes are usually asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes are usually asymptomatic | rel=r_associated | relid=0 | w=15
  3301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes at risk of developing acute, symptomatic methemoglobinemia after exposure to exogenous, methemoglobin-inducing agents | rel=r_associated | relid=0 | w=15
  3302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes demonstrate a milder phenotype, consistent with a semidominant inheritance pattern
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes demonstrate a milder phenotype, consistent with a semidominant inheritance pattern | rel=r_associated | relid=0 | w=15
  3303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes exhibit blue sclerae and soft velvety skin
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes exhibit blue sclerae and soft velvety skin | rel=r_associated | relid=0 | w=15
  3304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes have half-normal levels of apob-containing lipoproteins
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes have half-normal levels of apob-containing lipoproteins | rel=r_associated | relid=0 | w=15
  3305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes have mild, transient hypothyroidism in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes have mild, transient hypothyroidism in infancy | rel=r_associated | relid=0 | w=15
  3306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes have milder metabolic defect with increased serum 1,25(oh)2d3 and hypercalciuria, but no bone disease or rickets
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes have milder metabolic defect with increased serum 1,25(oh)2d3 and hypercalciuria, but no bone disease or rickets | rel=r_associated | relid=0 | w=15
  3307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes have plasma levels of triglycerides and/or hdl cholesterol that are intermediate between homozygotes and unaffected individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes have plasma levels of triglycerides and/or hdl cholesterol that are intermediate between homozygotes and unaffected individuals | rel=r_associated | relid=0 | w=15
  3308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes may also exhibit small joint hypermobility or conductive hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes may also exhibit small joint hypermobility or conductive hearing loss | rel=r_associated | relid=0 | w=15
  3309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes may also show increased susceptibility to toxic effects of thiopurine treatment | rel=r_associated | relid=0 | w=15
  3310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes may be at increased risk for infection or atypical hemolytic uremic syndrome (235400)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes may be at increased risk for infection or atypical hemolytic uremic syndrome (235400) | rel=r_associated | relid=0 | w=15
  3311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygotes may exhibit syndromic manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygotes may exhibit syndromic manifestations | rel=r_associated | relid=0 | w=15
  3312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous carriers exhibit palmoplantar hyperkeratosis (see 148700) | rel=r_associated | relid=0 | w=15
  3313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous carriers have an increased risk of metabolic dysfunction
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous carriers have an increased risk of metabolic dysfunction | rel=r_associated | relid=0 | w=15
  3314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous carriers have blue sclerae, small joint hypermobility, and mild thinning of cornea | rel=r_associated | relid=0 | w=15
  3315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous carriers have decreased blood pressure compared to the general population
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous carriers have decreased blood pressure compared to the general population | rel=r_associated | relid=0 | w=15
  3316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous deletion of the terminal band 22q13.3 including shank3 (606230)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous deletion of the terminal band 22q13.3 including shank3 (606230) | rel=r_associated | relid=0 | w=15
  3317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous female carriers may manifest symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous female carriers may manifest symptoms | rel=r_associated | relid=0 | w=15
  3318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous females have milder thyroid phenotype and no neurologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous females have milder thyroid phenotype and no neurologic abnormalities | rel=r_associated | relid=0 | w=15
  3319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous females may exhibit variable degrees of enzyme deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous females may exhibit variable degrees of enzyme deficiency | rel=r_associated | relid=0 | w=15
  3320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous females may have gout and/or sensorineural deafness
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous females may have gout and/or sensorineural deafness | rel=r_associated | relid=0 | w=15
  3321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous females more mildly affected than hemizygous males
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous females more mildly affected than hemizygous males | rel=r_associated | relid=0 | w=15
  3322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous females show variable expressivity (mild to severe manifestations) including hypodontia, conical teeth, reduction in scalp/body hair, and difficulty nursing
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous females show variable expressivity (mild to severe manifestations) including hypodontia, conical teeth, reduction in scalp/body hair, and difficulty nursing | rel=r_associated | relid=0 | w=15
  3323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous mutation carriers may have late-onset of mild symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous mutation carriers may have late-onset of mild symptoms | rel=r_associated | relid=0 | w=15
  3324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous mutation carriers may show mild symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous mutation carriers may show mild symptoms | rel=r_associated | relid=0 | w=15
  3325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous mutation carriers show toxicity to 5-fluorouracil (5fu)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous mutation carriers show toxicity to 5-fluorouracil (5fu) | rel=r_associated | relid=0 | w=15
  3326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous mutation present in 5-7% of the japanese population
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous mutation present in 5-7% of the japanese population | rel=r_associated | relid=0 | w=15
  3327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous mutations reported, see 606609.0006 and 606609.0007
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous mutations reported, see 606609.0006 and 606609.0007 | rel=r_associated | relid=0 | w=15
  3328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous parents are phenotypically normal but their cells show premature chromatid separation trait (pcs, 176430)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous parents are phenotypically normal but their cells show premature chromatid separation trait (pcs, 176430) | rel=r_associated | relid=0 | w=15
  3329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous titin mutation causes the less-severe tardive tibial muscular dystrophy (600334)
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous titin mutation causes the less-severe tardive tibial muscular dystrophy (600334) | rel=r_associated | relid=0 | w=15
  3330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:heterozygous, homozygous, and compound heterozygous coq2 mutations have been identified
    n1=Hyde (prurigo nodulaire de) | n2=en:heterozygous, homozygous, and compound heterozygous coq2 mutations have been identified | rel=r_associated | relid=0 | w=15
  3331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hhs is a more severe variant, often resulting in death in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:hhs is a more severe variant, often resulting in death in childhood | rel=r_associated | relid=0 | w=15
  3332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hid (hystrix-like ichthyosis with deafness, 602540) is identical to kid at the molecular level
    n1=Hyde (prurigo nodulaire de) | n2=en:hid (hystrix-like ichthyosis with deafness, 602540) is identical to kid at the molecular level | rel=r_associated | relid=0 | w=15
  3333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high disease prevalence among french-canadians
    n1=Hyde (prurigo nodulaire de) | n2=en:high disease prevalence among french-canadians | rel=r_associated | relid=0 | w=15
  3334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high early mortality rate if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:high early mortality rate if untreated | rel=r_associated | relid=0 | w=15
  3335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequencies affected before low frequencies
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequencies affected before low frequencies | rel=r_associated | relid=0 | w=15
  3336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency among french-canadians
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency among french-canadians | rel=r_associated | relid=0 | w=15
  3337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency among individuals of ashkenazi jewish descent (1 in 3,300)
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency among individuals of ashkenazi jewish descent (1 in 3,300) | rel=r_associated | relid=0 | w=15
  3338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in equatorial africa
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in equatorial africa | rel=r_associated | relid=0 | w=15
  3339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in finnish population
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in finnish population | rel=r_associated | relid=0 | w=15
  3340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in hutterite population
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in hutterite population | rel=r_associated | relid=0 | w=15
  3341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in japan (2 in 20,000, 0.1%)
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in japan (2 in 20,000, 0.1%) | rel=r_associated | relid=0 | w=15
  3342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in southern india (7% of all epilepsies)
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in southern india (7% of all epilepsies) | rel=r_associated | relid=0 | w=15
  3343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in the french-canadian population
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in the french-canadian population | rel=r_associated | relid=0 | w=15
  3344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency in tibetan individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency in tibetan individuals | rel=r_associated | relid=0 | w=15
  3345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency of absence seizures (several per day)
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency of absence seizures (several per day) | rel=r_associated | relid=0 | w=15
  3346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency of de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency of de novo mutations | rel=r_associated | relid=0 | w=15
  3347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency of levodopa-induced dyskinesias
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency of levodopa-induced dyskinesias | rel=r_associated | relid=0 | w=15
  3348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high frequency seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:high frequency seizures | rel=r_associated | relid=0 | w=15
  3349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence among ashkenazi jews
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence among ashkenazi jews | rel=r_associated | relid=0 | w=15
  3350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence among old order amish
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence among old order amish | rel=r_associated | relid=0 | w=15
  3351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence in iraqis and sephardic jewish individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence in iraqis and sephardic jewish individuals | rel=r_associated | relid=0 | w=15
  3352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence in saguenay-lac st. jean region of the province of quebec, canada and northern europe
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence in saguenay-lac st. jean region of the province of quebec, canada and northern europe | rel=r_associated | relid=0 | w=15
  3353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence in sweden and finland
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence in sweden and finland | rel=r_associated | relid=0 | w=15
  3354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence of diabetes mellitus noted in opll patients
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence of diabetes mellitus noted in opll patients | rel=r_associated | relid=0 | w=15
  3355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high incidence of e. coli sepsis in untreated neonates
    n1=Hyde (prurigo nodulaire de) | n2=en:high incidence of e. coli sepsis in untreated neonates | rel=r_associated | relid=0 | w=15
  3356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high intrafamilial and interfamilial variability
    n1=Hyde (prurigo nodulaire de) | n2=en:high intrafamilial and interfamilial variability | rel=r_associated | relid=0 | w=15
  3357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high mortality in infancy and early childhood (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:high mortality in infancy and early childhood (in some patients) | rel=r_associated | relid=0 | w=15
  3358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high occurrence of de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:high occurrence of de novo mutations | rel=r_associated | relid=0 | w=15
  3359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high pain threshold
    n1=Hyde (prurigo nodulaire de) | n2=en:high pain threshold | rel=r_associated | relid=0 | w=15
  3360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high prevalence among individuals of middle eastern or african descent
    n1=Hyde (prurigo nodulaire de) | n2=en:high prevalence among individuals of middle eastern or african descent | rel=r_associated | relid=0 | w=15
  3361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high prevalence in charlevoix-saguenay region of northeastern quebec
    n1=Hyde (prurigo nodulaire de) | n2=en:high prevalence in charlevoix-saguenay region of northeastern quebec | rel=r_associated | relid=0 | w=15
  3362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high prevalence in holguin province of cuba
    n1=Hyde (prurigo nodulaire de) | n2=en:high prevalence in holguin province of cuba | rel=r_associated | relid=0 | w=15
  3363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high prevalence in japan
    n1=Hyde (prurigo nodulaire de) | n2=en:high prevalence in japan | rel=r_associated | relid=0 | w=15
  3364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high prevalence in the east asian population
    n1=Hyde (prurigo nodulaire de) | n2=en:high prevalence in the east asian population | rel=r_associated | relid=0 | w=15
  3365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high recurrence rate
    n1=Hyde (prurigo nodulaire de) | n2=en:high recurrence rate | rel=r_associated | relid=0 | w=15
  3366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high risk of death in infancy due to cardiac failure
    n1=Hyde (prurigo nodulaire de) | n2=en:high risk of death in infancy due to cardiac failure | rel=r_associated | relid=0 | w=15
  3367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high risk of recurrence after surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:high risk of recurrence after surgery | rel=r_associated | relid=0 | w=15
  3368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:high risk pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:high risk pregnancy | rel=r_associated | relid=0 | w=15
  3369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:higher than expected incidence in identical twins
    n1=Hyde (prurigo nodulaire de) | n2=en:higher than expected incidence in identical twins | rel=r_associated | relid=0 | w=15
  3370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highest incidence in men of european descent
    n1=Hyde (prurigo nodulaire de) | n2=en:highest incidence in men of european descent | rel=r_associated | relid=0 | w=15
  3371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly penetrant, but low morbidity
    n1=Hyde (prurigo nodulaire de) | n2=en:highly penetrant, but low morbidity | rel=r_associated | relid=0 | w=15
  3372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable age at onset | rel=r_associated | relid=0 | w=15
  3373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable age at onset (range 9 to 69 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable age at onset (range 9 to 69 years) | rel=r_associated | relid=0 | w=15
  3374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable clinical and immunologic phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable clinical and immunologic phenotype | rel=r_associated | relid=0 | w=15
  3375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable clinical phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable clinical phenotype | rel=r_associated | relid=0 | w=15
  3376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable dysmorphic features | rel=r_associated | relid=0 | w=15
  3377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable expression
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable expression | rel=r_associated | relid=0 | w=15
  3378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable frequency and duration of episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable frequency and duration of episodes | rel=r_associated | relid=0 | w=15
  3379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable frequency and severity of attacks
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable frequency and severity of attacks | rel=r_associated | relid=0 | w=15
  3380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable intrafamilial severity
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable intrafamilial severity | rel=r_associated | relid=0 | w=15
  3381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable organ involvement and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable organ involvement and severity | rel=r_associated | relid=0 | w=15
  3382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable pathologic phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable pathologic phenotype | rel=r_associated | relid=0 | w=15
  3383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype and age of onset
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype and age of onset | rel=r_associated | relid=0 | w=15
  3384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype and severity | rel=r_associated | relid=0 | w=15
  3385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype and severity, even within families
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype and severity, even within families | rel=r_associated | relid=0 | w=15
  3386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype in females
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype in females | rel=r_associated | relid=0 | w=15
  3387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens')
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype including fluctuating phenotype ('fluctuans') or severe phenotype ('permanens') | rel=r_associated | relid=0 | w=15
  3388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104)
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype that includes several subtypes (see, e.g., 607485, 601104) | rel=r_associated | relid=0 | w=15
  3389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype with regard to pigmentation
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype with regard to pigmentation | rel=r_associated | relid=0 | w=15
  3390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype with respect to facial dysmorphism and neurologic features
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype with respect to facial dysmorphism and neurologic features | rel=r_associated | relid=0 | w=15
  3391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype, even within families
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype, even within families | rel=r_associated | relid=0 | w=15
  3392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype, ranging from asymptomatic to death by age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype, ranging from asymptomatic to death by age 3 years | rel=r_associated | relid=0 | w=15
  3393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype, ranging from asymptomatic to severe
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype, ranging from asymptomatic to severe | rel=r_associated | relid=0 | w=15
  3394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype, ranging from neonatal encephalopathy to mild mental retardation with autistic features
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype, ranging from neonatal encephalopathy to mild mental retardation with autistic features | rel=r_associated | relid=0 | w=15
  3395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable phenotype, some adults may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable phenotype, some adults may be asymptomatic | rel=r_associated | relid=0 | w=15
  3396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable severity
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable severity | rel=r_associated | relid=0 | w=15
  3397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable severity of muscle weakness
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable severity of muscle weakness | rel=r_associated | relid=0 | w=15
  3398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence
    n1=Hyde (prurigo nodulaire de) | n2=en:highly variable severity, ranging from death in utero to survival to adulthood with normal intelligence | rel=r_associated | relid=0 | w=15
  3399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hindwater
    n1=Hyde (prurigo nodulaire de) | n2=en:hindwater | rel=r_associated | relid=0 | w=15
  3400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hip girdle involvement precedes and is usually greater than shoulder girdle involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:hip girdle involvement precedes and is usually greater than shoulder girdle involvement | rel=r_associated | relid=0 | w=15
  3401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hip joint replacement often necessary
    n1=Hyde (prurigo nodulaire de) | n2=en:hip joint replacement often necessary | rel=r_associated | relid=0 | w=15
  3402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hip replacement in early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:hip replacement in early adulthood | rel=r_associated | relid=0 | w=15
  3403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:histologic features overlap with henoch-schonlein purpura (hspn)
    n1=Hyde (prurigo nodulaire de) | n2=en:histologic features overlap with henoch-schonlein purpura (hspn) | rel=r_associated | relid=0 | w=15
  3404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hla class ii alleles specify ketosis-prone diabetes (kpd) subgroup
    n1=Hyde (prurigo nodulaire de) | n2=en:hla class ii alleles specify ketosis-prone diabetes (kpd) subgroup | rel=r_associated | relid=0 | w=15
  3405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygosity or compound heterozygosity for lamb2 mutations conferring complete loss of function (e.g., truncating mutations) appear to be associated with pierson syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygosity or compound heterozygosity for lamb2 mutations conferring complete loss of function (e.g., truncating mutations) appear to be associated with pierson syndrome | rel=r_associated | relid=0 | w=15
  3406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygotes have earlier onset and a more severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygotes have earlier onset and a more severe disorder | rel=r_associated | relid=0 | w=15
  3407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygotes have more severe disease with earlier onset of thrombosis
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygotes have more severe disease with earlier onset of thrombosis | rel=r_associated | relid=0 | w=15
  3408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygous 9-snp haplotype in the promoter and coding region of malic enzyme 2 (me2, 154270.0001) increases risk for ige (odds ratio 6.1 with 95% confidence interval 2.9-12.7)
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygous 9-snp haplotype in the promoter and coding region of malic enzyme 2 (me2, 154270.0001) increases risk for ige (odds ratio 6.1 with 95% confidence interval 2.9-12.7) | rel=r_associated | relid=0 | w=15
  3409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygous mutation of kcne1 causes jervell and lange-nielsen syndrome (176261.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygous mutation of kcne1 causes jervell and lange-nielsen syndrome (176261.0001) | rel=r_associated | relid=0 | w=15
  3410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:homozygous patients have earlier-onset and more severe disease
    n1=Hyde (prurigo nodulaire de) | n2=en:homozygous patients have earlier-onset and more severe disease | rel=r_associated | relid=0 | w=15
  3411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hormone
    n1=Hyde (prurigo nodulaire de) | n2=en:hormone | rel=r_associated | relid=0 | w=15
  3412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hormones, hormone substitutes, and hormone antagonists
    n1=Hyde (prurigo nodulaire de) | n2=en:hormones, hormone substitutes, and hormone antagonists | rel=r_associated | relid=0 | w=15
  3413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del)
    n1=Hyde (prurigo nodulaire de) | n2=en:however, neonatal seizures, severe mental retardation, distinct dysmorphic features, and mitochondrial dysfunction are unique to 2p21 deletion syndrome (2p21del) | rel=r_associated | relid=0 | w=15
  3414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:human c1-esterase inhibitor
    n1=Hyde (prurigo nodulaire de) | n2=en:human c1-esterase inhibitor | rel=r_associated | relid=0 | w=15
  3415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:human cytomegalovirus immune globulin
    n1=Hyde (prurigo nodulaire de) | n2=en:human cytomegalovirus immune globulin | rel=r_associated | relid=0 | w=15
  3416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hundreds to thousands of patches of pale normal skin appear during childhood and increase in number and size over time
    n1=Hyde (prurigo nodulaire de) | n2=en:hundreds to thousands of patches of pale normal skin appear during childhood and increase in number and size over time | rel=r_associated | relid=0 | w=15
  3417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydraencephaly
    n1=Hyde (prurigo nodulaire de) | n2=en:hydraencephaly | rel=r_associated | relid=0 | w=15
  3418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydramnion
    n1=Hyde (prurigo nodulaire de) | n2=en:hydramnion | rel=r_associated | relid=0 | w=15
  3419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydranencephaly with proliferative vasculopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:hydranencephaly with proliferative vasculopathy | rel=r_associated | relid=0 | w=15
  3420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrargyrisme
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrargyrisme | rel=r_associated | relid=0 | w=15
  3421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrase
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrase | rel=r_associated | relid=0 | w=15
  3422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrencephalocele
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrencephalocele | rel=r_associated | relid=0 | w=15
  3423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrencephaly
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrencephaly | rel=r_associated | relid=0 | w=15
  3424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrin
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrin | rel=r_associated | relid=0 | w=15
  3425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydroa aestivalis
    n1=Hyde (prurigo nodulaire de) | n2=en:hydroa aestivalis | rel=r_associated | relid=0 | w=15
  3426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocalycosis
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocalycosis | rel=r_associated | relid=0 | w=15
  3427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocalyx
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocalyx | rel=r_associated | relid=0 | w=15
  3428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocarbon containing
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocarbon containing | rel=r_associated | relid=0 | w=15
  3429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocodone + chlorpheniramine
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocodone + chlorpheniramine | rel=r_associated | relid=0 | w=15
  3430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocortisone+chloramphenicol
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocortisone+chloramphenicol | rel=r_associated | relid=0 | w=15
  3431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrocortisone+clioquinol
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrocortisone+clioquinol | rel=r_associated | relid=0 | w=15
  3432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrolethalus syndrome 1
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrolethalus syndrome 1 | rel=r_associated | relid=0 | w=15
  3433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrophilic end of structural lipid molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrophilic end of structural lipid molecule | rel=r_associated | relid=0 | w=15
  3434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrophobic end of structural lipid molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrophobic end of structural lipid molecule | rel=r_associated | relid=0 | w=15
  3435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrops fetalis
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrops fetalis | rel=r_associated | relid=0 | w=15
  3436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrops fetalis is associated with death in utero (90%) or within 2 days of birth | rel=r_associated | relid=0 | w=15
  3437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrops fetalis, non-immune (rare)
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrops fetalis, non-immune (rare) | rel=r_associated | relid=0 | w=15
  3438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hydrops fetalis, nonimmune, with gracile bones and dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:hydrops fetalis, nonimmune, with gracile bones and dysmorphic features | rel=r_associated | relid=0 | w=15
  3439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypercalciuria and/or nephrolithiasis occurs in heterozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:hypercalciuria and/or nephrolithiasis occurs in heterozygotes | rel=r_associated | relid=0 | w=15
  3440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperchloremia
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperchloremia | rel=r_associated | relid=0 | w=15
  3441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperemesis gravidarum
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperemesis gravidarum | rel=r_associated | relid=0 | w=15
  3442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperkeratosis often present at birth but may appear later
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperkeratosis often present at birth but may appear later | rel=r_associated | relid=0 | w=15
  3443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperkeratosis triggered by chronic mechanical irritation
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperkeratosis triggered by chronic mechanical irritation | rel=r_associated | relid=0 | w=15
  3444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperlipidemia may be partially responsive to fat-restricted diet
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperlipidemia may be partially responsive to fat-restricted diet | rel=r_associated | relid=0 | w=15
  3445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperphagia and weight gain as well as immunologic abnormalities and hypogonadism can be reversed by exogenously administered recombinant leptin
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperphagia and weight gain as well as immunologic abnormalities and hypogonadism can be reversed by exogenously administered recombinant leptin | rel=r_associated | relid=0 | w=15
  3446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperpigmented patches increased in size and number with age
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperpigmented patches increased in size and number with age | rel=r_associated | relid=0 | w=15
  3447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperpigmented skin macules appear after age 3 years and increase in frequency with age
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperpigmented skin macules appear after age 3 years and increase in frequency with age | rel=r_associated | relid=0 | w=15
  3448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypersensitivity to ionizing radiation
    n1=Hyde (prurigo nodulaire de) | n2=en:hypersensitivity to ionizing radiation | rel=r_associated | relid=0 | w=15
  3449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypertension is presenting sign
    n1=Hyde (prurigo nodulaire de) | n2=en:hypertension is presenting sign | rel=r_associated | relid=0 | w=15
  3450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyperthermia in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperthermia in early childhood | rel=r_associated | relid=0 | w=15
  3451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypertrophic meckel's diverticulum
    n1=Hyde (prurigo nodulaire de) | n2=en:hypertrophic meckel's diverticulum | rel=r_associated | relid=0 | w=15
  3452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypochondrogenesis represents clinical variability within the achondrogenesis-hypochondrogenesis spectrum
    n1=Hyde (prurigo nodulaire de) | n2=en:hypochondrogenesis represents clinical variability within the achondrogenesis-hypochondrogenesis spectrum | rel=r_associated | relid=0 | w=15
  3453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypogonadism reported in a large swedish kindred
    n1=Hyde (prurigo nodulaire de) | n2=en:hypogonadism reported in a large swedish kindred | rel=r_associated | relid=0 | w=15
  3454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hyponatremia usually associated with gastroenteritis
    n1=Hyde (prurigo nodulaire de) | n2=en:hyponatremia usually associated with gastroenteritis | rel=r_associated | relid=0 | w=15
  3455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypothyroidism is less severe in individuals with high dietary iodine intake
    n1=Hyde (prurigo nodulaire de) | n2=en:hypothyroidism is less severe in individuals with high dietary iodine intake | rel=r_associated | relid=0 | w=15
  3456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypoventilation occurs in the absence of primary neuromuscular, lung, or cardiac disease, or an identifiable brainstem lesion
    n1=Hyde (prurigo nodulaire de) | n2=en:hypoventilation occurs in the absence of primary neuromuscular, lung, or cardiac disease, or an identifiable brainstem lesion | rel=r_associated | relid=0 | w=15
  3457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:hypromellose acetate succinate
    n1=Hyde (prurigo nodulaire de) | n2=en:hypromellose acetate succinate | rel=r_associated | relid=0 | w=15
  3458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:icelandic families
    n1=Hyde (prurigo nodulaire de) | n2=en:icelandic families | rel=r_associated | relid=0 | w=15
  3459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:icterus can be increased by oral contraceptives, pregnancy, or intercurrent illness
    n1=Hyde (prurigo nodulaire de) | n2=en:icterus can be increased by oral contraceptives, pregnancy, or intercurrent illness | rel=r_associated | relid=0 | w=15
  3460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:if onset of diabetes is before age 25, the diagnosis is consistent with maturity-onset diabetes of the young type 5 (mody5)
    n1=Hyde (prurigo nodulaire de) | n2=en:if onset of diabetes is before age 25, the diagnosis is consistent with maturity-onset diabetes of the young type 5 (mody5) | rel=r_associated | relid=0 | w=15
  3461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:immunity-related gtpase family m protein
    n1=Hyde (prurigo nodulaire de) | n2=en:immunity-related gtpase family m protein | rel=r_associated | relid=0 | w=15
  3462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:immunodeficiency is progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:immunodeficiency is progressive | rel=r_associated | relid=0 | w=15
  3463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:immunologic defects are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:immunologic defects are variable | rel=r_associated | relid=0 | w=15
  3464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:immunologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:immunologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  3465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:immunosuppressive therapy may be beneficial
    n1=Hyde (prurigo nodulaire de) | n2=en:immunosuppressive therapy may be beneficial | rel=r_associated | relid=0 | w=15
  3466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:impaired healing
    n1=Hyde (prurigo nodulaire de) | n2=en:impaired healing | rel=r_associated | relid=0 | w=15
  3467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:imprinting at 11p15.5
    n1=Hyde (prurigo nodulaire de) | n2=en:imprinting at 11p15.5 | rel=r_associated | relid=0 | w=15
  3468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:improvement of abnormal muscle biopsy and cox deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:improvement of abnormal muscle biopsy and cox deficiency | rel=r_associated | relid=0 | w=15
  3469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:improvement of epimetaphyseal changes with age
    n1=Hyde (prurigo nodulaire de) | n2=en:improvement of epimetaphyseal changes with age | rel=r_associated | relid=0 | w=15
  3470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:improvement with age
    n1=Hyde (prurigo nodulaire de) | n2=en:improvement with age | rel=r_associated | relid=0 | w=15
  3471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in 1 family, heterozygous mutations were associated with hypobetalipoproteinemia and acanthocytes without neurologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:in 1 family, heterozygous mutations were associated with hypobetalipoproteinemia and acanthocytes without neurologic abnormalities | rel=r_associated | relid=0 | w=15
  3472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in adults, may be considered part of a spectrum with hemolytic-uremic syndrome (hus, 235400)
    n1=Hyde (prurigo nodulaire de) | n2=en:in adults, may be considered part of a spectrum with hemolytic-uremic syndrome (hus, 235400) | rel=r_associated | relid=0 | w=15
  3473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in contrast to other forms of progeria, these patients do not have atherosclerosis, cardiac ischemia, or metabolic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:in contrast to other forms of progeria, these patients do not have atherosclerosis, cardiac ischemia, or metabolic abnormalities | rel=r_associated | relid=0 | w=15
  3474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in general, men have more severe disease than women
    n1=Hyde (prurigo nodulaire de) | n2=en:in general, men have more severe disease than women | rel=r_associated | relid=0 | w=15
  3475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in inbred old order mennonite population of lancaster county, msud prevalence is 1/176 newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:in inbred old order mennonite population of lancaster county, msud prevalence is 1/176 newborns | rel=r_associated | relid=0 | w=15
  3476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in severe attacks, hemiplegia or coma may last days to weeks
    n1=Hyde (prurigo nodulaire de) | n2=en:in severe attacks, hemiplegia or coma may last days to weeks | rel=r_associated | relid=0 | w=15
  3477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in some patients, qtc interval is prolonged only during exercise testing
    n1=Hyde (prurigo nodulaire de) | n2=en:in some patients, qtc interval is prolonged only during exercise testing | rel=r_associated | relid=0 | w=15
  3478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:in the absence of hydrops, death occurs within 3 months
    n1=Hyde (prurigo nodulaire de) | n2=en:in the absence of hydrops, death occurs within 3 months | rel=r_associated | relid=0 | w=15
  3479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:inborn error of the pyrimidine degradation pathway
    n1=Hyde (prurigo nodulaire de) | n2=en:inborn error of the pyrimidine degradation pathway | rel=r_associated | relid=0 | w=15
  3480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence - 1 in 25,000-100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence - 1 in 25,000-100,000 | rel=r_associated | relid=0 | w=15
  3481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence - 1/16,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence - 1/16,000 live births | rel=r_associated | relid=0 | w=15
  3482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 15,000-28,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 15,000-28,000 births | rel=r_associated | relid=0 | w=15
  3483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 20,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 20,000 | rel=r_associated | relid=0 | w=15
  3484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 30,000 male births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 30,000 male births | rel=r_associated | relid=0 | w=15
  3485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 300,000 in japan
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 300,000 in japan | rel=r_associated | relid=0 | w=15
  3486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 50,000-100,000 in western europe
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 50,000-100,000 in western europe | rel=r_associated | relid=0 | w=15
  3487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 6,000 to 1 in 8,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 6,000 to 1 in 8,000 live births | rel=r_associated | relid=0 | w=15
  3488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1 in 8,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1 in 8,000 live births | rel=r_associated | relid=0 | w=15
  3489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1-1.5/1,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1-1.5/1,000 live births | rel=r_associated | relid=0 | w=15
  3490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1/1,200-1/15,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1/1,200-1/15,000 live births | rel=r_associated | relid=0 | w=15
  3491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1/100,000 - 1/200,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1/100,000 - 1/200,000 live births | rel=r_associated | relid=0 | w=15
  3492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 1/20,000-1/64,000 male births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 1/20,000-1/64,000 male births | rel=r_associated | relid=0 | w=15
  3493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 2-5% of north american children
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 2-5% of north american children | rel=r_associated | relid=0 | w=15
  3494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 5-50 per million (children) and 10-40 per million (adults)
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 5-50 per million (children) and 10-40 per million (adults) | rel=r_associated | relid=0 | w=15
  3495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 7-15% in pacific island populations
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 7-15% in pacific island populations | rel=r_associated | relid=0 | w=15
  3496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence 8/1,000 newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence 8/1,000 newborns | rel=r_associated | relid=0 | w=15
  3497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence approximately 2-3/10,000 newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence approximately 2-3/10,000 newborns | rel=r_associated | relid=0 | w=15
  3498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence in finland is 1 in 76,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence in finland is 1 in 76,000 births | rel=r_associated | relid=0 | w=15
  3499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence in japan is 1 in 57,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence in japan is 1 in 57,000 | rel=r_associated | relid=0 | w=15
  3500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence in the finnish population of 0.2-1.3 cases per million per year
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence in the finnish population of 0.2-1.3 cases per million per year | rel=r_associated | relid=0 | w=15
  3501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence in united states of 1 in 55,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence in united states of 1 in 55,000 | rel=r_associated | relid=0 | w=15
  3502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence is estimated to be between 1 in 2,000 and 1 in 7,000 live births | rel=r_associated | relid=0 | w=15
  3503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence is less than 1 in 70,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence is less than 1 in 70,000 births | rel=r_associated | relid=0 | w=15
  3504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 0.51 per million in france
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 0.51 per million in france | rel=r_associated | relid=0 | w=15
  3505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 1,000,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 1,000,000 | rel=r_associated | relid=0 | w=15
  3506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 1.5 million births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 1.5 million births | rel=r_associated | relid=0 | w=15
  3507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 10,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 10,000 live births | rel=r_associated | relid=0 | w=15
  3508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 10,000 to 1 in 20,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 10,000 to 1 in 20,000 | rel=r_associated | relid=0 | w=15
  3509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 100 in some local nordic areas
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 100 in some local nordic areas | rel=r_associated | relid=0 | w=15
  3510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 100,000 | rel=r_associated | relid=0 | w=15
  3511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 100,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 100,000 births | rel=r_associated | relid=0 | w=15
  3512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 100,000 births in caucasians
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 100,000 births in caucasians | rel=r_associated | relid=0 | w=15
  3513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 100,000 to 125,000 at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 100,000 to 125,000 at birth | rel=r_associated | relid=0 | w=15
  3514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 120,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 120,000 live births | rel=r_associated | relid=0 | w=15
  3515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 150,000 live births in the general population
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 150,000 live births in the general population | rel=r_associated | relid=0 | w=15
  3516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 2,000 in saguenay-lac-saint-jean region
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 2,000 in saguenay-lac-saint-jean region | rel=r_associated | relid=0 | w=15
  3517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 20,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 20,000 live births | rel=r_associated | relid=0 | w=15
  3518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 25,000 livebirths
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 25,000 livebirths | rel=r_associated | relid=0 | w=15
  3519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 25,000 to 1 in 50,000 newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 25,000 to 1 in 50,000 newborns | rel=r_associated | relid=0 | w=15
  3520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 250,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 250,000 births | rel=r_associated | relid=0 | w=15
  3521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 276,000 in the netherlands
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 276,000 in the netherlands | rel=r_associated | relid=0 | w=15
  3522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 3,500 boys
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 3,500 boys | rel=r_associated | relid=0 | w=15
  3523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 3,900 births among jewish persons
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 3,900 births among jewish persons | rel=r_associated | relid=0 | w=15
  3524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 300,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 300,000 | rel=r_associated | relid=0 | w=15
  3525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 320,000 births among non-jewish persons
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 320,000 births among non-jewish persons | rel=r_associated | relid=0 | w=15
  3526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 39,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 39,000 | rel=r_associated | relid=0 | w=15
  3527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 40,000 infants worldwide
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 40,000 infants worldwide | rel=r_associated | relid=0 | w=15
  3528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 480 among old order amish
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 480 among old order amish | rel=r_associated | relid=0 | w=15
  3529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 5,000 to 1 in 10,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 5,000 to 1 in 10,000 | rel=r_associated | relid=0 | w=15
  3530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 5,000 to 1 in 7,000 in moroccan jewish individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 5,000 to 1 in 7,000 in moroccan jewish individuals | rel=r_associated | relid=0 | w=15
  3531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 5,000-8,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 5,000-8,000 | rel=r_associated | relid=0 | w=15
  3532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 50,000 to 1 in 100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 50,000 to 1 in 100,000 | rel=r_associated | relid=0 | w=15
  3533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 500,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 500,000 live births | rel=r_associated | relid=0 | w=15
  3534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 57,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 57,000 | rel=r_associated | relid=0 | w=15
  3535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 in 6,000 males
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 in 6,000 males | rel=r_associated | relid=0 | w=15
  3536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1 per 10,000 births in japan
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1 per 10,000 births in japan | rel=r_associated | relid=0 | w=15
  3537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1/100,000 in italy and finland
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1/100,000 in italy and finland | rel=r_associated | relid=0 | w=15
  3538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1/50,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1/50,000 births | rel=r_associated | relid=0 | w=15
  3539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 1% in yarmouth county, nova scotia
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 1% in yarmouth county, nova scotia | rel=r_associated | relid=0 | w=15
  3540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 12.2 per 100,000 in finland
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 12.2 per 100,000 in finland | rel=r_associated | relid=0 | w=15
  3541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of 4 per million per year
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of 4 per million per year | rel=r_associated | relid=0 | w=15
  3542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of all forms of cjd is 0.5 to 1.5 per million per year
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of all forms of cjd is 0.5 to 1.5 per million per year | rel=r_associated | relid=0 | w=15
  3543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of mh in anesthetized adults is 1 in 50,000-100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of mh in anesthetized adults is 1 in 50,000-100,000 | rel=r_associated | relid=0 | w=15
  3544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence of mh in anesthetized children is 1 in 15,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence of mh in anesthetized children is 1 in 15,000 | rel=r_associated | relid=0 | w=15
  3545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence ranges from 1 in 238,095 to 1 in 300,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence ranges from 1 in 238,095 to 1 in 300,000 births | rel=r_associated | relid=0 | w=15
  3546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence ranges from 1 in 40,000 to 1 in 350,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence ranges from 1 in 40,000 to 1 in 350,000 births | rel=r_associated | relid=0 | w=15
  3547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence ranges from 1 in 8,500 to 1 in 12,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence ranges from 1 in 8,500 to 1 in 12,000 births | rel=r_associated | relid=0 | w=15
  3548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence worldwide of 1 in 30,000 to 50,000
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence worldwide of 1 in 30,000 to 50,000 | rel=r_associated | relid=0 | w=15
  3549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence, 1 in 500 heterozygotes, 1 in 1,000,000 homozygotes | rel=r_associated | relid=0 | w=15
  3550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incidence, 1 in 650-1000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:incidence, 1 in 650-1000 live births | rel=r_associated | relid=0 | w=15
  3551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incompetent cervix
    n1=Hyde (prurigo nodulaire de) | n2=en:incompetent cervix | rel=r_associated | relid=0 | w=15
  3552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetance of some features
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetance of some features | rel=r_associated | relid=0 | w=15
  3553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance | rel=r_associated | relid=0 | w=15
  3554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance - approximately 50% males and 10% females with a pathogenic mtdna mutation develop the optic neuropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance - approximately 50% males and 10% females with a pathogenic mtdna mutation develop the optic neuropathy | rel=r_associated | relid=0 | w=15
  3555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance (50%)
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance (50%) | rel=r_associated | relid=0 | w=15
  3556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance (as low as 30% in some cases)
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance (as low as 30% in some cases) | rel=r_associated | relid=0 | w=15
  3557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance (range 13% to 77% by 50 years of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance (range 13% to 77% by 50 years of age) | rel=r_associated | relid=0 | w=15
  3558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance in carrier females
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance in carrier females | rel=r_associated | relid=0 | w=15
  3559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance in females
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance in females | rel=r_associated | relid=0 | w=15
  3560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance of optic atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance of optic atrophy | rel=r_associated | relid=0 | w=15
  3561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance of the 3 main clinical signs, myopathy, dementia, and paget disease
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance of the 3 main clinical signs, myopathy, dementia, and paget disease | rel=r_associated | relid=0 | w=15
  3562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance with 45 to 51 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance with 45 to 51 repeats | rel=r_associated | relid=0 | w=15
  3563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete penetrance, some individuals have only emg changes without other clinical signs
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete penetrance, some individuals have only emg changes without other clinical signs | rel=r_associated | relid=0 | w=15
  3564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete, age-associated penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete, age-associated penetrance | rel=r_associated | relid=0 | w=15
  3565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:incomplete, but high, penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:incomplete, but high, penetrance | rel=r_associated | relid=0 | w=15
  3566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased abortuses of homozygous or compound heterozygous fetuses
    n1=Hyde (prurigo nodulaire de) | n2=en:increased abortuses of homozygous or compound heterozygous fetuses | rel=r_associated | relid=0 | w=15
  3567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased amniotic fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:increased amniotic fluid | rel=r_associated | relid=0 | w=15
  3568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased aneuploidy in offspring
    n1=Hyde (prurigo nodulaire de) | n2=en:increased aneuploidy in offspring | rel=r_associated | relid=0 | w=15
  3569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased bleeding after surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:increased bleeding after surgery | rel=r_associated | relid=0 | w=15
  3570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased carbohydrate diet
    n1=Hyde (prurigo nodulaire de) | n2=en:increased carbohydrate diet | rel=r_associated | relid=0 | w=15
  3571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency among french-canadians from the charlevoix-saguenay-lac saint jean area of quebec (carrier rate 1 in 26)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency among french-canadians from the charlevoix-saguenay-lac saint jean area of quebec (carrier rate 1 in 26) | rel=r_associated | relid=0 | w=15
  3572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency among individuals of east asian descent
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency among individuals of east asian descent | rel=r_associated | relid=0 | w=15
  3573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency among japanese and chinese
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency among japanese and chinese | rel=r_associated | relid=0 | w=15
  3574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency among jewish iranian individuals from isfahan
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency among jewish iranian individuals from isfahan | rel=r_associated | relid=0 | w=15
  3575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in ashkenazi jewish population (1/100 are carriers)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in ashkenazi jewish population (1/100 are carriers) | rel=r_associated | relid=0 | w=15
  3576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in ashkenazi jewish population and in finland
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in ashkenazi jewish population and in finland | rel=r_associated | relid=0 | w=15
  3577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in ashkenazi jews (carrier frequency 1 in 14)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in ashkenazi jews (carrier frequency 1 in 14) | rel=r_associated | relid=0 | w=15
  3578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in eastern pennsylvania amish
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in eastern pennsylvania amish | rel=r_associated | relid=0 | w=15
  3579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in finland
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in finland | rel=r_associated | relid=0 | w=15
  3580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in finland (incidence 1:60,000 finnish newborns)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in finland (incidence 1:60,000 finnish newborns) | rel=r_associated | relid=0 | w=15
  3581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in finland (prevalence of 1 in 20,000)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in finland (prevalence of 1 in 20,000) | rel=r_associated | relid=0 | w=15
  3582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in individuals of asian descent
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in individuals of asian descent | rel=r_associated | relid=0 | w=15
  3583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in individuals originating from western scotland
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in individuals originating from western scotland | rel=r_associated | relid=0 | w=15
  3584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in iraqi jews, selected arab populations, french gypsies, and natives of southern india
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in iraqi jews, selected arab populations, french gypsies, and natives of southern india | rel=r_associated | relid=0 | w=15
  3585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in persian jews (1:1,300)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in persian jews (1:1,300) | rel=r_associated | relid=0 | w=15
  3586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the charlevoix and saguenat-lac-st-jean regions of quebec, canada (1 in 2,117 live births, carrier rate 1 in 23)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the charlevoix and saguenat-lac-st-jean regions of quebec, canada (1 in 2,117 live births, carrier rate 1 in 23) | rel=r_associated | relid=0 | w=15
  3587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the dariusleut hutterites (canada)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the dariusleut hutterites (canada) | rel=r_associated | relid=0 | w=15
  3588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the faroe islands (carrier 1 in 25)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the faroe islands (carrier 1 in 25) | rel=r_associated | relid=0 | w=15
  3589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the finnish population
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the finnish population | rel=r_associated | relid=0 | w=15
  3590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the ngobe-bugle tribe in the boca del toro province, on the northwestern caribbean coast of panama
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the ngobe-bugle tribe in the boca del toro province, on the northwestern caribbean coast of panama | rel=r_associated | relid=0 | w=15
  3591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in the state of bahia, brazil
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in the state of bahia, brazil | rel=r_associated | relid=0 | w=15
  3592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased frequency in vastebotten county in northern sweden and gelenau in southeastern germany
    n1=Hyde (prurigo nodulaire de) | n2=en:increased frequency in vastebotten county in northern sweden and gelenau in southeastern germany | rel=r_associated | relid=0 | w=15
  3593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased incidence in asian countries (e.g., 1.46 per 10,000 live births in taiwan) | rel=r_associated | relid=0 | w=15
  3594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased male to female ratio (7.5:1)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased male to female ratio (7.5:1) | rel=r_associated | relid=0 | w=15
  3595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased male-to-female ratio (3-4 to 1)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased male-to-female ratio (3-4 to 1) | rel=r_associated | relid=0 | w=15
  3596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased morbidity/mortality in affected males
    n1=Hyde (prurigo nodulaire de) | n2=en:increased morbidity/mortality in affected males | rel=r_associated | relid=0 | w=15
  3597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased paternal age
    n1=Hyde (prurigo nodulaire de) | n2=en:increased paternal age | rel=r_associated | relid=0 | w=15
  3598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence among the finnish
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence among the finnish | rel=r_associated | relid=0 | w=15
  3599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence in individuals of jewish-iraqi origin
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence in individuals of jewish-iraqi origin | rel=r_associated | relid=0 | w=15
  3600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence in individuals of turkish descent
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence in individuals of turkish descent | rel=r_associated | relid=0 | w=15
  3601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence in northern finland (7.3/100,000)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence in northern finland (7.3/100,000) | rel=r_associated | relid=0 | w=15
  3602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence in persons of ashkenazi jewish descent
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence in persons of ashkenazi jewish descent | rel=r_associated | relid=0 | w=15
  3603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased prevalence in the french-canadian population
    n1=Hyde (prurigo nodulaire de) | n2=en:increased prevalence in the french-canadian population | rel=r_associated | relid=0 | w=15
  3604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased rate of miscarriage in affected individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:increased rate of miscarriage in affected individuals | rel=r_associated | relid=0 | w=15
  3605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased recurrence risk with parental translocation
    n1=Hyde (prurigo nodulaire de) | n2=en:increased recurrence risk with parental translocation | rel=r_associated | relid=0 | w=15
  3606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of bilateral breast cancer
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of bilateral breast cancer | rel=r_associated | relid=0 | w=15
  3607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of developing early-onset aggressive cancers
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of developing early-onset aggressive cancers | rel=r_associated | relid=0 | w=15
  3608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of developing multiple primary cancers
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of developing multiple primary cancers | rel=r_associated | relid=0 | w=15
  3609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of early death
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of early death | rel=r_associated | relid=0 | w=15
  3610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of miscarriage
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of miscarriage | rel=r_associated | relid=0 | w=15
  3611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased risk of myeloproliferative disorders in those with somatic mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:increased risk of myeloproliferative disorders in those with somatic mutations | rel=r_associated | relid=0 | w=15
  3612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased sensitivity to heat
    n1=Hyde (prurigo nodulaire de) | n2=en:increased sensitivity to heat | rel=r_associated | relid=0 | w=15
  3613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased sensitivity to valproic acid toxicity
    n1=Hyde (prurigo nodulaire de) | n2=en:increased sensitivity to valproic acid toxicity | rel=r_associated | relid=0 | w=15
  3614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased spontaneous abortions in carrier mothers
    n1=Hyde (prurigo nodulaire de) | n2=en:increased spontaneous abortions in carrier mothers | rel=r_associated | relid=0 | w=15
  3615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased susceptibility to bacterial and opportunistic infections, such as pneumocystis carinii
    n1=Hyde (prurigo nodulaire de) | n2=en:increased susceptibility to bacterial and opportunistic infections, such as pneumocystis carinii | rel=r_associated | relid=0 | w=15
  3616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased susceptibility to infections
    n1=Hyde (prurigo nodulaire de) | n2=en:increased susceptibility to infections | rel=r_associated | relid=0 | w=15
  3617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased susceptibility to malignant hyperthermia
    n1=Hyde (prurigo nodulaire de) | n2=en:increased susceptibility to malignant hyperthermia | rel=r_associated | relid=0 | w=15
  3618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased susceptibility to neisseria infections
    n1=Hyde (prurigo nodulaire de) | n2=en:increased susceptibility to neisseria infections | rel=r_associated | relid=0 | w=15
  3619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased susceptibility to toxic effects of treatment with 6-mercaptopurine (6mp), 6-thioguanine (6tg), and azathioprine (aza)
    n1=Hyde (prurigo nodulaire de) | n2=en:increased susceptibility to toxic effects of treatment with 6-mercaptopurine (6mp), 6-thioguanine (6tg), and azathioprine (aza) | rel=r_associated | relid=0 | w=15
  3620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:increased tendency to chromosomal nondisjunction
    n1=Hyde (prurigo nodulaire de) | n2=en:increased tendency to chromosomal nondisjunction | rel=r_associated | relid=0 | w=15
  3621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:independent ambulation is maintained
    n1=Hyde (prurigo nodulaire de) | n2=en:independent ambulation is maintained | rel=r_associated | relid=0 | w=15
  3622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:individuals develop ability to stand and walk
    n1=Hyde (prurigo nodulaire de) | n2=en:individuals develop ability to stand and walk | rel=r_associated | relid=0 | w=15
  3623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:individuals do not develop erythrocytosis under hypoxic conditions
    n1=Hyde (prurigo nodulaire de) | n2=en:individuals do not develop erythrocytosis under hypoxic conditions | rel=r_associated | relid=0 | w=15
  3624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:individuals may accumulate more pigment in hair and eyes with age
    n1=Hyde (prurigo nodulaire de) | n2=en:individuals may accumulate more pigment in hair and eyes with age | rel=r_associated | relid=0 | w=15
  3625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:individuals with the pcs trait are phenotypically normal
    n1=Hyde (prurigo nodulaire de) | n2=en:individuals with the pcs trait are phenotypically normal | rel=r_associated | relid=0 | w=15
  3626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infant and newborn nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:infant and newborn nutrition | rel=r_associated | relid=0 | w=15
  3627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infant death may occur secondary to sepsis
    n1=Hyde (prurigo nodulaire de) | n2=en:infant death may occur secondary to sepsis | rel=r_associated | relid=0 | w=15
  3628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile form (gene deletion 'complex' with glycerol kinase deficiency and/or duchenne muscular dystrophy and/or congenital adrenal hypoplasia)
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile form (gene deletion 'complex' with glycerol kinase deficiency and/or duchenne muscular dystrophy and/or congenital adrenal hypoplasia) | rel=r_associated | relid=0 | w=15
  3629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile form accounts for 90% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile form accounts for 90% of cases | rel=r_associated | relid=0 | w=15
  3630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile form has onset within first 6 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile form has onset within first 6 months of life | rel=r_associated | relid=0 | w=15
  3631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile form usually leads to death by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile form usually leads to death by age 2 years | rel=r_associated | relid=0 | w=15
  3632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile hypophosphatasia
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=15
  3633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile onset
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile onset | rel=r_associated | relid=0 | w=15
  3634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile onset (in 1 patient)
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile onset (in 1 patient) | rel=r_associated | relid=0 | w=15
  3635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile onset with hepatic involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile onset with hepatic involvement | rel=r_associated | relid=0 | w=15
  3636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infantile, late-infantile, juvenile, and adult onset have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile, late-infantile, juvenile, and adult onset have been reported | rel=r_associated | relid=0 | w=15
  3637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants are stillborn or die before age 1
    n1=Hyde (prurigo nodulaire de) | n2=en:infants are stillborn or die before age 1 | rel=r_associated | relid=0 | w=15
  3638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants are stillborn or die shortly after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:infants are stillborn or die shortly after birth | rel=r_associated | relid=0 | w=15
  3639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants may die from apnea or aspiration
    n1=Hyde (prurigo nodulaire de) | n2=en:infants may die from apnea or aspiration | rel=r_associated | relid=0 | w=15
  3640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants may have acute life-threatening crises
    n1=Hyde (prurigo nodulaire de) | n2=en:infants may have acute life-threatening crises | rel=r_associated | relid=0 | w=15
  3641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants occasionally mistaken as having down syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:infants occasionally mistaken as having down syndrome | rel=r_associated | relid=0 | w=15
  3642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infants show normal size and appearance
    n1=Hyde (prurigo nodulaire de) | n2=en:infants show normal size and appearance | rel=r_associated | relid=0 | w=15
  3643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infections may precipitate ketotic episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:infections may precipitate ketotic episodes | rel=r_associated | relid=0 | w=15
  3644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:infertility
    n1=Hyde (prurigo nodulaire de) | n2=en:infertility | rel=r_associated | relid=0 | w=15
  3645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:inflammatory arthritis may develop in 30% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:inflammatory arthritis may develop in 30% of patients | rel=r_associated | relid=0 | w=15
  3646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:inheritance may be x-linked dominant
    n1=Hyde (prurigo nodulaire de) | n2=en:inheritance may be x-linked dominant | rel=r_associated | relid=0 | w=15
  3647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:inheritance pattern is unclear
    n1=Hyde (prurigo nodulaire de) | n2=en:inheritance pattern is unclear | rel=r_associated | relid=0 | w=15
  3648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:initial cases reclassified as having schwartz-jampel syndrome (sjs1, 255800)
    n1=Hyde (prurigo nodulaire de) | n2=en:initial cases reclassified as having schwartz-jampel syndrome (sjs1, 255800) | rel=r_associated | relid=0 | w=15
  3649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:initial development may appear normal
    n1=Hyde (prurigo nodulaire de) | n2=en:initial development may appear normal | rel=r_associated | relid=0 | w=15
  3650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:initial recovery, but residual neurologic impairment occurs after repeated encephalopathic episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:initial recovery, but residual neurologic impairment occurs after repeated encephalopathic episodes | rel=r_associated | relid=0 | w=15
  3651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:initially normal for first 6-18 months which is then followed by withdrawal and regression
    n1=Hyde (prurigo nodulaire de) | n2=en:initially normal for first 6-18 months which is then followed by withdrawal and regression | rel=r_associated | relid=0 | w=15
  3652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:initially normal rod responses may become significantly reduced at older age
    n1=Hyde (prurigo nodulaire de) | n2=en:initially normal rod responses may become significantly reduced at older age | rel=r_associated | relid=0 | w=15
  3653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:inorganic chemical
    n1=Hyde (prurigo nodulaire de) | n2=en:inorganic chemical | rel=r_associated | relid=0 | w=15
  3654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:insidious onset
    n1=Hyde (prurigo nodulaire de) | n2=en:insidious onset | rel=r_associated | relid=0 | w=15
  3655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:insulin dependent diabetes mellitus:acnc:pt:^patient:ord
    n1=Hyde (prurigo nodulaire de) | n2=en:insulin dependent diabetes mellitus:acnc:pt:^patient:ord | rel=r_associated | relid=0 | w=15
  3656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intellectual disability is variable
    n1=Hyde (prurigo nodulaire de) | n2=en:intellectual disability is variable | rel=r_associated | relid=0 | w=15
  3657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:intellectual regression and loss of speech precede the onset of motor retardation by more than 10 years | rel=r_associated | relid=0 | w=15
  3658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intelligence is normal
    n1=Hyde (prurigo nodulaire de) | n2=en:intelligence is normal | rel=r_associated | relid=0 | w=15
  3659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intercellular matrix component
    n1=Hyde (prurigo nodulaire de) | n2=en:intercellular matrix component | rel=r_associated | relid=0 | w=15
  3660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:interfamilial and intrafamilial clinical heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:interfamilial and intrafamilial clinical heterogeneity | rel=r_associated | relid=0 | w=15
  3661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:interferon-induced gtp-binding protein mx2
    n1=Hyde (prurigo nodulaire de) | n2=en:interferon-induced gtp-binding protein mx2 | rel=r_associated | relid=0 | w=15
  3662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intermediate expression in females
    n1=Hyde (prurigo nodulaire de) | n2=en:intermediate expression in females | rel=r_associated | relid=0 | w=15
  3663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intermediate levels of factor x in mildly symptomatic heterozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:intermediate levels of factor x in mildly symptomatic heterozygotes | rel=r_associated | relid=0 | w=15
  3664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intermediate: onset in first decade with slow progression or onset in second decade with rapid progression
    n1=Hyde (prurigo nodulaire de) | n2=en:intermediate: onset in first decade with slow progression or onset in second decade with rapid progression | rel=r_associated | relid=0 | w=15
  3665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intermittent exacerbations
    n1=Hyde (prurigo nodulaire de) | n2=en:intermittent exacerbations | rel=r_associated | relid=0 | w=15
  3666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intermittent pyrexia
    n1=Hyde (prurigo nodulaire de) | n2=en:intermittent pyrexia | rel=r_associated | relid=0 | w=15
  3667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:internal organ rupture may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:internal organ rupture may occur | rel=r_associated | relid=0 | w=15
  3668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intolerant of heat
    n1=Hyde (prurigo nodulaire de) | n2=en:intolerant of heat | rel=r_associated | relid=0 | w=15
  3669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intra-amniotic infection of fetus
    n1=Hyde (prurigo nodulaire de) | n2=en:intra-amniotic infection of fetus | rel=r_associated | relid=0 | w=15
  3670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intracellular accumulation of material can occur in neuronal and nonneuronal cells
    n1=Hyde (prurigo nodulaire de) | n2=en:intracellular accumulation of material can occur in neuronal and nonneuronal cells | rel=r_associated | relid=0 | w=15
  3671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intracellular accumulation of material may not always be apparent
    n1=Hyde (prurigo nodulaire de) | n2=en:intracellular accumulation of material may not always be apparent | rel=r_associated | relid=0 | w=15
  3672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial phenotypic variation may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial phenotypic variation may occur | rel=r_associated | relid=0 | w=15
  3673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability | rel=r_associated | relid=0 | w=15
  3674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability in degree of hypotrichosis
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability in degree of hypotrichosis | rel=r_associated | relid=0 | w=15
  3675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability in degree of nail involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability in degree of nail involvement | rel=r_associated | relid=0 | w=15
  3676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability in nail changes
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability in nail changes | rel=r_associated | relid=0 | w=15
  3677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability in severity
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability in severity | rel=r_associated | relid=0 | w=15
  3678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variability in severity of hypothyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variability in severity of hypothyroidism | rel=r_associated | relid=0 | w=15
  3679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrafamilial variation
    n1=Hyde (prurigo nodulaire de) | n2=en:intrafamilial variation | rel=r_associated | relid=0 | w=15
  3680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrathecal pressure:pressure:point in time:intrathecal space:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:intrathecal pressure:pressure:point in time:intrathecal space:quantitative | rel=r_associated | relid=0 | w=15
  3681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:intrauterine fetal death
    n1=Hyde (prurigo nodulaire de) | n2=en:intrauterine fetal death | rel=r_associated | relid=0 | w=15
  3682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:involuntary and nonvolitional phenomenon
    n1=Hyde (prurigo nodulaire de) | n2=en:involuntary and nonvolitional phenomenon | rel=r_associated | relid=0 | w=15
  3683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:iron
    n1=Hyde (prurigo nodulaire de) | n2=en:iron | rel=r_associated | relid=0 | w=15
  3684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:isolated cases
    n1=Hyde (prurigo nodulaire de) | n2=en:isolated cases | rel=r_associated | relid=0 | w=15
  3685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:isolated finding
    n1=Hyde (prurigo nodulaire de) | n2=en:isolated finding | rel=r_associated | relid=0 | w=15
  3686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:itch, pain, and body malodor often
    n1=Hyde (prurigo nodulaire de) | n2=en:itch, pain, and body malodor often | rel=r_associated | relid=0 | w=15
  3687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:jbts shows autosomal dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:jbts shows autosomal dominant inheritance | rel=r_associated | relid=0 | w=15
  3688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:joint dislocations become less frequent with age
    n1=Hyde (prurigo nodulaire de) | n2=en:joint dislocations become less frequent with age | rel=r_associated | relid=0 | w=15
  3689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:joint laxity decreases with age
    n1=Hyde (prurigo nodulaire de) | n2=en:joint laxity decreases with age | rel=r_associated | relid=0 | w=15
  3690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:joint replacement often necessary
    n1=Hyde (prurigo nodulaire de) | n2=en:joint replacement often necessary | rel=r_associated | relid=0 | w=15
  3691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:joint symptoms begin in third or fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:joint symptoms begin in third or fourth decade | rel=r_associated | relid=0 | w=15
  3692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile absence epilepsy (jae, 607631)
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile absence epilepsy (jae, 607631) | rel=r_associated | relid=0 | w=15
  3693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile and adult forms are isolated glycerol kinase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile and adult forms are isolated glycerol kinase deficiency | rel=r_associated | relid=0 | w=15
  3694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile form has onset between 4 and 19 years
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile form has onset between 4 and 19 years | rel=r_associated | relid=0 | w=15
  3695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile myoclonic epilepsy (jme, 606904)
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile myoclonic epilepsy (jme, 606904) | rel=r_associated | relid=0 | w=15
  3696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile onset 4 years to puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile onset 4 years to puberty | rel=r_associated | relid=0 | w=15
  3697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile patients have slower clinical course with preserved intellect, bulbar signs, ataxia, and spasticity
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile patients have slower clinical course with preserved intellect, bulbar signs, ataxia, and spasticity | rel=r_associated | relid=0 | w=15
  3698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile rigid early-onset form more often paternally inherited
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile rigid early-onset form more often paternally inherited | rel=r_associated | relid=0 | w=15
  3699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:juvenile-onset (before 15 years of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile-onset (before 15 years of age) | rel=r_associated | relid=0 | w=15
  3700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:keratitis-ichthyosis-deafness syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:keratitis-ichthyosis-deafness syndrome | rel=r_associated | relid=0 | w=15
  3701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:keratoconus, which was observed in 1 family, might be secondary to eye rubbing due to lca
    n1=Hyde (prurigo nodulaire de) | n2=en:keratoconus, which was observed in 1 family, might be secondary to eye rubbing due to lca | rel=r_associated | relid=0 | w=15
  3702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:kid syndrome and hid syndrome are identical at the molecular level
    n1=Hyde (prurigo nodulaire de) | n2=en:kid syndrome and hid syndrome are identical at the molecular level | rel=r_associated | relid=0 | w=15
  3703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:klippel-feil anomaly may be a part of other syndromes, including murcs (601076) and sprengel deformity (184400)
    n1=Hyde (prurigo nodulaire de) | n2=en:klippel-feil anomaly may be a part of other syndromes, including murcs (601076) and sprengel deformity (184400) | rel=r_associated | relid=0 | w=15
  3704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:klotho
    n1=Hyde (prurigo nodulaire de) | n2=en:klotho | rel=r_associated | relid=0 | w=15
  3705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:kniest like dysplasia lethal
    n1=Hyde (prurigo nodulaire de) | n2=en:kniest like dysplasia lethal | rel=r_associated | relid=0 | w=15
  3706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:known as the 'french variety' of usher syndrome since the majority of families are from poitou-charentes, france
    n1=Hyde (prurigo nodulaire de) | n2=en:known as the 'french variety' of usher syndrome since the majority of families are from poitou-charentes, france | rel=r_associated | relid=0 | w=15
  3707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:known or suspected fetal abnormality affecting management of mother
    n1=Hyde (prurigo nodulaire de) | n2=en:known or suspected fetal abnormality affecting management of mother | rel=r_associated | relid=0 | w=15
  3708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:known or suspected fetal anencephaly affecting obstetrical care
    n1=Hyde (prurigo nodulaire de) | n2=en:known or suspected fetal anencephaly affecting obstetrical care | rel=r_associated | relid=0 | w=15
  3709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:known or suspected fetal spina bifida with myelomeningocele affecting obstetrical care
    n1=Hyde (prurigo nodulaire de) | n2=en:known or suspected fetal spina bifida with myelomeningocele affecting obstetrical care | rel=r_associated | relid=0 | w=15
  3710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:l-dopa-induced dyskinesias
    n1=Hyde (prurigo nodulaire de) | n2=en:l-dopa-induced dyskinesias | rel=r_associated | relid=0 | w=15
  3711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:labor and delivery complication
    n1=Hyde (prurigo nodulaire de) | n2=en:labor and delivery complication | rel=r_associated | relid=0 | w=15
  3712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:labor complication
    n1=Hyde (prurigo nodulaire de) | n2=en:labor complication | rel=r_associated | relid=0 | w=15
  3713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:laboratory comment:txt:pt:report:nar
    n1=Hyde (prurigo nodulaire de) | n2=en:laboratory comment:txt:pt:report:nar | rel=r_associated | relid=0 | w=15
  3714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:laboratory director name:pn:pt:provider:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:laboratory director name:pn:pt:provider:nom | rel=r_associated | relid=0 | w=15
  3715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:laboratory findings are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:laboratory findings are variable | rel=r_associated | relid=0 | w=15
  3716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lack of treatment results in early death
    n1=Hyde (prurigo nodulaire de) | n2=en:lack of treatment results in early death | rel=r_associated | relid=0 | w=15
  3717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lactic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:lactic acid | rel=r_associated | relid=0 | w=15
  3718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:large for gestational age
    n1=Hyde (prurigo nodulaire de) | n2=en:large for gestational age | rel=r_associated | relid=0 | w=15
  3719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:laryngeal edema can result in asphyxiation
    n1=Hyde (prurigo nodulaire de) | n2=en:laryngeal edema can result in asphyxiation | rel=r_associated | relid=0 | w=15
  3720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:last name:pn:pt:^guardian or legally authorized representative:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:last name:pn:pt:^guardian or legally authorized representative:nom | rel=r_associated | relid=0 | w=15
  3721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late adult onset (after age 55 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:late adult onset (after age 55 years) | rel=r_associated | relid=0 | w=15
  3722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late effect of complication of pregnancy, childbirth, and the puerperium
    n1=Hyde (prurigo nodulaire de) | n2=en:late effect of complication of pregnancy, childbirth, and the puerperium | rel=r_associated | relid=0 | w=15
  3723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late infantile form has onset between 19 months and 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:late infantile form has onset between 19 months and 4 years | rel=r_associated | relid=0 | w=15
  3724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late infantile onset 6-24 months
    n1=Hyde (prurigo nodulaire de) | n2=en:late infantile onset 6-24 months | rel=r_associated | relid=0 | w=15
  3725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late onset combined immunodeficiency with allelic variant 102700.0020
    n1=Hyde (prurigo nodulaire de) | n2=en:late onset combined immunodeficiency with allelic variant 102700.0020 | rel=r_associated | relid=0 | w=15
  3726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:late pregnancy | rel=r_associated | relid=0 | w=15
  3727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late pregnancy bleeding
    n1=Hyde (prurigo nodulaire de) | n2=en:late pregnancy bleeding | rel=r_associated | relid=0 | w=15
  3728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late-adult onset (fifth to sixth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:late-adult onset (fifth to sixth decade) | rel=r_associated | relid=0 | w=15
  3729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late-adult onset (range 50 to 80 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:late-adult onset (range 50 to 80 years) | rel=r_associated | relid=0 | w=15
  3730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late-adult onset (usually after age 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:late-adult onset (usually after age 50 years) | rel=r_associated | relid=0 | w=15
  3731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late-adult onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:late-adult onset has been reported | rel=r_associated | relid=0 | w=15
  3732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:late-onset, slowly progressing form of retinitis pigmentosa
    n1=Hyde (prurigo nodulaire de) | n2=en:late-onset, slowly progressing form of retinitis pigmentosa | rel=r_associated | relid=0 | w=15
  3733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later childhood onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:later childhood onset has been reported | rel=r_associated | relid=0 | w=15
  3734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset (late childhood to young adult) has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset (late childhood to young adult) has been reported | rel=r_associated | relid=0 | w=15
  3735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset associated with milder severity has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset associated with milder severity has been reported | rel=r_associated | relid=0 | w=15
  3736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset can also occur (up to age 17 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset can also occur (up to age 17 years) | rel=r_associated | relid=0 | w=15
  3737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset has been rarely reported (up to age 68 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset has been rarely reported (up to age 68 years) | rel=r_associated | relid=0 | w=15
  3738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset has been reported | rel=r_associated | relid=0 | w=15
  3739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset has been reported (third or fourth decades)
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset has been reported (third or fourth decades) | rel=r_associated | relid=0 | w=15
  3740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset in females
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset in females | rel=r_associated | relid=0 | w=15
  3741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset is associated with slower progression and lesser severity
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset is associated with slower progression and lesser severity | rel=r_associated | relid=0 | w=15
  3742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset may occur | rel=r_associated | relid=0 | w=15
  3743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset may occur (1 to 11 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset may occur (1 to 11 years) | rel=r_associated | relid=0 | w=15
  3744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset of hearing loss in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset of hearing loss in some patients | rel=r_associated | relid=0 | w=15
  3745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset of ophthalmoparesis
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset of ophthalmoparesis | rel=r_associated | relid=0 | w=15
  3746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset of optic atrophy (mean 19 years, range 5 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset of optic atrophy (mean 19 years, range 5 to 50 years) | rel=r_associated | relid=0 | w=15
  3747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:later onset with a milder phenotype may also occur
    n1=Hyde (prurigo nodulaire de) | n2=en:later onset with a milder phenotype may also occur | rel=r_associated | relid=0 | w=15
  3748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lauryl glucoside
    n1=Hyde (prurigo nodulaire de) | n2=en:lauryl glucoside | rel=r_associated | relid=0 | w=15
  3749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:leakage of fluid ('gusher') if the stapes is disturbed
    n1=Hyde (prurigo nodulaire de) | n2=en:leakage of fluid ('gusher') if the stapes is disturbed | rel=r_associated | relid=0 | w=15
  3750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:left side involvement associated with serious cardiac defect
    n1=Hyde (prurigo nodulaire de) | n2=en:left side involvement associated with serious cardiac defect | rel=r_associated | relid=0 | w=15
  3751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:left side involvement more frequent than right side involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:left side involvement more frequent than right side involvement | rel=r_associated | relid=0 | w=15
  3752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:left sided involvement occurs more frequently
    n1=Hyde (prurigo nodulaire de) | n2=en:left sided involvement occurs more frequently | rel=r_associated | relid=0 | w=15
  3753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:leg pain
    n1=Hyde (prurigo nodulaire de) | n2=en:leg pain | rel=r_associated | relid=0 | w=15
  3754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:leg pain during childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:leg pain during childhood | rel=r_associated | relid=0 | w=15
  3755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:leigh syndrome, x-linked
    n1=Hyde (prurigo nodulaire de) | n2=en:leigh syndrome, x-linked | rel=r_associated | relid=0 | w=15
  3756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:length of attack, 3 to 7 days
    n1=Hyde (prurigo nodulaire de) | n2=en:length of attack, 3 to 7 days | rel=r_associated | relid=0 | w=15
  3757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:length of calorie fast:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:length of calorie fast:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  3758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:length of time post dose:time:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:length of time post dose:time:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  3759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:leopard is an acronym: lentigines, ekg abnormalities, ocular hypertelorism, obstructive cardiomyopathy, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness
    n1=Hyde (prurigo nodulaire de) | n2=en:leopard is an acronym: lentigines, ekg abnormalities, ocular hypertelorism, obstructive cardiomyopathy, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and deafness | rel=r_associated | relid=0 | w=15
  3760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions apparent at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions apparent at birth | rel=r_associated | relid=0 | w=15
  3761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions appear in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions appear in infancy or early childhood | rel=r_associated | relid=0 | w=15
  3762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions are present at birth or become apparent in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions are present at birth or become apparent in infancy | rel=r_associated | relid=0 | w=15
  3763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions become more prominent with sun exposure
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions become more prominent with sun exposure | rel=r_associated | relid=0 | w=15
  3764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions continue to grow until epiphyseal plate closure
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions continue to grow until epiphyseal plate closure | rel=r_associated | relid=0 | w=15
  3765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions grow and spread with age
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions grow and spread with age | rel=r_associated | relid=0 | w=15
  3766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions increase in size and number with age
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions increase in size and number with age | rel=r_associated | relid=0 | w=15
  3767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions occur mainly on the pinnae of the ears or on the face
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions occur mainly on the pinnae of the ears or on the face | rel=r_associated | relid=0 | w=15
  3768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lesions provoked by friction, sun exposure, heat, and injury
    n1=Hyde (prurigo nodulaire de) | n2=en:lesions provoked by friction, sun exposure, heat, and injury | rel=r_associated | relid=0 | w=15
  3769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:less severe phenotype in females
    n1=Hyde (prurigo nodulaire de) | n2=en:less severe phenotype in females | rel=r_associated | relid=0 | w=15
  3770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:less than 20% have onset at 18 years of age or less (dominant and recessive)
    n1=Hyde (prurigo nodulaire de) | n2=en:less than 20% have onset at 18 years of age or less (dominant and recessive) | rel=r_associated | relid=0 | w=15
  3771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:less than 50% penetrance in some families
    n1=Hyde (prurigo nodulaire de) | n2=en:less than 50% penetrance in some families | rel=r_associated | relid=0 | w=15
  3772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal | rel=r_associated | relid=0 | w=15
  3773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal congenital contracture syndrome 2
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal congenital contracture syndrome 2 | rel=r_associated | relid=0 | w=15
  3774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal congenital contracture syndrome 5
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal congenital contracture syndrome 5 | rel=r_associated | relid=0 | w=15
  3775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal in 40% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal in 40% of patients | rel=r_associated | relid=0 | w=15
  3776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal in males
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal in males | rel=r_associated | relid=0 | w=15
  3777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal in the neonatal period | rel=r_associated | relid=0 | w=15
  3778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal multiple pterygium syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal multiple pterygium syndrome | rel=r_associated | relid=0 | w=15
  3779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lethal tight skin contracture syndrome (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:lethal tight skin contracture syndrome (disorder) | rel=r_associated | relid=0 | w=15
  3780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:levodopa-induced dyskinesias
    n1=Hyde (prurigo nodulaire de) | n2=en:levodopa-induced dyskinesias | rel=r_associated | relid=0 | w=15
  3781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:levodopa-responsive
    n1=Hyde (prurigo nodulaire de) | n2=en:levodopa-responsive | rel=r_associated | relid=0 | w=15
  3782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:life-threatening in infancy due to sepsis
    n1=Hyde (prurigo nodulaire de) | n2=en:life-threatening in infancy due to sepsis | rel=r_associated | relid=0 | w=15
  3783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:life-threatening infections
    n1=Hyde (prurigo nodulaire de) | n2=en:life-threatening infections | rel=r_associated | relid=0 | w=15
  3784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifelong occurrence
    n1=Hyde (prurigo nodulaire de) | n2=en:lifelong occurrence | rel=r_associated | relid=0 | w=15
  3785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifetime risk of breast cancer in male mutation carriers in 6%
    n1=Hyde (prurigo nodulaire de) | n2=en:lifetime risk of breast cancer in male mutation carriers in 6% | rel=r_associated | relid=0 | w=15
  3786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifetime risk of breast cancer in mutation carriers is 60 to 85%
    n1=Hyde (prurigo nodulaire de) | n2=en:lifetime risk of breast cancer in mutation carriers is 60 to 85% | rel=r_associated | relid=0 | w=15
  3787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifetime risk of breast cancer in mutation carriers is 80 to 90%
    n1=Hyde (prurigo nodulaire de) | n2=en:lifetime risk of breast cancer in mutation carriers is 80 to 90% | rel=r_associated | relid=0 | w=15
  3788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20%
    n1=Hyde (prurigo nodulaire de) | n2=en:lifetime risk of ovarian cancer in mutation carriers is 10 to 20% | rel=r_associated | relid=0 | w=15
  3789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lifetime risk of ovarian cancer in mutation carriers is 40 to 50%
    n1=Hyde (prurigo nodulaire de) | n2=en:lifetime risk of ovarian cancer in mutation carriers is 40 to 50% | rel=r_associated | relid=0 | w=15
  3790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:likely allelic to sc phocomelia syndrome (269000)
    n1=Hyde (prurigo nodulaire de) | n2=en:likely allelic to sc phocomelia syndrome (269000) | rel=r_associated | relid=0 | w=15
  3791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limb malformations are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:limb malformations are variable | rel=r_associated | relid=0 | w=15
  3792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limb reduction defects typically involve the distal phalanges or entire digit, with rare involvement of more proximal limb structures
    n1=Hyde (prurigo nodulaire de) | n2=en:limb reduction defects typically involve the distal phalanges or entire digit, with rare involvement of more proximal limb structures | rel=r_associated | relid=0 | w=15
  3793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limb-girdle muscular dystrophy 1a (lgmd1a, 159000) is an allelic disorder with overlapping clinical features
    n1=Hyde (prurigo nodulaire de) | n2=en:limb-girdle muscular dystrophy 1a (lgmd1a, 159000) is an allelic disorder with overlapping clinical features | rel=r_associated | relid=0 | w=15
  3794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limb-girdle muscular dystrophy 1b (lgmd1b, 159001) is an allelic disorder with an overlapping phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:limb-girdle muscular dystrophy 1b (lgmd1b, 159001) is an allelic disorder with an overlapping phenotype | rel=r_associated | relid=0 | w=15
  3795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limb-girdle muscular dystrophy type 2l (lgmd2l, 611307) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:limb-girdle muscular dystrophy type 2l (lgmd2l, 611307) is an allelic disorder | rel=r_associated | relid=0 | w=15
  3796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limited clinical information provided for patients with bbs12 mutations (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:limited clinical information provided for patients with bbs12 mutations (last curated october 2014) | rel=r_associated | relid=0 | w=15
  3797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limited clinical information provided for patients with mks1 mutations (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:limited clinical information provided for patients with mks1 mutations (last curated october 2014) | rel=r_associated | relid=0 | w=15
  3798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:limited clinical information provided on patients with bbs7 mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:limited clinical information provided on patients with bbs7 mutations | rel=r_associated | relid=0 | w=15
  3799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:linked to 10q24 trisomy
    n1=Hyde (prurigo nodulaire de) | n2=en:linked to 10q24 trisomy | rel=r_associated | relid=0 | w=15
  3800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lipodystrophic appearance may be mild or not present
    n1=Hyde (prurigo nodulaire de) | n2=en:lipodystrophic appearance may be mild or not present | rel=r_associated | relid=0 | w=15
  3801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lipoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:lipoprotein | rel=r_associated | relid=0 | w=15
  3802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:live born infants die within few hours of birth
    n1=Hyde (prurigo nodulaire de) | n2=en:live born infants die within few hours of birth | rel=r_associated | relid=0 | w=15
  3803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liveborn often die within first week of life
    n1=Hyde (prurigo nodulaire de) | n2=en:liveborn often die within first week of life | rel=r_associated | relid=0 | w=15
  3804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver disease may be the most predominant finding
    n1=Hyde (prurigo nodulaire de) | n2=en:liver disease may be the most predominant finding | rel=r_associated | relid=0 | w=15
  3805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver enzymes decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:liver enzymes decrease with age | rel=r_associated | relid=0 | w=15
  3806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver functions return to normal after 3 to 4 months
    n1=Hyde (prurigo nodulaire de) | n2=en:liver functions return to normal after 3 to 4 months | rel=r_associated | relid=0 | w=15
  3807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver involvement can range from mild to severe
    n1=Hyde (prurigo nodulaire de) | n2=en:liver involvement can range from mild to severe | rel=r_associated | relid=0 | w=15
  3808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver size returns to normal after 3 months to 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:liver size returns to normal after 3 months to 3 years | rel=r_associated | relid=0 | w=15
  3809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:liver symptoms improve with age and disappear after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:liver symptoms improve with age and disappear after puberty | rel=r_associated | relid=0 | w=15
  3810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lmd is the homozygous form of the less severe leri-weill dyschondrosteosis (127300)
    n1=Hyde (prurigo nodulaire de) | n2=en:lmd is the homozygous form of the less severe leri-weill dyschondrosteosis (127300) | rel=r_associated | relid=0 | w=15
  3811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:long duration
    n1=Hyde (prurigo nodulaire de) | n2=en:long duration | rel=r_associated | relid=0 | w=15
  3812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:long headache duration (greater than 12 hours)
    n1=Hyde (prurigo nodulaire de) | n2=en:long headache duration (greater than 12 hours) | rel=r_associated | relid=0 | w=15
  3813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:longer disease duration than creutzfeldt-jakob disease
    n1=Hyde (prurigo nodulaire de) | n2=en:longer disease duration than creutzfeldt-jakob disease | rel=r_associated | relid=0 | w=15
  3814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss initially affects mid and high frequencies
    n1=Hyde (prurigo nodulaire de) | n2=en:loss initially affects mid and high frequencies | rel=r_associated | relid=0 | w=15
  3815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of ambulation | rel=r_associated | relid=0 | w=15
  3816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of ambulation within 10 years of onset
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of ambulation within 10 years of onset | rel=r_associated | relid=0 | w=15
  3817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of independent ambulation (in 2 of 3 patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of independent ambulation (in 2 of 3 patients) | rel=r_associated | relid=0 | w=15
  3818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of independent ambulation due to muscle weakness in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of independent ambulation due to muscle weakness in adulthood | rel=r_associated | relid=0 | w=15
  3819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of independent ambulation in the second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of independent ambulation in the second decade | rel=r_associated | relid=0 | w=15
  3820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of independent walking by teenage years (in some)
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of independent walking by teenage years (in some) | rel=r_associated | relid=0 | w=15
  3821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:loss of tumor suppressor gene
    n1=Hyde (prurigo nodulaire de) | n2=en:loss of tumor suppressor gene | rel=r_associated | relid=0 | w=15
  3822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:low physical performance
    n1=Hyde (prurigo nodulaire de) | n2=en:low physical performance | rel=r_associated | relid=0 | w=15
  3823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lower limb involvement occurs before upper limb involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:lower limb involvement occurs before upper limb involvement | rel=r_associated | relid=0 | w=15
  3824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lower limb involvement precedes upper limb involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:lower limb involvement precedes upper limb involvement | rel=r_associated | relid=0 | w=15
  3825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lower limb weakness is presenting feature
    n1=Hyde (prurigo nodulaire de) | n2=en:lower limb weakness is presenting feature | rel=r_associated | relid=0 | w=15
  3826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lower limbs more severely affected
    n1=Hyde (prurigo nodulaire de) | n2=en:lower limbs more severely affected | rel=r_associated | relid=0 | w=15
  3827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:luminal protein subunit
    n1=Hyde (prurigo nodulaire de) | n2=en:luminal protein subunit | rel=r_associated | relid=0 | w=15
  3828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:luton and torrance type differentiated based on histologic findings in cartilage
    n1=Hyde (prurigo nodulaire de) | n2=en:luton and torrance type differentiated based on histologic findings in cartilage | rel=r_associated | relid=0 | w=15
  3829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lymphedema resolves by age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:lymphedema resolves by age 3 years | rel=r_associated | relid=0 | w=15
  3830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lymphedema that presents at puberty is called meige disease (153200)
    n1=Hyde (prurigo nodulaire de) | n2=en:lymphedema that presents at puberty is called meige disease (153200) | rel=r_associated | relid=0 | w=15
  3831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lysosomal storage vacuoles in trachea, liver, cartilage, and heart
    n1=Hyde (prurigo nodulaire de) | n2=en:lysosomal storage vacuoles in trachea, liver, cartilage, and heart | rel=r_associated | relid=0 | w=15
  3832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:lytta vesicatoria preparation
    n1=Hyde (prurigo nodulaire de) | n2=en:lytta vesicatoria preparation | rel=r_associated | relid=0 | w=15
  3833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:macromolecular substances
    n1=Hyde (prurigo nodulaire de) | n2=en:macromolecular substances | rel=r_associated | relid=0 | w=15
  3834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:macrosomia
    n1=Hyde (prurigo nodulaire de) | n2=en:macrosomia | rel=r_associated | relid=0 | w=15
  3835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:madelung deformity more frequent and more severe in females
    n1=Hyde (prurigo nodulaire de) | n2=en:madelung deformity more frequent and more severe in females | rel=r_associated | relid=0 | w=15
  3836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maieutics
    n1=Hyde (prurigo nodulaire de) | n2=en:maieutics | rel=r_associated | relid=0 | w=15
  3837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:main aspects of phenotype attributed to defects in gtf2ird1 (604318) and gtf2i (601679)
    n1=Hyde (prurigo nodulaire de) | n2=en:main aspects of phenotype attributed to defects in gtf2ird1 (604318) and gtf2i (601679) | rel=r_associated | relid=0 | w=15
  3838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:major cause of death is heart failure
    n1=Hyde (prurigo nodulaire de) | n2=en:major cause of death is heart failure | rel=r_associated | relid=0 | w=15
  3839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:major fetal plasma protein produced by yolk sac and liver
    n1=Hyde (prurigo nodulaire de) | n2=en:major fetal plasma protein produced by yolk sac and liver | rel=r_associated | relid=0 | w=15
  3840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:major fluid shifts may occur in severe cases
    n1=Hyde (prurigo nodulaire de) | n2=en:major fluid shifts may occur in severe cases | rel=r_associated | relid=0 | w=15
  3841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:major histocompatibility complex gene
    n1=Hyde (prurigo nodulaire de) | n2=en:major histocompatibility complex gene | rel=r_associated | relid=0 | w=15
  3842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority are isolated cases
    n1=Hyde (prurigo nodulaire de) | n2=en:majority are isolated cases | rel=r_associated | relid=0 | w=15
  3843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority are sporadic cases, affected sibs have been described
    n1=Hyde (prurigo nodulaire de) | n2=en:majority are sporadic cases, affected sibs have been described | rel=r_associated | relid=0 | w=15
  3844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority are stillborn or die in early neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:majority are stillborn or die in early neonatal period | rel=r_associated | relid=0 | w=15
  3845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority cases are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:majority cases are sporadic | rel=r_associated | relid=0 | w=15
  3846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority die in neonatal period secondary to respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:majority die in neonatal period secondary to respiratory insufficiency | rel=r_associated | relid=0 | w=15
  3847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of affected individuals are female (85%)
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of affected individuals are female (85%) | rel=r_associated | relid=0 | w=15
  3848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases (95%) are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases (95%) are sporadic | rel=r_associated | relid=0 | w=15
  3849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases are due to de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases are due to de novo mutation | rel=r_associated | relid=0 | w=15
  3850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases are male
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases are male | rel=r_associated | relid=0 | w=15
  3851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases are secondary to de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases are secondary to de novo mutation | rel=r_associated | relid=0 | w=15
  3852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases are sporadic, often in tall, thin men
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases are sporadic, often in tall, thin men | rel=r_associated | relid=0 | w=15
  3853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases are sporadic, some autosomal dominant families have been described
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases are sporadic, some autosomal dominant families have been described | rel=r_associated | relid=0 | w=15
  3854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases diagnosed at age 10-15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases diagnosed at age 10-15 years | rel=r_associated | relid=0 | w=15
  3855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases from middle eastern countries
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases from middle eastern countries | rel=r_associated | relid=0 | w=15
  3856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases have been sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases have been sporadic | rel=r_associated | relid=0 | w=15
  3857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases have bilateral involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases have bilateral involvement | rel=r_associated | relid=0 | w=15
  3858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases in japan
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases in japan | rel=r_associated | relid=0 | w=15
  3859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases in manitoba indians, northeastern manitoba, canada
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases in manitoba indians, northeastern manitoba, canada | rel=r_associated | relid=0 | w=15
  3860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases in the afrikaner population of south africa
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases in the afrikaner population of south africa | rel=r_associated | relid=0 | w=15
  3861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases occur in brazilian population
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases occur in brazilian population | rel=r_associated | relid=0 | w=15
  3862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of cases sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of cases sporadic | rel=r_associated | relid=0 | w=15
  3863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of children die before age 2
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of children die before age 2 | rel=r_associated | relid=0 | w=15
  3864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of children die between 6 months and 5 yrs
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of children die between 6 months and 5 yrs | rel=r_associated | relid=0 | w=15
  3865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of eec cases appear to be secondary to tp63 (603273) mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of eec cases appear to be secondary to tp63 (603273) mutations | rel=r_associated | relid=0 | w=15
  3866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of female carriers have skewed x-inactivation (inactivation of chromosome containing the phf6 (300414) mutation)
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of female carriers have skewed x-inactivation (inactivation of chromosome containing the phf6 (300414) mutation) | rel=r_associated | relid=0 | w=15
  3867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of individuals are healthy
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of individuals are healthy | rel=r_associated | relid=0 | w=15
  3868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients are ambulatory
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients are ambulatory | rel=r_associated | relid=0 | w=15
  3869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients are pyridoxine-responsive
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients are pyridoxine-responsive | rel=r_associated | relid=0 | w=15
  3870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients are stillborn or die before 5 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients are stillborn or die before 5 months of age | rel=r_associated | relid=0 | w=15
  3871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients develop symptoms within the first few weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients develop symptoms within the first few weeks of life | rel=r_associated | relid=0 | w=15
  3872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients die in neonatal period secondary to respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients die in neonatal period secondary to respiratory insufficiency | rel=r_associated | relid=0 | w=15
  3873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients from italy and southwestern united states
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients from italy and southwestern united states | rel=r_associated | relid=0 | w=15
  3874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of patients have normal intelligence
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of patients have normal intelligence | rel=r_associated | relid=0 | w=15
  3875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of por deficiency patients have an abs-like phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of por deficiency patients have an abs-like phenotype | rel=r_associated | relid=0 | w=15
  3876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of wilms tumors are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of wilms tumors are sporadic | rel=r_associated | relid=0 | w=15
  3877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:majority of wws patients die within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:majority of wws patients die within the first year of life | rel=r_associated | relid=0 | w=15
  3878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:malabsorption syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:malabsorption syndrome | rel=r_associated | relid=0 | w=15
  3879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male infertility
    n1=Hyde (prurigo nodulaire de) | n2=en:male infertility | rel=r_associated | relid=0 | w=15
  3880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male patients have more severe disease than female patients
    n1=Hyde (prurigo nodulaire de) | n2=en:male patients have more severe disease than female patients | rel=r_associated | relid=0 | w=15
  3881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male predominance
    n1=Hyde (prurigo nodulaire de) | n2=en:male predominance | rel=r_associated | relid=0 | w=15
  3882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male predominance of 3:1 to 5:1
    n1=Hyde (prurigo nodulaire de) | n2=en:male predominance of 3:1 to 5:1 | rel=r_associated | relid=0 | w=15
  3883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male to female ratio 21:8
    n1=Hyde (prurigo nodulaire de) | n2=en:male to female ratio 21:8 | rel=r_associated | relid=0 | w=15
  3884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male to female ratio 4:1
    n1=Hyde (prurigo nodulaire de) | n2=en:male to female ratio 4:1 | rel=r_associated | relid=0 | w=15
  3885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male to female ratio 7:1
    n1=Hyde (prurigo nodulaire de) | n2=en:male to female ratio 7:1 | rel=r_associated | relid=0 | w=15
  3886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male to female ratio is greater than 3:1
    n1=Hyde (prurigo nodulaire de) | n2=en:male to female ratio is greater than 3:1 | rel=r_associated | relid=0 | w=15
  3887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male-limited trait
    n1=Hyde (prurigo nodulaire de) | n2=en:male-limited trait | rel=r_associated | relid=0 | w=15
  3888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male-to-female ratio 3 to 1
    n1=Hyde (prurigo nodulaire de) | n2=en:male-to-female ratio 3 to 1 | rel=r_associated | relid=0 | w=15
  3889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male-to-female ratio of 3:2 in childhood cases
    n1=Hyde (prurigo nodulaire de) | n2=en:male-to-female ratio of 3:2 in childhood cases | rel=r_associated | relid=0 | w=15
  3890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:male-to-female ratio, 1.8 to 1
    n1=Hyde (prurigo nodulaire de) | n2=en:male-to-female ratio, 1.8 to 1 | rel=r_associated | relid=0 | w=15
  3891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males are more commonly affected than females
    n1=Hyde (prurigo nodulaire de) | n2=en:males are more commonly affected than females | rel=r_associated | relid=0 | w=15
  3892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males are more severely affected
    n1=Hyde (prurigo nodulaire de) | n2=en:males are more severely affected | rel=r_associated | relid=0 | w=15
  3893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males are more severely affected than females
    n1=Hyde (prurigo nodulaire de) | n2=en:males are more severely affected than females | rel=r_associated | relid=0 | w=15
  3894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males are most severely affected, but females can also be affected
    n1=Hyde (prurigo nodulaire de) | n2=en:males are most severely affected, but females can also be affected | rel=r_associated | relid=0 | w=15
  3895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males born to affected females are stillborn with exophthalmos, omphalocele, thin calvaria, curved long bones, and hypoplastic/absence thumbs and halluces
    n1=Hyde (prurigo nodulaire de) | n2=en:males born to affected females are stillborn with exophthalmos, omphalocele, thin calvaria, curved long bones, and hypoplastic/absence thumbs and halluces | rel=r_associated | relid=0 | w=15
  3896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males carry mutations in the somatic mosaic state
    n1=Hyde (prurigo nodulaire de) | n2=en:males carry mutations in the somatic mosaic state | rel=r_associated | relid=0 | w=15
  3897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males died in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:males died in neonatal period | rel=r_associated | relid=0 | w=15
  3898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males may be more affected than females
    n1=Hyde (prurigo nodulaire de) | n2=en:males may be more affected than females | rel=r_associated | relid=0 | w=15
  3899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males more affected than females (2 to 2.5:1)
    n1=Hyde (prurigo nodulaire de) | n2=en:males more affected than females (2 to 2.5:1) | rel=r_associated | relid=0 | w=15
  3900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:males mores severely affected than females
    n1=Hyde (prurigo nodulaire de) | n2=en:males mores severely affected than females | rel=r_associated | relid=0 | w=15
  3901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:malnutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:malnutrition | rel=r_associated | relid=0 | w=15
  3902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:malnutrition can be severe, requiring total parenteral nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:malnutrition can be severe, requiring total parenteral nutrition | rel=r_associated | relid=0 | w=15
  3903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:malposition and malpresentation of fetus
    n1=Hyde (prurigo nodulaire de) | n2=en:malposition and malpresentation of fetus | rel=r_associated | relid=0 | w=15
  3904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders
    n1=Hyde (prurigo nodulaire de) | n2=en:management of homocystinuria includes low methionine, cystine supplemented diet for pyridoxine nonresponders and pyridoxine supplementation for pyridoxine responders | rel=r_associated | relid=0 | w=15
  3905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:manifestations continue to appear until 5th decade
    n1=Hyde (prurigo nodulaire de) | n2=en:manifestations continue to appear until 5th decade | rel=r_associated | relid=0 | w=15
  3906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:manifestations of cushing syndrome may be mild
    n1=Hyde (prurigo nodulaire de) | n2=en:manifestations of cushing syndrome may be mild | rel=r_associated | relid=0 | w=15
  3907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:manifestations present in second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:manifestations present in second decade of life | rel=r_associated | relid=0 | w=15
  3908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:manifests in infancy (including neonatal lethal) or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:manifests in infancy (including neonatal lethal) or childhood | rel=r_associated | relid=0 | w=15
  3909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many adults with typical form remain ambulatory
    n1=Hyde (prurigo nodulaire de) | n2=en:many adults with typical form remain ambulatory | rel=r_associated | relid=0 | w=15
  3910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases are asymptomatic | rel=r_associated | relid=0 | w=15
  3911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases are sporadic, but somatic and germline mosaicism has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases are sporadic, but somatic and germline mosaicism has been reported | rel=r_associated | relid=0 | w=15
  3912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases due to de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases due to de novo mutation | rel=r_associated | relid=0 | w=15
  3913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases due to de novo mutation or chromosome aberration
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases due to de novo mutation or chromosome aberration | rel=r_associated | relid=0 | w=15
  3914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases have submicroscopic subtelomeric deletions of chromosome 9q leading to haploinsufficiency of ehmt1 (607001)
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases have submicroscopic subtelomeric deletions of chromosome 9q leading to haploinsufficiency of ehmt1 (607001) | rel=r_associated | relid=0 | w=15
  3915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many cases result from de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:many cases result from de novo mutations | rel=r_associated | relid=0 | w=15
  3916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many features are present only in an untreated patient
    n1=Hyde (prurigo nodulaire de) | n2=en:many features are present only in an untreated patient | rel=r_associated | relid=0 | w=15
  3917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients are asymptomatic | rel=r_associated | relid=0 | w=15
  3918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients become wheelchair-bound | rel=r_associated | relid=0 | w=15
  3919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients become wheelchair-bound by second or third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients become wheelchair-bound by second or third decade | rel=r_associated | relid=0 | w=15
  3920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients become wheelchair-bound later in life
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients become wheelchair-bound later in life | rel=r_associated | relid=0 | w=15
  3921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients die by 1-3 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients die by 1-3 years of age | rel=r_associated | relid=0 | w=15
  3922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients lose independent mobility after 25 years
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients lose independent mobility after 25 years | rel=r_associated | relid=0 | w=15
  3923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients recover normally
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients recover normally | rel=r_associated | relid=0 | w=15
  3924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many patients require cardiac pacemakers
    n1=Hyde (prurigo nodulaire de) | n2=en:many patients require cardiac pacemakers | rel=r_associated | relid=0 | w=15
  3925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many studies have reported that the phenotype of tuberous sclerosis-1 (tsc1) is less severe than that of tuberous sclerosis-2 (i.e., higher iq, less macules, fewer seizures)
    n1=Hyde (prurigo nodulaire de) | n2=en:many studies have reported that the phenotype of tuberous sclerosis-1 (tsc1) is less severe than that of tuberous sclerosis-2 (i.e., higher iq, less macules, fewer seizures) | rel=r_associated | relid=0 | w=15
  3926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:many studies have reported that the phenotype of tuberous sclerosis-2 (tsc2) is more severe than that of tuberous sclerosis-1 (e.g., lower iq, more seizures, more macules, cust-like cortical tubers)
    n1=Hyde (prurigo nodulaire de) | n2=en:many studies have reported that the phenotype of tuberous sclerosis-2 (tsc2) is more severe than that of tuberous sclerosis-1 (e.g., lower iq, more seizures, more macules, cust-like cortical tubers) | rel=r_associated | relid=0 | w=15
  3927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked clinical heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:marked clinical heterogeneity | rel=r_associated | relid=0 | w=15
  3928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked clinical variability within families
    n1=Hyde (prurigo nodulaire de) | n2=en:marked clinical variability within families | rel=r_associated | relid=0 | w=15
  3929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked favorable response to l-dopa treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:marked favorable response to l-dopa treatment | rel=r_associated | relid=0 | w=15
  3930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked fetal hydrops
    n1=Hyde (prurigo nodulaire de) | n2=en:marked fetal hydrops | rel=r_associated | relid=0 | w=15
  3931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:marked heterogeneity | rel=r_associated | relid=0 | w=15
  3932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked inter- and intrafamilial variability, ranging from prenatal onset with severe symptoms to asymptomatic affected individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:marked inter- and intrafamilial variability, ranging from prenatal onset with severe symptoms to asymptomatic affected individuals | rel=r_associated | relid=0 | w=15
  3933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked intrafamilial and interfamilial variability
    n1=Hyde (prurigo nodulaire de) | n2=en:marked intrafamilial and interfamilial variability | rel=r_associated | relid=0 | w=15
  3934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked phenotypic variability
    n1=Hyde (prurigo nodulaire de) | n2=en:marked phenotypic variability | rel=r_associated | relid=0 | w=15
  3935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked phenotypic variability, even within an individual
    n1=Hyde (prurigo nodulaire de) | n2=en:marked phenotypic variability, even within an individual | rel=r_associated | relid=0 | w=15
  3936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked variability in the deletion size
    n1=Hyde (prurigo nodulaire de) | n2=en:marked variability in the deletion size | rel=r_associated | relid=0 | w=15
  3937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:marked variation in severity - severe early onset disease (neonatal period) and milder juvenile disease (onset 8-13 years) | rel=r_associated | relid=0 | w=15
  3938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:marshall syndrome is allelic to stickler syndrome, type 2 (604841)
    n1=Hyde (prurigo nodulaire de) | n2=en:marshall syndrome is allelic to stickler syndrome, type 2 (604841) | rel=r_associated | relid=0 | w=15
  3939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:masa is an acronym - mental retardation, adducted thumbs, shuffling gait, and aphasia
    n1=Hyde (prurigo nodulaire de) | n2=en:masa is an acronym - mental retardation, adducted thumbs, shuffling gait, and aphasia | rel=r_associated | relid=0 | w=15
  3940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:massive aortic aneurysm can cause airway compression in affected infants
    n1=Hyde (prurigo nodulaire de) | n2=en:massive aortic aneurysm can cause airway compression in affected infants | rel=r_associated | relid=0 | w=15
  3941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal anticipation bias
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal anticipation bias | rel=r_associated | relid=0 | w=15
  3942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal breast milk is protective
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal breast milk is protective | rel=r_associated | relid=0 | w=15
  3943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for abnormality of pelvic organ, unspecified
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for abnormality of pelvic organ, unspecified | rel=r_associated | relid=0 | w=15
  3944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for disproportion, unspecified
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for disproportion, unspecified | rel=r_associated | relid=0 | w=15
  3945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for known or suspected abnormality of pelvic organs
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for known or suspected abnormality of pelvic organs | rel=r_associated | relid=0 | w=15
  3946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for known or suspected disproportion
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for known or suspected disproportion | rel=r_associated | relid=0 | w=15
  3947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for known or suspected fetal abnormality and damage
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for known or suspected fetal abnormality and damage | rel=r_associated | relid=0 | w=15
  3948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for known or suspected malpresentation of fetus
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for known or suspected malpresentation of fetus | rel=r_associated | relid=0 | w=15
  3949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for malpresentation of fetus, unspecified
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for malpresentation of fetus, unspecified | rel=r_associated | relid=0 | w=15
  3950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for other fetal problems
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for other fetal problems | rel=r_associated | relid=0 | w=15
  3951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care for other known or suspected fetal problems
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care for other known or suspected fetal problems | rel=r_associated | relid=0 | w=15
  3952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal care related to the fetus and amniotic cavity and possible delivery problems
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal care related to the fetus and amniotic cavity and possible delivery problems | rel=r_associated | relid=0 | w=15
  3953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal complication of pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal complication of pregnancy | rel=r_associated | relid=0 | w=15
  3954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal death
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal death | rel=r_associated | relid=0 | w=15
  3955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal fever
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal fever | rel=r_associated | relid=0 | w=15
  3956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal hypotension
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal hypotension | rel=r_associated | relid=0 | w=15
  3957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal imprinting
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal imprinting | rel=r_associated | relid=0 | w=15
  3958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal imprinting of sgce results in reduced penetrance of the disorder when the mutation is inherited from the mother
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal imprinting of sgce results in reduced penetrance of the disorder when the mutation is inherited from the mother | rel=r_associated | relid=0 | w=15
  3959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal oligohydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal oligohydramnios | rel=r_associated | relid=0 | w=15
  3960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:maternal uniparental disomy (upd)7 reported in some cases
    n1=Hyde (prurigo nodulaire de) | n2=en:maternal uniparental disomy (upd)7 reported in some cases | rel=r_associated | relid=0 | w=15
  3961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be associated with other anomalies (e.g. okihiro syndrome (607323), wildervanck syndrome (314600))
    n1=Hyde (prurigo nodulaire de) | n2=en:may be associated with other anomalies (e.g. okihiro syndrome (607323), wildervanck syndrome (314600)) | rel=r_associated | relid=0 | w=15
  3962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be associated with polymorphisms in some surfactant genes, including sftpa1 (178630), sftpb (178640), and sftpc (178620)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be associated with polymorphisms in some surfactant genes, including sftpa1 (178630), sftpb (178640), and sftpc (178620) | rel=r_associated | relid=0 | w=15
  3963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:may be asymptomatic | rel=r_associated | relid=0 | w=15
  3964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be benign condition
    n1=Hyde (prurigo nodulaire de) | n2=en:may be benign condition | rel=r_associated | relid=0 | w=15
  3965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be due to imprinting defect
    n1=Hyde (prurigo nodulaire de) | n2=en:may be due to imprinting defect | rel=r_associated | relid=0 | w=15
  3966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be exacerbated by febrile illness
    n1=Hyde (prurigo nodulaire de) | n2=en:may be exacerbated by febrile illness | rel=r_associated | relid=0 | w=15
  3967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be extreme phenotype of generalized epilepsy with febrile seizures plus (gefs+, 604233)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be extreme phenotype of generalized epilepsy with febrile seizures plus (gefs+, 604233) | rel=r_associated | relid=0 | w=15
  3968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be fatal
    n1=Hyde (prurigo nodulaire de) | n2=en:may be fatal | rel=r_associated | relid=0 | w=15
  3969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be fatal in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:may be fatal in infancy | rel=r_associated | relid=0 | w=15
  3970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be induced by fever or hot bath
    n1=Hyde (prurigo nodulaire de) | n2=en:may be induced by fever or hot bath | rel=r_associated | relid=0 | w=15
  3971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be lethal if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:may be lethal if untreated | rel=r_associated | relid=0 | w=15
  3972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be lethal in infancy if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:may be lethal in infancy if untreated | rel=r_associated | relid=0 | w=15
  3973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be lethal in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:may be lethal in the neonatal period | rel=r_associated | relid=0 | w=15
  3974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be misdiagnosed as nightmares, night terrors, parasomnias, or psychiatric disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:may be misdiagnosed as nightmares, night terrors, parasomnias, or psychiatric disorders | rel=r_associated | relid=0 | w=15
  3975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be precipitated by minor illness (e.g., viral infection, fever)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be precipitated by minor illness (e.g., viral infection, fever) | rel=r_associated | relid=0 | w=15
  3976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be present in asymptomatic adults
    n1=Hyde (prurigo nodulaire de) | n2=en:may be present in asymptomatic adults | rel=r_associated | relid=0 | w=15
  3977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:may be progressive | rel=r_associated | relid=0 | w=15
  3978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be same disorder as autosomal recessive optic atrophy 3 (258501)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be same disorder as autosomal recessive optic atrophy 3 (258501) | rel=r_associated | relid=0 | w=15
  3979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be same entity as elejalde syndrome (256710)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be same entity as elejalde syndrome (256710) | rel=r_associated | relid=0 | w=15
  3980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be same entity as griscelli syndrome type i (214450) caused by mutation in the myosin va gene (160777)
    n1=Hyde (prurigo nodulaire de) | n2=en:may be same entity as griscelli syndrome type i (214450) caused by mutation in the myosin va gene (160777) | rel=r_associated | relid=0 | w=15
  3981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be seen in combination with duchenne muscular dystrophy (dmd, 310200) and/or glycerol kinase deficiency (307030) as part of a contiguous gene deletion syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:may be seen in combination with duchenne muscular dystrophy (dmd, 310200) and/or glycerol kinase deficiency (307030) as part of a contiguous gene deletion syndrome | rel=r_associated | relid=0 | w=15
  3982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be triggered by increased practice
    n1=Hyde (prurigo nodulaire de) | n2=en:may be triggered by increased practice | rel=r_associated | relid=0 | w=15
  3983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents
    n1=Hyde (prurigo nodulaire de) | n2=en:may be triggered by medications, including antineoplastic agents, immunotherapeutic agents, and antiplatelet agents | rel=r_associated | relid=0 | w=15
  3984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be triggered by minor head trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:may be triggered by minor head trauma | rel=r_associated | relid=0 | w=15
  3985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may be x-linked
    n1=Hyde (prurigo nodulaire de) | n2=en:may be x-linked | rel=r_associated | relid=0 | w=15
  3986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may coexist with autoimmune vitiligo or thyroiditis
    n1=Hyde (prurigo nodulaire de) | n2=en:may coexist with autoimmune vitiligo or thyroiditis | rel=r_associated | relid=0 | w=15
  3987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may fade with age
    n1=Hyde (prurigo nodulaire de) | n2=en:may fade with age | rel=r_associated | relid=0 | w=15
  3988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may have less severe phenotype than rsts patients with crebbp mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:may have less severe phenotype than rsts patients with crebbp mutations | rel=r_associated | relid=0 | w=15
  3989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may have seasonal variance in severity
    n1=Hyde (prurigo nodulaire de) | n2=en:may have seasonal variance in severity | rel=r_associated | relid=0 | w=15
  3990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may manifest as 'ataxic' phenotype without parkinsonian features
    n1=Hyde (prurigo nodulaire de) | n2=en:may manifest as 'ataxic' phenotype without parkinsonian features | rel=r_associated | relid=0 | w=15
  3991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features
    n1=Hyde (prurigo nodulaire de) | n2=en:may manifest as late-onset 'parkinsonian' phenotype without severe ataxic features | rel=r_associated | relid=0 | w=15
  3992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may not be clinically manifest until middle life
    n1=Hyde (prurigo nodulaire de) | n2=en:may not be clinically manifest until middle life | rel=r_associated | relid=0 | w=15
  3993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may occur cormorbidly with poland syndrome (173800)
    n1=Hyde (prurigo nodulaire de) | n2=en:may occur cormorbidly with poland syndrome (173800) | rel=r_associated | relid=0 | w=15
  3994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may occur in adults (also in pregnancy)
    n1=Hyde (prurigo nodulaire de) | n2=en:may occur in adults (also in pregnancy) | rel=r_associated | relid=0 | w=15
  3995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may or may not be responsive to pyridoxine (vitamin b6) treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:may or may not be responsive to pyridoxine (vitamin b6) treatment | rel=r_associated | relid=0 | w=15
  3996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may present in infancy with episodes of severe metabolic decompensation
    n1=Hyde (prurigo nodulaire de) | n2=en:may present in infancy with episodes of severe metabolic decompensation | rel=r_associated | relid=0 | w=15
  3997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may progress to other body regions after many years
    n1=Hyde (prurigo nodulaire de) | n2=en:may progress to other body regions after many years | rel=r_associated | relid=0 | w=15
  3998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may progress to upper limbs
    n1=Hyde (prurigo nodulaire de) | n2=en:may progress to upper limbs | rel=r_associated | relid=0 | w=15
  3999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may regress
    n1=Hyde (prurigo nodulaire de) | n2=en:may regress | rel=r_associated | relid=0 | w=15
  4000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may regress in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:may regress in adulthood | rel=r_associated | relid=0 | w=15
  4001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may result in death in neonatal period or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:may result in death in neonatal period or early childhood | rel=r_associated | relid=0 | w=15
  4002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may result in early death
    n1=Hyde (prurigo nodulaire de) | n2=en:may result in early death | rel=r_associated | relid=0 | w=15
  4003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may result in early death from severe diarrhea
    n1=Hyde (prurigo nodulaire de) | n2=en:may result in early death from severe diarrhea | rel=r_associated | relid=0 | w=15
  4004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may result in sudden death
    n1=Hyde (prurigo nodulaire de) | n2=en:may result in sudden death | rel=r_associated | relid=0 | w=15
  4005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:may show good response to levodopa
    n1=Hyde (prurigo nodulaire de) | n2=en:may show good response to levodopa | rel=r_associated | relid=0 | w=15
  4006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at diagnosis 16 years (range 6 to 22)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at diagnosis 16 years (range 6 to 22) | rel=r_associated | relid=0 | w=15
  4007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at diagnosis 8.8 years (range 0.2-23 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at diagnosis 8.8 years (range 0.2-23 years) | rel=r_associated | relid=0 | w=15
  4008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at diagnosis is 38 years(range 11-63 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at diagnosis is 38 years(range 11-63 years) | rel=r_associated | relid=0 | w=15
  4009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 10.6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 10.6 years | rel=r_associated | relid=0 | w=15
  4010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 12.5 years (range 2 to 15 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 12.5 years (range 2 to 15 years) | rel=r_associated | relid=0 | w=15
  4011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 15.2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 15.2 years | rel=r_associated | relid=0 | w=15
  4012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 16.5 years (range 9 to 35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 16.5 years (range 9 to 35 years) | rel=r_associated | relid=0 | w=15
  4013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 22 years (range 7 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 22 years (range 7 to 50 years) | rel=r_associated | relid=0 | w=15
  4014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 23.9 years (range 10 to 55 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 23.9 years (range 10 to 55 years) | rel=r_associated | relid=0 | w=15
  4015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 24 years (range 14 to 33 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 24 years (range 14 to 33 years) | rel=r_associated | relid=0 | w=15
  4016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 27 years (range 9 to 42)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 27 years (range 9 to 42) | rel=r_associated | relid=0 | w=15
  4017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 28 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 28 years | rel=r_associated | relid=0 | w=15
  4018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 30.7 years (range 6 to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 30.7 years (range 6 to 60 years) | rel=r_associated | relid=0 | w=15
  4019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 32 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 32 years | rel=r_associated | relid=0 | w=15
  4020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 33 years (range 20-60)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 33 years (range 20-60) | rel=r_associated | relid=0 | w=15
  4021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 35 years (range 20-60)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 35 years (range 20-60) | rel=r_associated | relid=0 | w=15
  4022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 45 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 45 years | rel=r_associated | relid=0 | w=15
  4023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 46.5 years (range 19-64)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 46.5 years (range 19-64) | rel=r_associated | relid=0 | w=15
  4024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 48 years (range 38 to 64)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 48 years (range 38 to 64) | rel=r_associated | relid=0 | w=15
  4025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 5 years | rel=r_associated | relid=0 | w=15
  4026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 57-60 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 57-60 years | rel=r_associated | relid=0 | w=15
  4027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset 66.8 years (range 47-77)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset 66.8 years (range 47-77) | rel=r_associated | relid=0 | w=15
  4028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset for sporadic cjd is 60 years (range, 50 to 70 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset for sporadic cjd is 60 years (range, 50 to 70 years) | rel=r_associated | relid=0 | w=15
  4029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset for variant cjd is 29 years (before age 45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset for variant cjd is 29 years (before age 45 years) | rel=r_associated | relid=0 | w=15
  4030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset is 10.4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset is 10.4 years | rel=r_associated | relid=0 | w=15
  4031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset is 13 years (range 6 to 43)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset is 13 years (range 6 to 43) | rel=r_associated | relid=0 | w=15
  4032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of bone disease is 40 years (range 23-65)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of bone disease is 40 years (range 23-65) | rel=r_associated | relid=0 | w=15
  4033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of bone fractures, 24 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of bone fractures, 24 years | rel=r_associated | relid=0 | w=15
  4034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of cerebellar ataxia is 52.8 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of cerebellar ataxia is 52.8 years | rel=r_associated | relid=0 | w=15
  4035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of dementia is 57 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of dementia is 57 years | rel=r_associated | relid=0 | w=15
  4036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of hypoglycemia may be delayed (median, 9 months, diagnosis sometimes made in adulthood) | rel=r_associated | relid=0 | w=15
  4037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of migraines is 42 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of migraines is 42 years | rel=r_associated | relid=0 | w=15
  4038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of muscle disease is 42 years (range 24-61)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of muscle disease is 42 years (range 24-61) | rel=r_associated | relid=0 | w=15
  4039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at onset of proximal muscle weakness, 31 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at onset of proximal muscle weakness, 31 years | rel=r_associated | relid=0 | w=15
  4040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at resolution of symptoms 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at resolution of symptoms 10 years | rel=r_associated | relid=0 | w=15
  4041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age at termination 3 to 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age at termination 3 to 4 years | rel=r_associated | relid=0 | w=15
  4042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of death is 34 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of death is 34 years | rel=r_associated | relid=0 | w=15
  4043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of diagnosis 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of diagnosis 40 years | rel=r_associated | relid=0 | w=15
  4044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of diagnosis is 40 years (range 11 to 79 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of diagnosis is 40 years (range 11 to 79 years) | rel=r_associated | relid=0 | w=15
  4045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of diagnosis of renal cell carcinoma is 46 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of diagnosis of renal cell carcinoma is 46 years | rel=r_associated | relid=0 | w=15
  4046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of diagnosis of uterine leiomyomas is 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of diagnosis of uterine leiomyomas is 30 years | rel=r_associated | relid=0 | w=15
  4047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 14-24 months
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 14-24 months | rel=r_associated | relid=0 | w=15
  4048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 16 to 19 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 16 to 19 years | rel=r_associated | relid=0 | w=15
  4049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 18 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 18 years | rel=r_associated | relid=0 | w=15
  4050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 20.6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 20.6 years | rel=r_associated | relid=0 | w=15
  4051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 21 years (range 14-35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 21 years (range 14-35 years) | rel=r_associated | relid=0 | w=15
  4052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 22 years (range 5-54)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 22 years (range 5-54) | rel=r_associated | relid=0 | w=15
  4053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 30 years | rel=r_associated | relid=0 | w=15
  4054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 30 years (range 25-42)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 30 years (range 25-42) | rel=r_associated | relid=0 | w=15
  4055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 30 years (range first to seventh decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 30 years (range first to seventh decade) | rel=r_associated | relid=0 | w=15
  4056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 31 years (range 5-60)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 31 years (range 5-60) | rel=r_associated | relid=0 | w=15
  4057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 34 months
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 34 months | rel=r_associated | relid=0 | w=15
  4058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 35-40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 35-40 years | rel=r_associated | relid=0 | w=15
  4059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 50 to 52 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 50 to 52 years | rel=r_associated | relid=0 | w=15
  4060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 50.2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 50.2 years | rel=r_associated | relid=0 | w=15
  4061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset 56 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset 56 years | rel=r_associated | relid=0 | w=15
  4062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset about 62 years (45-79 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset about 62 years (45-79 years) | rel=r_associated | relid=0 | w=15
  4063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset in third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset in third decade | rel=r_associated | relid=0 | w=15
  4064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of onset, 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of onset, 5 years | rel=r_associated | relid=0 | w=15
  4065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:mean age of presentation of renal cancer is 50 years, but earlier onset has been reported | rel=r_associated | relid=0 | w=15
  4066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean duration of symptoms 4.2 plus or minus 2.4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mean duration of symptoms 4.2 plus or minus 2.4 years | rel=r_associated | relid=0 | w=15
  4067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mean survival 5 months
    n1=Hyde (prurigo nodulaire de) | n2=en:mean survival 5 months | rel=r_associated | relid=0 | w=15
  4068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mechanical ventilation may be required
    n1=Hyde (prurigo nodulaire de) | n2=en:mechanical ventilation may be required | rel=r_associated | relid=0 | w=15
  4069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:meckel diverticulitis
    n1=Hyde (prurigo nodulaire de) | n2=en:meckel diverticulitis | rel=r_associated | relid=0 | w=15
  4070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mecobalamin / vitamin b 12
    n1=Hyde (prurigo nodulaire de) | n2=en:mecobalamin / vitamin b 12 | rel=r_associated | relid=0 | w=15
  4071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:meconium stained amniotic fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:meconium stained amniotic fluid | rel=r_associated | relid=0 | w=15
  4072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mecp2 mutations are those found in females with rett syndrome (312750)
    n1=Hyde (prurigo nodulaire de) | n2=en:mecp2 mutations are those found in females with rett syndrome (312750) | rel=r_associated | relid=0 | w=15
  4073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:med is a heterogeneous disorder (see med1 (132400), med2 (600204), med3 (600969), med4 (226900), med5 (608078), and med with diabetes mellitus (226980))
    n1=Hyde (prurigo nodulaire de) | n2=en:med is a heterogeneous disorder (see med1 (132400), med2 (600204), med3 (600969), med4 (226900), med5 (608078), and med with diabetes mellitus (226980)) | rel=r_associated | relid=0 | w=15
  4074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:medial onset of end stage renal disease 13 years
    n1=Hyde (prurigo nodulaire de) | n2=en:medial onset of end stage renal disease 13 years | rel=r_associated | relid=0 | w=15
  4075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age at diagnosis 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age at diagnosis 7 years | rel=r_associated | relid=0 | w=15
  4076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age at diagnosis, 59 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age at diagnosis, 59 years | rel=r_associated | relid=0 | w=15
  4077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age at onset 23 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age at onset 23 years | rel=r_associated | relid=0 | w=15
  4078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age at onset is 21 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age at onset is 21 years | rel=r_associated | relid=0 | w=15
  4079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys
    n1=Hyde (prurigo nodulaire de) | n2=en:median age at onset of puberty is 5.75 years in affected girls and 8.1 years in affected boys | rel=r_associated | relid=0 | w=15
  4080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of diagnosis - 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of diagnosis - 15 years | rel=r_associated | relid=0 | w=15
  4081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of diagnosis is 28 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of diagnosis is 28 years | rel=r_associated | relid=0 | w=15
  4082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of onset of leukoplakia - 7 years (range 1-26 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of onset of leukoplakia - 7 years (range 1-26 years) | rel=r_associated | relid=0 | w=15
  4083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of onset of nail dystrophy - 7 years (range 1-6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of onset of nail dystrophy - 7 years (range 1-6 years) | rel=r_associated | relid=0 | w=15
  4084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of onset of pancytopenia - 10 years (range 1-32 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of onset of pancytopenia - 10 years (range 1-32 years) | rel=r_associated | relid=0 | w=15
  4085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median age of onset of pigmentation - 8 years (range 1-15 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:median age of onset of pigmentation - 8 years (range 1-15 years) | rel=r_associated | relid=0 | w=15
  4086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median life expectancy, 13.4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median life expectancy, 13.4 years | rel=r_associated | relid=0 | w=15
  4087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median onset of neurologic symptoms is 13 years (range 5 to 28)
    n1=Hyde (prurigo nodulaire de) | n2=en:median onset of neurologic symptoms is 13 years (range 5 to 28) | rel=r_associated | relid=0 | w=15
  4088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median onset of proteinuria is 18 years (range 10 to 21)
    n1=Hyde (prurigo nodulaire de) | n2=en:median onset of proteinuria is 18 years (range 10 to 21) | rel=r_associated | relid=0 | w=15
  4089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median survival 5.7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median survival 5.7 years | rel=r_associated | relid=0 | w=15
  4090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:median survival is > 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:median survival is > 50 years | rel=r_associated | relid=0 | w=15
  4091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:medical director review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:medical director review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  4092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:medication
    n1=Hyde (prurigo nodulaire de) | n2=en:medication | rel=r_associated | relid=0 | w=15
  4093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:medullary thyroid cancer is aggressive and can occur in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:medullary thyroid cancer is aggressive and can occur in childhood | rel=r_associated | relid=0 | w=15
  4094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:meiotic origin >95% maternal, mostly meiosis i
    n1=Hyde (prurigo nodulaire de) | n2=en:meiotic origin >95% maternal, mostly meiosis i | rel=r_associated | relid=0 | w=15
  4095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:melnick-needles syndrome (mns, 309350) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:melnick-needles syndrome (mns, 309350) is an allelic disorder | rel=r_associated | relid=0 | w=15
  4096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:membranes absent
    n1=Hyde (prurigo nodulaire de) | n2=en:membranes absent | rel=r_associated | relid=0 | w=15
  4097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mental development worsens after onset of seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:mental development worsens after onset of seizures | rel=r_associated | relid=0 | w=15
  4098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mental retardation likely secondary to neonatal hypoxia
    n1=Hyde (prurigo nodulaire de) | n2=en:mental retardation likely secondary to neonatal hypoxia | rel=r_associated | relid=0 | w=15
  4099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mesomelia becomes more evident with age
    n1=Hyde (prurigo nodulaire de) | n2=en:mesomelia becomes more evident with age | rel=r_associated | relid=0 | w=15
  4100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:metabolic decompensation, episodic
    n1=Hyde (prurigo nodulaire de) | n2=en:metabolic decompensation, episodic | rel=r_associated | relid=0 | w=15
  4101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:metabolic rate^resting:engrto:pt:^patient:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:metabolic rate^resting:engrto:pt:^patient:qn | rel=r_associated | relid=0 | w=15
  4102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:methyl-cpg-binding domain protein 4
    n1=Hyde (prurigo nodulaire de) | n2=en:methyl-cpg-binding domain protein 4 | rel=r_associated | relid=0 | w=15
  4103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:microbiological
    n1=Hyde (prurigo nodulaire de) | n2=en:microbiological | rel=r_associated | relid=0 | w=15
  4104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:microdeletion is approximately 1.5mb in length
    n1=Hyde (prurigo nodulaire de) | n2=en:microdeletion is approximately 1.5mb in length | rel=r_associated | relid=0 | w=15
  4105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:microgyria
    n1=Hyde (prurigo nodulaire de) | n2=en:microgyria | rel=r_associated | relid=0 | w=15
  4106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:microtubule doublet
    n1=Hyde (prurigo nodulaire de) | n2=en:microtubule doublet | rel=r_associated | relid=0 | w=15
  4107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:microtubule triplet
    n1=Hyde (prurigo nodulaire de) | n2=en:microtubule triplet | rel=r_associated | relid=0 | w=15
  4108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:middle age onset
    n1=Hyde (prurigo nodulaire de) | n2=en:middle age onset | rel=r_associated | relid=0 | w=15
  4109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:midline defects
    n1=Hyde (prurigo nodulaire de) | n2=en:midline defects | rel=r_associated | relid=0 | w=15
  4110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:midwifery
    n1=Hyde (prurigo nodulaire de) | n2=en:midwifery | rel=r_associated | relid=0 | w=15
  4111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild adult form, with onset after age 13 years, no cardiac involvement, and restricted to muscle involvement with rhabdomyolysis
    n1=Hyde (prurigo nodulaire de) | n2=en:mild adult form, with onset after age 13 years, no cardiac involvement, and restricted to muscle involvement with rhabdomyolysis | rel=r_associated | relid=0 | w=15
  4112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild asymmetric regional disease (e.g. 180380.0029)
    n1=Hyde (prurigo nodulaire de) | n2=en:mild asymmetric regional disease (e.g. 180380.0029) | rel=r_associated | relid=0 | w=15
  4113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild cases show clinical, biochemical, and mri improvement after the second year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:mild cases show clinical, biochemical, and mri improvement after the second year of life | rel=r_associated | relid=0 | w=15
  4114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild disease course
    n1=Hyde (prurigo nodulaire de) | n2=en:mild disease course | rel=r_associated | relid=0 | w=15
  4115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:mild disorder | rel=r_associated | relid=0 | w=15
  4116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild expression in heterozygous carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:mild expression in heterozygous carriers | rel=r_associated | relid=0 | w=15
  4117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild facial dysmorphism is associated with duplication of the flna gene
    n1=Hyde (prurigo nodulaire de) | n2=en:mild facial dysmorphism is associated with duplication of the flna gene | rel=r_associated | relid=0 | w=15
  4118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild features such as digital clubbing may be apparent in older heterozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:mild features such as digital clubbing may be apparent in older heterozygotes | rel=r_associated | relid=0 | w=15
  4119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild involvement of face and arms
    n1=Hyde (prurigo nodulaire de) | n2=en:mild involvement of face and arms | rel=r_associated | relid=0 | w=15
  4120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild manifestations in carrier females (cleft lip, cleft tongue)
    n1=Hyde (prurigo nodulaire de) | n2=en:mild manifestations in carrier females (cleft lip, cleft tongue) | rel=r_associated | relid=0 | w=15
  4121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:mild phenotype | rel=r_associated | relid=0 | w=15
  4122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild phenotype onset - 11-18 months
    n1=Hyde (prurigo nodulaire de) | n2=en:mild phenotype onset - 11-18 months | rel=r_associated | relid=0 | w=15
  4123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild symptoms may occur in teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:mild symptoms may occur in teenage years | rel=r_associated | relid=0 | w=15
  4124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mild to severe forms of disease
    n1=Hyde (prurigo nodulaire de) | n2=en:mild to severe forms of disease | rel=r_associated | relid=0 | w=15
  4125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy
    n1=Hyde (prurigo nodulaire de) | n2=en:milder cases have isolated recurrent daytime sleepiness and/or lapses into sleep without cataplexy | rel=r_associated | relid=0 | w=15
  4126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder cases have onset in childhood or adulthood with history of muscle weakness since infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:milder cases have onset in childhood or adulthood with history of muscle weakness since infancy | rel=r_associated | relid=0 | w=15
  4127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder disease with a more favorable prognosis than cmd1u (613694) due to psen1 mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:milder disease with a more favorable prognosis than cmd1u (613694) due to psen1 mutations | rel=r_associated | relid=0 | w=15
  4128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder expression in female heterozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:milder expression in female heterozygotes | rel=r_associated | relid=0 | w=15
  4129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder form with onset in childhood, absence seizures, and learning difficulties
    n1=Hyde (prurigo nodulaire de) | n2=en:milder form with onset in childhood, absence seizures, and learning difficulties | rel=r_associated | relid=0 | w=15
  4130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder manifestations in heterozygous females (broad face, downslanting palpebral fissures, and cleft palate)
    n1=Hyde (prurigo nodulaire de) | n2=en:milder manifestations in heterozygous females (broad face, downslanting palpebral fissures, and cleft palate) | rel=r_associated | relid=0 | w=15
  4131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder phenotype associated with aberrant function of a single domain of the zeb2 protein rather than complete haploinsufficiency of zeb2
    n1=Hyde (prurigo nodulaire de) | n2=en:milder phenotype associated with aberrant function of a single domain of the zeb2 protein rather than complete haploinsufficiency of zeb2 | rel=r_associated | relid=0 | w=15
  4132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:milder, childhood form, with onset by age 4 years, lesser cardiac involvement, and hypoketotic hypoglycemia
    n1=Hyde (prurigo nodulaire de) | n2=en:milder, childhood form, with onset by age 4 years, lesser cardiac involvement, and hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=15
  4133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mildly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:mildly progressive | rel=r_associated | relid=0 | w=15
  4134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:miller-dieker syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:miller-dieker syndrome | rel=r_associated | relid=0 | w=15
  4135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mineral
    n1=Hyde (prurigo nodulaire de) | n2=en:mineral | rel=r_associated | relid=0 | w=15
  4136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mineral nutrients
    n1=Hyde (prurigo nodulaire de) | n2=en:mineral nutrients | rel=r_associated | relid=0 | w=15
  4137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:minicore myopathy with external ophthalmoplegia (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:minicore myopathy with external ophthalmoplegia (disorder) | rel=r_associated | relid=0 | w=15
  4138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:minimal response to surfactant treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:minimal response to surfactant treatment | rel=r_associated | relid=0 | w=15
  4139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:minimum duplication includes bhlha9 (615416)
    n1=Hyde (prurigo nodulaire de) | n2=en:minimum duplication includes bhlha9 (615416) | rel=r_associated | relid=0 | w=15
  4140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:minimum region of duplication is a 9.1-kb region located 40kb 5-prime of the ihh gene
    n1=Hyde (prurigo nodulaire de) | n2=en:minimum region of duplication is a 9.1-kb region located 40kb 5-prime of the ihh gene | rel=r_associated | relid=0 | w=15
  4141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:miscellaneous
    n1=Hyde (prurigo nodulaire de) | n2=en:miscellaneous | rel=r_associated | relid=0 | w=15
  4142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mitoxantrone
    n1=Hyde (prurigo nodulaire de) | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=15
  4143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mliii is a heterogeneous disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:mliii is a heterogeneous disorder | rel=r_associated | relid=0 | w=15
  4144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mode of inheritance is uncertain
    n1=Hyde (prurigo nodulaire de) | n2=en:mode of inheritance is uncertain | rel=r_associated | relid=0 | w=15
  4145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mode of inheritance is unclear
    n1=Hyde (prurigo nodulaire de) | n2=en:mode of inheritance is unclear | rel=r_associated | relid=0 | w=15
  4146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mode of inheritance is unclear, x-linked recessive inheritance could not be ruled out
    n1=Hyde (prurigo nodulaire de) | n2=en:mode of inheritance is unclear, x-linked recessive inheritance could not be ruled out | rel=r_associated | relid=0 | w=15
  4147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:moderate age-related improvement of pancreatic function
    n1=Hyde (prurigo nodulaire de) | n2=en:moderate age-related improvement of pancreatic function | rel=r_associated | relid=0 | w=15
  4148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:momo is an acronym - macrosomia, obesity, macrocrania, ocular abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:momo is an acronym - macrosomia, obesity, macrocrania, ocular abnormalities | rel=r_associated | relid=0 | w=15
  4149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:monomer
    n1=Hyde (prurigo nodulaire de) | n2=en:monomer | rel=r_associated | relid=0 | w=15
  4150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:monosaccharide
    n1=Hyde (prurigo nodulaire de) | n2=en:monosaccharide | rel=r_associated | relid=0 | w=15
  4151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in ashkenazi jews
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in ashkenazi jews | rel=r_associated | relid=0 | w=15
  4152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in females
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in females | rel=r_associated | relid=0 | w=15
  4153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in females (male:female ratio 4:1)
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in females (male:female ratio 4:1) | rel=r_associated | relid=0 | w=15
  4154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in males
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in males | rel=r_associated | relid=0 | w=15
  4155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in men (9:1 male:female ratio)
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in men (9:1 male:female ratio) | rel=r_associated | relid=0 | w=15
  4156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in men than women
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in men than women | rel=r_associated | relid=0 | w=15
  4157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in women
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in women | rel=r_associated | relid=0 | w=15
  4158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more common in women (90%)
    n1=Hyde (prurigo nodulaire de) | n2=en:more common in women (90%) | rel=r_associated | relid=0 | w=15
  4159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more commonly observed in women
    n1=Hyde (prurigo nodulaire de) | n2=en:more commonly observed in women | rel=r_associated | relid=0 | w=15
  4160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more frequent in females
    n1=Hyde (prurigo nodulaire de) | n2=en:more frequent in females | rel=r_associated | relid=0 | w=15
  4161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more frequent in individuals of asian descent
    n1=Hyde (prurigo nodulaire de) | n2=en:more frequent in individuals of asian descent | rel=r_associated | relid=0 | w=15
  4162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more frequent in males
    n1=Hyde (prurigo nodulaire de) | n2=en:more frequent in males | rel=r_associated | relid=0 | w=15
  4163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more prevalent in females
    n1=Hyde (prurigo nodulaire de) | n2=en:more prevalent in females | rel=r_associated | relid=0 | w=15
  4164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:more severe in males than in females
    n1=Hyde (prurigo nodulaire de) | n2=en:more severe in males than in females | rel=r_associated | relid=0 | w=15
  4165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:morning sickness
    n1=Hyde (prurigo nodulaire de) | n2=en:morning sickness | rel=r_associated | relid=0 | w=15
  4166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mortality approximately 20% in first 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:mortality approximately 20% in first 2 years | rel=r_associated | relid=0 | w=15
  4167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mortality, premature
    n1=Hyde (prurigo nodulaire de) | n2=en:mortality, premature | rel=r_associated | relid=0 | w=15
  4168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mosaic distribution of lesions
    n1=Hyde (prurigo nodulaire de) | n2=en:mosaic distribution of lesions | rel=r_associated | relid=0 | w=15
  4169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most (80 to 90%) of cases result from deletions of the sts gene
    n1=Hyde (prurigo nodulaire de) | n2=en:most (80 to 90%) of cases result from deletions of the sts gene | rel=r_associated | relid=0 | w=15
  4170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most affected infants die in the first month of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most affected infants die in the first month of life | rel=r_associated | relid=0 | w=15
  4171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most affected infants die shortly after birth from respiratory failure
    n1=Hyde (prurigo nodulaire de) | n2=en:most affected infants die shortly after birth from respiratory failure | rel=r_associated | relid=0 | w=15
  4172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most affected males die of respiratory failure within the first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most affected males die of respiratory failure within the first months of life | rel=r_associated | relid=0 | w=15
  4173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most affected patients die in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:most affected patients die in childhood | rel=r_associated | relid=0 | w=15
  4174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most become wheelchair-bound late in life
    n1=Hyde (prurigo nodulaire de) | n2=en:most become wheelchair-bound late in life | rel=r_associated | relid=0 | w=15
  4175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most carrier females have mild mental retardation and subtle facial changes
    n1=Hyde (prurigo nodulaire de) | n2=en:most carrier females have mild mental retardation and subtle facial changes | rel=r_associated | relid=0 | w=15
  4176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most case are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:most case are sporadic | rel=r_associated | relid=0 | w=15
  4177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases (98%) caused by expanded trinucleotide repeat (cgg)n in the fmr1 gene (309550.0004)
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases (98%) caused by expanded trinucleotide repeat (cgg)n in the fmr1 gene (309550.0004) | rel=r_associated | relid=0 | w=15
  4178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases are caused by mutation in the phox2b gene
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases are caused by mutation in the phox2b gene | rel=r_associated | relid=0 | w=15
  4179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases are caused by the factor v leiden mutation (r506q, 612309.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases are caused by the factor v leiden mutation (r506q, 612309.0001) | rel=r_associated | relid=0 | w=15
  4180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases are de novo occurrences, but rare autosomal dominant inheritance has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases are de novo occurrences, but rare autosomal dominant inheritance has been reported | rel=r_associated | relid=0 | w=15
  4181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases are isolated
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases are isolated | rel=r_associated | relid=0 | w=15
  4182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases are responsive to steroids
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases are responsive to steroids | rel=r_associated | relid=0 | w=15
  4183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases do not have mutations in the mapt gene, but map to chromosome 17q
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases do not have mutations in the mapt gene, but map to chromosome 17q | rel=r_associated | relid=0 | w=15
  4184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases due to de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases due to de novo mutation | rel=r_associated | relid=0 | w=15
  4185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases occur de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases occur de novo | rel=r_associated | relid=0 | w=15
  4186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases result from a de novo mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases result from a de novo mutation | rel=r_associated | relid=0 | w=15
  4187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases result from de novo mutation or deletion of rai1 (607642)
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases result from de novo mutation or deletion of rai1 (607642) | rel=r_associated | relid=0 | w=15
  4188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases result from de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases result from de novo mutations | rel=r_associated | relid=0 | w=15
  4189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most cases sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:most cases sporadic | rel=r_associated | relid=0 | w=15
  4190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most children become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:most children become wheelchair-bound | rel=r_associated | relid=0 | w=15
  4191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common age of clinical onset ranges from 16 to 33 years
    n1=Hyde (prurigo nodulaire de) | n2=en:most common age of clinical onset ranges from 16 to 33 years | rel=r_associated | relid=0 | w=15
  4192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common cancer in men aged 15-40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:most common cancer in men aged 15-40 years | rel=r_associated | relid=0 | w=15
  4193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common disorder of fatty acid oxidation (1/13,000 births)
    n1=Hyde (prurigo nodulaire de) | n2=en:most common disorder of fatty acid oxidation (1/13,000 births) | rel=r_associated | relid=0 | w=15
  4194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common episodic ataxia syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:most common episodic ataxia syndrome | rel=r_associated | relid=0 | w=15
  4195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of autosomal dominant hereditary spastic paraplegia (accounts for 40% of spg cases)
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of autosomal dominant hereditary spastic paraplegia (accounts for 40% of spg cases) | rel=r_associated | relid=0 | w=15
  4196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of bowel obstruction in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of bowel obstruction in infancy | rel=r_associated | relid=0 | w=15
  4197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of childhood idiopathic epilepsy
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of childhood idiopathic epilepsy | rel=r_associated | relid=0 | w=15
  4198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of congenital methemoglobinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of congenital methemoglobinemia | rel=r_associated | relid=0 | w=15
  4199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of inherited, congenital hydrocephalus
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of inherited, congenital hydrocephalus | rel=r_associated | relid=0 | w=15
  4200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common form of porphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:most common form of porphyria | rel=r_associated | relid=0 | w=15
  4201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common genetic abnormality is a (gaa)n trinucleotide repeat expansion in intron 1 of the fxn gene (606829.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:most common genetic abnormality is a (gaa)n trinucleotide repeat expansion in intron 1 of the fxn gene (606829.0001) | rel=r_associated | relid=0 | w=15
  4202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common inherited ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:most common inherited ataxia | rel=r_associated | relid=0 | w=15
  4203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common inherited bleeding disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:most common inherited bleeding disorder | rel=r_associated | relid=0 | w=15
  4204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common inherited giant platelet disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:most common inherited giant platelet disorder | rel=r_associated | relid=0 | w=15
  4205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common muscle disease of older persons
    n1=Hyde (prurigo nodulaire de) | n2=en:most common muscle disease of older persons | rel=r_associated | relid=0 | w=15
  4206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common mutation is leu276ile (606596.0004)
    n1=Hyde (prurigo nodulaire de) | n2=en:most common mutation is leu276ile (606596.0004) | rel=r_associated | relid=0 | w=15
  4207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common subtype of frontotemporal dementia (600274)
    n1=Hyde (prurigo nodulaire de) | n2=en:most common subtype of frontotemporal dementia (600274) | rel=r_associated | relid=0 | w=15
  4208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most common terminal deletion syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:most common terminal deletion syndrome | rel=r_associated | relid=0 | w=15
  4209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most frequently affected joints - hands (98%) and feet (88%)
    n1=Hyde (prurigo nodulaire de) | n2=en:most frequently affected joints - hands (98%) and feet (88%) | rel=r_associated | relid=0 | w=15
  4210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most have onset in first or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:most have onset in first or second decade | rel=r_associated | relid=0 | w=15
  4211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most have resolution of symptoms between 6 and 12 months
    n1=Hyde (prurigo nodulaire de) | n2=en:most have resolution of symptoms between 6 and 12 months | rel=r_associated | relid=0 | w=15
  4212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most individuals are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:most individuals are asymptomatic | rel=r_associated | relid=0 | w=15
  4213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most individuals are wheelchair-bound or bedridden by adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:most individuals are wheelchair-bound or bedridden by adolescence | rel=r_associated | relid=0 | w=15
  4214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most mutations occur de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:most mutations occur de novo | rel=r_associated | relid=0 | w=15
  4215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients appear unaffected in the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients appear unaffected in the first year of life | rel=r_associated | relid=0 | w=15
  4216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are asymptomatic | rel=r_associated | relid=0 | w=15
  4217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are asymptomatic and are detected by newborn screening
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are asymptomatic and are detected by newborn screening | rel=r_associated | relid=0 | w=15
  4218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are clinically asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are clinically asymptomatic | rel=r_associated | relid=0 | w=15
  4219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are clinically asymptomatic and show normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are clinically asymptomatic and show normal development | rel=r_associated | relid=0 | w=15
  4220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are female
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are female | rel=r_associated | relid=0 | w=15
  4221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are from finland
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are from finland | rel=r_associated | relid=0 | w=15
  4222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are severely affected
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are severely affected | rel=r_associated | relid=0 | w=15
  4223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients are stillborn or die in immediate neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients are stillborn or die in immediate neonatal period | rel=r_associated | relid=0 | w=15
  4224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become seizure-free by age 3 or 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become seizure-free by age 3 or 4 years | rel=r_associated | relid=0 | w=15
  4225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound | rel=r_associated | relid=0 | w=15
  4226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound after 20 to 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound after 20 to 30 years | rel=r_associated | relid=0 | w=15
  4227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound in adolescence | rel=r_associated | relid=0 | w=15
  4228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound in adolescence or as young adults
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound in adolescence or as young adults | rel=r_associated | relid=0 | w=15
  4229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound in later childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound in later childhood | rel=r_associated | relid=0 | w=15
  4230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients become wheelchair-bound in the second to fourth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients become wheelchair-bound in the second to fourth decades | rel=r_associated | relid=0 | w=15
  4231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients develop symptoms while on prophylactic vitamin d supplementation in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients develop symptoms while on prophylactic vitamin d supplementation in infancy | rel=r_associated | relid=0 | w=15
  4232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die from heart failure
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die from heart failure | rel=r_associated | relid=0 | w=15
  4233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in childhood | rel=r_associated | relid=0 | w=15
  4234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in early childhood | rel=r_associated | relid=0 | w=15
  4235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in first years of life | rel=r_associated | relid=0 | w=15
  4236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in infancy | rel=r_associated | relid=0 | w=15
  4237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in infancy features of pseudoxanthoma elasticum, an allelic disorder, have not yet been reported in gaci2 patients (the 4 surviving patients reported as of january 2012 are all age 5 years or less)
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in infancy features of pseudoxanthoma elasticum, an allelic disorder, have not yet been reported in gaci2 patients (the 4 surviving patients reported as of january 2012 are all age 5 years or less) | rel=r_associated | relid=0 | w=15
  4238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die in the neonatal period due to respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die in the neonatal period due to respiratory insufficiency | rel=r_associated | relid=0 | w=15
  4239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die of hepatic failure by 9 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die of hepatic failure by 9 months of age | rel=r_associated | relid=0 | w=15
  4240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die of renal failure in early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die of renal failure in early adulthood | rel=r_associated | relid=0 | w=15
  4241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients die within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients die within the first year of life | rel=r_associated | relid=0 | w=15
  4242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients do not learn to sit or walk
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients do not learn to sit or walk | rel=r_associated | relid=0 | w=15
  4243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have a family history of fragile x syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have a family history of fragile x syndrome | rel=r_associated | relid=0 | w=15
  4244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have adult onset of symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have adult onset of symptoms | rel=r_associated | relid=0 | w=15
  4245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have de novo mutations | rel=r_associated | relid=0 | w=15
  4246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have involvement of all nails, with more severe changes in the nails of the thumbs and great toes
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have involvement of all nails, with more severe changes in the nails of the thumbs and great toes | rel=r_associated | relid=0 | w=15
  4247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have no bleeding abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have no bleeding abnormalities | rel=r_associated | relid=0 | w=15
  4248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have pure spastic paraplegia, some have complicated spastic paraplegia
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have pure spastic paraplegia, some have complicated spastic paraplegia | rel=r_associated | relid=0 | w=15
  4249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have recurrent 'flares' of pustular rash with fever, although some develop chronic erythematous plaques without pustules
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have recurrent 'flares' of pustular rash with fever, although some develop chronic erythematous plaques without pustules | rel=r_associated | relid=0 | w=15
  4250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients have severe streptococcus pneumoniae infections
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients have severe streptococcus pneumoniae infections | rel=r_associated | relid=0 | w=15
  4251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients lose ambulation 2 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients lose ambulation 2 years after onset | rel=r_associated | relid=0 | w=15
  4252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients need assistance walking or are wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients need assistance walking or are wheelchair-bound | rel=r_associated | relid=0 | w=15
  4253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients need hip replacement by their mid-thirties
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients need hip replacement by their mid-thirties | rel=r_associated | relid=0 | w=15
  4254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients present in infancy with anemia
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients present in infancy with anemia | rel=r_associated | relid=0 | w=15
  4255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients remain ambulatory
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients remain ambulatory | rel=r_associated | relid=0 | w=15
  4256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients remain ambulatory in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients remain ambulatory in adulthood | rel=r_associated | relid=0 | w=15
  4257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients require ambulatory aids about 10 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients require ambulatory aids about 10 years after onset | rel=r_associated | relid=0 | w=15
  4258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients require liver transplant in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients require liver transplant in childhood | rel=r_associated | relid=0 | w=15
  4259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients require liver transplantation within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients require liver transplantation within the first year of life | rel=r_associated | relid=0 | w=15
  4260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients retain ambulation with aids
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients retain ambulation with aids | rel=r_associated | relid=0 | w=15
  4261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most patients show early childhood onset after a period of normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:most patients show early childhood onset after a period of normal development | rel=r_associated | relid=0 | w=15
  4262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most pregnancies with affected fetuses resulted in elective termination molecular genetics : caused by mutation in the homolog of the drosophila crumbs 2 gene (crb2, 609720.0006)
    n1=Hyde (prurigo nodulaire de) | n2=en:most pregnancies with affected fetuses resulted in elective termination molecular genetics : caused by mutation in the homolog of the drosophila crumbs 2 gene (crb2, 609720.0006) | rel=r_associated | relid=0 | w=15
  4263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most remit by 2 months
    n1=Hyde (prurigo nodulaire de) | n2=en:most remit by 2 months | rel=r_associated | relid=0 | w=15
  4264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most remit by 6 weeks (1-6 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:most remit by 6 weeks (1-6 months) | rel=r_associated | relid=0 | w=15
  4265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most reported cases come from the island of mauritius or nearby islands
    n1=Hyde (prurigo nodulaire de) | n2=en:most reported cases come from the island of mauritius or nearby islands | rel=r_associated | relid=0 | w=15
  4266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most retain independent ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:most retain independent ambulation | rel=r_associated | relid=0 | w=15
  4267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most severe form of gaucher disease
    n1=Hyde (prurigo nodulaire de) | n2=en:most severe form of gaucher disease | rel=r_associated | relid=0 | w=15
  4268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most severe type of von willebrand disease
    n1=Hyde (prurigo nodulaire de) | n2=en:most severe type of von willebrand disease | rel=r_associated | relid=0 | w=15
  4269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:most types show autosomal dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:most types show autosomal dominant inheritance | rel=r_associated | relid=0 | w=15
  4270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mother had rubella infection during pregnancy with daughter
    n1=Hyde (prurigo nodulaire de) | n2=en:mother had rubella infection during pregnancy with daughter | rel=r_associated | relid=0 | w=15
  4271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mother who carries the mutation is clinically unaffected
    n1=Hyde (prurigo nodulaire de) | n2=en:mother who carries the mutation is clinically unaffected | rel=r_associated | relid=0 | w=15
  4272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor developmental delay
    n1=Hyde (prurigo nodulaire de) | n2=en:motor developmental delay | rel=r_associated | relid=0 | w=15
  4273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor fluctuations
    n1=Hyde (prurigo nodulaire de) | n2=en:motor fluctuations | rel=r_associated | relid=0 | w=15
  4274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor impairment more significant than sensory impairment
    n1=Hyde (prurigo nodulaire de) | n2=en:motor impairment more significant than sensory impairment | rel=r_associated | relid=0 | w=15
  4275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor neuropathy more prominent than sensory neuropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:motor neuropathy more prominent than sensory neuropathy | rel=r_associated | relid=0 | w=15
  4276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor skills less affected than cognitive skills
    n1=Hyde (prurigo nodulaire de) | n2=en:motor skills less affected than cognitive skills | rel=r_associated | relid=0 | w=15
  4277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor symptoms are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:motor symptoms are variable | rel=r_associated | relid=0 | w=15
  4278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor symptoms develop later (about 5 years into illness)
    n1=Hyde (prurigo nodulaire de) | n2=en:motor symptoms develop later (about 5 years into illness) | rel=r_associated | relid=0 | w=15
  4279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:motor symptoms show mild clinical improvement with levodopa treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:motor symptoms show mild clinical improvement with levodopa treatment | rel=r_associated | relid=0 | w=15
  4280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mousy odor
    n1=Hyde (prurigo nodulaire de) | n2=en:mousy odor | rel=r_associated | relid=0 | w=15
  4281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:movements worsened by anxiety
    n1=Hyde (prurigo nodulaire de) | n2=en:movements worsened by anxiety | rel=r_associated | relid=0 | w=15
  4282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mps1 types are distinguished clinically by age of onset and progression or by mutation(s)
    n1=Hyde (prurigo nodulaire de) | n2=en:mps1 types are distinguished clinically by age of onset and progression or by mutation(s) | rel=r_associated | relid=0 | w=15
  4283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mucocutaneous immunodeficiency syndrome may be prominent
    n1=Hyde (prurigo nodulaire de) | n2=en:mucocutaneous immunodeficiency syndrome may be prominent | rel=r_associated | relid=0 | w=15
  4284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mulibrey is an acronym (muscle, liver, brain, and eyes)
    n1=Hyde (prurigo nodulaire de) | n2=en:mulibrey is an acronym (muscle, liver, brain, and eyes) | rel=r_associated | relid=0 | w=15
  4285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiorgan failure may result from hs
    n1=Hyde (prurigo nodulaire de) | n2=en:multiorgan failure may result from hs | rel=r_associated | relid=0 | w=15
  4286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple congenital anomalies-hypotonia-seizures syndrome 1
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple congenital anomalies-hypotonia-seizures syndrome 1 | rel=r_associated | relid=0 | w=15
  4287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple gastrointestinal atresias (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple gastrointestinal atresias (disorder) | rel=r_associated | relid=0 | w=15
  4288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple gene loci involved in causation of schizophrenia
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple gene loci involved in causation of schizophrenia | rel=r_associated | relid=0 | w=15
  4289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple lesions in familial cases
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple lesions in familial cases | rel=r_associated | relid=0 | w=15
  4290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple mitochondrial dna deletions are found in autosomal dominant pedigrees
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple mitochondrial dna deletions are found in autosomal dominant pedigrees | rel=r_associated | relid=0 | w=15
  4291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple mitochondrial dysfunctions syndrome 3
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple mitochondrial dysfunctions syndrome 3 | rel=r_associated | relid=0 | w=15
  4292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple pregnancy | rel=r_associated | relid=0 | w=15
  4293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple prenatal fractures
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple prenatal fractures | rel=r_associated | relid=0 | w=15
  4294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple seizures daily at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple seizures daily at onset | rel=r_associated | relid=0 | w=15
  4295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:multiple spontaneous abortions in obligate carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple spontaneous abortions in obligate carriers | rel=r_associated | relid=0 | w=15
  4296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:murcs association
    n1=Hyde (prurigo nodulaire de) | n2=en:murcs association | rel=r_associated | relid=0 | w=15
  4297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:muscle contractions in infancy occur in response to tactile stimulation or crying
    n1=Hyde (prurigo nodulaire de) | n2=en:muscle contractions in infancy occur in response to tactile stimulation or crying | rel=r_associated | relid=0 | w=15
  4298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:muscle involvement shows onset at birth or in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:muscle involvement shows onset at birth or in infancy | rel=r_associated | relid=0 | w=15
  4299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:muscle symptoms precede cardiac symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:muscle symptoms precede cardiac symptoms | rel=r_associated | relid=0 | w=15
  4300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:muscle weakness increases with age
    n1=Hyde (prurigo nodulaire de) | n2=en:muscle weakness increases with age | rel=r_associated | relid=0 | w=15
  4301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:muscle weakness occurs only in the presence of hyperthyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:muscle weakness occurs only in the presence of hyperthyroidism | rel=r_associated | relid=0 | w=15
  4302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mut- denotes individuals with structurally altered mutase with reduced affinity for adenosylcobalamin (adocbl)
    n1=Hyde (prurigo nodulaire de) | n2=en:mut- denotes individuals with structurally altered mutase with reduced affinity for adenosylcobalamin (adocbl) | rel=r_associated | relid=0 | w=15
  4303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mut-0 denotes individuals with cultured fibroblast mutase activity that is undetectable secondary to no functional mutase
    n1=Hyde (prurigo nodulaire de) | n2=en:mut-0 denotes individuals with cultured fibroblast mutase activity that is undetectable secondary to no functional mutase | rel=r_associated | relid=0 | w=15
  4304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutant alleles have 47 to 63 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:mutant alleles have 47 to 63 repeats | rel=r_associated | relid=0 | w=15
  4305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age | rel=r_associated | relid=0 | w=15
  4306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation carriers may show toxicity to 5-fluorouracil (5fu)
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation carriers may show toxicity to 5-fluorouracil (5fu) | rel=r_associated | relid=0 | w=15
  4307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation found in 1 puerto rican family (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation found in 1 puerto rican family (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in b3gat3 has been found in 1 emirati family and 1 emirati boy
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in b3gat3 has been found in 1 emirati family and 1 emirati boy | rel=r_associated | relid=0 | w=15
  4309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in nola3 found in 1 consanguineous saudi family (as of may 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in nola3 found in 1 consanguineous saudi family (as of may 2011) | rel=r_associated | relid=0 | w=15
  4310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in npr2 results in gain-of-function
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in npr2 results in gain-of-function | rel=r_associated | relid=0 | w=15
  4311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in rp9 gene in family (607331.0001) likely not pathogenic
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in rp9 gene in family (607331.0001) likely not pathogenic | rel=r_associated | relid=0 | w=15
  4312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in the hcrt gene has been identified in 1 patient
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in the hcrt gene has been identified in 1 patient | rel=r_associated | relid=0 | w=15
  4313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutation in the mass1 gene has been identified in 1 of 48 families with familial febrile seizures linked to 5q14
    n1=Hyde (prurigo nodulaire de) | n2=en:mutation in the mass1 gene has been identified in 1 of 48 families with familial febrile seizures linked to 5q14 | rel=r_associated | relid=0 | w=15
  4314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutational analysis revealed that the original weissenbacher-zweymuller patient had non-ophthalmic stickler syndrome (stkl3, 184840)
    n1=Hyde (prurigo nodulaire de) | n2=en:mutational analysis revealed that the original weissenbacher-zweymuller patient had non-ophthalmic stickler syndrome (stkl3, 184840) | rel=r_associated | relid=0 | w=15
  4315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutations in the cpo gene cause 3 clinically distinct disorders, hereditary coproporphyria (hcp), 'homozygous' variant hereditary coproporphyria, or harderoporphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:mutations in the cpo gene cause 3 clinically distinct disorders, hereditary coproporphyria (hcp), 'homozygous' variant hereditary coproporphyria, or harderoporphyria | rel=r_associated | relid=0 | w=15
  4316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutations occur de novo
    n1=Hyde (prurigo nodulaire de) | n2=en:mutations occur de novo | rel=r_associated | relid=0 | w=15
  4317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:mutations show partial penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:mutations show partial penetrance | rel=r_associated | relid=0 | w=15
  4318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myelodysplastic syndrome developed in 1 of 12 mutation-positive patients
    n1=Hyde (prurigo nodulaire de) | n2=en:myelodysplastic syndrome developed in 1 of 12 mutation-positive patients | rel=r_associated | relid=0 | w=15
  4319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myoclonic seizures occur on awakening or within 2 hours of awakening
    n1=Hyde (prurigo nodulaire de) | n2=en:myoclonic seizures occur on awakening or within 2 hours of awakening | rel=r_associated | relid=0 | w=15
  4320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myoclonus triggered by action, sudden movements, and inadvertent somatosensory stimuli
    n1=Hyde (prurigo nodulaire de) | n2=en:myoclonus triggered by action, sudden movements, and inadvertent somatosensory stimuli | rel=r_associated | relid=0 | w=15
  4321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myopathy, congenital, compton-north
    n1=Hyde (prurigo nodulaire de) | n2=en:myopathy, congenital, compton-north | rel=r_associated | relid=0 | w=15
  4322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myopathy, congenital, with fiber-type disproportion, x-linked
    n1=Hyde (prurigo nodulaire de) | n2=en:myopathy, congenital, with fiber-type disproportion, x-linked | rel=r_associated | relid=0 | w=15
  4323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:myotilinopathy (609200) is an allelic disorder with overlapping clinical features
    n1=Hyde (prurigo nodulaire de) | n2=en:myotilinopathy (609200) is an allelic disorder with overlapping clinical features | rel=r_associated | relid=0 | w=15
  4324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:n-myc oncogene (164840) amplification is associated with poor prognosis
    n1=Hyde (prurigo nodulaire de) | n2=en:n-myc oncogene (164840) amplification is associated with poor prognosis | rel=r_associated | relid=0 | w=15
  4325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nail changes may be intermittent in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:nail changes may be intermittent in some patients | rel=r_associated | relid=0 | w=15
  4326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nails appear normal at birth, with dystrophic changes developing within the first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:nails appear normal at birth, with dystrophic changes developing within the first decade of life | rel=r_associated | relid=0 | w=15
  4327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nails may be intermittently involved
    n1=Hyde (prurigo nodulaire de) | n2=en:nails may be intermittently involved | rel=r_associated | relid=0 | w=15
  4328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nails, palms, and soles are spared in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:nails, palms, and soles are spared in some patients | rel=r_associated | relid=0 | w=15
  4329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:name sponastrime = spo (spondylo), nas (nasal), strime (striated metaphyses)
    n1=Hyde (prurigo nodulaire de) | n2=en:name sponastrime = spo (spondylo), nas (nasal), strime (striated metaphyses) | rel=r_associated | relid=0 | w=15
  4330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:narcolepsy and deafness are the first symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:narcolepsy and deafness are the first symptoms | rel=r_associated | relid=0 | w=15
  4331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:natural aversion to carbohydrates
    n1=Hyde (prurigo nodulaire de) | n2=en:natural aversion to carbohydrates | rel=r_associated | relid=0 | w=15
  4332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:natural aversion to carbohydrates and favoring of protein
    n1=Hyde (prurigo nodulaire de) | n2=en:natural aversion to carbohydrates and favoring of protein | rel=r_associated | relid=0 | w=15
  4333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:natural serum rubber powder
    n1=Hyde (prurigo nodulaire de) | n2=en:natural serum rubber powder | rel=r_associated | relid=0 | w=15
  4334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:near-normoglycemic remission for period of months to years without insulin treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:near-normoglycemic remission for period of months to years without insulin treatment | rel=r_associated | relid=0 | w=15
  4335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nearly 100% penetrance by 60 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:nearly 100% penetrance by 60 years of age | rel=r_associated | relid=0 | w=15
  4336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:negative repeat expansion (reverse anticipation) can occur (approximately 5% of the time)
    n1=Hyde (prurigo nodulaire de) | n2=en:negative repeat expansion (reverse anticipation) can occur (approximately 5% of the time) | rel=r_associated | relid=0 | w=15
  4337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nemaline myopathy 10
    n1=Hyde (prurigo nodulaire de) | n2=en:nemaline myopathy 10 | rel=r_associated | relid=0 | w=15
  4338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neo-cholex powder
    n1=Hyde (prurigo nodulaire de) | n2=en:neo-cholex powder | rel=r_associated | relid=0 | w=15
  4339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neocate
    n1=Hyde (prurigo nodulaire de) | n2=en:neocate | rel=r_associated | relid=0 | w=15
  4340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal and late-infantile onset
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal and late-infantile onset | rel=r_associated | relid=0 | w=15
  4341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal death
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal death | rel=r_associated | relid=0 | w=15
  4342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal death secondary to pulmonary insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal death secondary to pulmonary insufficiency | rel=r_associated | relid=0 | w=15
  4343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal lethal due to respiratory insufficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal lethal due to respiratory insufficiency | rel=r_associated | relid=0 | w=15
  4344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal onset
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal onset | rel=r_associated | relid=0 | w=15
  4345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal onset of nephrotic syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal onset of nephrotic syndrome | rel=r_associated | relid=0 | w=15
  4346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal or infant death
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal or infant death | rel=r_associated | relid=0 | w=15
  4347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal sepsis
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=15
  4348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal severe hyperparathyroidism in homozygotes (239200)
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal severe hyperparathyroidism in homozygotes (239200) | rel=r_associated | relid=0 | w=15
  4349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neonatal/infantile death in most patients
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal/infantile death in most patients | rel=r_associated | relid=0 | w=15
  4350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neoplasm of meckel's diverticulum
    n1=Hyde (prurigo nodulaire de) | n2=en:neoplasm of meckel's diverticulum | rel=r_associated | relid=0 | w=15
  4351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neu-laxova syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:neu-laxova syndrome | rel=r_associated | relid=0 | w=15
  4352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuroendocrine recovery occurs in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:neuroendocrine recovery occurs in some patients | rel=r_associated | relid=0 | w=15
  4353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic deterioration is severe after age 2 to 2.5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic deterioration is severe after age 2 to 2.5 years | rel=r_associated | relid=0 | w=15
  4354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic dysfunction is infrequent and associated with delayed diagnosis
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic dysfunction is infrequent and associated with delayed diagnosis | rel=r_associated | relid=0 | w=15
  4355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic features are variable and not progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic features are variable and not progressive | rel=r_associated | relid=0 | w=15
  4356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic features have been diagnosed in ~30% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic features have been diagnosed in ~30% of cases | rel=r_associated | relid=0 | w=15
  4357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic features occur in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic features occur in adulthood | rel=r_associated | relid=0 | w=15
  4358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic features occur later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic features occur later in childhood | rel=r_associated | relid=0 | w=15
  4359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic findings closely resemble those of huntington disease (hd, 143100)
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic findings closely resemble those of huntington disease (hd, 143100) | rel=r_associated | relid=0 | w=15
  4360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic involvement may occur in the absence of visceral involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic involvement may occur in the absence of visceral involvement | rel=r_associated | relid=0 | w=15
  4361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic signs are present in the neonatal period only
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic signs are present in the neonatal period only | rel=r_associated | relid=0 | w=15
  4362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic signs last hours to days
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic signs last hours to days | rel=r_associated | relid=0 | w=15
  4363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic signs may not be present
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic signs may not be present | rel=r_associated | relid=0 | w=15
  4364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic signs onset during adolescence or young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic signs onset during adolescence or young adulthood | rel=r_associated | relid=0 | w=15
  4365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic symptoms are not always present or may appear late
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic symptoms are not always present or may appear late | rel=r_associated | relid=0 | w=15
  4366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic symptoms are progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic symptoms are progressive | rel=r_associated | relid=0 | w=15
  4367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic symptoms may develop decades later
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic symptoms may develop decades later | rel=r_associated | relid=0 | w=15
  4368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurologic symptoms may occur after trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:neurologic symptoms may occur after trauma | rel=r_associated | relid=0 | w=15
  4369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuromuscular forms can present as perinate, infant, child, or adult
    n1=Hyde (prurigo nodulaire de) | n2=en:neuromuscular forms can present as perinate, infant, child, or adult | rel=r_associated | relid=0 | w=15
  4370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuromuscular, cardiovascular, and infectious symptoms improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:neuromuscular, cardiovascular, and infectious symptoms improve with age | rel=r_associated | relid=0 | w=15
  4371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuropathic, cardiac, leptomeningeal, and ocular predominance may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:neuropathic, cardiac, leptomeningeal, and ocular predominance may occur | rel=r_associated | relid=0 | w=15
  4372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuropathy becomes apparent in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:neuropathy becomes apparent in childhood | rel=r_associated | relid=0 | w=15
  4373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neuropsychiatric manifestations are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:neuropsychiatric manifestations are variable | rel=r_associated | relid=0 | w=15
  4374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurotransmitter
    n1=Hyde (prurigo nodulaire de) | n2=en:neurotransmitter | rel=r_associated | relid=0 | w=15
  4375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurotransmitter receptor
    n1=Hyde (prurigo nodulaire de) | n2=en:neurotransmitter receptor | rel=r_associated | relid=0 | w=15
  4376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neurotransmitter treatment with l-dopa and serotonin or precursors is effective
    n1=Hyde (prurigo nodulaire de) | n2=en:neurotransmitter treatment with l-dopa and serotonin or precursors is effective | rel=r_associated | relid=0 | w=15
  4377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:neutral ceramidase
    n1=Hyde (prurigo nodulaire de) | n2=en:neutral ceramidase | rel=r_associated | relid=0 | w=15
  4378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:new skin lesions stop appearing before adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:new skin lesions stop appearing before adolescence | rel=r_associated | relid=0 | w=15
  4379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:newborn period is critical for survival
    n1=Hyde (prurigo nodulaire de) | n2=en:newborn period is critical for survival | rel=r_associated | relid=0 | w=15
  4380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:night blindness from early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:night blindness from early childhood | rel=r_associated | relid=0 | w=15
  4381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nine patients have been reported in detail (as of 14 june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:nine patients have been reported in detail (as of 14 june 2011) | rel=r_associated | relid=0 | w=15
  4382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ninety percent of cases are female
    n1=Hyde (prurigo nodulaire de) | n2=en:ninety percent of cases are female | rel=r_associated | relid=0 | w=15
  4383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ninety percent of patients with pbg deaminase deficiency are clinically unaffected
    n1=Hyde (prurigo nodulaire de) | n2=en:ninety percent of patients with pbg deaminase deficiency are clinically unaffected | rel=r_associated | relid=0 | w=15
  4384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no abdominal symptoms or neurologic symptoms in harderoporphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:no abdominal symptoms or neurologic symptoms in harderoporphyria | rel=r_associated | relid=0 | w=15
  4385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no abnormalities of hair, teeth, or bones
    n1=Hyde (prurigo nodulaire de) | n2=en:no abnormalities of hair, teeth, or bones | rel=r_associated | relid=0 | w=15
  4386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no abnormalities of skin, hair, teeth, or bones
    n1=Hyde (prurigo nodulaire de) | n2=en:no abnormalities of skin, hair, teeth, or bones | rel=r_associated | relid=0 | w=15
  4387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no cardiac or immune defects in patients from the 2 reported families
    n1=Hyde (prurigo nodulaire de) | n2=en:no cardiac or immune defects in patients from the 2 reported families | rel=r_associated | relid=0 | w=15
  4388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no chronic or permanent liver damage
    n1=Hyde (prurigo nodulaire de) | n2=en:no chronic or permanent liver damage | rel=r_associated | relid=0 | w=15
  4389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no clinical description given for 1 reported patient (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:no clinical description given for 1 reported patient (last curated december 2013) | rel=r_associated | relid=0 | w=15
  4390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no clinical details provided by the authors
    n1=Hyde (prurigo nodulaire de) | n2=en:no clinical details provided by the authors | rel=r_associated | relid=0 | w=15
  4391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no clinical manifestations were noted (incidental laboratory finding)
    n1=Hyde (prurigo nodulaire de) | n2=en:no clinical manifestations were noted (incidental laboratory finding) | rel=r_associated | relid=0 | w=15
  4392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no congenital form
    n1=Hyde (prurigo nodulaire de) | n2=en:no congenital form | rel=r_associated | relid=0 | w=15
  4393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:no dysmorphic features | rel=r_associated | relid=0 | w=15
  4394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no family history of
    n1=Hyde (prurigo nodulaire de) | n2=en:no family history of | rel=r_associated | relid=0 | w=15
  4395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no family history, de novo mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:no family history, de novo mutations | rel=r_associated | relid=0 | w=15
  4396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no features consistent with cystic fibrosis found in these patients
    n1=Hyde (prurigo nodulaire de) | n2=en:no features consistent with cystic fibrosis found in these patients | rel=r_associated | relid=0 | w=15
  4397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no fetal hydrops
    n1=Hyde (prurigo nodulaire de) | n2=en:no fetal hydrops | rel=r_associated | relid=0 | w=15
  4398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no history of familial hypercholesterolemia
    n1=Hyde (prurigo nodulaire de) | n2=en:no history of familial hypercholesterolemia | rel=r_associated | relid=0 | w=15
  4399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no increased fragility of hair
    n1=Hyde (prurigo nodulaire de) | n2=en:no increased fragility of hair | rel=r_associated | relid=0 | w=15
  4400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no male-to-male transmission
    n1=Hyde (prurigo nodulaire de) | n2=en:no male-to-male transmission | rel=r_associated | relid=0 | w=15
  4401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no mutations reported in la reunion island patients (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:no mutations reported in la reunion island patients (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no neurologic sequelae
    n1=Hyde (prurigo nodulaire de) | n2=en:no neurologic sequelae | rel=r_associated | relid=0 | w=15
  4403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no opportunistic infections
    n1=Hyde (prurigo nodulaire de) | n2=en:no opportunistic infections | rel=r_associated | relid=0 | w=15
  4404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no peripheral signs of hypothyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:no peripheral signs of hypothyroidism | rel=r_associated | relid=0 | w=15
  4405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no phenotype in heterozygotes
    n1=Hyde (prurigo nodulaire de) | n2=en:no phenotype in heterozygotes | rel=r_associated | relid=0 | w=15
  4406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no phenotypic difference between patients who are homozygous or heterozygous for mutations in the spink1 gene
    n1=Hyde (prurigo nodulaire de) | n2=en:no phenotypic difference between patients who are homozygous or heterozygous for mutations in the spink1 gene | rel=r_associated | relid=0 | w=15
  4407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no phenotypic manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:no phenotypic manifestations | rel=r_associated | relid=0 | w=15
  4408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no preceding skin inflammatory stage
    n1=Hyde (prurigo nodulaire de) | n2=en:no preceding skin inflammatory stage | rel=r_associated | relid=0 | w=15
  4409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no predisposition to skin tumor development
    n1=Hyde (prurigo nodulaire de) | n2=en:no predisposition to skin tumor development | rel=r_associated | relid=0 | w=15
  4410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no response or worsening with acetylcholinesterase inhibitors
    n1=Hyde (prurigo nodulaire de) | n2=en:no response or worsening with acetylcholinesterase inhibitors | rel=r_associated | relid=0 | w=15
  4411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no response to phenobarbital
    n1=Hyde (prurigo nodulaire de) | n2=en:no response to phenobarbital | rel=r_associated | relid=0 | w=15
  4412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no situs inversus
    n1=Hyde (prurigo nodulaire de) | n2=en:no situs inversus | rel=r_associated | relid=0 | w=15
  4413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no skeletal abnormalities in odontohypophosphatasia
    n1=Hyde (prurigo nodulaire de) | n2=en:no skeletal abnormalities in odontohypophosphatasia | rel=r_associated | relid=0 | w=15
  4414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:no systemic manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:no systemic manifestations | rel=r_associated | relid=0 | w=15
  4415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:noise exposure causes more severe hearing loss at high frequencies (2,000 to 8,000 hz)
    n1=Hyde (prurigo nodulaire de) | n2=en:noise exposure causes more severe hearing loss at high frequencies (2,000 to 8,000 hz) | rel=r_associated | relid=0 | w=15
  4416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-immune fetal hydrops (rare)
    n1=Hyde (prurigo nodulaire de) | n2=en:non-immune fetal hydrops (rare) | rel=r_associated | relid=0 | w=15
  4417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-immune hydrops fetalis
    n1=Hyde (prurigo nodulaire de) | n2=en:non-immune hydrops fetalis | rel=r_associated | relid=0 | w=15
  4418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-lysosomal glucosylceramidase
    n1=Hyde (prurigo nodulaire de) | n2=en:non-lysosomal glucosylceramidase | rel=r_associated | relid=0 | w=15
  4419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-progressive and more severe progressive forms
    n1=Hyde (prurigo nodulaire de) | n2=en:non-progressive and more severe progressive forms | rel=r_associated | relid=0 | w=15
  4420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-progressive or very slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:non-progressive or very slowly progressive | rel=r_associated | relid=0 | w=15
  4421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-rh blood group isoimmunization
    n1=Hyde (prurigo nodulaire de) | n2=en:non-rh blood group isoimmunization | rel=r_associated | relid=0 | w=15
  4422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:non-tender
    n1=Hyde (prurigo nodulaire de) | n2=en:non-tender | rel=r_associated | relid=0 | w=15
  4423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonpenetrance has been observed
    n1=Hyde (prurigo nodulaire de) | n2=en:nonpenetrance has been observed | rel=r_associated | relid=0 | w=15
  4424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonprogressive
    n1=Hyde (prurigo nodulaire de) | n2=en:nonprogressive | rel=r_associated | relid=0 | w=15
  4425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonprogressive hepatic form is less frequent
    n1=Hyde (prurigo nodulaire de) | n2=en:nonprogressive hepatic form is less frequent | rel=r_associated | relid=0 | w=15
  4426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonprogressive or slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:nonprogressive or slowly progressive | rel=r_associated | relid=0 | w=15
  4427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonrandom association of following anomalies--v (vertebral anomalies), a (anal atresia), c (cardiovascular anomalies), t (tracheoesophageal fistula), e (esophageal atresia), r (renal anomalies), l (preaxial limb anomalies)
    n1=Hyde (prurigo nodulaire de) | n2=en:nonrandom association of following anomalies--v (vertebral anomalies), a (anal atresia), c (cardiovascular anomalies), t (tracheoesophageal fistula), e (esophageal atresia), r (renal anomalies), l (preaxial limb anomalies) | rel=r_associated | relid=0 | w=15
  4428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonreflex epilepsy may occur later in 16 to 38% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:nonreflex epilepsy may occur later in 16 to 38% of patients | rel=r_associated | relid=0 | w=15
  4429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonsyndromic
    n1=Hyde (prurigo nodulaire de) | n2=en:nonsyndromic | rel=r_associated | relid=0 | w=15
  4430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonsyndromic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:nonsyndromic disorder | rel=r_associated | relid=0 | w=15
  4431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nontruncating (missense) lamb2 mutations may display variable phenotypes ranging from a milder variant of pierson syndrome to isolated congenital nephrotic syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:nontruncating (missense) lamb2 mutations may display variable phenotypes ranging from a milder variant of pierson syndrome to isolated congenital nephrotic syndrome | rel=r_associated | relid=0 | w=15
  4432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nonvolatile congener
    n1=Hyde (prurigo nodulaire de) | n2=en:nonvolatile congener | rel=r_associated | relid=0 | w=15
  4433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:noonan syndrome 8
    n1=Hyde (prurigo nodulaire de) | n2=en:noonan syndrome 8 | rel=r_associated | relid=0 | w=15
  4434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal - 5 to 37 copies of (ctg)n repeat in dmpk (605377)
    n1=Hyde (prurigo nodulaire de) | n2=en:normal - 5 to 37 copies of (ctg)n repeat in dmpk (605377) | rel=r_associated | relid=0 | w=15
  4435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal ability to tolerate heat
    n1=Hyde (prurigo nodulaire de) | n2=en:normal ability to tolerate heat | rel=r_associated | relid=0 | w=15
  4436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles contain 15 to 50 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles contain 15 to 50 repeats | rel=r_associated | relid=0 | w=15
  4437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles contain 6 to 28 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles contain 6 to 28 repeats | rel=r_associated | relid=0 | w=15
  4438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles contain up to 30 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles contain up to 30 repeats | rel=r_associated | relid=0 | w=15
  4439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles contain up to 44 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles contain up to 44 repeats | rel=r_associated | relid=0 | w=15
  4440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles have 10 to 29 repeats and pathologic alleles have 400 to 4,500 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles have 10 to 29 repeats and pathologic alleles have 400 to 4,500 repeats | rel=r_associated | relid=0 | w=15
  4441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles have 25 to 44 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles have 25 to 44 repeats | rel=r_associated | relid=0 | w=15
  4442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal alleles have 4 to 18 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:normal alleles have 4 to 18 repeats | rel=r_associated | relid=0 | w=15
  4443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:normal at birth | rel=r_associated | relid=0 | w=15
  4444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal birth (finding)
    n1=Hyde (prurigo nodulaire de) | n2=en:normal birth (finding) | rel=r_associated | relid=0 | w=15
  4445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal cag repeat length is 7 to 32 triplets
    n1=Hyde (prurigo nodulaire de) | n2=en:normal cag repeat length is 7 to 32 triplets | rel=r_associated | relid=0 | w=15
  4446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal delivery
    n1=Hyde (prurigo nodulaire de) | n2=en:normal delivery | rel=r_associated | relid=0 | w=15
  4447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal delivery, and other indications for care in pregnancy, labor, and delivery
    n1=Hyde (prurigo nodulaire de) | n2=en:normal delivery, and other indications for care in pregnancy, labor, and delivery | rel=r_associated | relid=0 | w=15
  4448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal development between episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:normal development between episodes | rel=r_associated | relid=0 | w=15
  4449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal development in first 6-12 months, followed by facial coarsening and progressive delay in physical and mental development
    n1=Hyde (prurigo nodulaire de) | n2=en:normal development in first 6-12 months, followed by facial coarsening and progressive delay in physical and mental development | rel=r_associated | relid=0 | w=15
  4450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal development until onset of seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:normal development until onset of seizures | rel=r_associated | relid=0 | w=15
  4451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal female secondary sexual characteristics
    n1=Hyde (prurigo nodulaire de) | n2=en:normal female secondary sexual characteristics | rel=r_associated | relid=0 | w=15
  4452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal fertility
    n1=Hyde (prurigo nodulaire de) | n2=en:normal fertility | rel=r_associated | relid=0 | w=15
  4453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal first month
    n1=Hyde (prurigo nodulaire de) | n2=en:normal first month | rel=r_associated | relid=0 | w=15
  4454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal growth and development after 1 year of age
    n1=Hyde (prurigo nodulaire de) | n2=en:normal growth and development after 1 year of age | rel=r_associated | relid=0 | w=15
  4455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal hemoglobin levels observed in fourth and fifth decades of life, if renal failure not severe
    n1=Hyde (prurigo nodulaire de) | n2=en:normal hemoglobin levels observed in fourth and fifth decades of life, if renal failure not severe | rel=r_associated | relid=0 | w=15
  4456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:normal in neonatal period | rel=r_associated | relid=0 | w=15
  4457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal intelligence in majority
    n1=Hyde (prurigo nodulaire de) | n2=en:normal intelligence in majority | rel=r_associated | relid=0 | w=15
  4458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal neonatal blood phenylalanine has been reported in rare patients
    n1=Hyde (prurigo nodulaire de) | n2=en:normal neonatal blood phenylalanine has been reported in rare patients | rel=r_associated | relid=0 | w=15
  4459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal neonatal course
    n1=Hyde (prurigo nodulaire de) | n2=en:normal neonatal course | rel=r_associated | relid=0 | w=15
  4460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal physical and neurologic development
    n1=Hyde (prurigo nodulaire de) | n2=en:normal physical and neurologic development | rel=r_associated | relid=0 | w=15
  4461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal range of expanded repeats 9-29, hd range 36-121
    n1=Hyde (prurigo nodulaire de) | n2=en:normal range of expanded repeats 9-29, hd range 36-121 | rel=r_associated | relid=0 | w=15
  4462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal sialophorin gene
    n1=Hyde (prurigo nodulaire de) | n2=en:normal sialophorin gene | rel=r_associated | relid=0 | w=15
  4463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:normal sweat electrolytes
    n1=Hyde (prurigo nodulaire de) | n2=en:normal sweat electrolytes | rel=r_associated | relid=0 | w=15
  4464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not all nails are affected in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:not all nails are affected in some patients | rel=r_associated | relid=0 | w=15
  4465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not all patients have a myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:not all patients have a myopathy | rel=r_associated | relid=0 | w=15
  4466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not all patients have facial dysmorphism
    n1=Hyde (prurigo nodulaire de) | n2=en:not all patients have facial dysmorphism | rel=r_associated | relid=0 | w=15
  4467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not all patients have skeletal muscle symptoms or mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:not all patients have skeletal muscle symptoms or mental retardation | rel=r_associated | relid=0 | w=15
  4468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not responsive to biotin treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:not responsive to biotin treatment | rel=r_associated | relid=0 | w=15
  4469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:not responsive to steroid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:not responsive to steroid treatment | rel=r_associated | relid=0 | w=15
  4470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nova scotian variant (type d) is considered a genetic isolate of npc1 and is associated with a mutation in the npc1 gene (607623.0004)
    n1=Hyde (prurigo nodulaire de) | n2=en:nova scotian variant (type d) is considered a genetic isolate of npc1 and is associated with a mutation in the npc1 gene (607623.0004) | rel=r_associated | relid=0 | w=15
  4471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nphp shows autosomal recessive inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:nphp shows autosomal recessive inheritance | rel=r_associated | relid=0 | w=15
  4472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nuchal cord
    n1=Hyde (prurigo nodulaire de) | n2=en:nuchal cord | rel=r_associated | relid=0 | w=15
  4473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nucleoporin
    n1=Hyde (prurigo nodulaire de) | n2=en:nucleoporin | rel=r_associated | relid=0 | w=15
  4474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:number of episodes varies from 1 to many (up to 20)
    n1=Hyde (prurigo nodulaire de) | n2=en:number of episodes varies from 1 to many (up to 20) | rel=r_associated | relid=0 | w=15
  4475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nursing therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:nursing therapy | rel=r_associated | relid=0 | w=15
  4476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutrient
    n1=Hyde (prurigo nodulaire de) | n2=en:nutrient | rel=r_associated | relid=0 | w=15
  4477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutrition for seniors
    n1=Hyde (prurigo nodulaire de) | n2=en:nutrition for seniors | rel=r_associated | relid=0 | w=15
  4478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutritional management
    n1=Hyde (prurigo nodulaire de) | n2=en:nutritional management | rel=r_associated | relid=0 | w=15
  4479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutritional risk index:arbitrary concentration:point in time:^patient:quantitative
    n1=Hyde (prurigo nodulaire de) | n2=en:nutritional risk index:arbitrary concentration:point in time:^patient:quantitative | rel=r_associated | relid=0 | w=15
  4480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutritional science
    n1=Hyde (prurigo nodulaire de) | n2=en:nutritional science | rel=r_associated | relid=0 | w=15
  4481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutritional supplement drink
    n1=Hyde (prurigo nodulaire de) | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=15
  4482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nutritional support
    n1=Hyde (prurigo nodulaire de) | n2=en:nutritional support | rel=r_associated | relid=0 | w=15
  4483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nyctalopia is a later feature of the disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:nyctalopia is a later feature of the disorder | rel=r_associated | relid=0 | w=15
  4484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nystagmus is often the presenting sign
    n1=Hyde (prurigo nodulaire de) | n2=en:nystagmus is often the presenting sign | rel=r_associated | relid=0 | w=15
  4485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:nystagmus may disappear by mid-childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:nystagmus may disappear by mid-childhood | rel=r_associated | relid=0 | w=15
  4486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obesity
    n1=Hyde (prurigo nodulaire de) | n2=en:obesity | rel=r_associated | relid=0 | w=15
  4487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obligate female carriers may show mild signs of muscle weakness, especially of the face
    n1=Hyde (prurigo nodulaire de) | n2=en:obligate female carriers may show mild signs of muscle weakness, especially of the face | rel=r_associated | relid=0 | w=15
  4488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obligatory heterozygotes are clinically unaffected
    n1=Hyde (prurigo nodulaire de) | n2=en:obligatory heterozygotes are clinically unaffected | rel=r_associated | relid=0 | w=15
  4489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:observed in individuals of bulgarian roma bowlmaker ethnic group
    n1=Hyde (prurigo nodulaire de) | n2=en:observed in individuals of bulgarian roma bowlmaker ethnic group | rel=r_associated | relid=0 | w=15
  4490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obstetric
    n1=Hyde (prurigo nodulaire de) | n2=en:obstetric | rel=r_associated | relid=0 | w=15
  4491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obstetrical
    n1=Hyde (prurigo nodulaire de) | n2=en:obstetrical | rel=r_associated | relid=0 | w=15
  4492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:obstetrics
    n1=Hyde (prurigo nodulaire de) | n2=en:obstetrics | rel=r_associated | relid=0 | w=15
  4493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occasional adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:occasional adult onset | rel=r_associated | relid=0 | w=15
  4494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occasional late-onset of symptoms with homozygosity (e.g. 612283.0005 protein c deficiency, homozygous)
    n1=Hyde (prurigo nodulaire de) | n2=en:occasional late-onset of symptoms with homozygosity (e.g. 612283.0005 protein c deficiency, homozygous) | rel=r_associated | relid=0 | w=15
  4495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occasionally germ cell tumor arise from extra gonadal site (e.g., mediastinum, retroperitoneum, pineal gland)
    n1=Hyde (prurigo nodulaire de) | n2=en:occasionally germ cell tumor arise from extra gonadal site (e.g., mediastinum, retroperitoneum, pineal gland) | rel=r_associated | relid=0 | w=15
  4496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occasionally low-dose insulin required
    n1=Hyde (prurigo nodulaire de) | n2=en:occasionally low-dose insulin required | rel=r_associated | relid=0 | w=15
  4497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs at age 20-50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs at age 20-50 years | rel=r_associated | relid=0 | w=15
  4498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs during pregnancy, most often in the third trimester
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs during pregnancy, most often in the third trimester | rel=r_associated | relid=0 | w=15
  4499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in ~3% pregnancies in western populations
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in ~3% pregnancies in western populations | rel=r_associated | relid=0 | w=15
  4500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in 1 in 50,000 newborn males
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in 1 in 50,000 newborn males | rel=r_associated | relid=0 | w=15
  4501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in 2-5 per 10,000 individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in 2-5 per 10,000 individuals | rel=r_associated | relid=0 | w=15
  4502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in about 1 in 10,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in about 1 in 10,000 births | rel=r_associated | relid=0 | w=15
  4503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in at least 1 in 55,000 male births (that figure may not include milder variants)
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in at least 1 in 55,000 male births (that figure may not include milder variants) | rel=r_associated | relid=0 | w=15
  4504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in full-term infants
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in full-term infants | rel=r_associated | relid=0 | w=15
  4505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in full-term newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in full-term newborns | rel=r_associated | relid=0 | w=15
  4506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in the absence of trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in the absence of trauma | rel=r_associated | relid=0 | w=15
  4507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs in women and is triggered by pregnancy or estrogen therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs in women and is triggered by pregnancy or estrogen therapy | rel=r_associated | relid=0 | w=15
  4508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs more frequently in females
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs more frequently in females | rel=r_associated | relid=0 | w=15
  4509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs most often among black africans
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs most often among black africans | rel=r_associated | relid=0 | w=15
  4510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs most often between 5 and 15 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs most often between 5 and 15 years of age | rel=r_associated | relid=0 | w=15
  4511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs most often in developing countries in tropical regions
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs most often in developing countries in tropical regions | rel=r_associated | relid=0 | w=15
  4512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs much more commonly in women
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs much more commonly in women | rel=r_associated | relid=0 | w=15
  4513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:occurs on right side in 75% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:occurs on right side in 75% of cases | rel=r_associated | relid=0 | w=15
  4514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:octanoic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:octanoic acid | rel=r_associated | relid=0 | w=15
  4515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ocular abnormalities may be very mild
    n1=Hyde (prurigo nodulaire de) | n2=en:ocular abnormalities may be very mild | rel=r_associated | relid=0 | w=15
  4516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ocular phenotype falls within a spectrum of retinal dystrophy from severe, leber congenital amaurosis, to less severe, juvenile retinitis pigmentosa
    n1=Hyde (prurigo nodulaire de) | n2=en:ocular phenotype falls within a spectrum of retinal dystrophy from severe, leber congenital amaurosis, to less severe, juvenile retinitis pigmentosa | rel=r_associated | relid=0 | w=15
  4517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oculomotor apraxia is not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:oculomotor apraxia is not always present | rel=r_associated | relid=0 | w=15
  4518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:odor of 'sweaty feet'
    n1=Hyde (prurigo nodulaire de) | n2=en:odor of 'sweaty feet' | rel=r_associated | relid=0 | w=15
  4519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oeis is an acronym for omphalocele, exstrophy of the cloaca, imperforate anus, and spinal defects
    n1=Hyde (prurigo nodulaire de) | n2=en:oeis is an acronym for omphalocele, exstrophy of the cloaca, imperforate anus, and spinal defects | rel=r_associated | relid=0 | w=15
  4520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often associated with chiari type i malformation (cm1, 118420)
    n1=Hyde (prurigo nodulaire de) | n2=en:often associated with chiari type i malformation (cm1, 118420) | rel=r_associated | relid=0 | w=15
  4521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often associated with klippel-feil anomaly (118100)
    n1=Hyde (prurigo nodulaire de) | n2=en:often associated with klippel-feil anomaly (118100) | rel=r_associated | relid=0 | w=15
  4522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often associated with syringomyelia (186700)
    n1=Hyde (prurigo nodulaire de) | n2=en:often associated with syringomyelia (186700) | rel=r_associated | relid=0 | w=15
  4523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often confused with tuberous sclerosis (191000)
    n1=Hyde (prurigo nodulaire de) | n2=en:often confused with tuberous sclerosis (191000) | rel=r_associated | relid=0 | w=15
  4524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often diagnosed between ages 3-4 months
    n1=Hyde (prurigo nodulaire de) | n2=en:often diagnosed between ages 3-4 months | rel=r_associated | relid=0 | w=15
  4525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often fatal due in infancy due to intractable diarrhea
    n1=Hyde (prurigo nodulaire de) | n2=en:often fatal due in infancy due to intractable diarrhea | rel=r_associated | relid=0 | w=15
  4526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often fatal in utero
    n1=Hyde (prurigo nodulaire de) | n2=en:often fatal in utero | rel=r_associated | relid=0 | w=15
  4527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often identified in newborn period
    n1=Hyde (prurigo nodulaire de) | n2=en:often identified in newborn period | rel=r_associated | relid=0 | w=15
  4528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often lethal in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:often lethal in infancy | rel=r_associated | relid=0 | w=15
  4529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often presents with cranial or cervical involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:often presents with cranial or cervical involvement | rel=r_associated | relid=0 | w=15
  4530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often reared as females until puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:often reared as females until puberty | rel=r_associated | relid=0 | w=15
  4531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often refractory to medical therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:often refractory to medical therapy | rel=r_associated | relid=0 | w=15
  4532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often results in death in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:often results in death in childhood | rel=r_associated | relid=0 | w=15
  4533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:often unilateral involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:often unilateral involvement | rel=r_associated | relid=0 | w=15
  4534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:old order amish, african american, and french patients have been described
    n1=Hyde (prurigo nodulaire de) | n2=en:old order amish, african american, and french patients have been described | rel=r_associated | relid=0 | w=15
  4535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:older individuals had moderate to severe hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:older individuals had moderate to severe hearing loss | rel=r_associated | relid=0 | w=15
  4536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:older patients become wheelchair-dependent
    n1=Hyde (prurigo nodulaire de) | n2=en:older patients become wheelchair-dependent | rel=r_associated | relid=0 | w=15
  4537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligogenic disorder in some patients who carry mutations in more than one neuroendocrine-related gene
    n1=Hyde (prurigo nodulaire de) | n2=en:oligogenic disorder in some patients who carry mutations in more than one neuroendocrine-related gene | rel=r_associated | relid=0 | w=15
  4538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligohydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:oligohydramnios | rel=r_associated | relid=0 | w=15
  4539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligohydramnios (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:oligohydramnios (in some patients) | rel=r_associated | relid=0 | w=15
  4540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligohydramnios in some cases
    n1=Hyde (prurigo nodulaire de) | n2=en:oligohydramnios in some cases | rel=r_associated | relid=0 | w=15
  4541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligohydramnios, severe
    n1=Hyde (prurigo nodulaire de) | n2=en:oligohydramnios, severe | rel=r_associated | relid=0 | w=15
  4542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oligosaccharide
    n1=Hyde (prurigo nodulaire de) | n2=en:oligosaccharide | rel=r_associated | relid=0 | w=15
  4543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:omphalomesenteric duct cyst
    n1=Hyde (prurigo nodulaire de) | n2=en:omphalomesenteric duct cyst | rel=r_associated | relid=0 | w=15
  4544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 3-generation korean family reported (as of january 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 3-generation korean family reported (as of january 2011) | rel=r_associated | relid=0 | w=15
  4545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 4-generation caucasian italian family with a heterozygous crybb3 mutation has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 4-generation caucasian italian family with a heterozygous crybb3 mutation has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 4-generation chinese family has been reported (as of 04/2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 4-generation chinese family has been reported (as of 04/2010) | rel=r_associated | relid=0 | w=15
  4547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 5-generation acc family with mutation in bms1 has been described (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 5-generation acc family with mutation in bms1 has been described (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 5-generation chinese family reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 5-generation chinese family reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  4549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one 9-generation family and 1 isolated patient described (last curated march 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one 9-generation family and 1 isolated patient described (last curated march 2014) | rel=r_associated | relid=0 | w=15
  4550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one amish family has been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one amish family has been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  4551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one brazilian family with 12 affected individuals reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one brazilian family with 12 affected individuals reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  4552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one brother and sister of micmac indian and french-canadian ancestry have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one brother and sister of micmac indian and french-canadian ancestry have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  4553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one canadian mennonite family has been reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one canadian mennonite family has been reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  4554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one child has been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one child has been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  4555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one chinese family and 1 unrelated patient have been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one chinese family and 1 unrelated patient have been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  4556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one chinese family has been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one chinese family has been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  4557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one chinese family has been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one chinese family has been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  4558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one chinese family has been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one chinese family has been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  4559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one chinese family with 14 affected individuals has been described (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one chinese family with 14 affected individuals has been described (last curated february 2014) | rel=r_associated | relid=0 | w=15
  4560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one compound heterozygous patient reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one compound heterozygous patient reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous arab israeli family has been reported (last curated february, 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous arab israeli family has been reported (last curated february, 2013) | rel=r_associated | relid=0 | w=15
  4562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous caucasian united kingdom family has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous caucasian united kingdom family has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous egyptian family with 4 affected individuals has been reported (as of december 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous egyptian family with 4 affected individuals has been reported (as of december 2011) | rel=r_associated | relid=0 | w=15
  4564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family has been reported (last curated december 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family has been reported (last curated december 2010) | rel=r_associated | relid=0 | w=15
  4565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family has been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family has been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  4566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family has been reported (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family has been reported (last curated may 2013) | rel=r_associated | relid=0 | w=15
  4567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family has been reported (last curated may 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family has been reported (last curated may 2014) | rel=r_associated | relid=0 | w=15
  4568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family of ashkenazi jewish origin has been reported (last cureated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family of ashkenazi jewish origin has been reported (last cureated may 2012) | rel=r_associated | relid=0 | w=15
  4569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family of indian descent has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family of indian descent has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous family with homozygosity for a cryab mutation has been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous family with homozygosity for a cryab mutation has been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  4571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous moroccan family has been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous moroccan family has been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  4572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been described (last curated march 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been described (last curated march 2015) | rel=r_associated | relid=0 | w=15
  4573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  4574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been reported (last curated june 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been reported (last curated june 2012) | rel=r_associated | relid=0 | w=15
  4575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  4576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family has been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family has been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  4578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani family reported (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani family reported (last curated august 2013) | rel=r_associated | relid=0 | w=15
  4579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous pakistani reported (last curated july 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous pakistani reported (last curated july 2015) | rel=r_associated | relid=0 | w=15
  4581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous saudi arabian family has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous saudi arabian family has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous saudi family had additional features of microcephaly, mental retardation, ophthalmoplegia, and syndactyly
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous saudi family had additional features of microcephaly, mental retardation, ophthalmoplegia, and syndactyly | rel=r_associated | relid=0 | w=15
  4583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous saudi family has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous saudi family has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous senegalese family has been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous senegalese family has been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  4585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous turkish family has been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous turkish family has been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  4586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous turkish family has been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous turkish family has been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  4587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one consanguineous turkish family has been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one consanguineous turkish family has been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  4588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family (4 affected members) has been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family (4 affected members) has been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  4589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family and 1 unrelated patient have been reported (last curated january 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family and 1 unrelated patient have been reported (last curated january 2011) | rel=r_associated | relid=0 | w=15
  4590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family and 1 unrelated patient have been reported (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family and 1 unrelated patient have been reported (last curated july 2013) | rel=r_associated | relid=0 | w=15
  4591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family and an unrelated patient have been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family and an unrelated patient have been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  4592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family from hong kong has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family from hong kong has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family from punjab, india has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family from punjab, india has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family from the old order amish has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family from the old order amish has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family had normal cognitive and neurologic development
    n1=Hyde (prurigo nodulaire de) | n2=en:one family had normal cognitive and neurologic development | rel=r_associated | relid=0 | w=15
  4596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported | rel=r_associated | relid=0 | w=15
  4597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of 4/2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of 4/2010) | rel=r_associated | relid=0 | w=15
  4598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of april 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of april 2012) | rel=r_associated | relid=0 | w=15
  4599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of august 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of august 2010) | rel=r_associated | relid=0 | w=15
  4600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of curation date may, 2013) onset in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of curation date may, 2013) onset in infancy | rel=r_associated | relid=0 | w=15
  4601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of january 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of january 2011) | rel=r_associated | relid=0 | w=15
  4602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  4603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  4604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of june 2011) | rel=r_associated | relid=0 | w=15
  4605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of october 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of october 2010) | rel=r_associated | relid=0 | w=15
  4606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  4607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  4608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated august 2013) | rel=r_associated | relid=0 | w=15
  4609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  4610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated december 2013) | rel=r_associated | relid=0 | w=15
  4611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  4612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated january 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated january 2010) | rel=r_associated | relid=0 | w=15
  4614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated january 2013) | rel=r_associated | relid=0 | w=15
  4615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated january 2014) | rel=r_associated | relid=0 | w=15
  4616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  4617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated june 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated june 2013) | rel=r_associated | relid=0 | w=15
  4618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  4619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated march 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated march 2014) | rel=r_associated | relid=0 | w=15
  4620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated march 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated march 2015) | rel=r_associated | relid=0 | w=15
  4621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  4622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  4623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  4624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  4625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  4626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated october 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated october 2013) | rel=r_associated | relid=0 | w=15
  4627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  4628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  4629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported and no additional clinical features were provided (last curated june 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported and no additional clinical features were provided (last curated june 2013) | rel=r_associated | relid=0 | w=15
  4630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family has been reported with limited clinical information (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family has been reported with limited clinical information (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family of algerian descent has been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family of algerian descent has been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family of french-canadian origin has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family of french-canadian origin has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family of italian-american descent has been described
    n1=Hyde (prurigo nodulaire de) | n2=en:one family of italian-american descent has been described | rel=r_associated | relid=0 | w=15
  4634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family of mali origin has been reported (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family of mali origin has been reported (last curated january 2013) | rel=r_associated | relid=0 | w=15
  4635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family of puerto rican descent has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family of puerto rican descent has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (as of may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (as of may 2012) | rel=r_associated | relid=0 | w=15
  4637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (as of november 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (as of november 2011) | rel=r_associated | relid=0 | w=15
  4638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated january 2014) | rel=r_associated | relid=0 | w=15
  4639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated july 2008)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated july 2008) | rel=r_associated | relid=0 | w=15
  4640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated june 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated june 2009) | rel=r_associated | relid=0 | w=15
  4641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated may 2013) | rel=r_associated | relid=0 | w=15
  4642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated november 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated november 2011) | rel=r_associated | relid=0 | w=15
  4643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  4644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported with mutation in a heterozygous mutation in dlx5 (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported with mutation in a heterozygous mutation in dlx5 (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family reported with piezo2 mutation (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family reported with piezo2 mutation (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 2 affected brothers has been reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 2 affected brothers has been reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  4647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 2 affected fetuses has been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 2 affected fetuses has been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  4648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 2 patients has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 2 patients has been reported | rel=r_associated | relid=0 | w=15
  4649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 2 sisters have been reported (as of march 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 2 sisters have been reported (as of march 2010) | rel=r_associated | relid=0 | w=15
  4650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 3 affected girls has been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 3 affected girls has been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  4651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 3 affected males has been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 3 affected males has been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  4652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 3 patients and 1 patient with sporadic disease have been reported (last curated june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 3 patients and 1 patient with sporadic disease have been reported (last curated june 2011) | rel=r_associated | relid=0 | w=15
  4653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 4 affected sibs has been reported (as of april 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 4 affected sibs has been reported (as of april 2012) | rel=r_associated | relid=0 | w=15
  4654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 5 affected members has been reported (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 5 affected members has been reported (last curated september 2012) | rel=r_associated | relid=0 | w=15
  4655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with 6 probands described (as of september 2000)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with 6 probands described (as of september 2000) | rel=r_associated | relid=0 | w=15
  4656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with a confirmed dcaf8 mutation has been reported (last curated june, 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with a confirmed dcaf8 mutation has been reported (last curated june, 2014) | rel=r_associated | relid=0 | w=15
  4657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with a confirmed pathogenic atp2b3 mutation has been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with a confirmed pathogenic atp2b3 mutation has been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  4658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with a fatal subacute encephalopathy has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with a fatal subacute encephalopathy has been reported | rel=r_associated | relid=0 | w=15
  4659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with autosomal dominant inheritance has been reported and 1 family with autosomal recessive inheritance has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with autosomal dominant inheritance has been reported and 1 family with autosomal recessive inheritance has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with confirmed cecr1 mutation has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with confirmed cecr1 mutation has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with confirmed genetic basis has been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with confirmed genetic basis has been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  4662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one family with late-adult onset and cerebellar ataxia has been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one family with late-adult onset and cerebellar ataxia has been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one french family has been reported (as of march 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one french family has been reported (as of march 2012) | rel=r_associated | relid=0 | w=15
  4664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one french family has been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one french family has been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  4665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one french family has been reported (last curated march 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one french family has been reported (last curated march 2013) | rel=r_associated | relid=0 | w=15
  4666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one german family has been reported (as of september 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:one german family has been reported (as of september 2009) | rel=r_associated | relid=0 | w=15
  4667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one highly consanguineous family has been reported (last curated may 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one highly consanguineous family has been reported (last curated may 2014) | rel=r_associated | relid=0 | w=15
  4668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one indian family has been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one indian family has been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  4669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one individual carried a heterozygous mutation, whereas the other carried a homozygous mutation.
    n1=Hyde (prurigo nodulaire de) | n2=en:one individual carried a heterozygous mutation, whereas the other carried a homozygous mutation. | rel=r_associated | relid=0 | w=15
  4670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one israeli arab family has been reported with ptprf mutation (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one israeli arab family has been reported with ptprf mutation (last curated september 2014) | rel=r_associated | relid=0 | w=15
  4671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one italian family has been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one italian family has been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  4672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one japanese family has been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one japanese family has been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  4673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one japanese patient has been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one japanese patient has been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  4674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one korean family has been reported (as of november 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one korean family has been reported (as of november 2011) | rel=r_associated | relid=0 | w=15
  4675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large 3-generation irish family has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large 3-generation irish family has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large 4-generation uruguayan family reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large 4-generation uruguayan family reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large consanguineous arab muslim family has been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large consanguineous arab muslim family has been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  4678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large consanguineous israeli bedouin kindred has been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large consanguineous israeli bedouin kindred has been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  4679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large family has been reported (as of 2008)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large family has been reported (as of 2008) | rel=r_associated | relid=0 | w=15
  4680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large family has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large family has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large family has been reported (last curated june 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large family has been reported (last curated june 2013) | rel=r_associated | relid=0 | w=15
  4682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large french family and 1 patient with sporadic occurrence have been reported (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large french family and 1 patient with sporadic occurrence have been reported (last curated january 2013) | rel=r_associated | relid=0 | w=15
  4683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large spanish family and 1 unrelated patient have been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large spanish family and 1 unrelated patient have been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  4684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one large swedish family has been reported (as of april 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one large swedish family has been reported (as of april 2012) | rel=r_associated | relid=0 | w=15
  4685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one likely consanguineous turkish family has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one likely consanguineous turkish family has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one living patient and 1 unrelated fetus have been reported (last curated august, 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one living patient and 1 unrelated fetus have been reported (last curated august, 2014) | rel=r_associated | relid=0 | w=15
  4687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one male and 3 unrelated females have been reported (last curated october 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one male and 3 unrelated females have been reported (last curated october 2013) | rel=r_associated | relid=0 | w=15
  4688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one of the 2 most common forms of albinism in the world, along with oca2
    n1=Hyde (prurigo nodulaire de) | n2=en:one of the 2 most common forms of albinism in the world, along with oca2 | rel=r_associated | relid=0 | w=15
  4689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one of the 2 most common forms of oca in the world along with oca1
    n1=Hyde (prurigo nodulaire de) | n2=en:one of the 2 most common forms of oca in the world along with oca1 | rel=r_associated | relid=0 | w=15
  4690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one of the most common autoimmune diseases
    n1=Hyde (prurigo nodulaire de) | n2=en:one of the most common autoimmune diseases | rel=r_associated | relid=0 | w=15
  4691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one pakistani family has been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one pakistani family has been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  4692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one pakistani family has been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one pakistani family has been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  4693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one pakistani family reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one pakistani family reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  4694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one pakistani reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one pakistani reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  4695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one palestinian family has been described (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one palestinian family has been described (last curated april 2014) | rel=r_associated | relid=0 | w=15
  4696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient (patient a) and 2 sibs have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient (patient a) and 2 sibs have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient described (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient described (last curated december 2013) | rel=r_associated | relid=0 | w=15
  4698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient described as having bbs, but with no clinical details has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient described as having bbs, but with no clinical details has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient died at 17 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient died at 17 months of age | rel=r_associated | relid=0 | w=15
  4700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient died at age 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient died at age 7 years | rel=r_associated | relid=0 | w=15
  4701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient from a consanguineous lebanese family and one patient from a consanguineous kurdish family have been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient from a consanguineous lebanese family and one patient from a consanguineous kurdish family have been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  4702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient had onset at age 4 months after normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient had onset at age 4 months after normal development | rel=r_associated | relid=0 | w=15
  4703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient had onset at birth and a more severe disorder resulting in death at a young age
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient had onset at birth and a more severe disorder resulting in death at a young age | rel=r_associated | relid=0 | w=15
  4704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported | rel=r_associated | relid=0 | w=15
  4705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of april 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of april 2011) | rel=r_associated | relid=0 | w=15
  4706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of august 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of august 2010) | rel=r_associated | relid=0 | w=15
  4707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  4708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of curation date may, 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of curation date may, 2013) | rel=r_associated | relid=0 | w=15
  4709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of december 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of december 2011) | rel=r_associated | relid=0 | w=15
  4710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  4711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  4712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of july 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of july 2010) | rel=r_associated | relid=0 | w=15
  4713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of march 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of march 2011) | rel=r_associated | relid=0 | w=15
  4714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of may 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of may 2011) | rel=r_associated | relid=0 | w=15
  4715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (as of sept 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (as of sept 2011) | rel=r_associated | relid=0 | w=15
  4716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  4717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  4718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  4719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated january 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated january 2010) | rel=r_associated | relid=0 | w=15
  4720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated january 2014) | rel=r_associated | relid=0 | w=15
  4721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  4722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated july 2013) | rel=r_associated | relid=0 | w=15
  4723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  4724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  4725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated november 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated november 2010) | rel=r_associated | relid=0 | w=15
  4726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  4727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  4728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  4730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient has had favorable response to high dose coenzyme q10 supplementation in combination with other medications
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient has had favorable response to high dose coenzyme q10 supplementation in combination with other medications | rel=r_associated | relid=0 | w=15
  4731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  4732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient reported with col3a1 mutation (120180.0020)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient reported with col3a1 mutation (120180.0020) | rel=r_associated | relid=0 | w=15
  4733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient reported with slitrk1 mutation (as of january 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient reported with slitrk1 mutation (as of january 2010) | rel=r_associated | relid=0 | w=15
  4734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient showed improvement and was thriving at 46 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient showed improvement and was thriving at 46 months of age | rel=r_associated | relid=0 | w=15
  4735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient studied at molecular level (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient studied at molecular level (as of july 2011) | rel=r_associated | relid=0 | w=15
  4736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient was less severely affected
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient was less severely affected | rel=r_associated | relid=0 | w=15
  4737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient who died at 5.5 months of age has been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient who died at 5.5 months of age has been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  4738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with a homozygous mutation has been reported (as of 14 june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with a homozygous mutation has been reported (as of 14 june 2011) | rel=r_associated | relid=0 | w=15
  4739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with a point mutation in the zbtb18 gene has been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with a point mutation in the zbtb18 gene has been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  4740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with additional features of fanconi anemia has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with additional features of fanconi anemia has been reported | rel=r_associated | relid=0 | w=15
  4741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with episodic ataxia and later onset has been reported (as of june 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with episodic ataxia and later onset has been reported (as of june 2010) | rel=r_associated | relid=0 | w=15
  4742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with limited clinical information has been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with limited clinical information has been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  4743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with normal cognition has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with normal cognition has been reported | rel=r_associated | relid=0 | w=15
  4744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with normal psychomotor development has been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with normal psychomotor development has been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  4745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one patient with severe congenital onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:one patient with severe congenital onset has been reported | rel=r_associated | relid=0 | w=15
  4746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one report of brother and sister from nonconsanguineous parents
    n1=Hyde (prurigo nodulaire de) | n2=en:one report of brother and sister from nonconsanguineous parents | rel=r_associated | relid=0 | w=15
  4747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one report of mother and son (last curated august 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:one report of mother and son (last curated august 2012) | rel=r_associated | relid=0 | w=15
  4748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one spanish family has been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one spanish family has been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  4749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one such patient has been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:one such patient has been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  4750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one swiss family with 19 affected individuals has been described (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:one swiss family with 19 affected individuals has been described (last curated february 2014) | rel=r_associated | relid=0 | w=15
  4751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one third of patients represent new mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:one third of patients represent new mutations | rel=r_associated | relid=0 | w=15
  4752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one turkish girl has been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:one turkish girl has been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  4753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one-third of cases are familial
    n1=Hyde (prurigo nodulaire de) | n2=en:one-third of cases are familial | rel=r_associated | relid=0 | w=15
  4754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:one-third of cases are sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:one-third of cases are sporadic | rel=r_associated | relid=0 | w=15
  4755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only 1 family had ultrastructural cellular findings of neuronal ceroid lipofuscinosis
    n1=Hyde (prurigo nodulaire de) | n2=en:only 1 family had ultrastructural cellular findings of neuronal ceroid lipofuscinosis | rel=r_associated | relid=0 | w=15
  4756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only 10% develop hypertension at 18 years of age or less
    n1=Hyde (prurigo nodulaire de) | n2=en:only 10% develop hypertension at 18 years of age or less | rel=r_associated | relid=0 | w=15
  4757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only 13% develop hypertension at 18 years of age or less
    n1=Hyde (prurigo nodulaire de) | n2=en:only 13% develop hypertension at 18 years of age or less | rel=r_associated | relid=0 | w=15
  4758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only 46,xy individuals are affected
    n1=Hyde (prurigo nodulaire de) | n2=en:only 46,xy individuals are affected | rel=r_associated | relid=0 | w=15
  4759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only apparent in patients taking eculizumab
    n1=Hyde (prurigo nodulaire de) | n2=en:only apparent in patients taking eculizumab | rel=r_associated | relid=0 | w=15
  4760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only female patients reported (last curated october 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:only female patients reported (last curated october 2013) | rel=r_associated | relid=0 | w=15
  4761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only some patients showed neurologic involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:only some patients showed neurologic involvement | rel=r_associated | relid=0 | w=15
  4762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:only women have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:only women have been reported | rel=r_associated | relid=0 | w=15
  4763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset - present at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset - present at birth | rel=r_associated | relid=0 | w=15
  4764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset <30 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset <30 months | rel=r_associated | relid=0 | w=15
  4765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 0-12 hours after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 0-12 hours after birth | rel=r_associated | relid=0 | w=15
  4766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 1-12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 1-12 years | rel=r_associated | relid=0 | w=15
  4767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 1-70 years of age (95% by early 50's)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 1-70 years of age (95% by early 50's) | rel=r_associated | relid=0 | w=15
  4768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 10-20 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 10-20 years of age | rel=r_associated | relid=0 | w=15
  4769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 13 to 63 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 13 to 63 years of age | rel=r_associated | relid=0 | w=15
  4770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 13-15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 13-15 years | rel=r_associated | relid=0 | w=15
  4771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 14 months to 4 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 14 months to 4 years of age | rel=r_associated | relid=0 | w=15
  4772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 2-4 years of age in iia
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 2-4 years of age in iia | rel=r_associated | relid=0 | w=15
  4773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 20-55 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 20-55 years of age | rel=r_associated | relid=0 | w=15
  4774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 23 to 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 23 to 30 years | rel=r_associated | relid=0 | w=15
  4775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 3 months of age up to 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 3 months of age up to 5 years | rel=r_associated | relid=0 | w=15
  4776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 30-40 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 30-40 years of age | rel=r_associated | relid=0 | w=15
  4777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 3rd to 4th decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 3rd to 4th decade of life | rel=r_associated | relid=0 | w=15
  4778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 5 to 10 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 5 to 10 years of age | rel=r_associated | relid=0 | w=15
  4779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 5 to 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 5 to 7 years | rel=r_associated | relid=0 | w=15
  4780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 5-30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 5-30 years | rel=r_associated | relid=0 | w=15
  4781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 50 to 65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 50 to 65 years | rel=r_associated | relid=0 | w=15
  4782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 6 months to 2.5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 6 months to 2.5 years | rel=r_associated | relid=0 | w=15
  4783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 6 to 12 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 6 to 12 months | rel=r_associated | relid=0 | w=15
  4784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 6 to 18 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 6 to 18 months | rel=r_associated | relid=0 | w=15
  4785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 6 to 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 6 to 30 years | rel=r_associated | relid=0 | w=15
  4786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 6-13 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 6-13 years | rel=r_associated | relid=0 | w=15
  4787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 7 to 15 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 7 to 15 months of age | rel=r_associated | relid=0 | w=15
  4788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 70-90 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 70-90 years | rel=r_associated | relid=0 | w=15
  4789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset 8-20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset 8-20 years | rel=r_associated | relid=0 | w=15
  4790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset about 6 months of age after normal growth and development in the first few months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset about 6 months of age after normal growth and development in the first few months of life | rel=r_associated | relid=0 | w=15
  4791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset after age 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset after age 40 years | rel=r_associated | relid=0 | w=15
  4792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset after puberty | rel=r_associated | relid=0 | w=15
  4793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset after third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset after third decade | rel=r_associated | relid=0 | w=15
  4794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset age 14-28 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset age 14-28 years | rel=r_associated | relid=0 | w=15
  4795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset age 15-25 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset age 15-25 years | rel=r_associated | relid=0 | w=15
  4796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset age 2 to 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset age 2 to 7 years | rel=r_associated | relid=0 | w=15
  4797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset age 20 to 51 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset age 20 to 51 years | rel=r_associated | relid=0 | w=15
  4798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset age 32 to 45 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset age 32 to 45 years | rel=r_associated | relid=0 | w=15
  4799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ages 2 to 14 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ages 2 to 14 years | rel=r_associated | relid=0 | w=15
  4800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset and diagnosis may occur later (after age 20 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset and diagnosis may occur later (after age 20 years) | rel=r_associated | relid=0 | w=15
  4801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset around adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset around adolescence | rel=r_associated | relid=0 | w=15
  4802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset around adolescence in males
    n1=Hyde (prurigo nodulaire de) | n2=en:onset around adolescence in males | rel=r_associated | relid=0 | w=15
  4803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset around age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset around age 2 years | rel=r_associated | relid=0 | w=15
  4804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset around puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset around puberty | rel=r_associated | relid=0 | w=15
  4805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset as neonate
    n1=Hyde (prurigo nodulaire de) | n2=en:onset as neonate | rel=r_associated | relid=0 | w=15
  4806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 2 to 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 2 to 15 years | rel=r_associated | relid=0 | w=15
  4807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 2 to 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 2 to 4 years | rel=r_associated | relid=0 | w=15
  4808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 4 to 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 4 to 10 years | rel=r_associated | relid=0 | w=15
  4809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 4 to 7 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 4 to 7 years | rel=r_associated | relid=0 | w=15
  4810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 4 to 9 weeks of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 4 to 9 weeks of age | rel=r_associated | relid=0 | w=15
  4811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 4 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 4 years of age | rel=r_associated | relid=0 | w=15
  4812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 5-24 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 5-24 months | rel=r_associated | relid=0 | w=15
  4813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 6-36 hours of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 6-36 hours of life | rel=r_associated | relid=0 | w=15
  4814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at 6-9 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at 6-9 months | rel=r_associated | relid=0 | w=15
  4815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at age 10 to 14 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at age 10 to 14 years | rel=r_associated | relid=0 | w=15
  4816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at age 3-5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at age 3-5 years | rel=r_associated | relid=0 | w=15
  4817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at age 36 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at age 36 years | rel=r_associated | relid=0 | w=15
  4818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at age 5 to 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at age 5 to 15 years | rel=r_associated | relid=0 | w=15
  4819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at age 5 years | rel=r_associated | relid=0 | w=15
  4820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at birth or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at birth or early childhood | rel=r_associated | relid=0 | w=15
  4821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at birth or early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at birth or early infancy | rel=r_associated | relid=0 | w=15
  4822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at birth or in first days or life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at birth or in first days or life | rel=r_associated | relid=0 | w=15
  4823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at birth or in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at birth or in first months of life | rel=r_associated | relid=0 | w=15
  4824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at day 1 of life has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at day 1 of life has been reported | rel=r_associated | relid=0 | w=15
  4825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at early age, associated with sudden death in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at early age, associated with sudden death in childhood | rel=r_associated | relid=0 | w=15
  4826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset at or soon after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset at or soon after birth | rel=r_associated | relid=0 | w=15
  4827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before 10 years of age in all patients
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before 10 years of age in all patients | rel=r_associated | relid=0 | w=15
  4828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before 18 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before 18 months of age | rel=r_associated | relid=0 | w=15
  4829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before 50 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before 50 years of age | rel=r_associated | relid=0 | w=15
  4830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before adolescence | rel=r_associated | relid=0 | w=15
  4831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 2 years | rel=r_associated | relid=0 | w=15
  4832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 20
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 20 | rel=r_associated | relid=0 | w=15
  4833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 20 years | rel=r_associated | relid=0 | w=15
  4834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 3 years | rel=r_associated | relid=0 | w=15
  4835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 40 years | rel=r_associated | relid=0 | w=15
  4836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 5 years | rel=r_associated | relid=0 | w=15
  4837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset before age 5 years in the absence of instruction
    n1=Hyde (prurigo nodulaire de) | n2=en:onset before age 5 years in the absence of instruction | rel=r_associated | relid=0 | w=15
  4838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 1-3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 1-3 years | rel=r_associated | relid=0 | w=15
  4839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 10 and 20 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 10 and 20 years of age | rel=r_associated | relid=0 | w=15
  4840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 12 and 30 years (average 22)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 12 and 30 years (average 22) | rel=r_associated | relid=0 | w=15
  4841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 13 to 37 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 13 to 37 years | rel=r_associated | relid=0 | w=15
  4842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 15 and 27 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 15 and 27 years | rel=r_associated | relid=0 | w=15
  4843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 18 and 65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 18 and 65 years | rel=r_associated | relid=0 | w=15
  4844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 2 and 4 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 2 and 4 years of age | rel=r_associated | relid=0 | w=15
  4845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 2 to 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 2 to 20 years | rel=r_associated | relid=0 | w=15
  4846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 2-5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 2-5 years | rel=r_associated | relid=0 | w=15
  4847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 28 and 42 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 28 and 42 years | rel=r_associated | relid=0 | w=15
  4848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 3 and 11 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 3 and 11 years of age | rel=r_associated | relid=0 | w=15
  4849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 3 and 6 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 3 and 6 months of age | rel=r_associated | relid=0 | w=15
  4850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 34 and 51 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 34 and 51 years of age | rel=r_associated | relid=0 | w=15
  4851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 5 and 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 5 and 20 years | rel=r_associated | relid=0 | w=15
  4852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 5 to 28 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 5 to 28 years of age | rel=r_associated | relid=0 | w=15
  4853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 6 and 12 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 6 and 12 months of age | rel=r_associated | relid=0 | w=15
  4854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 6 and 14 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 6 and 14 years | rel=r_associated | relid=0 | w=15
  4855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 6 and 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 6 and 15 years | rel=r_associated | relid=0 | w=15
  4856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 6 and 16 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 6 and 16 years of age | rel=r_associated | relid=0 | w=15
  4857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 6 and 9 months after normal early development
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 6 and 9 months after normal early development | rel=r_associated | relid=0 | w=15
  4858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 7 and 18 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 7 and 18 years | rel=r_associated | relid=0 | w=15
  4859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 7 and 27 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 7 and 27 years of age | rel=r_associated | relid=0 | w=15
  4860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 8 and 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 8 and 30 years | rel=r_associated | relid=0 | w=15
  4861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between 9 and 16 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between 9 and 16 years | rel=r_associated | relid=0 | w=15
  4862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between age 2 and 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between age 2 and 15 years | rel=r_associated | relid=0 | w=15
  4863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between age 30-50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between age 30-50 years | rel=r_associated | relid=0 | w=15
  4864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between age 4 to 7 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between age 4 to 7 months | rel=r_associated | relid=0 | w=15
  4865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between ages 1 to 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between ages 1 to 3 years | rel=r_associated | relid=0 | w=15
  4866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between ages 10 and 25 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between ages 10 and 25 years | rel=r_associated | relid=0 | w=15
  4867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between ages 12 and 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between ages 12 and 20 years | rel=r_associated | relid=0 | w=15
  4868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between ages 16-55
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between ages 16-55 | rel=r_associated | relid=0 | w=15
  4869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between ages 5 and 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between ages 5 and 15 years | rel=r_associated | relid=0 | w=15
  4870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between birth and 3 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between birth and 3 months of age | rel=r_associated | relid=0 | w=15
  4871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between second to sixth decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between second to sixth decades of life | rel=r_associated | relid=0 | w=15
  4872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset between the second and sixth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset between the second and sixth decades | rel=r_associated | relid=0 | w=15
  4873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset beyond the second year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset beyond the second year of life | rel=r_associated | relid=0 | w=15
  4874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset bimodal, ages 16-22 and ages 57-60
    n1=Hyde (prurigo nodulaire de) | n2=en:onset bimodal, ages 16-22 and ages 57-60 | rel=r_associated | relid=0 | w=15
  4875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset birth to 6 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset birth to 6 months | rel=r_associated | relid=0 | w=15
  4876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset birth to early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset birth to early childhood | rel=r_associated | relid=0 | w=15
  4877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset birth to early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset birth to early infancy | rel=r_associated | relid=0 | w=15
  4878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset by 1 year of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset by 1 year of age | rel=r_associated | relid=0 | w=15
  4879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset by 3 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset by 3 years of age | rel=r_associated | relid=0 | w=15
  4880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset by age 2 years | rel=r_associated | relid=0 | w=15
  4881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset day of life 1-10 in infants fed lactose-containing milk
    n1=Hyde (prurigo nodulaire de) | n2=en:onset day of life 1-10 in infants fed lactose-containing milk | rel=r_associated | relid=0 | w=15
  4882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset early childhood | rel=r_associated | relid=0 | w=15
  4883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset early in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset early in first decade | rel=r_associated | relid=0 | w=15
  4884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset first to seventh decade with 30 to 40 year mode
    n1=Hyde (prurigo nodulaire de) | n2=en:onset first to seventh decade with 30 to 40 year mode | rel=r_associated | relid=0 | w=15
  4885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in 1st to 3rd decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in 1st to 3rd decade of life | rel=r_associated | relid=0 | w=15
  4886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence | rel=r_associated | relid=0 | w=15
  4887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence or adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence or adulthood | rel=r_associated | relid=0 | w=15
  4888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence or adulthood has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence or adulthood has been reported | rel=r_associated | relid=0 | w=15
  4889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence or young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence or young adulthood | rel=r_associated | relid=0 | w=15
  4890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence or young adulthood has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence or young adulthood has been reported | rel=r_associated | relid=0 | w=15
  4891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adolescence to early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adolescence to early adulthood | rel=r_associated | relid=0 | w=15
  4892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in adulthood (third to fourth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in adulthood (third to fourth decade) | rel=r_associated | relid=0 | w=15
  4893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (1 to 7 years) of progressive cardiomyopathy and muscle weakness
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (1 to 7 years) of progressive cardiomyopathy and muscle weakness | rel=r_associated | relid=0 | w=15
  4894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (3 to 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (3 to 10 years) | rel=r_associated | relid=0 | w=15
  4895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (5 to 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (5 to 10 years) | rel=r_associated | relid=0 | w=15
  4896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (6-7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (6-7 years) | rel=r_associated | relid=0 | w=15
  4897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (ages 1.5 to 7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (ages 1.5 to 7 years) | rel=r_associated | relid=0 | w=15
  4898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (later than in antenatal bartter syndrome 241200)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (later than in antenatal bartter syndrome 241200) | rel=r_associated | relid=0 | w=15
  4899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (mean 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (mean 6 years) | rel=r_associated | relid=0 | w=15
  4900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (mean age 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (mean age 10 years) | rel=r_associated | relid=0 | w=15
  4901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range 0.5 to 7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range 0.5 to 7 years) | rel=r_associated | relid=0 | w=15
  4902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range 1 to 12 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range 1 to 12 years) | rel=r_associated | relid=0 | w=15
  4903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range 1 to 9 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range 1 to 9 years) | rel=r_associated | relid=0 | w=15
  4904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range 2 to 16 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range 2 to 16 years) | rel=r_associated | relid=0 | w=15
  4905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range 4 to 12 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range 4 to 12 years) | rel=r_associated | relid=0 | w=15
  4906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (range infancy to 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (range infancy to 10 years) | rel=r_associated | relid=0 | w=15
  4907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood (usually before age 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood (usually before age 5 years) | rel=r_associated | relid=0 | w=15
  4908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood of blistering and pigmentary changes
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood of blistering and pigmentary changes | rel=r_associated | relid=0 | w=15
  4909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or adolescence | rel=r_associated | relid=0 | w=15
  4910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or adolescence (mean age of 6 years, range 1 to 18)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or adolescence (mean age of 6 years, range 1 to 18) | rel=r_associated | relid=0 | w=15
  4911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or adolescence (median age of 9 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or adolescence (median age of 9 years) | rel=r_associated | relid=0 | w=15
  4912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or adolescence (range 6 to 15 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or adolescence (range 6 to 15 years) | rel=r_associated | relid=0 | w=15
  4913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or adolescence in most patients
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or adolescence in most patients | rel=r_associated | relid=0 | w=15
  4914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or as young adult
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or as young adult | rel=r_associated | relid=0 | w=15
  4915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or early adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or early adolescence | rel=r_associated | relid=0 | w=15
  4916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or early adulthood | rel=r_associated | relid=0 | w=15
  4917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or second decade | rel=r_associated | relid=0 | w=15
  4918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or teenage years (7 to 16 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or teenage years (7 to 16 years) | rel=r_associated | relid=0 | w=15
  4919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or young adulthood | rel=r_associated | relid=0 | w=15
  4920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood or youth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood or youth | rel=r_associated | relid=0 | w=15
  4921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood, adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood, adolescence | rel=r_associated | relid=0 | w=15
  4922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood, adolescence, and adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood, adolescence, and adulthood | rel=r_associated | relid=0 | w=15
  4923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in childhood, but most noticeable in mid-teens and early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in childhood, but most noticeable in mid-teens and early adulthood | rel=r_associated | relid=0 | w=15
  4924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early adulthood (average 26 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early adulthood (average 26 years) | rel=r_associated | relid=0 | w=15
  4925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (2-4 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (2-4 years) | rel=r_associated | relid=0 | w=15
  4926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (4 to 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (4 to 5 years) | rel=r_associated | relid=0 | w=15
  4927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (age 3)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (age 3) | rel=r_associated | relid=0 | w=15
  4928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (infancy to 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (infancy to 5 years) | rel=r_associated | relid=0 | w=15
  4929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (infancy to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (infancy to 6 years) | rel=r_associated | relid=0 | w=15
  4930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood (infancy to age 7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood (infancy to age 7 years) | rel=r_associated | relid=0 | w=15
  4931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood after initial normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood after initial normal development | rel=r_associated | relid=0 | w=15
  4932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood or adolescence | rel=r_associated | relid=0 | w=15
  4933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early childhood to puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early childhood to puberty | rel=r_associated | relid=0 | w=15
  4934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early first decade, although some patients have onset at birth or early in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early first decade, although some patients have onset at birth or early in infancy | rel=r_associated | relid=0 | w=15
  4935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early infancy | rel=r_associated | relid=0 | w=15
  4936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early infancy (2 to 3 months of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early infancy (2 to 3 months of age) | rel=r_associated | relid=0 | w=15
  4937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early infancy, between 2 weeks and 3 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early infancy, between 2 weeks and 3 months | rel=r_associated | relid=0 | w=15
  4938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early to late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early to late childhood | rel=r_associated | relid=0 | w=15
  4939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in early twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in early twenties | rel=r_associated | relid=0 | w=15
  4940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in feet and legs (peroneal distribution)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in feet and legs (peroneal distribution) | rel=r_associated | relid=0 | w=15
  4941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in females ranges from third to seventh decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in females ranges from third to seventh decade | rel=r_associated | relid=0 | w=15
  4942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fifth or sixth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fifth or sixth decade | rel=r_associated | relid=0 | w=15
  4943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fifties or sixties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fifties or sixties | rel=r_associated | relid=0 | w=15
  4944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first 2 decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first 2 decades | rel=r_associated | relid=0 | w=15
  4945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first 2 decades (range 6 to 15 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first 2 decades (range 6 to 15 years) | rel=r_associated | relid=0 | w=15
  4946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first 2 decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first 2 decades of life | rel=r_associated | relid=0 | w=15
  4947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first 6 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first 6 months of life | rel=r_associated | relid=0 | w=15
  4948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first 8 weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first 8 weeks of life | rel=r_associated | relid=0 | w=15
  4949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first and second decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first and second decades | rel=r_associated | relid=0 | w=15
  4950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first days of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first days of life | rel=r_associated | relid=0 | w=15
  4951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade | rel=r_associated | relid=0 | w=15
  4952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade (average 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade (average 5 years) | rel=r_associated | relid=0 | w=15
  4953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade (birth to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade (birth to 6 years) | rel=r_associated | relid=0 | w=15
  4954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade (birth to age 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade (birth to age 5 years) | rel=r_associated | relid=0 | w=15
  4955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade (e.g. 180380.0028)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade (e.g. 180380.0028) | rel=r_associated | relid=0 | w=15
  4956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decade of life | rel=r_associated | relid=0 | w=15
  4957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first decades (males)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first decades (males) | rel=r_associated | relid=0 | w=15
  4958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first few years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first few years of life | rel=r_associated | relid=0 | w=15
  4959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first hours to days of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first hours to days of life | rel=r_associated | relid=0 | w=15
  4960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first month of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first month of life | rel=r_associated | relid=0 | w=15
  4961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first months of life | rel=r_associated | relid=0 | w=15
  4962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first months or years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first months or years of life | rel=r_associated | relid=0 | w=15
  4963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first or second decade (range 4 to 13 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first or second decade (range 4 to 13 years) | rel=r_associated | relid=0 | w=15
  4964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first or second decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first or second decades | rel=r_associated | relid=0 | w=15
  4965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first weeks or months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first weeks or months of life | rel=r_associated | relid=0 | w=15
  4966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in first weeks to months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in first weeks to months of life | rel=r_associated | relid=0 | w=15
  4967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fourth and fifth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fourth and fifth decades | rel=r_associated | relid=0 | w=15
  4968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fourth decade | rel=r_associated | relid=0 | w=15
  4969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fourth to fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fourth to fifth decade | rel=r_associated | relid=0 | w=15
  4970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in fourth to sixth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in fourth to sixth decades | rel=r_associated | relid=0 | w=15
  4971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (1-2 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (1-2 years) | rel=r_associated | relid=0 | w=15
  4972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (3 months on)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (3 months on) | rel=r_associated | relid=0 | w=15
  4973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (3 to 7 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (3 to 7 months) | rel=r_associated | relid=0 | w=15
  4974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (average 4 months, but may be earlier)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (average 4 months, but may be earlier) | rel=r_associated | relid=0 | w=15
  4975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (first hours to weeks of life)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (first hours to weeks of life) | rel=r_associated | relid=0 | w=15
  4976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy (first year of life)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy (first year of life) | rel=r_associated | relid=0 | w=15
  4977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy after normal birth and neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy after normal birth and neonatal period | rel=r_associated | relid=0 | w=15
  4978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy after weaning
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy after weaning | rel=r_associated | relid=0 | w=15
  4979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy after weaning from being breast-fed
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy after weaning from being breast-fed | rel=r_associated | relid=0 | w=15
  4980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy and early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy and early childhood | rel=r_associated | relid=0 | w=15
  4981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy and third decade had been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy and third decade had been reported | rel=r_associated | relid=0 | w=15
  4982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy of acute hypoglycemic episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy of acute hypoglycemic episodes | rel=r_associated | relid=0 | w=15
  4983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or at birth | rel=r_associated | relid=0 | w=15
  4984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or childhood | rel=r_associated | relid=0 | w=15
  4985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or childhood (range 1 to 13 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or childhood (range 1 to 13 years) | rel=r_associated | relid=0 | w=15
  4986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or childhood (range 1 to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or childhood (range 1 to 6 years) | rel=r_associated | relid=0 | w=15
  4987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or early childhood | rel=r_associated | relid=0 | w=15
  4988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or early childhood (before age 3 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or early childhood (before age 3 years) | rel=r_associated | relid=0 | w=15
  4989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or early childhood (birth to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or early childhood (birth to 6 years) | rel=r_associated | relid=0 | w=15
  4990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or first years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or first years of life | rel=r_associated | relid=0 | w=15
  4991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy or late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy or late childhood | rel=r_associated | relid=0 | w=15
  4992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy up to 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy up to 3 years | rel=r_associated | relid=0 | w=15
  4993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy was reported in 1 family
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy was reported in 1 family | rel=r_associated | relid=0 | w=15
  4994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in infancy, but may not be diagnosed until later in mild cases
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in infancy, but may not be diagnosed until later in mild cases | rel=r_associated | relid=0 | w=15
  4995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late adulthood (44 to 73 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late adulthood (44 to 73 years) | rel=r_associated | relid=0 | w=15
  4996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late childhood or adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late childhood or adulthood | rel=r_associated | relid=0 | w=15
  4997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late childhood or early teens
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late childhood or early teens | rel=r_associated | relid=0 | w=15
  4998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late childhood/adolescence (approximately 15 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late childhood/adolescence (approximately 15 years) | rel=r_associated | relid=0 | w=15
  4999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late infancy | rel=r_associated | relid=0 | w=15
  5000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late teens to early forties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late teens to early forties | rel=r_associated | relid=0 | w=15
  5001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late teens to twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late teens to twenties | rel=r_associated | relid=0 | w=15
  5002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late twenties | rel=r_associated | relid=0 | w=15
  5003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late twenties to thirties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late twenties to thirties | rel=r_associated | relid=0 | w=15
  5004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in late-childhood to early adulthood (12 to 20 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in late-childhood to early adulthood (12 to 20 years) | rel=r_associated | relid=0 | w=15
  5005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in lower limbs
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in lower limbs | rel=r_associated | relid=0 | w=15
  5006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in males in first to third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in males in first to third decade | rel=r_associated | relid=0 | w=15
  5007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in mid to late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in mid to late childhood | rel=r_associated | relid=0 | w=15
  5008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in mid-adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in mid-adulthood | rel=r_associated | relid=0 | w=15
  5009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in middle age (44 to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in middle age (44 to 60 years) | rel=r_associated | relid=0 | w=15
  5010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in neonatal period or before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in neonatal period or before age 2 years | rel=r_associated | relid=0 | w=15
  5011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in neonatal period or early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in neonatal period or early infancy | rel=r_associated | relid=0 | w=15
  5012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in neonatal period or infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in neonatal period or infancy | rel=r_associated | relid=0 | w=15
  5013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in newborns or infants
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in newborns or infants | rel=r_associated | relid=0 | w=15
  5014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second and third decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second and third decades | rel=r_associated | relid=0 | w=15
  5015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second decade | rel=r_associated | relid=0 | w=15
  5016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second decade or as young adult
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second decade or as young adult | rel=r_associated | relid=0 | w=15
  5017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second decade or unilateral involvement indicates a diagnosis of 'progressive cribriform and zosteriform hyperpigmentation' (pczh)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second decade or unilateral involvement indicates a diagnosis of 'progressive cribriform and zosteriform hyperpigmentation' (pczh) | rel=r_associated | relid=0 | w=15
  5018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second decade, but sometimes earlier
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second decade, but sometimes earlier | rel=r_associated | relid=0 | w=15
  5019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second half of the first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second half of the first decade of life | rel=r_associated | relid=0 | w=15
  5020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second or third decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second or third decades | rel=r_associated | relid=0 | w=15
  5021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second to fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second to fifth decade | rel=r_associated | relid=0 | w=15
  5022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second to fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second to fourth decade | rel=r_associated | relid=0 | w=15
  5023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in second to third decades (postlingual)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in second to third decades (postlingual) | rel=r_associated | relid=0 | w=15
  5024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teenage or young adult years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teenage or young adult years | rel=r_associated | relid=0 | w=15
  5025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teenage years | rel=r_associated | relid=0 | w=15
  5026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teens has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teens has been reported | rel=r_associated | relid=0 | w=15
  5027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teens or young adulthood (range 13 to 45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teens or young adulthood (range 13 to 45 years) | rel=r_associated | relid=0 | w=15
  5028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teens to 20's
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teens to 20's | rel=r_associated | relid=0 | w=15
  5029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in teens to late twenties (range 14 to 44 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in teens to late twenties (range 14 to 44 years) | rel=r_associated | relid=0 | w=15
  5030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the 3rd decade of life or later
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the 3rd decade of life or later | rel=r_associated | relid=0 | w=15
  5031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first 2 years of life | rel=r_associated | relid=0 | w=15
  5032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first decade (range birth to 8 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first decade (range birth to 8 years) | rel=r_associated | relid=0 | w=15
  5033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first few months of life patients may need lifelong total parenteral nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first few months of life patients may need lifelong total parenteral nutrition | rel=r_associated | relid=0 | w=15
  5034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first hours or days of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first hours or days of life | rel=r_associated | relid=0 | w=15
  5035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first months of life (3 to 7 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first months of life (3 to 7 months) | rel=r_associated | relid=0 | w=15
  5036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the first or second decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the first or second decades of life | rel=r_associated | relid=0 | w=15
  5037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the fourth to sixth decades (mean 40 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the fourth to sixth decades (mean 40 years) | rel=r_associated | relid=0 | w=15
  5038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the neonatal period (0-38 days)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the neonatal period (0-38 days) | rel=r_associated | relid=0 | w=15
  5039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the perinatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the perinatal period | rel=r_associated | relid=0 | w=15
  5040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the second or third decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the second or third decade of life | rel=r_associated | relid=0 | w=15
  5041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the second to fourth decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the second to fourth decades of life | rel=r_associated | relid=0 | w=15
  5042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in the sixth or seventh decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in the sixth or seventh decades | rel=r_associated | relid=0 | w=15
  5043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in third decade | rel=r_associated | relid=0 | w=15
  5044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in third or fourth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in third or fourth decades | rel=r_associated | relid=0 | w=15
  5045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in third to fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in third to fourth decade | rel=r_associated | relid=0 | w=15
  5046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in utero or at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in utero or at birth | rel=r_associated | relid=0 | w=15
  5047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in utero or in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in utero or in infancy | rel=r_associated | relid=0 | w=15
  5048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in utero, infancy, or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in utero, infancy, or early childhood | rel=r_associated | relid=0 | w=15
  5049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in young adulthood | rel=r_associated | relid=0 | w=15
  5050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in young adulthood (range 18 to 23 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in young adulthood (range 18 to 23 years) | rel=r_associated | relid=0 | w=15
  5051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset in young adulthood or adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset in young adulthood or adulthood | rel=r_associated | relid=0 | w=15
  5052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset is usually in childhood or adolescence (2 to 18 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset is usually in childhood or adolescence (2 to 18 years) | rel=r_associated | relid=0 | w=15
  5053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset late childhood | rel=r_associated | relid=0 | w=15
  5054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset late childhood (8 to 14 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset late childhood (8 to 14 years) | rel=r_associated | relid=0 | w=15
  5055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset may also occur in early infancy, adolescence, or adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset may also occur in early infancy, adolescence, or adulthood | rel=r_associated | relid=0 | w=15
  5056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset may be precipitated by viral infection, reye-like episode following ingestion of aspirin
    n1=Hyde (prurigo nodulaire de) | n2=en:onset may be precipitated by viral infection, reye-like episode following ingestion of aspirin | rel=r_associated | relid=0 | w=15
  5057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset may be prelingual or in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset may be prelingual or in childhood | rel=r_associated | relid=0 | w=15
  5058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset may occur in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset may occur in adulthood | rel=r_associated | relid=0 | w=15
  5059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset mid to late adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset mid to late adulthood | rel=r_associated | relid=0 | w=15
  5060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset occurs earlier in males than females
    n1=Hyde (prurigo nodulaire de) | n2=en:onset occurs earlier in males than females | rel=r_associated | relid=0 | w=15
  5061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of abnormal eye movements in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of abnormal eye movements in early childhood | rel=r_associated | relid=0 | w=15
  5062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of acanthosis nigricans correlates with onset of diabetes
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of acanthosis nigricans correlates with onset of diabetes | rel=r_associated | relid=0 | w=15
  5063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of achalasia in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of achalasia in infancy or early childhood | rel=r_associated | relid=0 | w=15
  5064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of acne in adolescence, persists into adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of acne in adolescence, persists into adulthood | rel=r_associated | relid=0 | w=15
  5065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of acute encephalopathic attacks in childhood (3 to 7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of acute encephalopathic attacks in childhood (3 to 7 years) | rel=r_associated | relid=0 | w=15
  5066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of alopecia in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of alopecia in infancy | rel=r_associated | relid=0 | w=15
  5067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of arthritis in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of arthritis in early childhood | rel=r_associated | relid=0 | w=15
  5068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of ataxia and neuropathy in early twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of ataxia and neuropathy in early twenties | rel=r_associated | relid=0 | w=15
  5069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of ataxia between 1 and 3 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of ataxia between 1 and 3 years of age | rel=r_associated | relid=0 | w=15
  5070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of ataxia in early childhood (range 15 months to 3 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of ataxia in early childhood (range 15 months to 3 years) | rel=r_associated | relid=0 | w=15
  5071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of ataxia in the fifties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of ataxia in the fifties | rel=r_associated | relid=0 | w=15
  5072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of autoinflammation in infancy or first few years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of autoinflammation in infancy or first few years of life | rel=r_associated | relid=0 | w=15
  5073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of bleeding in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of bleeding in infancy or early childhood | rel=r_associated | relid=0 | w=15
  5074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of bleeding symptoms in childhood or young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of bleeding symptoms in childhood or young adulthood | rel=r_associated | relid=0 | w=15
  5075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of bone disease in second decade (range 18-44 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of bone disease in second decade (range 18-44 years) | rel=r_associated | relid=0 | w=15
  5076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of bone fragility in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of bone fragility in childhood | rel=r_associated | relid=0 | w=15
  5077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of calf hypotrophy may occur earlier
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of calf hypotrophy may occur earlier | rel=r_associated | relid=0 | w=15
  5078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cardiac involvement later, usually after age 20 years and after skeletal muscle involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cardiac involvement later, usually after age 20 years and after skeletal muscle involvement | rel=r_associated | relid=0 | w=15
  5079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cardiac symptoms in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cardiac symptoms in adolescence | rel=r_associated | relid=0 | w=15
  5080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cardiomyopathy may occur several months after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cardiomyopathy may occur several months after birth | rel=r_associated | relid=0 | w=15
  5081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cataracts in late adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cataracts in late adolescence | rel=r_associated | relid=0 | w=15
  5082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cholestatic jaundice 2-4 weeks of age and resolved during childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cholestatic jaundice 2-4 weeks of age and resolved during childhood | rel=r_associated | relid=0 | w=15
  5083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of choreoathetosis in childhood or young adult (6-23 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of choreoathetosis in childhood or young adult (6-23 years) | rel=r_associated | relid=0 | w=15
  5084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of choroideremia in second to third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of choroideremia in second to third decade | rel=r_associated | relid=0 | w=15
  5085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of chronic progressive polyneuropathy in late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of chronic progressive polyneuropathy in late childhood | rel=r_associated | relid=0 | w=15
  5086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of clinical features around puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of clinical features around puberty | rel=r_associated | relid=0 | w=15
  5087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of contractures in utero
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of contractures in utero | rel=r_associated | relid=0 | w=15
  5088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of cough in early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of cough in early adulthood | rel=r_associated | relid=0 | w=15
  5089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of crises in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of crises in early childhood | rel=r_associated | relid=0 | w=15
  5090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of deafness and diabetes in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of deafness and diabetes in adulthood | rel=r_associated | relid=0 | w=15
  5091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of deafness in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of deafness in early childhood | rel=r_associated | relid=0 | w=15
  5092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of dementia in the thirties or forties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of dementia in the thirties or forties | rel=r_associated | relid=0 | w=15
  5093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of diabetes in neonatal period/ early infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of diabetes in neonatal period/ early infancy | rel=r_associated | relid=0 | w=15
  5094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of diabetes in teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of diabetes in teenage years | rel=r_associated | relid=0 | w=15
  5095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of dilated cardiomyopathy less than 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of dilated cardiomyopathy less than 3 years | rel=r_associated | relid=0 | w=15
  5096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease 3-30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease 3-30 years | rel=r_associated | relid=0 | w=15
  5097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease 3-8 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease 3-8 years | rel=r_associated | relid=0 | w=15
  5098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease 7 months to 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease 7 months to 3 years | rel=r_associated | relid=0 | w=15
  5099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease after fourth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease after fourth decade of life | rel=r_associated | relid=0 | w=15
  5100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease around 10 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease around 10 years of age | rel=r_associated | relid=0 | w=15
  5101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease before 7 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease before 7 years of age | rel=r_associated | relid=0 | w=15
  5102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease between 25 and 40 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease between 25 and 40 years of age | rel=r_associated | relid=0 | w=15
  5103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease in fourth or fifth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease in fourth or fifth decade of life | rel=r_associated | relid=0 | w=15
  5104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease in late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease in late childhood | rel=r_associated | relid=0 | w=15
  5105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of disease within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of disease within the first year of life | rel=r_associated | relid=0 | w=15
  5106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of distal muscle weakness in adulthood (range twenties to forties), however, pes cavus or percussion-inducted contractions may be present earlier
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of distal muscle weakness in adulthood (range twenties to forties), however, pes cavus or percussion-inducted contractions may be present earlier | rel=r_associated | relid=0 | w=15
  5107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of dysmorphic features and developmental delay in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of dysmorphic features and developmental delay in infancy | rel=r_associated | relid=0 | w=15
  5108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of dystonia at 12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of dystonia at 12 years | rel=r_associated | relid=0 | w=15
  5109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of dystonia is in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of dystonia is in childhood | rel=r_associated | relid=0 | w=15
  5110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of edema in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of edema in childhood | rel=r_associated | relid=0 | w=15
  5111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of encephalopathy between ages 2 and 3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of encephalopathy between ages 2 and 3 years | rel=r_associated | relid=0 | w=15
  5112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of end-stage renal disease 15 to 20 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of end-stage renal disease 15 to 20 years after onset | rel=r_associated | relid=0 | w=15
  5113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of epiphyseal dysplasia and growth retardation in first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of epiphyseal dysplasia and growth retardation in first 2 years of life | rel=r_associated | relid=0 | w=15
  5114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of essential tremor between 16 and 44 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of essential tremor between 16 and 44 years | rel=r_associated | relid=0 | w=15
  5115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of febrile seizures typically between 6 months and 6 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of febrile seizures typically between 6 months and 6 years of age | rel=r_associated | relid=0 | w=15
  5116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of fracture usually when child begins to walk
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of fracture usually when child begins to walk | rel=r_associated | relid=0 | w=15
  5117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of fractures 4-18 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of fractures 4-18 months of life | rel=r_associated | relid=0 | w=15
  5118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of fractures in infancy to early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of fractures in infancy to early childhood | rel=r_associated | relid=0 | w=15
  5119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of gait abnormalities at 8 to 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of gait abnormalities at 8 to 40 years | rel=r_associated | relid=0 | w=15
  5120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of gastrointestinal tumors typically occurs in the second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of gastrointestinal tumors typically occurs in the second decade | rel=r_associated | relid=0 | w=15
  5121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of gaze palsy at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of gaze palsy at birth | rel=r_associated | relid=0 | w=15
  5122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hand involvement at 14 to 60 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hand involvement at 14 to 60 years | rel=r_associated | relid=0 | w=15
  5123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in adolescence | rel=r_associated | relid=0 | w=15
  5124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in childhood | rel=r_associated | relid=0 | w=15
  5125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in childhood (range 7 to 13 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in childhood (range 7 to 13 years) | rel=r_associated | relid=0 | w=15
  5126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in first or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in first or second decade | rel=r_associated | relid=0 | w=15
  5127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in late childhood | rel=r_associated | relid=0 | w=15
  5128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in late childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in late childhood or adolescence | rel=r_associated | relid=0 | w=15
  5129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss in second decade | rel=r_associated | relid=0 | w=15
  5130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss prior to or during adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss prior to or during adolescence | rel=r_associated | relid=0 | w=15
  5131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hearing loss ranges from childhood to young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hearing loss ranges from childhood to young adulthood | rel=r_associated | relid=0 | w=15
  5132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hematologic or cns tumors in the first or second decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hematologic or cns tumors in the first or second decades of life | rel=r_associated | relid=0 | w=15
  5133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hemolytic anemia shortly after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hemolytic anemia shortly after birth | rel=r_associated | relid=0 | w=15
  5134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hyperpigmentation in early childhood (3 months-6 years) that fades after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hyperpigmentation in early childhood (3 months-6 years) that fades after puberty | rel=r_associated | relid=0 | w=15
  5135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hyperuricemia or gout in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hyperuricemia or gout in young adulthood | rel=r_associated | relid=0 | w=15
  5136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of hypoglycemia and hyperinsulinism in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of hypoglycemia and hyperinsulinism in the neonatal period | rel=r_associated | relid=0 | w=15
  5137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of illness often associated with acute infection
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of illness often associated with acute infection | rel=r_associated | relid=0 | w=15
  5138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of insulin resistance may occur in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of insulin resistance may occur in childhood | rel=r_associated | relid=0 | w=15
  5139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of joint contractures later in life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of joint contractures later in life | rel=r_associated | relid=0 | w=15
  5140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of joint pain in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of joint pain in childhood | rel=r_associated | relid=0 | w=15
  5141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of kyphosis in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of kyphosis in childhood | rel=r_associated | relid=0 | w=15
  5142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of linear striations between 5 months and 6 years (only in affected females)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of linear striations between 5 months and 6 years (only in affected females) | rel=r_associated | relid=0 | w=15
  5143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of lipodystrophy in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of lipodystrophy in early childhood | rel=r_associated | relid=0 | w=15
  5144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of lipodystrophy later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of lipodystrophy later in childhood | rel=r_associated | relid=0 | w=15
  5145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of liver involvement in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of liver involvement in infancy | rel=r_associated | relid=0 | w=15
  5146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of lymphedema around puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of lymphedema around puberty | rel=r_associated | relid=0 | w=15
  5147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of lymphedema before puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of lymphedema before puberty | rel=r_associated | relid=0 | w=15
  5148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of macrocephaly in the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of macrocephaly in the first year of life | rel=r_associated | relid=0 | w=15
  5149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of major clinical features in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of major clinical features in young adulthood | rel=r_associated | relid=0 | w=15
  5150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of malignancy can occur throughout life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of malignancy can occur throughout life | rel=r_associated | relid=0 | w=15
  5151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of mental impairment in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of mental impairment in early childhood | rel=r_associated | relid=0 | w=15
  5152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of mild symptoms in first or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of mild symptoms in first or second decade | rel=r_associated | relid=0 | w=15
  5153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of motor disturbances in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of motor disturbances in childhood | rel=r_associated | relid=0 | w=15
  5154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of muscle weakness around age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of muscle weakness around age 5 years | rel=r_associated | relid=0 | w=15
  5155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of muscle weakness in early childhood, usually before age 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of muscle weakness in early childhood, usually before age 10 years | rel=r_associated | relid=0 | w=15
  5156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of muscle weakness in fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of muscle weakness in fifth decade | rel=r_associated | relid=0 | w=15
  5157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of myoclonus later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of myoclonus later in childhood | rel=r_associated | relid=0 | w=15
  5158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of nephrotic syndrome and thrombocytopenia in mid-childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of nephrotic syndrome and thrombocytopenia in mid-childhood | rel=r_associated | relid=0 | w=15
  5159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of neurologic disease in early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of neurologic disease in early adulthood | rel=r_associated | relid=0 | w=15
  5160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of neurologic events can occur between 4 and 35 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of neurologic events can occur between 4 and 35 years of age | rel=r_associated | relid=0 | w=15
  5161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of neurologic features is variable, even within the same family (range early childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of neurologic features is variable, even within the same family (range early childhood to adult) | rel=r_associated | relid=0 | w=15
  5162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of neurologic symptoms often by 30 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of neurologic symptoms often by 30 months | rel=r_associated | relid=0 | w=15
  5163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of neuromuscular symptoms between 6 months and 1 year of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of neuromuscular symptoms between 6 months and 1 year of age | rel=r_associated | relid=0 | w=15
  5164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of normal pressure hydrocephalus after age 65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of normal pressure hydrocephalus after age 65 years | rel=r_associated | relid=0 | w=15
  5165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of optic atrophy in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of optic atrophy in childhood | rel=r_associated | relid=0 | w=15
  5166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of optic atrophy in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of optic atrophy in infancy or early childhood | rel=r_associated | relid=0 | w=15
  5167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of optic neuropathy is usually in early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of optic neuropathy is usually in early adulthood | rel=r_associated | relid=0 | w=15
  5168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of osteoarthritis in teens to early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of osteoarthritis in teens to early adulthood | rel=r_associated | relid=0 | w=15
  5169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of other symptoms in adolescence or early adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of other symptoms in adolescence or early adulthood | rel=r_associated | relid=0 | w=15
  5170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of palmoplantar hyperkeratosis 7-8 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of palmoplantar hyperkeratosis 7-8 years of age | rel=r_associated | relid=0 | w=15
  5171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of parkinsonism in early twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of parkinsonism in early twenties | rel=r_associated | relid=0 | w=15
  5172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of parkinsonism in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of parkinsonism in first decade | rel=r_associated | relid=0 | w=15
  5173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of periodic paralysis (mean) 5 years (range) 8 months to 15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of periodic paralysis (mean) 5 years (range) 8 months to 15 years | rel=r_associated | relid=0 | w=15
  5174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of peripheral neuropathy or hearing loss in young adulthood (range 16 to 35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of peripheral neuropathy or hearing loss in young adulthood (range 16 to 35 years) | rel=r_associated | relid=0 | w=15
  5175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of progressive spastic paraplegia in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of progressive spastic paraplegia in childhood | rel=r_associated | relid=0 | w=15
  5176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of proteinuria in the second to fourth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of proteinuria in the second to fourth decades | rel=r_associated | relid=0 | w=15
  5177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of proteinuria in the third to fourth decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of proteinuria in the third to fourth decades | rel=r_associated | relid=0 | w=15
  5178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of renal dysfunction in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of renal dysfunction in early childhood | rel=r_associated | relid=0 | w=15
  5179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of renal failure in adulthood (range twenties to fifties)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of renal failure in adulthood (range twenties to fifties) | rel=r_associated | relid=0 | w=15
  5180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of scoliosis as early as 2 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of scoliosis as early as 2 years of age | rel=r_associated | relid=0 | w=15
  5181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures around 7 to 12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures around 7 to 12 years | rel=r_associated | relid=0 | w=15
  5182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures at 2-8 days of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures at 2-8 days of life | rel=r_associated | relid=0 | w=15
  5183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures before age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures before age 2 years | rel=r_associated | relid=0 | w=15
  5184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures between 8 and 11 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures between 8 and 11 months of age | rel=r_associated | relid=0 | w=15
  5185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures between 9 and 12 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures between 9 and 12 months of age | rel=r_associated | relid=0 | w=15
  5186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in first 6 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in first 6 months of life | rel=r_associated | relid=0 | w=15
  5187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in first months of life | rel=r_associated | relid=0 | w=15
  5188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in first months of life (usually 4 to 7 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in first months of life (usually 4 to 7 months) | rel=r_associated | relid=0 | w=15
  5189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in infancy | rel=r_associated | relid=0 | w=15
  5190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in infancy or early childhood | rel=r_associated | relid=0 | w=15
  5191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures in later childhood (5 to 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures in later childhood (5 to 10 years) | rel=r_associated | relid=0 | w=15
  5192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of seizures ranges from 2 to 11 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of seizures ranges from 2 to 11 years | rel=r_associated | relid=0 | w=15
  5193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of sensory neuropathy in later adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of sensory neuropathy in later adulthood | rel=r_associated | relid=0 | w=15
  5194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of skin lesions at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of skin lesions at birth | rel=r_associated | relid=0 | w=15
  5195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of skin manifestations from birth to puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of skin manifestations from birth to puberty | rel=r_associated | relid=0 | w=15
  5196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of sleep terrors between age 4 and 12 years old
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of sleep terrors between age 4 and 12 years old | rel=r_associated | relid=0 | w=15
  5197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of sleepwalking between 4 and 8 years old
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of sleepwalking between 4 and 8 years old | rel=r_associated | relid=0 | w=15
  5198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of slowly progressive spastic paraplegia in first or second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of slowly progressive spastic paraplegia in first or second decade | rel=r_associated | relid=0 | w=15
  5199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of spastic paraplegia in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of spastic paraplegia in first year of life | rel=r_associated | relid=0 | w=15
  5200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of spasticity by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of spasticity by age 2 years | rel=r_associated | relid=0 | w=15
  5201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of spasticity in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of spasticity in childhood | rel=r_associated | relid=0 | w=15
  5202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms 2-12 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms 2-12 months | rel=r_associated | relid=0 | w=15
  5203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms 2-4 weeks of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms 2-4 weeks of age | rel=r_associated | relid=0 | w=15
  5204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms 2-6 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms 2-6 years of age | rel=r_associated | relid=0 | w=15
  5205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms after age 5
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms after age 5 | rel=r_associated | relid=0 | w=15
  5206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms age 5-30
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms age 5-30 | rel=r_associated | relid=0 | w=15
  5207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms at 2-4 months
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms at 2-4 months | rel=r_associated | relid=0 | w=15
  5208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms between ages 3-8 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms between ages 3-8 years of age | rel=r_associated | relid=0 | w=15
  5209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in childhood with stiff, painful joints
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in childhood with stiff, painful joints | rel=r_associated | relid=0 | w=15
  5210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in early childhood | rel=r_associated | relid=0 | w=15
  5211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in fifth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in fifth decade | rel=r_associated | relid=0 | w=15
  5212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in first decade of life | rel=r_associated | relid=0 | w=15
  5213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in first or second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in first or second decade of life | rel=r_associated | relid=0 | w=15
  5214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in second decade of life | rel=r_associated | relid=0 | w=15
  5215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in second or third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in second or third decade | rel=r_associated | relid=0 | w=15
  5216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in second or third decade (mean 25 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in second or third decade (mean 25 years) | rel=r_associated | relid=0 | w=15
  5217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in the fourth to sixth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in the fourth to sixth decade of life | rel=r_associated | relid=0 | w=15
  5218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms in third to sixth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms in third to sixth decade of life | rel=r_associated | relid=0 | w=15
  5219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms less than one year
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms less than one year | rel=r_associated | relid=0 | w=15
  5220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms often associated with nonspecific febrile illness
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms often associated with nonspecific febrile illness | rel=r_associated | relid=0 | w=15
  5221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms usually between 12-15 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms usually between 12-15 years | rel=r_associated | relid=0 | w=15
  5222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms usually in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms usually in adulthood | rel=r_associated | relid=0 | w=15
  5223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of symptoms within the first 2 decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of symptoms within the first 2 decades of life | rel=r_associated | relid=0 | w=15
  5224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of thrombocytopenia in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of thrombocytopenia in early childhood | rel=r_associated | relid=0 | w=15
  5225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of thrombosis by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of thrombosis by age 2 years | rel=r_associated | relid=0 | w=15
  5226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of tremor usually before onset of seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of tremor usually before onset of seizures | rel=r_associated | relid=0 | w=15
  5227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of tumors usually in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of tumors usually in adulthood | rel=r_associated | relid=0 | w=15
  5228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of visual loss in childhood (around age 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of visual loss in childhood (around age 5 years) | rel=r_associated | relid=0 | w=15
  5229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset of visual loss in the first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset of visual loss in the first decade | rel=r_associated | relid=0 | w=15
  5230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset often begins in childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset often begins in childhood or adolescence | rel=r_associated | relid=0 | w=15
  5231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset often in late adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset often in late adolescence | rel=r_associated | relid=0 | w=15
  5232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset precipitated by fasting or illness
    n1=Hyde (prurigo nodulaire de) | n2=en:onset precipitated by fasting or illness | rel=r_associated | relid=0 | w=15
  5233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset prenatally or at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset prenatally or at birth | rel=r_associated | relid=0 | w=15
  5234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from 2 days to 7 months (most at 2-3 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from 2 days to 7 months (most at 2-3 months) | rel=r_associated | relid=0 | w=15
  5235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from birth to age 4 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from birth to age 4 years | rel=r_associated | relid=0 | w=15
  5236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from childhood (severe phenotype) to adulthood (limited phenotype)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from childhood (severe phenotype) to adulthood (limited phenotype) | rel=r_associated | relid=0 | w=15
  5237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from childhood to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from childhood to adulthood | rel=r_associated | relid=0 | w=15
  5238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from childhood to young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from childhood to young adulthood | rel=r_associated | relid=0 | w=15
  5239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from early childhood to adulthood (usually before age 15)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from early childhood to adulthood (usually before age 15) | rel=r_associated | relid=0 | w=15
  5240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from first to third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from first to third decade | rel=r_associated | relid=0 | w=15
  5241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset ranges from young adulthood to sixties
    n1=Hyde (prurigo nodulaire de) | n2=en:onset ranges from young adulthood to sixties | rel=r_associated | relid=0 | w=15
  5242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset second decade of life | rel=r_associated | relid=0 | w=15
  5243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset soon after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset soon after birth | rel=r_associated | relid=0 | w=15
  5244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset soon after birth or within the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset soon after birth or within the first year of life | rel=r_associated | relid=0 | w=15
  5245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually after age 40
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually after age 40 | rel=r_associated | relid=0 | w=15
  5246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually after viral-like infection
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually after viral-like infection | rel=r_associated | relid=0 | w=15
  5247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually associated with febrile illness
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually associated with febrile illness | rel=r_associated | relid=0 | w=15
  5248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually at 2 to 6 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually at 2 to 6 months of age | rel=r_associated | relid=0 | w=15
  5249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually at birth | rel=r_associated | relid=0 | w=15
  5250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually at birth, but may occur later
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually at birth, but may occur later | rel=r_associated | relid=0 | w=15
  5251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually before age 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually before age 10 years | rel=r_associated | relid=0 | w=15
  5252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually before age 40 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually before age 40 years | rel=r_associated | relid=0 | w=15
  5253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually before age 40 years (range 15 to 55)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually before age 40 years (range 15 to 55) | rel=r_associated | relid=0 | w=15
  5254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually between 30 and 50 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually between 30 and 50 years of age | rel=r_associated | relid=0 | w=15
  5255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually by age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually by age 2 years | rel=r_associated | relid=0 | w=15
  5256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in adolescence | rel=r_associated | relid=0 | w=15
  5257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in adulthood | rel=r_associated | relid=0 | w=15
  5258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in adulthood although childhood onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in adulthood although childhood onset has been reported | rel=r_associated | relid=0 | w=15
  5259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood | rel=r_associated | relid=0 | w=15
  5260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood (1 to 9 years of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood (1 to 9 years of age) | rel=r_associated | relid=0 | w=15
  5261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood (infancy to teens)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood (infancy to teens) | rel=r_associated | relid=0 | w=15
  5262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood (range 17 months to 39 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood (range 17 months to 39 years) | rel=r_associated | relid=0 | w=15
  5263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood (range 6 months to 16 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood (range 6 months to 16 years) | rel=r_associated | relid=0 | w=15
  5264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood (range infancy to late childhood)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood (range infancy to late childhood) | rel=r_associated | relid=0 | w=15
  5265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in childhood or adolescence | rel=r_associated | relid=0 | w=15
  5266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in early adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in early adolescence | rel=r_associated | relid=0 | w=15
  5267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in early childhood | rel=r_associated | relid=0 | w=15
  5268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in early childhood (but can range from infancy to adolescence)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in early childhood (but can range from infancy to adolescence) | rel=r_associated | relid=0 | w=15
  5269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in early childhood, although ranges from birth to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in early childhood, although ranges from birth to adulthood | rel=r_associated | relid=0 | w=15
  5270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first decade | rel=r_associated | relid=0 | w=15
  5271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first month of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first month of life | rel=r_associated | relid=0 | w=15
  5272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first or second decade (mean 10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first or second decade (mean 10 years) | rel=r_associated | relid=0 | w=15
  5273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first or second decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first or second decades | rel=r_associated | relid=0 | w=15
  5274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first to third decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first to third decade of life | rel=r_associated | relid=0 | w=15
  5275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in first year of life | rel=r_associated | relid=0 | w=15
  5276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy | rel=r_associated | relid=0 | w=15
  5277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy although later onset may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy although later onset may occur | rel=r_associated | relid=0 | w=15
  5278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy or childhood | rel=r_associated | relid=0 | w=15
  5279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy or early childhood | rel=r_associated | relid=0 | w=15
  5280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy or early childhood (9 months to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy or early childhood (9 months to 6 years) | rel=r_associated | relid=0 | w=15
  5281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in infancy or up to 2 years of age although later onset has been reported ('late-infantile')
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in infancy or up to 2 years of age although later onset has been reported ('late-infantile') | rel=r_associated | relid=0 | w=15
  5282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in late adolescence or early adulthood (range 15 to 45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in late adolescence or early adulthood (range 15 to 45 years) | rel=r_associated | relid=0 | w=15
  5283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in late infancy or childhood (1 to 6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in late infancy or childhood (1 to 6 years) | rel=r_associated | relid=0 | w=15
  5284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in mid-teens, average 15 years (range 2 to 20 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in mid-teens, average 15 years (range 2 to 20 years) | rel=r_associated | relid=0 | w=15
  5285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in second decade | rel=r_associated | relid=0 | w=15
  5286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in second decade (may occur earlier)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in second decade (may occur earlier) | rel=r_associated | relid=0 | w=15
  5287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in second decade of life, although earlier and later onset have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in second decade of life, although earlier and later onset have been reported | rel=r_associated | relid=0 | w=15
  5288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in second or third decades
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in second or third decades | rel=r_associated | relid=0 | w=15
  5289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in the first 4 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in the first 4 years of life | rel=r_associated | relid=0 | w=15
  5290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in the first decade (range 0.8 to 5 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in the first decade (range 0.8 to 5 years) | rel=r_associated | relid=0 | w=15
  5291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in the neck
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in the neck | rel=r_associated | relid=0 | w=15
  5292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in the neonatal period although later onset has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in the neonatal period although later onset has been reported | rel=r_associated | relid=0 | w=15
  5293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in the third decade (range 11 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in the third decade (range 11 to 50 years) | rel=r_associated | relid=0 | w=15
  5294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in third decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in third decade of life | rel=r_associated | relid=0 | w=15
  5295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in third or fourth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in third or fourth decade | rel=r_associated | relid=0 | w=15
  5296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually in young adulthood | rel=r_associated | relid=0 | w=15
  5297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset usually within first weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset usually within first weeks of life | rel=r_associated | relid=0 | w=15
  5298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within first 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within first 2 years | rel=r_associated | relid=0 | w=15
  5299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within first 2 years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within first 2 years of life | rel=r_associated | relid=0 | w=15
  5300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within first 3 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within first 3 months of life | rel=r_associated | relid=0 | w=15
  5301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within first 6 months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within first 6 months of life | rel=r_associated | relid=0 | w=15
  5302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within first year of life | rel=r_associated | relid=0 | w=15
  5303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:onset within the first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:onset within the first decade of life | rel=r_associated | relid=0 | w=15
  5304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ophthalmologic signs onset in first to sixth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:ophthalmologic signs onset in first to sixth decade | rel=r_associated | relid=0 | w=15
  5305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:opportunistic infection
    n1=Hyde (prurigo nodulaire de) | n2=en:opportunistic infection | rel=r_associated | relid=0 | w=15
  5306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:opsismodysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:opsismodysplasia | rel=r_associated | relid=0 | w=15
  5307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oral contraceptives may also cause symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:oral contraceptives may also cause symptoms | rel=r_associated | relid=0 | w=15
  5308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oral supplementation with ubiquinone does not result in major clinical improvement
    n1=Hyde (prurigo nodulaire de) | n2=en:oral supplementation with ubiquinone does not result in major clinical improvement | rel=r_associated | relid=0 | w=15
  5309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:organic chemistry
    n1=Hyde (prurigo nodulaire de) | n2=en:organic chemistry | rel=r_associated | relid=0 | w=15
  5310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:organic compound or molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:organic compound or molecule | rel=r_associated | relid=0 | w=15
  5311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:organic functional class
    n1=Hyde (prurigo nodulaire de) | n2=en:organic functional class | rel=r_associated | relid=0 | w=15
  5312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:original phenotype description based on patients from la reunion island in the indian ocean off the east coast of africa where the incidence is 1/1,500 births
    n1=Hyde (prurigo nodulaire de) | n2=en:original phenotype description based on patients from la reunion island in the indian ocean off the east coast of africa where the incidence is 1/1,500 births | rel=r_associated | relid=0 | w=15
  5313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:osmolite
    n1=Hyde (prurigo nodulaire de) | n2=en:osmolite | rel=r_associated | relid=0 | w=15
  5314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ossification evident 2-8 months following swelling
    n1=Hyde (prurigo nodulaire de) | n2=en:ossification evident 2-8 months following swelling | rel=r_associated | relid=0 | w=15
  5315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:osteopathia striata cranial sclerosis
    n1=Hyde (prurigo nodulaire de) | n2=en:osteopathia striata cranial sclerosis | rel=r_associated | relid=0 | w=15
  5316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other complications of pregnancy, nec in mdr
    n1=Hyde (prurigo nodulaire de) | n2=en:other complications of pregnancy, nec in mdr | rel=r_associated | relid=0 | w=15
  5317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions classifiable elsewhere of mother, antepartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions classifiable elsewhere of mother, antepartum condition or complication | rel=r_associated | relid=0 | w=15
  5318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions classifiable elsewhere of mother, delivered, with mention of postpartum complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions classifiable elsewhere of mother, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=15
  5319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
  5320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions classifiable elsewhere of mother, postpartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions classifiable elsewhere of mother, postpartum condition or complication | rel=r_associated | relid=0 | w=15
  5321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions classifiable elsewhere of mother, unspecified as to episode of care or not applicable
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions classifiable elsewhere of mother, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=15
  5322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions complicating pregnancy, childbirth, or the puerperium
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=15
  5323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other current conditions in the mother classifiable elsewhere, but complicating pregnancy, childbirth, or the puerperium
    n1=Hyde (prurigo nodulaire de) | n2=en:other current conditions in the mother classifiable elsewhere, but complicating pregnancy, childbirth, or the puerperium | rel=r_associated | relid=0 | w=15
  5324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other disorders of amniotic fluid and membranes
    n1=Hyde (prurigo nodulaire de) | n2=en:other disorders of amniotic fluid and membranes | rel=r_associated | relid=0 | w=15
  5325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other features of neurofibromatosis type i (nf1, 162200) may or may not be present
    n1=Hyde (prurigo nodulaire de) | n2=en:other features of neurofibromatosis type i (nf1, 162200) may or may not be present | rel=r_associated | relid=0 | w=15
  5326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other half show head circumference more retarded than height
    n1=Hyde (prurigo nodulaire de) | n2=en:other half show head circumference more retarded than height | rel=r_associated | relid=0 | w=15
  5327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other indications for care or intervention related to labor and delivery, nec in icd9cm
    n1=Hyde (prurigo nodulaire de) | n2=en:other indications for care or intervention related to labor and delivery, nec in icd9cm | rel=r_associated | relid=0 | w=15
  5328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other known or suspected fetal and placental problems affecting management of mother
    n1=Hyde (prurigo nodulaire de) | n2=en:other known or suspected fetal and placental problems affecting management of mother | rel=r_associated | relid=0 | w=15
  5329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other muscle become involved about 5 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:other muscle become involved about 5 years after onset | rel=r_associated | relid=0 | w=15
  5330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other problems associated with amniotic cavity and membranes
    n1=Hyde (prurigo nodulaire de) | n2=en:other problems associated with amniotic cavity and membranes | rel=r_associated | relid=0 | w=15
  5331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other specified complications of pregnancy, antepartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other specified complications of pregnancy, antepartum condition or complication | rel=r_associated | relid=0 | w=15
  5332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other specified complications of pregnancy, delivered, with mention of postpartum complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other specified complications of pregnancy, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=15
  5333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other specified complications of pregnancy, delivered, with or without mention of antepartum condition
    n1=Hyde (prurigo nodulaire de) | n2=en:other specified complications of pregnancy, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
  5334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other specified complications of pregnancy, postpartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:other specified complications of pregnancy, postpartum condition or complication | rel=r_associated | relid=0 | w=15
  5335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other tumors may also occur
    n1=Hyde (prurigo nodulaire de) | n2=en:other tumors may also occur | rel=r_associated | relid=0 | w=15
  5336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other variants of waardenburg syndrome include waardenburg syndrome type 1 (193500), waardenburg syndrome type 3 (148820), and waardenburg syndrome type 4 (277580)
    n1=Hyde (prurigo nodulaire de) | n2=en:other variants of waardenburg syndrome include waardenburg syndrome type 1 (193500), waardenburg syndrome type 3 (148820), and waardenburg syndrome type 4 (277580) | rel=r_associated | relid=0 | w=15
  5337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other variants of waardenburg syndrome include waardenburg syndrome type 2 (193510), waardenburg syndrome type 3 (148820), and waardenburg syndrome type 4 (277580)
    n1=Hyde (prurigo nodulaire de) | n2=en:other variants of waardenburg syndrome include waardenburg syndrome type 2 (193510), waardenburg syndrome type 3 (148820), and waardenburg syndrome type 4 (277580) | rel=r_associated | relid=0 | w=15
  5338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:other visual functions, including visual acuity, visual field, and color vision, are usually normal in these patients
    n1=Hyde (prurigo nodulaire de) | n2=en:other visual functions, including visual acuity, visual field, and color vision, are usually normal in these patients | rel=r_associated | relid=0 | w=15
  5339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:otopalatodigital syndrome type i (opd1, 311300) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:otopalatodigital syndrome type i (opd1, 311300) is an allelic disorder | rel=r_associated | relid=0 | w=15
  5340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:otopalatodigital syndrome type ii (opd2, 304120) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:otopalatodigital syndrome type ii (opd2, 304120) is an allelic disorder | rel=r_associated | relid=0 | w=15
  5341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:otopalatodigital syndrome type ii (opd2, 304120) is an allelic disorder with a more severe, frequently lethal phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:otopalatodigital syndrome type ii (opd2, 304120) is an allelic disorder with a more severe, frequently lethal phenotype | rel=r_associated | relid=0 | w=15
  5342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overall course less severe compared to patients with cfh (134370) mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:overall course less severe compared to patients with cfh (134370) mutations | rel=r_associated | relid=0 | w=15
  5343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overall prevalence is between 0.5 and 14 per 100,000 people per year
    n1=Hyde (prurigo nodulaire de) | n2=en:overall prevalence is between 0.5 and 14 per 100,000 people per year | rel=r_associated | relid=0 | w=15
  5344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlap with obsessive-compulsive disorder (ocd, 164230)
    n1=Hyde (prurigo nodulaire de) | n2=en:overlap with obsessive-compulsive disorder (ocd, 164230) | rel=r_associated | relid=0 | w=15
  5345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlap with tourette syndrome (137580)
    n1=Hyde (prurigo nodulaire de) | n2=en:overlap with tourette syndrome (137580) | rel=r_associated | relid=0 | w=15
  5346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlapping clinical spectrum and allelic to masa syndrome (303350)
    n1=Hyde (prurigo nodulaire de) | n2=en:overlapping clinical spectrum and allelic to masa syndrome (303350) | rel=r_associated | relid=0 | w=15
  5347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlapping features of digeorge syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:overlapping features of digeorge syndrome | rel=r_associated | relid=0 | w=15
  5348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlapping features with barber-say syndrome (209885)
    n1=Hyde (prurigo nodulaire de) | n2=en:overlapping features with barber-say syndrome (209885) | rel=r_associated | relid=0 | w=15
  5349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:overlapping pathologic features with x-linked myopathy with excessive autophagy (xmea, 310440)
    n1=Hyde (prurigo nodulaire de) | n2=en:overlapping pathologic features with x-linked myopathy with excessive autophagy (xmea, 310440) | rel=r_associated | relid=0 | w=15
  5350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:oxygen and carbon dioxide mixture
    n1=Hyde (prurigo nodulaire de) | n2=en:oxygen and carbon dioxide mixture | rel=r_associated | relid=0 | w=15
  5351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pain is noted to feel cold
    n1=Hyde (prurigo nodulaire de) | n2=en:pain is noted to feel cold | rel=r_associated | relid=0 | w=15
  5352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pain is relieved by antiinflammatory medication
    n1=Hyde (prurigo nodulaire de) | n2=en:pain is relieved by antiinflammatory medication | rel=r_associated | relid=0 | w=15
  5353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pain most commonly affects the trunk, extremities, pelvic region, buttocks
    n1=Hyde (prurigo nodulaire de) | n2=en:pain most commonly affects the trunk, extremities, pelvic region, buttocks | rel=r_associated | relid=0 | w=15
  5354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pain tends to occur later in the day
    n1=Hyde (prurigo nodulaire de) | n2=en:pain tends to occur later in the day | rel=r_associated | relid=0 | w=15
  5355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:painful cramping following ischemic exercise test
    n1=Hyde (prurigo nodulaire de) | n2=en:painful cramping following ischemic exercise test | rel=r_associated | relid=0 | w=15
  5356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pancreatic enzyme
    n1=Hyde (prurigo nodulaire de) | n2=en:pancreatic enzyme | rel=r_associated | relid=0 | w=15
  5357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pancreatin
    n1=Hyde (prurigo nodulaire de) | n2=en:pancreatin | rel=r_associated | relid=0 | w=15
  5358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:parasitology
    n1=Hyde (prurigo nodulaire de) | n2=en:parasitology | rel=r_associated | relid=0 | w=15
  5359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:parental somatic mosaicism in 2 cases produced mild phenotype in the patients
    n1=Hyde (prurigo nodulaire de) | n2=en:parental somatic mosaicism in 2 cases produced mild phenotype in the patients | rel=r_associated | relid=0 | w=15
  5360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:parietal foramina-2 (pfm2, 609597) are caused by mutations in the alx4 gene (605420)
    n1=Hyde (prurigo nodulaire de) | n2=en:parietal foramina-2 (pfm2, 609597) are caused by mutations in the alx4 gene (605420) | rel=r_associated | relid=0 | w=15
  5361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:paris-trousseau thrombocytopenia can occur in jacobsen syndrome (147791) in which similar platelet defects are accompanied by facial dysmorphism, cardiac defects, mental retardation, and deletion at 11q23
    n1=Hyde (prurigo nodulaire de) | n2=en:paris-trousseau thrombocytopenia can occur in jacobsen syndrome (147791) in which similar platelet defects are accompanied by facial dysmorphism, cardiac defects, mental retardation, and deletion at 11q23 | rel=r_associated | relid=0 | w=15
  5362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:part of 'dent disease complex'
    n1=Hyde (prurigo nodulaire de) | n2=en:part of 'dent disease complex' | rel=r_associated | relid=0 | w=15
  5363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:part of 'dent disease complex' (see 300009)
    n1=Hyde (prurigo nodulaire de) | n2=en:part of 'dent disease complex' (see 300009) | rel=r_associated | relid=0 | w=15
  5364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:partial deficiency of hypoxanthine phosphoribosyltransferase (hprt, 78% activity)
    n1=Hyde (prurigo nodulaire de) | n2=en:partial deficiency of hypoxanthine phosphoribosyltransferase (hprt, 78% activity) | rel=r_associated | relid=0 | w=15
  5365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:partial factor viii deficiency in heterozygous carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:partial factor viii deficiency in heterozygous carriers | rel=r_associated | relid=0 | w=15
  5366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:partial laminin alpha-2 deficiency results in milder phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:partial laminin alpha-2 deficiency results in milder phenotype | rel=r_associated | relid=0 | w=15
  5367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:partially responsive to laser treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:partially responsive to laser treatment | rel=r_associated | relid=0 | w=15
  5368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pasta
    n1=Hyde (prurigo nodulaire de) | n2=en:pasta | rel=r_associated | relid=0 | w=15
  5369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:paternal age effect
    n1=Hyde (prurigo nodulaire de) | n2=en:paternal age effect | rel=r_associated | relid=0 | w=15
  5370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:paternal anticipation bias
    n1=Hyde (prurigo nodulaire de) | n2=en:paternal anticipation bias | rel=r_associated | relid=0 | w=15
  5371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic alleles contain 52 to 86 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic alleles contain 52 to 86 repeats | rel=r_associated | relid=0 | w=15
  5372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic alleles contain 71 to 1,300 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic alleles contain 71 to 1,300 repeats | rel=r_associated | relid=0 | w=15
  5373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic alleles contain 75-11,000 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic alleles contain 75-11,000 repeats | rel=r_associated | relid=0 | w=15
  5374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic alleles contain greater than 41 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic alleles contain greater than 41 repeats | rel=r_associated | relid=0 | w=15
  5375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic alleles have 19 to 33 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic alleles have 19 to 33 repeats | rel=r_associated | relid=0 | w=15
  5376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathogenic cag repeat length is 51 to 78 triplets
    n1=Hyde (prurigo nodulaire de) | n2=en:pathogenic cag repeat length is 51 to 78 triplets | rel=r_associated | relid=0 | w=15
  5377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pathological aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:pathological aspects | rel=r_associated | relid=0 | w=15
  5378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patient with factor ix leyden variants (see, e.g., 300746.0001) have bleeding in childhood that improves or resolves after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:patient with factor ix leyden variants (see, e.g., 300746.0001) have bleeding in childhood that improves or resolves after puberty | rel=r_associated | relid=0 | w=15
  5379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patient with truncating mutations are more likely to develop neurologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:patient with truncating mutations are more likely to develop neurologic abnormalities | rel=r_associated | relid=0 | w=15
  5380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients achieve ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:patients achieve ambulation | rel=r_associated | relid=0 | w=15
  5381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are born with normal head circumference
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are born with normal head circumference | rel=r_associated | relid=0 | w=15
  5382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are often asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are often asymptomatic | rel=r_associated | relid=0 | w=15
  5383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are often of mediterranean origin
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are often of mediterranean origin | rel=r_associated | relid=0 | w=15
  5384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are prone to impaired thermoregulation
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are prone to impaired thermoregulation | rel=r_associated | relid=0 | w=15
  5385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are severely disabled as adults
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are severely disabled as adults | rel=r_associated | relid=0 | w=15
  5386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are susceptible to sepsis and dehydration
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are susceptible to sepsis and dehydration | rel=r_associated | relid=0 | w=15
  5387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients are typically blind by second or third decade of life, but pace of visual deterioration is highly variable
    n1=Hyde (prurigo nodulaire de) | n2=en:patients are typically blind by second or third decade of life, but pace of visual deterioration is highly variable | rel=r_associated | relid=0 | w=15
  5388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients become wheelchair-bound about 10 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:patients become wheelchair-bound about 10 years after onset | rel=r_associated | relid=0 | w=15
  5389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients become wheelchair-bound as adults
    n1=Hyde (prurigo nodulaire de) | n2=en:patients become wheelchair-bound as adults | rel=r_associated | relid=0 | w=15
  5390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients become wheelchair-bound in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:patients become wheelchair-bound in second decade | rel=r_associated | relid=0 | w=15
  5391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients between 30 and 60 years have discomfort with prolonged standing
    n1=Hyde (prurigo nodulaire de) | n2=en:patients between 30 and 60 years have discomfort with prolonged standing | rel=r_associated | relid=0 | w=15
  5392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients can be divided into 2 groups based on whether typical hand anomalies are present
    n1=Hyde (prurigo nodulaire de) | n2=en:patients can be divided into 2 groups based on whether typical hand anomalies are present | rel=r_associated | relid=0 | w=15
  5393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients can have als, ftd, or both
    n1=Hyde (prurigo nodulaire de) | n2=en:patients can have als, ftd, or both | rel=r_associated | relid=0 | w=15
  5394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients can have multiple seizure types
    n1=Hyde (prurigo nodulaire de) | n2=en:patients can have multiple seizure types | rel=r_associated | relid=0 | w=15
  5395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients develop aortic dissection with little or no aortic enlargement
    n1=Hyde (prurigo nodulaire de) | n2=en:patients develop aortic dissection with little or no aortic enlargement | rel=r_associated | relid=0 | w=15
  5396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients develop multiple tumors
    n1=Hyde (prurigo nodulaire de) | n2=en:patients develop multiple tumors | rel=r_associated | relid=0 | w=15
  5397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients do not exhibit ophthalmoplegia
    n1=Hyde (prurigo nodulaire de) | n2=en:patients do not exhibit ophthalmoplegia | rel=r_associated | relid=0 | w=15
  5398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients do not have clinical hypothyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:patients do not have clinical hypothyroidism | rel=r_associated | relid=0 | w=15
  5399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients do not have ectopia lentis
    n1=Hyde (prurigo nodulaire de) | n2=en:patients do not have ectopia lentis | rel=r_associated | relid=0 | w=15
  5400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients exhibit no signs of ocular or cutaneous albinism
    n1=Hyde (prurigo nodulaire de) | n2=en:patients exhibit no signs of ocular or cutaneous albinism | rel=r_associated | relid=0 | w=15
  5401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients frequently have additional malformations or abnormalities, especially in the hepatobiliary and gastrointestinal systems
    n1=Hyde (prurigo nodulaire de) | n2=en:patients frequently have additional malformations or abnormalities, especially in the hepatobiliary and gastrointestinal systems | rel=r_associated | relid=0 | w=15
  5402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients from 4 unrelated families have been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:patients from 4 unrelated families have been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  5403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients from old order amish community and turkey have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:patients from old order amish community and turkey have been reported | rel=r_associated | relid=0 | w=15
  5404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients gradually develop tolerance to carbohydrates over time
    n1=Hyde (prurigo nodulaire de) | n2=en:patients gradually develop tolerance to carbohydrates over time | rel=r_associated | relid=0 | w=15
  5405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have a distinctive shallow u-shaped audiogram
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have a distinctive shallow u-shaped audiogram | rel=r_associated | relid=0 | w=15
  5406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have increased numbers and earlier onset of neurofibromas compared to patients with neurofibromatosis-1 due to point mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have increased numbers and earlier onset of neurofibromas compared to patients with neurofibromatosis-1 due to point mutations | rel=r_associated | relid=0 | w=15
  5407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have no abnormalities of hair, teeth, or bone
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have no abnormalities of hair, teeth, or bone | rel=r_associated | relid=0 | w=15
  5408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have normal aldosterone/renin ratios and 24-hour urine aldosterone levels
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have normal aldosterone/renin ratios and 24-hour urine aldosterone levels | rel=r_associated | relid=0 | w=15
  5409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have normal levels of vitamin a, beta-carotene, and zinc
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have normal levels of vitamin a, beta-carotene, and zinc | rel=r_associated | relid=0 | w=15
  5410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have normal pituitary function
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have normal pituitary function | rel=r_associated | relid=0 | w=15
  5411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients have severe anemia requiring regular transfusions for normal activity
    n1=Hyde (prurigo nodulaire de) | n2=en:patients have severe anemia requiring regular transfusions for normal activity | rel=r_associated | relid=0 | w=15
  5412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients in whom echocardiography has been performed have a normal heart, heart valves, and aortic root
    n1=Hyde (prurigo nodulaire de) | n2=en:patients in whom echocardiography has been performed have a normal heart, heart valves, and aortic root | rel=r_associated | relid=0 | w=15
  5413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients look as if they have protein deficiency or malnutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:patients look as if they have protein deficiency or malnutrition | rel=r_associated | relid=0 | w=15
  5414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may be asymptomatic, but are at risk for metabolic decompensation
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may be asymptomatic, but are at risk for metabolic decompensation | rel=r_associated | relid=0 | w=15
  5415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may become totally dependent for all activities of daily living
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may become totally dependent for all activities of daily living | rel=r_associated | relid=0 | w=15
  5416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may become ventilator-dependent
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may become ventilator-dependent | rel=r_associated | relid=0 | w=15
  5417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may become wheelchair-bound | rel=r_associated | relid=0 | w=15
  5418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may become wheelchair-bound after about 12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may become wheelchair-bound after about 12 years | rel=r_associated | relid=0 | w=15
  5419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may become wheelchair-bound as adults
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may become wheelchair-bound as adults | rel=r_associated | relid=0 | w=15
  5420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may have a combination phenotype of pmc and hypp (see 603967.0005)
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may have a combination phenotype of pmc and hypp (see 603967.0005) | rel=r_associated | relid=0 | w=15
  5421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may have benign course until late adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may have benign course until late adulthood | rel=r_associated | relid=0 | w=15
  5422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may have head and neck paragangliomas only, adrenal or extraadrenal pheochromocytomas only, or both
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may have head and neck paragangliomas only, adrenal or extraadrenal pheochromocytomas only, or both | rel=r_associated | relid=0 | w=15
  5423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may have recurrent infections due to immunosuppressive therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may have recurrent infections due to immunosuppressive therapy | rel=r_associated | relid=0 | w=15
  5424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may have seizures only, dyskinesia only, or both
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may have seizures only, dyskinesia only, or both | rel=r_associated | relid=0 | w=15
  5425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may or may not have dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may or may not have dysmorphic features | rel=r_associated | relid=0 | w=15
  5426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may present with autoimmune features or primary immunodeficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may present with autoimmune features or primary immunodeficiency | rel=r_associated | relid=0 | w=15
  5427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may present with either renal or neurologic symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may present with either renal or neurologic symptoms | rel=r_associated | relid=0 | w=15
  5428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may present with recurrent illnesses or infections, or shock
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may present with recurrent illnesses or infections, or shock | rel=r_associated | relid=0 | w=15
  5429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may require implantable cardioverter defibrillators
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may require implantable cardioverter defibrillators | rel=r_associated | relid=0 | w=15
  5430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may show both optic neuropathy and dystonia or only 1 disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may show both optic neuropathy and dystonia or only 1 disorder | rel=r_associated | relid=0 | w=15
  5431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients may show normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:patients may show normal development | rel=r_associated | relid=0 | w=15
  5432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients need lifelong total parenteral nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:patients need lifelong total parenteral nutrition | rel=r_associated | relid=0 | w=15
  5433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients need support with walking or are wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:patients need support with walking or are wheelchair-bound | rel=r_associated | relid=0 | w=15
  5434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients of brazilian origin have a pure cerebellar atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:patients of brazilian origin have a pure cerebellar atrophy | rel=r_associated | relid=0 | w=15
  5435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients of mexican or amerindian origin have a complicated phenotype with additional neurologic features
    n1=Hyde (prurigo nodulaire de) | n2=en:patients of mexican or amerindian origin have a complicated phenotype with additional neurologic features | rel=r_associated | relid=0 | w=15
  5436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often become wheelchair-bound | rel=r_associated | relid=0 | w=15
  5437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often become wheelchair-bound 3 to 4 decades after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often become wheelchair-bound 3 to 4 decades after onset | rel=r_associated | relid=0 | w=15
  5438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often have a more severe and complicated phenotype in addition to peo
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often have a more severe and complicated phenotype in addition to peo | rel=r_associated | relid=0 | w=15
  5439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often have other clinical symptoms resulting from dysfunction of the autonomic nervous system
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often have other clinical symptoms resulting from dysfunction of the autonomic nervous system | rel=r_associated | relid=0 | w=15
  5440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often nonambulatory by the mid-twenties
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often nonambulatory by the mid-twenties | rel=r_associated | relid=0 | w=15
  5441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients often require implantation of a pacemaker
    n1=Hyde (prurigo nodulaire de) | n2=en:patients often require implantation of a pacemaker | rel=r_associated | relid=0 | w=15
  5442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients older than 60 years have severe degenerative arthritis in the feet
    n1=Hyde (prurigo nodulaire de) | n2=en:patients older than 60 years have severe degenerative arthritis in the feet | rel=r_associated | relid=0 | w=15
  5443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients present at birth with respiratory distress or poor head control
    n1=Hyde (prurigo nodulaire de) | n2=en:patients present at birth with respiratory distress or poor head control | rel=r_associated | relid=0 | w=15
  5444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients remain ambulatory
    n1=Hyde (prurigo nodulaire de) | n2=en:patients remain ambulatory | rel=r_associated | relid=0 | w=15
  5445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients require achilles tendon lengthening in first or second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:patients require achilles tendon lengthening in first or second decade of life | rel=r_associated | relid=0 | w=15
  5446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients retain ambulation even after long disease course
    n1=Hyde (prurigo nodulaire de) | n2=en:patients retain ambulation even after long disease course | rel=r_associated | relid=0 | w=15
  5447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients show sorbitol and glycerol intolerance
    n1=Hyde (prurigo nodulaire de) | n2=en:patients show sorbitol and glycerol intolerance | rel=r_associated | relid=0 | w=15
  5448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients usually require total thyroidectomy
    n1=Hyde (prurigo nodulaire de) | n2=en:patients usually require total thyroidectomy | rel=r_associated | relid=0 | w=15
  5449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients walk on tips of toes with dorsal foot deviated laterally
    n1=Hyde (prurigo nodulaire de) | n2=en:patients walk on tips of toes with dorsal foot deviated laterally | rel=r_associated | relid=0 | w=15
  5450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients who acquire ability to walk may lose it
    n1=Hyde (prurigo nodulaire de) | n2=en:patients who acquire ability to walk may lose it | rel=r_associated | relid=0 | w=15
  5451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with a more severe phenotype have been reported with mutations in more than 1 lqts-related gene
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with a more severe phenotype have been reported with mutations in more than 1 lqts-related gene | rel=r_associated | relid=0 | w=15
  5452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with abcb4 mutations benefit from ursodeoxycholic acid (udca) treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with abcb4 mutations benefit from ursodeoxycholic acid (udca) treatment | rel=r_associated | relid=0 | w=15
  5453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with adult onset present with psychiatric features
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with adult onset present with psychiatric features | rel=r_associated | relid=0 | w=15
  5454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with atypical form have milder disease, with onset in the first months of life and increased survival
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with atypical form have milder disease, with onset in the first months of life and increased survival | rel=r_associated | relid=0 | w=15
  5455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with autosomal dominant inheritance and a single gdap1 mutation have a less severe course with later onset
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with autosomal dominant inheritance and a single gdap1 mutation have a less severe course with later onset | rel=r_associated | relid=0 | w=15
  5456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with contiguous gene deletion of 8q24 have more severe features
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with contiguous gene deletion of 8q24 have more severe features | rel=r_associated | relid=0 | w=15
  5457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with glaucoma have nonsense or truncating sbf2 mutations (607697.0002)
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with glaucoma have nonsense or truncating sbf2 mutations (607697.0002) | rel=r_associated | relid=0 | w=15
  5458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with hemophilia b(m) variants (see, e.g., 300746.0030) also have prolonged pt
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with hemophilia b(m) variants (see, e.g., 300746.0030) also have prolonged pt | rel=r_associated | relid=0 | w=15
  5459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with homozygous mutations display mild palmoplantar keratoderma and woolly hair in addition to arvd
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with homozygous mutations display mild palmoplantar keratoderma and woolly hair in addition to arvd | rel=r_associated | relid=0 | w=15
  5460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with homozygous mutations have a more severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with homozygous mutations have a more severe disorder | rel=r_associated | relid=0 | w=15
  5461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with homozygous or compound heterozygous mutations have more severe renal glucose wasting than those with heterozygous mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with homozygous or compound heterozygous mutations have more severe renal glucose wasting than those with heterozygous mutations | rel=r_associated | relid=0 | w=15
  5462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with later onset do not have dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with later onset do not have dysmorphic features | rel=r_associated | relid=0 | w=15
  5463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with later onset have better prognosis
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with later onset have better prognosis | rel=r_associated | relid=0 | w=15
  5464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with longer disease duration show motor neuron involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with longer disease duration show motor neuron involvement | rel=r_associated | relid=0 | w=15
  5465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with meb have less severe features and longer survival
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with meb have less severe features and longer survival | rel=r_associated | relid=0 | w=15
  5466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with meb may acquire ability to walk and a few words
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with meb may acquire ability to walk and a few words | rel=r_associated | relid=0 | w=15
  5467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with medication-resistant hypertension require bilateral adrenalectomy
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with medication-resistant hypertension require bilateral adrenalectomy | rel=r_associated | relid=0 | w=15
  5468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with more severe phenotype have been reported with mutations in more than 1 lqt-related gene
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with more severe phenotype have been reported with mutations in more than 1 lqt-related gene | rel=r_associated | relid=0 | w=15
  5469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with more severe phenotype have been reported with mutations in more than 1 lqts-related gene
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with more severe phenotype have been reported with mutations in more than 1 lqts-related gene | rel=r_associated | relid=0 | w=15
  5470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with mutation in the nhlrc1 gene have slightly longer survival
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with mutation in the nhlrc1 gene have slightly longer survival | rel=r_associated | relid=0 | w=15
  5471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with mutations in the chrne gene have a milder phenotype because fetal chrng (100730) exhibits phenotypic rescue
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with mutations in the chrne gene have a milder phenotype because fetal chrng (100730) exhibits phenotypic rescue | rel=r_associated | relid=0 | w=15
  5472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with neurologic manifestations and sox10 mutations have the neurologic variant (pcwh, 609136)
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with neurologic manifestations and sox10 mutations have the neurologic variant (pcwh, 609136) | rel=r_associated | relid=0 | w=15
  5473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with null mutations have neonatal onset within 72 hours of birth
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with null mutations have neonatal onset within 72 hours of birth | rel=r_associated | relid=0 | w=15
  5474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with null mutations in (ctsd) show a more severe phenotype with onset at birth ('congenital ncl') and early death within days
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with null mutations in (ctsd) show a more severe phenotype with onset at birth ('congenital ncl') and early death within days | rel=r_associated | relid=0 | w=15
  5475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with residual enzyme activity have childhood or adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with residual enzyme activity have childhood or adult onset | rel=r_associated | relid=0 | w=15
  5476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with t2 deficiency and urinary abnormalities may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with t2 deficiency and urinary abnormalities may be asymptomatic | rel=r_associated | relid=0 | w=15
  5477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with the autosomal recessive disorder have a more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with the autosomal recessive disorder have a more severe phenotype | rel=r_associated | relid=0 | w=15
  5478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with total c4 deficiency are homozygous for double null c4 haplotype
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with total c4 deficiency are homozygous for double null c4 haplotype | rel=r_associated | relid=0 | w=15
  5479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients with variant cjd are homozygous for met129 polymorphism (176640.0005)
    n1=Hyde (prurigo nodulaire de) | n2=en:patients with variant cjd are homozygous for met129 polymorphism (176640.0005) | rel=r_associated | relid=0 | w=15
  5480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:patients younger than 30 years complain only that they cannot run fast
    n1=Hyde (prurigo nodulaire de) | n2=en:patients younger than 30 years complain only that they cannot run fast | rel=r_associated | relid=0 | w=15
  5481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pavm more frequent in hht1 than hht2
    n1=Hyde (prurigo nodulaire de) | n2=en:pavm more frequent in hht1 than hht2 | rel=r_associated | relid=0 | w=15
  5482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pavms occur more frequently in hereditary hemorrhagic telangiectasia 1 (hht1) than hht2
    n1=Hyde (prurigo nodulaire de) | n2=en:pavms occur more frequently in hereditary hemorrhagic telangiectasia 1 (hht1) than hht2 | rel=r_associated | relid=0 | w=15
  5483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pcd is a distinct disorder from premature chromatid separation (pcs, 176430), which occurs in all chromosomes
    n1=Hyde (prurigo nodulaire de) | n2=en:pcd is a distinct disorder from premature chromatid separation (pcs, 176430), which occurs in all chromosomes | rel=r_associated | relid=0 | w=15
  5484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pcs is a distinct disorder from premature centromere division (pcd, 212790), which affects only the x chromosome
    n1=Hyde (prurigo nodulaire de) | n2=en:pcs is a distinct disorder from premature centromere division (pcd, 212790), which affects only the x chromosome | rel=r_associated | relid=0 | w=15
  5485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peak age of onset in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:peak age of onset in second decade | rel=r_associated | relid=0 | w=15
  5486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peak age of onset in second decade (range childhood to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:peak age of onset in second decade (range childhood to 50 years) | rel=r_associated | relid=0 | w=15
  5487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peak age of onset in second decade (range childhood to 76 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:peak age of onset in second decade (range childhood to 76 years) | rel=r_associated | relid=0 | w=15
  5488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pectin
    n1=Hyde (prurigo nodulaire de) | n2=en:pectin | rel=r_associated | relid=0 | w=15
  5489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pectus carinatum present in obligate carrier mothers
    n1=Hyde (prurigo nodulaire de) | n2=en:pectus carinatum present in obligate carrier mothers | rel=r_associated | relid=0 | w=15
  5490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pediatric adverse events terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=15
  5491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pediatric terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=15
  5492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pedigrees compatible with autosomal dominant inheritance have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:pedigrees compatible with autosomal dominant inheritance have been reported | rel=r_associated | relid=0 | w=15
  5493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pedigrees consistent with autosomal dominant and autosomal recessive inheritance have been described
    n1=Hyde (prurigo nodulaire de) | n2=en:pedigrees consistent with autosomal dominant and autosomal recessive inheritance have been described | rel=r_associated | relid=0 | w=15
  5494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pelizaeus-merzbacher disease (pmd, 312080) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:pelizaeus-merzbacher disease (pmd, 312080) is an allelic disorder | rel=r_associated | relid=0 | w=15
  5495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pelvic floor disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:pelvic floor disorders | rel=r_associated | relid=0 | w=15
  5496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:penetrance 86% by 50 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:penetrance 86% by 50 years of age | rel=r_associated | relid=0 | w=15
  5497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:penetrance by age 50 is 93% in female mutation carriers and 68% in male mutation carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:penetrance by age 50 is 93% in female mutation carriers and 68% in male mutation carriers | rel=r_associated | relid=0 | w=15
  5498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:penetrance is usually complete by age 65 years
    n1=Hyde (prurigo nodulaire de) | n2=en:penetrance is usually complete by age 65 years | rel=r_associated | relid=0 | w=15
  5499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:penetrance of 70 to 80% over a lifetime in heterozygous mutation carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:penetrance of 70 to 80% over a lifetime in heterozygous mutation carriers | rel=r_associated | relid=0 | w=15
  5500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:penetrance of disease is complete between 30 and 40 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:penetrance of disease is complete between 30 and 40 years of age | rel=r_associated | relid=0 | w=15
  5501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pentoxyverine
    n1=Hyde (prurigo nodulaire de) | n2=en:pentoxyverine | rel=r_associated | relid=0 | w=15
  5502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peo is not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:peo is not always present | rel=r_associated | relid=0 | w=15
  5503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peptide
    n1=Hyde (prurigo nodulaire de) | n2=en:peptide | rel=r_associated | relid=0 | w=15
  5504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peptides hydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:peptides hydrolases | rel=r_associated | relid=0 | w=15
  5505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:percentages based on review of 51 published cases (pmid 24891339)
    n1=Hyde (prurigo nodulaire de) | n2=en:percentages based on review of 51 published cases (pmid 24891339) | rel=r_associated | relid=0 | w=15
  5506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:performing laboratory medical director:id:pt:facility:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:performing laboratory medical director:id:pt:facility:nom | rel=r_associated | relid=0 | w=15
  5507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:performing laboratory name:identifier:point in time:facility:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:performing laboratory name:identifier:point in time:facility:nominal | rel=r_associated | relid=0 | w=15
  5508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:performing laboratory phone:tele:pt:facility:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:performing laboratory phone:tele:pt:facility:nom | rel=r_associated | relid=0 | w=15
  5509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:performing laboratory:addr:pt:facility:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:performing laboratory:addr:pt:facility:nom | rel=r_associated | relid=0 | w=15
  5510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peri-implantational loss
    n1=Hyde (prurigo nodulaire de) | n2=en:peri-implantational loss | rel=r_associated | relid=0 | w=15
  5511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:perinatal lethal
    n1=Hyde (prurigo nodulaire de) | n2=en:perinatal lethal | rel=r_associated | relid=0 | w=15
  5512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:perinatal lethality
    n1=Hyde (prurigo nodulaire de) | n2=en:perinatal lethality | rel=r_associated | relid=0 | w=15
  5513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:perinatal mortality
    n1=Hyde (prurigo nodulaire de) | n2=en:perinatal mortality | rel=r_associated | relid=0 | w=15
  5514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:perinatal terminology
    n1=Hyde (prurigo nodulaire de) | n2=en:perinatal terminology | rel=r_associated | relid=0 | w=15
  5515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:periodic paralysis triggered by exercise, rest following exercise, prolonged periods of rest, and stress
    n1=Hyde (prurigo nodulaire de) | n2=en:periodic paralysis triggered by exercise, rest following exercise, prolonged periods of rest, and stress | rel=r_associated | relid=0 | w=15
  5516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:periodontium is less severely affected than in papillon-lefevre syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:periodontium is less severely affected than in papillon-lefevre syndrome | rel=r_associated | relid=0 | w=15
  5517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peripheral doublet microtubule of axoneme of cilium
    n1=Hyde (prurigo nodulaire de) | n2=en:peripheral doublet microtubule of axoneme of cilium | rel=r_associated | relid=0 | w=15
  5518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:peripheral neuropathy occurs in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:peripheral neuropathy occurs in adulthood | rel=r_associated | relid=0 | w=15
  5519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:periventricular heterotopia (300049) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:periventricular heterotopia (300049) is an allelic disorder | rel=r_associated | relid=0 | w=15
  5520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:perlman syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:perlman syndrome | rel=r_associated | relid=0 | w=15
  5521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:persistence of febrile seizures beyond age 6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:persistence of febrile seizures beyond age 6 years | rel=r_associated | relid=0 | w=15
  5522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:persistent bleeding after injury or surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:persistent bleeding after injury or surgery | rel=r_associated | relid=0 | w=15
  5523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:persistent bleeding after trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:persistent bleeding after trauma | rel=r_associated | relid=0 | w=15
  5524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:persistent exposure to fructose leads to chronic liver and kidney complications
    n1=Hyde (prurigo nodulaire de) | n2=en:persistent exposure to fructose leads to chronic liver and kidney complications | rel=r_associated | relid=0 | w=15
  5525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:petalosa
    n1=Hyde (prurigo nodulaire de) | n2=en:petalosa | rel=r_associated | relid=0 | w=15
  5526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phace is an acronym for posterior fossa brain malformation, large facial hemangiomas, arterial anomalies, cardiac anomalies and aortic coarctation, and eye abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:phace is an acronym for posterior fossa brain malformation, large facial hemangiomas, arterial anomalies, cardiac anomalies and aortic coarctation, and eye abnormalities | rel=r_associated | relid=0 | w=15
  5527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pharmacotherapeutic
    n1=Hyde (prurigo nodulaire de) | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=15
  5528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype combines features of hirschsprung disease (142623), charcot-marie-tooth disease type 1 (cmt1b, 118200), waardenburg-shah syndrome (277580), and central dysmyelinating leukodystrophy (312080)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype combines features of hirschsprung disease (142623), charcot-marie-tooth disease type 1 (cmt1b, 118200), waardenburg-shah syndrome (277580), and central dysmyelinating leukodystrophy (312080) | rel=r_associated | relid=0 | w=15
  5529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype is classically defined as aplasia cutis and transverse limb defects
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype is classically defined as aplasia cutis and transverse limb defects | rel=r_associated | relid=0 | w=15
  5530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype is indistinguishable from congenital cytomegalovirus (cmv) infection
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype is indistinguishable from congenital cytomegalovirus (cmv) infection | rel=r_associated | relid=0 | w=15
  5531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype is worsened by cold temperature
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype is worsened by cold temperature | rel=r_associated | relid=0 | w=15
  5532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype may be exacerbated by maltreatment in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype may be exacerbated by maltreatment in childhood | rel=r_associated | relid=0 | w=15
  5533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype may be influenced by maternal alcohol consumption during pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype may be influenced by maternal alcohol consumption during pregnancy | rel=r_associated | relid=0 | w=15
  5534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype may be oligogenic in some patients who carry mutations in more than one hh-associated gene
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype may be oligogenic in some patients who carry mutations in more than one hh-associated gene | rel=r_associated | relid=0 | w=15
  5535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype may or may not be consistent within a family.
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype may or may not be consistent within a family. | rel=r_associated | relid=0 | w=15
  5536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotype range from typical parkinson disease (168600) to dementia with lewy bodies (127750)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotype range from typical parkinson disease (168600) to dementia with lewy bodies (127750) | rel=r_associated | relid=0 | w=15
  5537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic heterogeneity
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic heterogeneity | rel=r_associated | relid=0 | w=15
  5538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap between neurofibromatosis type 1 (162200) and noonan syndrome (163950)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap between neurofibromatosis type 1 (162200) and noonan syndrome (163950) | rel=r_associated | relid=0 | w=15
  5539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with albright hereditary osteodystrophy (aho, 103580) and smith-magenis syndrome (sms, 182290)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with albright hereditary osteodystrophy (aho, 103580) and smith-magenis syndrome (sms, 182290) | rel=r_associated | relid=0 | w=15
  5540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with charcot-marie-tooth disease 2b (cmt2b, 600882)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with charcot-marie-tooth disease 2b (cmt2b, 600882) | rel=r_associated | relid=0 | w=15
  5541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with currarino syndrome (176450)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with currarino syndrome (176450) | rel=r_associated | relid=0 | w=15
  5542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with cytochrome c oxidase deficiency (220110)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with cytochrome c oxidase deficiency (220110) | rel=r_associated | relid=0 | w=15
  5543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with denys-drash syndrome (194080).
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with denys-drash syndrome (194080). | rel=r_associated | relid=0 | w=15
  5544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with desbuquois dysplasia (251450)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with desbuquois dysplasia (251450) | rel=r_associated | relid=0 | w=15
  5545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with fhm1 (141500) and sca6 (183086)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with fhm1 (141500) and sca6 (183086) | rel=r_associated | relid=0 | w=15
  5546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with frontotemporal dementia (600274)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with frontotemporal dementia (600274) | rel=r_associated | relid=0 | w=15
  5547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with hereditary sensory and autonomic neuropathy type i (hsan1, 162400)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with hereditary sensory and autonomic neuropathy type i (hsan1, 162400) | rel=r_associated | relid=0 | w=15
  5548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with munke syndrome (602849) due to a mutation in the fgfr3 gene (p250r, 134934.0014)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with munke syndrome (602849) due to a mutation in the fgfr3 gene (p250r, 134934.0014) | rel=r_associated | relid=0 | w=15
  5549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with neurofibromatosis 1 (nf1, 162200)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with neurofibromatosis 1 (nf1, 162200) | rel=r_associated | relid=0 | w=15
  5550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with noonan syndrome 3 (609942) or cardiofaciocutaneous syndrome (115150)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with noonan syndrome 3 (609942) or cardiofaciocutaneous syndrome (115150) | rel=r_associated | relid=0 | w=15
  5551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with parkinson disease
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with parkinson disease | rel=r_associated | relid=0 | w=15
  5552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with pkan neuroaxonal dystrophy (nbia1, 234200)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with pkan neuroaxonal dystrophy (nbia1, 234200) | rel=r_associated | relid=0 | w=15
  5553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with revesz syndrome (268130)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with revesz syndrome (268130) | rel=r_associated | relid=0 | w=15
  5554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with thrombotic thrombocytopenic purpura (ttp, 274150)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with thrombotic thrombocytopenic purpura (ttp, 274150) | rel=r_associated | relid=0 | w=15
  5555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with wagr syndrome (194072), frasier syndrome (136680)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with wagr syndrome (194072), frasier syndrome (136680) | rel=r_associated | relid=0 | w=15
  5556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic overlap with xeroderma pigmentosum (see, e.g., 278700)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic overlap with xeroderma pigmentosum (see, e.g., 278700) | rel=r_associated | relid=0 | w=15
  5557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic similarities to angelman syndrome (105830)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic similarities to angelman syndrome (105830) | rel=r_associated | relid=0 | w=15
  5558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic similarities to costello syndrome (218040)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic similarities to costello syndrome (218040) | rel=r_associated | relid=0 | w=15
  5559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic similarities to leigh syndrome (256000)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic similarities to leigh syndrome (256000) | rel=r_associated | relid=0 | w=15
  5560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic similarities to noonan syndrome (163950)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic similarities to noonan syndrome (163950) | rel=r_associated | relid=0 | w=15
  5561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variability
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variability | rel=r_associated | relid=0 | w=15
  5562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variability within families and among patients carrying the same mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variability within families and among patients carrying the same mutation | rel=r_associated | relid=0 | w=15
  5563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variability within families and among patients carrying the same mutation appears to be due to the oligogenic nature of the disorder, with some patients having mutations in more than 1 neuroendocrine-related gene
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variability within families and among patients carrying the same mutation appears to be due to the oligogenic nature of the disorder, with some patients having mutations in more than 1 neuroendocrine-related gene | rel=r_associated | relid=0 | w=15
  5564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variability, intrafamilial
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variability, intrafamilial | rel=r_associated | relid=0 | w=15
  5565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variation
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variation | rel=r_associated | relid=0 | w=15
  5566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variation (may affect language expression, reception, and/or articulation)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variation (may affect language expression, reception, and/or articulation) | rel=r_associated | relid=0 | w=15
  5567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypic variation in severity and symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypic variation in severity and symptoms | rel=r_associated | relid=0 | w=15
  5568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypically indistinguishable from hemophilia a (306700)
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypically indistinguishable from hemophilia a (306700) | rel=r_associated | relid=0 | w=15
  5569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenotypically mild form of joubert syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:phenotypically mild form of joubert syndrome | rel=r_associated | relid=0 | w=15
  5570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenylephrine + chlorpheniramine + codeine + potassium iodide
    n1=Hyde (prurigo nodulaire de) | n2=en:phenylephrine + chlorpheniramine + codeine + potassium iodide | rel=r_associated | relid=0 | w=15
  5571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane
    n1=Hyde (prurigo nodulaire de) | n2=en:phenylephrine + chlorpheniramine + ephedrine + carbetapentane | rel=r_associated | relid=0 | w=15
  5572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenylephrine + promethazine + codeine
    n1=Hyde (prurigo nodulaire de) | n2=en:phenylephrine + promethazine + codeine | rel=r_associated | relid=0 | w=15
  5573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phenylketonuria, maternal
    n1=Hyde (prurigo nodulaire de) | n2=en:phenylketonuria, maternal | rel=r_associated | relid=0 | w=15
  5574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phospholipid
    n1=Hyde (prurigo nodulaire de) | n2=en:phospholipid | rel=r_associated | relid=0 | w=15
  5575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:phospholipid-transporting atpase ib
    n1=Hyde (prurigo nodulaire de) | n2=en:phospholipid-transporting atpase ib | rel=r_associated | relid=0 | w=15
  5576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:photosynthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:photosynthesis | rel=r_associated | relid=0 | w=15
  5577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:physical features are apparent at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:physical features are apparent at birth | rel=r_associated | relid=0 | w=15
  5578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:physiologic decreased plasma cholinesterase activity in pregnancy, the puerperium, and newborns
    n1=Hyde (prurigo nodulaire de) | n2=en:physiologic decreased plasma cholinesterase activity in pregnancy, the puerperium, and newborns | rel=r_associated | relid=0 | w=15
  5579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:physiological aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:physiological aspects | rel=r_associated | relid=0 | w=15
  5580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:physiopathological
    n1=Hyde (prurigo nodulaire de) | n2=en:physiopathological | rel=r_associated | relid=0 | w=15
  5581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pigment cell
    n1=Hyde (prurigo nodulaire de) | n2=en:pigment cell | rel=r_associated | relid=0 | w=15
  5582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pigment does not develop with age
    n1=Hyde (prurigo nodulaire de) | n2=en:pigment does not develop with age | rel=r_associated | relid=0 | w=15
  5583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pigmentary abnormalities apparent at birth or in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:pigmentary abnormalities apparent at birth or in infancy | rel=r_associated | relid=0 | w=15
  5584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pigmented spots appear in infancy through childhood and fade in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:pigmented spots appear in infancy through childhood and fade in adulthood | rel=r_associated | relid=0 | w=15
  5585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:placenta disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:placenta disorder | rel=r_associated | relid=0 | w=15
  5586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:placenta previa
    n1=Hyde (prurigo nodulaire de) | n2=en:placenta previa | rel=r_associated | relid=0 | w=15
  5587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:placental abruption
    n1=Hyde (prurigo nodulaire de) | n2=en:placental abruption | rel=r_associated | relid=0 | w=15
  5588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:plantar contractures become apparent with onset of ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:plantar contractures become apparent with onset of ambulation | rel=r_associated | relid=0 | w=15
  5589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:plasma cholinesterase measurement
    n1=Hyde (prurigo nodulaire de) | n2=en:plasma cholinesterase measurement | rel=r_associated | relid=0 | w=15
  5590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:plasma membrane calcium-transporting atpase 3
    n1=Hyde (prurigo nodulaire de) | n2=en:plasma membrane calcium-transporting atpase 3 | rel=r_associated | relid=0 | w=15
  5591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pneumocytosis carinii infection (12 to 42%)
    n1=Hyde (prurigo nodulaire de) | n2=en:pneumocytosis carinii infection (12 to 42%) | rel=r_associated | relid=0 | w=15
  5592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poland syndrome can be associated with moebius syndrome (157900)
    n1=Hyde (prurigo nodulaire de) | n2=en:poland syndrome can be associated with moebius syndrome (157900) | rel=r_associated | relid=0 | w=15
  5593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polg mutations account for approximately 45% of all peo cases
    n1=Hyde (prurigo nodulaire de) | n2=en:polg mutations account for approximately 45% of all peo cases | rel=r_associated | relid=0 | w=15
  5594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnion
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnion | rel=r_associated | relid=0 | w=15
  5595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios | rel=r_associated | relid=0 | w=15
  5596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios (congenital form)
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios (congenital form) | rel=r_associated | relid=0 | w=15
  5597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios (in perinatal or congenital neuromuscular forms)
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios (in perinatal or congenital neuromuscular forms) | rel=r_associated | relid=0 | w=15
  5598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios (in some patients) | rel=r_associated | relid=0 | w=15
  5599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios (rare)
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios (rare) | rel=r_associated | relid=0 | w=15
  5600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios (severe form)
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios (severe form) | rel=r_associated | relid=0 | w=15
  5601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios with delivery
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios with delivery | rel=r_associated | relid=0 | w=15
  5602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, antepartum complication
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, antepartum complication | rel=r_associated | relid=0 | w=15
  5603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, antepartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, antepartum condition or complication | rel=r_associated | relid=0 | w=15
  5604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, chronic idiopathic
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, chronic idiopathic | rel=r_associated | relid=0 | w=15
  5605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, delivered, with or without mention of antepartum condition
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
  5606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, first trimester
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, first trimester | rel=r_associated | relid=0 | w=15
  5607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, megalencephaly, and symptomatic epilepsy
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, megalencephaly, and symptomatic epilepsy | rel=r_associated | relid=0 | w=15
  5608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, second trimester
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, second trimester | rel=r_associated | relid=0 | w=15
  5609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, third trimester
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, third trimester | rel=r_associated | relid=0 | w=15
  5610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, unspecified as to episode of care
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, unspecified as to episode of care | rel=r_associated | relid=0 | w=15
  5611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydramnios, unspecified trimester
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydramnios, unspecified trimester | rel=r_associated | relid=0 | w=15
  5612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyhydroxy compound
    n1=Hyde (prurigo nodulaire de) | n2=en:polyhydroxy compound | rel=r_associated | relid=0 | w=15
  5613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polymer
    n1=Hyde (prurigo nodulaire de) | n2=en:polymer | rel=r_associated | relid=0 | w=15
  5614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyoxyethylene-24-cholesteryl ether
    n1=Hyde (prurigo nodulaire de) | n2=en:polyoxyethylene-24-cholesteryl ether | rel=r_associated | relid=0 | w=15
  5615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polyps occur in teens
    n1=Hyde (prurigo nodulaire de) | n2=en:polyps occur in teens | rel=r_associated | relid=0 | w=15
  5616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polysaccharide
    n1=Hyde (prurigo nodulaire de) | n2=en:polysaccharide | rel=r_associated | relid=0 | w=15
  5617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:polysaccharides, bacterial
    n1=Hyde (prurigo nodulaire de) | n2=en:polysaccharides, bacterial | rel=r_associated | relid=0 | w=15
  5618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pontocerebellar hypoplasia type 4 (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:pontocerebellar hypoplasia type 4 (disorder) | rel=r_associated | relid=0 | w=15
  5619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor gonadotropin response to gonadotropin releasing hormone (gnrh)
    n1=Hyde (prurigo nodulaire de) | n2=en:poor gonadotropin response to gonadotropin releasing hormone (gnrh) | rel=r_associated | relid=0 | w=15
  5620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor or no response to glucocorticoid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:poor or no response to glucocorticoid treatment | rel=r_associated | relid=0 | w=15
  5621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor outcome
    n1=Hyde (prurigo nodulaire de) | n2=en:poor outcome | rel=r_associated | relid=0 | w=15
  5622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to acetylcholinesterase inhibitors
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to acetylcholinesterase inhibitors | rel=r_associated | relid=0 | w=15
  5623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to acetylcholinesterase inhibitors or cholinergic agents
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to acetylcholinesterase inhibitors or cholinergic agents | rel=r_associated | relid=0 | w=15
  5624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to g-csf treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to g-csf treatment | rel=r_associated | relid=0 | w=15
  5625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to l-dopa
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to l-dopa | rel=r_associated | relid=0 | w=15
  5626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to levodopa treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to levodopa treatment | rel=r_associated | relid=0 | w=15
  5627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:poor response to the c5 inhibitor eculizumab
    n1=Hyde (prurigo nodulaire de) | n2=en:poor response to the c5 inhibitor eculizumab | rel=r_associated | relid=0 | w=15
  5628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:positive family history in 12-33% patients
    n1=Hyde (prurigo nodulaire de) | n2=en:positive family history in 12-33% patients | rel=r_associated | relid=0 | w=15
  5629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible autosomal dominant (165199) and autosomal recessive (258650) forms
    n1=Hyde (prurigo nodulaire de) | n2=en:possible autosomal dominant (165199) and autosomal recessive (258650) forms | rel=r_associated | relid=0 | w=15
  5630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible autosomal dominant form 165199 and x-linked form, cmtx5 311070
    n1=Hyde (prurigo nodulaire de) | n2=en:possible autosomal dominant form 165199 and x-linked form, cmtx5 311070 | rel=r_associated | relid=0 | w=15
  5631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible autosomal recessive form 258650 and x-linked form cmtx5 311070
    n1=Hyde (prurigo nodulaire de) | n2=en:possible autosomal recessive form 258650 and x-linked form cmtx5 311070 | rel=r_associated | relid=0 | w=15
  5632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible defect of a specific lipase in the pathway of free fatty acid oxidation
    n1=Hyde (prurigo nodulaire de) | n2=en:possible defect of a specific lipase in the pathway of free fatty acid oxidation | rel=r_associated | relid=0 | w=15
  5633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible genetic heterogeneity (linkage to xp22 in some families)
    n1=Hyde (prurigo nodulaire de) | n2=en:possible genetic heterogeneity (linkage to xp22 in some families) | rel=r_associated | relid=0 | w=15
  5634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible gonadal mosaicism in one report
    n1=Hyde (prurigo nodulaire de) | n2=en:possible gonadal mosaicism in one report | rel=r_associated | relid=0 | w=15
  5635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible increase of aneuploidy in offspring
    n1=Hyde (prurigo nodulaire de) | n2=en:possible increase of aneuploidy in offspring | rel=r_associated | relid=0 | w=15
  5636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible x-linked dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:possible x-linked dominant inheritance | rel=r_associated | relid=0 | w=15
  5637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible x-linked inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:possible x-linked inheritance | rel=r_associated | relid=0 | w=15
  5638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possible x-linked recessive inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:possible x-linked recessive inheritance | rel=r_associated | relid=0 | w=15
  5639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possibly allelic to cohen syndrome (216550)
    n1=Hyde (prurigo nodulaire de) | n2=en:possibly allelic to cohen syndrome (216550) | rel=r_associated | relid=0 | w=15
  5640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:possibly x-linked recessive inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:possibly x-linked recessive inheritance | rel=r_associated | relid=0 | w=15
  5641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:post term pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:post term pregnancy | rel=r_associated | relid=0 | w=15
  5642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:postlingual onset
    n1=Hyde (prurigo nodulaire de) | n2=en:postlingual onset | rel=r_associated | relid=0 | w=15
  5643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:postpartum hemorrhage
    n1=Hyde (prurigo nodulaire de) | n2=en:postpartum hemorrhage | rel=r_associated | relid=0 | w=15
  5644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:potassium citrate + citric acid
    n1=Hyde (prurigo nodulaire de) | n2=en:potassium citrate + citric acid | rel=r_associated | relid=0 | w=15
  5645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pre-embryonic loss
    n1=Hyde (prurigo nodulaire de) | n2=en:pre-embryonic loss | rel=r_associated | relid=0 | w=15
  5646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by fatigue or alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by fatigue or alcohol | rel=r_associated | relid=0 | w=15
  5647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by febrile illness and fasting
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by febrile illness and fasting | rel=r_associated | relid=0 | w=15
  5648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by fever
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by fever | rel=r_associated | relid=0 | w=15
  5649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by general anesthesia
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by general anesthesia | rel=r_associated | relid=0 | w=15
  5650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by infection, fasting, or intercurrent illness
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by infection, fasting, or intercurrent illness | rel=r_associated | relid=0 | w=15
  5651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by mechanical compression or pressure on nerve
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by mechanical compression or pressure on nerve | rel=r_associated | relid=0 | w=15
  5652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitated by sleep deprivation
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitated by sleep deprivation | rel=r_associated | relid=0 | w=15
  5653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitating factors - ingestion of wheat gluten, rye, and/or barley
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitating factors - ingestion of wheat gluten, rye, and/or barley | rel=r_associated | relid=0 | w=15
  5654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitating factors include viral illness and pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitating factors include viral illness and pregnancy | rel=r_associated | relid=0 | w=15
  5655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:precipitous birth
    n1=Hyde (prurigo nodulaire de) | n2=en:precipitous birth | rel=r_associated | relid=0 | w=15
  5656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:predisposition to neoplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:predisposition to neoplasia | rel=r_associated | relid=0 | w=15
  5657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:predominantly occurs in young males with a high rate of atopic disease
    n1=Hyde (prurigo nodulaire de) | n2=en:predominantly occurs in young males with a high rate of atopic disease | rel=r_associated | relid=0 | w=15
  5658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:predominantly occurs in young males with high rate of atopic disease
    n1=Hyde (prurigo nodulaire de) | n2=en:predominantly occurs in young males with high rate of atopic disease | rel=r_associated | relid=0 | w=15
  5659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:preferably treated with iodine supplementation rather than thyroid hormone replacement
    n1=Hyde (prurigo nodulaire de) | n2=en:preferably treated with iodine supplementation rather than thyroid hormone replacement | rel=r_associated | relid=0 | w=15
  5660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy complication
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy complication | rel=r_associated | relid=0 | w=15
  5661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy complications, cardiovascular
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy complications, cardiovascular | rel=r_associated | relid=0 | w=15
  5662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy complications, hematologic
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy complications, hematologic | rel=r_associated | relid=0 | w=15
  5663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy complications, infectious
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy complications, infectious | rel=r_associated | relid=0 | w=15
  5664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy complications, neoplastic
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy complications, neoplastic | rel=r_associated | relid=0 | w=15
  5665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy disorder | rel=r_associated | relid=0 | w=15
  5666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy in diabetics
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy in diabetics | rel=r_associated | relid=0 | w=15
  5667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy with intrauterine device
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy with intrauterine device | rel=r_associated | relid=0 | w=15
  5668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pregnancy-related nausea and/or vomiting
    n1=Hyde (prurigo nodulaire de) | n2=en:pregnancy-related nausea and/or vomiting | rel=r_associated | relid=0 | w=15
  5669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prelingual onset
    n1=Hyde (prurigo nodulaire de) | n2=en:prelingual onset | rel=r_associated | relid=0 | w=15
  5670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prelingual onset in males
    n1=Hyde (prurigo nodulaire de) | n2=en:prelingual onset in males | rel=r_associated | relid=0 | w=15
  5671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:premature aging syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=15
  5672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:premature death may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:premature death may occur | rel=r_associated | relid=0 | w=15
  5673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:premature labor
    n1=Hyde (prurigo nodulaire de) | n2=en:premature labor | rel=r_associated | relid=0 | w=15
  5674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:premature rupture of membrane
    n1=Hyde (prurigo nodulaire de) | n2=en:premature rupture of membrane | rel=r_associated | relid=0 | w=15
  5675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal diagnosis available
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal diagnosis available | rel=r_associated | relid=0 | w=15
  5676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal diagnosis by ultrasound
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal diagnosis by ultrasound | rel=r_associated | relid=0 | w=15
  5677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal history of maternal diabetes in 35% of cases
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal history of maternal diabetes in 35% of cases | rel=r_associated | relid=0 | w=15
  5678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal injuries
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal injuries | rel=r_associated | relid=0 | w=15
  5679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal nutritional physiological phenomena
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal nutritional physiological phenomena | rel=r_associated | relid=0 | w=15
  5680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal onset
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal onset | rel=r_associated | relid=0 | w=15
  5681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal onset or onset in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal onset or onset in infancy | rel=r_associated | relid=0 | w=15
  5682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal or neonatal onset
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal or neonatal onset | rel=r_associated | relid=0 | w=15
  5683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal or perinatal death
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal or perinatal death | rel=r_associated | relid=0 | w=15
  5684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prenatal or perinatal lethality in hemizygous males
    n1=Hyde (prurigo nodulaire de) | n2=en:prenatal or perinatal lethality in hemizygous males | rel=r_associated | relid=0 | w=15
  5685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:preponderance of affected females (80%) to males
    n1=Hyde (prurigo nodulaire de) | n2=en:preponderance of affected females (80%) to males | rel=r_associated | relid=0 | w=15
  5686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:preribosome
    n1=Hyde (prurigo nodulaire de) | n2=en:preribosome | rel=r_associated | relid=0 | w=15
  5687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presence of 4 major features or 3 major and 2 minor features establishes the diagnosis
    n1=Hyde (prurigo nodulaire de) | n2=en:presence of 4 major features or 3 major and 2 minor features establishes the diagnosis | rel=r_associated | relid=0 | w=15
  5688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presence of additional features is variable
    n1=Hyde (prurigo nodulaire de) | n2=en:presence of additional features is variable | rel=r_associated | relid=0 | w=15
  5689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death
    n1=Hyde (prurigo nodulaire de) | n2=en:presence of severe midfacial and limb defects and birth length less than 37cm associated with stillborn or early infant death | rel=r_associated | relid=0 | w=15
  5690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:present at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:present at birth | rel=r_associated | relid=0 | w=15
  5691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:present in infancy in all affected individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:present in infancy in all affected individuals | rel=r_associated | relid=0 | w=15
  5692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:present in jewish yemenite population
    n1=Hyde (prurigo nodulaire de) | n2=en:present in jewish yemenite population | rel=r_associated | relid=0 | w=15
  5693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation after 18 months
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation after 18 months | rel=r_associated | relid=0 | w=15
  5694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation after 6 months
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation after 6 months | rel=r_associated | relid=0 | w=15
  5695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation at 3-6 weeks of age
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation at 3-6 weeks of age | rel=r_associated | relid=0 | w=15
  5696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation between 6-18 months
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation between 6-18 months | rel=r_associated | relid=0 | w=15
  5697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in adults - episodic or nocturnal diarrhea, flatulence, weight loss, iron deficiency anemia, macrocytic anemia, coagulopathy, vitamin d deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in adults - episodic or nocturnal diarrhea, flatulence, weight loss, iron deficiency anemia, macrocytic anemia, coagulopathy, vitamin d deficiency | rel=r_associated | relid=0 | w=15
  5698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in childhood includes waddling gait and knee pain/stiffness
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in childhood includes waddling gait and knee pain/stiffness | rel=r_associated | relid=0 | w=15
  5699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in children - diarrhea, constipation (rarely), short stature, pubertal delay, rickets, iron and folate deficiency with anemia | rel=r_associated | relid=0 | w=15
  5700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in early childhood | rel=r_associated | relid=0 | w=15
  5701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in first year of life | rel=r_associated | relid=0 | w=15
  5702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presentation in infants - impaired growth, diarrhea, abdominal distention, vomiting
    n1=Hyde (prurigo nodulaire de) | n2=en:presentation in infants - impaired growth, diarrhea, abdominal distention, vomiting | rel=r_associated | relid=0 | w=15
  5703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presenting symptoms - recurrent uti, polyuria/polydipsia, hematuria, and abacterial leukocyturia
    n1=Hyde (prurigo nodulaire de) | n2=en:presenting symptoms - recurrent uti, polyuria/polydipsia, hematuria, and abacterial leukocyturia | rel=r_associated | relid=0 | w=15
  5704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presenting symptoms in the upper body
    n1=Hyde (prurigo nodulaire de) | n2=en:presenting symptoms in the upper body | rel=r_associated | relid=0 | w=15
  5705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents as early-onset strokes in 43% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:presents as early-onset strokes in 43% of patients | rel=r_associated | relid=0 | w=15
  5706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents at 2 to 3 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:presents at 2 to 3 months of age | rel=r_associated | relid=0 | w=15
  5707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents at a later age than sporadic wilms tumor
    n1=Hyde (prurigo nodulaire de) | n2=en:presents at a later age than sporadic wilms tumor | rel=r_associated | relid=0 | w=15
  5708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents at a later stage than sporadic wilms tumor
    n1=Hyde (prurigo nodulaire de) | n2=en:presents at a later stage than sporadic wilms tumor | rel=r_associated | relid=0 | w=15
  5709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents at birth or early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:presents at birth or early childhood | rel=r_associated | relid=0 | w=15
  5710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents with 4 types of painful episodes - (1) birth crisis, babies are born red and stiff (2) rectal crisis, triggered by defecation or emotional factors (3) ocular crisis (4) mandibular crisis, triggered by eating or yawning
    n1=Hyde (prurigo nodulaire de) | n2=en:presents with 4 types of painful episodes - (1) birth crisis, babies are born red and stiff (2) rectal crisis, triggered by defecation or emotional factors (3) ocular crisis (4) mandibular crisis, triggered by eating or yawning | rel=r_associated | relid=0 | w=15
  5711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presents with inguinal hernia (prepubertal) or primary amenorrhea (post pubertal)
    n1=Hyde (prurigo nodulaire de) | n2=en:presents with inguinal hernia (prepubertal) or primary amenorrhea (post pubertal) | rel=r_associated | relid=0 | w=15
  5712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:presumed autosomal dominant with incomplete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:presumed autosomal dominant with incomplete penetrance | rel=r_associated | relid=0 | w=15
  5713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:preterm premature rupture of membrane
    n1=Hyde (prurigo nodulaire de) | n2=en:preterm premature rupture of membrane | rel=r_associated | relid=0 | w=15
  5714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence 1 in 1,250
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence 1 in 1,250 | rel=r_associated | relid=0 | w=15
  5715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence 1 in 8000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence 1 in 8000 | rel=r_associated | relid=0 | w=15
  5716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence 1-2% in northern european populations
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence 1-2% in northern european populations | rel=r_associated | relid=0 | w=15
  5717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence 1/10,000-1/15,000 female births
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence 1/10,000-1/15,000 female births | rel=r_associated | relid=0 | w=15
  5718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence approximately 1 in 4,000 males
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence approximately 1 in 4,000 males | rel=r_associated | relid=0 | w=15
  5719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence estimated at 1 in 50,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence estimated at 1 in 50,000 | rel=r_associated | relid=0 | w=15
  5720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence estimated at 1 in 86,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence estimated at 1 in 86,000 | rel=r_associated | relid=0 | w=15
  5721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in caucasians is 1 in 1,000,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in caucasians is 1 in 1,000,000 | rel=r_associated | relid=0 | w=15
  5722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in finland is 1 in 25,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in finland is 1 in 25,000 | rel=r_associated | relid=0 | w=15
  5723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in norway is 1 in 80,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in norway is 1 in 80,000 | rel=r_associated | relid=0 | w=15
  5724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in poland is 1 in 129,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in poland is 1 in 129,000 | rel=r_associated | relid=0 | w=15
  5725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in sardinia is 1 in 14,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in sardinia is 1 in 14,000 | rel=r_associated | relid=0 | w=15
  5726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in slovenia is 1 in 43,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in slovenia is 1 in 43,000 | rel=r_associated | relid=0 | w=15
  5727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in taiwan is 1 in 132,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in taiwan is 1 in 132,000 | rel=r_associated | relid=0 | w=15
  5728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence in the finnish population of 5.8 per million
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence in the finnish population of 5.8 per million | rel=r_associated | relid=0 | w=15
  5729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence is estimated to be 1 in 1,100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence is estimated to be 1 in 1,100,000 | rel=r_associated | relid=0 | w=15
  5730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence is estimated to be 1 in 150,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence is estimated to be 1 in 150,000 | rel=r_associated | relid=0 | w=15
  5731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence much higher in whites than blacks
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence much higher in whites than blacks | rel=r_associated | relid=0 | w=15
  5732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 0.5 to 1 in 1,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 0.5 to 1 in 1,000 | rel=r_associated | relid=0 | w=15
  5733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 0.6 to 10 per 100,000 individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 0.6 to 10 per 100,000 individuals | rel=r_associated | relid=0 | w=15
  5734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 1,429 in tanzania
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 1,429 in tanzania | rel=r_associated | relid=0 | w=15
  5735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 1,500
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 1,500 | rel=r_associated | relid=0 | w=15
  5736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 10,000 african-americans
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 10,000 african-americans | rel=r_associated | relid=0 | w=15
  5737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 10,000 caucasians
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 10,000 caucasians | rel=r_associated | relid=0 | w=15
  5738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 100,000 | rel=r_associated | relid=0 | w=15
  5739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 150 to 1 in 1,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 150 to 1 in 1,000 | rel=r_associated | relid=0 | w=15
  5740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 150,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 150,000 | rel=r_associated | relid=0 | w=15
  5741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 2,833 in zimbabwe
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 2,833 in zimbabwe | rel=r_associated | relid=0 | w=15
  5742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 200,000 to 1 in 800,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 200,000 to 1 in 800,000 | rel=r_associated | relid=0 | w=15
  5743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 227 hopi indians
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 227 hopi indians | rel=r_associated | relid=0 | w=15
  5744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 240 zuni indians
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 240 zuni indians | rel=r_associated | relid=0 | w=15
  5745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 28,000 african-americans
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 28,000 african-americans | rel=r_associated | relid=0 | w=15
  5746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 28,000 caucasians
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 28,000 caucasians | rel=r_associated | relid=0 | w=15
  5747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 3,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 3,000 | rel=r_associated | relid=0 | w=15
  5748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 3,900 in south africa
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 3,900 in south africa | rel=r_associated | relid=0 | w=15
  5749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 30,000 in northern europe
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 30,000 in northern europe | rel=r_associated | relid=0 | w=15
  5750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 300,000 in quebec
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 300,000 in quebec | rel=r_associated | relid=0 | w=15
  5751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 40,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 40,000 | rel=r_associated | relid=0 | w=15
  5752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 40,000 among caucasians
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 40,000 among caucasians | rel=r_associated | relid=0 | w=15
  5753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 40,000 to 1 in 80,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 40,000 to 1 in 80,000 | rel=r_associated | relid=0 | w=15
  5754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 50,000-70,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 50,000-70,000 live births | rel=r_associated | relid=0 | w=15
  5755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 6,000 to 1 in 10,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 6,000 to 1 in 10,000 | rel=r_associated | relid=0 | w=15
  5756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 7,900 in cameroon
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 7,900 in cameroon | rel=r_associated | relid=0 | w=15
  5757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 1 in 70,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 1 in 70,000 | rel=r_associated | relid=0 | w=15
  5758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 19 in 1,000,000 in sweden
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 19 in 1,000,000 in sweden | rel=r_associated | relid=0 | w=15
  5759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 2-7% in english-speaking preschool children
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 2-7% in english-speaking preschool children | rel=r_associated | relid=0 | w=15
  5760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of 7 in 100,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of 7 in 100,000 live births | rel=r_associated | relid=0 | w=15
  5761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of approximately 1 in 2000 individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of approximately 1 in 2000 individuals | rel=r_associated | relid=0 | w=15
  5762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of essential tremor ranges from 0.4 to 6% in the general population
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of essential tremor ranges from 0.4 to 6% in the general population | rel=r_associated | relid=0 | w=15
  5763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of homozygous c4a deficiency in sle 10-15x higher than general population
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of homozygous c4a deficiency in sle 10-15x higher than general population | rel=r_associated | relid=0 | w=15
  5764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of in 1 in 8,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of in 1 in 8,000 | rel=r_associated | relid=0 | w=15
  5765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of sleep terrors about 3% in children
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of sleep terrors about 3% in children | rel=r_associated | relid=0 | w=15
  5766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of sleep terrors less than 1% in adults
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of sleep terrors less than 1% in adults | rel=r_associated | relid=0 | w=15
  5767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of sleepwalking about 3% in adults
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of sleepwalking about 3% in adults | rel=r_associated | relid=0 | w=15
  5768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of sleepwalking up to 26% in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of sleepwalking up to 26% in childhood | rel=r_associated | relid=0 | w=15
  5769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence of true hypoprothrombinemia is 1 in 2 million
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence of true hypoprothrombinemia is 1 in 2 million | rel=r_associated | relid=0 | w=15
  5770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence ranges from 1 in 12,000 to 1 in 50,000
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence ranges from 1 in 12,000 to 1 in 50,000 | rel=r_associated | relid=0 | w=15
  5771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalence rates average 10-20% of the general population over age 60
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalence rates average 10-20% of the general population over age 60 | rel=r_associated | relid=0 | w=15
  5772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent among european, particularly spanish, gypsies (r1109x, 608206.0006)
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent among european, particularly spanish, gypsies (r1109x, 608206.0006) | rel=r_associated | relid=0 | w=15
  5773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent among individuals of east asian descent
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent among individuals of east asian descent | rel=r_associated | relid=0 | w=15
  5774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent among patients of asian descent, particularly japanese
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent among patients of asian descent, particularly japanese | rel=r_associated | relid=0 | w=15
  5775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent among the amish
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent among the amish | rel=r_associated | relid=0 | w=15
  5776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in arabic, turkish, armenian, and sephardic jewish populations
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in arabic, turkish, armenian, and sephardic jewish populations | rel=r_associated | relid=0 | w=15
  5777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in ashkenazi jews
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in ashkenazi jews | rel=r_associated | relid=0 | w=15
  5778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in bulgarian gypsies
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in bulgarian gypsies | rel=r_associated | relid=0 | w=15
  5779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in newfoundland
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in newfoundland | rel=r_associated | relid=0 | w=15
  5780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in north africa
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in north africa | rel=r_associated | relid=0 | w=15
  5781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in old order amish of lancaster county, pennsylvania and saulteaux/ojibway indians of canada
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in old order amish of lancaster county, pennsylvania and saulteaux/ojibway indians of canada | rel=r_associated | relid=0 | w=15
  5782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in quebec
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in quebec | rel=r_associated | relid=0 | w=15
  5783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in sweden
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in sweden | rel=r_associated | relid=0 | w=15
  5784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prevalent in the old order amish in the u.s. and in finland
    n1=Hyde (prurigo nodulaire de) | n2=en:prevalent in the old order amish in the u.s. and in finland | rel=r_associated | relid=0 | w=15
  5785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:primarily diagnosed in females
    n1=Hyde (prurigo nodulaire de) | n2=en:primarily diagnosed in females | rel=r_associated | relid=0 | w=15
  5786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:primary teeth affected greater than secondary teeth
    n1=Hyde (prurigo nodulaire de) | n2=en:primary teeth affected greater than secondary teeth | rel=r_associated | relid=0 | w=15
  5787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:probably autosomal dominant with rare instances of affected sibs due to germinal mosaicism
    n1=Hyde (prurigo nodulaire de) | n2=en:probably autosomal dominant with rare instances of affected sibs due to germinal mosaicism | rel=r_associated | relid=0 | w=15
  5788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:probenecid/colchicine
    n1=Hyde (prurigo nodulaire de) | n2=en:probenecid/colchicine | rel=r_associated | relid=0 | w=15
  5789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prodromal symptoms include nasal congestion, dry throat, severe fatigue, vertigo, and headache
    n1=Hyde (prurigo nodulaire de) | n2=en:prodromal symptoms include nasal congestion, dry throat, severe fatigue, vertigo, and headache | rel=r_associated | relid=0 | w=15
  5790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:profound dementia and death usually occurs by age 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:profound dementia and death usually occurs by age 50 years | rel=r_associated | relid=0 | w=15
  5791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prognosis good
    n1=Hyde (prurigo nodulaire de) | n2=en:prognosis good | rel=r_associated | relid=0 | w=15
  5792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progresses through puberty, then stabilizes
    n1=Hyde (prurigo nodulaire de) | n2=en:progresses through puberty, then stabilizes | rel=r_associated | relid=0 | w=15
  5793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progresses to involve upper limbs
    n1=Hyde (prurigo nodulaire de) | n2=en:progresses to involve upper limbs | rel=r_associated | relid=0 | w=15
  5794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:progression in adulthood | rel=r_associated | relid=0 | w=15
  5795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression more frequent in men than women
    n1=Hyde (prurigo nodulaire de) | n2=en:progression more frequent in men than women | rel=r_associated | relid=0 | w=15
  5796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression of disease stops at a best-corrected visual acuity of 0.2 (20/100) to 0.1 (20/200)
    n1=Hyde (prurigo nodulaire de) | n2=en:progression of disease stops at a best-corrected visual acuity of 0.2 (20/100) to 0.1 (20/200) | rel=r_associated | relid=0 | w=15
  5797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression of phenotype with age
    n1=Hyde (prurigo nodulaire de) | n2=en:progression of phenotype with age | rel=r_associated | relid=0 | w=15
  5798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression of the disorder is precipitated by viral symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:progression of the disorder is precipitated by viral symptoms | rel=r_associated | relid=0 | w=15
  5799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progression to profound hearing loss affecting all frequencies
    n1=Hyde (prurigo nodulaire de) | n2=en:progression to profound hearing loss affecting all frequencies | rel=r_associated | relid=0 | w=15
  5800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive cerebellar ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive cerebellar ataxia | rel=r_associated | relid=0 | w=15
  5801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive clinical course with onset in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive clinical course with onset in childhood | rel=r_associated | relid=0 | w=15
  5802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive deafness
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive deafness | rel=r_associated | relid=0 | w=15
  5803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive degenerative hip disease requiring replacement in 2nd to 4th decade
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive degenerative hip disease requiring replacement in 2nd to 4th decade | rel=r_associated | relid=0 | w=15
  5804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disease
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disease | rel=r_associated | relid=0 | w=15
  5805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disease is seen in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disease is seen in some patients | rel=r_associated | relid=0 | w=15
  5806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disease with onset in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disease with onset in infancy | rel=r_associated | relid=0 | w=15
  5807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disorder | rel=r_associated | relid=0 | w=15
  5808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disorder due to secondary myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disorder due to secondary myopathy | rel=r_associated | relid=0 | w=15
  5809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disorder regarding both neurologic and renal symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disorder regarding both neurologic and renal symptoms | rel=r_associated | relid=0 | w=15
  5810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disorder, usually with rapid, relentless course
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disorder, usually with rapid, relentless course | rel=r_associated | relid=0 | w=15
  5811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive disorder, with older patients exhibiting more severe symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive disorder, with older patients exhibiting more severe symptoms | rel=r_associated | relid=0 | w=15
  5812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive neurologic deterioration if untreated
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive neurologic deterioration if untreated | rel=r_associated | relid=0 | w=15
  5813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive or slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive or slowly progressive | rel=r_associated | relid=0 | w=15
  5814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive renal disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive renal disorder | rel=r_associated | relid=0 | w=15
  5815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive sclerosis with age
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive sclerosis with age | rel=r_associated | relid=0 | w=15
  5816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:progressive, with full manifestations at puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive, with full manifestations at puberty | rel=r_associated | relid=0 | w=15
  5817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:prominent psychiatric symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:prominent psychiatric symptoms | rel=r_associated | relid=0 | w=15
  5818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protamylasse
    n1=Hyde (prurigo nodulaire de) | n2=en:protamylasse | rel=r_associated | relid=0 | w=15
  5819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein and protein derivatives - dietary
    n1=Hyde (prurigo nodulaire de) | n2=en:protein and protein derivatives - dietary | rel=r_associated | relid=0 | w=15
  5820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein c deficiency is found in 3-4% of patients with venous thromboembolism
    n1=Hyde (prurigo nodulaire de) | n2=en:protein c deficiency is found in 3-4% of patients with venous thromboembolism | rel=r_associated | relid=0 | w=15
  5821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein complex
    n1=Hyde (prurigo nodulaire de) | n2=en:protein complex | rel=r_associated | relid=0 | w=15
  5822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein component
    n1=Hyde (prurigo nodulaire de) | n2=en:protein component | rel=r_associated | relid=0 | w=15
  5823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein s deficiency is found in 2-3% of patients with thromboembolism
    n1=Hyde (prurigo nodulaire de) | n2=en:protein s deficiency is found in 2-3% of patients with thromboembolism | rel=r_associated | relid=0 | w=15
  5824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protein-arginine deiminase type-4
    n1=Hyde (prurigo nodulaire de) | n2=en:protein-arginine deiminase type-4 | rel=r_associated | relid=0 | w=15
  5825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:proteinuria
    n1=Hyde (prurigo nodulaire de) | n2=en:proteinuria | rel=r_associated | relid=0 | w=15
  5826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:proteoglycan
    n1=Hyde (prurigo nodulaire de) | n2=en:proteoglycan | rel=r_associated | relid=0 | w=15
  5827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:protracted disease course
    n1=Hyde (prurigo nodulaire de) | n2=en:protracted disease course | rel=r_associated | relid=0 | w=15
  5828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:provoked by crying or emotional upset
    n1=Hyde (prurigo nodulaire de) | n2=en:provoked by crying or emotional upset | rel=r_associated | relid=0 | w=15
  5829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pseudoarylsulfatase a deficiency is an allelic disorder with reduced levels of arsa activity, but no neurologic manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudoarylsulfatase a deficiency is an allelic disorder with reduced levels of arsa activity, but no neurologic manifestations | rel=r_associated | relid=0 | w=15
  5830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pseudoephedrine + codeine + guaifenesin
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudoephedrine + codeine + guaifenesin | rel=r_associated | relid=0 | w=15
  5831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pseudomembrane formation triggered by injury, infection, irritation, surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudomembrane formation triggered by injury, infection, irritation, surgery | rel=r_associated | relid=0 | w=15
  5832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:psychiatric symptoms may be the presenting sign
    n1=Hyde (prurigo nodulaire de) | n2=en:psychiatric symptoms may be the presenting sign | rel=r_associated | relid=0 | w=15
  5833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:psychology qualifier
    n1=Hyde (prurigo nodulaire de) | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=15
  5834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:psychomotor delay may already be apparent at onset of seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:psychomotor delay may already be apparent at onset of seizures | rel=r_associated | relid=0 | w=15
  5835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ptosis is usually presenting feature
    n1=Hyde (prurigo nodulaire de) | n2=en:ptosis is usually presenting feature | rel=r_associated | relid=0 | w=15
  5836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:puerperal disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:puerperal disorders | rel=r_associated | relid=0 | w=15
  5837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pulsatile headache lasts hours to days
    n1=Hyde (prurigo nodulaire de) | n2=en:pulsatile headache lasts hours to days | rel=r_associated | relid=0 | w=15
  5838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pulse generator system for tympanic treatment of inner ear endolymphatic fluid
    n1=Hyde (prurigo nodulaire de) | n2=en:pulse generator system for tympanic treatment of inner ear endolymphatic fluid | rel=r_associated | relid=0 | w=15
  5839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:purine
    n1=Hyde (prurigo nodulaire de) | n2=en:purine | rel=r_associated | relid=0 | w=15
  5840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pyogenic arthritis, pyoderma gangrenosum and acne
    n1=Hyde (prurigo nodulaire de) | n2=en:pyogenic arthritis, pyoderma gangrenosum and acne | rel=r_associated | relid=0 | w=15
  5841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pyridoxine responsive individuals often have milder manifestations than those not responsive
    n1=Hyde (prurigo nodulaire de) | n2=en:pyridoxine responsive individuals often have milder manifestations than those not responsive | rel=r_associated | relid=0 | w=15
  5842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:pyrimidine
    n1=Hyde (prurigo nodulaire de) | n2=en:pyrimidine | rel=r_associated | relid=0 | w=15
  5843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:quinidine therapy is effective
    n1=Hyde (prurigo nodulaire de) | n2=en:quinidine therapy is effective | rel=r_associated | relid=0 | w=15
  5844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:radioresistant dna synthesis
    n1=Hyde (prurigo nodulaire de) | n2=en:radioresistant dna synthesis | rel=r_associated | relid=0 | w=15
  5845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:radiotherapeutic
    n1=Hyde (prurigo nodulaire de) | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=15
  5846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:range of onset 11 to 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:range of onset 11 to 50 years | rel=r_associated | relid=0 | w=15
  5847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapid disease progression
    n1=Hyde (prurigo nodulaire de) | n2=en:rapid disease progression | rel=r_associated | relid=0 | w=15
  5848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapid disease progression from ages 40 to 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:rapid disease progression from ages 40 to 50 years | rel=r_associated | relid=0 | w=15
  5849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapid progression in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:rapid progression in adolescence | rel=r_associated | relid=0 | w=15
  5850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapid progression to disability
    n1=Hyde (prurigo nodulaire de) | n2=en:rapid progression to disability | rel=r_associated | relid=0 | w=15
  5851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive | rel=r_associated | relid=0 | w=15
  5852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive (6-24 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive (6-24 months) | rel=r_associated | relid=0 | w=15
  5853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive course
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive course | rel=r_associated | relid=0 | w=15
  5854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive deterioration (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive deterioration (in some patients) | rel=r_associated | relid=0 | w=15
  5855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive disorder | rel=r_associated | relid=0 | w=15
  5856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive episodes | rel=r_associated | relid=0 | w=15
  5857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive neonatal onset with early death
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive neonatal onset with early death | rel=r_associated | relid=0 | w=15
  5858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive to persistent vegetative state or death
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive to persistent vegetative state or death | rel=r_associated | relid=0 | w=15
  5859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rapidly progressive, but slower than creutzfeldt-jakob disease (123400)
    n1=Hyde (prurigo nodulaire de) | n2=en:rapidly progressive, but slower than creutzfeldt-jakob disease (123400) | rel=r_associated | relid=0 | w=15
  5860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare adult cases reported
    n1=Hyde (prurigo nodulaire de) | n2=en:rare adult cases reported | rel=r_associated | relid=0 | w=15
  5861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:rare adult onset | rel=r_associated | relid=0 | w=15
  5862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:rare disorder | rel=r_associated | relid=0 | w=15
  5863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare patients with homozygous null mutations have most severe disease
    n1=Hyde (prurigo nodulaire de) | n2=en:rare patients with homozygous null mutations have most severe disease | rel=r_associated | relid=0 | w=15
  5864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare spontaneous improvement occurs (8%)
    n1=Hyde (prurigo nodulaire de) | n2=en:rare spontaneous improvement occurs (8%) | rel=r_associated | relid=0 | w=15
  5865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rare survival to teens
    n1=Hyde (prurigo nodulaire de) | n2=en:rare survival to teens | rel=r_associated | relid=0 | w=15
  5866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rarely produces clinical jaundice
    n1=Hyde (prurigo nodulaire de) | n2=en:rarely produces clinical jaundice | rel=r_associated | relid=0 | w=15
  5867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rarely reported in infants
    n1=Hyde (prurigo nodulaire de) | n2=en:rarely reported in infants | rel=r_associated | relid=0 | w=15
  5868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rarely, patients may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:rarely, patients may be asymptomatic | rel=r_associated | relid=0 | w=15
  5869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rarely, patients with childhood-onset may lose the renal phosphate-wasting defect
    n1=Hyde (prurigo nodulaire de) | n2=en:rarely, patients with childhood-onset may lose the renal phosphate-wasting defect | rel=r_associated | relid=0 | w=15
  5870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rash, edema, and arthralgia may occur during crisis
    n1=Hyde (prurigo nodulaire de) | n2=en:rash, edema, and arthralgia may occur during crisis | rel=r_associated | relid=0 | w=15
  5871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ratio female to male, 19:10 in index family
    n1=Hyde (prurigo nodulaire de) | n2=en:ratio female to male, 19:10 in index family | rel=r_associated | relid=0 | w=15
  5872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:raw sugar
    n1=Hyde (prurigo nodulaire de) | n2=en:raw sugar | rel=r_associated | relid=0 | w=15
  5873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reason for lab test:type:pt:bld.dot:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:reason for lab test:type:pt:bld.dot:nom | rel=r_associated | relid=0 | w=15
  5874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:receptor
    n1=Hyde (prurigo nodulaire de) | n2=en:receptor | rel=r_associated | relid=0 | w=15
  5875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recessive inheritance has been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:recessive inheritance has been reported | rel=r_associated | relid=0 | w=15
  5876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrence is possible
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrence is possible | rel=r_associated | relid=0 | w=15
  5877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrence of symptoms after cholecystectomy
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrence of symptoms after cholecystectomy | rel=r_associated | relid=0 | w=15
  5878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent acute episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent acute episodes | rel=r_associated | relid=0 | w=15
  5879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent acute episodes of neurologic deterioration associated with febrile illnesses
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent acute episodes of neurologic deterioration associated with febrile illnesses | rel=r_associated | relid=0 | w=15
  5880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent bacterial infection
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=15
  5881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent bacterial infections beginning in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent bacterial infections beginning in childhood | rel=r_associated | relid=0 | w=15
  5882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent bacterial infections with onset in the first or second year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent bacterial infections with onset in the first or second year of life | rel=r_associated | relid=0 | w=15
  5883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent bacterial, viral, and fungal infections
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=15
  5884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent cholestatic episodes in puberty, following surgery or severe trauma, and pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent cholestatic episodes in puberty, following surgery or severe trauma, and pregnancy | rel=r_associated | relid=0 | w=15
  5885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent febrile crises preceded by chills and accompanied by headache and bilateral cervical lymphadenopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent febrile crises preceded by chills and accompanied by headache and bilateral cervical lymphadenopathy | rel=r_associated | relid=0 | w=15
  5886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:recurrent febrile crises with lymphadenopathy, hepatosplenomegaly, vomiting, and diarrhea
    n1=Hyde (prurigo nodulaire de) | n2=en:recurrent febrile crises with lymphadenopathy, hepatosplenomegaly, vomiting, and diarrhea | rel=r_associated | relid=0 | w=15
  5887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced exercise tolerance
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced exercise tolerance | rel=r_associated | relid=0 | w=15
  5888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced fertility
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced fertility | rel=r_associated | relid=0 | w=15
  5889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced fetal movement
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced fetal movement | rel=r_associated | relid=0 | w=15
  5890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced life expectancy
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced life expectancy | rel=r_associated | relid=0 | w=15
  5891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced life expectancy, death by 10 years of age in 70% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced life expectancy, death by 10 years of age in 70% of patients | rel=r_associated | relid=0 | w=15
  5892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance (75%)
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance (75%) | rel=r_associated | relid=0 | w=15
  5893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance (89%)
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance (89%) | rel=r_associated | relid=0 | w=15
  5894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance (about 60%)
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance (about 60%) | rel=r_associated | relid=0 | w=15
  5895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance (approximately 54%)
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance (approximately 54%) | rel=r_associated | relid=0 | w=15
  5896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance (approximately 87%)
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance (approximately 87%) | rel=r_associated | relid=0 | w=15
  5897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance in females
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance in females | rel=r_associated | relid=0 | w=15
  5898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced penetrance, estimated to be 15% at 60 years, 21% at 70 years, and 32% at 80 years
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced penetrance, estimated to be 15% at 60 years, 21% at 70 years, and 32% at 80 years | rel=r_associated | relid=0 | w=15
  5899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reduced zinc in affected mother's breast milk is unresponsive to oral zinc supplementation
    n1=Hyde (prurigo nodulaire de) | n2=en:reduced zinc in affected mother's breast milk is unresponsive to oral zinc supplementation | rel=r_associated | relid=0 | w=15
  5900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab name:identifier:time reported elsewhere:reference lab test:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab name:identifier:time reported elsewhere:reference lab test:nominal | rel=r_associated | relid=0 | w=15
  5901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test identifier:id:xxx:reference lab test:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test identifier:id:xxx:reference lab test:nom | rel=r_associated | relid=0 | w=15
  5902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test method:type:time reported elsewhere:reference lab test:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test method:type:time reported elsewhere:reference lab test:narrative | rel=r_associated | relid=0 | w=15
  5903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test name:type:time reported elsewhere:reference lab test:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test name:type:time reported elsewhere:reference lab test:nominal | rel=r_associated | relid=0 | w=15
  5904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test number and name:identifier:time reported elsewhere:reference lab test:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test number and name:identifier:time reported elsewhere:reference lab test:nominal | rel=r_associated | relid=0 | w=15
  5905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test reference range:finding:time reported elsewhere:reference lab test:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test reference range:finding:time reported elsewhere:reference lab test:nominal | rel=r_associated | relid=0 | w=15
  5906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reference lab test results:finding:time reported elsewhere:reference lab test:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:reference lab test results:finding:time reported elsewhere:reference lab test:narrative | rel=r_associated | relid=0 | w=15
  5907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:regional, racial, and ethnic clustering has been noted
    n1=Hyde (prurigo nodulaire de) | n2=en:regional, racial, and ethnic clustering has been noted | rel=r_associated | relid=0 | w=15
  5908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:regression in infancy (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:regression in infancy (in some patients) | rel=r_associated | relid=0 | w=15
  5909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rehabilitation aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=15
  5910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relapsing-remitting course
    n1=Hyde (prurigo nodulaire de) | n2=en:relapsing-remitting course | rel=r_associated | relid=0 | w=15
  5911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relationship of rare neuropsychiatric signs to histidinemia is unclear
    n1=Hyde (prurigo nodulaire de) | n2=en:relationship of rare neuropsychiatric signs to histidinemia is unclear | rel=r_associated | relid=0 | w=15
  5912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatively benign course
    n1=Hyde (prurigo nodulaire de) | n2=en:relatively benign course | rel=r_associated | relid=0 | w=15
  5913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatively benign course after acute episodes in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:relatively benign course after acute episodes in childhood | rel=r_associated | relid=0 | w=15
  5914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatively mild course
    n1=Hyde (prurigo nodulaire de) | n2=en:relatively mild course | rel=r_associated | relid=0 | w=15
  5915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatively mild cutis laxa, associated with severe vascular abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:relatively mild cutis laxa, associated with severe vascular abnormalities | rel=r_associated | relid=0 | w=15
  5916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatively slow progression
    n1=Hyde (prurigo nodulaire de) | n2=en:relatively slow progression | rel=r_associated | relid=0 | w=15
  5917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relatives with multiple small congenital pigmented nevi
    n1=Hyde (prurigo nodulaire de) | n2=en:relatives with multiple small congenital pigmented nevi | rel=r_associated | relid=0 | w=15
  5918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:relief is achieved by cooling or by elevating the extremities
    n1=Hyde (prurigo nodulaire de) | n2=en:relief is achieved by cooling or by elevating the extremities | rel=r_associated | relid=0 | w=15
  5919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:renal anomalies are not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:renal anomalies are not always present | rel=r_associated | relid=0 | w=15
  5920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:renal failure in second or third decade
    n1=Hyde (prurigo nodulaire de) | n2=en:renal failure in second or third decade | rel=r_associated | relid=0 | w=15
  5921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:renal involvement and coloboma may not be present
    n1=Hyde (prurigo nodulaire de) | n2=en:renal involvement and coloboma may not be present | rel=r_associated | relid=0 | w=15
  5922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:repeat expansions range from 70 to over 1,000 (normal 5 to 30 repeats)
    n1=Hyde (prurigo nodulaire de) | n2=en:repeat expansions range from 70 to over 1,000 (normal 5 to 30 repeats) | rel=r_associated | relid=0 | w=15
  5923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:repeat is unstable if > 52 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:repeat is unstable if > 52 repeats | rel=r_associated | relid=0 | w=15
  5924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:repeat tracts may expand as patient ages (somatic instability)
    n1=Hyde (prurigo nodulaire de) | n2=en:repeat tracts may expand as patient ages (somatic instability) | rel=r_associated | relid=0 | w=15
  5925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported cases all sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:reported cases all sporadic | rel=r_associated | relid=0 | w=15
  5926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in 1 family (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in 1 family (last curated may 2013) | rel=r_associated | relid=0 | w=15
  5927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in 2 sibs (february 1991)
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in 2 sibs (february 1991) | rel=r_associated | relid=0 | w=15
  5928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in a large hutterite family
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in a large hutterite family | rel=r_associated | relid=0 | w=15
  5929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in individuals of amish or mennonite descent
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in individuals of amish or mennonite descent | rel=r_associated | relid=0 | w=15
  5930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in individuals of french canadian origin
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in individuals of french canadian origin | rel=r_associated | relid=0 | w=15
  5931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in individuals of jewish moroccan ancestry
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in individuals of jewish moroccan ancestry | rel=r_associated | relid=0 | w=15
  5932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in individuals of sephardic jewish ancestry
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in individuals of sephardic jewish ancestry | rel=r_associated | relid=0 | w=15
  5933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reported in the ohio amish anabaptist community
    n1=Hyde (prurigo nodulaire de) | n2=en:reported in the ohio amish anabaptist community | rel=r_associated | relid=0 | w=15
  5934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:resembles intrauterine torch infection but without intrauterine infection
    n1=Hyde (prurigo nodulaire de) | n2=en:resembles intrauterine torch infection but without intrauterine infection | rel=r_associated | relid=0 | w=15
  5935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:resembles pseudo-torch syndrome (251290)
    n1=Hyde (prurigo nodulaire de) | n2=en:resembles pseudo-torch syndrome (251290) | rel=r_associated | relid=0 | w=15
  5936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:residual neurologic deficits are slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:residual neurologic deficits are slowly progressive | rel=r_associated | relid=0 | w=15
  5937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:resource identifier:uri:pt:study:nom
    n1=Hyde (prurigo nodulaire de) | n2=en:resource identifier:uri:pt:study:nom | rel=r_associated | relid=0 | w=15
  5938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:respiratory distress may be precipitated by viral respiratory infection
    n1=Hyde (prurigo nodulaire de) | n2=en:respiratory distress may be precipitated by viral respiratory infection | rel=r_associated | relid=0 | w=15
  5939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:response to acetazolamide
    n1=Hyde (prurigo nodulaire de) | n2=en:response to acetazolamide | rel=r_associated | relid=0 | w=15
  5940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:response to benadryl (diphenhydramine)
    n1=Hyde (prurigo nodulaire de) | n2=en:response to benadryl (diphenhydramine) | rel=r_associated | relid=0 | w=15
  5941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:response to zinc supplementation
    n1=Hyde (prurigo nodulaire de) | n2=en:response to zinc supplementation | rel=r_associated | relid=0 | w=15
  5942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:responsive to high-dose biotin or biotin/thiamine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:responsive to high-dose biotin or biotin/thiamine treatment | rel=r_associated | relid=0 | w=15
  5943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:responsive to oral mannose therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:responsive to oral mannose therapy | rel=r_associated | relid=0 | w=15
  5944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:responsive to thiazide diuretics
    n1=Hyde (prurigo nodulaire de) | n2=en:responsive to thiazide diuretics | rel=r_associated | relid=0 | w=15
  5945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:responsive to treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:responsive to treatment | rel=r_associated | relid=0 | w=15
  5946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:responsive to vitamin b12 therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:responsive to vitamin b12 therapy | rel=r_associated | relid=0 | w=15
  5947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:results in severe motor disability and loss of independent ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:results in severe motor disability and loss of independent ambulation | rel=r_associated | relid=0 | w=15
  5948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retained membrane
    n1=Hyde (prurigo nodulaire de) | n2=en:retained membrane | rel=r_associated | relid=0 | w=15
  5949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retained products of conception
    n1=Hyde (prurigo nodulaire de) | n2=en:retained products of conception | rel=r_associated | relid=0 | w=15
  5950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reticulate acropigmentation of kitamura (hyperpigmentation found primarily in hands and feet)
    n1=Hyde (prurigo nodulaire de) | n2=en:reticulate acropigmentation of kitamura (hyperpigmentation found primarily in hands and feet) | rel=r_associated | relid=0 | w=15
  5951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:reticulate hyperpigmentation onset birth - 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:reticulate hyperpigmentation onset birth - 2 years | rel=r_associated | relid=0 | w=15
  5952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retinal arteriolar tortuosity develops in adolescence and is progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:retinal arteriolar tortuosity develops in adolescence and is progressive | rel=r_associated | relid=0 | w=15
  5953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retinal degeneration not always present
    n1=Hyde (prurigo nodulaire de) | n2=en:retinal degeneration not always present | rel=r_associated | relid=0 | w=15
  5954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retinal hemorrhages usually resolve without sequelae
    n1=Hyde (prurigo nodulaire de) | n2=en:retinal hemorrhages usually resolve without sequelae | rel=r_associated | relid=0 | w=15
  5955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:retinitis punctata albescens and macular degeneration starting in late childhood to early teens
    n1=Hyde (prurigo nodulaire de) | n2=en:retinitis punctata albescens and macular degeneration starting in late childhood to early teens | rel=r_associated | relid=0 | w=15
  5956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rh incompatibility
    n1=Hyde (prurigo nodulaire de) | n2=en:rh incompatibility | rel=r_associated | relid=0 | w=15
  5957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rhesus isoimmunization
    n1=Hyde (prurigo nodulaire de) | n2=en:rhesus isoimmunization | rel=r_associated | relid=0 | w=15
  5958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ribonucleic acid
    n1=Hyde (prurigo nodulaire de) | n2=en:ribonucleic acid | rel=r_associated | relid=0 | w=15
  5959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ribonucleoprotein
    n1=Hyde (prurigo nodulaire de) | n2=en:ribonucleoprotein | rel=r_associated | relid=0 | w=15
  5960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rickets and premature primary tooth loss occur in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:rickets and premature primary tooth loss occur in childhood | rel=r_associated | relid=0 | w=15
  5961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:right side affected greater than left side
    n1=Hyde (prurigo nodulaire de) | n2=en:right side affected greater than left side | rel=r_associated | relid=0 | w=15
  5962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ring protein subunit
    n1=Hyde (prurigo nodulaire de) | n2=en:ring protein subunit | rel=r_associated | relid=0 | w=15
  5963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risedronate + calcium
    n1=Hyde (prurigo nodulaire de) | n2=en:risedronate + calcium | rel=r_associated | relid=0 | w=15
  5964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk factors for development of tgct - family history, cryptorchidism (219050), testicular feminization (300068), klinefelter syndrome, previous tgct, gonadal dysgenesis
    n1=Hyde (prurigo nodulaire de) | n2=en:risk factors for development of tgct - family history, cryptorchidism (219050), testicular feminization (300068), klinefelter syndrome, previous tgct, gonadal dysgenesis | rel=r_associated | relid=0 | w=15
  5965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of affected offspring in maternal translocation carrier - 4-10%
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of affected offspring in maternal translocation carrier - 4-10% | rel=r_associated | relid=0 | w=15
  5966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of affected offspring in paternal translocation carrier - 0-7%
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of affected offspring in paternal translocation carrier - 0-7% | rel=r_associated | relid=0 | w=15
  5967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of sudden death
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of sudden death | rel=r_associated | relid=0 | w=15
  5968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of sudden death due to cardiac arrhythmias
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of sudden death due to cardiac arrhythmias | rel=r_associated | relid=0 | w=15
  5969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of sudden death due to cardiac defects
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of sudden death due to cardiac defects | rel=r_associated | relid=0 | w=15
  5970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of sudden death in childhood due to cardiac arrest
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of sudden death in childhood due to cardiac arrest | rel=r_associated | relid=0 | w=15
  5971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of sudden death with exertion
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of sudden death with exertion | rel=r_associated | relid=0 | w=15
  5972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:risk of thromboembolic stroke
    n1=Hyde (prurigo nodulaire de) | n2=en:risk of thromboembolic stroke | rel=r_associated | relid=0 | w=15
  5973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rna molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:rna molecule | rel=r_associated | relid=0 | w=15
  5974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:roentgenographic
    n1=Hyde (prurigo nodulaire de) | n2=en:roentgenographic | rel=r_associated | relid=0 | w=15
  5975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:rupture of membrane
    n1=Hyde (prurigo nodulaire de) | n2=en:rupture of membrane | rel=r_associated | relid=0 | w=15
  5976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:saccharide
    n1=Hyde (prurigo nodulaire de) | n2=en:saccharide | rel=r_associated | relid=0 | w=15
  5977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:saccharides measurement
    n1=Hyde (prurigo nodulaire de) | n2=en:saccharides measurement | rel=r_associated | relid=0 | w=15
  5978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:saccharides:acnc:pt:urine:ord
    n1=Hyde (prurigo nodulaire de) | n2=en:saccharides:acnc:pt:urine:ord | rel=r_associated | relid=0 | w=15
  5979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:salicylic acid + coal tar + sulfur
    n1=Hyde (prurigo nodulaire de) | n2=en:salicylic acid + coal tar + sulfur | rel=r_associated | relid=0 | w=15
  5980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sando (607459) is a phenotypic variant of autosomal recessive peo
    n1=Hyde (prurigo nodulaire de) | n2=en:sando (607459) is a phenotypic variant of autosomal recessive peo | rel=r_associated | relid=0 | w=15
  5981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sarcoplasmic/endoplasmic reticulum calcium atpase 2
    n1=Hyde (prurigo nodulaire de) | n2=en:sarcoplasmic/endoplasmic reticulum calcium atpase 2 | rel=r_associated | relid=0 | w=15
  5982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sca8 is caused by bidirectional transcription on chromosome 13q21 involving complementary repeat expansion in atxn8 (613289) and atxn8-opposite strand (603680)
    n1=Hyde (prurigo nodulaire de) | n2=en:sca8 is caused by bidirectional transcription on chromosome 13q21 involving complementary repeat expansion in atxn8 (613289) and atxn8-opposite strand (603680) | rel=r_associated | relid=0 | w=15
  5983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:scalp hair quality improves during pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:scalp hair quality improves during pregnancy | rel=r_associated | relid=0 | w=15
  5984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:scarf is an acronym - skeletal abnormalities, cutis laxa/craniosynostosis, ambiguous genitalia, retardation, and facial abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:scarf is an acronym - skeletal abnormalities, cutis laxa/craniosynostosis, ambiguous genitalia, retardation, and facial abnormalities | rel=r_associated | relid=0 | w=15
  5985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:schneckenbecken dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:schneckenbecken dysplasia | rel=r_associated | relid=0 | w=15
  5986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seasonal variation in severity of skin symptoms reported by some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:seasonal variation in severity of skin symptoms reported by some patients | rel=r_associated | relid=0 | w=15
  5987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:second most common form of usher syndrome type i
    n1=Hyde (prurigo nodulaire de) | n2=en:second most common form of usher syndrome type i | rel=r_associated | relid=0 | w=15
  5988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:secondary features include arterial hypertension and renal involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:secondary features include arterial hypertension and renal involvement | rel=r_associated | relid=0 | w=15
  5989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:secondary hemorrhage
    n1=Hyde (prurigo nodulaire de) | n2=en:secondary hemorrhage | rel=r_associated | relid=0 | w=15
  5990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:secondary prevention, avoid smoking, alcohol, and oxidants
    n1=Hyde (prurigo nodulaire de) | n2=en:secondary prevention, avoid smoking, alcohol, and oxidants | rel=r_associated | relid=0 | w=15
  5991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:secondary tumors develop within the skin lesions
    n1=Hyde (prurigo nodulaire de) | n2=en:secondary tumors develop within the skin lesions | rel=r_associated | relid=0 | w=15
  5992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see (277600) for a phenotypically similar autosomal recessive form
    n1=Hyde (prurigo nodulaire de) | n2=en:see (277600) for a phenotypically similar autosomal recessive form | rel=r_associated | relid=0 | w=15
  5993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see (608328) for a phenotypically similar autosomal dominant form
    n1=Hyde (prurigo nodulaire de) | n2=en:see (608328) for a phenotypically similar autosomal dominant form | rel=r_associated | relid=0 | w=15
  5994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 123000 for an autosomal dominant form due to mutation in ankh (605145)
    n1=Hyde (prurigo nodulaire de) | n2=en:see 123000 for an autosomal dominant form due to mutation in ankh (605145) | rel=r_associated | relid=0 | w=15
  5995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 171060.0005 for patients with homozygous abcb4 mutations and unaffected heterozygous family members
    n1=Hyde (prurigo nodulaire de) | n2=en:see 171060.0005 for patients with homozygous abcb4 mutations and unaffected heterozygous family members | rel=r_associated | relid=0 | w=15
  5996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 177850 for description of heterozygous phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see 177850 for description of heterozygous phenotype | rel=r_associated | relid=0 | w=15
  5997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 218400 for an autosomal recessive form caused by mutation in gja1 (121014.0021)
    n1=Hyde (prurigo nodulaire de) | n2=en:see 218400 for an autosomal recessive form caused by mutation in gja1 (121014.0021) | rel=r_associated | relid=0 | w=15
  5998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 255160 for an autosomal recessive form
    n1=Hyde (prurigo nodulaire de) | n2=en:see 255160 for an autosomal recessive form | rel=r_associated | relid=0 | w=15
  5999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 607731 for an autosomal recessive form
    n1=Hyde (prurigo nodulaire de) | n2=en:see 607731 for an autosomal recessive form | rel=r_associated | relid=0 | w=15
  6000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 608358 for an autosomal dominant form
    n1=Hyde (prurigo nodulaire de) | n2=en:see 608358 for an autosomal dominant form | rel=r_associated | relid=0 | w=15
  6001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see 609888 for a discussion on leprosy susceptibility
    n1=Hyde (prurigo nodulaire de) | n2=en:see 609888 for a discussion on leprosy susceptibility | rel=r_associated | relid=0 | w=15
  6002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also a childhood-onset form (114100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also a childhood-onset form (114100) | rel=r_associated | relid=0 | w=15
  6003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also adult-onset stiff person syndrome (184850)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also adult-onset stiff person syndrome (184850) | rel=r_associated | relid=0 | w=15
  6004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also an adult-onset form (213600)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also an adult-onset form (213600) | rel=r_associated | relid=0 | w=15
  6005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also antenatal bartter syndrome type 1 (601678) and bartter syndrome type 2 (241200)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also antenatal bartter syndrome type 1 (601678) and bartter syndrome type 2 (241200) | rel=r_associated | relid=0 | w=15
  6006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also antenatal bartter syndrome type 1 (601678), bartter syndrome type 2 (241200), bartter syndrome 3 (607364), and bartter syndrome 4b digenic (613090)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also antenatal bartter syndrome type 1 (601678), bartter syndrome type 2 (241200), bartter syndrome 3 (607364), and bartter syndrome 4b digenic (613090) | rel=r_associated | relid=0 | w=15
  6007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also antley-bixler syndrome (abs) with normal steroidogenesis (207410)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also antley-bixler syndrome (abs) with normal steroidogenesis (207410) | rel=r_associated | relid=0 | w=15
  6008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant fmf (134610), caused by heterozygous mutations in the mefv gene
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant fmf (134610), caused by heterozygous mutations in the mefv gene | rel=r_associated | relid=0 | w=15
  6009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant form (128230)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant form (128230) | rel=r_associated | relid=0 | w=15
  6010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant form (160800), which is less common and less severe
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant form (160800), which is less common and less severe | rel=r_associated | relid=0 | w=15
  6011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant form (176860)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant form (176860) | rel=r_associated | relid=0 | w=15
  6012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant giant axonal neuropathy (610100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant giant axonal neuropathy (610100) | rel=r_associated | relid=0 | w=15
  6013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant hypophosphatemic rickets (193100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant hypophosphatemic rickets (193100) | rel=r_associated | relid=0 | w=15
  6014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant lutheran-null phenotype (111150)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant lutheran-null phenotype (111150) | rel=r_associated | relid=0 | w=15
  6015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant peoa1 (157640)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant peoa1 (157640) | rel=r_associated | relid=0 | w=15
  6016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant robinow syndrome (180700)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant robinow syndrome (180700) | rel=r_associated | relid=0 | w=15
  6017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal dominant sick sinus syndrome (163800)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal dominant sick sinus syndrome (163800) | rel=r_associated | relid=0 | w=15
  6018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal form, 146450, and another x-linked form, 300633
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal form, 146450, and another x-linked form, 300633 | rel=r_associated | relid=0 | w=15
  6019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal form, 146450, and another x-linked form, 300758
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal form, 146450, and another x-linked form, 300758 | rel=r_associated | relid=0 | w=15
  6020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive bh4-dependent hyperphenylalaninemia (233910), an allelic disorder with a more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive bh4-dependent hyperphenylalaninemia (233910), an allelic disorder with a more severe phenotype | rel=r_associated | relid=0 | w=15
  6021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive familial mediterranean fever (fmf, 249100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive familial mediterranean fever (fmf, 249100) | rel=r_associated | relid=0 | w=15
  6022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive form (255700), which is more common and more severe
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive form (255700), which is more common and more severe | rel=r_associated | relid=0 | w=15
  6023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive form (612304)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive form (612304) | rel=r_associated | relid=0 | w=15
  6024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive peob (258450)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive peob (258450) | rel=r_associated | relid=0 | w=15
  6025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive robinow syndrome (268310)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive robinow syndrome (268310) | rel=r_associated | relid=0 | w=15
  6026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also autosomal recessive sick sinus syndrome (sss1, 608567)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also autosomal recessive sick sinus syndrome (sss1, 608567) | rel=r_associated | relid=0 | w=15
  6027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also benign familial infantile convulsions (bfic1, 601764)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also benign familial infantile convulsions (bfic1, 601764) | rel=r_associated | relid=0 | w=15
  6028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also benign familial neonatal-infantile convulsions (bfnis, 607745), which shows some phenotypic similarities
    n1=Hyde (prurigo nodulaire de) | n2=en:see also benign familial neonatal-infantile convulsions (bfnis, 607745), which shows some phenotypic similarities | rel=r_associated | relid=0 | w=15
  6029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also benign neonatal epilepsy (ebn1, 121200)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also benign neonatal epilepsy (ebn1, 121200) | rel=r_associated | relid=0 | w=15
  6030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also cblc (277400)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also cblc (277400) | rel=r_associated | relid=0 | w=15
  6031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also cbld (277410)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also cbld (277410) | rel=r_associated | relid=0 | w=15
  6032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also chromosome 2q32-q33 deletion syndrome (612313)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also chromosome 2q32-q33 deletion syndrome (612313) | rel=r_associated | relid=0 | w=15
  6033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also cmtx1 (302800) and cmt3x (302802)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also cmtx1 (302800) and cmt3x (302802) | rel=r_associated | relid=0 | w=15
  6034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also cmtx1 (302800) and cmtx2 (302801)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also cmtx1 (302800) and cmtx2 (302801) | rel=r_associated | relid=0 | w=15
  6035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also congenital stiff person syndrome (149400)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also congenital stiff person syndrome (149400) | rel=r_associated | relid=0 | w=15
  6036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also crigler-najjar syndrome type i (218800) which is also due to mutations in ugt1 (191740)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also crigler-najjar syndrome type i (218800) which is also due to mutations in ugt1 (191740) | rel=r_associated | relid=0 | w=15
  6037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also da2b (601680), which is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:see also da2b (601680), which is an allelic disorder | rel=r_associated | relid=0 | w=15
  6038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also dent disease 2 (300555)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also dent disease 2 (300555) | rel=r_associated | relid=0 | w=15
  6039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also distal hmn2a (158590)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also distal hmn2a (158590) | rel=r_associated | relid=0 | w=15
  6040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also dominant deb (131750), an allelic disorder with a less severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see also dominant deb (131750), an allelic disorder with a less severe phenotype | rel=r_associated | relid=0 | w=15
  6041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also dominant deb (131750), an allelic disorder with a similar phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see also dominant deb (131750), an allelic disorder with a similar phenotype | rel=r_associated | relid=0 | w=15
  6042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also dyggve-melchior-clausen disease (223800)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also dyggve-melchior-clausen disease (223800) | rel=r_associated | relid=0 | w=15
  6043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also dyssegmental dysplasia, silverman-handmaker type (224410)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also dyssegmental dysplasia, silverman-handmaker type (224410) | rel=r_associated | relid=0 | w=15
  6044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also ecyt2 (263400) and ecyt3 (609820)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also ecyt2 (263400) and ecyt3 (609820) | rel=r_associated | relid=0 | w=15
  6045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also erythrocytosis 1 (ecyt1, 133100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also erythrocytosis 1 (ecyt1, 133100) | rel=r_associated | relid=0 | w=15
  6046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also facial hemihypertrophy (133900)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also facial hemihypertrophy (133900) | rel=r_associated | relid=0 | w=15
  6047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also familial cold autoinflammatory syndrome (120100), an allelic disorder with overlapping features
    n1=Hyde (prurigo nodulaire de) | n2=en:see also familial cold autoinflammatory syndrome (120100), an allelic disorder with overlapping features | rel=r_associated | relid=0 | w=15
  6048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also familial developmental dysphasia (600117)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also familial developmental dysphasia (600117) | rel=r_associated | relid=0 | w=15
  6049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also febrile seizures (feb1, 121210)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also febrile seizures (feb1, 121210) | rel=r_associated | relid=0 | w=15
  6050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also french-canadian type of leigh syndrome (220111)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also french-canadian type of leigh syndrome (220111) | rel=r_associated | relid=0 | w=15
  6051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also gaucher disease type iii (231000), which is much less severe
    n1=Hyde (prurigo nodulaire de) | n2=en:see also gaucher disease type iii (231000), which is much less severe | rel=r_associated | relid=0 | w=15
  6052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also glanzmann thrombasthenia due to mutations in integrin alpha 2b (273800)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also glanzmann thrombasthenia due to mutations in integrin alpha 2b (273800) | rel=r_associated | relid=0 | w=15
  6053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also glut1ds2 (612126), an allelic disorder with a less severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see also glut1ds2 (612126), an allelic disorder with a less severe phenotype | rel=r_associated | relid=0 | w=15
  6054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also griscelli syndrome type 1 (214450) for a similar disorder without immunological abnormalities and griscelli syndrome type 3 (609227) for a similar disorder without neurologic or immunologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:see also griscelli syndrome type 1 (214450) for a similar disorder without immunological abnormalities and griscelli syndrome type 3 (609227) for a similar disorder without neurologic or immunologic abnormalities | rel=r_associated | relid=0 | w=15
  6055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also griscelli syndrome, type 1 (214450) for a similar disorder with characteristic neurologic disease and griscelli syndrome, type 2 (607624) for a similar disorder with characteristic immunodeficiency/hemophagocytic syndrome.
    n1=Hyde (prurigo nodulaire de) | n2=en:see also griscelli syndrome, type 1 (214450) for a similar disorder with characteristic neurologic disease and griscelli syndrome, type 2 (607624) for a similar disorder with characteristic immunodeficiency/hemophagocytic syndrome. | rel=r_associated | relid=0 | w=15
  6056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also hmn2b (608634)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also hmn2b (608634) | rel=r_associated | relid=0 | w=15
  6057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also infantile (600649) and late-onset (255110) cpt ii deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:see also infantile (600649) and late-onset (255110) cpt ii deficiency | rel=r_associated | relid=0 | w=15
  6058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also isolated pneumothorax (173600), an allelic disorder that may represent a mild form of the bhd syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:see also isolated pneumothorax (173600), an allelic disorder that may represent a mild form of the bhd syndrome | rel=r_associated | relid=0 | w=15
  6059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also junctional eb with pyloric atresia (226730)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also junctional eb with pyloric atresia (226730) | rel=r_associated | relid=0 | w=15
  6060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also later childhood-onset form (300718)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also later childhood-onset form (300718) | rel=r_associated | relid=0 | w=15
  6061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also lethal neonatal (608836) and adult forms (255110)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also lethal neonatal (608836) and adult forms (255110) | rel=r_associated | relid=0 | w=15
  6062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also mmaa (251100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also mmaa (251100) | rel=r_associated | relid=0 | w=15
  6063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also mmab (251110)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also mmab (251110) | rel=r_associated | relid=0 | w=15
  6064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also more severe phenotype peeling skin syndrome (270300)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also more severe phenotype peeling skin syndrome (270300) | rel=r_associated | relid=0 | w=15
  6065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also muckle-wells syndrome (191900), an allelic disorder with overlapping features
    n1=Hyde (prurigo nodulaire de) | n2=en:see also muckle-wells syndrome (191900), an allelic disorder with overlapping features | rel=r_associated | relid=0 | w=15
  6066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also oca1a (203100)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also oca1a (203100) | rel=r_associated | relid=0 | w=15
  6067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also oca1b, or 'yellow albinism,' an allelic disorder with residual tyrosinase activity and some pigmentation
    n1=Hyde (prurigo nodulaire de) | n2=en:see also oca1b, or 'yellow albinism,' an allelic disorder with residual tyrosinase activity and some pigmentation | rel=r_associated | relid=0 | w=15
  6068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also optic atrophy 1 (165500), an allelic disorder without deafness
    n1=Hyde (prurigo nodulaire de) | n2=en:see also optic atrophy 1 (165500), an allelic disorder without deafness | rel=r_associated | relid=0 | w=15
  6069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also optic atrophy with deafness (125250), an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:see also optic atrophy with deafness (125250), an allelic disorder | rel=r_associated | relid=0 | w=15
  6070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pachyonychia congenita, type 3 (pc1, 167200)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pachyonychia congenita, type 3 (pc1, 167200) | rel=r_associated | relid=0 | w=15
  6071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also park6 (605909), park7 (606324), and park9 (606693) for autosomal recessive disorders with overlapping phenotypes
    n1=Hyde (prurigo nodulaire de) | n2=en:see also park6 (605909), park7 (606324), and park9 (606693) for autosomal recessive disorders with overlapping phenotypes | rel=r_associated | relid=0 | w=15
  6072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also peeling skin syndrome, acral type (609796)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also peeling skin syndrome, acral type (609796) | rel=r_associated | relid=0 | w=15
  6073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also perinatal lethal variant (608013), which is more severe
    n1=Hyde (prurigo nodulaire de) | n2=en:see also perinatal lethal variant (608013), which is more severe | rel=r_associated | relid=0 | w=15
  6074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pfm3 on chromosome 4q21-q23 (609566)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pfm3 on chromosome 4q21-q23 (609566) | rel=r_associated | relid=0 | w=15
  6075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pgl1 (168000)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pgl1 (168000) | rel=r_associated | relid=0 | w=15
  6076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pgl2 (601650), pgl3 (605373), and pgl4 (115310)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pgl2 (601650), pgl3 (605373), and pgl4 (115310) | rel=r_associated | relid=0 | w=15
  6077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pseudohypoparathyroidism type ia (103580)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pseudohypoparathyroidism type ia (103580) | rel=r_associated | relid=0 | w=15
  6078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pseudohypoparathyroidism type ia (php1a, 103580)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pseudohypoparathyroidism type ia (php1a, 103580) | rel=r_associated | relid=0 | w=15
  6079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pseudohypoparathyroidism type ib (603233) and ic (612462)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pseudohypoparathyroidism type ib (603233) and ic (612462) | rel=r_associated | relid=0 | w=15
  6080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also pseudopseudohypoparathyroidism (612463)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also pseudopseudohypoparathyroidism (612463) | rel=r_associated | relid=0 | w=15
  6081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also recessive deb (226600), an allelic disorder with a more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see also recessive deb (226600), an allelic disorder with a more severe phenotype | rel=r_associated | relid=0 | w=15
  6082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also severe, early-onset form (300717)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also severe, early-onset form (300717) | rel=r_associated | relid=0 | w=15
  6083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also simplex eb with pyloric atresia (612138)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also simplex eb with pyloric atresia (612138) | rel=r_associated | relid=0 | w=15
  6084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also simpson-golabi-behmel syndrome 1 (sgbs1, 312870)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also simpson-golabi-behmel syndrome 1 (sgbs1, 312870) | rel=r_associated | relid=0 | w=15
  6085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also the autosomal recessive form (243000)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also the autosomal recessive form (243000) | rel=r_associated | relid=0 | w=15
  6086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also the homozygous state, mosaic variegated aneuploidy (mva, 257300)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also the homozygous state, mosaic variegated aneuploidy (mva, 257300) | rel=r_associated | relid=0 | w=15
  6087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also the lethal neonatal (608836) and infantile (600649) forms
    n1=Hyde (prurigo nodulaire de) | n2=en:see also the lethal neonatal (608836) and infantile (600649) forms | rel=r_associated | relid=0 | w=15
  6088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also the non-herlitz type of jeb (226650), a less severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:see also the non-herlitz type of jeb (226650), a less severe disorder | rel=r_associated | relid=0 | w=15
  6089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also the x-linked form (300291)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also the x-linked form (300291) | rel=r_associated | relid=0 | w=15
  6090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also two x-linked forms 300633 and 300758
    n1=Hyde (prurigo nodulaire de) | n2=en:see also two x-linked forms 300633 and 300758 | rel=r_associated | relid=0 | w=15
  6091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked (310400) and autosomal dominant (160150) forms
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked (310400) and autosomal dominant (160150) forms | rel=r_associated | relid=0 | w=15
  6092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked alpha-thalassemia/mental retardation syndrome (301040)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked alpha-thalassemia/mental retardation syndrome (301040) | rel=r_associated | relid=0 | w=15
  6093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked dominant form (300652)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked dominant form (300652) | rel=r_associated | relid=0 | w=15
  6094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked edmd (310300)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked edmd (310300) | rel=r_associated | relid=0 | w=15
  6095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked leigh syndrome (312170)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked leigh syndrome (312170) | rel=r_associated | relid=0 | w=15
  6096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see also x-linked nephrocalcinosis (310468), x-linked recessive hypophosphatemic rickets (300554), and low-molecular-weight proteinuria with nephrocalcinosis (308990)
    n1=Hyde (prurigo nodulaire de) | n2=en:see also x-linked nephrocalcinosis (310468), x-linked recessive hypophosphatemic rickets (300554), and low-molecular-weight proteinuria with nephrocalcinosis (308990) | rel=r_associated | relid=0 | w=15
  6097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see cmt4a (214400) for autosomal recessive demyelinating forms
    n1=Hyde (prurigo nodulaire de) | n2=en:see cmt4a (214400) for autosomal recessive demyelinating forms | rel=r_associated | relid=0 | w=15
  6098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see ebn1 (121200) for an autosomal dominant form
    n1=Hyde (prurigo nodulaire de) | n2=en:see ebn1 (121200) for an autosomal dominant form | rel=r_associated | relid=0 | w=15
  6099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see entry 104300 for general information on alzheimer disease
    n1=Hyde (prurigo nodulaire de) | n2=en:see entry 104300 for general information on alzheimer disease | rel=r_associated | relid=0 | w=15
  6100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see joubert syndrome 7 (611560), an allelic disorder with a less severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see joubert syndrome 7 (611560), an allelic disorder with a less severe phenotype | rel=r_associated | relid=0 | w=15
  6101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see myotonic dystonia 1 (dm1, 160900) for a disorder with a similar phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:see myotonic dystonia 1 (dm1, 160900) for a disorder with a similar phenotype | rel=r_associated | relid=0 | w=15
  6102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see pkd1 (601313) due to mutation in polycystin 1 (601313), pkd2 (173910) due to mutation in polycystin 2 (173910), and pkd3 (600666)
    n1=Hyde (prurigo nodulaire de) | n2=en:see pkd1 (601313) due to mutation in polycystin 1 (601313), pkd2 (173910) due to mutation in polycystin 2 (173910), and pkd3 (600666) | rel=r_associated | relid=0 | w=15
  6103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see speech-language disorder 1 602081 and familial developmental dysphasia 600117 for similar disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:see speech-language disorder 1 602081 and familial developmental dysphasia 600117 for similar disorders | rel=r_associated | relid=0 | w=15
  6104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:see the more common methemoglobinemia types i and ii (250800)
    n1=Hyde (prurigo nodulaire de) | n2=en:see the more common methemoglobinemia types i and ii (250800) | rel=r_associated | relid=0 | w=15
  6105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seen more frequently in infants of diabetic mothers
    n1=Hyde (prurigo nodulaire de) | n2=en:seen more frequently in infants of diabetic mothers | rel=r_associated | relid=0 | w=15
  6106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:segmental distribution often affecting 1 limb
    n1=Hyde (prurigo nodulaire de) | n2=en:segmental distribution often affecting 1 limb | rel=r_associated | relid=0 | w=15
  6107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure frequency decreases during early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure frequency decreases during early childhood | rel=r_associated | relid=0 | w=15
  6108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure onset after 3 months
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure onset after 3 months | rel=r_associated | relid=0 | w=15
  6109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure onset at a mean of 14 months (range 6 to 36 months)
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure onset at a mean of 14 months (range 6 to 36 months) | rel=r_associated | relid=0 | w=15
  6110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure onset between 3 and 11 years
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure onset between 3 and 11 years | rel=r_associated | relid=0 | w=15
  6111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure onset in first months or years of life
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure onset in first months or years of life | rel=r_associated | relid=0 | w=15
  6112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizure severity and frequency tend to improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:seizure severity and frequency tend to improve with age | rel=r_associated | relid=0 | w=15
  6113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures and cognitive involvement are variable findings
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures and cognitive involvement are variable findings | rel=r_associated | relid=0 | w=15
  6114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures and dystonia peak during childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures and dystonia peak during childhood | rel=r_associated | relid=0 | w=15
  6115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are easily controlled by medications
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are easily controlled by medications | rel=r_associated | relid=0 | w=15
  6116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are fever-sensitive
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are fever-sensitive | rel=r_associated | relid=0 | w=15
  6117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are followed by drowsiness in most cases
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are followed by drowsiness in most cases | rel=r_associated | relid=0 | w=15
  6118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are often refractory
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are often refractory | rel=r_associated | relid=0 | w=15
  6119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are poorly responsive to treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are poorly responsive to treatment | rel=r_associated | relid=0 | w=15
  6120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are provoked by immersion in hot or warm water
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are provoked by immersion in hot or warm water | rel=r_associated | relid=0 | w=15
  6121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are refractory
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are refractory | rel=r_associated | relid=0 | w=15
  6122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are refractory to medication
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are refractory to medication | rel=r_associated | relid=0 | w=15
  6123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are refractory to treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are refractory to treatment | rel=r_associated | relid=0 | w=15
  6124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are responsive to pyridoxine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are responsive to pyridoxine treatment | rel=r_associated | relid=0 | w=15
  6125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are sensitive to hyperventilation
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are sensitive to hyperventilation | rel=r_associated | relid=0 | w=15
  6126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are usually intractable
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are usually intractable | rel=r_associated | relid=0 | w=15
  6127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are usually refractory
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are usually refractory | rel=r_associated | relid=0 | w=15
  6128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures are usually refractory at first
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures are usually refractory at first | rel=r_associated | relid=0 | w=15
  6129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures become nearly continuous
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures become nearly continuous | rel=r_associated | relid=0 | w=15
  6130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures easily controlled by medications
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures easily controlled by medications | rel=r_associated | relid=0 | w=15
  6131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures last about 30 seconds to 3 minutes
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures last about 30 seconds to 3 minutes | rel=r_associated | relid=0 | w=15
  6132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may be precipitated by sleep deprivation, alcohol consumption, or flashing lights
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may be precipitated by sleep deprivation, alcohol consumption, or flashing lights | rel=r_associated | relid=0 | w=15
  6133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may be refractory
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may be refractory | rel=r_associated | relid=0 | w=15
  6134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may be triggered by infection
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may be triggered by infection | rel=r_associated | relid=0 | w=15
  6135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may improve with age | rel=r_associated | relid=0 | w=15
  6136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may occur upon awakening or at any time during the day
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may occur upon awakening or at any time during the day | rel=r_associated | relid=0 | w=15
  6137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may occur with illness
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may occur with illness | rel=r_associated | relid=0 | w=15
  6138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may persist into adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may persist into adulthood | rel=r_associated | relid=0 | w=15
  6139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may remit in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may remit in adolescence | rel=r_associated | relid=0 | w=15
  6140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures may remit with age (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures may remit with age (in some patients) | rel=r_associated | relid=0 | w=15
  6141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures occur in absence of intracranial infection or defined pathologic or traumatic cause | rel=r_associated | relid=0 | w=15
  6142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures occur upon awakening
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures occur upon awakening | rel=r_associated | relid=0 | w=15
  6143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures precipitated by fatigue or alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures precipitated by fatigue or alcohol | rel=r_associated | relid=0 | w=15
  6144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures recur in 33% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures recur in 33% of patients | rel=r_associated | relid=0 | w=15
  6145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures remit by age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures remit by age 5 years | rel=r_associated | relid=0 | w=15
  6146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures remit in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures remit in early childhood | rel=r_associated | relid=0 | w=15
  6147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures remit in later childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures remit in later childhood | rel=r_associated | relid=0 | w=15
  6148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures resolve by 4 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures resolve by 4 months of age | rel=r_associated | relid=0 | w=15
  6149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures tend to become more focal with age
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures tend to become more focal with age | rel=r_associated | relid=0 | w=15
  6150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures tend to occur upon awakening
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures tend to occur upon awakening | rel=r_associated | relid=0 | w=15
  6151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures tend to remit later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures tend to remit later in childhood | rel=r_associated | relid=0 | w=15
  6152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures usually occur in the first months of life
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures usually occur in the first months of life | rel=r_associated | relid=0 | w=15
  6153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures usually remit in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures usually remit in adolescence | rel=r_associated | relid=0 | w=15
  6154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures usually remit spontaneously by 12 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures usually remit spontaneously by 12 months of age | rel=r_associated | relid=0 | w=15
  6155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seizures, recurrent, refractory
    n1=Hyde (prurigo nodulaire de) | n2=en:seizures, recurrent, refractory | rel=r_associated | relid=0 | w=15
  6156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sener syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:sener syndrome | rel=r_associated | relid=0 | w=15
  6157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sensorineural hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:sensorineural hearing loss | rel=r_associated | relid=0 | w=15
  6158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sensorineural hearing loss may be presenting feature
    n1=Hyde (prurigo nodulaire de) | n2=en:sensorineural hearing loss may be presenting feature | rel=r_associated | relid=0 | w=15
  6159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sensory loss is rapidly progressive and severe
    n1=Hyde (prurigo nodulaire de) | n2=en:sensory loss is rapidly progressive and severe | rel=r_associated | relid=0 | w=15
  6160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:serum triglycerides decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:serum triglycerides decrease with age | rel=r_associated | relid=0 | w=15
  6161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 01:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 01:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 02:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 02:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 03:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 03:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 04:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 04:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 05:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 05:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 06:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 06:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 07:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 07:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 08:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 08:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 09:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 09:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 10:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 10:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 11:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 11:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 12:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 12:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 13:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 13:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 14:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 14:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 15:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 15:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 16:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 16:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 17:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 17:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 18:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 18:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 19:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 19:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 20:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 20:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 21:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 21:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 22:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 22:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 23:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 23:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 24:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 24:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 25:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 25:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 26:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 26:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 27:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 27:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 28:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 28:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 29:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 29:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 30:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 30:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 31:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 31:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 32:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 32:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 33:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 33:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 34:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 34:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 35:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 35:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 36:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 36:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 37:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 37:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 38:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 38:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 39:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 39:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 40:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 40:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 41:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 41:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 42:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 42:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 43:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 43:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 44:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 44:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 45:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 45:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 46:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 46:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 47:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 47:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 48:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 48:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 49:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 49:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 50:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 50:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 51:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 51:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 52:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 52:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 53:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 53:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 54:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 54:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 55:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 55:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 56:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 56:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 57:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 57:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 58:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 58:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 59:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 59:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 60:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 60:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 61:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 61:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 62:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 62:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 63:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 63:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 64:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 64:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 65:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 65:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 66:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 66:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 67:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 67:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 68:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 68:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 69:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 69:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 70:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 70:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 71:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 71:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 72:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 72:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 73:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 73:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 74:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 74:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 75:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 75:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 76:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 76:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 77:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 77:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 78:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 78:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 79:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 79:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:service comment 80:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:service comment 80:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seven patients reported (as of march 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:seven patients reported (as of march 2011) | rel=r_associated | relid=0 | w=15
  6242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seventy percent of cases are stillborn
    n1=Hyde (prurigo nodulaire de) | n2=en:seventy percent of cases are stillborn | rel=r_associated | relid=0 | w=15
  6243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:seventy percent of cases have associated anomalies
    n1=Hyde (prurigo nodulaire de) | n2=en:seventy percent of cases have associated anomalies | rel=r_associated | relid=0 | w=15
  6244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:several forms of autosomal recessive spastic paraplegia (see 270800)
    n1=Hyde (prurigo nodulaire de) | n2=en:several forms of autosomal recessive spastic paraplegia (see 270800) | rel=r_associated | relid=0 | w=15
  6245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe ambulatory restriction
    n1=Hyde (prurigo nodulaire de) | n2=en:severe ambulatory restriction | rel=r_associated | relid=0 | w=15
  6246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe clinical course
    n1=Hyde (prurigo nodulaire de) | n2=en:severe clinical course | rel=r_associated | relid=0 | w=15
  6247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe course
    n1=Hyde (prurigo nodulaire de) | n2=en:severe course | rel=r_associated | relid=0 | w=15
  6248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:severe disorder | rel=r_associated | relid=0 | w=15
  6249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe epilepsy may lead to early death
    n1=Hyde (prurigo nodulaire de) | n2=en:severe epilepsy may lead to early death | rel=r_associated | relid=0 | w=15
  6250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe form with onset at 3 to 4 months of age and severe developmental delay
    n1=Hyde (prurigo nodulaire de) | n2=en:severe form with onset at 3 to 4 months of age and severe developmental delay | rel=r_associated | relid=0 | w=15
  6251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe hearing loss by age 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:severe hearing loss by age 50 years | rel=r_associated | relid=0 | w=15
  6252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe incapacitation in 10-20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:severe incapacitation in 10-20 years | rel=r_associated | relid=0 | w=15
  6253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe infantile cases usually die by 6 months
    n1=Hyde (prurigo nodulaire de) | n2=en:severe infantile cases usually die by 6 months | rel=r_associated | relid=0 | w=15
  6254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe infantile form presents before 6 months
    n1=Hyde (prurigo nodulaire de) | n2=en:severe infantile form presents before 6 months | rel=r_associated | relid=0 | w=15
  6255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe infections in untreated patients with neutropenia
    n1=Hyde (prurigo nodulaire de) | n2=en:severe infections in untreated patients with neutropenia | rel=r_associated | relid=0 | w=15
  6256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe involvement of legs
    n1=Hyde (prurigo nodulaire de) | n2=en:severe involvement of legs | rel=r_associated | relid=0 | w=15
  6257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe neurodegenerative course resulting in a comatose state or death
    n1=Hyde (prurigo nodulaire de) | n2=en:severe neurodegenerative course resulting in a comatose state or death | rel=r_associated | relid=0 | w=15
  6258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:severe phenotype | rel=r_associated | relid=0 | w=15
  6259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe phenotype onset - neonate
    n1=Hyde (prurigo nodulaire de) | n2=en:severe phenotype onset - neonate | rel=r_associated | relid=0 | w=15
  6260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=en:severe polyhydramnios | rel=r_associated | relid=0 | w=15
  6261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe volume depletion
    n1=Hyde (prurigo nodulaire de) | n2=en:severe volume depletion | rel=r_associated | relid=0 | w=15
  6262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severe, early-onset, usually within the first days of life, with cardiomyopathy and early death
    n1=Hyde (prurigo nodulaire de) | n2=en:severe, early-onset, usually within the first days of life, with cardiomyopathy and early death | rel=r_associated | relid=0 | w=15
  6263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severely affected individuals may carry 2 mutated alleles
    n1=Hyde (prurigo nodulaire de) | n2=en:severely affected individuals may carry 2 mutated alleles | rel=r_associated | relid=0 | w=15
  6264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severity of clinical phenotype varies both within and between kindreds
    n1=Hyde (prurigo nodulaire de) | n2=en:severity of clinical phenotype varies both within and between kindreds | rel=r_associated | relid=0 | w=15
  6265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severity of hematologic disorder decreases with advancing age
    n1=Hyde (prurigo nodulaire de) | n2=en:severity of hematologic disorder decreases with advancing age | rel=r_associated | relid=0 | w=15
  6266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severity of phenotype is not related to residual enzyme activity
    n1=Hyde (prurigo nodulaire de) | n2=en:severity of phenotype is not related to residual enzyme activity | rel=r_associated | relid=0 | w=15
  6267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severity of phenotype may vary with x-inactivation patterns and/or mutation type
    n1=Hyde (prurigo nodulaire de) | n2=en:severity of phenotype may vary with x-inactivation patterns and/or mutation type | rel=r_associated | relid=0 | w=15
  6268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:severity of skin symptoms may vary within families
    n1=Hyde (prurigo nodulaire de) | n2=en:severity of skin symptoms may vary within families | rel=r_associated | relid=0 | w=15
  6269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sex ratio - 2 females to 1 male
    n1=Hyde (prurigo nodulaire de) | n2=en:sex ratio - 2 females to 1 male | rel=r_associated | relid=0 | w=15
  6270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sex ratio - 2.3 males-to-1 female
    n1=Hyde (prurigo nodulaire de) | n2=en:sex ratio - 2.3 males-to-1 female | rel=r_associated | relid=0 | w=15
  6271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sex ratio of 4-4.5 males to 1 female
    n1=Hyde (prurigo nodulaire de) | n2=en:sex ratio of 4-4.5 males to 1 female | rel=r_associated | relid=0 | w=15
  6272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sexual infantilism
    n1=Hyde (prurigo nodulaire de) | n2=en:sexual infantilism | rel=r_associated | relid=0 | w=15
  6273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:shields classification -
    n1=Hyde (prurigo nodulaire de) | n2=en:shields classification - | rel=r_associated | relid=0 | w=15
  6274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short is an acronym for short stature, hyperextensibility of joints/hernia, ocular depression, rieger anomaly, teething delay
    n1=Hyde (prurigo nodulaire de) | n2=en:short is an acronym for short stature, hyperextensibility of joints/hernia, ocular depression, rieger anomaly, teething delay | rel=r_associated | relid=0 | w=15
  6275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short limbs become more apparent during childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:short limbs become more apparent during childhood | rel=r_associated | relid=0 | w=15
  6276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short rib-polydactyly syndrome, beemer type
    n1=Hyde (prurigo nodulaire de) | n2=en:short rib-polydactyly syndrome, beemer type | rel=r_associated | relid=0 | w=15
  6277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short stepped shuffling gait
    n1=Hyde (prurigo nodulaire de) | n2=en:short stepped shuffling gait | rel=r_associated | relid=0 | w=15
  6278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short survival (less than 10 years after onset)
    n1=Hyde (prurigo nodulaire de) | n2=en:short survival (less than 10 years after onset) | rel=r_associated | relid=0 | w=15
  6279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short umbilical cord
    n1=Hyde (prurigo nodulaire de) | n2=en:short umbilical cord | rel=r_associated | relid=0 | w=15
  6280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:short-rib thoracic dysplasia 8 with or without polydactyly
    n1=Hyde (prurigo nodulaire de) | n2=en:short-rib thoracic dysplasia 8 with or without polydactyly | rel=r_associated | relid=0 | w=15
  6281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:shoulder dystocia
    n1=Hyde (prurigo nodulaire de) | n2=en:shoulder dystocia | rel=r_associated | relid=0 | w=15
  6282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:significant clinical overlap with sotos syndrome (117550)
    n1=Hyde (prurigo nodulaire de) | n2=en:significant clinical overlap with sotos syndrome (117550) | rel=r_associated | relid=0 | w=15
  6283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:significant number of patients are stillborn or die in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:significant number of patients are stillborn or die in neonatal period | rel=r_associated | relid=0 | w=15
  6284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:significant phenotypic variability
    n1=Hyde (prurigo nodulaire de) | n2=en:significant phenotypic variability | rel=r_associated | relid=0 | w=15
  6285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:signs and symptoms depend on tumor location and activity
    n1=Hyde (prurigo nodulaire de) | n2=en:signs and symptoms depend on tumor location and activity | rel=r_associated | relid=0 | w=15
  6286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar clinical features to edsi (130000) but less severe
    n1=Hyde (prurigo nodulaire de) | n2=en:similar clinical features to edsi (130000) but less severe | rel=r_associated | relid=0 | w=15
  6287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar clinical phenotype to edsiii (130020)
    n1=Hyde (prurigo nodulaire de) | n2=en:similar clinical phenotype to edsiii (130020) | rel=r_associated | relid=0 | w=15
  6288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar disorder to x-linked pelizaeus-merzbacher disease (pmd, 312080)
    n1=Hyde (prurigo nodulaire de) | n2=en:similar disorder to x-linked pelizaeus-merzbacher disease (pmd, 312080) | rel=r_associated | relid=0 | w=15
  6289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar phenotype to juvenile neuronal ceroid lipofuscinosis 3 (cln3, 204200)
    n1=Hyde (prurigo nodulaire de) | n2=en:similar phenotype to juvenile neuronal ceroid lipofuscinosis 3 (cln3, 204200) | rel=r_associated | relid=0 | w=15
  6290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar phenotype to x-linked hypophosphatemia (xlh, 307800)
    n1=Hyde (prurigo nodulaire de) | n2=en:similar phenotype to x-linked hypophosphatemia (xlh, 307800) | rel=r_associated | relid=0 | w=15
  6291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar to infantile neuroaxonal dystrophy (inad, 256600)
    n1=Hyde (prurigo nodulaire de) | n2=en:similar to infantile neuroaxonal dystrophy (inad, 256600) | rel=r_associated | relid=0 | w=15
  6292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:similar to spondylometaphyseal dysplasia, type a4 (609052) but without anterior tonguing of vertebrae
    n1=Hyde (prurigo nodulaire de) | n2=en:similar to spondylometaphyseal dysplasia, type a4 (609052) but without anterior tonguing of vertebrae | rel=r_associated | relid=0 | w=15
  6293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:simple febrile seizures usually remit by age 6 years
    n1=Hyde (prurigo nodulaire de) | n2=en:simple febrile seizures usually remit by age 6 years | rel=r_associated | relid=0 | w=15
  6294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:single lesions in sporadic cases
    n1=Hyde (prurigo nodulaire de) | n2=en:single lesions in sporadic cases | rel=r_associated | relid=0 | w=15
  6295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:single mitochondrial dna deletions are found in sporadic kss patients
    n1=Hyde (prurigo nodulaire de) | n2=en:single mitochondrial dna deletions are found in sporadic kss patients | rel=r_associated | relid=0 | w=15
  6296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:single umbilical artery
    n1=Hyde (prurigo nodulaire de) | n2=en:single umbilical artery | rel=r_associated | relid=0 | w=15
  6297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sister of affected male siblings had mild learning disabilities and obesity
    n1=Hyde (prurigo nodulaire de) | n2=en:sister of affected male siblings had mild learning disabilities and obesity | rel=r_associated | relid=0 | w=15
  6298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six genetically confirmed patients have been reported (as of december 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:six genetically confirmed patients have been reported (as of december 2009) | rel=r_associated | relid=0 | w=15
  6299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients from 1 saudi arabian family have been reported (last curated december 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients from 1 saudi arabian family have been reported (last curated december 2011) | rel=r_associated | relid=0 | w=15
  6300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients from 4 families have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients from 4 families have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients have been reported (5/18/2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients have been reported (5/18/2011) | rel=r_associated | relid=0 | w=15
  6302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients have been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients have been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  6303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients have been reported (as of october 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients have been reported (as of october 2011) | rel=r_associated | relid=0 | w=15
  6304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:six patients reported (last curated march 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:six patients reported (last curated march 2015) | rel=r_associated | relid=0 | w=15
  6305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:size of deletion varies from cytogenetically visible deletions to undetectable cytogenetic deletions
    n1=Hyde (prurigo nodulaire de) | n2=en:size of deletion varies from cytogenetically visible deletions to undetectable cytogenetic deletions | rel=r_associated | relid=0 | w=15
  6306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skeletal abnormalities are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:skeletal abnormalities are variable | rel=r_associated | relid=0 | w=15
  6307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skeletal and endocrine features have not been fully characterized in all of the patients reported
    n1=Hyde (prurigo nodulaire de) | n2=en:skeletal and endocrine features have not been fully characterized in all of the patients reported | rel=r_associated | relid=0 | w=15
  6308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skeletal and facial features are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:skeletal and facial features are variable | rel=r_associated | relid=0 | w=15
  6309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skeletal dysplasia and progressive central nervous system degeneration, lethal
    n1=Hyde (prurigo nodulaire de) | n2=en:skeletal dysplasia and progressive central nervous system degeneration, lethal | rel=r_associated | relid=0 | w=15
  6310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skewed x-inactivation in carriers
    n1=Hyde (prurigo nodulaire de) | n2=en:skewed x-inactivation in carriers | rel=r_associated | relid=0 | w=15
  6311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin abnormalities can be present at birth or appear later in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin abnormalities can be present at birth or appear later in infancy or childhood | rel=r_associated | relid=0 | w=15
  6312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin abnormalities tend to decrease with age
    n1=Hyde (prurigo nodulaire de) | n2=en:skin abnormalities tend to decrease with age | rel=r_associated | relid=0 | w=15
  6313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin appears normal at birth, with development of generalized ichthyosis in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin appears normal at birth, with development of generalized ichthyosis in childhood | rel=r_associated | relid=0 | w=15
  6314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin blistering and photosensitivity improve in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin blistering and photosensitivity improve in adulthood | rel=r_associated | relid=0 | w=15
  6315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin changes are progressive in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin changes are progressive in childhood | rel=r_associated | relid=0 | w=15
  6316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin changes have onset in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin changes have onset in childhood | rel=r_associated | relid=0 | w=15
  6317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin cleanser
    n1=Hyde (prurigo nodulaire de) | n2=en:skin cleanser | rel=r_associated | relid=0 | w=15
  6318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin erythroderma may resolve early, leaving atrophic lesions
    n1=Hyde (prurigo nodulaire de) | n2=en:skin erythroderma may resolve early, leaving atrophic lesions | rel=r_associated | relid=0 | w=15
  6319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin hydration
    n1=Hyde (prurigo nodulaire de) | n2=en:skin hydration | rel=r_associated | relid=0 | w=15
  6320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesion appear shortly after birth and tend to disappear in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesion appear shortly after birth and tend to disappear in young adulthood | rel=r_associated | relid=0 | w=15
  6321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions are fully penetrant by second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions are fully penetrant by second decade | rel=r_associated | relid=0 | w=15
  6322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions are primarily trauma-induced but occasionally appear spontaneously
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions are primarily trauma-induced but occasionally appear spontaneously | rel=r_associated | relid=0 | w=15
  6323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions exacerbated by heat, exercise (sweating), and sunlight
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions exacerbated by heat, exercise (sweating), and sunlight | rel=r_associated | relid=0 | w=15
  6324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions improve in the summer
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions improve in the summer | rel=r_associated | relid=0 | w=15
  6325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions manifest in the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions manifest in the first year of life | rel=r_associated | relid=0 | w=15
  6326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions resolve between 6 months and 2 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions resolve between 6 months and 2 years of age | rel=r_associated | relid=0 | w=15
  6327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions tend to occur on distal extremities or at elbows and knees
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions tend to occur on distal extremities or at elbows and knees | rel=r_associated | relid=0 | w=15
  6328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin lesions worsen with heat or sun exposure
    n1=Hyde (prurigo nodulaire de) | n2=en:skin lesions worsen with heat or sun exposure | rel=r_associated | relid=0 | w=15
  6329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin manifestation less frequently observed in cold climates
    n1=Hyde (prurigo nodulaire de) | n2=en:skin manifestation less frequently observed in cold climates | rel=r_associated | relid=0 | w=15
  6330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin manifestations appear in infancy or childhood and are gradually progressive until the mid-to-late second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:skin manifestations appear in infancy or childhood and are gradually progressive until the mid-to-late second decade of life | rel=r_associated | relid=0 | w=15
  6331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin manifestations are more severe and of later onset than papillon-lefevre syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:skin manifestations are more severe and of later onset than papillon-lefevre syndrome | rel=r_associated | relid=0 | w=15
  6332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin manifestations may not be present
    n1=Hyde (prurigo nodulaire de) | n2=en:skin manifestations may not be present | rel=r_associated | relid=0 | w=15
  6333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin peeling exacerbated by heat, friction, and humidity
    n1=Hyde (prurigo nodulaire de) | n2=en:skin peeling exacerbated by heat, friction, and humidity | rel=r_associated | relid=0 | w=15
  6334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:skin wrinkling improves with age
    n1=Hyde (prurigo nodulaire de) | n2=en:skin wrinkling improves with age | rel=r_associated | relid=0 | w=15
  6335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slc25a4 mutations account for approximately 4% of all peo cases
    n1=Hyde (prurigo nodulaire de) | n2=en:slc25a4 mutations account for approximately 4% of all peo cases | rel=r_associated | relid=0 | w=15
  6336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sleep disturbance or sleep apnea (obstructive, central, or mixed)
    n1=Hyde (prurigo nodulaire de) | n2=en:sleep disturbance or sleep apnea (obstructive, central, or mixed) | rel=r_associated | relid=0 | w=15
  6337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sleep terrors usually remit during adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:sleep terrors usually remit during adolescence | rel=r_associated | relid=0 | w=15
  6338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sleepwalking triggered by alcohol, sleep deprivation, stress
    n1=Hyde (prurigo nodulaire de) | n2=en:sleepwalking triggered by alcohol, sleep deprivation, stress | rel=r_associated | relid=0 | w=15
  6339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sleepwalking usually remits in adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:sleepwalking usually remits in adolescence | rel=r_associated | relid=0 | w=15
  6340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slight increased risk for malignancy
    n1=Hyde (prurigo nodulaire de) | n2=en:slight increased risk for malignancy | rel=r_associated | relid=0 | w=15
  6341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slight male predominance (3:2)
    n1=Hyde (prurigo nodulaire de) | n2=en:slight male predominance (3:2) | rel=r_associated | relid=0 | w=15
  6342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slightly increased female:male ratio (1.4:1 to 2:1)
    n1=Hyde (prurigo nodulaire de) | n2=en:slightly increased female:male ratio (1.4:1 to 2:1) | rel=r_associated | relid=0 | w=15
  6343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slow course of functional deterioration compared to severity of mri findings
    n1=Hyde (prurigo nodulaire de) | n2=en:slow course of functional deterioration compared to severity of mri findings | rel=r_associated | relid=0 | w=15
  6344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slow or nonprogressive
    n1=Hyde (prurigo nodulaire de) | n2=en:slow or nonprogressive | rel=r_associated | relid=0 | w=15
  6345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slow progression
    n1=Hyde (prurigo nodulaire de) | n2=en:slow progression | rel=r_associated | relid=0 | w=15
  6346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slow progression without marked disability
    n1=Hyde (prurigo nodulaire de) | n2=en:slow progression without marked disability | rel=r_associated | relid=0 | w=15
  6347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slow, progressive growth, then stable
    n1=Hyde (prurigo nodulaire de) | n2=en:slow, progressive growth, then stable | rel=r_associated | relid=0 | w=15
  6348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slowly or non-progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:slowly or non-progressive | rel=r_associated | relid=0 | w=15
  6349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slowly or nonprogressive
    n1=Hyde (prurigo nodulaire de) | n2=en:slowly or nonprogressive | rel=r_associated | relid=0 | w=15
  6350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slowly progressive disease
    n1=Hyde (prurigo nodulaire de) | n2=en:slowly progressive disease | rel=r_associated | relid=0 | w=15
  6351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:slowly progressive or nonprogressive course
    n1=Hyde (prurigo nodulaire de) | n2=en:slowly progressive or nonprogressive course | rel=r_associated | relid=0 | w=15
  6352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:small for gestational age
    n1=Hyde (prurigo nodulaire de) | n2=en:small for gestational age | rel=r_associated | relid=0 | w=15
  6353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:small placenta
    n1=Hyde (prurigo nodulaire de) | n2=en:small placenta | rel=r_associated | relid=0 | w=15
  6354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:smaller repeat lengths in younger generations (reverse anticipation)
    n1=Hyde (prurigo nodulaire de) | n2=en:smaller repeat lengths in younger generations (reverse anticipation) | rel=r_associated | relid=0 | w=15
  6355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sodium
    n1=Hyde (prurigo nodulaire de) | n2=en:sodium | rel=r_associated | relid=0 | w=15
  6356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sodium citrate and citric acid
    n1=Hyde (prurigo nodulaire de) | n2=en:sodium citrate and citric acid | rel=r_associated | relid=0 | w=15
  6357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sodium/potassium-transporting atpase subunit alpha-1
    n1=Hyde (prurigo nodulaire de) | n2=en:sodium/potassium-transporting atpase subunit alpha-1 | rel=r_associated | relid=0 | w=15
  6358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:solitary disease is more common in males
    n1=Hyde (prurigo nodulaire de) | n2=en:solitary disease is more common in males | rel=r_associated | relid=0 | w=15
  6359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:somatic mutations occur in adrenal tumor tissue (601639.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:somatic mutations occur in adrenal tumor tissue (601639.0001) | rel=r_associated | relid=0 | w=15
  6360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:somatic or germline mosaicism may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:somatic or germline mosaicism may occur | rel=r_associated | relid=0 | w=15
  6361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some affected individuals have normal subsequent development
    n1=Hyde (prurigo nodulaire de) | n2=en:some affected individuals have normal subsequent development | rel=r_associated | relid=0 | w=15
  6362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some boys with premutations (55 to 200 repeats) may show milder features, including autistic features
    n1=Hyde (prurigo nodulaire de) | n2=en:some boys with premutations (55 to 200 repeats) may show milder features, including autistic features | rel=r_associated | relid=0 | w=15
  6363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some carrier females have episodes of significant hyperammonemia in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:some carrier females have episodes of significant hyperammonemia in infancy or childhood | rel=r_associated | relid=0 | w=15
  6364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some carrier females have mild features
    n1=Hyde (prurigo nodulaire de) | n2=en:some carrier females have mild features | rel=r_associated | relid=0 | w=15
  6365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some carrier females may manifest mild symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:some carrier females may manifest mild symptoms | rel=r_associated | relid=0 | w=15
  6366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some familial occurrence, most de novo aberrations
    n1=Hyde (prurigo nodulaire de) | n2=en:some familial occurrence, most de novo aberrations | rel=r_associated | relid=0 | w=15
  6367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some families have axonal cmt (cmt2m)
    n1=Hyde (prurigo nodulaire de) | n2=en:some families have axonal cmt (cmt2m) | rel=r_associated | relid=0 | w=15
  6368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features are variable
    n1=Hyde (prurigo nodulaire de) | n2=en:some features are variable | rel=r_associated | relid=0 | w=15
  6369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features are variable, even within families
    n1=Hyde (prurigo nodulaire de) | n2=en:some features are variable, even within families | rel=r_associated | relid=0 | w=15
  6370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features are variably expressed
    n1=Hyde (prurigo nodulaire de) | n2=en:some features are variably expressed | rel=r_associated | relid=0 | w=15
  6371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features are variably present
    n1=Hyde (prurigo nodulaire de) | n2=en:some features are variably present | rel=r_associated | relid=0 | w=15
  6372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features may be progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:some features may be progressive | rel=r_associated | relid=0 | w=15
  6373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features may be variable
    n1=Hyde (prurigo nodulaire de) | n2=en:some features may be variable | rel=r_associated | relid=0 | w=15
  6374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some features occur in adolescence, including migraine, seizures, and psychiatric disorders
    n1=Hyde (prurigo nodulaire de) | n2=en:some features occur in adolescence, including migraine, seizures, and psychiatric disorders | rel=r_associated | relid=0 | w=15
  6375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some female carriers are more mildly affected
    n1=Hyde (prurigo nodulaire de) | n2=en:some female carriers are more mildly affected | rel=r_associated | relid=0 | w=15
  6376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some female heterozygotes express phenotypic features (e.g., coarse facies, mild mental retardation)
    n1=Hyde (prurigo nodulaire de) | n2=en:some female heterozygotes express phenotypic features (e.g., coarse facies, mild mental retardation) | rel=r_associated | relid=0 | w=15
  6377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some females are affected
    n1=Hyde (prurigo nodulaire de) | n2=en:some females are affected | rel=r_associated | relid=0 | w=15
  6378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some females have only deafness and ovarian dysgenesis without neurologic abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:some females have only deafness and ovarian dysgenesis without neurologic abnormalities | rel=r_associated | relid=0 | w=15
  6379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some heterozygotes exhibit a mild phenotype of cutaneous syndactyly between the second and third toes
    n1=Hyde (prurigo nodulaire de) | n2=en:some heterozygotes exhibit a mild phenotype of cutaneous syndactyly between the second and third toes | rel=r_associated | relid=0 | w=15
  6380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some heterozygotes may have increased urinary excretion of cystine and may develop stones
    n1=Hyde (prurigo nodulaire de) | n2=en:some heterozygotes may have increased urinary excretion of cystine and may develop stones | rel=r_associated | relid=0 | w=15
  6381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some heterozygous carriers may have mild manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:some heterozygous carriers may have mild manifestations | rel=r_associated | relid=0 | w=15
  6382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some heterozygous cpt2 mutation carriers may be symptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:some heterozygous cpt2 mutation carriers may be symptomatic | rel=r_associated | relid=0 | w=15
  6383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some more severely affected patients may die in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:some more severely affected patients may die in infancy | rel=r_associated | relid=0 | w=15
  6384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some mutation carriers have mild features of frontonasal dysplasia (613451)
    n1=Hyde (prurigo nodulaire de) | n2=en:some mutation carriers have mild features of frontonasal dysplasia (613451) | rel=r_associated | relid=0 | w=15
  6385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some mutations have been found in homozygosity and the phenotype is more severe than that of the heterozygous parents
    n1=Hyde (prurigo nodulaire de) | n2=en:some mutations have been found in homozygosity and the phenotype is more severe than that of the heterozygous parents | rel=r_associated | relid=0 | w=15
  6386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients acquire late ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients acquire late ambulation | rel=r_associated | relid=0 | w=15
  6387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients are asymptomatic and detected only by newborn screening
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients are asymptomatic and detected only by newborn screening | rel=r_associated | relid=0 | w=15
  6388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients are clinically unaffected.
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients are clinically unaffected. | rel=r_associated | relid=0 | w=15
  6389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients become wheelchair-bound | rel=r_associated | relid=0 | w=15
  6390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients born in consanguineous families may carry homozygous mutations, but the phenotype does not appear to be more severe
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients born in consanguineous families may carry homozygous mutations, but the phenotype does not appear to be more severe | rel=r_associated | relid=0 | w=15
  6391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients can attend special school
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients can attend special school | rel=r_associated | relid=0 | w=15
  6392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients can be treated with large doses of vitamin d and calcium
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients can be treated with large doses of vitamin d and calcium | rel=r_associated | relid=0 | w=15
  6393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients can hold menial jobs
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients can hold menial jobs | rel=r_associated | relid=0 | w=15
  6394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients carry heterozygous mutations
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients carry heterozygous mutations | rel=r_associated | relid=0 | w=15
  6395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients develop diabetes mellitus as adolescents
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients develop diabetes mellitus as adolescents | rel=r_associated | relid=0 | w=15
  6396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients develop ophthalmoplegia in middle age
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients develop ophthalmoplegia in middle age | rel=r_associated | relid=0 | w=15
  6397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not achieve independent ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not achieve independent ambulation | rel=r_associated | relid=0 | w=15
  6398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not develop renal failure
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not develop renal failure | rel=r_associated | relid=0 | w=15
  6399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not develop stroke
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not develop stroke | rel=r_associated | relid=0 | w=15
  6400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not have bone disease
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not have bone disease | rel=r_associated | relid=0 | w=15
  6401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not have dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not have dysmorphic features | rel=r_associated | relid=0 | w=15
  6402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not have thin corpus callosum
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not have thin corpus callosum | rel=r_associated | relid=0 | w=15
  6403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not manifest renal disease in the first decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not manifest renal disease in the first decade of life | rel=r_associated | relid=0 | w=15
  6404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not reach end-stage renal failure
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not reach end-stage renal failure | rel=r_associated | relid=0 | w=15
  6405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients do not show neurologic abnormalities or dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients do not show neurologic abnormalities or dysmorphic features | rel=r_associated | relid=0 | w=15
  6406. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients exhibit minimal central lesions with severe peripheral lesions, and vice-versa
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients exhibit minimal central lesions with severe peripheral lesions, and vice-versa | rel=r_associated | relid=0 | w=15
  6407. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients experience later reversal of hypogonadotropic hypogonadism
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients experience later reversal of hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=15
  6408. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a contiguous gene defect involving both the cyp21a2 (613815) and the tnxb (600985) genes
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a contiguous gene defect involving both the cyp21a2 (613815) and the tnxb (600985) genes | rel=r_associated | relid=0 | w=15
  6409. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a contiguous gene syndrome due to loss of adjacent genes (sts, 308100 and kal1, 300836) on xp22.3 via deletions and translocations
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a contiguous gene syndrome due to loss of adjacent genes (sts, 308100 and kal1, 300836) on xp22.3 via deletions and translocations | rel=r_associated | relid=0 | w=15
  6410. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a crouzon-like appearance
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a crouzon-like appearance | rel=r_associated | relid=0 | w=15
  6411. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a milder nonprogressive phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a milder nonprogressive phenotype | rel=r_associated | relid=0 | w=15
  6412. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a more severe phenotype and have febrile and afebrile seizures after childhood (gefs+)
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a more severe phenotype and have febrile and afebrile seizures after childhood (gefs+) | rel=r_associated | relid=0 | w=15
  6413. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a secreted but biologically inactive mutant leptin
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a secreted but biologically inactive mutant leptin | rel=r_associated | relid=0 | w=15
  6414. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have a severe phenotype with neurologic manifestations beginning at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have a severe phenotype with neurologic manifestations beginning at birth | rel=r_associated | relid=0 | w=15
  6415. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have additional neurologic involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have additional neurologic involvement | rel=r_associated | relid=0 | w=15
  6416. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have an attenuated phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have an attenuated phenotype | rel=r_associated | relid=0 | w=15
  6417. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have asymptomatic hypocalcemia
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have asymptomatic hypocalcemia | rel=r_associated | relid=0 | w=15
  6418. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have cessation of seizures at a mean of 12 years
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have cessation of seizures at a mean of 12 years | rel=r_associated | relid=0 | w=15
  6419. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have isolated cfeom
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have isolated cfeom | rel=r_associated | relid=0 | w=15
  6420. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have juvenile-onset myoclonic epilepsy
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have juvenile-onset myoclonic epilepsy | rel=r_associated | relid=0 | w=15
  6421. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have later onset and more variable phenotype (mngie)
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have later onset and more variable phenotype (mngie) | rel=r_associated | relid=0 | w=15
  6422. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have later onset of the disorder as young adults
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have later onset of the disorder as young adults | rel=r_associated | relid=0 | w=15
  6423. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have milder persistent blistering
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have milder persistent blistering | rel=r_associated | relid=0 | w=15
  6424. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have milder phenotype with later onset of symptoms, in second to third decades of life
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have milder phenotype with later onset of symptoms, in second to third decades of life | rel=r_associated | relid=0 | w=15
  6425. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have no clinical symptoms and are detected by routine newborn screening
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have no clinical symptoms and are detected by routine newborn screening | rel=r_associated | relid=0 | w=15
  6426. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have no manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have no manifestations | rel=r_associated | relid=0 | w=15
  6427. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have no or mild manifestations and normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have no or mild manifestations and normal development | rel=r_associated | relid=0 | w=15
  6428. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have only ambiguous genitalia or other evidence of disordered steroidogenesis
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have only ambiguous genitalia or other evidence of disordered steroidogenesis | rel=r_associated | relid=0 | w=15
  6429. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have only ocular involvement or only oral involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have only ocular involvement or only oral involvement | rel=r_associated | relid=0 | w=15
  6430. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have only plantar surface involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have only plantar surface involvement | rel=r_associated | relid=0 | w=15
  6431. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have onset at birth or in early infancy, whereas other have onset in late childhood or adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have onset at birth or in early infancy, whereas other have onset in late childhood or adolescence | rel=r_associated | relid=0 | w=15
  6432. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have persistence of seizures to adulthood, but then show remission
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have persistence of seizures to adulthood, but then show remission | rel=r_associated | relid=0 | w=15
  6433. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have resolution of symptoms in first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have resolution of symptoms in first year of life | rel=r_associated | relid=0 | w=15
  6434. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients have subclinical exocrine pancreatic deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients have subclinical exocrine pancreatic deficiency | rel=r_associated | relid=0 | w=15
  6435. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may be asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may be asymptomatic | rel=r_associated | relid=0 | w=15
  6436. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may be clinically asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may be clinically asymptomatic | rel=r_associated | relid=0 | w=15
  6437. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may become bedridden 10 to 20 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may become bedridden 10 to 20 years after onset | rel=r_associated | relid=0 | w=15
  6438. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may become wheelchair-bound | rel=r_associated | relid=0 | w=15
  6439. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may benefit from coenzyme q10 treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may benefit from coenzyme q10 treatment | rel=r_associated | relid=0 | w=15
  6440. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may develop concurrent failure to thrive and dyslipidemia
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may develop concurrent failure to thrive and dyslipidemia | rel=r_associated | relid=0 | w=15
  6441. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may develop interictal progressive ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may develop interictal progressive ataxia | rel=r_associated | relid=0 | w=15
  6442. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may die from cardiomyopathy in the first or second decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may die from cardiomyopathy in the first or second decade of life | rel=r_associated | relid=0 | w=15
  6443. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may die in infancy, whereas others survive into adulthood and are only mildly affected or essentially clinically asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may die in infancy, whereas others survive into adulthood and are only mildly affected or essentially clinically asymptomatic | rel=r_associated | relid=0 | w=15
  6444. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have a milder phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have a milder phenotype | rel=r_associated | relid=0 | w=15
  6445. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have a more protracted disorder with neurodegeneration
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have a more protracted disorder with neurodegeneration | rel=r_associated | relid=0 | w=15
  6446. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have isolated cardiac involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have isolated cardiac involvement | rel=r_associated | relid=0 | w=15
  6447. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have isolated myokymia
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have isolated myokymia | rel=r_associated | relid=0 | w=15
  6448. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have normal brain imaging
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have normal brain imaging | rel=r_associated | relid=0 | w=15
  6449. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have normal development until onset of seizures in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have normal development until onset of seizures in infancy | rel=r_associated | relid=0 | w=15
  6450. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have normal psychomotor development
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have normal psychomotor development | rel=r_associated | relid=0 | w=15
  6451. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have residual muscle weakness
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have residual muscle weakness | rel=r_associated | relid=0 | w=15
  6452. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may have unilateral involvement, may be able to raise the eye above midline, or may not have ptosis--these patients are classified as having cfeom3 (cfeom3b)
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may have unilateral involvement, may be able to raise the eye above midline, or may not have ptosis--these patients are classified as having cfeom3 (cfeom3b) | rel=r_associated | relid=0 | w=15
  6453. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may live to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may live to adulthood | rel=r_associated | relid=0 | w=15
  6454. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may lose independent ambulation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may lose independent ambulation | rel=r_associated | relid=0 | w=15
  6455. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may not achieve walking
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may not achieve walking | rel=r_associated | relid=0 | w=15
  6456. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may not have recurrent infections
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may not have recurrent infections | rel=r_associated | relid=0 | w=15
  6457. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may not present until adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may not present until adulthood | rel=r_associated | relid=0 | w=15
  6458. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may present with adult-onset small fiber neuropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may present with adult-onset small fiber neuropathy | rel=r_associated | relid=0 | w=15
  6459. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may present with myopathic features
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may present with myopathic features | rel=r_associated | relid=0 | w=15
  6460. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may present with transient neonatal hypotonia, and then later develop classic pmc in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may present with transient neonatal hypotonia, and then later develop classic pmc in childhood | rel=r_associated | relid=0 | w=15
  6461. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may respond to thiamine treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may respond to thiamine treatment | rel=r_associated | relid=0 | w=15
  6462. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may show a favorable response to oral coenzyme q10 supplementation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may show a favorable response to oral coenzyme q10 supplementation | rel=r_associated | relid=0 | w=15
  6463. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may show mild decrease in head circumference over time
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may show mild decrease in head circumference over time | rel=r_associated | relid=0 | w=15
  6464. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may show neurologic improvement late in life
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may show neurologic improvement late in life | rel=r_associated | relid=0 | w=15
  6465. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients may show response to immunosuppressive agents
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients may show response to immunosuppressive agents | rel=r_associated | relid=0 | w=15
  6466. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients never achieve sitting
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients never achieve sitting | rel=r_associated | relid=0 | w=15
  6467. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients never achieve walking or running
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients never achieve walking or running | rel=r_associated | relid=0 | w=15
  6468. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients never gain ambulation or become wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients never gain ambulation or become wheelchair-bound | rel=r_associated | relid=0 | w=15
  6469. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients present with apparent nonsyndromic dilated cardiomyopathy in early childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients present with apparent nonsyndromic dilated cardiomyopathy in early childhood | rel=r_associated | relid=0 | w=15
  6470. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients present with spasticity, whereas others present with cerebellar ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients present with spasticity, whereas others present with cerebellar ataxia | rel=r_associated | relid=0 | w=15
  6471. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients report cyclical changes in severity of symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients report cyclical changes in severity of symptoms | rel=r_associated | relid=0 | w=15
  6472. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients report increased tolerance to heat
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients report increased tolerance to heat | rel=r_associated | relid=0 | w=15
  6473. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients report seasonal variation in symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients report seasonal variation in symptoms | rel=r_associated | relid=0 | w=15
  6474. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients require cardiac transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients require cardiac transplantation | rel=r_associated | relid=0 | w=15
  6475. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients require insulin for treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients require insulin for treatment | rel=r_associated | relid=0 | w=15
  6476. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients respond to acetazolamide
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients respond to acetazolamide | rel=r_associated | relid=0 | w=15
  6477. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show a favorable response to sulfonylurea treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show a favorable response to sulfonylurea treatment | rel=r_associated | relid=0 | w=15
  6478. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show delayed development from birth
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show delayed development from birth | rel=r_associated | relid=0 | w=15
  6479. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show improvement during summer or with fever
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show improvement during summer or with fever | rel=r_associated | relid=0 | w=15
  6480. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show improvement in muscle power in the teenage years
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show improvement in muscle power in the teenage years | rel=r_associated | relid=0 | w=15
  6481. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show infantile onset
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show infantile onset | rel=r_associated | relid=0 | w=15
  6482. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show no bleeding abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show no bleeding abnormalities | rel=r_associated | relid=0 | w=15
  6483. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show normal development until onset of disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show normal development until onset of disorder | rel=r_associated | relid=0 | w=15
  6484. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show onset in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show onset in childhood | rel=r_associated | relid=0 | w=15
  6485. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show onset later in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show onset later in childhood | rel=r_associated | relid=0 | w=15
  6486. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show rapid disease progression
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show rapid disease progression | rel=r_associated | relid=0 | w=15
  6487. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients show significant clinical improvement with riboflavin supplementation
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients show significant clinical improvement with riboflavin supplementation | rel=r_associated | relid=0 | w=15
  6488. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients survive infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients survive infancy | rel=r_associated | relid=0 | w=15
  6489. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients with 2 opa1 mutations have a more severe phenotype with earlier onset
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients with 2 opa1 mutations have a more severe phenotype with earlier onset | rel=r_associated | relid=0 | w=15
  6490. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients with advanced loss of vision have normal eog
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients with advanced loss of vision have normal eog | rel=r_associated | relid=0 | w=15
  6491. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients with heterozygous mutations may be symptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients with heterozygous mutations may be symptomatic | rel=r_associated | relid=0 | w=15
  6492. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients with onset of severe disease in infancy are diagnosed with leber congenital amaurosis, whereas other patients with childhood onset of less severe retinal dystrophy are diagnosed with retinitis pigmentosa
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients with onset of severe disease in infancy are diagnosed with leber congenital amaurosis, whereas other patients with childhood onset of less severe retinal dystrophy are diagnosed with retinitis pigmentosa | rel=r_associated | relid=0 | w=15
  6493. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some patients with vitelliform macular dystrophy are homozygous or compound heterozygous for mutations in best1, with their heterozygous relatives showing milder forms of eye disease
    n1=Hyde (prurigo nodulaire de) | n2=en:some patients with vitelliform macular dystrophy are homozygous or compound heterozygous for mutations in best1, with their heterozygous relatives showing milder forms of eye disease | rel=r_associated | relid=0 | w=15
  6494. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some pedigrees are consistent with autosomal dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:some pedigrees are consistent with autosomal dominant inheritance | rel=r_associated | relid=0 | w=15
  6495. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some phenotypic overlap with alpers syndrome (mtdps4a, 203700)
    n1=Hyde (prurigo nodulaire de) | n2=en:some phenotypic overlap with alpers syndrome (mtdps4a, 203700) | rel=r_associated | relid=0 | w=15
  6496. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some phenotypic overlap with rett syndrome (312750)
    n1=Hyde (prurigo nodulaire de) | n2=en:some phenotypic overlap with rett syndrome (312750) | rel=r_associated | relid=0 | w=15
  6497. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:some response to l-dopa therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:some response to l-dopa therapy | rel=r_associated | relid=0 | w=15
  6498. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sparing of some nails in some individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:sparing of some nails in some individuals | rel=r_associated | relid=0 | w=15
  6499. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spastic paraplegia 2 (spg2, 312920) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:spastic paraplegia 2 (spg2, 312920) is an allelic disorder | rel=r_associated | relid=0 | w=15
  6500. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spasticity is slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:spasticity is slowly progressive | rel=r_associated | relid=0 | w=15
  6501. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spasticity occurs before parkinsonism
    n1=Hyde (prurigo nodulaire de) | n2=en:spasticity occurs before parkinsonism | rel=r_associated | relid=0 | w=15
  6502. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:specialized branches of medicine
    n1=Hyde (prurigo nodulaire de) | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
  6503. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spectrum of malformations resulting from impaired midline cleavage of the embryonic forebrain
    n1=Hyde (prurigo nodulaire de) | n2=en:spectrum of malformations resulting from impaired midline cleavage of the embryonic forebrain | rel=r_associated | relid=0 | w=15
  6504. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spinal involvement improves with age
    n1=Hyde (prurigo nodulaire de) | n2=en:spinal involvement improves with age | rel=r_associated | relid=0 | w=15
  6505. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spinal tumors are necessary for diagnosis
    n1=Hyde (prurigo nodulaire de) | n2=en:spinal tumors are necessary for diagnosis | rel=r_associated | relid=0 | w=15
  6506. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:splenectomy increases thrombotic risk in these patients
    n1=Hyde (prurigo nodulaire de) | n2=en:splenectomy increases thrombotic risk in these patients | rel=r_associated | relid=0 | w=15
  6507. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous abortion
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous abortion | rel=r_associated | relid=0 | w=15
  6508. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous bleeding is rare
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous bleeding is rare | rel=r_associated | relid=0 | w=15
  6509. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous chromosomal instability with multiple rearrangements, especially chromosome 7 and 14
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous chromosomal instability with multiple rearrangements, especially chromosome 7 and 14 | rel=r_associated | relid=0 | w=15
  6510. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous resolution by 12 months of age with no recurrence later in life
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous resolution by 12 months of age with no recurrence later in life | rel=r_associated | relid=0 | w=15
  6511. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous resolution of seizures by 12 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous resolution of seizures by 12 months of age | rel=r_associated | relid=0 | w=15
  6512. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous resolution usually after 12 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous resolution usually after 12 months of age | rel=r_associated | relid=0 | w=15
  6513. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous resorption (rare)
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous resorption (rare) | rel=r_associated | relid=0 | w=15
  6514. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous reversal of gnrh deficiency may occur in some patients
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous reversal of gnrh deficiency may occur in some patients | rel=r_associated | relid=0 | w=15
  6515. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous rupture of membranes
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous rupture of membranes | rel=r_associated | relid=0 | w=15
  6516. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneous tumor regression may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneous tumor regression may occur | rel=r_associated | relid=0 | w=15
  6517. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spontaneously resolves by 5 to 6 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:spontaneously resolves by 5 to 6 months of age | rel=r_associated | relid=0 | w=15
  6518. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sporadic cases often single lesions versus multiple lesions in familial cases
    n1=Hyde (prurigo nodulaire de) | n2=en:sporadic cases often single lesions versus multiple lesions in familial cases | rel=r_associated | relid=0 | w=15
  6519. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sporadic occurrence
    n1=Hyde (prurigo nodulaire de) | n2=en:sporadic occurrence | rel=r_associated | relid=0 | w=15
  6520. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sporadic occurrence is associated with advanced paternal age
    n1=Hyde (prurigo nodulaire de) | n2=en:sporadic occurrence is associated with advanced paternal age | rel=r_associated | relid=0 | w=15
  6521. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sporadic or acquired pct precipitated by alcohol, estrogens, iron, and polychlorinated cyclic hydrocarbons
    n1=Hyde (prurigo nodulaire de) | n2=en:sporadic or acquired pct precipitated by alcohol, estrogens, iron, and polychlorinated cyclic hydrocarbons | rel=r_associated | relid=0 | w=15
  6522. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:spots occur in 95% of patients but can be absent
    n1=Hyde (prurigo nodulaire de) | n2=en:spots occur in 95% of patients but can be absent | rel=r_associated | relid=0 | w=15
  6523. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stable or slowly progressive course
    n1=Hyde (prurigo nodulaire de) | n2=en:stable or slowly progressive course | rel=r_associated | relid=0 | w=15
  6524. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stage ii, rapid developmental regression (onset 1-4 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:stage ii, rapid developmental regression (onset 1-4 years) | rel=r_associated | relid=0 | w=15
  6525. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stage iii, pseudostationary period (onset 2-10 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:stage iii, pseudostationary period (onset 2-10 years) | rel=r_associated | relid=0 | w=15
  6526. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stage iv, late motor deterioration (when ambulation ceases)
    n1=Hyde (prurigo nodulaire de) | n2=en:stage iv, late motor deterioration (when ambulation ceases) | rel=r_associated | relid=0 | w=15
  6527. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:starch, corn
    n1=Hyde (prurigo nodulaire de) | n2=en:starch, corn | rel=r_associated | relid=0 | w=15
  6528. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:static or slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:static or slowly progressive | rel=r_associated | relid=0 | w=15
  6529. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:static, nonprogressive disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:static, nonprogressive disorder | rel=r_associated | relid=0 | w=15
  6530. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stickler syndrome (108300) and marshall syndrome share several characteristics such as midface hypoplasia, high myopia, and sensorineural hearing loss
    n1=Hyde (prurigo nodulaire de) | n2=en:stickler syndrome (108300) and marshall syndrome share several characteristics such as midface hypoplasia, high myopia, and sensorineural hearing loss | rel=r_associated | relid=0 | w=15
  6531. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stillbirth
    n1=Hyde (prurigo nodulaire de) | n2=en:stillbirth | rel=r_associated | relid=0 | w=15
  6532. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stillborn or death in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:stillborn or death in infancy | rel=r_associated | relid=0 | w=15
  6533. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stillborn or death shortly after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:stillborn or death shortly after birth | rel=r_associated | relid=0 | w=15
  6534. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stillborn or infantile death usual in prenatal form
    n1=Hyde (prurigo nodulaire de) | n2=en:stillborn or infantile death usual in prenatal form | rel=r_associated | relid=0 | w=15
  6535. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stillborn or lethal in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:stillborn or lethal in the neonatal period | rel=r_associated | relid=0 | w=15
  6536. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:stokes-adams syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:stokes-adams syndrome | rel=r_associated | relid=0 | w=15
  6537. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:striking intrafamilial variability
    n1=Hyde (prurigo nodulaire de) | n2=en:striking intrafamilial variability | rel=r_associated | relid=0 | w=15
  6538. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:structural lipid molecule
    n1=Hyde (prurigo nodulaire de) | n2=en:structural lipid molecule | rel=r_associated | relid=0 | w=15
  6539. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:structural protein gene
    n1=Hyde (prurigo nodulaire de) | n2=en:structural protein gene | rel=r_associated | relid=0 | w=15
  6540. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subchorial thrombus
    n1=Hyde (prurigo nodulaire de) | n2=en:subchorial thrombus | rel=r_associated | relid=0 | w=15
  6541. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subchorionic intervillositis
    n1=Hyde (prurigo nodulaire de) | n2=en:subchorionic intervillositis | rel=r_associated | relid=0 | w=15
  6542. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subclavian artery supply disruption in embryogenesis has been suggested as etiology
    n1=Hyde (prurigo nodulaire de) | n2=en:subclavian artery supply disruption in embryogenesis has been suggested as etiology | rel=r_associated | relid=0 | w=15
  6543. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subset of patients have cytochrome c oxidase deficiency (see 220110)
    n1=Hyde (prurigo nodulaire de) | n2=en:subset of patients have cytochrome c oxidase deficiency (see 220110) | rel=r_associated | relid=0 | w=15
  6544. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subset of patients have french-canadian leigh syndrome (220111)
    n1=Hyde (prurigo nodulaire de) | n2=en:subset of patients have french-canadian leigh syndrome (220111) | rel=r_associated | relid=0 | w=15
  6545. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subset of patients have leigh syndrome (256000)
    n1=Hyde (prurigo nodulaire de) | n2=en:subset of patients have leigh syndrome (256000) | rel=r_associated | relid=0 | w=15
  6546. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subset of patients with sco2 (604272) mutations have cardioencephalomyopathy (604377)
    n1=Hyde (prurigo nodulaire de) | n2=en:subset of patients with sco2 (604272) mutations have cardioencephalomyopathy (604377) | rel=r_associated | relid=0 | w=15
  6547. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtle facial phenotype compared to other types of hpe
    n1=Hyde (prurigo nodulaire de) | n2=en:subtle facial phenotype compared to other types of hpe | rel=r_associated | relid=0 | w=15
  6548. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtle personality and behavioral changes are presenting signs
    n1=Hyde (prurigo nodulaire de) | n2=en:subtle personality and behavioral changes are presenting signs | rel=r_associated | relid=0 | w=15
  6549. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtype 3a comprises myoclonus and dementia
    n1=Hyde (prurigo nodulaire de) | n2=en:subtype 3a comprises myoclonus and dementia | rel=r_associated | relid=0 | w=15
  6550. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtype 3b comprises horizontal supranuclear gaze palsy and aggressive systemic disease
    n1=Hyde (prurigo nodulaire de) | n2=en:subtype 3b comprises horizontal supranuclear gaze palsy and aggressive systemic disease | rel=r_associated | relid=0 | w=15
  6551. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtype 3c (231005) comprises cardiovascular calcifications
    n1=Hyde (prurigo nodulaire de) | n2=en:subtype 3c (231005) comprises cardiovascular calcifications | rel=r_associated | relid=0 | w=15
  6552. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:subtype of migraine with aura
    n1=Hyde (prurigo nodulaire de) | n2=en:subtype of migraine with aura | rel=r_associated | relid=0 | w=15
  6553. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:successful treatment with oral isotretinoin
    n1=Hyde (prurigo nodulaire de) | n2=en:successful treatment with oral isotretinoin | rel=r_associated | relid=0 | w=15
  6554. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sucrose
    n1=Hyde (prurigo nodulaire de) | n2=en:sucrose | rel=r_associated | relid=0 | w=15
  6555. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden cardiac death frequent in affected families
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden cardiac death frequent in affected families | rel=r_associated | relid=0 | w=15
  6556. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden cardiac death in some families
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden cardiac death in some families | rel=r_associated | relid=0 | w=15
  6557. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death | rel=r_associated | relid=0 | w=15
  6558. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death due to cardiac arrhythmia may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death due to cardiac arrhythmia may occur | rel=r_associated | relid=0 | w=15
  6559. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death due to cardiomyopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death due to cardiomyopathy | rel=r_associated | relid=0 | w=15
  6560. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death in affected females occurs in the forties
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death in affected females occurs in the forties | rel=r_associated | relid=0 | w=15
  6561. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death in affected males occurs in teens
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death in affected males occurs in teens | rel=r_associated | relid=0 | w=15
  6562. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death secondary to impaction of medulla oblongata
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death secondary to impaction of medulla oblongata | rel=r_associated | relid=0 | w=15
  6563. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden death within first days of life
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden death within first days of life | rel=r_associated | relid=0 | w=15
  6564. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden infant death may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden infant death may occur | rel=r_associated | relid=0 | w=15
  6565. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sudden infantile death may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden infantile death may occur | rel=r_associated | relid=0 | w=15
  6566. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugar
    n1=Hyde (prurigo nodulaire de) | n2=en:sugar | rel=r_associated | relid=0 | w=15
  6567. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugar acids
    n1=Hyde (prurigo nodulaire de) | n2=en:sugar acids | rel=r_associated | relid=0 | w=15
  6568. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugar alcohols
    n1=Hyde (prurigo nodulaire de) | n2=en:sugar alcohols | rel=r_associated | relid=0 | w=15
  6569. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugar phosphates
    n1=Hyde (prurigo nodulaire de) | n2=en:sugar phosphates | rel=r_associated | relid=0 | w=15
  6570. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugar substitute
    n1=Hyde (prurigo nodulaire de) | n2=en:sugar substitute | rel=r_associated | relid=0 | w=15
  6571. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:sugars and starches
    n1=Hyde (prurigo nodulaire de) | n2=en:sugars and starches | rel=r_associated | relid=0 | w=15
  6572. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:summer prurigo
    n1=Hyde (prurigo nodulaire de) | n2=en:summer prurigo | rel=r_associated | relid=0 | w=15
  6573. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:supervisor review:impression/interpretation of study:point in time:to be specified in another part of the message:nominal
    n1=Hyde (prurigo nodulaire de) | n2=en:supervisor review:impression/interpretation of study:point in time:to be specified in another part of the message:nominal | rel=r_associated | relid=0 | w=15
  6574. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:surgical aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:surgical aspects | rel=r_associated | relid=0 | w=15
  6575. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:surgical intervention is not always curative
    n1=Hyde (prurigo nodulaire de) | n2=en:surgical intervention is not always curative | rel=r_associated | relid=0 | w=15
  6576. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival greater than one year rare
    n1=Hyde (prurigo nodulaire de) | n2=en:survival greater than one year rare | rel=r_associated | relid=0 | w=15
  6577. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival past infancy is rare
    n1=Hyde (prurigo nodulaire de) | n2=en:survival past infancy is rare | rel=r_associated | relid=0 | w=15
  6578. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival to 10 years
    n1=Hyde (prurigo nodulaire de) | n2=en:survival to 10 years | rel=r_associated | relid=0 | w=15
  6579. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival to 20 years in severe form
    n1=Hyde (prurigo nodulaire de) | n2=en:survival to 20 years in severe form | rel=r_associated | relid=0 | w=15
  6580. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival to 20s-60s in iib
    n1=Hyde (prurigo nodulaire de) | n2=en:survival to 20s-60s in iib | rel=r_associated | relid=0 | w=15
  6581. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival to 5-15 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:survival to 5-15 years of age | rel=r_associated | relid=0 | w=15
  6582. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survival to advanced age
    n1=Hyde (prurigo nodulaire de) | n2=en:survival to advanced age | rel=r_associated | relid=0 | w=15
  6583. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:surviving infants develop severe nonbullous ichthyosiform erythroderma
    n1=Hyde (prurigo nodulaire de) | n2=en:surviving infants develop severe nonbullous ichthyosiform erythroderma | rel=r_associated | relid=0 | w=15
  6584. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survivors develop dysautonomia-like symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:survivors develop dysautonomia-like symptoms | rel=r_associated | relid=0 | w=15
  6585. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survivors have mental retardation, spasticity, and adducted thumbs (masa syndrome findings (303350))
    n1=Hyde (prurigo nodulaire de) | n2=en:survivors have mental retardation, spasticity, and adducted thumbs (masa syndrome findings (303350)) | rel=r_associated | relid=0 | w=15
  6586. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:survivors may develop renal insufficiency and hepatic dysfunction
    n1=Hyde (prurigo nodulaire de) | n2=en:survivors may develop renal insufficiency and hepatic dysfunction | rel=r_associated | relid=0 | w=15
  6587. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:susceptibility to infections start in the first year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:susceptibility to infections start in the first year of life | rel=r_associated | relid=0 | w=15
  6588. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:susceptibility to infections starts in the first week of life
    n1=Hyde (prurigo nodulaire de) | n2=en:susceptibility to infections starts in the first week of life | rel=r_associated | relid=0 | w=15
  6589. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:swelling starts to fade by age 30 years and gradually becomes unremarkable
    n1=Hyde (prurigo nodulaire de) | n2=en:swelling starts to fade by age 30 years and gradually becomes unremarkable | rel=r_associated | relid=0 | w=15
  6590. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptom onset at birth or infancy arnold-chiari type ii is uniquely associated with myelomeninogocele (182940)
    n1=Hyde (prurigo nodulaire de) | n2=en:symptom onset at birth or infancy arnold-chiari type ii is uniquely associated with myelomeninogocele (182940) | rel=r_associated | relid=0 | w=15
  6591. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptom onset ranges from infancy to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:symptom onset ranges from infancy to adulthood | rel=r_associated | relid=0 | w=15
  6592. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptomatic if > 200 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:symptomatic if > 200 repeats | rel=r_associated | relid=0 | w=15
  6593. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms aggravated by fatigue, exertion, sleep deprivation, emotion, hunger
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms aggravated by fatigue, exertion, sleep deprivation, emotion, hunger | rel=r_associated | relid=0 | w=15
  6594. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms ameliorate with age
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms ameliorate with age | rel=r_associated | relid=0 | w=15
  6595. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms are aggravated by febrile illness
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms are aggravated by febrile illness | rel=r_associated | relid=0 | w=15
  6596. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms are not apparent at rest
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms are not apparent at rest | rel=r_associated | relid=0 | w=15
  6597. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms are often responsive to alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms are often responsive to alcohol | rel=r_associated | relid=0 | w=15
  6598. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms are responsive to cobalamin treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms are responsive to cobalamin treatment | rel=r_associated | relid=0 | w=15
  6599. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms begin focally, later segmental or generalized
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms begin focally, later segmental or generalized | rel=r_associated | relid=0 | w=15
  6600. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms benefit from sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms benefit from sleep | rel=r_associated | relid=0 | w=15
  6601. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms can be prevented by strict dietary restriction
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms can be prevented by strict dietary restriction | rel=r_associated | relid=0 | w=15
  6602. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms develop immediately after birth
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms develop immediately after birth | rel=r_associated | relid=0 | w=15
  6603. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms highly variable - rapidly progressive course leading to hepatic failure versus acute hepatic crisis
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms highly variable - rapidly progressive course leading to hepatic failure versus acute hepatic crisis | rel=r_associated | relid=0 | w=15
  6604. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms improve during the summer
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms improve during the summer | rel=r_associated | relid=0 | w=15
  6605. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms improve following sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms improve following sleep | rel=r_associated | relid=0 | w=15
  6606. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms induced by strenuous exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms induced by strenuous exercise | rel=r_associated | relid=0 | w=15
  6607. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms may be aggravated by acute illness
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms may be aggravated by acute illness | rel=r_associated | relid=0 | w=15
  6608. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms may be exacerbated by pregnancy or trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms may be exacerbated by pregnancy or trauma | rel=r_associated | relid=0 | w=15
  6609. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms may be exacerbated in women during pregnancy or by oral contraceptives (see 614972)
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms may be exacerbated in women during pregnancy or by oral contraceptives (see 614972) | rel=r_associated | relid=0 | w=15
  6610. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms may be precipitated by infection
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms may be precipitated by infection | rel=r_associated | relid=0 | w=15
  6611. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms may decrease after age 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms may decrease after age 30 years | rel=r_associated | relid=0 | w=15
  6612. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms must occur for 6 months including 1 month of characteristic symptoms (e.g. delusions) to make diagnosis
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms must occur for 6 months including 1 month of characteristic symptoms (e.g. delusions) to make diagnosis | rel=r_associated | relid=0 | w=15
  6613. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms noted at 2-3 years
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms noted at 2-3 years | rel=r_associated | relid=0 | w=15
  6614. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms occur only during pregnancy (usual onset after 6 weeks gestation)
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms occur only during pregnancy (usual onset after 6 weeks gestation) | rel=r_associated | relid=0 | w=15
  6615. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms occur only during sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms occur only during sleep | rel=r_associated | relid=0 | w=15
  6616. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms of zinc deficiency occur only in exclusively breastfed infants
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms of zinc deficiency occur only in exclusively breastfed infants | rel=r_associated | relid=0 | w=15
  6617. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms often decrease or remit with age
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms often decrease or remit with age | rel=r_associated | relid=0 | w=15
  6618. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms often improve gradually with age
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms often improve gradually with age | rel=r_associated | relid=0 | w=15
  6619. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by alcohol, caffeine, fatigue, stress, exertion, ovulation, menstruation | rel=r_associated | relid=0 | w=15
  6620. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by exercise and excitement
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by exercise and excitement | rel=r_associated | relid=0 | w=15
  6621. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by stress, exertion, fatigue, alcohol
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by stress, exertion, fatigue, alcohol | rel=r_associated | relid=0 | w=15
  6622. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by sudden movement, stress, exertion, exercise, fatigue, caffeine, alcohol, cigarettes
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by sudden movement, stress, exertion, exercise, fatigue, caffeine, alcohol, cigarettes | rel=r_associated | relid=0 | w=15
  6623. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by sudden movement, stress, exertion, fatigue
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by sudden movement, stress, exertion, fatigue | rel=r_associated | relid=0 | w=15
  6624. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by sudden movement, stress, exertion, fatigue, illness
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by sudden movement, stress, exertion, fatigue, illness | rel=r_associated | relid=0 | w=15
  6625. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by sudden movement, stress, exertion, fatigue' attacks typically last for hours
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by sudden movement, stress, exertion, fatigue' attacks typically last for hours | rel=r_associated | relid=0 | w=15
  6626. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms precipitated by sudden movements
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms precipitated by sudden movements | rel=r_associated | relid=0 | w=15
  6627. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms progress with worsening myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms progress with worsening myopathy | rel=r_associated | relid=0 | w=15
  6628. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms relieved by ovarian suppression
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms relieved by ovarian suppression | rel=r_associated | relid=0 | w=15
  6629. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms relieved by progesterone antagonist (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms relieved by progesterone antagonist (in some patients) | rel=r_associated | relid=0 | w=15
  6630. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms relieved by serotonin antagonist (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms relieved by serotonin antagonist (in some patients) | rel=r_associated | relid=0 | w=15
  6631. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms remain focal
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms remain focal | rel=r_associated | relid=0 | w=15
  6632. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms resolve over weeks to months with usually no residual symptoms between attacks
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms resolve over weeks to months with usually no residual symptoms between attacks | rel=r_associated | relid=0 | w=15
  6633. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms show insidious onset in the late first through third decades
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms show insidious onset in the late first through third decades | rel=r_associated | relid=0 | w=15
  6634. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms tend to improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms tend to improve with age | rel=r_associated | relid=0 | w=15
  6635. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms typically begin in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms typically begin in childhood | rel=r_associated | relid=0 | w=15
  6636. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually appear in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually appear in adulthood | rel=r_associated | relid=0 | w=15
  6637. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually induced only by strenuous exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually induced only by strenuous exercise | rel=r_associated | relid=0 | w=15
  6638. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually last 30-60 minutes
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually last 30-60 minutes | rel=r_associated | relid=0 | w=15
  6639. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually manifest in childhood including waddling gait and painful, stiff joints
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually manifest in childhood including waddling gait and painful, stiff joints | rel=r_associated | relid=0 | w=15
  6640. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually occur in adults
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually occur in adults | rel=r_associated | relid=0 | w=15
  6641. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms usually resolve without treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms usually resolve without treatment | rel=r_associated | relid=0 | w=15
  6642. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms vary according to location of tumor
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms vary according to location of tumor | rel=r_associated | relid=0 | w=15
  6643. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms vary from asymptomatic patients to patients with metabolic acidosis
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms vary from asymptomatic patients to patients with metabolic acidosis | rel=r_associated | relid=0 | w=15
  6644. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:symptoms worsen with fatigue and exercise
    n1=Hyde (prurigo nodulaire de) | n2=en:symptoms worsen with fatigue and exercise | rel=r_associated | relid=0 | w=15
  6645. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:syncope
    n1=Hyde (prurigo nodulaire de) | n2=en:syncope | rel=r_associated | relid=0 | w=15
  6646. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:syndromic forms of dense granule only platelet storage pool deficiencies (delta-spd) include hermansky-pudlak syndrome (203300) and chediak-hygashi syndrome (214500)
    n1=Hyde (prurigo nodulaire de) | n2=en:syndromic forms of dense granule only platelet storage pool deficiencies (delta-spd) include hermansky-pudlak syndrome (203300) and chediak-hygashi syndrome (214500) | rel=r_associated | relid=0 | w=15
  6647. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:syringe caps
    n1=Hyde (prurigo nodulaire de) | n2=en:syringe caps | rel=r_associated | relid=0 | w=15
  6648. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:systemic amyloid deposition may occur
    n1=Hyde (prurigo nodulaire de) | n2=en:systemic amyloid deposition may occur | rel=r_associated | relid=0 | w=15
  6649. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:systemic granulomatous disease
    n1=Hyde (prurigo nodulaire de) | n2=en:systemic granulomatous disease | rel=r_associated | relid=0 | w=15
  6650. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:systemic iron overload due to ineffective erythropoiesis
    n1=Hyde (prurigo nodulaire de) | n2=en:systemic iron overload due to ineffective erythropoiesis | rel=r_associated | relid=0 | w=15
  6651. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:t-cell lymphopenia is more severe early in life
    n1=Hyde (prurigo nodulaire de) | n2=en:t-cell lymphopenia is more severe early in life | rel=r_associated | relid=0 | w=15
  6652. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tamoxifen
    n1=Hyde (prurigo nodulaire de) | n2=en:tamoxifen | rel=r_associated | relid=0 | w=15
  6653. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:teeth may undergo post-eruptive changes
    n1=Hyde (prurigo nodulaire de) | n2=en:teeth may undergo post-eruptive changes | rel=r_associated | relid=0 | w=15
  6654. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:telangiectases persist in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:telangiectases persist in adulthood | rel=r_associated | relid=0 | w=15
  6655. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:telangiectasia become evident between the second and eighth year of life
    n1=Hyde (prurigo nodulaire de) | n2=en:telangiectasia become evident between the second and eighth year of life | rel=r_associated | relid=0 | w=15
  6656. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:temperature instability
    n1=Hyde (prurigo nodulaire de) | n2=en:temperature instability | rel=r_associated | relid=0 | w=15
  6657. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tendency to lighter pigmentation than unaffected relatives
    n1=Hyde (prurigo nodulaire de) | n2=en:tendency to lighter pigmentation than unaffected relatives | rel=r_associated | relid=0 | w=15
  6658. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thalidomide
    n1=Hyde (prurigo nodulaire de) | n2=en:thalidomide | rel=r_associated | relid=0 | w=15
  6659. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thanatophoric dysplasia, type i (disorder)
    n1=Hyde (prurigo nodulaire de) | n2=en:thanatophoric dysplasia, type i (disorder) | rel=r_associated | relid=0 | w=15
  6660. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the acronym midas is microphthalmia, dermal aplasia, sclerocornea
    n1=Hyde (prurigo nodulaire de) | n2=en:the acronym midas is microphthalmia, dermal aplasia, sclerocornea | rel=r_associated | relid=0 | w=15
  6661. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the characteristic changes in the spine resolve by adolescence
    n1=Hyde (prurigo nodulaire de) | n2=en:the characteristic changes in the spine resolve by adolescence | rel=r_associated | relid=0 | w=15
  6662. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the familial form of pityriasis rubra pilaris is generally resistant to treatment and persists
    n1=Hyde (prurigo nodulaire de) | n2=en:the familial form of pityriasis rubra pilaris is generally resistant to treatment and persists | rel=r_associated | relid=0 | w=15
  6663. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the frequency is estimated at 1/20,000 to 1/50,000 births
    n1=Hyde (prurigo nodulaire de) | n2=en:the frequency is estimated at 1/20,000 to 1/50,000 births | rel=r_associated | relid=0 | w=15
  6664. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the lower the s-ado:saicr ratio, the more severe the phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:the lower the s-ado:saicr ratio, the more severe the phenotype | rel=r_associated | relid=0 | w=15
  6665. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the majority of female heterozygotes reveal ophthalmologic abnormalities - multiple, micropunctate, gray lens opacities or single, dense posterior cataract
    n1=Hyde (prurigo nodulaire de) | n2=en:the majority of female heterozygotes reveal ophthalmologic abnormalities - multiple, micropunctate, gray lens opacities or single, dense posterior cataract | rel=r_associated | relid=0 | w=15
  6666. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the majority of patients (~95%) have 1 of 3 mtdna point mutations (g3460a 516000.0001, g11778a 516003.0001, or t14484c 516006.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:the majority of patients (~95%) have 1 of 3 mtdna point mutations (g3460a 516000.0001, g11778a 516003.0001, or t14484c 516006.0001) | rel=r_associated | relid=0 | w=15
  6667. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the most studied group is efe pygmies from ituri forest in northeast zaire
    n1=Hyde (prurigo nodulaire de) | n2=en:the most studied group is efe pygmies from ituri forest in northeast zaire | rel=r_associated | relid=0 | w=15
  6668. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the mttl1 c.3243a-g transition (590050.0001) is the most common mutation
    n1=Hyde (prurigo nodulaire de) | n2=en:the mttl1 c.3243a-g transition (590050.0001) is the most common mutation | rel=r_associated | relid=0 | w=15
  6669. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:the relationship of central core disease to moderate multiminicore with hand involvement is unclear, for a description of classic multiminicore disease, see 602771
    n1=Hyde (prurigo nodulaire de) | n2=en:the relationship of central core disease to moderate multiminicore with hand involvement is unclear, for a description of classic multiminicore disease, see 602771 | rel=r_associated | relid=0 | w=15
  6670. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:therapeutic aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=15
  6671. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:therapy-induced dyskinesias
    n1=Hyde (prurigo nodulaire de) | n2=en:therapy-induced dyskinesias | rel=r_associated | relid=0 | w=15
  6672. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:there are several subtypes
    n1=Hyde (prurigo nodulaire de) | n2=en:there are several subtypes | rel=r_associated | relid=0 | w=15
  6673. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thiamine supplementation may be beneficial
    n1=Hyde (prurigo nodulaire de) | n2=en:thiamine supplementation may be beneficial | rel=r_associated | relid=0 | w=15
  6674. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thin, fine hair described in few individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:thin, fine hair described in few individuals | rel=r_associated | relid=0 | w=15
  6675. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thiosugars
    n1=Hyde (prurigo nodulaire de) | n2=en:thiosugars | rel=r_associated | relid=0 | w=15
  6676. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:this patient died at age 2 years
    n1=Hyde (prurigo nodulaire de) | n2=en:this patient died at age 2 years | rel=r_associated | relid=0 | w=15
  6677. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:this patient died at age 8 months
    n1=Hyde (prurigo nodulaire de) | n2=en:this patient died at age 8 months | rel=r_associated | relid=0 | w=15
  6678. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:this specific disorder has been described in 1 family (ke)
    n1=Hyde (prurigo nodulaire de) | n2=en:this specific disorder has been described in 1 family (ke) | rel=r_associated | relid=0 | w=15
  6679. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thoracic abnormalities tend to improve with age
    n1=Hyde (prurigo nodulaire de) | n2=en:thoracic abnormalities tend to improve with age | rel=r_associated | relid=0 | w=15
  6680. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thorax anomaly ameliorates with age (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:thorax anomaly ameliorates with age (in some patients) | rel=r_associated | relid=0 | w=15
  6681. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:those who survive initial acute episode have no recurrence of hepatic involvement, but may have persistent hypotonia
    n1=Hyde (prurigo nodulaire de) | n2=en:those who survive initial acute episode have no recurrence of hepatic involvement, but may have persistent hypotonia | rel=r_associated | relid=0 | w=15
  6682. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:those with intermediate repeat expansions show reduced penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:those with intermediate repeat expansions show reduced penetrance | rel=r_associated | relid=0 | w=15
  6683. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:those with larger deletions of chromosome 2q23.1 tend to have more dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:those with larger deletions of chromosome 2q23.1 tend to have more dysmorphic features | rel=r_associated | relid=0 | w=15
  6684. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:threatened term labor
    n1=Hyde (prurigo nodulaire de) | n2=en:threatened term labor | rel=r_associated | relid=0 | w=15
  6685. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three affected sibs have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:three affected sibs have been reported | rel=r_associated | relid=0 | w=15
  6686. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three amish patients have been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three amish patients have been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  6687. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three distinct clinical forms - endemic (equatorial africa), sporadic, and immunodeficiency-associated (e.g., hiv infection)
    n1=Hyde (prurigo nodulaire de) | n2=en:three distinct clinical forms - endemic (equatorial africa), sporadic, and immunodeficiency-associated (e.g., hiv infection) | rel=r_associated | relid=0 | w=15
  6688. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families described (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families described (last curated january 2014) | rel=r_associated | relid=0 | w=15
  6689. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (as of 28 june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (as of 28 june 2011) | rel=r_associated | relid=0 | w=15
  6690. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (as of december 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (as of december 2011) | rel=r_associated | relid=0 | w=15
  6691. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  6692. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (last curated april 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (last curated april 2011) | rel=r_associated | relid=0 | w=15
  6693. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (last curated august 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (last curated august 2012) | rel=r_associated | relid=0 | w=15
  6694. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (last curated july 2013) | rel=r_associated | relid=0 | w=15
  6695. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (last curated november 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (last curated november 2010) | rel=r_associated | relid=0 | w=15
  6696. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three families have been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three families have been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  6697. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three forms of cjd: acquired (including variant), sporadic, and inherited
    n1=Hyde (prurigo nodulaire de) | n2=en:three forms of cjd: acquired (including variant), sporadic, and inherited | rel=r_associated | relid=0 | w=15
  6698. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three girls from 2 unrelated families have been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three girls from 2 unrelated families have been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  6699. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three main clinical forms
    n1=Hyde (prurigo nodulaire de) | n2=en:three main clinical forms | rel=r_associated | relid=0 | w=15
  6700. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three main phenotypes
    n1=Hyde (prurigo nodulaire de) | n2=en:three main phenotypes | rel=r_associated | relid=0 | w=15
  6701. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three major clinical forms are apparent
    n1=Hyde (prurigo nodulaire de) | n2=en:three major clinical forms are apparent | rel=r_associated | relid=0 | w=15
  6702. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three males in 1 family have been reported (last curated august 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three males in 1 family have been reported (last curated august 2012) | rel=r_associated | relid=0 | w=15
  6703. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients (2 related) reported (last curated march 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients (2 related) reported (last curated march 2013) | rel=r_associated | relid=0 | w=15
  6704. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients (2 sisters and 1 unrelated female) have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients (2 sisters and 1 unrelated female) have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  6705. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients from 1 french canadian family have been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients from 1 french canadian family have been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  6706. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients from 1 mexican family has been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients from 1 mexican family has been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  6707. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients from 2 families have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients from 2 families have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  6708. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been described (last curated january 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been described (last curated january 2013) | rel=r_associated | relid=0 | w=15
  6709. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been reported | rel=r_associated | relid=0 | w=15
  6710. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  6711. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  6712. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been reported (as of november 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been reported (as of november 2010) | rel=r_associated | relid=0 | w=15
  6713. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients have been reported (as of october 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients have been reported (as of october 2009) | rel=r_associated | relid=0 | w=15
  6714. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients in one family have been reported (as of october 2011), and only one mutation carrier exhibited mental retardation and ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients in one family have been reported (as of october 2011), and only one mutation carrier exhibited mental retardation and ataxia | rel=r_associated | relid=0 | w=15
  6715. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three patients reported, one with a wdpcp mutation (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:three patients reported, one with a wdpcp mutation (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6716. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three stages of disease progression - stage 1 (subclinical), stage 2 (early myoclonic), stage 3 (disabling myoclonic)
    n1=Hyde (prurigo nodulaire de) | n2=en:three stages of disease progression - stage 1 (subclinical), stage 2 (early myoclonic), stage 3 (disabling myoclonic) | rel=r_associated | relid=0 | w=15
  6717. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three subtypes of pfeiffer syndrome have been described - type 1: 'mild' autosomal dominant
    n1=Hyde (prurigo nodulaire de) | n2=en:three subtypes of pfeiffer syndrome have been described - type 1: 'mild' autosomal dominant | rel=r_associated | relid=0 | w=15
  6718. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three times more common in males
    n1=Hyde (prurigo nodulaire de) | n2=en:three times more common in males | rel=r_associated | relid=0 | w=15
  6719. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three type of cystinosis are recognized - infantile nephropathic (219800), juvenile or adolescent nephropathic (219900), and adult nonnephropathic (219750)
    n1=Hyde (prurigo nodulaire de) | n2=en:three type of cystinosis are recognized - infantile nephropathic (219800), juvenile or adolescent nephropathic (219900), and adult nonnephropathic (219750) | rel=r_associated | relid=0 | w=15
  6720. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three types of cystinosis are recognized
    n1=Hyde (prurigo nodulaire de) | n2=en:three types of cystinosis are recognized | rel=r_associated | relid=0 | w=15
  6721. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three types of pct: type i (176090) sporadic, presents in adults: types ii and iii (176100) familial, presents in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:three types of pct: type i (176090) sporadic, presents in adults: types ii and iii (176100) familial, presents in childhood | rel=r_associated | relid=0 | w=15
  6722. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated boys have been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated boys have been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  6723. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated caucasian patients have been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated caucasian patients have been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  6724. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (as of june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (as of june 2011) | rel=r_associated | relid=0 | w=15
  6725. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  6726. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6727. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (last curated june 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (last curated june 2012) | rel=r_associated | relid=0 | w=15
  6728. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  6729. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated families have been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated families have been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  6730. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated girls have been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated girls have been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  6731. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  6732. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated january 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated january 2010) | rel=r_associated | relid=0 | w=15
  6733. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  6734. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated july 2013) | rel=r_associated | relid=0 | w=15
  6735. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  6736. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated patients have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated patients have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6737. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three unrelated turkish families have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:three unrelated turkish families have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6738. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:three variants distinguished by age of onset - infantile ( onset before age 2), juvenile (onset in childhood), and adult
    n1=Hyde (prurigo nodulaire de) | n2=en:three variants distinguished by age of onset - infantile ( onset before age 2), juvenile (onset in childhood), and adult | rel=r_associated | relid=0 | w=15
  6739. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thromboembolism is the most common cause of death
    n1=Hyde (prurigo nodulaire de) | n2=en:thromboembolism is the most common cause of death | rel=r_associated | relid=0 | w=15
  6740. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thrombosis triggered by pregnancy, oral contraceptives, trauma, surgery
    n1=Hyde (prurigo nodulaire de) | n2=en:thrombosis triggered by pregnancy, oral contraceptives, trauma, surgery | rel=r_associated | relid=0 | w=15
  6741. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:thyroid gland carcinoma
    n1=Hyde (prurigo nodulaire de) | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=15
  6742. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tictology
    n1=Hyde (prurigo nodulaire de) | n2=en:tictology | rel=r_associated | relid=0 | w=15
  6743. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:time of analysis:tmstp:pt:xxx:qn
    n1=Hyde (prurigo nodulaire de) | n2=en:time of analysis:tmstp:pt:xxx:qn | rel=r_associated | relid=0 | w=15
  6744. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tocology
    n1=Hyde (prurigo nodulaire de) | n2=en:tocology | rel=r_associated | relid=0 | w=15
  6745. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:toddler nutrition
    n1=Hyde (prurigo nodulaire de) | n2=en:toddler nutrition | rel=r_associated | relid=0 | w=15
  6746. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:toe-walking gait
    n1=Hyde (prurigo nodulaire de) | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=15
  6747. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tooth agenesis ranges from 1 missing tooth to marked oligodontia
    n1=Hyde (prurigo nodulaire de) | n2=en:tooth agenesis ranges from 1 missing tooth to marked oligodontia | rel=r_associated | relid=0 | w=15
  6748. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:topotecan
    n1=Hyde (prurigo nodulaire de) | n2=en:topotecan | rel=r_associated | relid=0 | w=15
  6749. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:torso and upper body remain normal in shape and contour
    n1=Hyde (prurigo nodulaire de) | n2=en:torso and upper body remain normal in shape and contour | rel=r_associated | relid=0 | w=15
  6750. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:toxicologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:toxicologist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  6751. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:transfusion of plasma, which has apoc-ii, causes decrease in plasma triglycerides
    n1=Hyde (prurigo nodulaire de) | n2=en:transfusion of plasma, which has apoc-ii, causes decrease in plasma triglycerides | rel=r_associated | relid=0 | w=15
  6752. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trauma may accelerate symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:trauma may accelerate symptoms | rel=r_associated | relid=0 | w=15
  6753. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trauma, anxiety, and/or stress can precipitate or aggravate edema
    n1=Hyde (prurigo nodulaire de) | n2=en:trauma, anxiety, and/or stress can precipitate or aggravate edema | rel=r_associated | relid=0 | w=15
  6754. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trauma, im injection, surgery can be foci of ectopic ossification
    n1=Hyde (prurigo nodulaire de) | n2=en:trauma, im injection, surgery can be foci of ectopic ossification | rel=r_associated | relid=0 | w=15
  6755. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with betaine, especially for pyridoxine nonresponders
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with betaine, especially for pyridoxine nonresponders | rel=r_associated | relid=0 | w=15
  6756. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with bh4 is effective
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with bh4 is effective | rel=r_associated | relid=0 | w=15
  6757. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with dichloroacetate (dca) prolongs survival
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with dichloroacetate (dca) prolongs survival | rel=r_associated | relid=0 | w=15
  6758. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with enzyme replacement therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with enzyme replacement therapy | rel=r_associated | relid=0 | w=15
  6759. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with folinic acid offers some benefit for anemia and seizure control
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with folinic acid offers some benefit for anemia and seizure control | rel=r_associated | relid=0 | w=15
  6760. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with hematopoietic stem cell transplant if diagnosed at < 24 months of age
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with hematopoietic stem cell transplant if diagnosed at < 24 months of age | rel=r_associated | relid=0 | w=15
  6761. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with levodopa is not effective
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with levodopa is not effective | rel=r_associated | relid=0 | w=15
  6762. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with oral coenzyme q may ameliorate symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with oral coenzyme q may ameliorate symptoms | rel=r_associated | relid=0 | w=15
  6763. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with oral folic acid can ameliorate, resolve, or prevent clinical symptoms and myelination defects
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with oral folic acid can ameliorate, resolve, or prevent clinical symptoms and myelination defects | rel=r_associated | relid=0 | w=15
  6764. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with polyethylene glycol-modified bovine ada, bone marrow transplantation, and/or gene therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with polyethylene glycol-modified bovine ada, bone marrow transplantation, and/or gene therapy | rel=r_associated | relid=0 | w=15
  6765. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with serine and glycine replacement may alleviate features if started at birth
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with serine and glycine replacement may alleviate features if started at birth | rel=r_associated | relid=0 | w=15
  6766. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:treatment with vitamin d and phosphate is effective
    n1=Hyde (prurigo nodulaire de) | n2=en:treatment with vitamin d and phosphate is effective | rel=r_associated | relid=0 | w=15
  6767. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tremor is aggravated by emotional stress
    n1=Hyde (prurigo nodulaire de) | n2=en:tremor is aggravated by emotional stress | rel=r_associated | relid=0 | w=15
  6768. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tremor is aggravated by low glucose or light
    n1=Hyde (prurigo nodulaire de) | n2=en:tremor is aggravated by low glucose or light | rel=r_associated | relid=0 | w=15
  6769. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tremor may be elicited by movement or postural maintenance
    n1=Hyde (prurigo nodulaire de) | n2=en:tremor may be elicited by movement or postural maintenance | rel=r_associated | relid=0 | w=15
  6770. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tremors develop after seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:tremors develop after seizures | rel=r_associated | relid=0 | w=15
  6771. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trichohepatoenteric syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:trichohepatoenteric syndrome | rel=r_associated | relid=0 | w=15
  6772. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triggered by exercise, fasting, or other metabolic stresses
    n1=Hyde (prurigo nodulaire de) | n2=en:triggered by exercise, fasting, or other metabolic stresses | rel=r_associated | relid=0 | w=15
  6773. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triggered by minor head trauma
    n1=Hyde (prurigo nodulaire de) | n2=en:triggered by minor head trauma | rel=r_associated | relid=0 | w=15
  6774. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triggered by pregnancy, drugs, chemotherapy, cancer, bone marrow transplantation, infection
    n1=Hyde (prurigo nodulaire de) | n2=en:triggered by pregnancy, drugs, chemotherapy, cancer, bone marrow transplantation, infection | rel=r_associated | relid=0 | w=15
  6775. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triggered by use of antibiotics (24% of cases) and nonsteroidal antiinflammatory drugs (18% of cases)
    n1=Hyde (prurigo nodulaire de) | n2=en:triggered by use of antibiotics (24% of cases) and nonsteroidal antiinflammatory drugs (18% of cases) | rel=r_associated | relid=0 | w=15
  6776. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triggers are variable, even within a family
    n1=Hyde (prurigo nodulaire de) | n2=en:triggers are variable, even within a family | rel=r_associated | relid=0 | w=15
  6777. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:triglycerides
    n1=Hyde (prurigo nodulaire de) | n2=en:triglycerides | rel=r_associated | relid=0 | w=15
  6778. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tromethamine
    n1=Hyde (prurigo nodulaire de) | n2=en:tromethamine | rel=r_associated | relid=0 | w=15
  6779. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trp2 (langer-giedion syndrome, 150230) is a microdeletion syndrome involving deletions of both the trps1 (604386) and ext1 (608177) genes
    n1=Hyde (prurigo nodulaire de) | n2=en:trp2 (langer-giedion syndrome, 150230) is a microdeletion syndrome involving deletions of both the trps1 (604386) and ext1 (608177) genes | rel=r_associated | relid=0 | w=15
  6780. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:trps2 (langer-giedion syndrome, 150230) is a microdeletion syndrome involving deletions of both trps1 (190350) and ext1 (608177) genes
    n1=Hyde (prurigo nodulaire de) | n2=en:trps2 (langer-giedion syndrome, 150230) is a microdeletion syndrome involving deletions of both trps1 (190350) and ext1 (608177) genes | rel=r_associated | relid=0 | w=15
  6781. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:truncating mutations in crebbp found in 10% of patients
    n1=Hyde (prurigo nodulaire de) | n2=en:truncating mutations in crebbp found in 10% of patients | rel=r_associated | relid=0 | w=15
  6782. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tumor predisposition syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:tumor predisposition syndrome | rel=r_associated | relid=0 | w=15
  6783. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tumor suppressor gene
    n1=Hyde (prurigo nodulaire de) | n2=en:tumor suppressor gene | rel=r_associated | relid=0 | w=15
  6784. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tumors are microsatellite stable
    n1=Hyde (prurigo nodulaire de) | n2=en:tumors are microsatellite stable | rel=r_associated | relid=0 | w=15
  6785. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tumors may show spontaneous regression
    n1=Hyde (prurigo nodulaire de) | n2=en:tumors may show spontaneous regression | rel=r_associated | relid=0 | w=15
  6786. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tumors usually develop between 40 and 60 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:tumors usually develop between 40 and 60 years of age | rel=r_associated | relid=0 | w=15
  6787. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:turmeric extract
    n1=Hyde (prurigo nodulaire de) | n2=en:turmeric extract | rel=r_associated | relid=0 | w=15
  6788. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:twelve or more lesions per eye in individuals over 60 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:twelve or more lesions per eye in individuals over 60 years of age | rel=r_associated | relid=0 | w=15
  6789. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:twenty-five percent of affected babies are stillborn
    n1=Hyde (prurigo nodulaire de) | n2=en:twenty-five percent of affected babies are stillborn | rel=r_associated | relid=0 | w=15
  6790. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two affected sibs have been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two affected sibs have been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  6791. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two alpha-globin genes - 5-prime or alpha-2 and 3-prime or alpha-1
    n1=Hyde (prurigo nodulaire de) | n2=en:two alpha-globin genes - 5-prime or alpha-2 and 3-prime or alpha-1 | rel=r_associated | relid=0 | w=15
  6792. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two arab muslim families have been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two arab muslim families have been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  6793. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two autosomal dominant families have been reported (as of may 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two autosomal dominant families have been reported (as of may 2011) | rel=r_associated | relid=0 | w=15
  6794. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two brothers have been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two brothers have been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  6795. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two brothers have been reported (last curated august 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two brothers have been reported (last curated august 2012) | rel=r_associated | relid=0 | w=15
  6796. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two chinese sisters and one chinese woman have been described (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two chinese sisters and one chinese woman have been described (last curated april 2014) | rel=r_associated | relid=0 | w=15
  6797. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two clinical forms - type i (deficiency of b5r is isolated to erythrocytes) and type ii (deficiency of b5r in all cell types)
    n1=Hyde (prurigo nodulaire de) | n2=en:two clinical forms - type i (deficiency of b5r is isolated to erythrocytes) and type ii (deficiency of b5r in all cell types) | rel=r_associated | relid=0 | w=15
  6798. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two clinical presentations - solely neurologic form and a neurologic-multivisceral form
    n1=Hyde (prurigo nodulaire de) | n2=en:two clinical presentations - solely neurologic form and a neurologic-multivisceral form | rel=r_associated | relid=0 | w=15
  6799. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two complementation groups - pcca (secondary to defects in the alpha chain of pcc, 232000) and pccbc (secondary to defects in the beta subunit of pcc, 232050)
    n1=Hyde (prurigo nodulaire de) | n2=en:two complementation groups - pcca (secondary to defects in the alpha chain of pcc, 232000) and pccbc (secondary to defects in the beta subunit of pcc, 232050) | rel=r_associated | relid=0 | w=15
  6800. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two consanguineous turkish families have been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two consanguineous turkish families have been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  6801. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two consanguineous turkish families have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two consanguineous turkish families have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6802. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two different phenotypes exist - severe phenotype (early infantile onset, epileptic encephalopathy and often cardiomyopathy) and mild phenotype (more variable clinical presentation)
    n1=Hyde (prurigo nodulaire de) | n2=en:two different phenotypes exist - severe phenotype (early infantile onset, epileptic encephalopathy and often cardiomyopathy) and mild phenotype (more variable clinical presentation) | rel=r_associated | relid=0 | w=15
  6803. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families described (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families described (last curated july 2013) | rel=r_associated | relid=0 | w=15
  6804. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families described (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families described (last curated november 2013) | rel=r_associated | relid=0 | w=15
  6805. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of 6/2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of 6/2011) | rel=r_associated | relid=0 | w=15
  6806. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of curation date april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of curation date april 2014) | rel=r_associated | relid=0 | w=15
  6807. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of june 2011) | rel=r_associated | relid=0 | w=15
  6808. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of march 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of march 2012) | rel=r_associated | relid=0 | w=15
  6809. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of may 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of may 2011) | rel=r_associated | relid=0 | w=15
  6810. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of may 2012) | rel=r_associated | relid=0 | w=15
  6811. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  6812. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  6813. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated december 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated december 2010) | rel=r_associated | relid=0 | w=15
  6814. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated december 2013) | rel=r_associated | relid=0 | w=15
  6815. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  6816. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  6817. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (last curated january 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (last curated january 2011) | rel=r_associated | relid=0 | w=15
  6818. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families have been reported (september 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families have been reported (september 2010) | rel=r_associated | relid=0 | w=15
  6819. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families of canadian origin have been reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families of canadian origin have been reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  6820. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families of french-canadian origin have been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families of french-canadian origin have been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  6821. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  6822. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families reported (last curated february 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families reported (last curated february 2013) | rel=r_associated | relid=0 | w=15
  6823. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families reported (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families reported (last curated september 2012) | rel=r_associated | relid=0 | w=15
  6824. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families reported with 2 sibs each (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families reported with 2 sibs each (last curated october 2012) | rel=r_associated | relid=0 | w=15
  6825. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two families with different phenotypes have been reported (as of september 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two families with different phenotypes have been reported (as of september 2010) | rel=r_associated | relid=0 | w=15
  6826. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two fetuses from terminated pregnancies in 1 family have been reported (last curated march 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two fetuses from terminated pregnancies in 1 family have been reported (last curated march 2015) | rel=r_associated | relid=0 | w=15
  6827. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two fetuses have been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two fetuses have been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  6828. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two forms: iia (severe) and iib (mild)
    n1=Hyde (prurigo nodulaire de) | n2=en:two forms: iia (severe) and iib (mild) | rel=r_associated | relid=0 | w=15
  6829. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two japanese brothers have been reported (as of september 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two japanese brothers have been reported (as of september 2011) | rel=r_associated | relid=0 | w=15
  6830. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two japanese families have been reported (as of february 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two japanese families have been reported (as of february 2012) | rel=r_associated | relid=0 | w=15
  6831. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two japanese patients have been reported (last curated march 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two japanese patients have been reported (last curated march 2013) | rel=r_associated | relid=0 | w=15
  6832. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two jordanian sibs have been reported (last curated november 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two jordanian sibs have been reported (last curated november 2014) | rel=r_associated | relid=0 | w=15
  6833. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two loci control synthesis of c4, c4a (120810) and c4b (120820)
    n1=Hyde (prurigo nodulaire de) | n2=en:two loci control synthesis of c4, c4a (120810) and c4b (120820) | rel=r_associated | relid=0 | w=15
  6834. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two loci described - eec1 (129900) and eec3 (604292)
    n1=Hyde (prurigo nodulaire de) | n2=en:two loci described - eec1 (129900) and eec3 (604292) | rel=r_associated | relid=0 | w=15
  6835. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two main groups defined by age at onset: childhood (1 to 3 years) and onset after puberty
    n1=Hyde (prurigo nodulaire de) | n2=en:two main groups defined by age at onset: childhood (1 to 3 years) and onset after puberty | rel=r_associated | relid=0 | w=15
  6836. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two main phenotypes, early-onset with neurologic defects and early-adult onset with gout
    n1=Hyde (prurigo nodulaire de) | n2=en:two main phenotypes, early-onset with neurologic defects and early-adult onset with gout | rel=r_associated | relid=0 | w=15
  6837. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two main phenotypes, metabolic and neurologic
    n1=Hyde (prurigo nodulaire de) | n2=en:two main phenotypes, metabolic and neurologic | rel=r_associated | relid=0 | w=15
  6838. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two main phenotypes, severe and mild
    n1=Hyde (prurigo nodulaire de) | n2=en:two main phenotypes, severe and mild | rel=r_associated | relid=0 | w=15
  6839. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two main presentations
    n1=Hyde (prurigo nodulaire de) | n2=en:two main presentations | rel=r_associated | relid=0 | w=15
  6840. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two of 3 patients became wheelchair-bound
    n1=Hyde (prurigo nodulaire de) | n2=en:two of 3 patients became wheelchair-bound | rel=r_associated | relid=0 | w=15
  6841. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two of 6 patients became wheelchair-bound by age 20 years
    n1=Hyde (prurigo nodulaire de) | n2=en:two of 6 patients became wheelchair-bound by age 20 years | rel=r_associated | relid=0 | w=15
  6842. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two pairs of sisters described from two canadian dariusleut hutterite families (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two pairs of sisters described from two canadian dariusleut hutterite families (last curated september 2013) | rel=r_associated | relid=0 | w=15
  6843. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two pakistani families have been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two pakistani families have been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  6844. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two pakistani families reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two pakistani families reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  6845. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two pakistani families with a homozygous crybb3 mutation have been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two pakistani families with a homozygous crybb3 mutation have been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  6846. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients from 1 italian family have been reported (as of april 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients from 1 italian family have been reported (as of april 2010) | rel=r_associated | relid=0 | w=15
  6847. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients from spain have been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients from spain have been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  6848. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients have been reported | rel=r_associated | relid=0 | w=15
  6849. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients have been reported (as of august 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients have been reported (as of august 2010) | rel=r_associated | relid=0 | w=15
  6850. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients have been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients have been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  6851. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients in one ashkenzai jewish family described (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients in one ashkenzai jewish family described (last curated june 2014) | rel=r_associated | relid=0 | w=15
  6852. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients reported (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients reported (last curated may 2013) | rel=r_associated | relid=0 | w=15
  6853. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients required liver transplantation
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients required liver transplantation | rel=r_associated | relid=0 | w=15
  6854. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients with a wws phenotype have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients with a wws phenotype have been reported | rel=r_associated | relid=0 | w=15
  6855. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients with heterozygous prickle1 mutations and limited clinical and familial details have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients with heterozygous prickle1 mutations and limited clinical and familial details have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6856. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients with point mutations in rad21 have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients with point mutations in rad21 have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  6857. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two patients without cardiomyopathy or cataracts have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two patients without cardiomyopathy or cataracts have been reported | rel=r_associated | relid=0 | w=15
  6858. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two peaks of onset, childhood and adult
    n1=Hyde (prurigo nodulaire de) | n2=en:two peaks of onset, childhood and adult | rel=r_associated | relid=0 | w=15
  6859. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two presentations - rapid, fatal disorder of infancy and slowly progressive muscular disorder of childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:two presentations - rapid, fatal disorder of infancy and slowly progressive muscular disorder of childhood | rel=r_associated | relid=0 | w=15
  6860. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two probands have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two probands have been reported | rel=r_associated | relid=0 | w=15
  6861. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two related patients have been reported (as of november 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two related patients have been reported (as of november 2010) | rel=r_associated | relid=0 | w=15
  6862. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs born of consanguineous moroccan parents have been reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs born of consanguineous moroccan parents have been reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  6863. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs died before 2 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs died before 2 years of age | rel=r_associated | relid=0 | w=15
  6864. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs have been reported (as of august 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs have been reported (as of august 2011) | rel=r_associated | relid=0 | w=15
  6865. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs have been reported (last curated july 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs have been reported (last curated july 2013) | rel=r_associated | relid=0 | w=15
  6866. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs have been reported (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs have been reported (last curated may 2013) | rel=r_associated | relid=0 | w=15
  6867. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs have been reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs have been reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  6868. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs have been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs have been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  6869. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sibs, a boy and a girl, have been reported (as of july 2009)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sibs, a boy and a girl, have been reported (as of july 2009) | rel=r_associated | relid=0 | w=15
  6870. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sisters have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sisters have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  6871. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sisters have been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sisters have been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  6872. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two sisters, born of consanguineous moroccan parents, have been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two sisters, born of consanguineous moroccan parents, have been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  6873. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two subtypes - seminoma and nonseminoma
    n1=Hyde (prurigo nodulaire de) | n2=en:two subtypes - seminoma and nonseminoma | rel=r_associated | relid=0 | w=15
  6874. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two subtypes based on pathologic findings of 'balloon cells' - type iia, absence of balloon cells and type iib, presence of balloon cells
    n1=Hyde (prurigo nodulaire de) | n2=en:two subtypes based on pathologic findings of 'balloon cells' - type iia, absence of balloon cells and type iib, presence of balloon cells | rel=r_associated | relid=0 | w=15
  6875. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two subtypes noninflammatory type a and inflammatory type b
    n1=Hyde (prurigo nodulaire de) | n2=en:two subtypes noninflammatory type a and inflammatory type b | rel=r_associated | relid=0 | w=15
  6876. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two subtypes, episodic (85% of patients) and chronic (15%)
    n1=Hyde (prurigo nodulaire de) | n2=en:two subtypes, episodic (85% of patients) and chronic (15%) | rel=r_associated | relid=0 | w=15
  6877. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two thirds of patients are female
    n1=Hyde (prurigo nodulaire de) | n2=en:two thirds of patients are female | rel=r_associated | relid=0 | w=15
  6878. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two types - lethal neonatal and less severe, late onset
    n1=Hyde (prurigo nodulaire de) | n2=en:two types - lethal neonatal and less severe, late onset | rel=r_associated | relid=0 | w=15
  6879. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two types - one with premature ovarian failure (bpes type 1) and one without pof (bpes type 2)
    n1=Hyde (prurigo nodulaire de) | n2=en:two types - one with premature ovarian failure (bpes type 1) and one without pof (bpes type 2) | rel=r_associated | relid=0 | w=15
  6880. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two types - severe infantile form (type i) and milder form (type ii)
    n1=Hyde (prurigo nodulaire de) | n2=en:two types - severe infantile form (type i) and milder form (type ii) | rel=r_associated | relid=0 | w=15
  6881. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two types of platelet gpiv deficiency - type i, absence gpiv on monocytes (173510.0005) and type ii, presence gpiv on monocytes (173510.0001)
    n1=Hyde (prurigo nodulaire de) | n2=en:two types of platelet gpiv deficiency - type i, absence gpiv on monocytes (173510.0005) and type ii, presence gpiv on monocytes (173510.0001) | rel=r_associated | relid=0 | w=15
  6882. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two types, type i or type a (classical cockayne syndrome, 216400) and type ii or type b (severe cockayne syndrome, 133540)
    n1=Hyde (prurigo nodulaire de) | n2=en:two types, type i or type a (classical cockayne syndrome, 216400) and type ii or type b (severe cockayne syndrome, 133540) | rel=r_associated | relid=0 | w=15
  6883. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated boys reported with relatively mild phenotype (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated boys reported with relatively mild phenotype (last curated may 2012) | rel=r_associated | relid=0 | w=15
  6884. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated chinese families have been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated chinese families have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  6885. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated chinese families have been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated chinese families have been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  6886. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated consanguineous families (saudi arabian and israeli palestinian) have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  6887. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated consanguineous families have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated consanguineous families have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6888. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families and 1 isolated patient have been reported (last curated june 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families and 1 isolated patient have been reported (last curated june 2012) | rel=r_associated | relid=0 | w=15
  6889. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (as of july 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (as of july 2011) | rel=r_associated | relid=0 | w=15
  6890. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (as of october 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (as of october 2010) | rel=r_associated | relid=0 | w=15
  6891. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  6892. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated august 2013) | rel=r_associated | relid=0 | w=15
  6893. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  6894. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  6895. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated february 2014) | rel=r_associated | relid=0 | w=15
  6896. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  6897. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated january 2014) | rel=r_associated | relid=0 | w=15
  6898. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated july 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated july 2012) | rel=r_associated | relid=0 | w=15
  6899. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  6900. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated june 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated june 2012) | rel=r_associated | relid=0 | w=15
  6901. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated june 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated june 2014) | rel=r_associated | relid=0 | w=15
  6902. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated may 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated may 2013) | rel=r_associated | relid=0 | w=15
  6903. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated may 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated may 2014) | rel=r_associated | relid=0 | w=15
  6904. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated november 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated november 2012) | rel=r_associated | relid=0 | w=15
  6905. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  6906. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated october 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated october 2014) | rel=r_associated | relid=0 | w=15
  6907. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated september 2012) | rel=r_associated | relid=0 | w=15
  6908. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  6909. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6910. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families have been reported, 1 showing autosomal dominant inheritance and 1 showing autosomal recessive inheritance (last curated february 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families have been reported, 1 showing autosomal dominant inheritance and 1 showing autosomal recessive inheritance (last curated february 2014) | rel=r_associated | relid=0 | w=15
  6911. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated families, one north african descent and one of italian descent, have been reported (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated families, one north african descent and one of italian descent, have been reported (last curated august 2014) | rel=r_associated | relid=0 | w=15
  6912. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated girls reported (last curated october 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated girls reported (last curated october 2013) | rel=r_associated | relid=0 | w=15
  6913. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated individuals have been reported (last curated january 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated individuals have been reported (last curated january 2014) | rel=r_associated | relid=0 | w=15
  6914. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated japanese families have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated japanese families have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6915. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated japanese patients have been reported (last curated may 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated japanese patients have been reported (last curated may 2012) | rel=r_associated | relid=0 | w=15
  6916. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported | rel=r_associated | relid=0 | w=15
  6917. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (as of august 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (as of august 2010) | rel=r_associated | relid=0 | w=15
  6918. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  6919. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (as of june 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (as of june 2011) | rel=r_associated | relid=0 | w=15
  6920. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (as of may 2011)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (as of may 2011) | rel=r_associated | relid=0 | w=15
  6921. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated april 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated april 2013) | rel=r_associated | relid=0 | w=15
  6922. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated april 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated april 2014) | rel=r_associated | relid=0 | w=15
  6923. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated august 2013) | rel=r_associated | relid=0 | w=15
  6924. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated december 2010)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated december 2010) | rel=r_associated | relid=0 | w=15
  6925. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated december 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated december 2012) | rel=r_associated | relid=0 | w=15
  6926. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated december 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated december 2013) | rel=r_associated | relid=0 | w=15
  6927. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated february 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated february 2015) | rel=r_associated | relid=0 | w=15
  6928. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated january 2015)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated january 2015) | rel=r_associated | relid=0 | w=15
  6929. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated july 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated july 2014) | rel=r_associated | relid=0 | w=15
  6930. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated july 2014) onset in infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated july 2014) onset in infancy or childhood | rel=r_associated | relid=0 | w=15
  6931. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated june 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated june 2012) | rel=r_associated | relid=0 | w=15
  6932. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated june 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated june 2013) | rel=r_associated | relid=0 | w=15
  6933. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated march 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated march 2014) | rel=r_associated | relid=0 | w=15
  6934. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated october 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated october 2012) | rel=r_associated | relid=0 | w=15
  6935. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated october 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated october 2013) | rel=r_associated | relid=0 | w=15
  6936. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated september 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated september 2013) | rel=r_associated | relid=0 | w=15
  6937. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6938. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported, 1 with normal neurologic development and the other with profound neurologic abnormalities (last curated august 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported, 1 with normal neurologic development and the other with profound neurologic abnormalities (last curated august 2014) | rel=r_associated | relid=0 | w=15
  6939. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients have been reported, but nadk2 mutation has only been confirmed in 1 patient (last curated september 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients have been reported, but nadk2 mutation has only been confirmed in 1 patient (last curated september 2014) | rel=r_associated | relid=0 | w=15
  6940. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients reported (last curated september 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients reported (last curated september 2012) | rel=r_associated | relid=0 | w=15
  6941. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with confirmed mutations have been reported (as of january 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with confirmed mutations have been reported (as of january 2012) | rel=r_associated | relid=0 | w=15
  6942. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with de novo mutations have been reported (last curated november 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with de novo mutations have been reported (last curated november 2013) | rel=r_associated | relid=0 | w=15
  6943. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with different phenotypes have been reported (as of march 2012)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with different phenotypes have been reported (as of march 2012) | rel=r_associated | relid=0 | w=15
  6944. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with epileptic encephalopathy have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with epileptic encephalopathy have been reported | rel=r_associated | relid=0 | w=15
  6945. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with pathogenic csf2rb mutations have been reported (last curated december 2014)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with pathogenic csf2rb mutations have been reported (last curated december 2014) | rel=r_associated | relid=0 | w=15
  6946. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two unrelated patients with slightly different phenotypes have been reported (last curated august 2013)
    n1=Hyde (prurigo nodulaire de) | n2=en:two unrelated patients with slightly different phenotypes have been reported (last curated august 2013) | rel=r_associated | relid=0 | w=15
  6947. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations)
    n1=Hyde (prurigo nodulaire de) | n2=en:two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations) | rel=r_associated | relid=0 | w=15
  6948. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 1 - associated with osteogenesis imperfecta (125490)
    n1=Hyde (prurigo nodulaire de) | n2=en:type 1 - associated with osteogenesis imperfecta (125490) | rel=r_associated | relid=0 | w=15
  6949. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 1 porencephaly is usually unilateral and results from destructive lesions
    n1=Hyde (prurigo nodulaire de) | n2=en:type 1 porencephaly is usually unilateral and results from destructive lesions | rel=r_associated | relid=0 | w=15
  6950. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2 - hereditary opalescent dentin, not associated with bone defect (125490)
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2 - hereditary opalescent dentin, not associated with bone defect (125490) | rel=r_associated | relid=0 | w=15
  6951. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2 porencephaly is usually symmetrical and results from developmental malformation
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2 porencephaly is usually symmetrical and results from developmental malformation | rel=r_associated | relid=0 | w=15
  6952. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2 thanatophoric dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2 thanatophoric dysplasia | rel=r_associated | relid=0 | w=15
  6953. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2: cloverleaf skull, elbow ankylosis, early demise, sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2: cloverleaf skull, elbow ankylosis, early demise, sporadic | rel=r_associated | relid=0 | w=15
  6954. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2a is characterized by deficiency of high molecular weight monomers
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2a is characterized by deficiency of high molecular weight monomers | rel=r_associated | relid=0 | w=15
  6955. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2b is characterized by increased affinity for platelet glycoprotein 1b
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2b is characterized by increased affinity for platelet glycoprotein 1b | rel=r_associated | relid=0 | w=15
  6956. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2cb is characterized by defective binding affinity for collagen types i and iii
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2cb is characterized by defective binding affinity for collagen types i and iii | rel=r_associated | relid=0 | w=15
  6957. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2m is characterized by decreased platelet adhesion in the presence of high molecular weight monomers
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2m is characterized by decreased platelet adhesion in the presence of high molecular weight monomers | rel=r_associated | relid=0 | w=15
  6958. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2n is characterized by decreased binding affinity for factor viii
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2n is characterized by decreased binding affinity for factor viii | rel=r_associated | relid=0 | w=15
  6959. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 2n shows autosomal recessive inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:type 2n shows autosomal recessive inheritance | rel=r_associated | relid=0 | w=15
  6960. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 3 - brandywine isolate opalescent dentin (125500)
    n1=Hyde (prurigo nodulaire de) | n2=en:type 3 - brandywine isolate opalescent dentin (125500) | rel=r_associated | relid=0 | w=15
  6961. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type 3: craniosynostosis, early demise, sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:type 3: craniosynostosis, early demise, sporadic | rel=r_associated | relid=0 | w=15
  6962. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type a characterized by progressive myoclonic epilepsy
    n1=Hyde (prurigo nodulaire de) | n2=en:type a characterized by progressive myoclonic epilepsy | rel=r_associated | relid=0 | w=15
  6963. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type b characterized by dementia, motor disturbances, and facial dyskinesia
    n1=Hyde (prurigo nodulaire de) | n2=en:type b characterized by dementia, motor disturbances, and facial dyskinesia | rel=r_associated | relid=0 | w=15
  6964. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i b5r endemic in athabascan indians, navajo indians, and yakutsk natives of siberia
    n1=Hyde (prurigo nodulaire de) | n2=en:type i b5r endemic in athabascan indians, navajo indians, and yakutsk natives of siberia | rel=r_associated | relid=0 | w=15
  6965. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i has most severe manifestations by age 4-5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:type i has most severe manifestations by age 4-5 years | rel=r_associated | relid=0 | w=15
  6966. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i is infantile-onset, severe
    n1=Hyde (prurigo nodulaire de) | n2=en:type i is infantile-onset, severe | rel=r_associated | relid=0 | w=15
  6967. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i onset at 8 to 15 months of age after normal development
    n1=Hyde (prurigo nodulaire de) | n2=en:type i onset at 8 to 15 months of age after normal development | rel=r_associated | relid=0 | w=15
  6968. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i patients have undetectable aprt activity and are homozygous or compound heterozygous for null alleles
    n1=Hyde (prurigo nodulaire de) | n2=en:type i patients have undetectable aprt activity and are homozygous or compound heterozygous for null alleles | rel=r_associated | relid=0 | w=15
  6969. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type i sialidosis (cherry-red spot/myoclonus syndrome ) - mild disease, no dysmorphic features, onset in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:type i sialidosis (cherry-red spot/myoclonus syndrome ) - mild disease, no dysmorphic features, onset in second decade | rel=r_associated | relid=0 | w=15
  6970. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type ii achondrogenesis
    n1=Hyde (prurigo nodulaire de) | n2=en:type ii achondrogenesis | rel=r_associated | relid=0 | w=15
  6971. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type ii is adult-onset (kanzaki disease, 609242)
    n1=Hyde (prurigo nodulaire de) | n2=en:type ii is adult-onset (kanzaki disease, 609242) | rel=r_associated | relid=0 | w=15
  6972. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type ii is progressive and leads to shortened lifespan
    n1=Hyde (prurigo nodulaire de) | n2=en:type ii is progressive and leads to shortened lifespan | rel=r_associated | relid=0 | w=15
  6973. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type ii patients are usually japanese and have significant aprt activity (10-25%)
    n1=Hyde (prurigo nodulaire de) | n2=en:type ii patients are usually japanese and have significant aprt activity (10-25%) | rel=r_associated | relid=0 | w=15
  6974. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type ii sialidosis - severe disease, dysmorphic features, variable onset (congenital or hydropic (in utero), infantile (1-12 months), juvenile (2-20 years))
    n1=Hyde (prurigo nodulaire de) | n2=en:type ii sialidosis - severe disease, dysmorphic features, variable onset (congenital or hydropic (in utero), infantile (1-12 months), juvenile (2-20 years)) | rel=r_associated | relid=0 | w=15
  6975. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type iia tends to have more severe phenotype with earlier onset
    n1=Hyde (prurigo nodulaire de) | n2=en:type iia tends to have more severe phenotype with earlier onset | rel=r_associated | relid=0 | w=15
  6976. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type iii is intermediate form
    n1=Hyde (prurigo nodulaire de) | n2=en:type iii is intermediate form | rel=r_associated | relid=0 | w=15
  6977. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type iiia has both liver and muscle involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:type iiia has both liver and muscle involvement | rel=r_associated | relid=0 | w=15
  6978. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:type iiib liver involvement only (15% of all cases)
    n1=Hyde (prurigo nodulaire de) | n2=en:type iiib liver involvement only (15% of all cases) | rel=r_associated | relid=0 | w=15
  6979. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:types of psoriasis include - plaque, guttate, erythrodermic, pustular
    n1=Hyde (prurigo nodulaire de) | n2=en:types of psoriasis include - plaque, guttate, erythrodermic, pustular | rel=r_associated | relid=0 | w=15
  6980. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:typical attacks last from seconds to minutes, but longer occurrences have been reported
    n1=Hyde (prurigo nodulaire de) | n2=en:typical attacks last from seconds to minutes, but longer occurrences have been reported | rel=r_associated | relid=0 | w=15
  6981. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:typical onset in adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:typical onset in adulthood | rel=r_associated | relid=0 | w=15
  6982. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:typically no physical features of albright hereditary osteodystrophy (aho)
    n1=Hyde (prurigo nodulaire de) | n2=en:typically no physical features of albright hereditary osteodystrophy (aho) | rel=r_associated | relid=0 | w=15
  6983. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:tyshchenko syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:tyshchenko syndrome | rel=r_associated | relid=0 | w=15
  6984. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:u.s. frequency higher in blacks than whites
    n1=Hyde (prurigo nodulaire de) | n2=en:u.s. frequency higher in blacks than whites | rel=r_associated | relid=0 | w=15
  6985. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:udp-galactose-4-epimerase deficiency in circulating blood cells only ('peripheral' or 'mild' form, usually asymptomatic)
    n1=Hyde (prurigo nodulaire de) | n2=en:udp-galactose-4-epimerase deficiency in circulating blood cells only ('peripheral' or 'mild' form, usually asymptomatic) | rel=r_associated | relid=0 | w=15
  6986. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ullrich congenital muscular dystrophy (254090) is an allelic disorder with autosomal recessive inheritance and a more severe phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:ullrich congenital muscular dystrophy (254090) is an allelic disorder with autosomal recessive inheritance and a more severe phenotype | rel=r_associated | relid=0 | w=15
  6987. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ultrarapid metabolizers have multiple copies of the cyp2d6 gene (124030.0007)
    n1=Hyde (prurigo nodulaire de) | n2=en:ultrarapid metabolizers have multiple copies of the cyp2d6 gene (124030.0007) | rel=r_associated | relid=0 | w=15
  6988. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ultrasound detection in second trimester of pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:ultrasound detection in second trimester of pregnancy | rel=r_associated | relid=0 | w=15
  6989. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:umbilical cord finding
    n1=Hyde (prurigo nodulaire de) | n2=en:umbilical cord finding | rel=r_associated | relid=0 | w=15
  6990. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unaffected individuals carry 3 to 14 repeats, whereas affected individuals carry 650 to 2,500 repeats
    n1=Hyde (prurigo nodulaire de) | n2=en:unaffected individuals carry 3 to 14 repeats, whereas affected individuals carry 650 to 2,500 repeats | rel=r_associated | relid=0 | w=15
  6991. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unbalanced chromosomal translocation carrier have thin body habitus, shallow orbital ridges, arched eyebrows, exophthalmia, ptosis, bilateral ophthalmoplegia, thin upper lip, kyphosis, pectus excavatum, and mental retardation
    n1=Hyde (prurigo nodulaire de) | n2=en:unbalanced chromosomal translocation carrier have thin body habitus, shallow orbital ridges, arched eyebrows, exophthalmia, ptosis, bilateral ophthalmoplegia, thin upper lip, kyphosis, pectus excavatum, and mental retardation | rel=r_associated | relid=0 | w=15
  6992. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uncaria tomentosa extract
    n1=Hyde (prurigo nodulaire de) | n2=en:uncaria tomentosa extract | rel=r_associated | relid=0 | w=15
  6993. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unclassified ingredients [chemical/ingredient]
    n1=Hyde (prurigo nodulaire de) | n2=en:unclassified ingredients [chemical/ingredient] | rel=r_associated | relid=0 | w=15
  6994. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uncommon and rare features seen in the most severely affected patients
    n1=Hyde (prurigo nodulaire de) | n2=en:uncommon and rare features seen in the most severely affected patients | rel=r_associated | relid=0 | w=15
  6995. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uncommon disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:uncommon disorder | rel=r_associated | relid=0 | w=15
  6996. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uniparental disomy, paternal, chromosome 14
    n1=Hyde (prurigo nodulaire de) | n2=en:uniparental disomy, paternal, chromosome 14 | rel=r_associated | relid=0 | w=15
  6997. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unspecified complication of pregnancy, antepartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:unspecified complication of pregnancy, antepartum condition or complication | rel=r_associated | relid=0 | w=15
  6998. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unspecified complication of pregnancy, delivered, with or without mention of antepartum condition
    n1=Hyde (prurigo nodulaire de) | n2=en:unspecified complication of pregnancy, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
  6999. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unspecified complication of pregnancy, unspecified as to episode of care or not applicable
    n1=Hyde (prurigo nodulaire de) | n2=en:unspecified complication of pregnancy, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=15
  7000. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unspecified problem associated with amniotic cavity and membranes, antepartum condition or complication
    n1=Hyde (prurigo nodulaire de) | n2=en:unspecified problem associated with amniotic cavity and membranes, antepartum condition or complication | rel=r_associated | relid=0 | w=15
  7001. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unspecified problem associated with amniotic cavity and membranes, delivered, with or without mention of antepartum condition
    n1=Hyde (prurigo nodulaire de) | n2=en:unspecified problem associated with amniotic cavity and membranes, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=15
  7002. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unusual cabbage-like odor
    n1=Hyde (prurigo nodulaire de) | n2=en:unusual cabbage-like odor | rel=r_associated | relid=0 | w=15
  7003. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:unusual skill with jigsaw puzzle
    n1=Hyde (prurigo nodulaire de) | n2=en:unusual skill with jigsaw puzzle | rel=r_associated | relid=0 | w=15
  7004. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:up to 25% of patients are asymptomatic or mildly affected, suggesting incomplete penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:up to 25% of patients are asymptomatic or mildly affected, suggesting incomplete penetrance | rel=r_associated | relid=0 | w=15
  7005. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:up to 50% of patients may have various additional congenital anomalies
    n1=Hyde (prurigo nodulaire de) | n2=en:up to 50% of patients may have various additional congenital anomalies | rel=r_associated | relid=0 | w=15
  7006. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:up to 60% of female mutation carriers develop lobular breast cancer
    n1=Hyde (prurigo nodulaire de) | n2=en:up to 60% of female mutation carriers develop lobular breast cancer | rel=r_associated | relid=0 | w=15
  7007. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:upper limb involvement in first decade
    n1=Hyde (prurigo nodulaire de) | n2=en:upper limb involvement in first decade | rel=r_associated | relid=0 | w=15
  7008. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:upper limb involvement may occur later
    n1=Hyde (prurigo nodulaire de) | n2=en:upper limb involvement may occur later | rel=r_associated | relid=0 | w=15
  7009. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:upper limb involvement occur later
    n1=Hyde (prurigo nodulaire de) | n2=en:upper limb involvement occur later | rel=r_associated | relid=0 | w=15
  7010. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:upper limb involvement usually occurs later
    n1=Hyde (prurigo nodulaire de) | n2=en:upper limb involvement usually occurs later | rel=r_associated | relid=0 | w=15
  7011. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:upper urinary tract usually normal
    n1=Hyde (prurigo nodulaire de) | n2=en:upper urinary tract usually normal | rel=r_associated | relid=0 | w=15
  7012. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uracil-dna glycosylase
    n1=Hyde (prurigo nodulaire de) | n2=en:uracil-dna glycosylase | rel=r_associated | relid=0 | w=15
  7013. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ureohydrolases
    n1=Hyde (prurigo nodulaire de) | n2=en:ureohydrolases | rel=r_associated | relid=0 | w=15
  7014. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:urinalysis specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative
    n1=Hyde (prurigo nodulaire de) | n2=en:urinalysis specialist review:impression/interpretation of study:point in time:to be specified in another part of the message:narrative | rel=r_associated | relid=0 | w=15
  7015. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:urine turns dark on standing and alkalinization
    n1=Hyde (prurigo nodulaire de) | n2=en:urine turns dark on standing and alkalinization | rel=r_associated | relid=0 | w=15
  7016. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:urioste martinez-frias syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:urioste martinez-frias syndrome | rel=r_associated | relid=0 | w=15
  7017. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:use of ultrasonography
    n1=Hyde (prurigo nodulaire de) | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=15
  7018. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:user syndrome type ii (congenital moderate-severe deafness, normal vestibular dysfunction, and onset of retinitis pigmentosa in late second to early third decade) - 3 loci
    n1=Hyde (prurigo nodulaire de) | n2=en:user syndrome type ii (congenital moderate-severe deafness, normal vestibular dysfunction, and onset of retinitis pigmentosa in late second to early third decade) - 3 loci | rel=r_associated | relid=0 | w=15
  7019. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:ush3 cases account for 40% of all usher patients in finland
    n1=Hyde (prurigo nodulaire de) | n2=en:ush3 cases account for 40% of all usher patients in finland | rel=r_associated | relid=0 | w=15
  7020. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usher syndrome type i (congenital profound deafness, absent vestibular function, and prepubertal onset of retinitis pigmentosa) - 7 loci
    n1=Hyde (prurigo nodulaire de) | n2=en:usher syndrome type i (congenital profound deafness, absent vestibular function, and prepubertal onset of retinitis pigmentosa) - 7 loci | rel=r_associated | relid=0 | w=15
  7021. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usher syndrome type iii (postlingual progressive deafness, variable vestibular dysfunction, and progressive retinitis pigmentosa with variable age of onset) - 1 locus
    n1=Hyde (prurigo nodulaire de) | n2=en:usher syndrome type iii (postlingual progressive deafness, variable vestibular dysfunction, and progressive retinitis pigmentosa with variable age of onset) - 1 locus | rel=r_associated | relid=0 | w=15
  7022. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usual age of onset in the 20s and 30s
    n1=Hyde (prurigo nodulaire de) | n2=en:usual age of onset in the 20s and 30s | rel=r_associated | relid=0 | w=15
  7023. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usual onset before age 6 years and death by age 20
    n1=Hyde (prurigo nodulaire de) | n2=en:usual onset before age 6 years and death by age 20 | rel=r_associated | relid=0 | w=15
  7024. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usual onset under age 30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:usual onset under age 30 years | rel=r_associated | relid=0 | w=15
  7025. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually a manifestation of the carney complex (cnc1, 1609890)
    n1=Hyde (prurigo nodulaire de) | n2=en:usually a manifestation of the carney complex (cnc1, 1609890) | rel=r_associated | relid=0 | w=15
  7026. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually a sporadic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:usually a sporadic disorder | rel=r_associated | relid=0 | w=15
  7027. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:usually adult onset | rel=r_associated | relid=0 | w=15
  7028. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually affects children
    n1=Hyde (prurigo nodulaire de) | n2=en:usually affects children | rel=r_associated | relid=0 | w=15
  7029. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:usually asymptomatic | rel=r_associated | relid=0 | w=15
  7030. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually begins in feet and legs (peroneal distribution)
    n1=Hyde (prurigo nodulaire de) | n2=en:usually begins in feet and legs (peroneal distribution) | rel=r_associated | relid=0 | w=15
  7031. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually begins in feet and legs (peroneal distribution), but may progress to upper limbs
    n1=Hyde (prurigo nodulaire de) | n2=en:usually begins in feet and legs (peroneal distribution), but may progress to upper limbs | rel=r_associated | relid=0 | w=15
  7032. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually clinically asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:usually clinically asymptomatic | rel=r_associated | relid=0 | w=15
  7033. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually death in utero or rarely in neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:usually death in utero or rarely in neonatal period | rel=r_associated | relid=0 | w=15
  7034. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually fatal
    n1=Hyde (prurigo nodulaire de) | n2=en:usually fatal | rel=r_associated | relid=0 | w=15
  7035. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually fatal by age 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:usually fatal by age 5 years | rel=r_associated | relid=0 | w=15
  7036. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually fatal in first 2 decades
    n1=Hyde (prurigo nodulaire de) | n2=en:usually fatal in first 2 decades | rel=r_associated | relid=0 | w=15
  7037. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually fatal in infancy
    n1=Hyde (prurigo nodulaire de) | n2=en:usually fatal in infancy | rel=r_associated | relid=0 | w=15
  7038. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually fatal within the first few weeks of life
    n1=Hyde (prurigo nodulaire de) | n2=en:usually fatal within the first few weeks of life | rel=r_associated | relid=0 | w=15
  7039. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually favorable response to treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:usually favorable response to treatment | rel=r_associated | relid=0 | w=15
  7040. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually follows a static course or is slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:usually follows a static course or is slowly progressive | rel=r_associated | relid=0 | w=15
  7041. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually lethal in the neonatal period
    n1=Hyde (prurigo nodulaire de) | n2=en:usually lethal in the neonatal period | rel=r_associated | relid=0 | w=15
  7042. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually no increased fragility of hair
    n1=Hyde (prurigo nodulaire de) | n2=en:usually no increased fragility of hair | rel=r_associated | relid=0 | w=15
  7043. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually occurs in children younger than 5 years
    n1=Hyde (prurigo nodulaire de) | n2=en:usually occurs in children younger than 5 years | rel=r_associated | relid=0 | w=15
  7044. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually occurs in young adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:usually occurs in young adulthood | rel=r_associated | relid=0 | w=15
  7045. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually occurs in young adults
    n1=Hyde (prurigo nodulaire de) | n2=en:usually occurs in young adults | rel=r_associated | relid=0 | w=15
  7046. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually poor response to steroid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:usually poor response to steroid treatment | rel=r_associated | relid=0 | w=15
  7047. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually presents in third to fourth decade (but onset can range from childhood to elderly)
    n1=Hyde (prurigo nodulaire de) | n2=en:usually presents in third to fourth decade (but onset can range from childhood to elderly) | rel=r_associated | relid=0 | w=15
  7048. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:usually progressive | rel=r_associated | relid=0 | w=15
  7049. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually shows early age at onset (range 1 to 7 years, mean 4.6 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:usually shows early age at onset (range 1 to 7 years, mean 4.6 years) | rel=r_associated | relid=0 | w=15
  7050. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually sporadic
    n1=Hyde (prurigo nodulaire de) | n2=en:usually sporadic | rel=r_associated | relid=0 | w=15
  7051. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually sporadic disorder resulting from de novo 22q11.2 deletion
    n1=Hyde (prurigo nodulaire de) | n2=en:usually sporadic disorder resulting from de novo 22q11.2 deletion | rel=r_associated | relid=0 | w=15
  7052. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually sporadic, but 1-2% of cases are familial
    n1=Hyde (prurigo nodulaire de) | n2=en:usually sporadic, but 1-2% of cases are familial | rel=r_associated | relid=0 | w=15
  7053. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually sporadic, few cases described with autosomal dominant inheritance
    n1=Hyde (prurigo nodulaire de) | n2=en:usually sporadic, few cases described with autosomal dominant inheritance | rel=r_associated | relid=0 | w=15
  7054. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:usually symptomatic in adulthood with history of weakness since infancy or childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:usually symptomatic in adulthood with history of weakness since infancy or childhood | rel=r_associated | relid=0 | w=15
  7055. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uterine leiomyomata are found in hereditary leiomyomatosis and renal cell cancer syndrome (150800)
    n1=Hyde (prurigo nodulaire de) | n2=en:uterine leiomyomata are found in hereditary leiomyomatosis and renal cell cancer syndrome (150800) | rel=r_associated | relid=0 | w=15
  7056. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:uterine rupture
    n1=Hyde (prurigo nodulaire de) | n2=en:uterine rupture | rel=r_associated | relid=0 | w=15
  7057. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:v 15-1 stabilizer
    n1=Hyde (prurigo nodulaire de) | n2=en:v 15-1 stabilizer | rel=r_associated | relid=0 | w=15
  7058. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vaginal bleeding during pregnancy
    n1=Hyde (prurigo nodulaire de) | n2=en:vaginal bleeding during pregnancy | rel=r_associated | relid=0 | w=15
  7059. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vanishing twin syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:vanishing twin syndrome | rel=r_associated | relid=0 | w=15
  7060. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variability in extent of dislocation of lens and/or displacement of pupil, both within families and between eyes in a single individual
    n1=Hyde (prurigo nodulaire de) | n2=en:variability in extent of dislocation of lens and/or displacement of pupil, both within families and between eyes in a single individual | rel=r_associated | relid=0 | w=15
  7061. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:variable abnormalities | rel=r_associated | relid=0 | w=15
  7062. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at diagnosis
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at diagnosis | rel=r_associated | relid=0 | w=15
  7063. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset | rel=r_associated | relid=0 | w=15
  7064. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (8 to 62 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (8 to 62 years) | rel=r_associated | relid=0 | w=15
  7065. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (birth to adolescence)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (birth to adolescence) | rel=r_associated | relid=0 | w=15
  7066. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (birth to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (birth to adult) | rel=r_associated | relid=0 | w=15
  7067. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (childhood to adult) | rel=r_associated | relid=0 | w=15
  7068. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (childhood to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (childhood to adulthood) | rel=r_associated | relid=0 | w=15
  7069. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (childhood to age 50)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (childhood to age 50) | rel=r_associated | relid=0 | w=15
  7070. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (earliest reported 7 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (earliest reported 7 years) | rel=r_associated | relid=0 | w=15
  7071. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (infant to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (infant to adult) | rel=r_associated | relid=0 | w=15
  7072. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (late childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (late childhood to adult) | rel=r_associated | relid=0 | w=15
  7073. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 10 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 10 to 50 years) | rel=r_associated | relid=0 | w=15
  7074. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 14 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 14 to 50 years) | rel=r_associated | relid=0 | w=15
  7075. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 15 to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 15 to 60 years) | rel=r_associated | relid=0 | w=15
  7076. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 2 to 48 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 2 to 48 years) | rel=r_associated | relid=0 | w=15
  7077. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 2 to 59 years, mean 24 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 2 to 59 years, mean 24 years) | rel=r_associated | relid=0 | w=15
  7078. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 25 to 78 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 25 to 78 years) | rel=r_associated | relid=0 | w=15
  7079. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 4 to 40 years, mostly in first or second decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 4 to 40 years, mostly in first or second decade) | rel=r_associated | relid=0 | w=15
  7080. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 6 to 54 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 6 to 54 years) | rel=r_associated | relid=0 | w=15
  7081. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range 8 to 60 years, mean 32)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range 8 to 60 years, mean 32) | rel=r_associated | relid=0 | w=15
  7082. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range birth to 60 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range birth to 60 years) | rel=r_associated | relid=0 | w=15
  7083. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range childhood to adult) | rel=r_associated | relid=0 | w=15
  7084. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range childhood to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range childhood to adulthood) | rel=r_associated | relid=0 | w=15
  7085. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range childhood to late adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range childhood to late adult) | rel=r_associated | relid=0 | w=15
  7086. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range childhood to mid-sixties)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range childhood to mid-sixties) | rel=r_associated | relid=0 | w=15
  7087. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range first to fourth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range first to fourth decade) | rel=r_associated | relid=0 | w=15
  7088. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range first to third decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range first to third decade) | rel=r_associated | relid=0 | w=15
  7089. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range from early childhood to mid-adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range from early childhood to mid-adult) | rel=r_associated | relid=0 | w=15
  7090. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range infancy to 30 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range infancy to 30 years) | rel=r_associated | relid=0 | w=15
  7091. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range infancy to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range infancy to adulthood) | rel=r_associated | relid=0 | w=15
  7092. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range infancy to late adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range infancy to late adulthood) | rel=r_associated | relid=0 | w=15
  7093. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range late infancy to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range late infancy to adulthood) | rel=r_associated | relid=0 | w=15
  7094. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (range teens to late adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (range teens to late adult) | rel=r_associated | relid=0 | w=15
  7095. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset (usually 20 to 30 years of age)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset (usually 20 to 30 years of age) | rel=r_associated | relid=0 | w=15
  7096. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset from childhood to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset from childhood to adulthood | rel=r_associated | relid=0 | w=15
  7097. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset of seizures
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset of seizures | rel=r_associated | relid=0 | w=15
  7098. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, but usually in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, but usually in childhood | rel=r_associated | relid=0 | w=15
  7099. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, early childhood to adult
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, early childhood to adult | rel=r_associated | relid=0 | w=15
  7100. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, first to second decades
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, first to second decades | rel=r_associated | relid=0 | w=15
  7101. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, from birth to ninth decade
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, from birth to ninth decade | rel=r_associated | relid=0 | w=15
  7102. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, infancy to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, infancy to adulthood | rel=r_associated | relid=0 | w=15
  7103. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, most often in second decade
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, most often in second decade | rel=r_associated | relid=0 | w=15
  7104. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, mostly in third decade (range teenage years to fourth decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, mostly in third decade (range teenage years to fourth decade) | rel=r_associated | relid=0 | w=15
  7105. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, range from infancy to adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, range from infancy to adulthood | rel=r_associated | relid=0 | w=15
  7106. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, range infancy to adult
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, range infancy to adult | rel=r_associated | relid=0 | w=15
  7107. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, ranges from third to fifth decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, ranges from third to fifth decade of life | rel=r_associated | relid=0 | w=15
  7108. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, ranging from 18 months to 27 years
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, ranging from 18 months to 27 years | rel=r_associated | relid=0 | w=15
  7109. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, ranging from childhood to adult
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, ranging from childhood to adult | rel=r_associated | relid=0 | w=15
  7110. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, ranging from childhood to late adulthood
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, ranging from childhood to late adulthood | rel=r_associated | relid=0 | w=15
  7111. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age at onset, usually in first decade, but can occur later
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age at onset, usually in first decade, but can occur later | rel=r_associated | relid=0 | w=15
  7112. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset | rel=r_associated | relid=0 | w=15
  7113. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (6 to 35 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (6 to 35 years) | rel=r_associated | relid=0 | w=15
  7114. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (7-59 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (7-59 years) | rel=r_associated | relid=0 | w=15
  7115. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (childhood to adult) | rel=r_associated | relid=0 | w=15
  7116. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (childhood to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (childhood to adulthood) | rel=r_associated | relid=0 | w=15
  7117. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (childhood to young adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (childhood to young adulthood) | rel=r_associated | relid=0 | w=15
  7118. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (first to third decades)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (first to third decades) | rel=r_associated | relid=0 | w=15
  7119. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (infancy to 63 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (infancy to 63 years) | rel=r_associated | relid=0 | w=15
  7120. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range 1 to 30 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range 1 to 30 years) | rel=r_associated | relid=0 | w=15
  7121. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range 1-40 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range 1-40 years) | rel=r_associated | relid=0 | w=15
  7122. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range 13 to 67 years, median 48 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range 13 to 67 years, median 48 years) | rel=r_associated | relid=0 | w=15
  7123. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range 4 months to 45 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range 4 months to 45 years) | rel=r_associated | relid=0 | w=15
  7124. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range 4 to 47 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range 4 to 47 years) | rel=r_associated | relid=0 | w=15
  7125. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range early childhood to adult)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range early childhood to adult) | rel=r_associated | relid=0 | w=15
  7126. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset (range first to third decade)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset (range first to third decade) | rel=r_associated | relid=0 | w=15
  7127. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset of parkinsonism (first decade to adulthood)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset of parkinsonism (first decade to adulthood) | rel=r_associated | relid=0 | w=15
  7128. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset of renal manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset of renal manifestations | rel=r_associated | relid=0 | w=15
  7129. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset, from 6 to 50 years of age
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset, from 6 to 50 years of age | rel=r_associated | relid=0 | w=15
  7130. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset, from early childhood to seventh decade of life
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset, from early childhood to seventh decade of life | rel=r_associated | relid=0 | w=15
  7131. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable age of onset, ranging from 11 to 50 years
    n1=Hyde (prurigo nodulaire de) | n2=en:variable age of onset, ranging from 11 to 50 years | rel=r_associated | relid=0 | w=15
  7132. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable cardiac defects
    n1=Hyde (prurigo nodulaire de) | n2=en:variable cardiac defects | rel=r_associated | relid=0 | w=15
  7133. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable cataract phenotypes within a family
    n1=Hyde (prurigo nodulaire de) | n2=en:variable cataract phenotypes within a family | rel=r_associated | relid=0 | w=15
  7134. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable clinical features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable clinical features | rel=r_associated | relid=0 | w=15
  7135. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable clinical phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:variable clinical phenotype | rel=r_associated | relid=0 | w=15
  7136. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable clinical presentation
    n1=Hyde (prurigo nodulaire de) | n2=en:variable clinical presentation | rel=r_associated | relid=0 | w=15
  7137. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable clinical presentation ranging from acute onset to normal adult
    n1=Hyde (prurigo nodulaire de) | n2=en:variable clinical presentation ranging from acute onset to normal adult | rel=r_associated | relid=0 | w=15
  7138. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable clinical severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable clinical severity | rel=r_associated | relid=0 | w=15
  7139. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable degree of severity of widening and deviation of fifth fingers, both within and between affected individuals
    n1=Hyde (prurigo nodulaire de) | n2=en:variable degree of severity of widening and deviation of fifth fingers, both within and between affected individuals | rel=r_associated | relid=0 | w=15
  7140. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable disease severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable disease severity | rel=r_associated | relid=0 | w=15
  7141. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable distribution, may be focal, segmental, multifocal, or generalized
    n1=Hyde (prurigo nodulaire de) | n2=en:variable distribution, may be focal, segmental, multifocal, or generalized | rel=r_associated | relid=0 | w=15
  7142. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable duration (minutes to hours)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable duration (minutes to hours) | rel=r_associated | relid=0 | w=15
  7143. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable dysmorphic features | rel=r_associated | relid=0 | w=15
  7144. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expression
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expression | rel=r_associated | relid=0 | w=15
  7145. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expression and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expression and severity | rel=r_associated | relid=0 | w=15
  7146. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expression in females otopalatodigital syndrome type i (opd1, 311300) is an allelic disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expression in females otopalatodigital syndrome type i (opd1, 311300) is an allelic disorder | rel=r_associated | relid=0 | w=15
  7147. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expressivity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expressivity | rel=r_associated | relid=0 | w=15
  7148. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expressivity in families
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expressivity in families | rel=r_associated | relid=0 | w=15
  7149. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expressivity of each feature
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expressivity of each feature | rel=r_associated | relid=0 | w=15
  7150. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expressivity within a family
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expressivity within a family | rel=r_associated | relid=0 | w=15
  7151. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable expressivity, some patients may be clinically asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:variable expressivity, some patients may be clinically asymptomatic | rel=r_associated | relid=0 | w=15
  7152. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable extraneurologic features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable extraneurologic features | rel=r_associated | relid=0 | w=15
  7153. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable facial dysmorphic features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable facial dysmorphic features | rel=r_associated | relid=0 | w=15
  7154. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable features | rel=r_associated | relid=0 | w=15
  7155. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable features and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable features and severity | rel=r_associated | relid=0 | w=15
  7156. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable features present
    n1=Hyde (prurigo nodulaire de) | n2=en:variable features present | rel=r_associated | relid=0 | w=15
  7157. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable frequency (2 per day up to 1 per month)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable frequency (2 per day up to 1 per month) | rel=r_associated | relid=0 | w=15
  7158. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable frequency (daily to monthly)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable frequency (daily to monthly) | rel=r_associated | relid=0 | w=15
  7159. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable frequency (weekly to yearly)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable frequency (weekly to yearly) | rel=r_associated | relid=0 | w=15
  7160. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable frequency and duration of episodes
    n1=Hyde (prurigo nodulaire de) | n2=en:variable frequency and duration of episodes | rel=r_associated | relid=0 | w=15
  7161. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable frequency and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable frequency and severity | rel=r_associated | relid=0 | w=15
  7162. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable heat tolerance
    n1=Hyde (prurigo nodulaire de) | n2=en:variable heat tolerance | rel=r_associated | relid=0 | w=15
  7163. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable ictal semiology
    n1=Hyde (prurigo nodulaire de) | n2=en:variable ictal semiology | rel=r_associated | relid=0 | w=15
  7164. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable infectious phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:variable infectious phenotype | rel=r_associated | relid=0 | w=15
  7165. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable involvement of hematologic parameters
    n1=Hyde (prurigo nodulaire de) | n2=en:variable involvement of hematologic parameters | rel=r_associated | relid=0 | w=15
  7166. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable manifestation of features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable manifestation of features | rel=r_associated | relid=0 | w=15
  7167. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:variable manifestations | rel=r_associated | relid=0 | w=15
  7168. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable neurologic phenotype
    n1=Hyde (prurigo nodulaire de) | n2=en:variable neurologic phenotype | rel=r_associated | relid=0 | w=15
  7169. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable neuroradiologic findings
    n1=Hyde (prurigo nodulaire de) | n2=en:variable neuroradiologic findings | rel=r_associated | relid=0 | w=15
  7170. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable number of nails involved
    n1=Hyde (prurigo nodulaire de) | n2=en:variable number of nails involved | rel=r_associated | relid=0 | w=15
  7171. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable pattern of body involvement although symptoms may predominate in upper or lower body
    n1=Hyde (prurigo nodulaire de) | n2=en:variable pattern of body involvement although symptoms may predominate in upper or lower body | rel=r_associated | relid=0 | w=15
  7172. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable penetrance
    n1=Hyde (prurigo nodulaire de) | n2=en:variable penetrance | rel=r_associated | relid=0 | w=15
  7173. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable penetrance and expressivity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable penetrance and expressivity | rel=r_associated | relid=0 | w=15
  7174. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable penetrance of these features
    n1=Hyde (prurigo nodulaire de) | n2=en:variable penetrance of these features | rel=r_associated | relid=0 | w=15
  7175. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype (myotonia may or may not be present)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype (myotonia may or may not be present) | rel=r_associated | relid=0 | w=15
  7176. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype (range from completely female to males with mild undermasculinization)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype (range from completely female to males with mild undermasculinization) | rel=r_associated | relid=0 | w=15
  7177. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype and severity | rel=r_associated | relid=0 | w=15
  7178. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype depending on residual enzyme activity
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype depending on residual enzyme activity | rel=r_associated | relid=0 | w=15
  7179. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype ranging from woolly to sparse hair, even within a single family
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype ranging from woolly to sparse hair, even within a single family | rel=r_associated | relid=0 | w=15
  7180. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype within families
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype within families | rel=r_associated | relid=0 | w=15
  7181. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype within families ranging from woolly hair to hypotrichosis
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype within families ranging from woolly hair to hypotrichosis | rel=r_associated | relid=0 | w=15
  7182. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype, particularly with regard to cortical malformations
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype, particularly with regard to cortical malformations | rel=r_associated | relid=0 | w=15
  7183. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotype, some patients have very mild symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotype, some patients have very mild symptoms | rel=r_associated | relid=0 | w=15
  7184. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable phenotypic expression
    n1=Hyde (prurigo nodulaire de) | n2=en:variable phenotypic expression | rel=r_associated | relid=0 | w=15
  7185. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable presentation
    n1=Hyde (prurigo nodulaire de) | n2=en:variable presentation | rel=r_associated | relid=0 | w=15
  7186. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable presentation and evolution of symptoms
    n1=Hyde (prurigo nodulaire de) | n2=en:variable presentation and evolution of symptoms | rel=r_associated | relid=0 | w=15
  7187. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable presentation and manifestations
    n1=Hyde (prurigo nodulaire de) | n2=en:variable presentation and manifestations | rel=r_associated | relid=0 | w=15
  7188. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable progression
    n1=Hyde (prurigo nodulaire de) | n2=en:variable progression | rel=r_associated | relid=0 | w=15
  7189. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable progression rate
    n1=Hyde (prurigo nodulaire de) | n2=en:variable progression rate | rel=r_associated | relid=0 | w=15
  7190. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable response to acetazolamide and carbamazepine
    n1=Hyde (prurigo nodulaire de) | n2=en:variable response to acetazolamide and carbamazepine | rel=r_associated | relid=0 | w=15
  7191. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable response to acetylcholinesterase inhibitors
    n1=Hyde (prurigo nodulaire de) | n2=en:variable response to acetylcholinesterase inhibitors | rel=r_associated | relid=0 | w=15
  7192. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable response to levodopa treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:variable response to levodopa treatment | rel=r_associated | relid=0 | w=15
  7193. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable response to steroid treatment
    n1=Hyde (prurigo nodulaire de) | n2=en:variable response to steroid treatment | rel=r_associated | relid=0 | w=15
  7194. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable response to vitamin b12 therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:variable response to vitamin b12 therapy | rel=r_associated | relid=0 | w=15
  7195. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity (in patients with hsan2d)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity (in patients with hsan2d) | rel=r_associated | relid=0 | w=15
  7196. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity (mild symptoms to severe handicap)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity (mild symptoms to severe handicap) | rel=r_associated | relid=0 | w=15
  7197. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity and progression
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity and progression | rel=r_associated | relid=0 | w=15
  7198. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity of brain malformations
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity of brain malformations | rel=r_associated | relid=0 | w=15
  7199. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity of phenotype and other features may be present
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity of phenotype and other features may be present | rel=r_associated | relid=0 | w=15
  7200. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity ranging from asymptomatic euthyroid to severe hypothyroidism
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity ranging from asymptomatic euthyroid to severe hypothyroidism | rel=r_associated | relid=0 | w=15
  7201. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity that correlates with rate and magnitude of neuronal protein accumulation
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity that correlates with rate and magnitude of neuronal protein accumulation | rel=r_associated | relid=0 | w=15
  7202. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, correlates with age at onset
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, correlates with age at onset | rel=r_associated | relid=0 | w=15
  7203. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, even within families
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, even within families | rel=r_associated | relid=0 | w=15
  7204. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, intrafamilial
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, intrafamilial | rel=r_associated | relid=0 | w=15
  7205. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, ranging from 'typical' to 'severe' disease
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, ranging from 'typical' to 'severe' disease | rel=r_associated | relid=0 | w=15
  7206. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, ranging from central severe to peripheral to transient
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, ranging from central severe to peripheral to transient | rel=r_associated | relid=0 | w=15
  7207. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable severity, some patients have a protracted course with little neurologic involvement
    n1=Hyde (prurigo nodulaire de) | n2=en:variable severity, some patients have a protracted course with little neurologic involvement | rel=r_associated | relid=0 | w=15
  7208. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable survival
    n1=Hyde (prurigo nodulaire de) | n2=en:variable survival | rel=r_associated | relid=0 | w=15
  7209. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variable survival (some neonatal lethality)
    n1=Hyde (prurigo nodulaire de) | n2=en:variable survival (some neonatal lethality) | rel=r_associated | relid=0 | w=15
  7210. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variably expressivity
    n1=Hyde (prurigo nodulaire de) | n2=en:variably expressivity | rel=r_associated | relid=0 | w=15
  7211. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variably severity
    n1=Hyde (prurigo nodulaire de) | n2=en:variably severity | rel=r_associated | relid=0 | w=15
  7212. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variant at may present with dystonia only
    n1=Hyde (prurigo nodulaire de) | n2=en:variant at may present with dystonia only | rel=r_associated | relid=0 | w=15
  7213. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variant lesch-nyhan, 1.5-8% hprt activity with neurologic abnormalities, but no self-injurious behavior
    n1=Hyde (prurigo nodulaire de) | n2=en:variant lesch-nyhan, 1.5-8% hprt activity with neurologic abnormalities, but no self-injurious behavior | rel=r_associated | relid=0 | w=15
  7214. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:variation in slc24a5 has also been associated with variation in skin color (shep4)
    n1=Hyde (prurigo nodulaire de) | n2=en:variation in slc24a5 has also been associated with variation in skin color (shep4) | rel=r_associated | relid=0 | w=15
  7215. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vasculitic symptoms are associated with cold exposure (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:vasculitic symptoms are associated with cold exposure (in some patients) | rel=r_associated | relid=0 | w=15
  7216. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vast majority of heterozygotes are asymptomatic
    n1=Hyde (prurigo nodulaire de) | n2=en:vast majority of heterozygotes are asymptomatic | rel=r_associated | relid=0 | w=15
  7217. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vegetarian diet
    n1=Hyde (prurigo nodulaire de) | n2=en:vegetarian diet | rel=r_associated | relid=0 | w=15
  7218. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:venous malformations previously referred to as angiomas or hemangiomas
    n1=Hyde (prurigo nodulaire de) | n2=en:venous malformations previously referred to as angiomas or hemangiomas | rel=r_associated | relid=0 | w=15
  7219. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vertical eye movement abnormalities appear before horizontal eye movement abnormalities
    n1=Hyde (prurigo nodulaire de) | n2=en:vertical eye movement abnormalities appear before horizontal eye movement abnormalities | rel=r_associated | relid=0 | w=15
  7220. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:very few patients reported
    n1=Hyde (prurigo nodulaire de) | n2=en:very few patients reported | rel=r_associated | relid=0 | w=15
  7221. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:very low occurrence of retinal, hepatic, pancreatic, and renal anomalies
    n1=Hyde (prurigo nodulaire de) | n2=en:very low occurrence of retinal, hepatic, pancreatic, and renal anomalies | rel=r_associated | relid=0 | w=15
  7222. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:very rare
    n1=Hyde (prurigo nodulaire de) | n2=en:very rare | rel=r_associated | relid=0 | w=15
  7223. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:very slow progression
    n1=Hyde (prurigo nodulaire de) | n2=en:very slow progression | rel=r_associated | relid=0 | w=15
  7224. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:very variable phenotype, with some patients having many features and others only a few
    n1=Hyde (prurigo nodulaire de) | n2=en:very variable phenotype, with some patients having many features and others only a few | rel=r_associated | relid=0 | w=15
  7225. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vesicoureteral reflux 3
    n1=Hyde (prurigo nodulaire de) | n2=en:vesicoureteral reflux 3 | rel=r_associated | relid=0 | w=15
  7226. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:veterinary aspects
    n1=Hyde (prurigo nodulaire de) | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=15
  7227. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vhl type 1 - renal carcinoma and hemangioblastoma
    n1=Hyde (prurigo nodulaire de) | n2=en:vhl type 1 - renal carcinoma and hemangioblastoma | rel=r_associated | relid=0 | w=15
  7228. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vhl type 2a - hemangioblastoma and pheochromocytoma
    n1=Hyde (prurigo nodulaire de) | n2=en:vhl type 2a - hemangioblastoma and pheochromocytoma | rel=r_associated | relid=0 | w=15
  7229. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vhl type 2b - renal carcinoma and pheochromocytoma
    n1=Hyde (prurigo nodulaire de) | n2=en:vhl type 2b - renal carcinoma and pheochromocytoma | rel=r_associated | relid=0 | w=15
  7230. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vhl type 2c - pheochromocytoma only
    n1=Hyde (prurigo nodulaire de) | n2=en:vhl type 2c - pheochromocytoma only | rel=r_associated | relid=0 | w=15
  7231. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:virtually all patients with this condition are female
    n1=Hyde (prurigo nodulaire de) | n2=en:virtually all patients with this condition are female | rel=r_associated | relid=0 | w=15
  7232. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:viruses
    n1=Hyde (prurigo nodulaire de) | n2=en:viruses | rel=r_associated | relid=0 | w=15
  7233. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visceral manifestations are less apparent
    n1=Hyde (prurigo nodulaire de) | n2=en:visceral manifestations are less apparent | rel=r_associated | relid=0 | w=15
  7234. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visceral multicentric involvement has a poorer prognosis than solitary lesions limited to the skin
    n1=Hyde (prurigo nodulaire de) | n2=en:visceral multicentric involvement has a poorer prognosis than solitary lesions limited to the skin | rel=r_associated | relid=0 | w=15
  7235. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visceral myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:visceral myopathy | rel=r_associated | relid=0 | w=15
  7236. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visual acuity varies considerably, depending on the presence of secondary defects such as retinal exudates or detachment
    n1=Hyde (prurigo nodulaire de) | n2=en:visual acuity varies considerably, depending on the presence of secondary defects such as retinal exudates or detachment | rel=r_associated | relid=0 | w=15
  7237. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visual and hearing loss are slowly progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:visual and hearing loss are slowly progressive | rel=r_associated | relid=0 | w=15
  7238. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visual field and color defects invariably present only in patients with advanced loss of vision
    n1=Hyde (prurigo nodulaire de) | n2=en:visual field and color defects invariably present only in patients with advanced loss of vision | rel=r_associated | relid=0 | w=15
  7239. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visual impairment is present at birth and is progressive
    n1=Hyde (prurigo nodulaire de) | n2=en:visual impairment is present at birth and is progressive | rel=r_associated | relid=0 | w=15
  7240. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:visual symptoms present by late childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:visual symptoms present by late childhood | rel=r_associated | relid=0 | w=15
  7241. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin | rel=r_associated | relid=0 | w=15
  7242. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin / trace element
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin / trace element | rel=r_associated | relid=0 | w=15
  7243. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin a compound
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin a compound | rel=r_associated | relid=0 | w=15
  7244. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin b complex
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin b complex | rel=r_associated | relid=0 | w=15
  7245. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin e compound
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin e compound | rel=r_associated | relid=0 | w=15
  7246. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitamin k
    n1=Hyde (prurigo nodulaire de) | n2=en:vitamin k | rel=r_associated | relid=0 | w=15
  7247. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:vitellointestinal band
    n1=Hyde (prurigo nodulaire de) | n2=en:vitellointestinal band | rel=r_associated | relid=0 | w=15
  7248. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:waddling gait
    n1=Hyde (prurigo nodulaire de) | n2=en:waddling gait | rel=r_associated | relid=0 | w=15
  7249. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:waddling gait noted at age 15-20 months
    n1=Hyde (prurigo nodulaire de) | n2=en:waddling gait noted at age 15-20 months | rel=r_associated | relid=0 | w=15
  7250. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:waddling gait, often presenting sign in second year
    n1=Hyde (prurigo nodulaire de) | n2=en:waddling gait, often presenting sign in second year | rel=r_associated | relid=0 | w=15
  7251. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:waddling gate
    n1=Hyde (prurigo nodulaire de) | n2=en:waddling gate | rel=r_associated | relid=0 | w=15
  7252. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:walking delay
    n1=Hyde (prurigo nodulaire de) | n2=en:walking delay | rel=r_associated | relid=0 | w=15
  7253. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:warm weather and alcohol are alleviating factors
    n1=Hyde (prurigo nodulaire de) | n2=en:warm weather and alcohol are alleviating factors | rel=r_associated | relid=0 | w=15
  7254. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wasting of hands often occurs first
    n1=Hyde (prurigo nodulaire de) | n2=en:wasting of hands often occurs first | rel=r_associated | relid=0 | w=15
  7255. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wasting of the hands is the first and most prominent manifestation
    n1=Hyde (prurigo nodulaire de) | n2=en:wasting of the hands is the first and most prominent manifestation | rel=r_associated | relid=0 | w=15
  7256. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:waxing and waning cardiomyopathy (in some patients)
    n1=Hyde (prurigo nodulaire de) | n2=en:waxing and waning cardiomyopathy (in some patients) | rel=r_associated | relid=0 | w=15
  7257. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:weakness during pregnancy in affected females
    n1=Hyde (prurigo nodulaire de) | n2=en:weakness during pregnancy in affected females | rel=r_associated | relid=0 | w=15
  7258. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:weight maintenance regimen
    n1=Hyde (prurigo nodulaire de) | n2=en:weight maintenance regimen | rel=r_associated | relid=0 | w=15
  7259. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wheelchair use at 20-30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:wheelchair use at 20-30 years | rel=r_associated | relid=0 | w=15
  7260. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wheelchair use by 10-30 years
    n1=Hyde (prurigo nodulaire de) | n2=en:wheelchair use by 10-30 years | rel=r_associated | relid=0 | w=15
  7261. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wheelchair-bound after 2 decades of disease onset
    n1=Hyde (prurigo nodulaire de) | n2=en:wheelchair-bound after 2 decades of disease onset | rel=r_associated | relid=0 | w=15
  7262. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wheelchair-bound average 12 years after onset
    n1=Hyde (prurigo nodulaire de) | n2=en:wheelchair-bound average 12 years after onset | rel=r_associated | relid=0 | w=15
  7263. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide clinical variability
    n1=Hyde (prurigo nodulaire de) | n2=en:wide clinical variability | rel=r_associated | relid=0 | w=15
  7264. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide phenotypic variability
    n1=Hyde (prurigo nodulaire de) | n2=en:wide phenotypic variability | rel=r_associated | relid=0 | w=15
  7265. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide phenotypic variability and severity
    n1=Hyde (prurigo nodulaire de) | n2=en:wide phenotypic variability and severity | rel=r_associated | relid=0 | w=15
  7266. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide phenotypic variation
    n1=Hyde (prurigo nodulaire de) | n2=en:wide phenotypic variation | rel=r_associated | relid=0 | w=15
  7267. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide range of onset from childhood to adult (10 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:wide range of onset from childhood to adult (10 to 50 years) | rel=r_associated | relid=0 | w=15
  7268. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide range of severity between affected members of the same family
    n1=Hyde (prurigo nodulaire de) | n2=en:wide range of severity between affected members of the same family | rel=r_associated | relid=0 | w=15
  7269. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:wide spectrum of severity
    n1=Hyde (prurigo nodulaire de) | n2=en:wide spectrum of severity | rel=r_associated | relid=0 | w=15
  7270. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:women affected more than men (3:2)
    n1=Hyde (prurigo nodulaire de) | n2=en:women affected more than men (3:2) | rel=r_associated | relid=0 | w=15
  7271. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:women are more often affected
    n1=Hyde (prurigo nodulaire de) | n2=en:women are more often affected | rel=r_associated | relid=0 | w=15
  7272. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:women may be mildly affected
    n1=Hyde (prurigo nodulaire de) | n2=en:women may be mildly affected | rel=r_associated | relid=0 | w=15
  7273. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worldwide frequency of 1 in 100,000 infants
    n1=Hyde (prurigo nodulaire de) | n2=en:worldwide frequency of 1 in 100,000 infants | rel=r_associated | relid=0 | w=15
  7274. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worldwide frequency of 1 in 2,000,000
    n1=Hyde (prurigo nodulaire de) | n2=en:worldwide frequency of 1 in 2,000,000 | rel=r_associated | relid=0 | w=15
  7275. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worldwide incidence of 1 in 185,000 live births
    n1=Hyde (prurigo nodulaire de) | n2=en:worldwide incidence of 1 in 185,000 live births | rel=r_associated | relid=0 | w=15
  7276. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worldwide prevalence of 1/100,000
    n1=Hyde (prurigo nodulaire de) | n2=en:worldwide prevalence of 1/100,000 | rel=r_associated | relid=0 | w=15
  7277. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worsened by immunosuppressive therapy
    n1=Hyde (prurigo nodulaire de) | n2=en:worsened by immunosuppressive therapy | rel=r_associated | relid=0 | w=15
  7278. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worsening of hand weakness with cold (in some)
    n1=Hyde (prurigo nodulaire de) | n2=en:worsening of hand weakness with cold (in some) | rel=r_associated | relid=0 | w=15
  7279. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:worsening of symptoms during sleep
    n1=Hyde (prurigo nodulaire de) | n2=en:worsening of symptoms during sleep | rel=r_associated | relid=0 | w=15
  7280. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:x-linked centronuclear myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:x-linked centronuclear myopathy | rel=r_associated | relid=0 | w=15
  7281. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:x-linked inheritance could not be ruled out
    n1=Hyde (prurigo nodulaire de) | n2=en:x-linked inheritance could not be ruled out | rel=r_associated | relid=0 | w=15
  7282. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:x-linked mental retardation-hypotonic facies syndrome (309580) is an allelic disorder without alpha-thalassemia
    n1=Hyde (prurigo nodulaire de) | n2=en:x-linked mental retardation-hypotonic facies syndrome (309580) is an allelic disorder without alpha-thalassemia | rel=r_associated | relid=0 | w=15
  7283. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:x-linked recessive cytochrome b-negative cgd
    n1=Hyde (prurigo nodulaire de) | n2=en:x-linked recessive cytochrome b-negative cgd | rel=r_associated | relid=0 | w=15
  7284. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:xy karyotype
    n1=Hyde (prurigo nodulaire de) | n2=en:xy karyotype | rel=r_associated | relid=0 | w=15
  7285. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:yolk sac absent
    n1=Hyde (prurigo nodulaire de) | n2=en:yolk sac absent | rel=r_associated | relid=0 | w=15
  7286. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:yolk sac present
    n1=Hyde (prurigo nodulaire de) | n2=en:yolk sac present | rel=r_associated | relid=0 | w=15
  7287. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:young adult onset
    n1=Hyde (prurigo nodulaire de) | n2=en:young adult onset | rel=r_associated | relid=0 | w=15
  7288. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:young adult onset (range 13 to 50 years)
    n1=Hyde (prurigo nodulaire de) | n2=en:young adult onset (range 13 to 50 years) | rel=r_associated | relid=0 | w=15
  7289. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:young-adult onset (18-30 years) of sensory ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:young-adult onset (18-30 years) of sensory ataxia | rel=r_associated | relid=0 | w=15
  7290. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:yunis varon syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:yunis varon syndrome | rel=r_associated | relid=0 | w=15
  7291. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:z allele most common, only in caucasians
    n1=Hyde (prurigo nodulaire de) | n2=en:z allele most common, only in caucasians | rel=r_associated | relid=0 | w=15
  7292. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> en:zinc deficiency in breastfed offspring resolves after weaning
    n1=Hyde (prurigo nodulaire de) | n2=en:zinc deficiency in breastfed offspring resolves after weaning | rel=r_associated | relid=0 | w=15
  7293. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> encéphalo-cystocèle
    n1=Hyde (prurigo nodulaire de) | n2=encéphalo-cystocèle | rel=r_associated | relid=0 | w=15
  7294. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> encéphalocystocèle
    n1=Hyde (prurigo nodulaire de) | n2=encéphalocystocèle | rel=r_associated | relid=0 | w=15
  7295. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> enfant de mère diabétique
    n1=Hyde (prurigo nodulaire de) | n2=enfant de mère diabétique | rel=r_associated | relid=0 | w=15
  7296. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> enzyme
    n1=Hyde (prurigo nodulaire de) | n2=enzyme | rel=r_associated | relid=0 | w=15
  7297. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> épimères
    n1=Hyde (prurigo nodulaire de) | n2=épimères | rel=r_associated | relid=0 | w=15
  7298. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> érythème polymorphe
    n1=Hyde (prurigo nodulaire de) | n2=érythème polymorphe | rel=r_associated | relid=0 | w=15
  7299. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> excès
    n1=Hyde (prurigo nodulaire de) | n2=excès | rel=r_associated | relid=0 | w=15
  7300. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> excès de liquide amniotique
    n1=Hyde (prurigo nodulaire de) | n2=excès de liquide amniotique | rel=r_associated | relid=0 | w=15
  7301. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> exencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=exencéphalie | rel=r_associated | relid=0 | w=15
  7302. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> faux du cerveau
    n1=Hyde (prurigo nodulaire de) | n2=faux du cerveau | rel=r_associated | relid=0 | w=15
  7303. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> féculent
    n1=Hyde (prurigo nodulaire de) | n2=féculent | rel=r_associated | relid=0 | w=15
  7304. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> glucide complexe
    n1=Hyde (prurigo nodulaire de) | n2=glucide complexe | rel=r_associated | relid=0 | w=15
  7305. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> glucides
    n1=Hyde (prurigo nodulaire de) | n2=glucides | rel=r_associated | relid=0 | w=15
  7306. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> glucose
    n1=Hyde (prurigo nodulaire de) | n2=glucose | rel=r_associated | relid=0 | w=15
  7307. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> glycéraldéhyde
    n1=Hyde (prurigo nodulaire de) | n2=glycéraldéhyde | rel=r_associated | relid=0 | w=15
  7308. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> glycogène
    n1=Hyde (prurigo nodulaire de) | n2=glycogène | rel=r_associated | relid=0 | w=15
  7309. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> grossesse
    n1=Hyde (prurigo nodulaire de) | n2=grossesse | rel=r_associated | relid=0 | w=15
  7310. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> Günther (maladie de)
    n1=Hyde (prurigo nodulaire de) | n2=Günther (maladie de) | rel=r_associated | relid=0 | w=15
  7311. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hauteur utérine
    n1=Hyde (prurigo nodulaire de) | n2=hauteur utérine | rel=r_associated | relid=0 | w=15
  7312. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hémi-hydranencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=hémi-hydranencéphalie | rel=r_associated | relid=0 | w=15
  7313. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hémihydranencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=hémihydranencéphalie | rel=r_associated | relid=0 | w=15
  7314. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hémisphère cérébral
    n1=Hyde (prurigo nodulaire de) | n2=hémisphère cérébral | rel=r_associated | relid=0 | w=15
  7315. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> herpès
    n1=Hyde (prurigo nodulaire de) | n2=herpès | rel=r_associated | relid=0 | w=15
  7316. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> holoside
    n1=Hyde (prurigo nodulaire de) | n2=holoside | rel=r_associated | relid=0 | w=15
  7317. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hormone antidiurétique
    n1=Hyde (prurigo nodulaire de) | n2=hormone antidiurétique | rel=r_associated | relid=0 | w=15
  7318. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> Hutchinson (acné prurigo de)
    n1=Hyde (prurigo nodulaire de) | n2=Hutchinson (acné prurigo de) | rel=r_associated | relid=0 | w=15
  7319. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydranencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=hydranencéphalie | rel=r_associated | relid=0 | w=15
  7320. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydranencéphalie avec vasculopathie proliférative
    n1=Hyde (prurigo nodulaire de) | n2=hydranencéphalie avec vasculopathie proliférative | rel=r_associated | relid=0 | w=15
  7321. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydranencéphalies
    n1=Hyde (prurigo nodulaire de) | n2=hydranencéphalies | rel=r_associated | relid=0 | w=15
  7322. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrargyre
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyre | rel=r_associated | relid=0 | w=15
  7323. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydratase
    n1=Hyde (prurigo nodulaire de) | n2=hydratase | rel=r_associated | relid=0 | w=15
  7324. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydratation
    n1=Hyde (prurigo nodulaire de) | n2=hydratation | rel=r_associated | relid=0 | w=15
  7325. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydratation cutanée
    n1=Hyde (prurigo nodulaire de) | n2=hydratation cutanée | rel=r_associated | relid=0 | w=15
  7326. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrate
    n1=Hyde (prurigo nodulaire de) | n2=hydrate | rel=r_associated | relid=0 | w=15
  7327. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrate de carbone
    n1=Hyde (prurigo nodulaire de) | n2=hydrate de carbone | rel=r_associated | relid=0 | w=15
  7328. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrates de carbone
    n1=Hyde (prurigo nodulaire de) | n2=hydrates de carbone | rel=r_associated | relid=0 | w=15
  7329. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=hydrencéphalie | rel=r_associated | relid=0 | w=15
  7330. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrencéphalocèle
    n1=Hyde (prurigo nodulaire de) | n2=hydrencéphalocèle | rel=r_associated | relid=0 | w=15
  7331. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrine
    n1=Hyde (prurigo nodulaire de) | n2=hydrine | rel=r_associated | relid=0 | w=15
  7332. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydro-encéphalocèle
    n1=Hyde (prurigo nodulaire de) | n2=hydro-encéphalocèle | rel=r_associated | relid=0 | w=15
  7333. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydroa vacciniforme
    n1=Hyde (prurigo nodulaire de) | n2=hydroa vacciniforme | rel=r_associated | relid=0 | w=15
  7334. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydroadénome
    n1=Hyde (prurigo nodulaire de) | n2=hydroadénome | rel=r_associated | relid=0 | w=15
  7335. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrocalice
    n1=Hyde (prurigo nodulaire de) | n2=hydrocalice | rel=r_associated | relid=0 | w=15
  7336. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrocarboner
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarboner | rel=r_associated | relid=0 | w=15
  7337. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrocéphalie anencéphalique
    n1=Hyde (prurigo nodulaire de) | n2=hydrocéphalie anencéphalique | rel=r_associated | relid=0 | w=15
  7338. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrocéphalie postérieure
    n1=Hyde (prurigo nodulaire de) | n2=hydrocéphalie postérieure | rel=r_associated | relid=0 | w=15
  7339. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydrocéphalocèle
    n1=Hyde (prurigo nodulaire de) | n2=hydrocéphalocèle | rel=r_associated | relid=0 | w=15
  7340. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hydroencéphalocèle
    n1=Hyde (prurigo nodulaire de) | n2=hydroencéphalocèle | rel=r_associated | relid=0 | w=15
  7341. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> hypoplasie d'une partie de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=hypoplasie d'une partie de l'encéphale | rel=r_associated | relid=0 | w=15
  7342. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> index amniotique
    n1=Hyde (prurigo nodulaire de) | n2=index amniotique | rel=r_associated | relid=0 | w=15
  7343. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> interruption médicale de grossesse
    n1=Hyde (prurigo nodulaire de) | n2=interruption médicale de grossesse | rel=r_associated | relid=0 | w=15
  7344. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> intox
    n1=Hyde (prurigo nodulaire de) | n2=intox | rel=r_associated | relid=0 | w=15
  7345. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> inuline
    n1=Hyde (prurigo nodulaire de) | n2=inuline | rel=r_associated | relid=0 | w=15
  7346. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> lésion cutanée
    n1=Hyde (prurigo nodulaire de) | n2=lésion cutanée | rel=r_associated | relid=0 | w=15
  7347. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> lévulose
    n1=Hyde (prurigo nodulaire de) | n2=lévulose | rel=r_associated | relid=0 | w=15
  7348. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> liquide amniotique
    n1=Hyde (prurigo nodulaire de) | n2=liquide amniotique | rel=r_associated | relid=0 | w=15
  7349. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> liquide céphalo-rachidien
    n1=Hyde (prurigo nodulaire de) | n2=liquide céphalo-rachidien | rel=r_associated | relid=0 | w=15
  7350. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> lissencéphalie
    n1=Hyde (prurigo nodulaire de) | n2=lissencéphalie | rel=r_associated | relid=0 | w=15
  7351. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> lucite polymorphe
    n1=Hyde (prurigo nodulaire de) | n2=lucite polymorphe | rel=r_associated | relid=0 | w=15
  7352. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> macrocéphalie
    n1=Hyde (prurigo nodulaire de) | n2=macrocéphalie | rel=r_associated | relid=0 | w=15
  7353. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> maladie de Steinert
    n1=Hyde (prurigo nodulaire de) | n2=maladie de Steinert | rel=r_associated | relid=0 | w=15
  7354. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> maladie professionnelle
    n1=Hyde (prurigo nodulaire de) | n2=maladie professionnelle | rel=r_associated | relid=0 | w=15
  7355. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> malformation du système nerveux
    n1=Hyde (prurigo nodulaire de) | n2=malformation du système nerveux | rel=r_associated | relid=0 | w=15
  7356. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> malformations congénitales du corps calleux
    n1=Hyde (prurigo nodulaire de) | n2=malformations congénitales du corps calleux | rel=r_associated | relid=0 | w=15
  7357. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> masse molaire
    n1=Hyde (prurigo nodulaire de) | n2=masse molaire | rel=r_associated | relid=0 | w=15
  7358. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> microgyrie
    n1=Hyde (prurigo nodulaire de) | n2=microgyrie | rel=r_associated | relid=0 | w=15
  7359. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> minéral
    n1=Hyde (prurigo nodulaire de) | n2=minéral | rel=r_associated | relid=0 | w=15
  7360. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> molécule
    n1=Hyde (prurigo nodulaire de) | n2=molécule | rel=r_associated | relid=0 | w=15
  7361. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> nutriment
    n1=Hyde (prurigo nodulaire de) | n2=nutriment | rel=r_associated | relid=0 | w=15
  7362. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> ose
    n1=Hyde (prurigo nodulaire de) | n2=ose | rel=r_associated | relid=0 | w=15
  7363. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> oside
    n1=Hyde (prurigo nodulaire de) | n2=oside | rel=r_associated | relid=0 | w=15
  7364. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> pachygyrie
    n1=Hyde (prurigo nodulaire de) | n2=pachygyrie | rel=r_associated | relid=0 | w=15
  7365. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> pâtes
    n1=Hyde (prurigo nodulaire de) | n2=pâtes | rel=r_associated | relid=0 | w=15
  7366. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> pathologie de l'encéphale
    n1=Hyde (prurigo nodulaire de) | n2=pathologie de l'encéphale | rel=r_associated | relid=0 | w=15
  7367. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> plexus choroïdes
    n1=Hyde (prurigo nodulaire de) | n2=plexus choroïdes | rel=r_associated | relid=0 | w=15
  7368. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> poisson
    n1=Hyde (prurigo nodulaire de) | n2=poisson | rel=r_associated | relid=0 | w=15
  7369. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> polyamnios
    n1=Hyde (prurigo nodulaire de) | n2=polyamnios | rel=r_associated | relid=0 | w=15
  7370. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> polyholoside
    n1=Hyde (prurigo nodulaire de) | n2=polyholoside | rel=r_associated | relid=0 | w=15
  7371. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> polyhydramnios
    n1=Hyde (prurigo nodulaire de) | n2=polyhydramnios | rel=r_associated | relid=0 | w=15
  7372. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> polyoside
    n1=Hyde (prurigo nodulaire de) | n2=polyoside | rel=r_associated | relid=0 | w=15
  7373. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> pomme
    n1=Hyde (prurigo nodulaire de) | n2=pomme | rel=r_associated | relid=0 | w=15
  7374. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> pomme
    (fruit)
    n1=Hyde (prurigo nodulaire de) | n2=pomme
    (fruit)
    | rel=r_associated | relid=0 | w=15
  7375. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> posséder
    n1=Hyde (prurigo nodulaire de) | n2=posséder | rel=r_associated | relid=0 | w=15
  7376. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> produit alimentaire
    n1=Hyde (prurigo nodulaire de) | n2=produit alimentaire | rel=r_associated | relid=0 | w=15
  7377. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> prurigo aestival
    n1=Hyde (prurigo nodulaire de) | n2=prurigo aestival | rel=r_associated | relid=0 | w=15
  7378. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> prurigo aestivalis de Hutchinson
    n1=Hyde (prurigo nodulaire de) | n2=prurigo aestivalis de Hutchinson | rel=r_associated | relid=0 | w=15
  7379. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> prurigo des adolescents
    n1=Hyde (prurigo nodulaire de) | n2=prurigo des adolescents | rel=r_associated | relid=0 | w=15
  7380. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> prurigo estival
    n1=Hyde (prurigo nodulaire de) | n2=prurigo estival | rel=r_associated | relid=0 | w=15
  7381. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> recommandé : glucidique
    n1=Hyde (prurigo nodulaire de) | n2=recommandé : glucidique | rel=r_associated | relid=0 | w=15
  7382. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> rubéole
    n1=Hyde (prurigo nodulaire de) | n2=rubéole | rel=r_associated | relid=0 | w=15
  7383. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> saccharide
    n1=Hyde (prurigo nodulaire de) | n2=saccharide | rel=r_associated | relid=0 | w=15
  7384. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sans sucre
    n1=Hyde (prurigo nodulaire de) | n2=sans sucre | rel=r_associated | relid=0 | w=15
  7385. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> signe du flot
    n1=Hyde (prurigo nodulaire de) | n2=signe du flot | rel=r_associated | relid=0 | w=15
  7386. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> Spécialités médicales
    n1=Hyde (prurigo nodulaire de) | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
  7387. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> substance
    n1=Hyde (prurigo nodulaire de) | n2=substance | rel=r_associated | relid=0 | w=15
  7388. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> substance fondamentale
    n1=Hyde (prurigo nodulaire de) | n2=substance fondamentale | rel=r_associated | relid=0 | w=15
  7389. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sucre
    n1=Hyde (prurigo nodulaire de) | n2=sucre | rel=r_associated | relid=0 | w=15
  7390. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sucre simple
    n1=Hyde (prurigo nodulaire de) | n2=sucre simple | rel=r_associated | relid=0 | w=15
  7391. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sucre
    (chimie)
    n1=Hyde (prurigo nodulaire de) | n2=sucre
    (chimie)
    | rel=r_associated | relid=0 | w=15
  7392. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sucres
    n1=Hyde (prurigo nodulaire de) | n2=sucres | rel=r_associated | relid=0 | w=15
  7393. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> sugar
    n1=Hyde (prurigo nodulaire de) | n2=sugar | rel=r_associated | relid=0 | w=15
  7394. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> syndrome de Fraley
    n1=Hyde (prurigo nodulaire de) | n2=syndrome de Fraley | rel=r_associated | relid=0 | w=15
  7395. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> tocologie
    n1=Hyde (prurigo nodulaire de) | n2=tocologie | rel=r_associated | relid=0 | w=15
  7396. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> toxoplasmose
    n1=Hyde (prurigo nodulaire de) | n2=toxoplasmose | rel=r_associated | relid=0 | w=15
  7397. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> trisomie
    n1=Hyde (prurigo nodulaire de) | n2=trisomie | rel=r_associated | relid=0 | w=15
  7398. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> trisomie 13
    n1=Hyde (prurigo nodulaire de) | n2=trisomie 13 | rel=r_associated | relid=0 | w=15
  7399. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> type de glucide
    n1=Hyde (prurigo nodulaire de) | n2=type de glucide | rel=r_associated | relid=0 | w=15
  7400. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> uropathie obstructive
    n1=Hyde (prurigo nodulaire de) | n2=uropathie obstructive | rel=r_associated | relid=0 | w=15
  7401. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> UVA
    n1=Hyde (prurigo nodulaire de) | n2=UVA | rel=r_associated | relid=0 | w=15
  7402. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> vacciniforme
    n1=Hyde (prurigo nodulaire de) | n2=vacciniforme | rel=r_associated | relid=0 | w=15
  7403. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> végétaux
    n1=Hyde (prurigo nodulaire de) | n2=végétaux | rel=r_associated | relid=0 | w=15
  7404. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> viande
    n1=Hyde (prurigo nodulaire de) | n2=viande | rel=r_associated | relid=0 | w=15
  7405. Hyde (prurigo nodulaire de) -- r_associated #0: 15 / 0.195 -> vieilli
    n1=Hyde (prurigo nodulaire de) | n2=vieilli | rel=r_associated | relid=0 | w=15
  7406. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> -ase
    n1=Hyde (prurigo nodulaire de) | n2=-ase | rel=r_associated | relid=0 | w=10
  7407. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> amnios
    n1=Hyde (prurigo nodulaire de) | n2=amnios | rel=r_associated | relid=0 | w=10
  7408. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> carbure
    n1=Hyde (prurigo nodulaire de) | n2=carbure | rel=r_associated | relid=0 | w=10
  7409. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> dermatose vésiculobulleuse
    n1=Hyde (prurigo nodulaire de) | n2=dermatose vésiculobulleuse | rel=r_associated | relid=0 | w=10
  7410. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> déshydratase
    n1=Hyde (prurigo nodulaire de) | n2=déshydratase | rel=r_associated | relid=0 | w=10
  7411. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:17q21 microdeletion syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:17q21 microdeletion syndrome | rel=r_associated | relid=0 | w=10
  7412. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:22q telomere deletion syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:22q telomere deletion syndrome | rel=r_associated | relid=0 | w=10
  7413. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:5 alpha steroid reductase 2 deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:5 alpha steroid reductase 2 deficiency | rel=r_associated | relid=0 | w=10
  7414. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:abetalipoproteinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:abetalipoproteinemia | rel=r_associated | relid=0 | w=10
  7415. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acantholysis
    n1=Hyde (prurigo nodulaire de) | n2=en:acantholysis | rel=r_associated | relid=0 | w=10
  7416. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acatalasemia
    n1=Hyde (prurigo nodulaire de) | n2=en:acatalasemia | rel=r_associated | relid=0 | w=10
  7417. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:achenbach syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:achenbach syndrome | rel=r_associated | relid=0 | w=10
  7418. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:achromatopsia
    n1=Hyde (prurigo nodulaire de) | n2=en:achromatopsia | rel=r_associated | relid=0 | w=10
  7419. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acneiform dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:acneiform dermatitis | rel=r_associated | relid=0 | w=10
  7420. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acrocallosal syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:acrocallosal syndrome | rel=r_associated | relid=0 | w=10
  7421. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acrodermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:acrodermatitis | rel=r_associated | relid=0 | w=10
  7422. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acromegaly
    n1=Hyde (prurigo nodulaire de) | n2=en:acromegaly | rel=r_associated | relid=0 | w=10
  7423. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:acute intermittent porphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:acute intermittent porphyria | rel=r_associated | relid=0 | w=10
  7424. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:adenine phosphoribosyltransferase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:adenine phosphoribosyltransferase deficiency | rel=r_associated | relid=0 | w=10
  7425. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:agnosia
    n1=Hyde (prurigo nodulaire de) | n2=en:agnosia | rel=r_associated | relid=0 | w=10
  7426. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ainhum
    n1=Hyde (prurigo nodulaire de) | n2=en:ainhum | rel=r_associated | relid=0 | w=10
  7427. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:albright's hereditary osteodystrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:albright's hereditary osteodystrophy | rel=r_associated | relid=0 | w=10
  7428. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:allan-herndon-dudley syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:allan-herndon-dudley syndrome | rel=r_associated | relid=0 | w=10
  7429. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:allgrove syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:allgrove syndrome | rel=r_associated | relid=0 | w=10
  7430. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:alpha thalassemia x-linked mental retardation syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:alpha thalassemia x-linked mental retardation syndrome | rel=r_associated | relid=0 | w=10
  7431. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:amaurosis fugax
    n1=Hyde (prurigo nodulaire de) | n2=en:amaurosis fugax | rel=r_associated | relid=0 | w=10
  7432. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:analbuminemia
    n1=Hyde (prurigo nodulaire de) | n2=en:analbuminemia | rel=r_associated | relid=0 | w=10
  7433. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:anencephaly
    n1=Hyde (prurigo nodulaire de) | n2=en:anencephaly | rel=r_associated | relid=0 | w=10
  7434. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:aniridia
    n1=Hyde (prurigo nodulaire de) | n2=en:aniridia | rel=r_associated | relid=0 | w=10
  7435. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:aortic coarctation
    n1=Hyde (prurigo nodulaire de) | n2=en:aortic coarctation | rel=r_associated | relid=0 | w=10
  7436. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:arakawa syndrome ii
    n1=Hyde (prurigo nodulaire de) | n2=en:arakawa syndrome ii | rel=r_associated | relid=0 | w=10
  7437. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:argininosuccinic aciduria
    n1=Hyde (prurigo nodulaire de) | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=10
  7438. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:arrhythmogenic right ventricular dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:arrhythmogenic right ventricular dysplasia | rel=r_associated | relid=0 | w=10
  7439. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:atransferrinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:atransferrinemia | rel=r_associated | relid=0 | w=10
  7440. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:auditory perceptual disorder
    n1=Hyde (prurigo nodulaire de) | n2=en:auditory perceptual disorder | rel=r_associated | relid=0 | w=10
  7441. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:autosomal dominant optic atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:autosomal dominant optic atrophy | rel=r_associated | relid=0 | w=10
  7442. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:bartter syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:bartter syndrome | rel=r_associated | relid=0 | w=10
  7443. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:benign mucous membrane pemphigoid
    n1=Hyde (prurigo nodulaire de) | n2=en:benign mucous membrane pemphigoid | rel=r_associated | relid=0 | w=10
  7444. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:bernard-soulier syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:bernard-soulier syndrome | rel=r_associated | relid=0 | w=10
  7445. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:biotinidase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=10
  7446. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:brown-sequard syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:brown-sequard syndrome | rel=r_associated | relid=0 | w=10
  7447. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:bullous pemphigoid
    n1=Hyde (prurigo nodulaire de) | n2=en:bullous pemphigoid | rel=r_associated | relid=0 | w=10
  7448. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cadasil syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:cadasil syndrome | rel=r_associated | relid=0 | w=10
  7449. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:carbohydrate-deficient glycoprotein syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:carbohydrate-deficient glycoprotein syndrome | rel=r_associated | relid=0 | w=10
  7450. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:carnitine palmitoyltransferase ii deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:carnitine palmitoyltransferase ii deficiency | rel=r_associated | relid=0 | w=10
  7451. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:carnosinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:carnosinemia | rel=r_associated | relid=0 | w=10
  7452. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cartilage hair hypoplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:cartilage hair hypoplasia | rel=r_associated | relid=0 | w=10
  7453. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cataplexy
    n1=Hyde (prurigo nodulaire de) | n2=en:cataplexy | rel=r_associated | relid=0 | w=10
  7454. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cerebrooculofacioskeletal syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:cerebrooculofacioskeletal syndrome | rel=r_associated | relid=0 | w=10
  7455. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:charge syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:charge syndrome | rel=r_associated | relid=0 | w=10
  7456. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:chondrodysplasia punctata
    n1=Hyde (prurigo nodulaire de) | n2=en:chondrodysplasia punctata | rel=r_associated | relid=0 | w=10
  7457. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:choroideremia
    n1=Hyde (prurigo nodulaire de) | n2=en:choroideremia | rel=r_associated | relid=0 | w=10
  7458. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cleidocranial dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:cleidocranial dysplasia | rel=r_associated | relid=0 | w=10
  7459. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:coffin-lowry syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:coffin-lowry syndrome | rel=r_associated | relid=0 | w=10
  7460. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:combined lipase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:combined lipase deficiency | rel=r_associated | relid=0 | w=10
  7461. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:complex regional pain syndrome ii
    n1=Hyde (prurigo nodulaire de) | n2=en:complex regional pain syndrome ii | rel=r_associated | relid=0 | w=10
  7462. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:congenital bilateral aplasia of the vas deferens
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital bilateral aplasia of the vas deferens | rel=r_associated | relid=0 | w=10
  7463. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:congenital disorder of deglycosylation
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital disorder of deglycosylation | rel=r_associated | relid=0 | w=10
  7464. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:congenital fiber-type disproportion
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital fiber-type disproportion | rel=r_associated | relid=0 | w=10
  7465. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:congenital myasthenic syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital myasthenic syndrome | rel=r_associated | relid=0 | w=10
  7466. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:congenital structural myopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:congenital structural myopathy | rel=r_associated | relid=0 | w=10
  7467. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:contact dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:contact dermatitis | rel=r_associated | relid=0 | w=10
  7468. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cor triatriatum
    n1=Hyde (prurigo nodulaire de) | n2=en:cor triatriatum | rel=r_associated | relid=0 | w=10
  7469. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:craniofacial dysostosis
    n1=Hyde (prurigo nodulaire de) | n2=en:craniofacial dysostosis | rel=r_associated | relid=0 | w=10
  7470. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cryopyrin-associated periodic syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:cryopyrin-associated periodic syndrome | rel=r_associated | relid=0 | w=10
  7471. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cutis laxa
    n1=Hyde (prurigo nodulaire de) | n2=en:cutis laxa | rel=r_associated | relid=0 | w=10
  7472. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:cystinuria
    n1=Hyde (prurigo nodulaire de) | n2=en:cystinuria | rel=r_associated | relid=0 | w=10
  7473. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dandy-walker malformation
    n1=Hyde (prurigo nodulaire de) | n2=en:dandy-walker malformation | rel=r_associated | relid=0 | w=10
  7474. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:de sanctis-cacchione syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:de sanctis-cacchione syndrome | rel=r_associated | relid=0 | w=10
  7475. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:deafness, autosomal recessive 1a
    n1=Hyde (prurigo nodulaire de) | n2=en:deafness, autosomal recessive 1a | rel=r_associated | relid=0 | w=10
  7476. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:deafness, autosomal recessive 49
    n1=Hyde (prurigo nodulaire de) | n2=en:deafness, autosomal recessive 49 | rel=r_associated | relid=0 | w=10
  7477. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:deletion 18q syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:deletion 18q syndrome | rel=r_associated | relid=0 | w=10
  7478. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dentinogenesis imperfecta
    n1=Hyde (prurigo nodulaire de) | n2=en:dentinogenesis imperfecta | rel=r_associated | relid=0 | w=10
  7479. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitic reaction of face
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitic reaction of face | rel=r_associated | relid=0 | w=10
  7480. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis due to alkalis
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis due to alkalis | rel=r_associated | relid=0 | w=10
  7481. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis due to food taken internally
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis due to food taken internally | rel=r_associated | relid=0 | w=10
  7482. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis due to other specified substances taken internally
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis due to other specified substances taken internally | rel=r_associated | relid=0 | w=10
  7483. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis herpetiformis
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis herpetiformis | rel=r_associated | relid=0 | w=10
  7484. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis simplex erythematosa
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis simplex erythematosa | rel=r_associated | relid=0 | w=10
  7485. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatitis, atopic
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatitis, atopic | rel=r_associated | relid=0 | w=10
  7486. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dermatosis papulosa nigra
    n1=Hyde (prurigo nodulaire de) | n2=en:dermatosis papulosa nigra | rel=r_associated | relid=0 | w=10
  7487. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:diffuse cerebral sclerosis of schilder
    n1=Hyde (prurigo nodulaire de) | n2=en:diffuse cerebral sclerosis of schilder | rel=r_associated | relid=0 | w=10
  7488. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dihydropyrimidine dehydrogenase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:dihydropyrimidine dehydrogenase deficiency | rel=r_associated | relid=0 | w=10
  7489. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:drug- and toxin-induced pulmonary arterial hypertension
    n1=Hyde (prurigo nodulaire de) | n2=en:drug- and toxin-induced pulmonary arterial hypertension | rel=r_associated | relid=0 | w=10
  7490. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dubowitz syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:dubowitz syndrome | rel=r_associated | relid=0 | w=10
  7491. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:dyschromatosis symmetrica hereditaria
    n1=Hyde (prurigo nodulaire de) | n2=en:dyschromatosis symmetrica hereditaria | rel=r_associated | relid=0 | w=10
  7492. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ectodermal dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:ectodermal dysplasia | rel=r_associated | relid=0 | w=10
  7493. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ectromelia
    n1=Hyde (prurigo nodulaire de) | n2=en:ectromelia | rel=r_associated | relid=0 | w=10
  7494. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:eczema
    n1=Hyde (prurigo nodulaire de) | n2=en:eczema | rel=r_associated | relid=0 | w=10
  7495. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ellis-van creveld syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:ellis-van creveld syndrome | rel=r_associated | relid=0 | w=10
  7496. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:encephalocele
    n1=Hyde (prurigo nodulaire de) | n2=en:encephalocele | rel=r_associated | relid=0 | w=10
  7497. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:episodic pain syndrome, familial, 3
    n1=Hyde (prurigo nodulaire de) | n2=en:episodic pain syndrome, familial, 3 | rel=r_associated | relid=0 | w=10
  7498. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:erythema multiforme
    n1=Hyde (prurigo nodulaire de) | n2=en:erythema multiforme | rel=r_associated | relid=0 | w=10
  7499. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:erythroderma
    n1=Hyde (prurigo nodulaire de) | n2=en:erythroderma | rel=r_associated | relid=0 | w=10
  7500. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:erythromelalgia
    n1=Hyde (prurigo nodulaire de) | n2=en:erythromelalgia | rel=r_associated | relid=0 | w=10
  7501. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:erythropoietic protoporphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:erythropoietic protoporphyria | rel=r_associated | relid=0 | w=10
  7502. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:factor v leiden
    n1=Hyde (prurigo nodulaire de) | n2=en:factor v leiden | rel=r_associated | relid=0 | w=10
  7503. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:familial benign pemphigus
    n1=Hyde (prurigo nodulaire de) | n2=en:familial benign pemphigus | rel=r_associated | relid=0 | w=10
  7504. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:familial hypertrophic cardiomyopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:familial hypertrophic cardiomyopathy | rel=r_associated | relid=0 | w=10
  7505. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:familial mediterranean fever
    n1=Hyde (prurigo nodulaire de) | n2=en:familial mediterranean fever | rel=r_associated | relid=0 | w=10
  7506. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:familial periodic paralysis
    n1=Hyde (prurigo nodulaire de) | n2=en:familial periodic paralysis | rel=r_associated | relid=0 | w=10
  7507. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:fatal familial insomnia
    n1=Hyde (prurigo nodulaire de) | n2=en:fatal familial insomnia | rel=r_associated | relid=0 | w=10
  7508. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:felty syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:felty syndrome | rel=r_associated | relid=0 | w=10
  7509. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:fibrodysplasia ossificans progressiva
    n1=Hyde (prurigo nodulaire de) | n2=en:fibrodysplasia ossificans progressiva | rel=r_associated | relid=0 | w=10
  7510. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:focal dermal hypoplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:focal dermal hypoplasia | rel=r_associated | relid=0 | w=10
  7511. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:fragile x syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:fragile x syndrome | rel=r_associated | relid=0 | w=10
  7512. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:friedreich ataxia
    n1=Hyde (prurigo nodulaire de) | n2=en:friedreich ataxia | rel=r_associated | relid=0 | w=10
  7513. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:frontotemporal dementia
    n1=Hyde (prurigo nodulaire de) | n2=en:frontotemporal dementia | rel=r_associated | relid=0 | w=10
  7514. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:fuchs endothelial dystrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:fuchs endothelial dystrophy | rel=r_associated | relid=0 | w=10
  7515. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:gastric antral vascular ectasia
    n1=Hyde (prurigo nodulaire de) | n2=en:gastric antral vascular ectasia | rel=r_associated | relid=0 | w=10
  7516. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:generalized arterial calcification of infancy 1
    n1=Hyde (prurigo nodulaire de) | n2=en:generalized arterial calcification of infancy 1 | rel=r_associated | relid=0 | w=10
  7517. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:gerstmann-straussler-scheinker disease
    n1=Hyde (prurigo nodulaire de) | n2=en:gerstmann-straussler-scheinker disease | rel=r_associated | relid=0 | w=10
  7518. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:gitelman syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:gitelman syndrome | rel=r_associated | relid=0 | w=10
  7519. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:glucose-6-phosphate dehydrogenase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:glucose-6-phosphate dehydrogenase deficiency | rel=r_associated | relid=0 | w=10
  7520. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:glycine encephalopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:glycine encephalopathy | rel=r_associated | relid=0 | w=10
  7521. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:goldenhar syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:goldenhar syndrome | rel=r_associated | relid=0 | w=10
  7522. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:granulomatous dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:granulomatous dermatitis | rel=r_associated | relid=0 | w=10
  7523. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:griscelli syndrome type 2
    n1=Hyde (prurigo nodulaire de) | n2=en:griscelli syndrome type 2 | rel=r_associated | relid=0 | w=10
  7524. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:gyrate atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:gyrate atrophy | rel=r_associated | relid=0 | w=10
  7525. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hallermann syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:hallermann syndrome | rel=r_associated | relid=0 | w=10
  7526. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hard skin syndrome parana type
    n1=Hyde (prurigo nodulaire de) | n2=en:hard skin syndrome parana type | rel=r_associated | relid=0 | w=10
  7527. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hellp syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:hellp syndrome | rel=r_associated | relid=0 | w=10
  7528. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hemophagocytic lymphohistiocytosis
    n1=Hyde (prurigo nodulaire de) | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=10
  7529. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hepatolenticular degeneration
    n1=Hyde (prurigo nodulaire de) | n2=en:hepatolenticular degeneration | rel=r_associated | relid=0 | w=10
  7530. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hereditary coproporphyria
    n1=Hyde (prurigo nodulaire de) | n2=en:hereditary coproporphyria | rel=r_associated | relid=0 | w=10
  7531. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hereditary hyperbilirubinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:hereditary hyperbilirubinemia | rel=r_associated | relid=0 | w=10
  7532. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hereditary orotic aciduria
    n1=Hyde (prurigo nodulaire de) | n2=en:hereditary orotic aciduria | rel=r_associated | relid=0 | w=10
  7533. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:heritable pulmonary arterial hypertension
    n1=Hyde (prurigo nodulaire de) | n2=en:heritable pulmonary arterial hypertension | rel=r_associated | relid=0 | w=10
  7534. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:herpes simplex dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:herpes simplex dermatitis | rel=r_associated | relid=0 | w=10
  7535. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:heterotaxy syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:heterotaxy syndrome | rel=r_associated | relid=0 | w=10
  7536. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hmg-coa lyase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:hmg-coa lyase deficiency | rel=r_associated | relid=0 | w=10
  7537. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:holocarboxylase synthetase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=10
  7538. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:holt-oram syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:holt-oram syndrome | rel=r_associated | relid=0 | w=10
  7539. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hyaline membrane syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:hyaline membrane syndrome | rel=r_associated | relid=0 | w=10
  7540. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hydroa vacciniforme, familial
    n1=Hyde (prurigo nodulaire de) | n2=en:hydroa vacciniforme, familial | rel=r_associated | relid=0 | w=10
  7541. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hymenolepiasis
    n1=Hyde (prurigo nodulaire de) | n2=en:hymenolepiasis | rel=r_associated | relid=0 | w=10
  7542. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hyperkalemic periodic paralysis
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperkalemic periodic paralysis | rel=r_associated | relid=0 | w=10
  7543. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | rel=r_associated | relid=0 | w=10
  7544. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hypoalphalipoproteinemia
    n1=Hyde (prurigo nodulaire de) | n2=en:hypoalphalipoproteinemia | rel=r_associated | relid=0 | w=10
  7545. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:hypokalemic periodic paralysis
    n1=Hyde (prurigo nodulaire de) | n2=en:hypokalemic periodic paralysis | rel=r_associated | relid=0 | w=10
  7546. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ichthyosis
    n1=Hyde (prurigo nodulaire de) | n2=en:ichthyosis | rel=r_associated | relid=0 | w=10
  7547. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:idiopathic hypersomnolence
    n1=Hyde (prurigo nodulaire de) | n2=en:idiopathic hypersomnolence | rel=r_associated | relid=0 | w=10
  7548. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:immunoglobulin a deficiency 1
    n1=Hyde (prurigo nodulaire de) | n2=en:immunoglobulin a deficiency 1 | rel=r_associated | relid=0 | w=10
  7549. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:imperforate vagina
    n1=Hyde (prurigo nodulaire de) | n2=en:imperforate vagina | rel=r_associated | relid=0 | w=10
  7550. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:infantile neuroaxonal dystrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:infantile neuroaxonal dystrophy | rel=r_associated | relid=0 | w=10
  7551. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:inflammation dorsum of left foot
    n1=Hyde (prurigo nodulaire de) | n2=en:inflammation dorsum of left foot | rel=r_associated | relid=0 | w=10
  7552. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:iridocorneal endothelial syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:iridocorneal endothelial syndrome | rel=r_associated | relid=0 | w=10
  7553. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:jacobsen syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:jacobsen syndrome | rel=r_associated | relid=0 | w=10
  7554. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:jeune syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:jeune syndrome | rel=r_associated | relid=0 | w=10
  7555. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:juvenile x-linked retinoschisis
    n1=Hyde (prurigo nodulaire de) | n2=en:juvenile x-linked retinoschisis | rel=r_associated | relid=0 | w=10
  7556. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:kallmann syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:kallmann syndrome | rel=r_associated | relid=0 | w=10
  7557. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:kearns-sayre syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:kearns-sayre syndrome | rel=r_associated | relid=0 | w=10
  7558. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:keratodermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:keratodermatitis | rel=r_associated | relid=0 | w=10
  7559. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:kimura disease
    n1=Hyde (prurigo nodulaire de) | n2=en:kimura disease | rel=r_associated | relid=0 | w=10
  7560. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:klippel-feil syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:klippel-feil syndrome | rel=r_associated | relid=0 | w=10
  7561. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:kluver-bucy syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:kluver-bucy syndrome | rel=r_associated | relid=0 | w=10
  7562. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:korsakoff syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:korsakoff syndrome | rel=r_associated | relid=0 | w=10
  7563. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lafora disease
    n1=Hyde (prurigo nodulaire de) | n2=en:lafora disease | rel=r_associated | relid=0 | w=10
  7564. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lateral medullary syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:lateral medullary syndrome | rel=r_associated | relid=0 | w=10
  7565. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:leber hereditary optic atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:leber hereditary optic atrophy | rel=r_associated | relid=0 | w=10
  7566. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:leigh disease
    n1=Hyde (prurigo nodulaire de) | n2=en:leigh disease | rel=r_associated | relid=0 | w=10
  7567. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:leopard syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:leopard syndrome | rel=r_associated | relid=0 | w=10
  7568. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:leptospirosis
    n1=Hyde (prurigo nodulaire de) | n2=en:leptospirosis | rel=r_associated | relid=0 | w=10
  7569. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lesch-nyhan syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:lesch-nyhan syndrome | rel=r_associated | relid=0 | w=10
  7570. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:levocardia
    n1=Hyde (prurigo nodulaire de) | n2=en:levocardia | rel=r_associated | relid=0 | w=10
  7571. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lichen planus
    n1=Hyde (prurigo nodulaire de) | n2=en:lichen planus | rel=r_associated | relid=0 | w=10
  7572. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lichen sclerosus et atrophicus
    n1=Hyde (prurigo nodulaire de) | n2=en:lichen sclerosus et atrophicus | rel=r_associated | relid=0 | w=10
  7573. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lig4 syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:lig4 syndrome | rel=r_associated | relid=0 | w=10
  7574. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:linear iga bullous dermatosis
    n1=Hyde (prurigo nodulaire de) | n2=en:linear iga bullous dermatosis | rel=r_associated | relid=0 | w=10
  7575. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:long-chain acyl-coa dehydrogenase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:long-chain acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=10
  7576. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:lysosomal storage disease
    n1=Hyde (prurigo nodulaire de) | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=10
  7577. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:malakoplakia
    n1=Hyde (prurigo nodulaire de) | n2=en:malakoplakia | rel=r_associated | relid=0 | w=10
  7578. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:malignant atrophic papulosis
    n1=Hyde (prurigo nodulaire de) | n2=en:malignant atrophic papulosis | rel=r_associated | relid=0 | w=10
  7579. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mallory-weiss syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:mallory-weiss syndrome | rel=r_associated | relid=0 | w=10
  7580. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mansonelliasis
    n1=Hyde (prurigo nodulaire de) | n2=en:mansonelliasis | rel=r_associated | relid=0 | w=10
  7581. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:marburg virus disease
    n1=Hyde (prurigo nodulaire de) | n2=en:marburg virus disease | rel=r_associated | relid=0 | w=10
  7582. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:marshall syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:marshall syndrome | rel=r_associated | relid=0 | w=10
  7583. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:meckel-gruber syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:meckel-gruber syndrome | rel=r_associated | relid=0 | w=10
  7584. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:meesmann corneal dystrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:meesmann corneal dystrophy | rel=r_associated | relid=0 | w=10
  7585. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:melkersson-rosenthal syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:melkersson-rosenthal syndrome | rel=r_associated | relid=0 | w=10
  7586. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:meningeal tuberculosis
    n1=Hyde (prurigo nodulaire de) | n2=en:meningeal tuberculosis | rel=r_associated | relid=0 | w=10
  7587. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:merrf syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:merrf syndrome | rel=r_associated | relid=0 | w=10
  7588. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:methylmalonic acidemia
    n1=Hyde (prurigo nodulaire de) | n2=en:methylmalonic acidemia | rel=r_associated | relid=0 | w=10
  7589. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:microcephaly and chorioretinopathy, autosomal recessive, type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:microcephaly and chorioretinopathy, autosomal recessive, type 1 | rel=r_associated | relid=0 | w=10
  7590. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mitochondrial neurogastrointestingal encephalopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:mitochondrial neurogastrointestingal encephalopathy | rel=r_associated | relid=0 | w=10
  7591. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mixed connective tissue disease
    n1=Hyde (prurigo nodulaire de) | n2=en:mixed connective tissue disease | rel=r_associated | relid=0 | w=10
  7592. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mobius syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:mobius syndrome | rel=r_associated | relid=0 | w=10
  7593. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:monilethrix
    n1=Hyde (prurigo nodulaire de) | n2=en:monilethrix | rel=r_associated | relid=0 | w=10
  7594. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:moyamoya disease
    n1=Hyde (prurigo nodulaire de) | n2=en:moyamoya disease | rel=r_associated | relid=0 | w=10
  7595. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:mulibrey nanism
    n1=Hyde (prurigo nodulaire de) | n2=en:mulibrey nanism | rel=r_associated | relid=0 | w=10
  7596. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:multicentric osteolysis, nodulosis, and arthropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:multicentric osteolysis, nodulosis, and arthropathy | rel=r_associated | relid=0 | w=10
  7597. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:multiple system atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:multiple system atrophy | rel=r_associated | relid=0 | w=10
  7598. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:myhre syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:myhre syndrome | rel=r_associated | relid=0 | w=10
  7599. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:myositis
    n1=Hyde (prurigo nodulaire de) | n2=en:myositis | rel=r_associated | relid=0 | w=10
  7600. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:n-acetylglutamate synthase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:n-acetylglutamate synthase deficiency | rel=r_associated | relid=0 | w=10
  7601. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:nail-patella syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:nail-patella syndrome | rel=r_associated | relid=0 | w=10
  7602. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:neonatal progeroid syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:neonatal progeroid syndrome | rel=r_associated | relid=0 | w=10
  7603. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:nephrogenic fibrosing dermopathy
    n1=Hyde (prurigo nodulaire de) | n2=en:nephrogenic fibrosing dermopathy | rel=r_associated | relid=0 | w=10
  7604. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:neuroacanthocytosis
    n1=Hyde (prurigo nodulaire de) | n2=en:neuroacanthocytosis | rel=r_associated | relid=0 | w=10
  7605. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:neurodermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:neurodermatitis | rel=r_associated | relid=0 | w=10
  7606. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:neuronal intranuclear inclusion disease
    n1=Hyde (prurigo nodulaire de) | n2=en:neuronal intranuclear inclusion disease | rel=r_associated | relid=0 | w=10
  7607. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:neurotoxicity syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:neurotoxicity syndrome | rel=r_associated | relid=0 | w=10
  7608. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:norrie syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:norrie syndrome | rel=r_associated | relid=0 | w=10
  7609. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ochronosis
    n1=Hyde (prurigo nodulaire de) | n2=en:ochronosis | rel=r_associated | relid=0 | w=10
  7610. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:oeis complex
    n1=Hyde (prurigo nodulaire de) | n2=en:oeis complex | rel=r_associated | relid=0 | w=10
  7611. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:optic neuritis
    n1=Hyde (prurigo nodulaire de) | n2=en:optic neuritis | rel=r_associated | relid=0 | w=10
  7612. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:orofaciodigital syndrome type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:orofaciodigital syndrome type 1 | rel=r_associated | relid=0 | w=10
  7613. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:ossification of posterior longitudinal ligament
    n1=Hyde (prurigo nodulaire de) | n2=en:ossification of posterior longitudinal ligament | rel=r_associated | relid=0 | w=10
  7614. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:osteopetrosis with renal tubular acidosis
    n1=Hyde (prurigo nodulaire de) | n2=en:osteopetrosis with renal tubular acidosis | rel=r_associated | relid=0 | w=10
  7615. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:otopalatodigital syndrome type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:otopalatodigital syndrome type 1 | rel=r_associated | relid=0 | w=10
  7616. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pain agnosia
    n1=Hyde (prurigo nodulaire de) | n2=en:pain agnosia | rel=r_associated | relid=0 | w=10
  7617. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pallister-killian syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:pallister-killian syndrome | rel=r_associated | relid=0 | w=10
  7618. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pancreatic lipase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:pancreatic lipase deficiency | rel=r_associated | relid=0 | w=10
  7619. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:panuveitis
    n1=Hyde (prurigo nodulaire de) | n2=en:panuveitis | rel=r_associated | relid=0 | w=10
  7620. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:paragonimiasis
    n1=Hyde (prurigo nodulaire de) | n2=en:paragonimiasis | rel=r_associated | relid=0 | w=10
  7621. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pearson marrow-pancreas syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:pearson marrow-pancreas syndrome | rel=r_associated | relid=0 | w=10
  7622. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pelizaeus-merzbacher disease
    n1=Hyde (prurigo nodulaire de) | n2=en:pelizaeus-merzbacher disease | rel=r_associated | relid=0 | w=10
  7623. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pentalogy of cantrell
    n1=Hyde (prurigo nodulaire de) | n2=en:pentalogy of cantrell | rel=r_associated | relid=0 | w=10
  7624. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:perioral dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:perioral dermatitis | rel=r_associated | relid=0 | w=10
  7625. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:phosphoenolpyruvate carboxykinase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=10
  7626. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pick's disease
    n1=Hyde (prurigo nodulaire de) | n2=en:pick's disease | rel=r_associated | relid=0 | w=10
  7627. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pierre robin syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:pierre robin syndrome | rel=r_associated | relid=0 | w=10
  7628. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:piriformis muscle syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:piriformis muscle syndrome | rel=r_associated | relid=0 | w=10
  7629. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pityriasis rosea
    n1=Hyde (prurigo nodulaire de) | n2=en:pityriasis rosea | rel=r_associated | relid=0 | w=10
  7630. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:plague
    n1=Hyde (prurigo nodulaire de) | n2=en:plague | rel=r_associated | relid=0 | w=10
  7631. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:poland syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:poland syndrome | rel=r_associated | relid=0 | w=10
  7632. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:porokeratosis
    n1=Hyde (prurigo nodulaire de) | n2=en:porokeratosis | rel=r_associated | relid=0 | w=10
  7633. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:potocki-lupski syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:potocki-lupski syndrome | rel=r_associated | relid=0 | w=10
  7634. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:prekallikrein deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:prekallikrein deficiency | rel=r_associated | relid=0 | w=10
  7635. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:primary hypertrophic osteoarthropathy
    n1=Hyde (prurigo nodulaire de) | n2=en:primary hypertrophic osteoarthropathy | rel=r_associated | relid=0 | w=10
  7636. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:progeria
    n1=Hyde (prurigo nodulaire de) | n2=en:progeria | rel=r_associated | relid=0 | w=10
  7637. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:progressive muscular atrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:progressive muscular atrophy | rel=r_associated | relid=0 | w=10
  7638. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:prolidase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=10
  7639. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:proteus syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:proteus syndrome | rel=r_associated | relid=0 | w=10
  7640. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pseudoachondroplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudoachondroplasia | rel=r_associated | relid=0 | w=10
  7641. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pseudohypoaldosteronism
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudohypoaldosteronism | rel=r_associated | relid=0 | w=10
  7642. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pseudotumor cerebri
    n1=Hyde (prurigo nodulaire de) | n2=en:pseudotumor cerebri | rel=r_associated | relid=0 | w=10
  7643. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:psoriasiform dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:psoriasiform dermatitis | rel=r_associated | relid=0 | w=10
  7644. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:psoriasis
    n1=Hyde (prurigo nodulaire de) | n2=en:psoriasis | rel=r_associated | relid=0 | w=10
  7645. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pulmonary alveolar proteinosis
    n1=Hyde (prurigo nodulaire de) | n2=en:pulmonary alveolar proteinosis | rel=r_associated | relid=0 | w=10
  7646. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:pyruvate dehydrogenase deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:pyruvate dehydrogenase deficiency | rel=r_associated | relid=0 | w=10
  7647. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:radiation-induced dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:radiation-induced dermatitis | rel=r_associated | relid=0 | w=10
  7648. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:rash aggravated
    n1=Hyde (prurigo nodulaire de) | n2=en:rash aggravated | rel=r_associated | relid=0 | w=10
  7649. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:retinoschisis
    n1=Hyde (prurigo nodulaire de) | n2=en:retinoschisis | rel=r_associated | relid=0 | w=10
  7650. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:rhizomelic dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:rhizomelic dysplasia | rel=r_associated | relid=0 | w=10
  7651. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:russell-silver syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:russell-silver syndrome | rel=r_associated | relid=0 | w=10
  7652. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:scimitar syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:scimitar syndrome | rel=r_associated | relid=0 | w=10
  7653. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:scleromyxedema
    n1=Hyde (prurigo nodulaire de) | n2=en:scleromyxedema | rel=r_associated | relid=0 | w=10
  7654. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:seborrheic dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:seborrheic dermatitis | rel=r_associated | relid=0 | w=10
  7655. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:seborrheic dermatitis of scalp
    n1=Hyde (prurigo nodulaire de) | n2=en:seborrheic dermatitis of scalp | rel=r_associated | relid=0 | w=10
  7656. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:selective antibody deficiency with normal immunoglobulins
    n1=Hyde (prurigo nodulaire de) | n2=en:selective antibody deficiency with normal immunoglobulins | rel=r_associated | relid=0 | w=10
  7657. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:short rib-polydactyly syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:short rib-polydactyly syndrome | rel=r_associated | relid=0 | w=10
  7658. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:shprintzen-goldberg craniosynostosis syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:shprintzen-goldberg craniosynostosis syndrome | rel=r_associated | relid=0 | w=10
  7659. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:simpson golabi behmel syndrome type 1
    n1=Hyde (prurigo nodulaire de) | n2=en:simpson golabi behmel syndrome type 1 | rel=r_associated | relid=0 | w=10
  7660. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:sjogren-larsson syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:sjogren-larsson syndrome | rel=r_associated | relid=0 | w=10
  7661. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:skin diseases, vesiculobullous
    n1=Hyde (prurigo nodulaire de) | n2=en:skin diseases, vesiculobullous | rel=r_associated | relid=0 | w=10
  7662. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:smith-magenis syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:smith-magenis syndrome | rel=r_associated | relid=0 | w=10
  7663. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:spasmodic torticollis
    n1=Hyde (prurigo nodulaire de) | n2=en:spasmodic torticollis | rel=r_associated | relid=0 | w=10
  7664. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:spondyloepimetaphyseal dysplasia, sponastrime type
    n1=Hyde (prurigo nodulaire de) | n2=en:spondyloepimetaphyseal dysplasia, sponastrime type | rel=r_associated | relid=0 | w=10
  7665. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:spongiotic dermatitis
    n1=Hyde (prurigo nodulaire de) | n2=en:spongiotic dermatitis | rel=r_associated | relid=0 | w=10
  7666. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:stargardt disease
    n1=Hyde (prurigo nodulaire de) | n2=en:stargardt disease | rel=r_associated | relid=0 | w=10
  7667. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:stickler syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:stickler syndrome | rel=r_associated | relid=0 | w=10
  7668. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:stiff skin syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:stiff skin syndrome | rel=r_associated | relid=0 | w=10
  7669. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:sudden unexplained death in childhood
    n1=Hyde (prurigo nodulaire de) | n2=en:sudden unexplained death in childhood | rel=r_associated | relid=0 | w=10
  7670. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:sunct syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:sunct syndrome | rel=r_associated | relid=0 | w=10
  7671. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:surfactant protein deficiency
    n1=Hyde (prurigo nodulaire de) | n2=en:surfactant protein deficiency | rel=r_associated | relid=0 | w=10
  7672. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:swyer james syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:swyer james syndrome | rel=r_associated | relid=0 | w=10
  7673. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:syringomyelia
    n1=Hyde (prurigo nodulaire de) | n2=en:syringomyelia | rel=r_associated | relid=0 | w=10
  7674. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:tangier disease
    n1=Hyde (prurigo nodulaire de) | n2=en:tangier disease | rel=r_associated | relid=0 | w=10
  7675. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:thanatophoric dysplasia
    n1=Hyde (prurigo nodulaire de) | n2=en:thanatophoric dysplasia | rel=r_associated | relid=0 | w=10
  7676. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:thrombocytopenia 2
    n1=Hyde (prurigo nodulaire de) | n2=en:thrombocytopenia 2 | rel=r_associated | relid=0 | w=10
  7677. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:thyroid hormone resistance syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:thyroid hormone resistance syndrome | rel=r_associated | relid=0 | w=10
  7678. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:tolosa-hunt syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:tolosa-hunt syndrome | rel=r_associated | relid=0 | w=10
  7679. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:tracheobronchomalacia
    n1=Hyde (prurigo nodulaire de) | n2=en:tracheobronchomalacia | rel=r_associated | relid=0 | w=10
  7680. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:transient global amnesia
    n1=Hyde (prurigo nodulaire de) | n2=en:transient global amnesia | rel=r_associated | relid=0 | w=10
  7681. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:treacher collins syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:treacher collins syndrome | rel=r_associated | relid=0 | w=10
  7682. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:trichorhinophalangeal syndrome type i
    n1=Hyde (prurigo nodulaire de) | n2=en:trichorhinophalangeal syndrome type i | rel=r_associated | relid=0 | w=10
  7683. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:trichothiodystrophy
    n1=Hyde (prurigo nodulaire de) | n2=en:trichothiodystrophy | rel=r_associated | relid=0 | w=10
  7684. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:triploidy syndrome
    n1=Hyde (prurigo nodulaire de) | n2=en:triploidy syndrome | rel=r_associated | relid=0 | w=10
  7685. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:true hermaphroditism
    n1=Hyde (prurigo nodulaire de) | n2=en:true hermaphroditism | rel=r_associated | relid=0 | w=10
  7686. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:urticaria
    n1=Hyde (prurigo nodulaire de) | n2=en:urticaria | rel=r_associated | relid=0 | w=10
  7687. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> en:vesicular hand eczema
    n1=Hyde (prurigo nodulaire de) | n2=en:vesicular hand eczema | rel=r_associated | relid=0 | w=10
  7688. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> Hutchinson
    n1=Hyde (prurigo nodulaire de) | n2=Hutchinson | rel=r_associated | relid=0 | w=10
  7689. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> hydrargyririsme
    n1=Hyde (prurigo nodulaire de) | n2=hydrargyririsme | rel=r_associated | relid=0 | w=10
  7690. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> hydroa estival
    n1=Hyde (prurigo nodulaire de) | n2=hydroa estival | rel=r_associated | relid=0 | w=10
  7691. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> hydroas vacciniformes
    n1=Hyde (prurigo nodulaire de) | n2=hydroas vacciniformes | rel=r_associated | relid=0 | w=10
  7692. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> hydrocarburé
    n1=Hyde (prurigo nodulaire de) | n2=hydrocarburé | rel=r_associated | relid=0 | w=10
  7693. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> prurigo actinique (sud-américain)
    n1=Hyde (prurigo nodulaire de) | n2=prurigo actinique (sud-américain) | rel=r_associated | relid=0 | w=10
  7694. Hyde (prurigo nodulaire de) -- r_associated #0: 10 / 0.13 -> prurigo actinique de Hutchinson
    n1=Hyde (prurigo nodulaire de) | n2=prurigo actinique de Hutchinson | rel=r_associated | relid=0 | w=10
  7695. Hyde (prurigo nodulaire de) -- r_associated #0: 5 / 0.065 -> en:medicine
    n1=Hyde (prurigo nodulaire de) | n2=en:medicine | rel=r_associated | relid=0 | w=5
  7696. Hyde (prurigo nodulaire de) -- r_associated #0: 5 / 0.065 -> technique
    n1=Hyde (prurigo nodulaire de) | n2=technique | rel=r_associated | relid=0 | w=5
≈ 340 relations entrantes

  1. carbohydrate --- r_associated #0: 63 --> Hyde (prurigo nodulaire de)
    n1=carbohydrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=63
  2. en:carbohydrate --- r_associated #0: 56 --> Hyde (prurigo nodulaire de)
    n1=en:carbohydrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=56
  3. hydratase --- r_associated #0: 50 --> Hyde (prurigo nodulaire de)
    n1=hydratase | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=50
  4. glucide --- r_associated #0: 46 --> Hyde (prurigo nodulaire de)
    n1=glucide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=46
  5. en:hydrargyria --- r_associated #0: 45 --> Hyde (prurigo nodulaire de)
    n1=en:hydrargyria | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=45
  6. hydrargirose --- r_associated #0: 45 --> Hyde (prurigo nodulaire de)
    n1=hydrargirose | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=45
  7. en:hydratase --- r_associated #0: 44 --> Hyde (prurigo nodulaire de)
    n1=en:hydratase | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=44
  8. en:hydrargyrism --- r_associated #0: 41 --> Hyde (prurigo nodulaire de)
    n1=en:hydrargyrism | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=41
  9. en:hydrocarbon --- r_associated #0: 40 --> Hyde (prurigo nodulaire de)
    n1=en:hydrocarbon | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=40
  10. hydrargyrie --- r_associated #0: 40 --> Hyde (prurigo nodulaire de)
    n1=hydrargyrie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=40
  11. hydrocarbure --- r_associated #0: 40 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=40
  12. hydrocarbon --- r_associated #0: 37 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbon | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=37
  13. en:nodular prurigo --- r_associated #0: 35 --> Hyde (prurigo nodulaire de)
    n1=en:nodular prurigo | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=35
  14. prurigo nodulaire de Hyde --- r_associated #0: 35 --> Hyde (prurigo nodulaire de)
    n1=prurigo nodulaire de Hyde | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=35
  15. hydrargyrisme --- r_associated #0: 34 --> Hyde (prurigo nodulaire de)
    n1=hydrargyrisme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=34
  16. en:saccharide --- r_associated #0: 29 --> Hyde (prurigo nodulaire de)
    n1=en:saccharide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=29
  17. prurigo nodulaire de hyde --- r_associated #0: 29 --> Hyde (prurigo nodulaire de)
    n1=prurigo nodulaire de hyde | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=29
  18. Hydramnios --- r_associated #0: 27 --> Hyde (prurigo nodulaire de)
    n1=Hydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=27
  19. hydrate de carbone --- r_associated #0: 27 --> Hyde (prurigo nodulaire de)
    n1=hydrate de carbone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=27
  20. en:glucid --- r_associated #0: 26 --> Hyde (prurigo nodulaire de)
    n1=en:glucid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=26
  21. intoxication mercurielle --- r_associated #0: 26 --> Hyde (prurigo nodulaire de)
    n1=intoxication mercurielle | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=26
  22. en:hydrargyrirism --- r_associated #0: 25 --> Hyde (prurigo nodulaire de)
    n1=en:hydrargyrirism | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=25
  23. en:hydrase --- r_associated #0: 25 --> Hyde (prurigo nodulaire de)
    n1=en:hydrase | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=25
  24. hydrocarboné --- r_associated #0: 25 --> Hyde (prurigo nodulaire de)
    n1=hydrocarboné | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=25
  25. en:mercurialism --- r_associated #0: 24 --> Hyde (prurigo nodulaire de)
    n1=en:mercurialism | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=24
  26. en:hydrocarbon containing --- r_associated #0: 23 --> Hyde (prurigo nodulaire de)
    n1=en:hydrocarbon containing | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=23
  27. en:mercury poisoning --- r_associated #0: 22 --> Hyde (prurigo nodulaire de)
    n1=en:mercury poisoning | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=22
  28. en:hydrargyrisme --- r_associated #0: 21 --> Hyde (prurigo nodulaire de)
    n1=en:hydrargyrisme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=21
  29. hydroa vacciniforme --- r_associated #0: 21 --> Hyde (prurigo nodulaire de)
    n1=hydroa vacciniforme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=21
  30. 205-207 hydrocarbures --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=205-207 hydrocarbures | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  31. Arabie Saoudite --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Arabie Saoudite | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  32. Chimie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Chimie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  33. Erika --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Erika | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  34. Hyde --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Hyde | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  35. Hydrargyrie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Hydrargyrie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  36. Hydrocarbure --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Hydrocarbure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  37. Médecine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=Médecine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  38. biochimie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=biochimie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  39. bitume --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=bitume | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  40. brut --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=brut | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  41. butane --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=butane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  42. carbone --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=carbone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  43. carburant
    (Nom)
     --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=carburant
    (Nom)
    | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  44. chimie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=chimie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  45. chimie organique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=chimie organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  46. chymie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=chymie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  47. combustibilité --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=combustibilité | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  48. composé organique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=composé organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  49. cuisine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=cuisine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  50. cuisine
    (art culinaire)
     --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=cuisine
    (art culinaire)
    | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  51. effet toxique du mercure et ses composés --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=effet toxique du mercure et ses composés | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  52. en:1 carbon compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:1 carbon compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  53. en:2-ethyl-3-hydroxypropionate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:2-ethyl-3-hydroxypropionate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  54. en:2-hydroxybutyrate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:2-hydroxybutyrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  55. en:21-methyl-7-hentriacontanone --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:21-methyl-7-hentriacontanone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  56. en:5-acetoxy-19-methylnonacosane --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:5-acetoxy-19-methylnonacosane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  57. en:agonists --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:agonists | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  58. en:alcohol [chemical class] --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alcohol [chemical class] | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  59. en:alcohols, phenols, and ethers --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alcohols, phenols, and ethers | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  60. en:aldehyde --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aldehyde | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  61. en:aldehydes and ketones --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aldehydes and ketones | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  62. en:alicyclic compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alicyclic compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  63. en:alkaloid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alkaloid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  64. en:alkanes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alkanes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  65. en:alkenes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alkenes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  66. en:alkynes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alkynes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  67. en:alpha-hydroxyglutarate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:alpha-hydroxyglutarate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  68. en:amides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:amides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  69. en:amidines --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:amidines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  70. en:amine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:amine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  71. en:amino acid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:amino acid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  72. en:amino acid, peptide, or protein --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:amino acid, peptide, or protein | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  73. en:analysis aspect --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:analysis aspect | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  74. en:anhydrides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:anhydrides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  75. en:animal alkaloids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:animal alkaloids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  76. en:aromatic naphtha, type i --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aromatic naphtha, type i | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  77. en:aromex --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aromex | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  78. en:aspects of adverse effects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aspects of adverse effects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  79. en:aspects of radiation effects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aspects of radiation effects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  80. en:asphalt --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:asphalt | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  81. en:aza compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aza compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  82. en:aza compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:aza compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  83. en:azides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:azides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  84. en:azo compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:azo compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  85. en:biphosphonate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:biphosphonate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  86. en:boron compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:boron compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  87. en:carbamylhydrazine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carbamylhydrazine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  88. en:carbohydrate derivative --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carbohydrate derivative | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  89. en:carbon disulfide --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carbon disulfide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  90. en:carbonyl compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carbonyl compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  91. en:carboxylic acids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carboxylic acids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  92. en:carboxylic acids and derivatives --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carboxylic acids and derivatives | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  93. en:carpenter's kumylotox --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:carpenter's kumylotox | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  94. en:catenanes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:catenanes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  95. en:chemical aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:chemical aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  96. en:chemical synthesis --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:chemical synthesis | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  97. en:contraindications aspect --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:contraindications aspect | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  98. en:cyanates --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:cyanates | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  99. en:cyclic compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:cyclic compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  100. en:dioxamate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:dioxamate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  101. en:emulkop --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:emulkop | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  102. en:ethers --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:ethers | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  103. en:exposure as collected domain --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:exposure as collected domain | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  104. en:free radical --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:free radical | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  105. en:genetic aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:genetic aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  106. en:gilsonite --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:gilsonite | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  107. en:glycols and derivatives --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:glycols and derivatives | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  108. en:glycoside --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:glycoside | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  109. en:glycoside compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:glycoside compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  110. en:halocarbon compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:halocarbon compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  111. en:heterocyclic compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:heterocyclic compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  112. en:historical aspects qualifier --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:historical aspects qualifier | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  113. en:histosol --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:histosol | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  114. en:hydrazines --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:hydrazines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  115. en:hydrocarbons, cyclic --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:hydrocarbons, cyclic | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  116. en:imides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:imides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  117. en:imines --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:imines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  118. en:imino acids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:imino acids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  119. en:immunology aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:immunology aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  120. en:in blood --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:in blood | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  121. en:in cerebrospinal fluid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:in cerebrospinal fluid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  122. en:in urine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:in urine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  123. en:isocyanates --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:isocyanates | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  124. en:isopentane --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:isopentane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  125. en:isoprenoid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:isoprenoid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  126. en:jp4 aviation fuel --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:jp4 aviation fuel | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  127. en:jp8 aviation fuel --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:jp8 aviation fuel | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  128. en:ketone --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:ketone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  129. en:lactone compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:lactone compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  130. en:lewis acids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:lewis acids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  131. en:lewis bases --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:lewis bases | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  132. en:lipid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:lipid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  133. en:lipid or lipoprotein --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:lipid or lipoprotein | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  134. en:m-2000 compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:m-2000 compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  135. en:maleic acid --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:maleic acid | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  136. en:mechanism of action qualifier --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:mechanism of action qualifier | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  137. en:mesylates --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:mesylates | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  138. en:metabolic aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:metabolic aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  139. en:nitrate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  140. en:nitriles --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitriles | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  141. en:nitrites --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitrites | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  142. en:nitro compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitro compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  143. en:nitroarene compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitroarene compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  144. en:nitrogen compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitrogen compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  145. en:nitroso compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nitroso compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  146. en:nucleic acids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nucleic acids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  147. en:nucleic acids, nucleosides, and nucleotides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nucleic acids, nucleosides, and nucleotides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  148. en:nucleoside --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nucleoside | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  149. en:nucleotide --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:nucleotide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  150. en:onium compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:onium compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  151. en:organic acid (substance) --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic acid (substance) | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  152. en:organic acid or derivative --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic acid or derivative | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  153. en:organic base --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic base | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  154. en:organic boron compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic boron compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  155. en:organic chemical --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic chemical | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  156. en:organic chloride compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic chloride compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  157. en:organic ester --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic ester | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  158. en:organic halogen compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic halogen compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  159. en:organic nitrogen compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic nitrogen compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  160. en:organic oxide --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic oxide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  161. en:organic oxoacids --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic oxoacids | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  162. en:organic phosphate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic phosphate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  163. en:organic phosphorus and sulfur compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic phosphorus and sulfur compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  164. en:organic silicon compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic silicon compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  165. en:organic solvents --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic solvents | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  166. en:organic sulfur compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organic sulfur compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  167. en:organo-metallic, phosphorus, boron derivatives --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organo-metallic, phosphorus, boron derivatives | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  168. en:organochlorine compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organochlorine compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  169. en:organometallic compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organometallic compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  170. en:organophosphorus compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organophosphorus compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  171. en:organoselenium compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organoselenium compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  172. en:organosilicon compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:organosilicon compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  173. en:oxalate --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:oxalate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  174. en:paraffin --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:paraffin | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  175. en:paraphenylene --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:paraphenylene | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  176. en:petrolatum --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:petrolatum | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  177. en:pharmacokinetic aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:pharmacokinetic aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  178. en:phenol compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:phenol compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  179. en:poisoning aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:poisoning aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  180. en:polycyclic compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:polycyclic compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  181. en:polymethane --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:polymethane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  182. en:polyphenol --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:polyphenol | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  183. en:protein --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:protein | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  184. en:quinone compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:quinone compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  185. en:resorcin(4)arene receptor --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:resorcin(4)arene receptor | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  186. en:ring compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:ring compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  187. en:rotaxanes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:rotaxanes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  188. en:s-8 fuel --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:s-8 fuel | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  189. en:semicarbazides --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:semicarbazides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  190. en:simple organic compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:simple organic compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  191. en:solvent of abuse --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:solvent of abuse | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  192. en:standards characteristics --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:standards characteristics | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  193. en:steroid compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:steroid compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  194. en:sulfur compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:sulfur compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  195. en:synthetic monomer --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:synthetic monomer | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  196. en:synthetic polymer --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:synthetic polymer | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  197. en:taxonomic --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:taxonomic | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  198. en:technique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:technique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  199. en:therapeutic use - qualifier --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:therapeutic use - qualifier | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  200. en:toxicity aspects --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:toxicity aspects | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  201. en:triazene compound --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:triazene compound | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  202. en:urea --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:urea | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  203. en:vivonex --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:vivonex | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  204. en:volatile inhalant --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:volatile inhalant | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  205. en:volatile organic compounds --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=en:volatile organic compounds | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  206. essence --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=essence | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  207. explosion --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=explosion | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  208. fuel --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=fuel | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  209. glycoside --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=glycoside | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  210. golfe Persique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=golfe Persique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  211. goudron --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=goudron | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  212. huile --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=huile | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  213. hydrargie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrargie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  214. hydrargyrismes --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrargyrismes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  215. hydrargyrose --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrargyrose | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  216. hydrocarbone --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  217. hydrocarbure aromatique polycyclique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbure aromatique polycyclique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  218. hydrocarbure insaturé --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbure insaturé | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  219. hydrocarbure polycyclique aromatique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbure polycyclique aromatique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  220. hydrocarbure ramifié --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocarbure ramifié | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  221. hydrocéphalie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=hydrocéphalie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  222. incendie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=incendie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  223. intoxication --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=intoxication | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  224. intoxication au mercure --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=intoxication au mercure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  225. maladie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=maladie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  226. maladie de Minamata --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=maladie de Minamata | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  227. maladie de minamata --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=maladie de minamata | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  228. maladie
    (médecine)
     --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=maladie
    (médecine)
    | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  229. maladies --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=maladies | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  230. marée noire --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=marée noire | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  231. mercure --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=mercure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  232. mercure et ses composés --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=mercure et ses composés | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  233. mercurialisme --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=mercurialisme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  234. médecine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=médecine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  235. médecine
    (science)
     --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=médecine
    (science)
    | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  236. nodulaire --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=nodulaire | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  237. or noir --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=or noir | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  238. pathologie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=pathologie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  239. processus pathologique --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=processus pathologique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  240. protein --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=protein | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  241. proteine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=proteine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  242. protéine --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=protéine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  243. prurigo --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=prurigo | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  244. pétrole brut --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=pétrole brut | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  245. pétrolier --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=pétrolier | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  246. raffinage --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=raffinage | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  247. raffinerie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=raffinerie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  248. sans plomb 98 --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=sans plomb 98 | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  249. supertanker --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=supertanker | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  250. énergie --- r_associated #0: 20 --> Hyde (prurigo nodulaire de)
    n1=énergie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=20
  251. Chimie Organique --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=Chimie Organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  252. Hydrate de carbone --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=Hydrate de carbone | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  253. en protéines --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en protéines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  254. en:acute polyhydramnios --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:acute polyhydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  255. en:chronic polyhydramnios --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:chronic polyhydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  256. en:corneal hydration --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:corneal hydration | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  257. en:hydraencephaly --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydraencephaly | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  258. en:hydramnion --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydramnion | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  259. en:hydranencephaly --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydranencephaly | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  260. en:hydrencephalocele --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydrencephalocele | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  261. en:hydrencephaly --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydrencephaly | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  262. en:hydrin --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydrin | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  263. en:hydroa aestivalis --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydroa aestivalis | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  264. en:hydroa vacciniforme --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydroa vacciniforme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  265. en:hydrocalyx --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:hydrocalyx | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  266. en:polyhydramnion --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:polyhydramnion | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  267. en:skin hydration --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:skin hydration | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  268. en:summer prurigo --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:summer prurigo | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  269. en:the Persian Gulf --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=en:the Persian Gulf | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  270. glucagonome (syndrome du) --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=glucagonome (syndrome du) | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  271. hydramnios --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  272. hydramnios aigu --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydramnios aigu | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  273. hydramnios chronique --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydramnios chronique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  274. hydranencéphalie --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydranencéphalie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  275. hydratation cutanée --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydratation cutanée | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  276. hydrencéphalie --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydrencéphalie | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  277. hydrencéphalocèle --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydrencéphalocèle | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  278. hydrine --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydrine | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  279. hydroa --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydroa | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  280. hydroa aestivalis --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydroa aestivalis | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  281. hydroa vacciniforme de Bazin --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydroa vacciniforme de Bazin | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  282. hydroadénome --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydroadénome | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  283. hydrocalice --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=hydrocalice | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  284. isocyanates --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=isocyanates | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  285. produit chimique organique --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=produit chimique organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  286. prurigo aestivalis de Hutchinson --- r_associated #0: 15 --> Hyde (prurigo nodulaire de)
    n1=prurigo aestivalis de Hutchinson | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=15
  287. Arabie Séoudite --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Arabie Séoudite | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  288. Arabie séoudite --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Arabie séoudite | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  289. Carbohydrate --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Carbohydrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  290. Glucide --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Glucide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  291. Hydrargyrisme --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Hydrargyrisme | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  292. Maladie de Minamata --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=Maladie de Minamata | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  293. aldéhyde --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=aldéhyde | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  294. amides --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=amides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  295. anhydrides --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=anhydrides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  296. azides --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=azides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  297. biphosphonate --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=biphosphonate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  298. caténanes --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=caténanes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  299. composé chimique organique --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=composé chimique organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  300. cyanates --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=cyanates | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  301. en:Arabian Gulf --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:Arabian Gulf | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  302. en:black gold --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:black gold | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  303. en:carbon hydrate --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:carbon hydrate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  304. en:glucagonoma syndrome --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:glucagonoma syndrome | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  305. en:necrolytic migratory erythema --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:necrolytic migratory erythema | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  306. en:polyhydramnios --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:polyhydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  307. en:prurigo --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:prurigo | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  308. en:the Arabian Gulf --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=en:the Arabian Gulf | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  309. hydrazines --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=hydrazines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  310. hydroencéphalocèle --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=hydroencéphalocèle | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  311. imides --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=imides | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  312. intoxication par le mercure --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=intoxication par le mercure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  313. isopentane --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=isopentane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  314. lipide --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=lipide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  315. nitriles --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=nitriles | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  316. nitrites --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=nitrites | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  317. oxalate --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=oxalate | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  318. petrolatum --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=petrolatum | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  319. rotaxanes --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=rotaxanes | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  320. saccaride --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=saccaride | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  321. saccharide --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=saccharide | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  322. ventriculomégalie cérébrale --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=ventriculomégalie cérébrale | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  323. éthers --- r_associated #0: 10 --> Hyde (prurigo nodulaire de)
    n1=éthers | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=10
  324. Arabie saoudite --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Arabie saoudite | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  325. Chimie organique --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Chimie organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  326. Composé organique --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Composé organique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  327. Golfe Persique --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Golfe Persique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  328. Hydrocarbure aromatique polycyclique --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Hydrocarbure aromatique polycyclique | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  329. Intoxication au mercure --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Intoxication au mercure | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  330. Marée Noire --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Marée Noire | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  331. Marée noire --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Marée noire | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  332. Or Noir --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Or Noir | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  333. Prurigo --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Prurigo | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  334. Pétrole brut --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=Pétrole brut | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  335. amidines --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=amidines | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  336. en:cerebral ventriculomegaly --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=en:cerebral ventriculomegaly | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  337. en:ventriculomeglia --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=en:ventriculomeglia | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  338. glucane --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=glucane | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  339. glucidase --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=glucidase | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
  340. polyhydramnios --- r_associated #0: 5 --> Hyde (prurigo nodulaire de)
    n1=polyhydramnios | n2=Hyde (prurigo nodulaire de) | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr